ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
203282_at	1,4-alpha-glucan branching enzyme 1(GBE1)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006091~generation of precursor metabolites and energy,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003844~1,4-alpha-glucan branching enzyme activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0030246~carbohydrate binding,GO:0043169~cation binding,	IPR004193:Glycoside hydrolase, family 13, N-terminal,IPR006047:Glycosyl hydrolase, family 13, catalytic domain,IPR006048:Alpha-amylase, C-terminal all beta,IPR006407:1,4-alpha-glucan-branching enzyme,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013781:Glycoside hydrolase, catalytic domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015902:Glycoside hydrolase, family 13,IPR017853:Glycoside hydrolase, superfamily,	hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,	232500~Glycogen storage disease IV,263570~Polyglucosan body disease, adult form,	PIRSF000463:1,4-alpha-glucan branching enzyme,	SM00642:Aamy,	3D-structure,Acetylation,Complete proteome,Disease mutation,Glycogen biosynthesis,Glycogen storage disease,Glycosyltransferase,Neuropathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:1,4-alpha-glucan-branching enzyme,modified residue,sequence conflict,sequence variant,
215535_s_at, 32836_at	1-acylglycerol-3-phosphate O-acyltransferase 1(AGPAT1)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0001961~positive regulation of cytokine-mediated signaling pathway,GO:0006644~phospholipid metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005515~protein binding,	IPR002123:Phospholipid/glycerol acyltransferase,IPR004552:1-acyl-sn-glycerol-3-phosphate acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04975:Fat digestion and absorption,			SM00563:PlsC,	Acyltransferase,Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,sequence variant,short sequence motif:HXXXXD motif,transmembrane region,
210678_s_at, 32837_at	1-acylglycerol-3-phosphate O-acyltransferase 2(AGPAT2)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0001961~positive regulation of cytokine-mediated signaling pathway,GO:0006644~phospholipid metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0008152~metabolic process,GO:0008544~epidermis development,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Phospholipid/glycerol acyltransferase,IPR004552:1-acyl-sn-glycerol-3-phosphate acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04975:Fat digestion and absorption,	608594~Lipodystrophy, congenital generalized, type 1,		SM00563:PlsC,	Acyltransferase,Alternative splicing,Complete proteome,Congenital generalized lipodystrophy,Diabetes mellitus,Disease mutation,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:1-acyl-sn-glycerol-3-phosphate acyltransferase beta,modified residue,sequence conflict,sequence variant,short sequence motif:HXXXXD motif,splice variant,transmembrane region,
219723_x_at	1-acylglycerol-3-phosphate O-acyltransferase 3(AGPAT3)	Homo sapiens				GO:0006654~phosphatidic acid biosynthetic process,GO:0008152~metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0000139~Golgi membrane,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Phospholipid/glycerol acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00563:PlsC,	Acyltransferase,Alternative splicing,Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleus,Phospholipid biosynthesis,Phospholipid metabolism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:1-acyl-sn-glycerol-3-phosphate acyltransferase gamma,sequence conflict,short sequence motif:HXXXXD motif,splice variant,transmembrane region,
219693_at	1-acylglycerol-3-phosphate O-acyltransferase 4(AGPAT4)	Homo sapiens				GO:0006654~phosphatidic acid biosynthetic process,GO:0008152~metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005515~protein binding,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Phospholipid/glycerol acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00563:PlsC,	Acyltransferase,Alternative splicing,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:1-acyl-sn-glycerol-3-phosphate acyltransferase delta,short sequence motif:HXXXXD motif,transmembrane region,
218096_at	1-acylglycerol-3-phosphate O-acyltransferase 5(AGPAT5)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006639~acylglycerol metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0008152~metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005515~protein binding,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Phospholipid/glycerol acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00563:PlsC,	Acyltransferase,Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,Mitochondrion,Nucleus,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon,sequence conflict,sequence variant,short sequence motif:HXXXXD motif,transmembrane region,
208912_s_at	2',3'-cyclic nucleotide 3' phosphodiesterase(CNP)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007268~chemical synaptic transmission,GO:0007409~axonogenesis,GO:0007568~aging,GO:0008344~adult locomotory behavior,GO:0009214~cyclic nucleotide catabolic process,GO:0009636~response to toxic substance,GO:0021762~substantia nigra development,GO:0030900~forebrain development,GO:0032496~response to lipopolysaccharide,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048709~oligodendrocyte differentiation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0016020~membrane,GO:0031143~pseudopodium,GO:0035748~myelin sheath abaxonal region,GO:0035749~myelin sheath adaxonal region,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0004113~2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,GO:0030551~cyclic nucleotide binding,	IPR008431:Cyclic nucleotide phosphodiesterase,IPR009097:RNA ligase/cyclic nucleotide phosphodiesterase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF000970:2',3'-cyclic-nucleotide 3'-phosphodiesterase,		3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Hydrolase,Lipoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,RNA-binding,	active site:Proton acceptor,active site:Proton donor,binding site:Substrate,chain:2',3'-cyclic-nucleotide 3'- phosphodiesterase,helix,modified residue,sequence variant,splice variant,strand,turn,
202869_at, 205552_s_at	2'-5'-oligoadenylate synthetase 1(OAS1)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006955~immune response,GO:0009615~response to virus,GO:0035457~cellular response to interferon-alpha,GO:0042593~glucose homeostasis,GO:0045071~negative regulation of viral genome replication,GO:0051259~protein oligomerization,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060700~regulation of ribonuclease activity,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0001730~2'-5'-oligoadenylate synthetase activity,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR002934:Nucleotidyl transferase domain,IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006117:2-5-oligoadenylate synthetase, conserved site,IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal,IPR026774:2'-5'-oligoadenylate synthase,	hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	222100~Diabetes mellitus, type 1, susceptibility to,Viral infection, susceptibility to~Viral infection, susceptibility to,			3D-structure,Alternative splicing,Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Endoplasmic reticulum,Immunity,Innate immunity,Magnesium,Metal-binding,Microsome,Mitochondrion,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Secreted,Transferase,	chain:2'-5'-oligoadenylate synthetase 1,mutagenesis site,region of interest:Necessary for binding to dsRNA,sequence conflict,sequence variant,splice variant,
206553_at, 204972_at	2'-5'-oligoadenylate synthetase 2(OAS2)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006401~RNA catabolic process,GO:0006486~protein glycosylation,GO:0006955~immune response,GO:0009615~response to virus,GO:0018377~protein myristoylation,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0001730~2'-5'-oligoadenylate synthetase activity,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR002934:Nucleotidyl transferase domain,IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006117:2-5-oligoadenylate synthetase, conserved site,IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal,IPR026774:2'-5'-oligoadenylate synthase,	hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,				Acetylation,Alternative splicing,Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Immunity,Innate immunity,Lipoprotein,Magnesium,Metal-binding,Microsome,Mitochondrion,Myristate,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transferase,	chain:2'-5'-oligoadenylate synthetase 2,compositionally biased region:Pro-rich (linker),lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,region of interest:OAS domain 1,region of interest:OAS domain 2,sequence conflict,splice variant,
218400_at	2'-5'-oligoadenylate synthetase 3(OAS3)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006955~immune response,GO:0009615~response to virus,GO:0045071~negative regulation of viral genome replication,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060700~regulation of ribonuclease activity,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001730~2'-5'-oligoadenylate synthetase activity,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR002934:Nucleotidyl transferase domain,IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006117:2-5-oligoadenylate synthetase, conserved site,IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal,IPR026774:2'-5'-oligoadenylate synthase,	hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,				3D-structure,Acetylation,Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Immunity,Innate immunity,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transferase,Transmembrane,Transmembrane helix,	chain:2'-5'-oligoadenylate synthetase 3,modified residue,region of interest:Linker,region of interest:OAS domain 1,region of interest:OAS domain 2,region of interest:OAS domain 3,sequence conflict,sequence variant,
205660_at, 210797_s_at	2'-5'-oligoadenylate synthetase like(OASL)	Homo sapiens				GO:0009615~response to virus,GO:0045071~negative regulation of viral genome replication,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0001730~2'-5'-oligoadenylate synthetase activity,GO:0003677~DNA binding,GO:0003725~double-stranded RNA binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0046966~thyroid hormone receptor binding,	IPR000626:Ubiquitin,IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006117:2-5-oligoadenylate synthetase, conserved site,IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal,IPR026774:2'-5'-oligoadenylate synthase,				SM00213:UBQ,	3D-structure,Acetylation,Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Immunity,Innate immunity,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:59 kDa 2'-5'-oligoadenylate synthetase- like protein,domain:Ubiquitin-like 1,domain:Ubiquitin-like 2,helix,sequence conflict,sequence variant,splice variant,strand,turn,
39817_s_at, 213871_s_at, 204238_s_at	2'-deoxynucleoside 5'-phosphate N-hydrolase 1(DNPH1)	Homo sapiens				GO:0008283~cell proliferation,GO:0009116~nucleoside metabolic process,GO:0009117~nucleotide metabolic process,GO:0009159~deoxyribonucleoside monophosphate catabolic process,GO:0030307~positive regulation of cell growth,GO:0030855~epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0050144~nucleoside deoxyribosyltransferase activity,GO:0070694~deoxyribonucleoside 5'-monophosphate N-glycosidase activity,	IPR007710:Nucleoside 2-deoxyribosyltransferase,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Glycosidase,Hydrolase,Nucleotide metabolism,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	binding site:Substrate,chain:Deoxyribonucleoside 5'-monophosphate N- glycosidase,modified residue,
202447_at	2,4-dienoyl-CoA reductase 1, mitochondrial(DECR1)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0051289~protein homotetramerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0008670~2,4-dienoyl-CoA reductase (NADPH) activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0070402~NADPH binding,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Fatty acid metabolism,Lipid metabolism,Mitochondrion,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:2,4-dienoyl-CoA reductase, mitochondrial,helix,modified residue,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
219664_s_at	2,4-dienoyl-CoA reductase 2, peroxisomal(DECR2)	Homo sapiens				GO:0006636~unsaturated fatty acid biosynthetic process,GO:0044255~cellular lipid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005778~peroxisomal membrane,	GO:0005102~receptor binding,GO:0008670~2,4-dienoyl-CoA reductase (NADPH) activity,GO:0019166~trans-2-enoyl-CoA reductase (NADPH) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa04146:Peroxisome,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Fatty acid metabolism,Lipid metabolism,NADP,Oxidoreductase,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Peroxisomal 2,4-dienoyl-CoA reductase,modified residue,nucleotide phosphate-binding region:NADP,short sequence motif:Microbody targeting signal,splice variant,
212500_at, 212502_at	2-aminoethanethiol dioxygenase(ADO)	Homo sapiens				GO:0000098~sulfur amino acid catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0046872~metal ion binding,GO:0047800~cysteamine dioxygenase activity,	IPR011051:RmlC-like cupin domain,IPR012864:Cysteamine dioxygenase,IPR014710:RmlC-like jelly roll fold,	hsa00430:Taurine and hypotaurine metabolism,hsa01100:Metabolic pathways,				Complete proteome,Dioxygenase,Iron,Metal-binding,Oxidoreductase,Polymorphism,Reference proteome,	chain:2-aminoethanethiol dioxygenase,sequence variant,
221090_s_at	2-oxoglutarate and iron dependent oxygenase domain containing 1(OGFOD1)	Homo sapiens				GO:0006449~regulation of translational termination,GO:0008283~cell proliferation,GO:0018126~protein hydroxylation,GO:0019511~peptidyl-proline hydroxylation,GO:0034063~stress granule assembly,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,	GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,GO:0031543~peptidyl-proline dioxygenase activity,GO:0031544~peptidyl-proline 3-dioxygenase activity,	IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,IPR019601:Oxoglutarate/iron-dependent oxygenase, C-terminal degradation domain,				SM00702:P4Hc,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Vitamin C,	binding site:2-oxoglutarate,chain:2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1,domain:Fe2OG dioxygenase,metal ion-binding site:Iron,sequence conflict,sequence variant,splice variant,
219245_s_at, 219246_s_at, 44617_at	2-oxoglutarate and iron dependent oxygenase domain containing 2(OGFOD2)	Homo sapiens				GO:0055114~oxidation-reduction process,		GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0031418~L-ascorbic acid binding,GO:0051213~dioxygenase activity,	IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,				SM00702:P4Hc,	Alternative splicing,Complete proteome,Dioxygenase,Iron,Metal-binding,Oxidoreductase,Proteomics identification,Reference proteome,Vitamin C,	binding site:2-oxoglutarate,chain:2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,domain:Fe2OG dioxygenase,metal ion-binding site:Iron,sequence conflict,splice variant,
219254_at, 64438_at, 53071_s_at	2-oxoglutarate and iron dependent oxygenase domain containing 3(OGFOD3)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0031418~L-ascorbic acid binding,GO:0051213~dioxygenase activity,	IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,				SM00702:P4Hc,	Alternative splicing,Complete proteome,Dioxygenase,Glycoprotein,Iron,Membrane,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Vitamin C,	chain:PKHD domain-containing transmembrane protein C17orf101,domain:Fe2OG dioxygenase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200862_at	24-dehydrocholesterol reductase(DHCR24)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0009725~response to hormone,GO:0009888~tissue development,GO:0030539~male genitalia development,GO:0031639~plasminogen activation,GO:0033489~cholesterol biosynthetic process via desmosterol,GO:0033490~cholesterol biosynthetic process via lathosterol,GO:0042987~amyloid precursor protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043588~skin development,GO:0055114~oxidation-reduction process,GO:0061024~membrane organization,GO:1901214~regulation of neuron death,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000246~delta24(24-1) sterol reductase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0019899~enzyme binding,GO:0042605~peptide antigen binding,GO:0050614~delta24-sterol reductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR006094:FAD linked oxidase, N-terminal,IPR016166:FAD-binding, type 2,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,	602398~Desmosterolosis,			Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,FAD,Flavoprotein,Golgi apparatus,Lipid biosynthesis,Lipid metabolism,Membrane,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Signal,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:24-dehydrocholesterol reductase,domain:FAD-binding PCMH-type,modified residue,nucleotide phosphate-binding region:FAD,sequence variant,signal peptide,site:Cleavage; by caspase,transmembrane region,
219391_at	3'(2'), 5'-bisphosphate nucleotidase 1(BPNT1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0007399~nervous system development,GO:0016311~dephosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0008441~3'(2'),5'-bisphosphate nucleotidase activity,	IPR000760:Inositol monophosphatase,IPR020550:Inositol monophosphatase, conserved site,IPR020583:Inositol monophosphatase, metal-binding site,	hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Hydrolase,Lithium,Magnesium,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,	binding site:Substrate,chain:3'(2'),5'-bisphosphate nucleotidase 1,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 1; via carbonyl oxygen,metal ion-binding site:Magnesium 2,modified residue,region of interest:Substrate binding,sequence conflict,splice variant,strand,turn,
209043_at	3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPSS1)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0000103~sulfate assimilation,GO:0001501~skeletal system development,GO:0016310~phosphorylation,GO:0050428~3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,	GO:0005829~cytosol,	GO:0004020~adenylylsulfate kinase activity,GO:0004781~sulfate adenylyltransferase (ATP) activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,	IPR002650:Sulphate adenylyltransferase,IPR002891:Adenylylsulphate kinase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR015947:PUA-like domain,IPR024951:Sulphate adenylyltransferase catalytic domain,IPR025980:ATP-sulfurylase PUA-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa00450:Selenocompound metabolism,hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,ATP-binding,Complete proteome,Kinase,Multifunctional enzyme,Nucleotide-binding,Nucleotidyltransferase,Polymorphism,Reference proteome,Transferase,	active site:Phosphoserine intermediate,chain:Bifunctional 3'-phosphoadenosine 5'- phosphosulfate synthase 1,helix,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Adenylyl-sulfate kinase,region of interest:Sulfate adenylyltransferase,sequence conflict,sequence variant,short sequence motif:PP-motif,strand,turn,
203058_s_at, 203059_s_at, 203060_s_at	3'-phosphoadenosine 5'-phosphosulfate synthase 2(PAPSS2)	Homo sapiens				GO:0000103~sulfate assimilation,GO:0001501~skeletal system development,GO:0007596~blood coagulation,GO:0016310~phosphorylation,GO:0050428~3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,GO:0060348~bone development,	GO:0005829~cytosol,	GO:0004020~adenylylsulfate kinase activity,GO:0004781~sulfate adenylyltransferase (ATP) activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,	IPR002650:Sulphate adenylyltransferase,IPR002891:Adenylylsulphate kinase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR015947:PUA-like domain,IPR024951:Sulphate adenylyltransferase catalytic domain,IPR025980:ATP-sulfurylase PUA-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa00450:Selenocompound metabolism,hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	612847~Brachyolmia 4 with mild epiphyseal and metaphyseal changes,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Dwarfism,Kinase,Multifunctional enzyme,Nucleotide-binding,Nucleotidyltransferase,Polymorphism,Reference proteome,Transferase,	active site:Phosphoserine intermediate,chain:Bifunctional 3'-phosphoadenosine 5'- phosphosulfate synthase 2,helix,nucleotide phosphate-binding region:ATP,region of interest:Adenylyl-sulfate kinase,region of interest:Sulfate adenylyltransferase,sequence conflict,sequence variant,short sequence motif:PP-motif,splice variant,strand,turn,
202539_s_at, 202540_s_at	3-hydroxy-3-methylglutaryl-CoA reductase(HMGCR)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0006743~ubiquinone metabolic process,GO:0007568~aging,GO:0007584~response to nutrient,GO:0008299~isoprenoid biosynthetic process,GO:0008542~visual learning,GO:0010664~negative regulation of striated muscle cell apoptotic process,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0015936~coenzyme A metabolic process,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0043407~negative regulation of MAP kinase activity,GO:0045445~myoblast differentiation,GO:0045471~response to ethanol,GO:0045908~negative regulation of vasodilation,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051262~protein tetramerization,GO:0055114~oxidation-reduction process,GO:0061045~negative regulation of wound healing,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004420~hydroxymethylglutaryl-CoA reductase (NADPH) activity,GO:0005515~protein binding,GO:0042282~hydroxymethylglutaryl-CoA reductase activity,GO:0042803~protein homodimerization activity,GO:0050661~NADP binding,GO:0050662~coenzyme binding,GO:0051721~protein phosphatase 2A binding,GO:0070402~NADPH binding,	IPR000731:Sterol-sensing domain,IPR002202:Hydroxymethylglutaryl-CoA reductase, class I/II,IPR004554:Hydroxymethylglutaryl-CoA reductase, eukaryotic/arcaheal type,IPR004816:Hydroxymethylglutaryl-CoA reductase, metazoan,IPR009023:Hydroxymethylglutaryl-CoA reductase, class I/II, NAD/NADP-binding,IPR009029:Hydroxymethylglutaryl-CoA reductase, class I/II, substrate-binding,IPR023074:Hydroxymethylglutaryl-CoA reductase, class I/II, catalytic domain,IPR023076:Hydroxymethylglutaryl-CoA reductase, class I/II, conserved site,IPR023282:Hydroxymethylglutaryl-CoA reductase, N-terminal,	hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa04152:AMPK signaling pathway,hsa04976:Bile secretion,	Low density lipoprotein cholesterol level QTL 3~Low density lipoprotein cholesterol level QTL 3,Statins, attenuated cholesterol lowering by~Statins, attenuated cholesterol lowering by,			3D-structure,Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Endoplasmic reticulum,Glycoprotein,Isopeptide bond,Lipid biosynthesis,Lipid metabolism,Membrane,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,Ubl conjugation,	active site:Charge relay system,active site:Proton donor,chain:3-hydroxy-3-methylglutaryl-coenzyme A reductase,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Catalytic,region of interest:Linker,sequence variant,splice variant,strand,transmembrane region,turn,
205822_s_at, 221750_at	3-hydroxy-3-methylglutaryl-CoA synthase 1(HMGCS1)	Homo sapiens		h_s1pPathway:SREBP control of lipid synthesis,		GO:0001889~liver development,GO:0006629~lipid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0007420~brain development,GO:0008299~isoprenoid biosynthetic process,GO:0008584~male gonad development,GO:0009645~response to low light intensity stimulus,GO:0014074~response to purine-containing compound,GO:0033197~response to vitamin E,GO:0042493~response to drug,GO:0046690~response to tellurium ion,GO:0055094~response to lipoprotein particle,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0071397~cellular response to cholesterol,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004421~hydroxymethylglutaryl-CoA synthase activity,GO:0008144~drug binding,GO:0016853~isomerase activity,GO:0042803~protein homodimerization activity,GO:0043177~organic acid binding,	IPR000590:Hydroxymethylglutaryl-coenzyme A synthase, active site,IPR010122:Hydroxymethylglutaryl-CoA synthase, eukaryotic,IPR013528:Hydroxymethylglutaryl-coenzyme A synthase, N-terminal,IPR013746:Hydroxymethylglutaryl-coenzyme A synthase C-terminal,IPR016039:Thiolase-like,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				3D-structure,Acetylation,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Cytoplasm,Lipid biosynthesis,Lipid metabolism,Phosphoprotein,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transferase,	chain:Hydroxymethylglutaryl-CoA synthase, cytoplasmic,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
204607_at	3-hydroxy-3-methylglutaryl-CoA synthase 2(HMGCS2)	Homo sapiens				GO:0006695~cholesterol biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0046951~ketone body biosynthetic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0004421~hydroxymethylglutaryl-CoA synthase activity,	IPR000590:Hydroxymethylglutaryl-coenzyme A synthase, active site,IPR010122:Hydroxymethylglutaryl-CoA synthase, eukaryotic,IPR013528:Hydroxymethylglutaryl-coenzyme A synthase, N-terminal,IPR013746:Hydroxymethylglutaryl-coenzyme A synthase C-terminal,IPR016039:Thiolase-like,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	605911~HMG-CoA synthase-2 deficiency,			3D-structure,Acetylation,Alternative splicing,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Lipid biosynthesis,Lipid metabolism,Mitochondrion,Phosphoprotein,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transferase,Transit peptide,	chain:Hydroxymethylglutaryl-CoA synthase, mitochondrial,helix,modified residue,sequence variant,strand,transit peptide:Mitochondrion,turn,
219654_at	3-hydroxyacyl-CoA dehydratase 1(HACD1)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0007275~multicellular organism development,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0034622~cellular macromolecular complex assembly,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0071529~cementum mineralization,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,GO:0046848~hydroxyapatite binding,GO:0080023~3R-hydroxyacyl-CoA dehydratase activity,GO:0102344~3-hydroxy-behenoyl-CoA dehydratase activity,GO:0102345~3-hydroxy-lignoceroyl-CoA dehydratase activity,	IPR007482:Protein-tyrosine phosphatase-like, PTPLA,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Alternative splicing,Complete proteome,Developmental protein,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Lyase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein-tyrosine phosphatase-like member A,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
212640_at	3-hydroxyacyl-CoA dehydratase 2(HACD2)	Homo sapiens				GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,GO:0080023~3R-hydroxyacyl-CoA dehydratase activity,GO:0102344~3-hydroxy-behenoyl-CoA dehydratase activity,GO:0102345~3-hydroxy-lignoceroyl-CoA dehydratase activity,	IPR007482:Protein-tyrosine phosphatase-like, PTPLA,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Acetylation,Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Lyase,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein-tyrosine phosphatase-like member B,compositionally biased region:Poly-Gly,glycosylation site:N-linked (GlcNAc...),modified residue,transmembrane region,
217777_s_at	3-hydroxyacyl-CoA dehydratase 3(HACD3)	Homo sapiens				GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007257~activation of JUN kinase activity,GO:0007264~small GTPase mediated signal transduction,GO:0007266~Rho protein signal transduction,GO:0016601~Rac protein signal transduction,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0043547~positive regulation of GTPase activity,GO:0045070~positive regulation of viral genome replication,GO:0046726~positive regulation by virus of viral protein levels in host cell,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031965~nuclear membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,GO:0102344~3-hydroxy-behenoyl-CoA dehydratase activity,GO:0102345~3-hydroxy-lignoceroyl-CoA dehydratase activity,	IPR007052:CS-like domain,IPR007482:Protein-tyrosine phosphatase-like, PTPLA,IPR008978:HSP20-like chaperone,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Acetylation,Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Lyase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein tyrosine phosphatase-like protein PTPLAD1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Lys,domain:CS,modified residue,sequence conflict,sequence variant,transmembrane region,
205657_at	3-hydroxyanthranilate 3,4-dioxygenase(HAAO)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0010043~response to zinc ion,GO:0019805~quinolinate biosynthetic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0043420~anthranilate metabolic process,GO:0046686~response to cadmium ion,GO:0046874~quinolinate metabolic process,GO:0055114~oxidation-reduction process,GO:0070050~neuron cellular homeostasis,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0009055~electron carrier activity,	IPR010329:3-hydroxyanthranilic acid dioxygenase,IPR011051:RmlC-like cupin domain,IPR014710:RmlC-like jelly roll fold,IPR016700:3-hydroxyanthranilate 3, 4-dioxygenase, metazoan,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,		PIRSF017681:3-hydroxyanthranilate 3,4-dioxygenase, animal type,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Dioxygenase,Iron,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,	binding site:Dioxygen,binding site:Substrate,chain:3-hydroxyanthranilate 3,4-dioxygenase,helix,metal ion-binding site:Iron; catalytic,sequence variant,splice variant,strand,turn,
211715_s_at	3-hydroxybutyrate dehydrogenase, type 1(BDH1)	Homo sapiens				GO:0046951~ketone body biosynthetic process,GO:0046952~ketone body catabolic process,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0099617~matrix side of mitochondrial inner membrane,	GO:0003858~3-hydroxybutyrate dehydrogenase activity,GO:0016491~oxidoreductase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00072:Synthesis and degradation of ketone bodies,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,				Acetylation,Allosteric enzyme,Complete proteome,Glycoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	active site:Proton acceptor,binding site:Substrate,chain:D-beta-hydroxybutyrate dehydrogenase, mitochondrial,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,transit peptide:Mitochondrion,
218285_s_at	3-hydroxybutyrate dehydrogenase, type 2(BDH2)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0019290~siderophore biosynthetic process,GO:0030855~epithelial cell differentiation,GO:0042168~heme metabolic process,GO:0046951~ketone body biosynthetic process,GO:0055072~iron ion homeostasis,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003858~3-hydroxybutyrate dehydrogenase activity,GO:0008667~2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0051287~NAD binding,	IPR002347:Glucose/ribitol dehydrogenase,IPR003560:2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00072:Synthesis and degradation of ketone bodies,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:3-hydroxybutyrate dehydrogenase type 2,helix,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,splice variant,strand,turn,
203711_s_at, 213374_x_at	3-hydroxyisobutyryl-CoA hydrolase(HIBCH)	Homo sapiens			Lipid metabolism,	GO:0006574~valine catabolic process,GO:0006635~fatty acid beta-oxidation,GO:0009083~branched-chain amino acid catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0003860~3-hydroxyisobutyryl-CoA hydrolase activity,	IPR014748:Crontonase, C-terminal,	hsa00280:Valine, leucine and isoleucine degradation,hsa00410:beta-Alanine metabolism,hsa00640:Propanoate metabolism,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	250620~3-hydroxyisobutryl-CoA hydrolase deficiency,			3D-structure,Acetylation,Alternative splicing,Branched-chain amino acid catabolism,Complete proteome,Disease mutation,Hydrolase,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:3-hydroxyisobutyryl-CoA hydrolase, mitochondrial,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
202772_at	3-hydroxymethyl-3-methylglutaryl-CoA lyase(HMGCL)	Homo sapiens				GO:0001889~liver development,GO:0006552~leucine catabolic process,GO:0006629~lipid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0007005~mitochondrion organization,GO:0007584~response to nutrient,GO:0042594~response to starvation,GO:0046951~ketone body biosynthetic process,GO:0051262~protein tetramerization,GO:0070542~response to fatty acid,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,	GO:0000062~fatty-acyl-CoA binding,GO:0000287~magnesium ion binding,GO:0004419~hydroxymethylglutaryl-CoA lyase activity,GO:0005102~receptor binding,GO:0016829~lyase activity,GO:0030145~manganese ion binding,GO:0031406~carboxylic acid binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000138:Hydroxymethylglutaryl-CoA lyase, active site,IPR000891:Pyruvate carboxyltransferase,IPR013785:Aldolase-type TIM barrel,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	246450~HMG-CoA lyase deficiency,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Lyase,Metal-binding,Mitochondrion,Peroxisome,Proteomics identification,Reference proteome,Transit peptide,	binding site:Substrate,chain:Hydroxymethylglutaryl-CoA lyase, mitochondrial,helix,metal ion-binding site:Divalent metal cation,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
202419_at, 222359_x_at	3-ketodihydrosphingosine reductase(KDSR)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism / General function prediction only,	GO:0006666~3-keto-sphinganine metabolic process,GO:0030148~sphingolipid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0016491~oxidoreductase activity,GO:0047560~3-dehydrosphinganine reductase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,	Lymphoma/leukemia, B-cell, variant~Lymphoma/leukemia, B-cell, variant,			Alternative splicing,Chromosomal rearrangement,Complete proteome,Endoplasmic reticulum,Lipid metabolism,Membrane,NADP,Oxidoreductase,Proteomics identification,Proto-oncogene,Reference proteome,Signal,Sphingolipid metabolism,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:Substrate,chain:3-ketodihydrosphingosine reductase,nucleotide phosphate-binding region:NADP,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
202780_at	3-oxoacid CoA-transferase 1(OXCT1)	Homo sapiens			Lipid metabolism,	GO:0007420~brain development,GO:0007507~heart development,GO:0007584~response to nutrient,GO:0008152~metabolic process,GO:0009725~response to hormone,GO:0014823~response to activity,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042182~ketone catabolic process,GO:0042493~response to drug,GO:0042594~response to starvation,GO:0045471~response to ethanol,GO:0046950~cellular ketone body metabolic process,GO:0046952~ketone body catabolic process,GO:0060612~adipose tissue development,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,GO:0042803~protein homodimerization activity,	IPR004163:Coenzyme A transferase binding site,IPR004164:Coenzyme A transferase active site,IPR004165:Coenzyme A transferase family I,IPR012791:3-oxoacid CoA-transferase, subunit B,IPR012792:3-oxoacid CoA-transferase, subunit A,IPR014388:3-oxoacid CoA-transferase,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,	245050~Succinyl CoA:3-oxoacid CoA transferase deficiency,	PIRSF000858:3-oxoacid CoA-transferase,	SM00882:SM00882,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transit peptide,	chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial,helix,region of interest:CoA-binding,sequence variant,strand,transit peptide:Mitochondrion,turn,
220256_s_at	3-oxoacid CoA-transferase 2(OXCT2)	Homo sapiens			Lipid metabolism,	GO:0008152~metabolic process,GO:0046952~ketone body catabolic process,	GO:0005739~mitochondrion,GO:0031514~motile cilium,	GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,	IPR004163:Coenzyme A transferase binding site,IPR004164:Coenzyme A transferase active site,IPR004165:Coenzyme A transferase family I,IPR012791:3-oxoacid CoA-transferase, subunit B,IPR012792:3-oxoacid CoA-transferase, subunit A,IPR014388:3-oxoacid CoA-transferase,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,		PIRSF000858:3-oxoacid CoA-transferase,	SM00882:SM00882,	Complete proteome,Mitochondrion,Polymorphism,Reference proteome,Transferase,Transit peptide,	chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial,region of interest:CoA-binding,sequence conflict,sequence variant,transit peptide:Mitochondrion,
219133_at	3-oxoacyl-ACP synthase, mitochondrial(OXSM)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0006637~acyl-CoA metabolic process,GO:0008152~metabolic process,GO:0051790~short-chain fatty acid biosynthetic process,GO:0051792~medium-chain fatty acid biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0004315~3-oxoacyl-[acyl-carrier-protein] synthase activity,	IPR014030:Beta-ketoacyl synthase, N-terminal,IPR014031:Beta-ketoacyl synthase, C-terminal,IPR016039:Thiolase-like,IPR017568:3-oxoacyl-[acyl-carrier-protein] synthase 2,IPR018201:Beta-ketoacyl synthase, active site,IPR020841:Polyketide synthase, beta-ketoacyl synthase domain,	hsa00061:Fatty acid biosynthesis,hsa00780:Biotin metabolism,hsa01100:Metabolic pathways,hsa01212:Fatty acid metabolism,		PIRSF000447:3-oxoacyl-[acyl-carrier-protein] synthase,	SM00825:SM00825,	3D-structure,Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial,helix,modified residue,sequence variant,strand,transit peptide:Mitochondrion,turn,
204524_at, 221244_s_at, 32029_at	3-phosphoinositide dependent protein kinase 1(PDPK1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,83.Growth_factors_Survival_factors_Mitogens,	h_aktPathway:AKT Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_mtorPathway:mTOR Signaling Pathway,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,		GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0003323~type B pancreatic cell development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006972~hyperosmotic response,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0010518~positive regulation of phospholipase activity,GO:0010594~regulation of endothelial cell migration,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0016477~cell migration,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0019722~calcium-mediated signaling,GO:0030036~actin cytoskeleton organization,GO:0030168~platelet activation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031295~T cell costimulation,GO:0032148~activation of protein kinase B activity,GO:0032869~cellular response to insulin stimulus,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0035556~intracellular signal transduction,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043304~regulation of mast cell degranulation,GO:0043524~negative regulation of neuron apoptotic process,GO:0046777~protein autophosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048041~focal adhesion assembly,GO:0050852~T cell receptor signaling pathway,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0097191~extrinsic apoptotic signaling pathway,GO:1990416~cellular response to brain-derived neurotrophic factor stimulus,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0042995~cell projection,GO:0043204~perikaryon,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004676~3-phosphoinositide-dependent protein kinase activity,GO:0005158~insulin receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016004~phospholipase activator activity,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0043274~phospholipase binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,	hsa03320:PPAR signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04510:Focal adhesion,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04931:Insulin resistance,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05205:Proteoglycans in cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05223:Non-small cell lung cancer,hsa05231:Choline metabolism in cancer,			SM00220:S_TKc,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:3-phosphoinositide-dependent protein kinase 1,compositionally biased region:Poly-Ser,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,splice variant,strand,turn,
209460_at, 206527_at, 209459_s_at	4-aminobutyrate aminotransferase(ABAT)	Homo sapiens				GO:0001666~response to hypoxia,GO:0007568~aging,GO:0007620~copulation,GO:0007626~locomotory behavior,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0009449~gamma-aminobutyric acid biosynthetic process,GO:0009450~gamma-aminobutyric acid catabolic process,GO:0010039~response to iron ion,GO:0014053~negative regulation of gamma-aminobutyric acid secretion,GO:0021549~cerebellum development,GO:0031652~positive regulation of heat generation,GO:0032024~positive regulation of insulin secretion,GO:0033602~negative regulation of dopamine secretion,GO:0035094~response to nicotine,GO:0035640~exploration behavior,GO:0042135~neurotransmitter catabolic process,GO:0042493~response to drug,GO:0045471~response to ethanol,GO:0045776~negative regulation of blood pressure,GO:0045964~positive regulation of dopamine metabolic process,GO:0048148~behavioral response to cocaine,GO:0070474~positive regulation of uterine smooth muscle contraction,GO:0090331~negative regulation of platelet aggregation,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:1902722~positive regulation of prolactin secretion,GO:1904450~positive regulation of aspartate secretion,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0032144~4-aminobutyrate transaminase complex,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0003867~4-aminobutyrate transaminase activity,GO:0008483~transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0032145~succinate-semialdehyde dehydrogenase binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0047298~(S)-3-amino-2-methylpropionate transaminase activity,GO:0051536~iron-sulfur cluster binding,	IPR004631:4-aminobutyrate aminotransferase, eukaryotic,IPR005814:Aminotransferase class-III,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00280:Valine, leucine and isoleucine degradation,hsa00410:beta-Alanine metabolism,hsa00640:Propanoate metabolism,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04727:GABAergic synapse,	613163~GABA-transaminase deficiency,	PIRSF000521:4-aminobutyrate/lysine/ornithine transaminase,		Acetylation,Aminotransferase,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Iron,Iron-sulfur,Metal-binding,Mitochondrion,Neurotransmitter degradation,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Signal,Transferase,Transit peptide,	chain:4-aminobutyrate aminotransferase, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
206024_at	4-hydroxyphenylpyruvate dioxygenase(HPD)	Homo sapiens				GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0055114~oxidation-reduction process,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003868~4-hydroxyphenylpyruvate dioxygenase activity,GO:0046872~metal ion binding,	IPR004360:Glyoxalase/fosfomycin resistance/dioxygenase domain,IPR005956:4-hydroxyphenylpyruvate dioxygenase,	hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis,hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,hsa01100:Metabolic pathways,	140350~Hawkinsinuria,276710~Tyrosinemia, type III,	PIRSF009283:4-hydroxyphenylpyruvate dioxygenase,		3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Dioxygenase,Disease mutation,Iron,Mental retardation,Metal-binding,Oxidoreductase,Phenylalanine catabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tyrosine catabolism,	chain:4-hydroxyphenylpyruvate dioxygenase,helix,metal ion-binding site:Iron,modified residue,sequence conflict,sequence variant,strand,turn,
219214_s_at	5', 3'-nucleotidase, cytosolic(NT5C)	Homo sapiens				GO:0006195~purine nucleotide catabolic process,GO:0009223~pyrimidine deoxyribonucleotide catabolic process,GO:0009264~deoxyribonucleotide catabolic process,GO:0016311~dephosphorylation,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0008252~nucleotidase activity,GO:0008253~5'-nucleotidase activity,GO:0019103~pyrimidine nucleotide binding,GO:0046872~metal ion binding,	IPR010708:5'(3')-deoxyribonucleotidase,IPR023214:HAD-like domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Magnesium,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,binding site:Phosphate,binding site:Substrate,chain:5'(3')-deoxyribonucleotidase, cytosolic type,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,sequence variant,splice variant,strand,turn,
219708_at	5',3'-nucleotidase, mitochondrial(NT5M)	Homo sapiens				GO:0006260~DNA replication,GO:0009223~pyrimidine deoxyribonucleotide catabolic process,GO:0009264~deoxyribonucleotide catabolic process,GO:0016311~dephosphorylation,GO:0046079~dUMP catabolic process,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000166~nucleotide binding,GO:0008252~nucleotidase activity,GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR010708:5'(3')-deoxyribonucleotidase,IPR023214:HAD-like domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				3D-structure,Complete proteome,Hydrolase,Magnesium,Metal-binding,Mitochondrion,Nucleotide metabolism,Nucleotide-binding,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,binding site:Phosphate,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:5'(3')-deoxyribonucleotidase, mitochondrial,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,strand,transit peptide:Mitochondrion,turn,
205633_s_at	5'-aminolevulinate synthase 1(ALAS1)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,		GO:0006778~porphyrin-containing compound metabolic process,GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0007005~mitochondrion organization,GO:0009058~biosynthetic process,GO:0033014~tetrapyrrole biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003824~catalytic activity,GO:0003870~5-aminolevulinate synthase activity,GO:0005515~protein binding,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,	IPR001917:Aminotransferase, class-II, pyridoxal-phosphate binding site,IPR004839:Aminotransferase, class I/classII,IPR010961:Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase,IPR015118:5-aminolevulinate synthase presequence,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00260:Glycine, serine and threonine metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,				Acyltransferase,Alternative splicing,Complete proteome,Heme biosynthesis,Mitochondrion,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	chain:5-aminolevulinate synthase, nonspecific, mitochondrial,modified residue,sequence conflict,splice variant,transit peptide:Mitochondrion,
211560_s_at	5'-aminolevulinate synthase 2(ALAS2)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,	Posttranslational modification, protein turnover, chaperones,	GO:0001666~response to hypoxia,GO:0006778~porphyrin-containing compound metabolic process,GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006879~cellular iron ion homeostasis,GO:0009058~biosynthetic process,GO:0030218~erythrocyte differentiation,GO:0032364~oxygen homeostasis,GO:0042541~hemoglobin biosynthetic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0003824~catalytic activity,GO:0003870~5-aminolevulinate synthase activity,GO:0005515~protein binding,GO:0016594~glycine binding,GO:0030170~pyridoxal phosphate binding,GO:0050662~coenzyme binding,	IPR001917:Aminotransferase, class-II, pyridoxal-phosphate binding site,IPR004839:Aminotransferase, class I/classII,IPR010961:Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase,IPR015118:5-aminolevulinate synthase presequence,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00260:Glycine, serine and threonine metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,	300751~Anemia, sideroblastic, X-linked,300752~Protoporphyria, erythropoietic, X-linked,			Acyltransferase,Alternative splicing,Complete proteome,Disease mutation,Heme biosynthesis,Mitochondrion,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	chain:5-aminolevulinate synthase, erythroid- specific, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
218051_s_at	5'-nucleotidase domain containing 2(NT5DC2)	Homo sapiens				GO:0016311~dephosphorylation,		GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,		Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 2,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,sequence conflict,sequence variant,splice variant,
218786_at	5'-nucleotidase domain containing 3(NT5DC3)	Homo sapiens				GO:0016311~dephosphorylation,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043235~receptor complex,	GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,		Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 3,compositionally biased region:Poly-Ala,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,region of interest:Substrate binding,sequence variant,splice variant,
203939_at	5'-nucleotidase ecto(NT5E)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006195~purine nucleotide catabolic process,GO:0006196~AMP catabolic process,GO:0006259~DNA metabolic process,GO:0007159~leukocyte cell-cell adhesion,GO:0009166~nucleotide catabolic process,GO:0016311~dephosphorylation,GO:0046086~adenosine biosynthetic process,GO:0046135~pyrimidine nucleoside catabolic process,GO:0050728~negative regulation of inflammatory response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0008253~5'-nucleotidase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR006146:5'-Nucleotidase, conserved site,IPR006179:5'-Nucleotidase/apyrase,IPR008334:5'-Nucleotidase, C-terminal,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,	211800~Calcification of joints and arteries,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zinc,	binding site:Substrate,chain:5'-nucleotidase,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,propeptide:Removed in mature form,region of interest:Substrate binding,sequence variant,signal peptide,site:Transition state stabilizer,
209155_s_at	5'-nucleotidase, cytosolic II(NT5C2)	Homo sapiens				GO:0006195~purine nucleotide catabolic process,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0017144~drug metabolic process,GO:0046040~IMP metabolic process,GO:0046085~adenosine metabolic process,	GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,GO:0050146~nucleoside phosphotransferase activity,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,	613162~Spastic paraplegia 45, autosomal recessive,	PIRSF017434:cytosolic purine 5'-nucleotidase,		3D-structure,Allosteric enzyme,Alternative splicing,Complete proteome,Cytoplasm,Hereditary spastic paraplegia,Hydrolase,Magnesium,Metal-binding,Neurodegeneration,Nucleotide metabolism,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Allosteric activator 1,binding site:Allosteric activator 1; via carbonyl oxygen,binding site:Allosteric activator 2,chain:Cytosolic purine 5'-nucleotidase,compositionally biased region:Asp/Glu-rich (acidic),helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,region of interest:Substrate binding,sequence variant,strand,turn,
208758_at	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase(ATIC)	Homo sapiens				GO:0003360~brainstem development,GO:0006139~nucleobase-containing compound metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006189~'de novo' IMP biosynthetic process,GO:0009116~nucleoside metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0010035~response to inorganic substance,GO:0021549~cerebellum development,GO:0021987~cerebral cortex development,GO:0031100~organ regeneration,GO:0046452~dihydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0098609~cell-cell adhesion,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003937~IMP cyclohydrolase activity,GO:0004643~phosphoribosylaminoimidazolecarboxamide formyltransferase activity,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002695:AICARFT/IMPCHase bienzyme,IPR011607:Methylglyoxal synthase-like domain,IPR016193:Cytidine deaminase-like,IPR024050:AICAR transformylase, insert domain,IPR024051:AICAR transformylase domain,	hsa00230:Purine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	608688~AICA-ribosiduria due to ATIC deficiency,	PIRSF000414:bifunctional purine biosynthesis protein, PurH type,	SM00798:AICARFT_IMPCHas,SM00851:SM00851,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Epilepsy,Hydrolase,Multifunctional enzyme,Polymorphism,Proteomics identification,Purine biosynthesis,Reference proteome,Transferase,	active site:Proton acceptor,binding site:AICAR,binding site:AICAR; shared with dimeric partner,binding site:AICAR; via carbonyl oxygen,binding site:AICAR; via carbonyl oxygen; shared with dimeric partner,chain:Bifunctional purine biosynthesis protein PURH,helix,modified residue,nucleotide phosphate-binding region:IMP,region of interest:AICAR binding,sequence conflict,sequence variant,site:Transition state stabilizer,strand,turn,
218043_s_at	5-azacytidine induced 2(AZI2)	Homo sapiens				GO:0000278~mitotic cell cycle,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0032607~interferon-alpha production,GO:0032609~interferon-gamma production,GO:0032635~interleukin-6 production,GO:0032640~tumor necrosis factor production,GO:0042110~T cell activation,GO:0044565~dendritic cell proliferation,GO:0097028~dendritic cell differentiation,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR024581:Tbk1/Ikki binding domain,	hsa04622:RIG-I-like receptor signaling pathway,				Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,	chain:5-azacytidine-induced protein 2,modified residue,region of interest:Interaction with TBK1,splice variant,
201677_at, 201678_s_at	5-hydroxymethylcytosine (hmC) binding, ES cell-specific(HMCES)	Homo sapiens				GO:0006508~proteolysis,		GO:0003677~DNA binding,GO:0008233~peptidase activity,	IPR003738:Protein of unknown function DUF159,					3D-structure,Complete proteome,DNA-binding,Hydrolase,Isopeptide bond,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Ubl conjugation,	chain:UPF0361 protein DC12,modified residue,sequence conflict,
221351_at	5-hydroxytryptamine receptor 1A(HTR1A)	Homo sapiens				GO:0001662~behavioral fear response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007198~adenylate cyclase-inhibiting serotonin receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0014062~regulation of serotonin secretion,GO:0035640~exploration behavior,GO:0042053~regulation of dopamine metabolic process,GO:0042310~vasoconstriction,GO:0042428~serotonin metabolic process,GO:0046883~regulation of hormone secretion,GO:0050795~regulation of behavior,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0005515~protein binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000610:5-Hydroxytryptamine 1A receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,	614674~Periodic fever, menstrual cycle dependent,		SM01381:SM01381,	Behavior,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Isopeptide bond,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1A,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210799_at	5-hydroxytryptamine receptor 1B(HTR1B)	Homo sapiens				GO:0002031~G-protein coupled receptor internalization,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007198~adenylate cyclase-inhibiting serotonin receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007631~feeding behavior,GO:0014059~regulation of dopamine secretion,GO:0014063~negative regulation of serotonin secretion,GO:0030818~negative regulation of cAMP biosynthetic process,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0035690~cellular response to drug,GO:0042220~response to cocaine,GO:0042310~vasoconstriction,GO:0042493~response to drug,GO:0042756~drinking behavior,GO:0045471~response to ethanol,GO:0046849~bone remodeling,GO:0050795~regulation of behavior,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051385~response to mineralocorticoid,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0071312~cellular response to alkaloid,GO:0071502~cellular response to temperature stimulus,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0005515~protein binding,GO:0008144~drug binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002147:5-Hydroxytryptamine 1B receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	3D-structure,Behavior,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1B,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207368_at	5-hydroxytryptamine receptor 1D(HTR1D)	Homo sapiens				GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0009636~response to toxic substance,GO:0014827~intestine smooth muscle contraction,GO:0040012~regulation of locomotion,GO:0042310~vasoconstriction,GO:0042493~response to drug,GO:0050795~regulation of behavior,GO:0051209~release of sequestered calcium ion into cytosol,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000505:5-Hydroxytryptamine 1D receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1D,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207404_s_at	5-hydroxytryptamine receptor 1E(HTR1E)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0030815~negative regulation of cAMP metabolic process,GO:0042493~response to drug,GO:0051209~release of sequestered calcium ion into cytosol,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004930~G-protein coupled receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005515~protein binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,IPR027425:5-Hydroxytryptamine 1E receptor,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1E,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221458_at	5-hydroxytryptamine receptor 1F(HTR1F)	Homo sapiens				GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0042493~response to drug,GO:0051209~release of sequestered calcium ion into cytosol,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000450:5-Hydroxytryptamine 1F receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 1F,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211616_s_at, 207135_at	5-hydroxytryptamine receptor 2A(HTR2A)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006939~smooth muscle contraction,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007208~phospholipase C-activating serotonin receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007568~aging,GO:0007613~memory,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0010513~positive regulation of phosphatidylinositol biosynthetic process,GO:0014059~regulation of dopamine secretion,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014824~artery smooth muscle contraction,GO:0014832~urinary bladder smooth muscle contraction,GO:0030431~sleep,GO:0042493~response to drug,GO:0043267~negative regulation of potassium ion transport,GO:0043406~positive regulation of MAP kinase activity,GO:0044380~protein localization to cytoskeleton,GO:0045600~positive regulation of fat cell differentiation,GO:0045821~positive regulation of glycolytic process,GO:0045907~positive regulation of vasoconstriction,GO:0046718~viral entry into host cell,GO:0046883~regulation of hormone secretion,GO:0048148~behavioral response to cocaine,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050795~regulation of behavior,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030424~axon,GO:0030425~dendrite,GO:0031410~cytoplasmic vesicle,GO:0043025~neuronal cell body,GO:0043198~dendritic shaft,GO:0070852~cell body fiber,	GO:0001618~virus receptor activity,GO:0001965~G-protein alpha-subunit binding,GO:0004993~G-protein coupled serotonin receptor activity,GO:0008144~drug binding,GO:0030594~neurotransmitter receptor activity,GO:0032403~protein complex binding,GO:0051378~serotonin binding,GO:0071886~1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000455:5-Hydroxytryptamine 2A receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,	103780~Alcohol dependence, susceptibility to,164230~Obsessive-compulsive disorder, susceptibility to,181500~Schizophrenia, susceptibility to,606788~Anorexia nervosa, susceptibility to,608516~Major depressive disorder, response to citalopram therapy in,608516~Seasonal affective disorder, susceptibility to,		SM01381:SM01381,	Alternative splicing,Behavior,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Disulfide bond,G-protein coupled receptor,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Transmembrane helixFT                                EEGTLHQFNYCERCSESQNNKC,	chain:5-hydroxytryptamine receptor 2A,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,short sequence motif:PDZ-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206638_at	5-hydroxytryptamine receptor 2B(HTR2B)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0001819~positive regulation of cytokine production,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002031~G-protein coupled receptor internalization,GO:0003007~heart morphogenesis,GO:0003300~cardiac muscle hypertrophy,GO:0006182~cGMP biosynthetic process,GO:0006874~cellular calcium ion homeostasis,GO:0006939~smooth muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007507~heart development,GO:0007610~behavior,GO:0008284~positive regulation of cell proliferation,GO:0010507~negative regulation of autophagy,GO:0010513~positive regulation of phosphatidylinositol biosynthetic process,GO:0014033~neural crest cell differentiation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014827~intestine smooth muscle contraction,GO:0016310~phosphorylation,GO:0019722~calcium-mediated signaling,GO:0042310~vasoconstriction,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0048598~embryonic morphogenesis,GO:0050715~positive regulation of cytokine secretion,GO:0050795~regulation of behavior,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051781~positive regulation of cell division,GO:0060548~negative regulation of cell death,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070528~protein kinase C signaling,GO:0071502~cellular response to temperature stimulus,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0045202~synapse,	GO:0001965~G-protein alpha-subunit binding,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005096~GTPase activator activity,GO:0008144~drug binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000482:5-Hydroxytryptamine 2B receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,			SM01381:SM01381,	3D-structure,Behavior,Cell junction,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Synapse,Synaptosome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 2B,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,short sequence motif:PDZ-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211479_s_at, 207307_at	5-hydroxytryptamine receptor 2C(HTR2C)	Homo sapiens		h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,		GO:0001662~behavioral fear response,GO:0006182~cGMP biosynthetic process,GO:0006874~cellular calcium ion homeostasis,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007208~phospholipase C-activating serotonin receptor signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0010513~positive regulation of phosphatidylinositol biosynthetic process,GO:0031644~regulation of neurological system process,GO:0032098~regulation of appetite,GO:0042493~response to drug,GO:0043397~regulation of corticotropin-releasing hormone secretion,GO:0045600~positive regulation of fat cell differentiation,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0001587~Gq/11-coupled serotonin receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0008144~drug binding,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,GO:0071886~1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000377:5-Hydroxytryptamine 2C receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04726:Serotonergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,			SM01381:SM01381,	Alternative splicing,Behavior,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,RNA editing,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 2C,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,short sequence motif:PDZ-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216615_s_at, 217002_s_at	5-hydroxytryptamine receptor 3A(HTR3A)	Homo sapiens				GO:0006811~ion transport,GO:0007165~signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0032414~positive regulation of ion transmembrane transporter activity,GO:0034220~ion transmembrane transport,GO:0042220~response to cocaine,GO:0045471~response to ethanol,GO:0071363~cellular response to growth factor stimulus,GO:0098655~cation transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,GO:1904602~serotonin-activated cation-selective channel complex,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005232~serotonin-activated cation-selective channel activity,GO:0005515~protein binding,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0022850~serotonin-gated cation channel activity,GO:0042166~acetylcholine binding,GO:0051378~serotonin binding,	IPR002394:Nicotinic acetylcholine receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR008132:5-hydroxytryptamine 3 receptor,IPR008133:5-hydroxytryptamine 3 receptor, A subunit,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04726:Serotonergic synapse,				Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:5-hydroxytryptamine receptor 3A,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:HA-stretch,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221084_at	5-hydroxytryptamine receptor 3B(HTR3B)	Homo sapiens				GO:0006811~ion transport,GO:0007271~synaptic transmission, cholinergic,GO:0034220~ion transmembrane transport,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0045211~postsynaptic membrane,GO:1904602~serotonin-activated cation-selective channel complex,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005232~serotonin-activated cation-selective channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,	IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR008132:5-hydroxytryptamine 3 receptor,IPR008133:5-hydroxytryptamine 3 receptor, A subunit,IPR008134:5-hydroxytryptamine 3 receptor, B subunit,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04726:Serotonergic synapse,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:5-hydroxytryptamine receptor 3B,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:HA-stretch,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207577_at, 207578_s_at, 216939_s_at	5-hydroxytryptamine receptor 4(HTR4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007210~serotonin receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0032098~regulation of appetite,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,	GO:0004993~G-protein coupled serotonin receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001520:5-Hydroxytryptamine 4 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221362_at	5-hydroxytryptamine receptor 5A(HTR5A)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007198~adenylate cyclase-inhibiting serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0019933~cAMP-mediated signaling,GO:0021766~hippocampus development,GO:0032355~response to estradiol,	GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0043204~perikaryon,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0051378~serotonin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001397:5-Hydroxytryptamine 5A receptor,IPR002231:5-Hydroxytryptamine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 5A,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206944_at	5-hydroxytryptamine receptor 6(HTR6)	Homo sapiens				GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007210~serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0021795~cerebral cortex cell migration,GO:0032008~positive regulation of TOR signaling,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0030425~dendrite,	GO:0004969~histamine receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0005515~protein binding,GO:0030594~neurotransmitter receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 6,disulfide bond,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207818_s_at, 216098_s_at, 207927_at	5-hydroxytryptamine receptor 7(HTR7)	Homo sapiens				GO:0006939~smooth muscle contraction,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007192~adenylate cyclase-activating serotonin receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007623~circadian rhythm,GO:0008015~blood circulation,GO:0042310~vasoconstriction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0004993~G-protein coupled serotonin receptor activity,GO:0030594~neurotransmitter receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001069:5-Hydroxytryptamine 7 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04014:Ras signaling pathway,hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203200_s_at, 203199_s_at	5-methyltetrahydrofolate-homocysteine methyltransferase reductase(MTRR)	Homo sapiens				GO:0000096~sulfur amino acid metabolic process,GO:0006306~DNA methylation,GO:0006555~methionine metabolic process,GO:0009086~methionine biosynthetic process,GO:0009235~cobalamin metabolic process,GO:0032259~methylation,GO:0033353~S-adenosylmethionine cycle,GO:0043418~homocysteine catabolic process,GO:0046655~folic acid metabolic process,GO:0055114~oxidation-reduction process,GO:1904042~negative regulation of cystathionine beta-synthase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,	GO:0003958~NADPH-hemoprotein reductase activity,GO:0005515~protein binding,GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,GO:0016723~oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,GO:0030586~[methionine synthase] reductase activity,GO:0050444~aquacobalamin reductase (NADPH) activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,GO:0070402~NADPH binding,GO:0071949~FAD binding,	IPR001094:Flavodoxin,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR003097:FAD-binding, type 1,IPR008254:Flavodoxin/nitric oxide synthase,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR023173:NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain-3,		236270~Homocystinuria-megaloblastic anemia, cbl E type,601634~Neural tube defects, folate-sensitive, susceptibility to,			3D-structure,Alternative splicing,Amino-acid biosynthesis,Complete proteome,Cytoplasm,Disease mutation,FAD,Flavoprotein,FMN,Methionine biosynthesis,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,	chain:Methionine synthase reductase, mitochondrial,domain:FAD-binding FR-type,domain:Flavodoxin-like,helix,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NADP,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
203774_at	5-methyltetrahydrofolate-homocysteine methyltransferase(MTR)	Homo sapiens				GO:0000096~sulfur amino acid metabolic process,GO:0007399~nervous system development,GO:0009086~methionine biosynthetic process,GO:0009235~cobalamin metabolic process,GO:0031103~axon regeneration,GO:0032259~methylation,GO:0042558~pteridine-containing compound metabolic process,GO:0048678~response to axon injury,GO:0071732~cellular response to nitric oxide,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008705~methionine synthase activity,GO:0008898~S-adenosylmethionine-homocysteine S-methyltransferase activity,GO:0031419~cobalamin binding,	IPR000489:Pterin-binding,IPR003726:Homocysteine S-methyltransferase,IPR003759:Cobalamin (vitamin B12)-binding module, cap domain,IPR004223:Vitamin B12-dependent methionine synthase, activation domain,IPR006158:Cobalamin (vitamin B12)-binding domain,IPR011005:Dihydropteroate synthase-like,IPR011822:5-methyltetrahydrofolate--homocysteine methyltransferase,	hsa00270:Cysteine and methionine metabolism,hsa00450:Selenocompound metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01230:Biosynthesis of amino acids,	250940~Homocystinuria-megaloblastic anemia, cblG complementation type,601634~Neural tube defects, folate-sensitive, susceptibility to,	PIRSF000381:cobalamin-dependent methionine synthase,	SM01018:SM01018,	3D-structure,Alternative splicing,Amino-acid biosynthesis,Cobalamin,Cobalt,Complete proteome,Cytoplasm,Disease mutation,Metal-binding,Methionine biosynthesis,Methyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transferase,Zinc,	binding site:Cobalamin,binding site:Cobalamin; via carbonyl oxygen,binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Methionine synthase,domain:AdoMet activation,domain:B12-binding,domain:B12-binding N-terminal,domain:Hcy-binding,domain:Pterin-binding,helix,metal ion-binding site:Cobalt (cobalamin axial ligand),metal ion-binding site:Zinc,region of interest:Cobalamin-binding,region of interest:S-adenosyl-L-methionine binding,sequence variant,strand,turn,
222025_s_at	5-oxoprolinase (ATP-hydrolysing)(OPLAH)	Homo sapiens			Amino acid transport and metabolism / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006749~glutathione metabolic process,GO:0006750~glutathione biosynthetic process,	GO:0005829~cytosol,	GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017168~5-oxoprolinase (ATP-hydrolyzing) activity,	IPR002821:Hydantoinase/oxoprolinase,IPR003692:Hydantoinase B/oxoprolinase,IPR008040:Hydantoinaseoxoprolinase, N-terminal,	hsa00480:Glutathione metabolism,	260005~5-oxoprolinase deficiency,			ATP-binding,Complete proteome,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:5-oxoprolinase,sequence conflict,sequence variant,
207537_at	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1(PFKFB1)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0016311~dephosphorylation,GO:0031100~organ regeneration,GO:0032868~response to insulin,GO:0033133~positive regulation of glucokinase activity,GO:0033762~response to glucagon,GO:0042594~response to starvation,GO:0046835~carbohydrate phosphorylation,GO:0051384~response to glucocorticoid,GO:0051591~response to cAMP,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,GO:0043540~6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,	GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019900~kinase binding,GO:0042802~identical protein binding,GO:0070095~fructose-6-phosphate binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,hsa04922:Glucagon signaling pathway,			SM00855:SM00855,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 1,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence conflict,strand,turn,
209992_at, 207931_s_at	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0006089~lactate metabolic process,GO:0006096~glycolytic process,GO:0009749~response to glucose,GO:0016311~dephosphorylation,GO:0032024~positive regulation of insulin secretion,GO:0033133~positive regulation of glucokinase activity,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,hsa04919:Thyroid hormone signaling pathway,			SM00855:SM00855,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence conflict,splice variant,
202464_s_at	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3(PFKFB3)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0007420~brain development,GO:0016311~dephosphorylation,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005524~ATP binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04066:HIF-1 signaling pathway,hsa04152:AMPK signaling pathway,			SM00855:SM00855,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 3,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence conflict,splice variant,strand,turn,
206246_at	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4(PFKFB4)	Homo sapiens				GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0016311~dephosphorylation,GO:0046835~carbohydrate phosphorylation,GO:0061621~canonical glycolysis,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005524~ATP binding,	IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, active site,IPR003094:Fructose-2,6-bisphosphatase,IPR013078:Histidine phosphatase superfamily, clade-1,IPR013079:6-phosphofructo-2-kinase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00051:Fructose and mannose metabolism,hsa04152:AMPK signaling pathway,			SM00855:SM00855,	Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Kinase,Multifunctional enzyme,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Proton donor,active site:Tele-phosphohistidine intermediate,binding site:Fructose-6-phosphate,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 4,modified residue,nucleotide phosphate-binding region:ATP,region of interest:6-phosphofructo-2-kinase,region of interest:Fructose-2,6-bisphosphatase,sequence variant,
218387_s_at, 218388_at	6-phosphogluconolactonase(PGLS)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006098~pentose-phosphate shunt,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0017057~6-phosphogluconolactonase activity,	IPR005900:6-phosphogluconolactonase, DevB-type,IPR006148:Glucosamine/galactosamine-6-phosphate isomerase,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,				Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Phosphoprotein,Proteomics identification,Reference proteome,	chain:6-phosphogluconolactonase,modified residue,
209694_at	6-pyruvoyltetrahydropterin synthase(PTS)	Homo sapiens				GO:0006520~cellular amino acid metabolic process,GO:0006729~tetrahydrobiopterin biosynthetic process,GO:0007417~central nervous system development,GO:0050999~regulation of nitric-oxide synthase activity,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0003874~6-pyruvoyltetrahydropterin synthase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR007115:6-pyruvoyl tetrahydropterin synthase/QueD family protein,IPR022469:6-pyruvoyl tetrahydropterin synthase, histidine active site,IPR022470:6-pyruvoyl tetrahydropterin synthase, cysteine active site,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,	261640~Hyperphenylalaninemia, BH4-deficient, A,	PIRSF006113:6-pyruvoyl tetrahydropterin synthase,		3D-structure,Complete proteome,Disease mutation,Lyase,Metal-binding,Phenylketonuria,Phosphoprotein,Proteomics identification,Reference proteome,Tetrahydrobiopterin biosynthesis,Zinc,	active site:Charge relay system,active site:Proton acceptor,chain:6-pyruvoyl tetrahydrobiopterin synthase,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,
201790_s_at, 201791_s_at	7-dehydrocholesterol reductase(DHCR7)	Homo sapiens				GO:0001568~blood vessel development,GO:0006695~cholesterol biosynthetic process,GO:0009791~post-embryonic development,GO:0030154~cell differentiation,GO:0030324~lung development,GO:0033489~cholesterol biosynthetic process via desmosterol,GO:0033490~cholesterol biosynthetic process via lathosterol,GO:0035264~multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0045540~regulation of cholesterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005640~nuclear outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0047598~7-dehydrocholesterol reductase activity,GO:0050661~NADP binding,	IPR001171:Ergosterol biosynthesis ERG4/ERG24,IPR018083:Sterol reductase, conserved site,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,	270400~Smith-Lemli-Opitz syndrome,			Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Membrane,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:7-dehydrocholesterol reductase,modified residue,sequence conflict,sequence variant,transmembrane region,
205760_s_at, 215272_at, 205301_s_at	8-oxoguanine DNA glycosylase(OGG1)	Homo sapiens				GO:0002526~acute inflammatory response,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007568~aging,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0032355~response to estradiol,GO:0033158~regulation of protein import into nucleus, translocation,GO:0033683~nucleotide-excision repair, DNA incision,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0045007~depurination,GO:0045008~depyrimidination,GO:0045471~response to ethanol,GO:0051593~response to folic acid,GO:0071276~cellular response to cadmium ion,GO:1901291~negative regulation of double-strand break repair via single-strand annealing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0003684~damaged DNA binding,GO:0003824~catalytic activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008534~oxidized purine nucleobase lesion DNA N-glycosylase activity,GO:0032357~oxidized purine DNA binding,GO:0034039~8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,	IPR003265:HhH-GPD domain,IPR004577:8-oxoguanine DNA-glycosylase,IPR011257:DNA glycosylase,IPR012904:8-oxoguanine DNA glycosylase, N-terminal,IPR023170:Helix-turn-helix, base-excision DNA repair, C-terminal,	hsa03410:Base excision repair,	144700~Renal cell carcinoma, clear cell, somatic,		SM00478:ENDO3c,	3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,Glycosidase,Hydrolase,Lyase,Mitochondrion,Multifunctional enzyme,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,	active site:Schiff-base intermediate with DNA,binding site:8-oxoguanine,binding site:8-oxoguanine; via carbonyl oxygen,binding site:DNA,chain:N-glycosylase/DNA lyase,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
201895_at	A-Raf proto-oncogene, serine/threonine kinase(ARAF)	Homo sapiens		h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000165~MAPK cascade,GO:0006464~cellular protein modification process,GO:0032006~regulation of TOR signaling,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR003116:Raf-like Ras-binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020454:Diacylglycerol/phorbol-ester binding,	hsa04012:ErbB signaling pathway,hsa04068:FoxO signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04720:Long-term potentiation,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,			SM00109:C1,SM00220:S_TKc,SM00455:RBD,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:A-Raf proto-oncogene serine/threonine- protein kinase,domain:Protein kinase,domain:RBD,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,zinc finger region:Phorbol-ester/DAG-type,
201674_s_at, 210626_at, 201675_at, 210625_s_at	A-kinase anchoring protein 1(AKAP1)	Homo sapiens				GO:0007596~blood coagulation,GO:0010738~regulation of protein kinase A signaling,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0034237~protein kinase A regulatory subunit binding,GO:0044822~poly(A) RNA binding,	IPR002999:Tudor domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,SM00333:TUDOR,	Alternative splicing,Complete proteome,Kinase,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transferase,Transit peptide,Transmembrane,Transmembrane helix,	chain:A kinase anchor protein 1, mitochondrial,domain:KH,domain:Tudor,modified residue,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
205045_at, 213396_s_at	A-kinase anchoring protein 10(AKAP10)	Homo sapiens				GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0008104~protein localization,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0016301~kinase activity,	IPR016137:Regulator of G protein signalling superfamily,		115080~Cardiac conduction defect, susceptibility to,		SM00315:RGS,	3D-structure,Complete proteome,Cytoplasm,Kinase,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transferase,Transit peptide,	chain:A kinase anchor protein 10, mitochondrial,domain:RGS 1,domain:RGS 2,modified residue,region of interest:PKA-RII subunit binding,sequence conflict,sequence variant,transit peptide:Mitochondrion,
215336_at, 203156_at	A-kinase anchoring protein 11(AKAP11)	Homo sapiens				GO:0010738~regulation of protein kinase A signaling,GO:0035556~intracellular signal transduction,	GO:0005777~peroxisome,GO:0005815~microtubule organizing center,	GO:0008157~protein phosphatase 1 binding,GO:0051018~protein kinase A binding,	IPR008382:SPHK1-interactor/A-kinase anchor 110kDa,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,	chain:A-kinase anchor protein 11,compositionally biased region:Ser-rich,modified residue,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,
210517_s_at	A-kinase anchoring protein 12(AKAP12)	Homo sapiens				GO:0006605~protein targeting,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010739~positive regulation of protein kinase A signaling,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0090036~regulation of protein kinase C signaling,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0008179~adenylate cyclase binding,GO:0051018~protein kinase A binding,	IPR001573:Protein kinase A anchoring, WSK motif,IPR018459:RII binding domain,					Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Lipoprotein,Membrane,Myristate,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ubl conjugation,	chain:A-kinase anchor protein 12,compositionally biased region:Poly-Glu,domain:AKAP 1,domain:AKAP 2,domain:AKAP 3,modified residue,region of interest:Involved in PKC-binding,region of interest:RII-binding,sequence conflict,sequence variant,splice variant,
209534_x_at, 222024_s_at, 222023_at, 221718_s_at, 208325_s_at	A-kinase anchoring protein 13(AKAP13)	Homo sapiens		h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,		GO:0006468~protein phosphorylation,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007507~heart development,GO:0010611~regulation of cardiac muscle hypertrophy,GO:0035023~regulation of Rho protein signal transduction,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051168~nuclear export,GO:0055007~cardiac muscle cell differentiation,GO:0060297~regulation of sarcomere organization,GO:0060348~bone development,GO:0071875~adrenergic receptor signaling pathway,GO:0071883~activation of MAPK activity by adrenergic receptor signaling pathway,GO:0086023~adrenergic receptor signaling pathway involved in heart process,GO:1900169~regulation of glucocorticoid mediated signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030864~cortical actin cytoskeleton,GO:0048471~perinuclear region of cytoplasm,	GO:0004691~cAMP-dependent protein kinase activity,GO:0004871~signal transducer activity,GO:0005078~MAP-kinase scaffold activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017048~Rho GTPase binding,GO:0032947~protein complex scaffold,GO:0046872~metal ion binding,GO:0051018~protein kinase A binding,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011993:Pleckstrin homology-like domain,IPR018459:RII binding domain,				SM00109:C1,SM00233:PH,SM00325:RhoGEF,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Kinase,Membrane,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:A-kinase anchor protein 13,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:DH,domain:PH,modified residue,mutagenesis site,region of interest:Interaction with ESR1,region of interest:RII-binding,sequence conflict,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
203624_at, 210269_s_at	A-kinase anchoring protein 17A(AKAP17A)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007165~signal transduction,GO:0008380~RNA splicing,GO:0042113~B cell activation,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0051018~protein kinase A binding,	IPR012677:Nucleotide-binding, alpha-beta plait,					Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Ubl conjugation,	chain:Splicing factor, arginine/serine-rich 17A,compositionally biased region:Arg-rich,domain:RRM,modified residue,sequence conflict,sequence variant,splice variant,
202760_s_at, 202759_s_at	A-kinase anchoring protein 2(AKAP2)	Homo sapiens				GO:0007015~actin filament organization,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0008104~protein localization,								Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:A-kinase anchor protein 2,chain:Paralemmin-2,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,splice variant,
207344_at	A-kinase anchoring protein 3(AKAP3)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007338~single fertilization,GO:0007340~acrosome reaction,GO:0008104~protein localization,GO:0010738~regulation of protein kinase A signaling,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0035686~sperm fibrous sheath,GO:0097228~sperm principal piece,	GO:0005515~protein binding,GO:0051018~protein kinase A binding,	IPR008382:SPHK1-interactor/A-kinase anchor 110kDa,IPR018292:A-kinase anchor 110kDa, C-terminal,IPR018459:RII binding domain,IPR020799:A-kinase anchor 110kDa,				SM00807:SM00807,	Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:A-kinase anchor protein 3,modified residue,mutagenesis site,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,
207019_s_at	A-kinase anchoring protein 4(AKAP4)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007165~signal transduction,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007338~single fertilization,GO:0010738~regulation of protein kinase A signaling,GO:0030317~sperm motility,GO:0044458~motile cilium assembly,GO:0045184~establishment of protein localization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005952~cAMP-dependent protein kinase complex,GO:0030018~Z disc,GO:0031514~motile cilium,GO:0035686~sperm fibrous sheath,GO:0048471~perinuclear region of cytoplasm,GO:0097228~sperm principal piece,	GO:0051018~protein kinase A binding,	IPR008382:SPHK1-interactor/A-kinase anchor 110kDa,IPR018292:A-kinase anchor 110kDa, C-terminal,IPR018459:RII binding domain,IPR020799:A-kinase anchor 110kDa,				SM00807:SM00807,	Alternative splicing,Cell projection,Cilium,Cilium biogenesis/degradation,Complete proteome,Flagellum,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:A-kinase anchor protein 4,modified residue,region of interest:PKA-RI and PKA-RII subunit binding domain,region of interest:PKA-RI-alpha subunit binding domain,sequence conflict,sequence variant,splice variant,
207800_at	A-kinase anchoring protein 5(AKAP5)	Homo sapiens				GO:0006605~protein targeting,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0010739~positive regulation of protein kinase A signaling,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0036394~amylase secretion,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008179~adenylate cyclase binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0051018~protein kinase A binding,	IPR001573:Protein kinase A anchoring, WSK motif,					3D-structure,Calmodulin-binding,Complete proteome,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,	chain:A-kinase anchor protein 5,domain:AKAP,helix,mutagenesis site,region of interest:Essential to the intracellular anchoring function,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,turn,
217669_s_at, 205359_at	A-kinase anchoring protein 6(AKAP6)	Homo sapiens				GO:0001508~action potential,GO:0006605~protein targeting,GO:0010738~regulation of protein kinase A signaling,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0019933~cAMP-mediated signaling,GO:0030307~positive regulation of cell growth,GO:0030818~negative regulation of cAMP biosynthetic process,GO:0032514~positive regulation of protein phosphatase type 2B activity,GO:0035556~intracellular signal transduction,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051533~positive regulation of NFAT protein import into nucleus,GO:0060306~regulation of membrane repolarization,GO:0060316~positive regulation of ryanodine-sensitive calcium-release channel activity,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,GO:0071320~cellular response to cAMP,GO:0071345~cellular response to cytokine stimulus,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1902261~positive regulation of delayed rectifier potassium channel activity,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005901~caveola,GO:0014701~junctional sarcoplasmic reticulum membrane,GO:0014704~intercalated disc,GO:0016529~sarcoplasmic reticulum,GO:0030315~T-tubule,GO:0031965~nuclear membrane,GO:0034704~calcium channel complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008179~adenylate cyclase binding,GO:0016301~kinase activity,GO:0032947~protein complex scaffold,GO:0034237~protein kinase A regulatory subunit binding,GO:0043495~protein anchor,GO:0044325~ion channel binding,GO:0051018~protein kinase A binding,	IPR002017:Spectrin repeat,IPR018159:Spectrin/alpha-actinin,IPR026696:A-kinase anchor protein 6/Centrosomal protein of 68kDa,				SM00150:SPEC,	Alternative splicing,Complete proteome,Kinase,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sarcoplasmic reticulum,Transferase,	chain:A-kinase anchor protein 6,compositionally biased region:Ser-rich,region of interest:PKA-RII subunit binding domain,repeat:Spectrin 1,repeat:Spectrin 2,sequence conflict,sequence variant,
205771_s_at, 211172_x_at	A-kinase anchoring protein 7(AKAP7)	Homo sapiens				GO:0001508~action potential,GO:0006811~ion transport,GO:0008104~protein localization,GO:0010738~regulation of protein kinase A signaling,GO:0035556~intracellular signal transduction,GO:0060306~regulation of membrane repolarization,GO:0071320~cellular response to cAMP,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1902261~positive regulation of delayed rectifier potassium channel activity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0051018~protein kinase A binding,	IPR009097:RNA ligase/cyclic nucleotide phosphodiesterase,IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain,IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain,					3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:A-kinase anchor protein 7 isoform gamma,chain:A-kinase anchor protein 7 isoforms alpha and beta,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,region of interest:Required for apical membrane localization,region of interest:Required for membrane localization,region of interest:RII-binding,sequence variant,splice variant,
218064_s_at, 215741_x_at, 222160_at	A-kinase anchoring protein 8 like(AKAP8L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007076~mitotic chromosome condensation,GO:0008380~RNA splicing,GO:0010793~regulation of mRNA export from nucleus,GO:0031065~positive regulation of histone deacetylation,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051081~nuclear envelope disassembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0016301~kinase activity,GO:0017151~DEAD/H-box RNA helicase binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Kinase,Metal-binding,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:A-kinase anchor protein 8-like,compositionally biased region:Gly/Tyr-rich,compositionally biased region:Pro-rich,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:C2H2 AKAP95-type 1,zinc finger region:C2H2 AKAP95-type 2,
203848_at, 203847_s_at	A-kinase anchoring protein 8(AKAP8)	Homo sapiens		h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,		GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0007165~signal transduction,GO:0015031~protein transport,GO:0031065~positive regulation of histone deacetylation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045087~innate immune response,GO:0071222~cellular response to lipopolysaccharide,GO:0071380~cellular response to prostaglandin E stimulus,	GO:0000793~condensed chromosome,GO:0001939~female pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017151~DEAD/H-box RNA helicase binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),					Complete proteome,Cytoplasm,DNA-binding,Immunity,Innate immunity,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transport,Zinc,Zinc-finger,	chain:A-kinase anchor protein 8,compositionally biased region:Poly-Gly,modified residue,region of interest:RII-binding,sequence variant,short sequence motif:Nuclear localization signal,zinc finger region:C2H2 AKAP95-type 1,zinc finger region:C2H2 AKAP95-type 2,
207870_at, 215483_at, 210962_s_at	A-kinase anchoring protein 9(AKAP9)	Homo sapiens		h_akapcentrosomePathway:Protein Kinase A at the Centrosome,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0000165~MAPK cascade,GO:0006810~transport,GO:0007020~microtubule nucleation,GO:0007165~signal transduction,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007268~chemical synaptic transmission,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043547~positive regulation of GTPase activity,GO:0051602~response to electrical stimulus,GO:0060306~regulation of membrane repolarization,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0061337~cardiac conduction,GO:0071320~cellular response to cAMP,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098909~regulation of cardiac muscle cell action potential involved in regulation of contraction,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,	GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005801~cis-Golgi network,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0008076~voltage-gated potassium channel complex,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0044307~dendritic branch,GO:0097060~synaptic membrane,	GO:0003677~DNA binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,GO:0016301~kinase activity,GO:0032947~protein complex scaffold,GO:0034237~protein kinase A regulatory subunit binding,GO:0044325~ion channel binding,	IPR005539:ELK,IPR019528:Pericentrin/AKAP-450 centrosomal targeting domain,		611820~Long QT syndrome-11,		SM01188:SM01188,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Golgi apparatus,Kinase,Long QT syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:A-kinase anchor protein 9,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Leu,modified residue,region of interest:PKA-RII subunit binding domain,sequence conflict,sequence variant,splice variant,
219953_s_at, 220987_s_at	A-kinase interacting protein 1(AKIP1)	Homo sapiens				GO:0034446~substrate adhesion-dependent cell spreading,GO:1901222~regulation of NIK/NF-kappaB signaling,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Nucleus,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Proline-rich protein BCA3,sequence conflict,sequence variant,splice variant,
218089_at	AAR2 splicing factor homolog(AAR2)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,			IPR007946:A1 cistron-splicing factor, AAR2,					Acetylation,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C20orf4,modified residue,sequence conflict,sequence variant,
202740_at	ABHD14A-ACY1 readthrough(ABHD14A-ACY1)	Homo sapiens				GO:0006520~cellular amino acid metabolic process,GO:0043171~peptide catabolic process,	GO:0005737~cytoplasm,	GO:0004046~aminoacylase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0070573~metallodipeptidase activity,	IPR001261:ArgE/DapE/ACY1/CPG2/YscS, conserved site,IPR002933:Peptidase M20,IPR010159:N-acyl-L-amino-acid amidohydrolase,IPR011650:Peptidase M20, dimerisation domain,					Complete proteome,Reference proteome,Signal,
220518_at	ABI family member 3 binding protein(ABI3BP)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,	GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005518~collagen binding,GO:0008201~heparin binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Alternative splicing,Complete proteome,Glycoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Target of Nesh-SH3,compositionally biased region:Pro-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,
202123_s_at	ABL proto-oncogene 1, non-receptor tyrosine kinase(ABL1)	Homo sapiens		h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,		GO:0001922~B-1 B cell homeostasis,GO:0001934~positive regulation of protein phosphorylation,GO:0002322~B cell proliferation involved in immune response,GO:0002333~transitional one stage B cell differentiation,GO:0006298~mismatch repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0006914~autophagy,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006979~response to oxidative stress,GO:0007050~cell cycle arrest,GO:0007067~mitotic nuclear division,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008306~associative learning,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010506~regulation of autophagy,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021587~cerebellum morphogenesis,GO:0022408~negative regulation of cell-cell adhesion,GO:0030035~microspike assembly,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030514~negative regulation of BMP signaling pathway,GO:0030516~regulation of axon extension,GO:0031113~regulation of microtubule polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0033690~positive regulation of osteoblast proliferation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034599~cellular response to oxidative stress,GO:0034976~response to endoplasmic reticulum stress,GO:0035791~platelet-derived growth factor receptor-beta signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042770~signal transduction in response to DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043525~positive regulation of neuron apoptotic process,GO:0045087~innate immune response,GO:0045184~establishment of protein localization,GO:0045907~positive regulation of vasoconstriction,GO:0045930~negative regulation of mitotic cell cycle,GO:0045931~positive regulation of mitotic cell cycle,GO:0046632~alpha-beta T cell differentiation,GO:0046777~protein autophosphorylation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048668~collateral sprouting,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050798~activated T cell proliferation,GO:0050853~B cell receptor signaling pathway,GO:0050885~neuromuscular process controlling balance,GO:0051149~positive regulation of muscle cell differentiation,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051353~positive regulation of oxidoreductase activity,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0060020~Bergmann glial cell differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071871~response to epinephrine,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0090135~actin filament branching,GO:1900006~positive regulation of dendrite development,GO:1900042~positive regulation of interleukin-2 secretion,GO:1900275~negative regulation of phospholipase C activity,GO:1901216~positive regulation of neuron death,GO:1901300~positive regulation of hydrogen peroxide-mediated programmed cell death,GO:1902715~positive regulation of interferon-gamma secretion,GO:1903053~regulation of extracellular matrix organization,GO:1903055~positive regulation of extracellular matrix organization,GO:1903210~glomerular visceral epithelial cell apoptotic process,GO:1903351~cellular response to dopamine,GO:1904528~positive regulation of microtubule binding,GO:1904531~positive regulation of actin filament binding,GO:1990051~activation of protein kinase C activity,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,GO:2000145~regulation of cell motility,GO:2000249~regulation of actin cytoskeleton reorganization,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000773~negative regulation of cellular senescence,GO:2001020~regulation of response to DNA damage stimulus,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0030426~growth cone,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031252~cell leading edge,GO:0031965~nuclear membrane,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003785~actin monomer binding,GO:0004515~nicotinate-nucleotide adenylyltransferase activity,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005080~protein kinase C binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0019905~syntaxin binding,GO:0030145~manganese ion binding,GO:0051015~actin filament binding,GO:0051019~mitogen-activated protein kinase binding,GO:0070064~proline-rich region binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015015:F-actin binding,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04110:Cell cycle,hsa04360:Axon guidance,hsa04722:Neurotrophin signaling pathway,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05220:Chronic myeloid leukemia,hsa05416:Viral myocarditis,	Leukemia, Philadelphia chromosome-positive, resistant to imatinib~Leukemia, Philadelphia chromosome-positive, resistant to imatinib,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,SM00808:FABD,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Autophagy,Cell adhesion,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA repair,DNA-binding,Endocytosis,Kinase,Lipoprotein,Magnesium,Manganese,Membrane,Metal-binding,Mitochondrion,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase ABL1,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:Protein kinase,domain:SH2,domain:SH3,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:CAP,sequence conflict,sequence variant,short sequence motif:Kinase activation loop,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form BCR- ABL oncogene,splice variant,strand,turn,
206411_s_at	ABL proto-oncogene 2, non-receptor tyrosine kinase(ABL2)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010506~regulation of autophagy,GO:0010863~positive regulation of phospholipase C activity,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0051353~positive regulation of oxidoreductase activity,GO:0071300~cellular response to retinoic acid,GO:2000145~regulation of cell motility,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0000287~magnesium ion binding,GO:0003785~actin monomer binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030145~manganese ion binding,GO:0051015~actin filament binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015015:F-actin binding,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa05416:Viral myocarditis,	Leukemia, acute myeloid, with eosinophilia~Leukemia, acute myeloid, with eosinophilia,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,SM00808:FABD,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell adhesion,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Lipoprotein,Magnesium,Manganese,Metal-binding,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase ABL2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,region of interest:CAP,sequence conflict,sequence variant,short sequence motif:Kinase activation loop,short sequence motif:Nuclear localization signal,splice variant,strand,
216929_x_at, 214504_at	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)(ABO)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0009247~glycolipid biosynthetic process,GO:0030259~lipid glycosylation,	GO:0005576~extracellular region,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0032580~Golgi cisterna membrane,	GO:0004380~glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,GO:0004381~fucosylgalactoside 3-alpha-galactosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016758~transferase activity, transferring hexosyl groups,GO:0046872~metal ion binding,GO:0047276~N-acetyllactosaminide 3-alpha-galactosyltransferase activity,	IPR005076:Glycosyl transferase, family 6,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,	616093~Blood group, ABO system,			3D-structure,Blood group antigen,Complete proteome,Direct protein sequencing,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	binding site:Glycoprotein fucosyl-galactosyl group,binding site:UDP-N-acetyl-galactosamine,chain:Fucosylglycoprotein alpha-N- acetylgalactosaminyltransferase soluble form,chain:Histo-blood group ABO system transferase,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Manganese,mutagenesis site,region of interest:UDP-N-acetyl-galactosamine binding,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
206134_at	ADAM like decysin 1(ADAMDEC1)	Homo sapiens				GO:0006508~proteolysis,GO:0006955~immune response,GO:0007162~negative regulation of cell adhesion,GO:0007229~integrin-mediated signaling pathway,	GO:0005576~extracellular region,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Integrin,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal,Zinc,Zymogen,	chain:ADAM DEC1,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence variant,signal peptide,
214895_s_at, 202603_at, 202604_x_at	ADAM metallopeptidase domain 10(ADAM10)	Homo sapiens		h_appPathway:Generation of amyloid b-peptide by PS1,		GO:0001701~in utero embryonic development,GO:0006468~protein phosphorylation,GO:0006509~membrane protein ectodomain proteolysis,GO:0007162~negative regulation of cell adhesion,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0007229~integrin-mediated signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0010820~positive regulation of T cell chemotaxis,GO:0016485~protein processing,GO:0022617~extracellular matrix disassembly,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0034612~response to tumor necrosis factor,GO:0042117~monocyte activation,GO:0048013~ephrin receptor signaling pathway,GO:0051088~PMA-inducible membrane protein ectodomain proteolysis,GO:0051089~constitutive protein ectodomain proteolysis,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0097038~perinuclear endoplasmic reticulum,GO:0097197~tetraspanin-enriched microdomain,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR024079:Metallopeptidase, catalytic domain,IPR027053:Disintegrin and metalloproteinase domain-containing protein 10,	hsa05010:Alzheimer's disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	615537~Reticulate acropigmentation of Kitamura,615590~Alzheimer disease 18, susceptibility to,		SM00050:DISIN,	3D-structure,Alternative splicing,Alzheimer disease,Amyloidosis,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Metal-binding,Metalloprotease,Neurodegeneration,Notch signaling pathway,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 10,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207880_at	ADAM metallopeptidase domain 11(ADAM11)	Homo sapiens				GO:0006508~proteolysis,GO:0007229~integrin-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008237~metallopeptidase activity,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 11,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215613_at, 213790_at, 204943_at, 202952_s_at	ADAM metallopeptidase domain 12(ADAM12)	Homo sapiens		h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,		GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007520~myoblast fusion,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Integrin,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 12,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,sequence variant,short sequence motif:Cysteine switch,short sequence motif:SH3-binding; class I,short sequence motif:SH3-binding; class II,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
217007_s_at	ADAM metallopeptidase domain 15(ADAM15)	Homo sapiens				GO:0001525~angiogenesis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008584~male gonad development,GO:0022617~extracellular matrix disassembly,GO:0030308~negative regulation of cell growth,GO:0030336~negative regulation of cell migration,GO:0030574~collagen catabolic process,GO:0042246~tissue regeneration,GO:0045087~innate immune response,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0070528~protein kinase C signaling,GO:1900121~negative regulation of receptor binding,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Angiogenesis,Cell adhesion,Cell junction,Cell projection,Cleavage on pair of basic residues,Collagen degradation,Complete proteome,Cytoplasmic vesicle,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 15,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205746_s_at, 205745_x_at, 213532_at	ADAM metallopeptidase domain 17(ADAM17)	Homo sapiens		h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_notchPathway:Proteolysis and Signaling Pathway of Notch ,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,		GO:0001666~response to hypoxia,GO:0001934~positive regulation of protein phosphorylation,GO:0002446~neutrophil mediated immunity,GO:0002467~germinal center formation,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0007155~cell adhesion,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0008284~positive regulation of cell proliferation,GO:0010820~positive regulation of T cell chemotaxis,GO:0030183~B cell differentiation,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031293~membrane protein intracellular domain proteolysis,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0032496~response to lipopolysaccharide,GO:0032722~positive regulation of chemokine production,GO:0033025~regulation of mast cell apoptotic process,GO:0033077~T cell differentiation in thymus,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0033627~cell adhesion mediated by integrin,GO:0035313~wound healing, spreading of epidermal cells,GO:0035625~epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,GO:0042493~response to drug,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0048536~spleen development,GO:0048870~cell motility,GO:0050830~defense response to Gram-positive bacterium,GO:0051088~PMA-inducible membrane protein ectodomain proteolysis,GO:0051272~positive regulation of cellular component movement,GO:0055099~response to high density lipoprotein particle,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0032587~ruffle membrane,GO:0045121~membrane raft,	GO:0004222~metalloendopeptidase activity,GO:0005112~Notch binding,GO:0005138~interleukin-6 receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR024079:Metallopeptidase, catalytic domain,	hsa04330:Notch signaling pathway,hsa05010:Alzheimer's disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	614328~Inflammatory skin and bowel disease, neonatal, 1,		SM00050:DISIN,	3D-structure,Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Notch signaling pathway,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 17,compositionally biased region:Cys-rich,compositionally biased region:Poly-Val,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,region of interest:Crambin-like,sequence conflict,sequence variant,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
207597_at	ADAM metallopeptidase domain 18(ADAM18)	Homo sapiens				GO:0006508~proteolysis,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Spermatogenesis,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 18,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209765_at, 221128_at	ADAM metallopeptidase domain 19(ADAM19)	Homo sapiens				GO:0006509~membrane protein ectodomain proteolysis,GO:0007507~heart development,	GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 19,compositionally biased region:Cys-rich,compositionally biased region:Poly-Glu,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,sequence variant,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207664_at	ADAM metallopeptidase domain 2(ADAM2)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0007342~fusion of sperm to egg plasma membrane,GO:0008542~visual learning,GO:0030534~adult behavior,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008237~metallopeptidase activity,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 2,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207423_s_at, 207422_at	ADAM metallopeptidase domain 20(ADAM20)	Homo sapiens				GO:0006508~proteolysis,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Protease,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 20,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207665_at	ADAM metallopeptidase domain 21(ADAM21)	Homo sapiens				GO:0006508~proteolysis,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0043025~neuronal cell body,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Protease,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 21,compositionally biased region:Cys-rich,compositionally biased region:Poly-Val,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,short sequence motif:Cysteine switch,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208237_x_at, 206616_s_at, 206615_s_at, 208226_x_at, 213411_at, 208227_x_at	ADAM metallopeptidase domain 22(ADAM22)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,GO:0008344~adult locomotory behavior,GO:0022011~myelination in peripheral nervous system,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	3D-structure,Alternative splicing,Cell adhesion,Cell projection,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 22,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
213808_at, 206046_at	ADAM metallopeptidase domain 23(ADAM23)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 23,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:May bind the integrin receptor,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208269_s_at, 205997_at, 208268_at	ADAM metallopeptidase domain 28(ADAM28)	Homo sapiens				GO:0006508~proteolysis,GO:0007283~spermatogenesis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 28,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221446_at	ADAM metallopeptidase domain 30(ADAM30)	Homo sapiens				GO:0006508~proteolysis,GO:0007339~binding of sperm to zona pellucida,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Endosome,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 30,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:5 X 9 AA approximate repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216998_s_at, 217003_s_at	ADAM metallopeptidase domain 5 (pseudogene)(ADAM5)	Homo sapiens							IPR000742:Epidermal growth factor-like domain,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,EGF-like domain,Reference proteome,	chain:Putative disintegrin and metalloproteinase domain-containing protein 5,domain:Disintegrin,domain:EGF-like,splice variant,
211238_at, 211239_s_at	ADAM metallopeptidase domain 7(ADAM7)	Homo sapiens				GO:0006508~proteolysis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 7,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205180_s_at, 205179_s_at	ADAM metallopeptidase domain 8(ADAM8)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0001525~angiogenesis,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002675~positive regulation of acute inflammatory response,GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0007229~integrin-mediated signaling pathway,GO:0010954~positive regulation of protein processing,GO:0016337~single organismal cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0022617~extracellular matrix disassembly,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0035419~activation of MAPK activity involved in innate immune response,GO:0043524~negative regulation of neuron apoptotic process,GO:0045780~positive regulation of bone resorption,GO:0045785~positive regulation of cell adhesion,GO:0048247~lymphocyte chemotaxis,GO:0050714~positive regulation of protein secretion,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051897~positive regulation of protein kinase B signaling,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071456~cellular response to hypoxia,GO:2000309~positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,GO:2000391~positive regulation of neutrophil extravasation,GO:2000415~positive regulation of fibronectin-dependent thymocyte migration,GO:2000418~positive regulation of eosinophil migration,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0032010~phagolysosome,GO:0032127~dense core granule membrane,GO:0042581~specific granule,GO:0070820~tertiary granule,GO:0071065~alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,GO:0071133~alpha9-beta1 integrin-ADAM8 complex,	GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043621~protein self-association,GO:0050839~cell adhesion molecule binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Integrin,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zinc,	chain:Disintegrin and metalloproteinase domain- containing protein 8,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202381_at	ADAM metallopeptidase domain 9(ADAM9)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0006509~membrane protein ectodomain proteolysis,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0010042~response to manganese ion,GO:0016477~cell migration,GO:0030216~keratinocyte differentiation,GO:0033627~cell adhesion mediated by integrin,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0033631~cell-cell adhesion mediated by integrin,GO:0034241~positive regulation of macrophage fusion,GO:0034612~response to tumor necrosis factor,GO:0034616~response to laminar fluid shear stress,GO:0042117~monocyte activation,GO:0042542~response to hydrogen peroxide,GO:0050714~positive regulation of protein secretion,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051088~PMA-inducible membrane protein ectodomain proteolysis,GO:0051384~response to glucocorticoid,GO:0051549~positive regulation of keratinocyte migration,GO:0051592~response to calcium ion,GO:0071222~cellular response to lipopolysaccharide,	GO:0005615~extracellular space,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0031233~intrinsic component of external side of plasma membrane,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0005080~protein kinase C binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0043236~laminin binding,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,		612775~Cone-rod dystrophy 9,		SM00050:DISIN,SM00608:ACR,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cone-rod dystrophy,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Zinc,	chain:Disintegrin and metalloproteinase domain- containing protein 9,compositionally biased region:Cys-rich,compositionally biased region:Poly-Pro,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,modified residue,sequence conflict,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
222162_s_at	ADAM metallopeptidase with thrombospondin type 1 motif 1(ADAMTS1)	Homo sapiens				GO:0001542~ovulation from ovarian follicle,GO:0001822~kidney development,GO:0006508~proteolysis,GO:0007229~integrin-mediated signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0060347~heart trabecula formation,	GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,	GO:0004222~metalloendopeptidase activity,GO:0008201~heparin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR010294:ADAM-TS Spacer 1,IPR013273:Peptidase M12B, ADAM-TS,IPR013274:Peptidase M12B, ADAM-TS1,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,SM00608:ACR,	3D-structure,Calcium,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Heparin-binding,Hydrolase,Integrin,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 1,compositionally biased region:Cys-rich,compositionally biased region:Poly-Lys,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,strand,turn,
221421_s_at	ADAM metallopeptidase with thrombospondin type 1 motif 12(ADAMTS12)	Homo sapiens				GO:0007160~cell-matrix adhesion,GO:0016477~cell migration,GO:0030167~proteoglycan catabolic process,GO:0032331~negative regulation of chondrocyte differentiation,GO:0050727~regulation of inflammatory response,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071773~cellular response to BMP stimulus,GO:1901509~regulation of endothelial tube morphogenesis,GO:1902203~negative regulation of hepatocyte growth factor receptor signaling pathway,GO:1902548~negative regulation of cellular response to vascular endothelial growth factor stimulus,GO:2001113~negative regulation of cellular response to hepatocyte growth factor stimulus,	GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 12,compositionally biased region:Cys-rich,compositionally biased region:Poly-Glu,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,region of interest:Spacer 1,region of interest:Spacer 2,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,
220208_at	ADAM metallopeptidase with thrombospondin type 1 motif 13(ADAMTS13)	Homo sapiens				GO:0006508~proteolysis,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0009100~glycoprotein metabolic process,GO:0009636~response to toxic substance,GO:0014075~response to amine,GO:0016485~protein processing,GO:0030168~platelet activation,GO:0035864~response to potassium ion,GO:0036066~protein O-linked fucosylation,GO:0043171~peptide catabolic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071346~cellular response to interferon-gamma,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0009986~cell surface,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,	IPR000859:CUB domain,IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR006586:ADAM, cysteine-rich,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,		274150~Thrombotic thrombocytopenic purpura, familial,		SM00209:TSP1,SM00608:ACR,	3D-structure,Alternative splicing,Blood coagulation,Calcium,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 13,disulfide bond,domain:CUB 1,domain:CUB 2,domain:Disintegrin,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Zinc; catalytic,mutagenesis site,region of interest:Cysteine-rich,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
214454_at, 214535_s_at	ADAM metallopeptidase with thrombospondin type 1 motif 2(ADAMTS2)	Homo sapiens				GO:0007283~spermatogenesis,GO:0016485~protein processing,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0030574~collagen catabolic process,GO:0043588~skin development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR013275:Peptidase M12B, ADAM-TS2,IPR024079:Metallopeptidase, catalytic domain,		225410~Ehlers-Danlos syndrome, type VIIC,		SM00209:TSP1,	Alternative splicing,Collagen degradation,Complete proteome,Disulfide bond,Ehlers-Danlos syndrome,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 2,compositionally biased region:Cys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
220717_at	ADAM metallopeptidase with thrombospondin type 1 motif 20(ADAMTS20)	Homo sapiens				GO:0006508~proteolysis,GO:0009967~positive regulation of signal transduction,GO:0030198~extracellular matrix organization,GO:0043066~negative regulation of apoptotic process,GO:0045636~positive regulation of melanocyte differentiation,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR012314:Peptidase M12B, GON-ADAMTSs,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 20,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:GON,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 10,domain:TSP type-1 11,domain:TSP type-1 12,domain:TSP type-1 13,domain:TSP type-1 14,domain:TSP type-1 15,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,domain:TSP type-1 9,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Spacer,sequence conflict,sequence variant,signal peptide,splice variant,
214913_at	ADAM metallopeptidase with thrombospondin type 1 motif 3(ADAMTS3)	Homo sapiens				GO:0007229~integrin-mediated signaling pathway,GO:0010573~vascular endothelial growth factor production,GO:0016485~protein processing,GO:0030199~collagen fibril organization,GO:0030574~collagen catabolic process,GO:0032964~collagen biosynthetic process,GO:0043206~extracellular fibril organization,GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Heparin-binding,Hydrolase,Integrin,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 3,compositionally biased region:Cys-rich,compositionally biased region:Poly-Arg,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Spacer,sequence conflict,sequence variant,signal peptide,
219935_at	ADAM metallopeptidase with thrombospondin type 1 motif 5(ADAMTS5)	Homo sapiens				GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0036066~protein O-linked fucosylation,GO:0042742~defense response to bacterium,GO:0044691~tooth eruption,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0050840~extracellular matrix binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR010294:ADAM-TS Spacer 1,IPR013273:Peptidase M12B, ADAM-TS,IPR013276:Peptidase M12B, ADAM-TS5,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,SM00608:ACR,	3D-structure,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 5,compositionally biased region:Cys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 2,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:Spacer,sequence variant,short sequence motif:Cysteine switch,signal peptide,strand,turn,
220866_at	ADAM metallopeptidase with thrombospondin type 1 motif 6(ADAMTS6)	Homo sapiens				GO:0003279~cardiac septum development,GO:0006508~proteolysis,GO:0035904~aorta development,GO:0060976~coronary vasculature development,	GO:0005578~proteinaceous extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 6,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Spacer,sequence conflict,signal peptide,splice variant,
220705_s_at, 220706_at	ADAM metallopeptidase with thrombospondin type 1 motif 7(ADAMTS7)	Homo sapiens				GO:0032331~negative regulation of chondrocyte differentiation,GO:0036066~protein O-linked fucosylation,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071773~cellular response to BMP stimulus,	GO:0005578~proteinaceous extracellular matrix,GO:0005788~endoplasmic reticulum lumen,GO:0009986~cell surface,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteoglycan,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 7,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,
220677_s_at, 220676_at	ADAM metallopeptidase with thrombospondin type 1 motif 8(ADAMTS8)	Homo sapiens				GO:0006508~proteolysis,GO:0008285~negative regulation of cell proliferation,GO:0035435~phosphate ion transmembrane transport,	GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008201~heparin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0009673~low-affinity phosphate transmembrane transporter activity,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR010294:ADAM-TS Spacer 1,IPR013273:Peptidase M12B, ADAM-TS,IPR013277:Peptidase M12B, ADAM-TS8,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,SM00608:ACR,	Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Heparin-binding,Hydrolase,Metal-binding,Metalloprotease,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 8,compositionally biased region:Cys-rich,compositionally biased region:Poly-Pro,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 2,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,modified residue,region of interest:Spacer,sequence conflict,signal peptide,
220287_at	ADAM metallopeptidase with thrombospondin type 1 motif 9(ADAMTS9)	Homo sapiens				GO:0006508~proteolysis,GO:0006516~glycoprotein catabolic process,GO:0007275~multicellular organism development,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0045636~positive regulation of melanocyte differentiation,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR012314:Peptidase M12B, GON-ADAMTSs,IPR013273:Peptidase M12B, ADAM-TS,IPR024079:Metallopeptidase, catalytic domain,				SM00209:TSP1,	Alternative splicing,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Endoplasmic reticulum,ER-Golgi transport,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Protein transport,Reference proteome,Repeat,Secreted,Signal,Transport,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 9,compositionally biased region:Cys-rich,compositionally biased region:Poly-Ser,disulfide bond,domain:Disintegrin,domain:GON,domain:Peptidase M12B,domain:TSP type-1 1,domain:TSP type-1 10,domain:TSP type-1 11,domain:TSP type-1 12,domain:TSP type-1 13,domain:TSP type-1 14,domain:TSP type-1 15,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,domain:TSP type-1 9,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,splice variant,
206629_at	ADAMTS like 2(ADAMTSL2)	Homo sapiens				GO:0006508~proteolysis,GO:0030198~extracellular matrix organization,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0060481~lobar bronchus epithelium development,	GO:0005578~proteinaceous extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0050436~microfibril binding,	IPR000884:Thrombospondin, type 1 repeat,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,		231050~Geleophysic dysplasia 1,		SM00209:TSP1,	Complete proteome,Disease mutation,Disulfide bond,Dwarfism,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 2,disulfide bond,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
213974_at	ADAMTS like 3(ADAMTSL3)	Homo sapiens				GO:0006508~proteolysis,	GO:0005578~proteinaceous extracellular matrix,	GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR010909:PLAC,IPR013098:Immunoglobulin I-set,IPR013273:Peptidase M12B, ADAM-TS,IPR013783:Immunoglobulin-like fold,				SM00209:TSP1,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 10,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,domain:TSP type-1 7,domain:TSP type-1 8,domain:TSP type-1 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
220578_at	ADAMTS like 4(ADAMTSL4)	Homo sapiens				GO:0002064~epithelial cell development,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0030198~extracellular matrix organization,GO:0036066~protein O-linked fucosylation,GO:0043065~positive regulation of apoptotic process,	GO:0005614~interstitial matrix,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR000884:Thrombospondin, type 1 repeat,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,		225100~Ectopia lentis, isolated, autosomal recessive,225200~Ectopia lentis et pupillae,		SM00209:TSP1,	Alternative splicing,Apoptosis,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 4,compositionally biased region:Pro-rich,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
207151_at	ADCYAP receptor type I(ADCYAP1R1)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007283~spermatogenesis,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0019933~cAMP-mediated signaling,GO:0030154~cell differentiation,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0032355~response to estradiol,GO:0033555~multicellular organismal response to stress,GO:0042493~response to drug,GO:0045471~response to ethanol,GO:0046545~development of primary female sexual characteristics,GO:0060548~negative regulation of cell death,GO:0060732~positive regulation of inositol phosphate biosynthetic process,	GO:0005768~endosome,GO:0005791~rough endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0005923~bicellular tight junction,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004999~vasoactive intestinal polypeptide receptor activity,GO:0005515~protein binding,GO:0008179~adenylate cyclase binding,GO:0030306~ADP-ribosylation factor binding,GO:0042923~neuropeptide binding,	IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR002285:GPCR, family 2, pituitary adenylate cyclase activating polypeptide type 1 receptor,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04713:Circadian entrainment,hsa04911:Insulin secretion,hsa04924:Renin secretion,			SM00008:HormR,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Spermatogenesis,Transducer,Transmembrane,Transmembrane helix,	chain:Pituitary adenylate cyclase-activating polypeptide type I receptor,glycosylation site:N-linked (GlcNAc...),helix,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
203321_s_at, 203322_at	ADNP homeobox 2(ADNP2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030182~neuron differentiation,GO:0030307~positive regulation of cell growth,GO:0034599~cellular response to oxidative stress,GO:0060548~negative regulation of cell death,GO:0071300~cellular response to retinoic acid,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00389:HOX,	Complete proteome,DNA-binding,Homeobox,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:ADNP homeobox protein 2,compositionally biased region:Pro-rich,DNA-binding region:Homeobox,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
220980_s_at	ADP dependent glucokinase(ADPGK)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006006~glucose metabolic process,GO:0006096~glycolytic process,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0043843~ADP-specific glucokinase activity,GO:0046872~metal ion binding,	IPR007666:ADP-specific phosphofructokinase/glucokinase,	hsa00010:Glycolysis / Gluconeogenesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,				Alternative splicing,Complete proteome,Glycolysis,Kinase,Magnesium,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,chain:ADP-dependent glucokinase,domain:ADPK,metal ion-binding site:Magnesium,sequence variant,signal peptide,splice variant,
200011_s_at, 211622_s_at, 200734_s_at	ADP ribosylation factor 3(ARF3)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,				Alternative splicing,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Myristate,Nucleotide-binding,Protein transport,Reference proteome,Transport,	chain:ADP-ribosylation factor 3,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,
201097_s_at, 201096_s_at	ADP ribosylation factor 4(ARF4)	Homo sapiens				GO:0006471~protein ADP-ribosylation,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007420~brain development,GO:0007612~learning,GO:0015031~protein transport,GO:0016477~cell migration,GO:0031584~activation of phospholipase D activity,GO:0043066~negative regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045176~apical protein localization,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048678~response to axon injury,GO:0060996~dendritic spine development,GO:0061512~protein localization to cilium,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0032587~ruffle membrane,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Complete proteome,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ADP-ribosylation factor 4,helix,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,sequence variant,strand,turn,
201526_at	ADP ribosylation factor 5(ARF5)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,				3D-structure,Coiled coil,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:ADP-ribosylation factor 5,helix,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,strand,turn,
203312_x_at, 203311_s_at	ADP ribosylation factor 6(ARF6)	Homo sapiens				GO:0001889~liver development,GO:0006928~movement of cell or subcellular component,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0030838~positive regulation of actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0033028~myeloid cell apoptotic process,GO:0034394~protein localization to cell surface,GO:0035020~regulation of Rac protein signal transduction,GO:0036010~protein localization to endosome,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:0051489~regulation of filopodium assembly,GO:0060998~regulation of dendritic spine development,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090162~establishment of epithelial cell polarity,GO:0097284~hepatocyte apoptotic process,GO:2000171~negative regulation of dendrite development,	GO:0001726~ruffle,GO:0005622~intracellular,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0030496~midbody,GO:0031527~filopodium membrane,GO:0032154~cleavage furrow,GO:0043209~myelin sheath,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031996~thioesterase binding,GO:0047485~protein N-terminus binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04014:Ras signaling pathway,hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,				3D-structure,Cell cycle,Cell division,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Differentiation,Endosome,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Myristate,Neurogenesis,Nucleotide-binding,Protein transport,Reference proteome,Transport,	chain:ADP-ribosylation factor 6,helix,lipid moiety-binding region:N-myristoyl glycine,mutagenesis site,nucleotide phosphate-binding region:GTP,strand,turn,
217888_s_at	ADP ribosylation factor GTPase activating protein 1(ARFGAP1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,GO:0030100~regulation of endocytosis,GO:0036498~IRE1-mediated unfolded protein response,GO:0043547~positive regulation of GTPase activity,	GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0045202~synapse,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa04144:Endocytosis,			SM00105:ArfGap,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Zinc,Zinc-finger,	chain:ADP-ribosylation factor GTPase-activating protein 1,domain:Arf-GAP,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
211975_at	ADP ribosylation factor GTPase activating protein 2(ARFGAP2)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa04144:Endocytosis,			SM00105:ArfGap,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Zinc,Zinc-finger,	chain:ADP-ribosylation factor GTPase-activating protein 2,domain:Arf-GAP,helix,modified residue,region of interest:Required for interaction with coatomer,sequence conflict,sequence variant,strand,turn,zinc finger region:C4-type,
202211_at	ADP ribosylation factor GTPase activating protein 3(ARFGAP3)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0009306~protein secretion,GO:0016192~vesicle-mediated transport,GO:0043547~positive regulation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa04144:Endocytosis,			SM00105:ArfGap,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,ER-Golgi transport,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Zinc,Zinc-finger,	chain:ADP-ribosylation factor GTPase-activating protein 3,compositionally biased region:Ser-rich,domain:Arf-GAP,helix,modified residue,sequence conflict,sequence variant,strand,turn,zinc finger region:C4-type,
202955_s_at, 202956_at, 216266_s_at	ADP ribosylation factor guanine nucleotide exchange factor 1(ARFGEF1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,	General function prediction only,	GO:0006887~exocytosis,GO:0007030~Golgi organization,GO:0010256~endomembrane system organization,GO:0015031~protein transport,GO:0030837~negative regulation of actin filament polymerization,GO:0031175~neuron projection development,GO:0032012~regulation of ARF protein signal transduction,GO:0034260~negative regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0051897~positive regulation of protein kinase B signaling,GO:0090284~positive regulation of protein glycosylation in Golgi,GO:0090303~positive regulation of wound healing,GO:2000114~regulation of establishment of cell polarity,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0030532~small nuclear ribonucleoprotein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0034237~protein kinase A regulatory subunit binding,	IPR000904:SEC7-like,IPR011989:Armadillo-like helical,IPR015403:Domain of unknown function DUF1981, SEC7 associated,IPR016024:Armadillo-type fold,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Golgi apparatus,Guanine-nucleotide releasing factor,Membrane,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Brefeldin A-inhibited guanine nucleotide- exchange protein 1,domain:SEC7,modified residue,sequence conflict,sequence variant,
215931_s_at, 215927_at, 218098_at	ADP ribosylation factor guanine nucleotide exchange factor 2(ARFGEF2)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,	General function prediction only,	GO:0001881~receptor recycling,GO:0006887~exocytosis,GO:0006893~Golgi to plasma membrane transport,GO:0007032~endosome organization,GO:0010256~endomembrane system organization,GO:0015031~protein transport,GO:0032012~regulation of ARF protein signal transduction,GO:0032760~positive regulation of tumor necrosis factor production,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0000139~Golgi membrane,GO:0005802~trans-Golgi network,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005879~axonemal microtubule,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0032279~asymmetric synapse,GO:0032280~symmetric synapse,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0050811~GABA receptor binding,	IPR000904:SEC7-like,IPR011989:Armadillo-like helical,IPR015403:Domain of unknown function DUF1981, SEC7 associated,IPR016024:Armadillo-type fold,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,	608097~Periventricular heterotopia with microcephaly,		SM00222:Sec7,	3D-structure,Acetylation,Cell junction,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Disease mutation,Endosome,Golgi apparatus,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Synapse,Transport,	chain:Brefeldin A-inhibited guanine nucleotide- exchange protein 2,domain:SEC7,modified residue,sequence conflict,sequence variant,
214483_s_at, 218230_at	ADP ribosylation factor interacting protein 1(ARFIP1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0034315~regulation of Arp2/3 complex-mediated actin nucleation,GO:0050708~regulation of protein secretion,GO:0098609~cell-cell adhesion,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0032588~trans-Golgi network membrane,	GO:0019904~protein domain specific binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR010504:Arfaptin homology (AH) domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM01015:SM01015,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Reference proteome,	chain:Arfaptin-1,domain:AH,modified residue,splice variant,
202109_at	ADP ribosylation factor interacting protein 2(ARFIP2)	Homo sapiens		h_rac1Pathway:Rac 1 cell motility signaling pathway,		GO:0006928~movement of cell or subcellular component,GO:0007264~small GTPase mediated signal transduction,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0031529~ruffle organization,GO:0034315~regulation of Arp2/3 complex-mediated actin nucleation,GO:0098609~cell-cell adhesion,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005938~cell cortex,GO:0032588~trans-Golgi network membrane,	GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019904~protein domain specific binding,GO:0030742~GTP-dependent protein binding,GO:0042802~identical protein binding,GO:0048365~Rac GTPase binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR010504:Arfaptin homology (AH) domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM01015:SM01015,	3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Arfaptin-2,domain:AH,helix,turn,
201658_at, 201657_at, 201659_s_at	ADP ribosylation factor like GTPase 1(ARL1)	Homo sapiens				GO:0007030~Golgi organization,GO:0007264~small GTPase mediated signal transduction,GO:0009404~toxin metabolic process,GO:0031584~activation of phospholipase D activity,GO:0034067~protein localization to Golgi apparatus,GO:0042147~retrograde transport, endosome to Golgi,GO:0048193~Golgi vesicle transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0032588~trans-Golgi network membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008047~enzyme activator activity,GO:0019904~protein domain specific binding,GO:0046872~metal ion binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Complete proteome,Golgi apparatus,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Proteomics identification,Reference proteome,	binding site:GTP; via amide nitrogen,chain:ADP-ribosylation factor-like protein 1,helix,lipid moiety-binding region:N-myristoyl glycine,metal ion-binding site:Magnesium,nucleotide phosphate-binding region:GTP,strand,turn,
220468_at	ADP ribosylation factor like GTPase 14(ARL14)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasmic vesicle,GTP-binding,Lipoprotein,Myristate,Nucleotide-binding,Polymorphism,Reference proteome,	chain:ADP-ribosylation factor-like protein 14,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
219842_at	ADP ribosylation factor like GTPase 15(ARL15)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0070062~extracellular exosome,	GO:0005525~GTP binding,	IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:ADP-ribosylation factor-like protein 15,nucleotide phosphate-binding region:GTP,sequence conflict,
210718_s_at, 210435_at	ADP ribosylation factor like GTPase 17B(ARL17B)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,	GO:0005525~GTP binding,	IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,ER-Golgi transport,Golgi apparatus,GTP-binding,Lipoprotein,Myristate,Nucleotide-binding,Polymorphism,Protein transport,Reference proteome,Transport,
202092_s_at	ADP ribosylation factor like GTPase 2 binding protein(ARL2BP)	Homo sapiens				GO:0007165~signal transduction,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0050790~regulation of catalytic activity,GO:0050796~regulation of insulin secretion,GO:0051457~maintenance of protein location in nucleus,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005929~cilium,GO:0030496~midbody,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,	IPR023379:ADP-ribosylation factor-like 2-binding protein, domain,		615434~Retinitis pigmentosa with or without situs inversus,			3D-structure,Alternative splicing,Cell projection,Ciliopathy,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Mitochondrion,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:ADP-ribosylation factor-like protein 2- binding protein,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
202564_x_at	ADP ribosylation factor like GTPase 2(ARL2)	Homo sapiens				GO:0007021~tubulin complex assembly,GO:0007049~cell cycle,GO:0007264~small GTPase mediated signal transduction,GO:0010811~positive regulation of cell-substrate adhesion,GO:0031113~regulation of microtubule polymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0034260~negative regulation of GTPase activity,GO:0050796~regulation of insulin secretion,GO:0051297~centrosome organization,GO:0051457~maintenance of protein location in nucleus,GO:0070830~bicellular tight junction assembly,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005929~cilium,GO:0016328~lateral plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005095~GTPase inhibitor activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative splicing,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Isopeptide bond,Lipoprotein,Mitochondrion,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	binding site:GTP; via amide nitrogen,chain:ADP-ribosylation factor-like protein 2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence variant,strand,
213433_at, 202641_at	ADP ribosylation factor like GTPase 3(ARL3)	Homo sapiens				GO:0000910~cytokinesis,GO:0001822~kidney development,GO:0006892~post-Golgi vesicle-mediated transport,GO:0007224~smoothened signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0042073~intraciliary transport,GO:0042461~photoreceptor cell development,GO:0060271~cilium morphogenesis,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005929~cilium,GO:0030496~midbody,GO:0032391~photoreceptor connecting cilium,GO:0070062~extracellular exosome,GO:0072372~primary cilium,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008017~microtubule binding,GO:0019003~GDP binding,GO:0046872~metal ion binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell cycle,Cell division,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Golgi apparatus,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transport,	binding site:GTP,binding site:GTP; via amide nitrogen,chain:ADP-ribosylation factor-like protein 3,lipid moiety-binding region:N-myristoyl glycine,metal ion-binding site:Magnesium,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,
205020_s_at	ADP ribosylation factor like GTPase 4A(ARL4A)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0050873~brown fat cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell membrane,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Reference proteome,	chain:ADP-ribosylation factor-like protein 4A,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,sequence variant,
213759_at, 202207_at, 202206_at, 202208_s_at	ADP ribosylation factor like GTPase 4C(ARL4C)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0032456~endocytic recycling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030175~filopodium,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0043014~alpha-tubulin binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Reference proteome,Transport,	chain:ADP-ribosylation factor-like protein 4C,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,
203586_s_at, 203587_at	ADP ribosylation factor like GTPase 4D(ARL4D)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0009306~protein secretion,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell membrane,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,	chain:ADP-ribosylation factor-like protein 4D,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,sequence variant,
211935_at	ADP ribosylation factor like GTPase 6 interacting protein 1(ARL6IP1)	Homo sapiens				GO:0002038~positive regulation of L-glutamate transport,GO:0006613~cotranslational protein targeting to membrane,GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0071787~endoplasmic reticulum tubular network assembly,GO:1990809~endoplasmic reticulum tubular network membrane organization,	GO:0005784~Sec61 translocon complex,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,			615685~Spastic paraplegia 61, autosomal recessive,			Alternative splicing,Apoptosis,Complete proteome,Endoplasmic reticulum,Hereditary spastic paraplegia,Membrane,Neurodegeneration,Reference proteome,Transmembrane,Transmembrane helix,	chain:ADP-ribosylation factor-like protein 6- interacting protein 1,transmembrane region,
220597_s_at, 218216_x_at	ADP ribosylation factor like GTPase 6 interacting protein 4(ARL6IP4)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR019532:Nuclear RNA-splicing-associated protein, SR-25,					Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,	chain:ADP-ribosylation factor-like protein 6- interacting protein 4,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
200760_s_at, 200761_s_at	ADP ribosylation factor like GTPase 6 interacting protein 5(ARL6IP5)	Homo sapiens				GO:0002037~negative regulation of L-glutamate transport,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010917~negative regulation of mitochondrial membrane potential,GO:0015813~L-glutamate transport,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR004895:Prenylated rab acceptor PRA1,					Acetylation,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:PRA1 family protein 3,modified residue,region of interest:Targeting to endoplasmic reticulum membrane,sequence conflict,topological domain:Cytoplasmic,transmembrane region,
217852_s_at	ADP ribosylation factor like GTPase 8B(ARL8B)	Homo sapiens				GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007264~small GTPase mediated signal transduction,GO:0032418~lysosome localization,GO:0051301~cell division,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0051233~spindle midzone,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Endosome,GTP-binding,Lysosome,Membrane,Nucleotide-binding,Reference proteome,	chain:ADP-ribosylation factor-like protein 8B,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Mediates targeting to membranes,strand,turn,
203174_s_at, 215984_s_at	ADP ribosylation factor related protein 1(ARFRP1)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007369~gastrulation,GO:0034067~protein localization to Golgi apparatus,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,GO:0032588~trans-Golgi network membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Alternative splicing,Complete proteome,Golgi apparatus,GTP-binding,Nucleotide-binding,Polymorphism,Reference proteome,	chain:ADP-ribosylation factor-related protein 1,nucleotide phosphate-binding region:GTP,sequence variant,
220606_s_at	ADP-ribose/CDP-alcohol diphosphatase, manganese dependent(ADPRM)	Homo sapiens				GO:0034656~nucleobase-containing small molecule catabolic process,	GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0047631~ADP-ribose diphosphatase activity,GO:0047734~CDP-glycerol diphosphatase activity,	IPR004843:Metallophosphoesterase domain,	hsa00230:Purine metabolism,hsa00564:Glycerophospholipid metabolism,				Acetylation,Alternative splicing,Complete proteome,Hydrolase,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	chain:Manganese-dependent ADP-ribose/CDP- alcohol diphosphatase,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,sequence conflict,sequence variant,splice variant,
207863_at	ADP-ribosylarginine hydrolase(ADPRH)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006886~intracellular protein transport,GO:0031338~regulation of vesicle fusion,GO:0051725~protein de-ADP-ribosylation,GO:0090630~activation of GTPase activity,	GO:0005622~intracellular,GO:0012505~endomembrane system,	GO:0000287~magnesium ion binding,GO:0003875~ADP-ribosylarginine hydrolase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0017137~Rab GTPase binding,	IPR005502:ADP-ribosylation/Crystallin J1,IPR012108:ADP-ribosylarginine hydrolase,			PIRSF016939:ADP-ribosylarginine hydrolase,		3D-structure,Complete proteome,Hydrolase,Magnesium,Proteomics identification,Reference proteome,	chain:[Protein ADP-ribosylarginine] hydrolase,
207919_at	ADP-ribosyltransferase 1(ART1)	Homo sapiens				GO:0006471~protein ADP-ribosylation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0031225~anchored component of membrane,GO:0033017~sarcoplasmic reticulum membrane,	GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0003956~NAD(P)+-protein-arginine ADP-ribosyltransferase activity,	IPR000768:NAD:arginine ADP-ribosyltransferase, ART,					Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,GPI-anchor,Lipoprotein,Membrane,NAD,NADP,Polymorphism,Reference proteome,Sarcoplasmic reticulum,Signal,Transferase,	binding site:NAD,chain:GPI-linked NAD(P)(+)--arginine ADP- ribosyltransferase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
210147_at	ADP-ribosyltransferase 3(ART3)	Homo sapiens				GO:0006471~protein ADP-ribosylation,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0003956~NAD(P)+-protein-arginine ADP-ribosyltransferase activity,GO:0016740~transferase activity,	IPR000768:NAD:arginine ADP-ribosyltransferase, ART,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,GPI-anchor,Lipoprotein,Membrane,NAD,NADP,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,	binding site:NAD,chain:Ecto-ADP-ribosyltransferase 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,region of interest:3 X 10 AA tandem repeats of [GS]-E-K-N- [QW]-K-L-E-D-H,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,signal peptide,splice variant,
207220_at	ADP-ribosyltransferase 4 (Dombrock blood group)(ART4)	Homo sapiens				GO:0006471~protein ADP-ribosylation,GO:0006525~arginine metabolic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0003956~NAD(P)+-protein-arginine ADP-ribosyltransferase activity,GO:0016740~transferase activity,	IPR000768:NAD:arginine ADP-ribosyltransferase, ART,		616060~Blood group, Dombrock,			Blood group antigen,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,GPI-anchor,Lipoprotein,Membrane,NAD,NADP,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	binding site:NAD,chain:Ecto-ADP-ribosyltransferase 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
201792_at	AE binding protein 1(AEBP1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0006351~transcription, DNA-templated,GO:0006518~peptide metabolic process,GO:0007517~muscle organ development,GO:0016485~protein processing,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0004185~serine-type carboxypeptidase activity,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000834:Peptidase M14, carboxypeptidase A,IPR008969:Carboxypeptidase-like, regulatory domain,IPR008979:Galactose-binding domain-like,IPR014766:Carboxypeptidase, regulatory domain,				SM00231:FA58C,SM00631:Zn_pept,	Alternative splicing,Calmodulin-binding,Complete proteome,Cytoplasm,DNA-binding,Glycoprotein,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Secreted,Signal,Transcription,Transcription regulation,	chain:Adipocyte enhancer-binding protein 1,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,domain:F5/8 type C,glycosylation site:N-linked (GlcNAc...),region of interest:Interaction with MAPK1 and MAPK3,region of interest:Interaction with PTEN,region of interest:Required for DNA-binding and interaction with NFKBIA,region of interest:Required for transcriptional repression,sequence conflict,sequence variant,signal peptide,splice variant,
201924_at, 215451_s_at, 211826_s_at	AF4/FMR2 family member 1(AFF1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0008023~transcription elongation factor complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR007797:Transcription factor AF4/FMR2,	hsa05202:Transcriptional misregulation in cancer,				3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:AF4/FMR2 family member 1,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,
216364_s_at, 206105_at, 210957_s_at	AF4/FMR2 family member 2(AFF2)	Homo sapiens				GO:0006397~mRNA processing,GO:0007420~brain development,GO:0007611~learning or memory,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,	GO:0016607~nuclear speck,	GO:0002151~G-quadruplex RNA binding,	IPR007797:Transcription factor AF4/FMR2,		309548~Mental retardation, X-linked, FRAXE type,			Alternative splicing,Complete proteome,Mental retardation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,Triplet repeat expansion,	chain:AF4/FMR2 family member 2,modified residue,sequence conflict,sequence variant,splice variant,
205734_s_at, 205735_s_at	AF4/FMR2 family member 3(AFF3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034612~response to tumor necrosis factor,GO:0035116~embryonic hindlimb morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003690~double-stranded DNA binding,	IPR007797:Transcription factor AF4/FMR2,					Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AF4/FMR2 family member 3,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,
219199_at	AF4/FMR2 family member 4(AFF4)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007286~spermatid development,	GO:0008023~transcription elongation factor complex,GO:0035327~transcriptionally active chromatin,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR007797:Transcription factor AF4/FMR2,		616368~CHOPS syndrome,			3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,Disease mutation,Dwarfism,Nucleus,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:AF4/FMR2 family member 4,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,site:Breakpoint for insertion to form MLL-AFF4 fusion protein,splice variant,
210409_at	AFDN antisense RNA 1 (head to head)(AFDN-AS1)	Homo sapiens												Alternative splicing,Complete proteome,Reference proteome,Repeat,	chain:Uncharacterized protein C6orf124,compositionally biased region:Gly-rich,region of interest:4 X 5 AA repeat of A-G-S-K-W-[VAG],repeat:1,repeat:2,repeat:3,repeat:4,splice variant,
202486_at	AFG3 like matrix AAA peptidase subunit 2(AFG3L2)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0007409~axonogenesis,GO:0007528~neuromuscular junction development,GO:0008053~mitochondrial fusion,GO:0021675~nerve development,GO:0034982~mitochondrial protein processing,GO:0036444~calcium ion transmembrane import into mitochondrion,GO:0040014~regulation of multicellular organism growth,GO:0042407~cristae formation,GO:0042552~myelination,GO:0045041~protein import into mitochondrial intermembrane space,GO:0048747~muscle fiber development,GO:0051560~mitochondrial calcium ion homeostasis,GO:0060013~righting reflex,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005745~m-AAA complex,GO:0016021~integral component of membrane,	GO:0004176~ATP-dependent peptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0051082~unfolded protein binding,	IPR000642:Peptidase M41,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR005936:Peptidase, FtsH,IPR011546:Peptidase M41, FtsH extracellular,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		610246~Spinocerebellar ataxia 28,614487~Ataxia, spastic, 5, autosomal recessive,		SM00382:AAA,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Hydrolase,Membrane,Metal-binding,Metalloprotease,Mitochondrion,Neurodegeneration,Nucleotide-binding,Protease,Proteomics identification,Reference proteome,Spinocerebellar ataxia,Transmembrane,Transmembrane helix,Zinc,	chain:AFG3-like protein 2,metal ion-binding site:Zinc; catalytic,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,transmembrane region,
212980_at	AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast)(AHSA2)	Homo sapiens				GO:0032781~positive regulation of ATPase activity,		GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0051087~chaperone binding,	IPR015310:Activator of Hsp90 ATPase, N-terminal,				SM01000:SM01000,	Alternative splicing,Chaperone,Complete proteome,Polymorphism,Reference proteome,Stress response,	chain:Activator of 90 kDa heat shock protein ATPase homolog 2,sequence variant,splice variant,
212992_at	AHNAK nucleoprotein 2(AHNAK2)	Homo sapiens				GO:0001778~plasma membrane repair,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0030659~cytoplasmic vesicle membrane,GO:0042383~sarcolemma,GO:0043034~costamere,	GO:0005515~protein binding,	IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Protein AHNAK2,domain:PDZ,modified residue,sequence conflict,sequence variant,splice variant,
211986_at, 220016_at	AHNAK nucleoprotein(AHNAK)	Homo sapiens			Function unknown,	GO:0043484~regulation of RNA splicing,GO:0051259~protein oligomerization,GO:0098609~cell-cell adhesion,GO:1901385~regulation of voltage-gated calcium channel activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030315~T-tubule,GO:0031982~vesicle,GO:0042383~sarcolemma,GO:0043034~costamere,GO:0044291~cell-cell contact zone,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0044548~S100 protein binding,GO:0044822~poly(A) RNA binding,GO:0097493~structural molecule activity conferring elasticity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Viral nucleoprotein,Virion,	chain:Neuroblast differentiation-associated protein AHNAK,compositionally biased region:Gly-rich,domain:PDZ,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
213367_at	AI894139 pseudogene(LOC155060)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0016021~integral component of membrane,	GO:0003676~nucleic acid binding,	IPR001909:Krueppel-associated box,IPR022137:Protein of unknown function DUF3669, zinc finger protein,				SM00349:KRAB,	Membrane,Transmembrane,Transmembrane helix,	chain:Protein ZNF783,domain:KRAB,modified residue,
218373_at	AKT interacting protein(AKTIP)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0006915~apoptotic process,GO:0007032~endosome organization,GO:0007040~lysosome organization,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0016567~protein ubiquitination,GO:0032092~positive regulation of protein binding,GO:0045022~early endosome to late endosome transport,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030897~HOPS complex,GO:0070695~FHF complex,	GO:0005515~protein binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,					Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:AKT-interacting protein,mutagenesis site,sequence conflict,splice variant,
207163_s_at	AKT serine/threonine kinase 1(AKT1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,37.Akt-PKB_Effector_of_P13K_in_Vivo,83.Growth_factors_Survival_factors_Mitogens,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_crebPathway:Transcription factor CREB and its extracellular signals,h_edg1Pathway:Phospholipids as signalling intermediaries,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_gcrpathway:Corticosteroids and cardioprotection,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_plcPathway:Phospholipase C Signaling Pathway,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_trkaPathway:Trka Receptor Signaling Pathway,		GO:0000060~protein import into nucleus, translocation,GO:0001649~osteoblast differentiation,GO:0001893~maternal placenta development,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0005978~glycogen biosynthetic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006809~nitric oxide biosynthetic process,GO:0006924~activation-induced cell death of T cells,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007281~germ cell development,GO:0007568~aging,GO:0008283~cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0008637~apoptotic mitochondrial changes,GO:0009408~response to heat,GO:0010507~negative regulation of autophagy,GO:0010629~negative regulation of gene expression,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010763~positive regulation of fibroblast migration,GO:0010765~positive regulation of sodium ion transport,GO:0010907~positive regulation of glucose metabolic process,GO:0010951~negative regulation of endopeptidase activity,GO:0010975~regulation of neuron projection development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0015758~glucose transport,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021510~spinal cord development,GO:0030030~cell projection organization,GO:0030154~cell differentiation,GO:0030163~protein catabolic process,GO:0030168~platelet activation,GO:0030212~hyaluronan metabolic process,GO:0030307~positive regulation of cell growth,GO:0030334~regulation of cell migration,GO:0031018~endocrine pancreas development,GO:0031295~T cell costimulation,GO:0031641~regulation of myelination,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031999~negative regulation of fatty acid beta-oxidation,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0032094~response to food,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032287~peripheral nervous system myelin maintenance,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032869~cellular response to insulin stimulus,GO:0032880~regulation of protein localization,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034405~response to fluid shear stress,GO:0035556~intracellular signal transduction,GO:0035655~interleukin-18-mediated signaling pathway,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038128~ERBB2 signaling pathway,GO:0042593~glucose homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043488~regulation of mRNA stability,GO:0043491~protein kinase B signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045792~negative regulation of cell size,GO:0045861~negative regulation of proteolysis,GO:0045907~positive regulation of vasoconstriction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046329~negative regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051146~striated muscle cell differentiation,GO:0060416~response to growth hormone,GO:0060644~mammary gland epithelial cell differentiation,GO:0060709~glycogen cell differentiation involved in embryonic placenta development,GO:0060716~labyrinthine layer blood vessel development,GO:0070141~response to UV-A,GO:0071260~cellular response to mechanical stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071456~cellular response to hypoxia,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:0097194~execution phase of apoptosis,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0100002~negative regulation of protein kinase activity by protein phosphorylation,GO:1900182~positive regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901976~regulation of cell cycle checkpoint,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990418~response to insulin-like growth factor stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005819~spindle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0015630~microtubule cytoskeleton,GO:0031982~vesicle,GO:0036064~ciliary basal body,GO:0043234~protein complex,GO:0098794~postsynapse,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0032794~GTPase activating protein binding,GO:0042802~identical protein binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0051721~protein phosphatase 2A binding,GO:0071889~14-3-3 protein binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	114480~Breast cancer, somatic,114500~Colorectal cancer, somatic,167000~Ovarian cancer, somatic,176920~Proteus syndrome, somatic,181500~Schizophrenia, susceptibility to,615109~Cowden syndrome 6,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Carbohydrate metabolism,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,Disulfide bond,Glucose metabolism,Glycogen biosynthesis,Glycogen metabolism,Glycoprotein,Isopeptide bond,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Sugar transport,Transferase,Translation regulation,Transport,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-alpha serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
203809_s_at, 211453_s_at	AKT serine/threonine kinase 2(AKT2)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0005978~glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0008643~carbohydrate transport,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010907~positive regulation of glucose metabolic process,GO:0018105~peptidyl-serine phosphorylation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031340~positive regulation of vesicle fusion,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032287~peripheral nervous system myelin maintenance,GO:0032869~cellular response to insulin stimulus,GO:0035556~intracellular signal transduction,GO:0045444~fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0060644~mammary gland epithelial cell differentiation,GO:0065002~intracellular protein transmembrane transport,GO:0071156~regulation of cell cycle arrest,GO:0072659~protein localization to plasma membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:0090630~activation of GTPase activity,GO:2000147~positive regulation of cell motility,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0032587~ruffle membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	125853~Diabetes mellitus, type II,240900~Hypoinsulinemic hypoglycemia with hemihypertrophy,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Carbohydrate metabolism,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Diabetes mellitus,Disease mutation,Disulfide bond,Endosome,Glucose metabolism,Glycogen biosynthesis,Glycogen metabolism,Glycoprotein,Isopeptide bond,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Sugar transport,Transferase,Translation regulation,Transport,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-beta serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
212609_s_at, 219393_s_at, 212607_at	AKT serine/threonine kinase 3(AKT3)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	615937~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-gamma serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
203614_at	ALG11, alpha-1,2-mannosyltransferase(ALG11)	Homo sapiens				GO:0097502~mannosylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004377~GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,	IPR001296:Glycosyl transferase, family 1,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	613661~Congenital disorder of glycosylation, type Ip,			Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Asparagine-linked glycosylation protein 11 homolog,chain:U3 small nucleolar RNA-associated protein 14 homolog C,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,transmembrane region,
218444_at	ALG12, alpha-1,6-mannosyltransferase(ALG12)	Homo sapiens				GO:0006457~protein folding,GO:0006487~protein N-linked glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0097502~mannosylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000009~alpha-1,6-mannosyltransferase activity,GO:0000030~mannosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0052917~dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,	IPR005599:GPI mannosyltransferase,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	607143~Congenital disorder of glycosylation, type Ig,			Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl-P-Man:Man(7)GlcNAc(2)-PP- dolichyl-alpha-1,6-mannosyltransferase,sequence conflict,sequence variant,transmembrane region,
205583_s_at, 219015_s_at, 205584_at	ALG13, UDP-N-acetylglucosaminyltransferase subunit(ALG13)	Homo sapiens				GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006508~proteolysis,	GO:0005789~endoplasmic reticulum membrane,GO:0043541~UDP-N-acetylglucosamine transferase complex,	GO:0004577~N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR002999:Tudor domain,IPR003323:Ovarian tumour, otubain,IPR007235:Glycosyl transferase, family 28, C-terminal,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	300884~Congenital disorder of glycosylation, type Is,			Alternative splicing,Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Epilepsy,Glycosyltransferase,Hydrolase,Multifunctional enzyme,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Transferase,Ubl conjugation pathway,	chain:UDP-N-acetylglucosamine transferase subunit ALG13 homolog,chain:Uncharacterized protein CXorf45,sequence conflict,
207396_s_at	ALG3, alpha-1,3- mannosyltransferase(ALG3)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0097502~mannosylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0000033~alpha-1,3-mannosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0052925~dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,	IPR007873:Glycosyltransferase, ALG3,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	601110~Congenital disorder of glycosylation, type Id,			Alternative splicing,Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl-P-Man:Man(5)GlcNAc(2)-PP- dolichyl mannosyltransferase,modified residue,sequence variant,transmembrane region,
218203_at	ALG5, dolichyl-phosphate beta-glucosyltransferase(ALG5)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006487~protein N-linked glycosylation,GO:0006506~GPI anchor biosynthetic process,GO:0007368~determination of left/right symmetry,GO:0018279~protein N-linked glycosylation via asparagine,GO:0019348~dolichol metabolic process,GO:0035269~protein O-linked mannosylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004169~dolichyl-phosphate-mannose-protein mannosyltransferase activity,GO:0004576~oligosaccharyl transferase activity,GO:0004581~dolichyl-phosphate beta-glucosyltransferase activity,GO:0004582~dolichyl-phosphate beta-D-mannosyltransferase activity,	IPR001173:Glycosyl transferase, family 2,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl-phosphate beta- glucosyltransferase,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
219649_at	ALG6, alpha-1,3-glucosyltransferase(ALG6)	Homo sapiens				GO:0006487~protein N-linked glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006490~oligosaccharide-lipid intermediate biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004583~dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0042281~dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,GO:0046527~glucosyltransferase activity,	IPR004856:Glycosyl transferase, ALG6/ALG8,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	603147~Congenital disorder of glycosylation, type Ic,			Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:Dolichyl pyrophosphate Man9GlcNAc2 alpha- 1,3-glucosyltransferase,sequence conflict,sequence variant,transmembrane region,
203545_at	ALG8, alpha-1,3-glucosyltransferase(ALG8)	Homo sapiens				GO:0006487~protein N-linked glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006490~oligosaccharide-lipid intermediate biosynthetic process,GO:0097502~mannosylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0000033~alpha-1,3-mannosyltransferase activity,GO:0004583~dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,GO:0016740~transferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0042281~dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,	IPR004856:Glycosyl transferase, ALG6/ALG8,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	608104~Congenital disorder of glycosylation, type Ih,			Alternative splicing,Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3- glucosyltransferase,sequence conflict,sequence variant,transmembrane region,
219374_s_at	ALG9, alpha-1,2-mannosyltransferase(ALG9)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0097502~mannosylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000026~alpha-1,2-mannosyltransferase activity,GO:0000030~mannosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0052918~dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,GO:0052926~dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,	IPR005599:GPI mannosyltransferase,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	608776~Congenital disorder of glycosylation, type Il,			Alternative splicing,Chromosomal rearrangement,Complete proteome,Congenital disorder of glycosylation,Disease mutation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,2-mannosyltransferase ALG9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,site:Breakpoint for translocation,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
214707_x_at, 214221_at, 214220_s_at	ALMS1, centrosome and basal body associated protein(ALMS1)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0001736~establishment of planar polarity,GO:0006629~lipid metabolic process,GO:0007286~spermatid development,GO:0007605~sensory perception of sound,GO:0016197~endosomal transport,GO:0019722~calcium-mediated signaling,GO:0030728~ovulation,GO:0040015~negative regulation of multicellular organism growth,GO:0042384~cilium assembly,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045598~regulation of fat cell differentiation,GO:0046548~retinal rod cell development,GO:0050673~epithelial cell proliferation,GO:0051492~regulation of stress fiber assembly,GO:0060122~inner ear receptor stereocilium organization,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0031514~motile cilium,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0051393~alpha-actinin binding,			203800~Alstrom syndrome,			Alternative splicing,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cone-rod dystrophy,Cytoplasm,Cytoskeleton,Deafness,Diabetes mellitus,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Alstrom syndrome protein 1,compositionally biased region:Glu-rich,modified residue,region of interest:34 X 47 AA approximate tandem repeat,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33,repeat:34,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,
222333_at	ALS2 C-terminal like(ALS2CL)	Homo sapiens			Function unknown,	GO:0007032~endosome organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0042802~identical protein binding,	IPR000219:Dbl homology (DH) domain,IPR003123:Vacuolar sorting protein 9,IPR003409:MORN motif,				SM00698:MORN,	Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:ALS2 C-terminal-like protein,domain:VPS9,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,repeat:MORN 8,sequence conflict,sequence variant,splice variant,
206837_at	ALX homeobox 1(ALX1)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001502~cartilage condensation,GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009952~anterior/posterior pattern specification,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0030326~embryonic limb morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0060021~palate development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005794~Golgi apparatus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		613456~Frontonasal dysplasia 3,		SM00389:HOX,	Acetylation,Activator,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ALX homeobox protein 1,DNA-binding region:Homeobox,modified residue,sequence conflict,short sequence motif:OAR,
207690_at	ALX homeobox 3(ALX3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007389~pattern specification process,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0042981~regulation of apoptotic process,GO:0048701~embryonic cranial skeleton morphogenesis,	GO:0005634~nucleus,	GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		136760~Frontonasal dysplasia 1,		SM00389:HOX,	Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein aristaless-like 3,DNA-binding region:Homeobox,sequence conflict,sequence variant,
208330_at	ALX homeobox 4(ALX4)	Homo sapiens				GO:0001501~skeletal system development,GO:0001942~hair follicle development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007517~muscle organ development,GO:0009791~post-embryonic development,GO:0009952~anterior/posterior pattern specification,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048704~embryonic skeletal system morphogenesis,GO:0060021~palate development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,GO:0071837~HMG box domain binding,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		609597~Parietal foramina 2,613451~Frontonasal dysplasia 2,615529~Craniosynostosis 5, susceptibility to,		SM00389:HOX,	3D-structure,Activator,Complete proteome,Craniosynostosis,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein aristaless-like 4,compositionally biased region:Poly-Gln,DNA-binding region:Homeobox,sequence conflict,sequence variant,short sequence motif:OAR,
220076_at	ANKH inorganic pyrophosphate transport regulator(ANKH)	Homo sapiens				GO:0001501~skeletal system development,GO:0007626~locomotory behavior,GO:0030500~regulation of bone mineralization,GO:0030505~inorganic diphosphate transport,GO:0035435~phosphate ion transmembrane transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0019867~outer membrane,	GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0030504~inorganic diphosphate transmembrane transporter activity,	IPR009887:Progressive ankylosis,		118600~Chondrocalcinosis 2,123000~Craniometaphyseal dysplasia,			Alternative splicing,Complete proteome,Deafness,Disease mutation,Membrane,Phosphate transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Progressive ankylosis protein homolog,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208772_at, 219081_at, 214919_s_at, 208773_s_at	ANKHD1-EIF4EBP3 readthrough(ANKHD1-EIF4EBP3)	Homo sapiens			General function prediction only,	GO:0045087~innate immune response,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR002110:Ankyrin repeat,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00322:KH,	Acetylation,Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,	chain:Ankyrin repeat and KH domain-containing protein 1,chain:Eukaryotic translation initiation factor 4E-binding protein 3,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:KH,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 12,repeat:ANK 13,repeat:ANK 14,repeat:ANK 15,repeat:ANK 16,repeat:ANK 17,repeat:ANK 18,repeat:ANK 19,repeat:ANK 2,repeat:ANK 20,repeat:ANK 21,repeat:ANK 22,repeat:ANK 23,repeat:ANK 24,repeat:ANK 25,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence variant,splice variant,
220710_at	ANP32A intronic transcript 1(ANP32A-IT1)	Homo sapiens													chain:Putative uncharacterized protein C15orf28,
205434_s_at, 214998_at, 205435_s_at, 211186_s_at, 214956_at	AP2 associated kinase 1(AAK1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006897~endocytosis,GO:0032880~regulation of protein localization,GO:0045747~positive regulation of Notch signaling pathway,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:2000369~regulation of clathrin-mediated endocytosis,	GO:0005737~cytoplasm,GO:0005905~clathrin-coated pit,GO:0019897~extrinsic component of plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0031252~cell leading edge,GO:0043195~terminal bouton,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0035612~AP-2 adaptor complex binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR026105:BMP-2-inducible protein kinase,				SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell membrane,Coated pit,Complete proteome,Endocytosis,Kinase,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:AP2-associated protein kinase 1,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
218698_at	APAF1 interacting protein(APIP)	Homo sapiens				GO:0006915~apoptotic process,GO:0019284~L-methionine biosynthetic process from S-adenosylmethionine,GO:0019509~L-methionine biosynthetic process from methylthioadenosine,GO:0043066~negative regulation of apoptotic process,GO:0051289~protein homotetramerization,GO:0070269~pyroptosis,GO:0070372~regulation of ERK1 and ERK2 cascade,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0046570~methylthioribulose 1-phosphate dehydratase activity,GO:0046872~metal ion binding,	IPR001303:Class II aldolase/adducin N-terminal,IPR017714:Methylthioribulose-1-phosphate dehydratase,IPR027514:Methylthioribulose-1-phosphate dehydratase, eukaryotes,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,			SM01007:SM01007,	3D-structure,Alternative splicing,Amino-acid biosynthesis,Apoptosis,Complete proteome,Cytoplasm,Lyase,Metal-binding,Methionine biosynthesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:APAF1-interacting protein,metal ion-binding site:Zinc,sequence conflict,sequence variant,
203527_s_at, 203525_s_at, 215310_at, 203526_s_at, 216933_x_at	APC, WNT signaling pathway regulator(APC)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,90.IB_and-cat-Arm_processing_of_Ci,97.Immune_injury_MS-lesions_MS_antigen,	h_alkPathway:ALK in cardiac myocytes,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_tgfbPathway:TGF beta signaling pathway,h_wntPathway:WNT Signaling Pathway,		GO:0000281~mitotic cytokinesis,GO:0001708~cell fate specification,GO:0006461~protein complex assembly,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0006974~cellular response to DNA damage stimulus,GO:0007026~negative regulation of microtubule depolymerization,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007155~cell adhesion,GO:0007389~pattern specification process,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0032886~regulation of microtubule-based process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045595~regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060070~canonical Wnt signaling pathway,GO:0070830~bicellular tight junction assembly,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005923~bicellular tight junction,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0030027~lamellipodium,GO:0030877~beta-catenin destruction complex,GO:0032587~ruffle membrane,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0045295~gamma-catenin binding,GO:0045296~cadherin binding,GO:0051010~microtubule plus-end binding,	IPR000225:Armadillo,IPR009223:Adenomatous polyposis coli protein, cysteine-rich repeat,IPR009224:SAMP,IPR009232:EB-1 binding,IPR009234:Adenomatous polyposis coli protein basic domain,IPR009240:Adenomatous polyposis coli protein, 15 residue repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026818:Adenomatous polyposis coli (APC)  family,IPR026831:Adenomatous polyposis coli domain,IPR026836:Adenomatous polyposis coli,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,	114500~Colorectal cancer, somatic,114550~Hepatoblastoma, somatic,135290~Desmoid disease, hereditary,175100~Adenomatous polyposis coli,175100~Brain tumor-polyposis syndrome 2,175100~Gardner syndrome,613659~Gastric cancer, somatic,Adenoma, periampullary, somatic~Adenoma, periampullary, somatic,		SM00185:ARM,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Adenomatous polyposis coli protein,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Leu-rich,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,region of interest:Highly charged,region of interest:Responsible for down-regulation through a process mediated by direct ubiquitination,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,sequence conflict,sequence variant,short sequence motif:PDZ-binding,splice variant,turn,
205320_at, 217174_s_at	APC2, WNT signaling pathway regulator(APC2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0001708~cell fate specification,GO:0007026~negative regulation of microtubule depolymerization,GO:0007389~pattern specification process,GO:0008283~cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0030178~negative regulation of Wnt signaling pathway,GO:0035414~negative regulation of catenin import into nucleus,GO:0045595~regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005884~actin filament,GO:0015630~microtubule cytoskeleton,GO:0016342~catenin complex,GO:0030877~beta-catenin destruction complex,GO:0031258~lamellipodium membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0045295~gamma-catenin binding,	IPR000225:Armadillo,IPR009223:Adenomatous polyposis coli protein, cysteine-rich repeat,IPR009224:SAMP,IPR009234:Adenomatous polyposis coli protein basic domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026818:Adenomatous polyposis coli (APC)  family,IPR026831:Adenomatous polyposis coli domain,IPR026837:Adenomatous polyposis coli 2,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,			SM00185:ARM,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Wnt signaling pathway,	chain:Adenomatous polyposis coli protein 2,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,region of interest:5 X 20 AA approximate repeat of F-X-V-E- X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S,region of interest:Interaction with CTNNB1,region of interest:Interaction with MAPRE1 and MAPRE3,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,sequence conflict,sequence variant,splice variant,
213454_at	APITD1-CORT readthrough(APITD1-CORT)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0006281~DNA repair,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0031297~replication fork processing,GO:0031398~positive regulation of protein ubiquitination,GO:0034080~CENP-A containing nucleosome assembly,GO:0036297~interstrand cross-link repair,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,GO:0071821~FANCM-MHF complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR009072:Histone-fold,IPR018142:Somatostatin/Cortistatin, C-terminal,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Kinetochore,Mitosis,Nucleus,Proteomics identification,Reference proteome,
220951_s_at	APOBEC1 complementation factor(A1CF)	Homo sapiens				GO:0006397~mRNA processing,GO:0010609~mRNA localization resulting in posttranscriptional regulation of gene expression,GO:0016554~cytidine to uridine editing,GO:0016556~mRNA modification,GO:0050821~protein stabilization,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0030895~apolipoprotein B mRNA editing enzyme complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR006535:HnRNP R/Q splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014720:Double-stranded RNA-binding-like domain,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,mRNA processing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:APOBEC1 complementation factor,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,mutagenesis site,region of interest:Required for nuclear localization,sequence conflict,sequence variant,splice variant,strand,
210873_x_at	APOBEC3A and APOBEC3B deletion hybrid(APOBEC3A_B)	Homo sapiens				GO:0010529~negative regulation of transposition,GO:0044356~clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0051607~defense response to virus,GO:0070383~DNA cytosine deamination,GO:0071466~cellular response to xenobiotic stimulus,GO:0080111~DNA demethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004126~cytidine deaminase activity,GO:0008270~zinc ion binding,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,GO:0047844~deoxycytidine deaminase activity,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR013158:APOBEC-like, N-terminal,IPR016192:APOBEC/CMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,					3D-structure,Alternative initiation,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Immunity,Innate immunity,Lipoprotein,Metal-binding,Nucleus,Polymorphism,Reference proteome,Zinc,
204561_x_at, 206738_at	APOC4-APOC2 readthrough (NMD candidate)(APOC4-APOC2)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006869~lipid transport,	GO:0042627~chylomicron,	GO:0008047~enzyme activator activity,	IPR008019:Apolipoprotein C-II,IPR023121:ApoC-II domain,					Complete proteome,Proteomics identification,Reference proteome,Signal,
200721_s_at, 200720_s_at	ARP1 actin-related protein 1 homolog A, centractin alpha(ACTR1A)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0016192~vesicle-mediated transport,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005869~dynactin complex,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:1990752~microtubule end,	GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Alpha-centractin,modified residue,
202135_s_at	ARP1 actin-related protein 1 homolog B, centractin beta(ACTR1B)	Homo sapiens				GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005869~dynactin complex,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:1990752~microtubule end,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nitration,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Beta-centractin,modified residue,sequence variant,
200729_s_at, 200727_s_at, 200728_at	ARP2 actin related protein 2 homolog(ACTR2)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0008356~asymmetric cell division,GO:0016344~meiotic chromosome movement towards spindle pole,GO:0016482~cytosolic transport,GO:0033206~meiotic cytokinesis,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042384~cilium assembly,GO:0048013~ephrin receptor signaling pathway,GO:0051653~spindle localization,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030478~actin cap,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005524~ATP binding,GO:0051015~actin filament binding,	IPR004000:Actin-related protein,IPR020902:Actin/actin-like conserved site,IPR027306:Actin-related protein 2 (Arp2),				SM00268:ACTIN,	Acetylation,Actin-binding,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Actin-related protein 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
218868_at	ARP3 actin related protein 3 homolog B(ACTR3B)	Homo sapiens				GO:0034314~Arp2/3 complex-mediated actin nucleation,	GO:0005737~cytoplasm,GO:0005885~Arp2/3 protein complex,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005524~ATP binding,	IPR004000:Actin-related protein,IPR015623:Actin-related protein 3 (Arp3),IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,Actin-binding,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Actin-related protein 3B,modified residue,sequence variant,splice variant,
213102_at, 213101_s_at, 200996_at	ARP3 actin related protein 3 homolog(ACTR3)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_rhoPathway:Rho cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0008356~asymmetric cell division,GO:0016344~meiotic chromosome movement towards spindle pole,GO:0033206~meiotic cytokinesis,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048013~ephrin receptor signaling pathway,GO:0051653~spindle localization,GO:0060271~cilium morphogenesis,	GO:0005829~cytosol,GO:0005885~Arp2/3 protein complex,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0070062~extracellular exosome,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051015~actin filament binding,	IPR004000:Actin-related protein,IPR015623:Actin-related protein 3 (Arp3),IPR020902:Actin/actin-like conserved site,				SM00268:ACTIN,	Acetylation,Actin-binding,ATP-binding,Cell projection,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Actin-related protein 3,modified residue,
219623_at, 222147_s_at	ARP5 actin-related protein 5 homolog(ACTR5)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0070914~UV-damage excision repair,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031011~Ino80 complex,	GO:0005515~protein binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,				SM00268:ACTIN,	Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA recombination,DNA repair,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Actin-related protein 5,sequence conflict,sequence variant,
218395_at	ARP6 actin-related protein 6 homolog(ACTR6)	Homo sapiens				GO:0006338~chromatin remodeling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0005515~protein binding,	IPR004000:Actin-related protein,				SM00268:ACTIN,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Proteomics identification,Reference proteome,	chain:Actin-related protein 6,modified residue,sequence conflict,
218658_s_at	ARP8 actin-related protein 8 homolog(ACTR8)	Homo sapiens				GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0031011~Ino80 complex,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR004000:Actin-related protein,				SM00268:ACTIN,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Chromosome,Complete proteome,DNA damage,DNA recombination,DNA repair,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Actin-related protein 8,modified residue,sequence conflict,sequence variant,
210129_s_at, 211672_s_at, 203670_at	ARPC4-TTLL3 readthrough(ARPC4-TTLL3)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0030041~actin filament polymerization,GO:0034314~Arp2/3 complex-mediated actin nucleation,	GO:0005737~cytoplasm,GO:0005885~Arp2/3 protein complex,		IPR004344:Tubulin-tyrosine ligase,IPR008384:ARP2/3 complex, 20kDa subunit (P20-Arc),					Actin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Reference proteome,
218554_s_at	ASH1 like histone lysine methyltransferase(ASH1L)	Homo sapiens				GO:0002674~negative regulation of acute inflammatory response,GO:0006323~DNA packaging,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0032635~interleukin-6 production,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043409~negative regulation of MAPK cascade,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051568~histone H3-K4 methylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005923~bicellular tight junction,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001025:Bromo adjacent homology (BAH) domain,IPR001214:SET domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR006560:AWS,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017956:AT hook, DNA-binding motif,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	hsa00310:Lysine degradation,			SM00249:PHD,SM00297:BROMO,SM00317:SET,SM00384:AT_hook,SM00439:BAH,SM00570:AWS,	3D-structure,Acetylation,Activator,Alternative splicing,Bromodomain,Cell junction,Chromatin regulator,Chromosome,Complete proteome,Isopeptide bond,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Tight junction,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:Probable histone-lysine N- methyltransferase ASH1L,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,domain:AWS,domain:BAH,domain:Bromo,domain:Post-SET,domain:SET,modified residue,sequence conflict,sequence variant,zinc finger region:PHD-type,
209517_s_at	ASH2 like histone lysine methyltransferase complex subunit(ASH2L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051568~histone H3-K4 methylation,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,GO:0048188~Set1C/COMPASS complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008168~methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:1990188~euchromatin binding,	IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	chain:Set1/Ash2 histone methyltransferase complex subunit ASH2,domain:B30.2/SPRY,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
207288_at	ASMTL antisense RNA 1(ASMTL-AS1)	Homo sapiens													chain:Putative uncharacterized protein encoded by NCRNA00105,sequence conflict,splice variant,
218908_at	ASPSCR1, UBX domain containing tether for SLC2A4(ASPSCR1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0042593~glucose homeostasis,GO:0046324~regulation of glucose import,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0019898~extrinsic component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR001012:UBX,IPR021569:GLUT4 regulating protein TUG,	hsa05202:Transcriptional misregulation in cancer,	606243~Alveolar soft-part sarcoma,			Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Tether containing UBX domain for GLUT4,domain:UBX,modified residue,region of interest:Interaction with GLUT4,sequence conflict,sequence variant,site:Breakpoint for translocation to form ASPSCR1-TFE3,splice variant,
205002_at	AT-hook DNA binding motif containing 1(AHDC1)	Homo sapiens						GO:0003677~DNA binding,			615829~Xia-Gibbs syndrome,			Acetylation,Complete proteome,DNA-binding,Mental retardation,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:A.T hook DNA-binding motif-containing protein 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,modified residue,sequence conflict,sequence variant,
214766_s_at	AT-hook containing transcription factor 1(AHCTF1)	Homo sapiens				GO:0000910~cytokinesis,GO:0006355~regulation of transcription, DNA-templated,GO:0007062~sister chromatid cohesion,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000777~condensed chromosome kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR025151:ELYS-like domain,					Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,DNA-binding,Kinetochore,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Protein ELYS,DNA-binding region:A.T hook,modified residue,region of interest:Mediates transcriptional activity,region of interest:Necessary for cytoplasmic localization,region of interest:Necessary for nuclear localization,sequence conflict,sequence variant,splice variant,
210649_s_at, 218917_s_at, 212152_x_at, 207591_s_at	AT-rich interaction domain 1A(ARID1A)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0003205~cardiac chamber development,GO:0003408~optic cup formation involved in camera-type eye development,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016569~covalent chromatin modification,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030900~forebrain development,GO:0042766~nucleosome mobilization,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048096~chromatin-mediated maintenance of transcription,GO:0055007~cardiac muscle cell differentiation,GO:0060674~placenta blood vessel development,GO:1901998~toxin transport,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031491~nucleosome binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021906:Protein of unknown function DUF3518,		614607~Mental retardation, autosomal dominant 14,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AT-rich interactive domain-containing protein 1A,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,domain:ARID,helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:LXXLL,splice variant,strand,turn,
205865_at	AT-rich interaction domain 3A(ARID3A)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0045121~membrane raft,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR023334:REKLES domain,				SM00501:BRIGHT,	3D-structure,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:AT-rich interactive domain-containing protein 3A,compositionally biased region:Ala-rich,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,domain:ARID,domain:NAP,helix,modified residue,mutagenesis site,region of interest:Homodimerization,region of interest:Important for cytoplasmic localization,region of interest:Important for nuclear localization,sequence conflict,sequence variant,
218964_at	AT-rich interaction domain 3B(ARID3B)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR023334:REKLES domain,				SM00501:BRIGHT,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	chain:AT-rich interactive domain-containing protein 3B,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ala,compositionally biased region:Ser-rich,domain:ARID,modified residue,mutagenesis site,region of interest:Interaction with ARID3A,region of interest:Interaction with RB1,sequence conflict,splice variant,
205062_x_at	AT-rich interaction domain 4A(ARID4A)	Homo sapiens				GO:0006349~regulation of gene expression by genetic imprinting,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0016575~histone deacetylation,GO:0034773~histone H4-K20 trimethylation,GO:0036124~histone H3-K9 trimethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048821~erythrocyte development,GO:0080182~histone H3-K4 trimethylation,GO:0097368~establishment of Sertoli cell barrier,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0044212~transcription regulatory region DNA binding,	IPR000953:Chromo domain/shadow,IPR001606:ARID/BRIGHT DNA-binding domain,IPR002999:Tudor domain,IPR012603:RBB1NT,IPR016197:Chromo domain-like,IPR025995:RNA binding activity-knot of a chromodomain,				SM00298:CHROMO,SM00333:TUDOR,SM00501:BRIGHT,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:AT-rich interactive domain-containing protein 4A,domain:ARID,helix,modified residue,region of interest:Retinoblastoma protein binding,sequence conflict,sequence variant,splice variant,strand,turn,
221230_s_at, 214139_at	AT-rich interaction domain 4B(ARID4B)	Homo sapiens				GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0016575~histone deacetylation,GO:0034773~histone H4-K20 trimethylation,GO:0036124~histone H3-K9 trimethylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097368~establishment of Sertoli cell barrier,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR002999:Tudor domain,IPR012603:RBB1NT,IPR016197:Chromo domain-like,IPR025995:RNA binding activity-knot of a chromodomain,				SM00333:TUDOR,SM00501:BRIGHT,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:AT-rich interactive domain-containing protein 4B,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:ARID,modified residue,region of interest:Antigenic epitope,sequence conflict,splice variant,
213138_at	AT-rich interaction domain 5A(ARID5A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001606:ARID/BRIGHT DNA-binding domain,				SM00501:BRIGHT,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:AT-rich interactive domain-containing protein 5A,domain:ARID,modified residue,
212614_at	AT-rich interaction domain 5B(ARID5B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001822~kidney development,GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0009791~post-embryonic development,GO:0010761~fibroblast migration,GO:0016577~histone demethylation,GO:0030325~adrenal gland development,GO:0035264~multicellular organism growth,GO:0045444~fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048468~cell development,GO:0048644~muscle organ morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060021~palate development,GO:0060325~face morphogenesis,GO:0060612~adipose tissue development,GO:0060613~fat pad development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0032452~histone demethylase activity,GO:0044212~transcription regulatory region DNA binding,	IPR001606:ARID/BRIGHT DNA-binding domain,				SM00501:BRIGHT,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:AT-rich interactive domain-containing protein 5B,domain:ARID,helix,modified residue,sequence conflict,splice variant,strand,turn,
201855_s_at, 201854_s_at	ATM interactor(ATMIN)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060271~cilium morphogenesis,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0045502~dynein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA damage,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:ATM interactor,compositionally biased region:Ala-rich,region of interest:Required for formation of RAD51 foci,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; degenerate,
210858_x_at, 208442_s_at, 212672_at	ATM serine/threonine kinase(ATM)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007004~telomere maintenance via telomerase,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030889~negative regulation of B cell proliferation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033129~positive regulation of histone phosphorylation,GO:0033151~V(D)J recombination,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0046777~protein autophosphorylation,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0051972~regulation of telomerase activity,GO:0071044~histone mRNA catabolic process,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0072434~signal transduction involved in mitotic G2 DNA damage checkpoint,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:1990391~DNA repair complex,	GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016740~transferase activity,GO:0032403~protein complex binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR014009:PIK-related kinase,IPR015519:ATM/Tel1,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021668:Telomere-length maintenance and DNA damage repair,	hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	114480~Breast cancer, susceptibility to,208900~Ataxia-telangiectasia,Lymphoma, B-cell non-Hodgkin, somatic~Lymphoma, B-cell non-Hodgkin, somatic,Lymphoma, mantle cell~Lymphoma, mantle cell,T-cell prolymphocytic leukemia, somatic~T-cell prolymphocytic leukemia, somatic,		SM00146:PI3Kc,SM01342:SM01342,SM01343:SM01343,	Acetylation,ATP-binding,Cell cycle,Complete proteome,Cytoplasmic vesicle,Disease mutation,DNA damage,DNA-binding,Kinase,Neurodegeneration,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	chain:Serine-protein kinase ATM,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,region of interest:Interaction with ABL1,sequence conflict,sequence variant,splice variant,
216066_at, 203504_s_at, 203505_at	ATP binding cassette subfamily A member 1(ABCA1)	Homo sapiens		h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0002790~peptide secretion,GO:0006497~protein lipidation,GO:0006911~phagocytosis, engulfment,GO:0007040~lysosome organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007584~response to nutrient,GO:0008203~cholesterol metabolic process,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010875~positive regulation of cholesterol efflux,GO:0010887~negative regulation of cholesterol storage,GO:0015917~aminophospholipid transport,GO:0016197~endosomal transport,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0032367~intracellular cholesterol transport,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034380~high-density lipoprotein particle assembly,GO:0034616~response to laminar fluid shear stress,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0042157~lipoprotein metabolic process,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0043691~reverse cholesterol transport,GO:0045332~phospholipid translocation,GO:0050702~interleukin-1 beta secretion,GO:0055091~phospholipid homeostasis,GO:0055098~response to low-density lipoprotein particle,GO:0060155~platelet dense granule organization,GO:0071222~cellular response to lipopolysaccharide,GO:0071300~cellular response to retinoic acid,GO:0071397~cellular response to cholesterol,GO:0090107~regulation of high-density lipoprotein particle assembly,GO:0098656~anion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0030139~endocytic vesicle,GO:0034364~high-density lipoprotein particle,GO:0045121~membrane raft,GO:0045335~phagocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0005102~receptor binding,GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015485~cholesterol binding,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0019905~syntaxin binding,GO:0031267~small GTPase binding,GO:0034185~apolipoprotein binding,GO:0034186~apolipoprotein A-I binding,GO:0034188~apolipoprotein A-I receptor activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0051117~ATPase binding,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090556~phosphatidylserine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04975:Fat digestion and absorption,	143890~Coronary artery disease in familial hypercholesterolemia, protection against,205400~Tangier disease,604091~HDL deficiency, type 2,		SM00382:AAA,	Atherosclerosis,ATP-binding,Cholesterol metabolism,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Lipid metabolism,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 1,disulfide bond,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Extracellular,transmembrane region,
220159_at	ATP binding cassette subfamily A member 11, pseudogene(ABCA11P)	Homo sapiens				GO:0006810~transport,	GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003439:ABC transporter-like,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Reference proteome,	chain:Putative ATP-binding cassette sub-family A member 11,modified residue,sequence conflict,
215465_at	ATP binding cassette subfamily A member 12(ABCA12)	Homo sapiens				GO:0006869~lipid transport,GO:0010875~positive regulation of cholesterol efflux,GO:0019725~cellular homeostasis,GO:0031424~keratinization,GO:0032940~secretion by cell,GO:0033700~phospholipid efflux,GO:0035627~ceramide transport,GO:0043129~surfactant homeostasis,GO:0045055~regulated exocytosis,GO:0048286~lung alveolus development,GO:0055085~transmembrane transport,GO:0055088~lipid homeostasis,GO:0061436~establishment of skin barrier,GO:0072659~protein localization to plasma membrane,GO:2000010~positive regulation of protein localization to cell surface,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0097209~epidermal lamellar body,	GO:0005102~receptor binding,GO:0005215~transporter activity,GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0034040~lipid-transporting ATPase activity,GO:0034191~apolipoprotein A-I receptor binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	242500~Ichthyosis, autosomal recessive 4B (harlequin),601277~Ichthyosis, congenital, autosomal recessive 4A,		SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ichthyosis,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 12,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
210100_s_at, 210099_at, 212772_s_at	ATP binding cassette subfamily A member 2(ABCA2)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0032383~regulation of intracellular cholesterol transport,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0048545~response to steroid hormone,GO:0055085~transmembrane transport,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005815~microtubule organizing center,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0043190~ATP-binding cassette (ABC) transporter complex,	GO:0000166~nucleotide binding,GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04142:Lysosome,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Endosome,Glycoprotein,Lysosome,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
204343_at	ATP binding cassette subfamily A member 3(ABCA3)	Homo sapiens				GO:0006810~transport,GO:0006869~lipid transport,GO:0042493~response to drug,GO:0044267~cellular protein metabolic process,GO:0051384~response to glucocorticoid,GO:0055085~transmembrane transport,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0097208~alveolar lamellar body,GO:0097232~lamellar body membrane,GO:0097233~alveolar lamellar body membrane,	GO:0005215~transporter activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR026969:ATP-binding cassette sub-family A member 3,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	610921~Surfactant metabolism dysfunction, pulmonary, 3,		SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 3,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,transmembrane region,
210082_at	ATP binding cassette subfamily A member 4(ABCA4)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006649~phospholipid transfer to membrane,GO:0006810~transport,GO:0006869~lipid transport,GO:0007601~visual perception,GO:0007603~phototransduction, visible light,GO:0045332~phospholipid translocation,GO:0045494~photoreceptor cell maintenance,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0097381~photoreceptor disc membrane,	GO:0005215~transporter activity,GO:0005395~eye pigment precursor transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005951:Rim ABC transporter,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	153800~Macular degeneration, age-related, 2,248200~Fundus flavimaculatus,248200~Retinal dystrophy, early-onset severe,248200~Stargardt disease 1,601718~Retinitis pigmentosa 19,604116~Cone-rod dystrophy 3,		SM00382:AAA,	Age-related macular degeneration,ATP-binding,Complete proteome,Cone-rod dystrophy,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Sensory transduction,Stargardt disease,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Retinal-specific ATP-binding cassette transporter,disulfide bond,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Extracellular,transmembrane region,
213353_at	ATP binding cassette subfamily A member 5(ABCA5)	Homo sapiens			Defense mechanisms,	GO:0006869~lipid transport,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0033344~cholesterol efflux,GO:0034375~high-density lipoprotein particle remodeling,GO:0043691~reverse cholesterol transport,GO:0055085~transmembrane transport,	GO:0000139~Golgi membrane,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Endosome,Glycoprotein,Golgi apparatus,Lysosome,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 5,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
217504_at	ATP binding cassette subfamily A member 6(ABCA6)	Homo sapiens			Defense mechanisms,	GO:0006869~lipid transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 6,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
219577_s_at	ATP binding cassette subfamily A member 7(ABCA7)	Homo sapiens				GO:0006909~phagocytosis,GO:0007613~memory,GO:0010875~positive regulation of cholesterol efflux,GO:0015917~aminophospholipid transport,GO:0018149~peptide cross-linking,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034380~high-density lipoprotein particle assembly,GO:0034504~protein localization to nucleus,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,GO:0045332~phospholipid translocation,GO:0050766~positive regulation of phagocytosis,GO:0055085~transmembrane transport,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1900223~positive regulation of beta-amyloid clearance,GO:1901076~positive regulation of engulfment of apoptotic cell,GO:1902430~negative regulation of beta-amyloid formation,GO:1902995~positive regulation of phospholipid efflux,	GO:0000139~Golgi membrane,GO:0001891~phagocytic cup,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0031901~early endosome membrane,GO:0032587~ruffle membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0034188~apolipoprotein A-I receptor activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090556~phosphatidylserine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,Alzheimer disease,Amyloidosis,ATP-binding,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Membrane,Neurodegeneration,Nucleotide-binding,Phagocytosis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 7,disulfide bond,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,topological domain:Extracellular,transmembrane region,
204719_at	ATP binding cassette subfamily A member 8(ABCA8)	Homo sapiens			Defense mechanisms,	GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0006869~lipid transport,GO:0042908~xenobiotic transport,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 8,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence variant,splice variant,transmembrane region,
209994_s_at, 209993_at	ATP binding cassette subfamily B member 1(ABCB1)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,	Defense mechanisms,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0042493~response to drug,GO:0042908~xenobiotic transport,GO:0045332~phospholipid translocation,GO:0055085~transmembrane transport,GO:0072089~stem cell proliferation,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,hsa05206:MicroRNAs in cancer,	120080~Colchicine resistance,612244~Inflammatory bowel disease 13,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance protein 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
208288_at, 211224_s_at	ATP binding cassette subfamily B member 11(ABCB11)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Defense mechanisms,	GO:0006699~bile acid biosynthetic process,GO:0006810~transport,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0035725~sodium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0008554~sodium-exporting ATPase activity, phosphorylative mechanism,GO:0015126~canalicular bile acid transmembrane transporter activity,GO:0015432~bile acid-exporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	601847~Cholestasis, progressive familial intrahepatic 2,605479~Cholestasis, benign recurrent intrahepatic, 2,		SM00382:AAA,	ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Intrahepatic cholestasis,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Bile salt export pump,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Interaction with HAX1,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207819_s_at	ATP binding cassette subfamily B member 4(ABCB4)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Defense mechanisms,Posttranslational modification, protein turnover, chaperones,	GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0032376~positive regulation of cholesterol transport,GO:0032782~bile acid secretion,GO:0042493~response to drug,GO:0042908~xenobiotic transport,GO:0045332~phospholipid translocation,GO:0055085~transmembrane transport,GO:0055088~lipid homeostasis,GO:0061092~positive regulation of phospholipid translocation,GO:1901557~response to fenofibrate,GO:1903413~cellular response to bile acid,GO:2001140~positive regulation of phospholipid transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0045121~membrane raft,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0008525~phosphatidylcholine transporter activity,GO:0008559~xenobiotic-transporting ATPase activity,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090554~phosphatidylcholine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	600803~Gallbladder disease 1,602347~Cholestasis, progressive familial intrahepatic 3,614972~Cholestasis, intrahepatic, of pregnancy, 3,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Disease mutation,Glycoprotein,Hydrolase,Intrahepatic cholestasis,Lipid transport,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance protein 3,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,region of interest:Interaction with HAX1,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203191_at, 203192_at	ATP binding cassette subfamily B member 6 (Langereis blood group)(ABCB6)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006779~porphyrin-containing compound biosynthetic process,GO:0006810~transport,GO:0006879~cellular iron ion homeostasis,GO:0007420~brain development,GO:0015886~heme transport,GO:0043588~skin development,GO:0055085~transmembrane transport,	GO:0000139~Golgi membrane,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0015232~heme transporter activity,GO:0015439~heme-transporting ATPase activity,GO:0015562~efflux transmembrane transporter activity,GO:0020037~heme binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	111600~Blood group, Langereis system,609153~Pseudohyperkalemia, familial, 2, due to red cell leak,614497~Microphthalmia, isolated, with coloboma 7,615402~Dyschromatosis universalis hereditaria 3,		SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Dyskeratosis congenita,Endoplasmic reticulum,Endosome,Golgi apparatus,Membrane,Microphthalmia,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 6, mitochondrial,domain:ABC transmembrane type-1,domain:ABC transporter,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,transmembrane region,
209620_s_at	ATP binding cassette subfamily B member 7(ABCB7)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006810~transport,GO:0006879~cellular iron ion homeostasis,GO:0015886~heme transport,GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0015232~heme transporter activity,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	301310~Anemia, sideroblastic, with ataxia,		SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 7, mitochondrial,domain:ABC transmembrane type-1,domain:ABC transporter,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,transmembrane region,
207561_s_at, 206317_s_at	ATP binding cassette subfamily B member 8(ABCB8)	Homo sapiens			Defense mechanisms,	GO:0006810~transport,GO:0055085~transmembrane transport,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 8, mitochondrial,domain:ABC transmembrane type-1,domain:ABC transporter,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,transmembrane region,
207321_s_at, 214209_s_at	ATP binding cassette subfamily B member 9(ABCB9)	Homo sapiens				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0035672~oligopeptide transmembrane transport,GO:0055085~transmembrane transport,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015421~oligopeptide-transporting ATPase activity,GO:0015440~peptide-transporting ATPase activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04142:Lysosome,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Lysosome,Membrane,Nucleotide-binding,Peptide transport,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 9,compositionally biased region:Poly-Glu,domain:ABC transmembrane type-1,domain:ABC transporter,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,splice variant,transmembrane region,
202805_s_at, 202804_at	ATP binding cassette subfamily C member 1(ABCC1)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,	Defense mechanisms,	GO:0006691~leukotriene metabolic process,GO:0006810~transport,GO:0009235~cobalamin metabolic process,GO:0015889~cobalamin transport,GO:0035461~vitamin transmembrane transport,GO:0042493~response to drug,GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0015420~cobalamin-transporting ATPase activity,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005292:Multi drug resistance-associated protein,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04071:Sphingolipid signaling pathway,hsa04977:Vitamin digestion and absorption,hsa05206:MicroRNAs in cancer,			SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	binding site:ATP 1,chain:Multidrug resistance-associated protein 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
213485_s_at, 215873_x_at	ATP binding cassette subfamily C member 10(ABCC10)	Homo sapiens			Defense mechanisms,	GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance-associated protein 7,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
206155_at	ATP binding cassette subfamily C member 2(ABCC2)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0015723~bilirubin transport,GO:0015732~prostaglandin transport,GO:0030644~cellular chloride ion homeostasis,GO:0031427~response to methotrexate,GO:0043627~response to estrogen,GO:0046685~response to arsenic-containing substance,GO:0048545~response to steroid hormone,GO:0055085~transmembrane transport,GO:0070327~thyroid hormone transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0046581~intercellular canaliculus,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008514~organic anion transmembrane transporter activity,GO:0015127~bilirubin transmembrane transporter activity,GO:0019904~protein domain specific binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005292:Multi drug resistance-associated protein,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	237500~Dubin-Johnson syndrome,		SM00382:AAA,	ATP-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Canalicular multispecific organic anion transporter 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208161_s_at, 209641_s_at	ATP binding cassette subfamily C member 3(ABCC3)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006810~transport,GO:0015721~bile acid and bile salt transport,GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,	GO:0005524~ATP binding,GO:0008514~organic anion transmembrane transporter activity,GO:0015432~bile acid-exporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005292:Multi drug resistance-associated protein,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Canalicular multispecific organic anion transporter 2,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203196_at	ATP binding cassette subfamily C member 4(ABCC4)	Homo sapiens			Defense mechanisms,	GO:0002576~platelet degranulation,GO:0010243~response to organonitrogen compound,GO:0014070~response to organic cyclic compound,GO:0032310~prostaglandin secretion,GO:0042384~cilium assembly,GO:0042493~response to drug,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0055085~transmembrane transport,GO:0055114~oxidation-reduction process,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0031088~platelet dense granule membrane,	GO:0005524~ATP binding,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016404~15-hydroxyprostaglandin dehydrogenase (NAD+) activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04024:cAMP signaling pathway,hsa04976:Bile secretion,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance-associated protein 4,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
209380_s_at	ATP binding cassette subfamily C member 5(ABCC5)	Homo sapiens			Defense mechanisms,	GO:0006810~transport,GO:0015711~organic anion transport,GO:0030213~hyaluronan biosynthetic process,GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0008514~organic anion transmembrane transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance-associated protein 5,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,transmembrane region,
208480_s_at, 214033_at, 215559_at	ATP binding cassette subfamily C member 6(ABCC6)	Homo sapiens				GO:0006810~transport,GO:0007601~visual perception,GO:0042493~response to drug,GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005292:Multi drug resistance-associated protein,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	177850~Pseudoxanthoma elasticum, forme fruste,264800~Pseudoxanthoma elasticum,614473~Arterial calcification, generalized, of infancy, 2,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Sensory transduction,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Multidrug resistance-associated protein 6,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210246_s_at, 210245_at	ATP binding cassette subfamily C member 8(ABCC8)	Homo sapiens			Defense mechanisms,Energy production and conversion / Posttranslational modification, protein turnover, chaperones,	GO:0006813~potassium ion transport,GO:0007165~signal transduction,GO:0009268~response to pH,GO:0010043~response to zinc ion,GO:0032496~response to lipopolysaccharide,GO:0032868~response to insulin,GO:0042493~response to drug,GO:0043268~positive regulation of potassium ion transport,GO:0046676~negative regulation of insulin secretion,GO:0050796~regulation of insulin secretion,GO:0055085~transmembrane transport,GO:0071310~cellular response to organic substance,GO:0071805~potassium ion transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,GO:0030672~synaptic vesicle membrane,GO:0042383~sarcolemma,	GO:0005267~potassium channel activity,GO:0005524~ATP binding,GO:0008281~sulfonylurea receptor activity,GO:0015272~ATP-activated inward rectifier potassium channel activity,GO:0019905~syntaxin binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,GO:0044325~ion channel binding,	IPR000388:Sulphonylurea receptor,IPR000844:Sulphonylurea receptor, type 1,IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04911:Insulin secretion,hsa04930:Type II diabetes mellitus,	125853~Diabetes mellitus, noninsulin-dependent,240800~Hypoglycemia of infancy, leucine-sensitive,256450~Hyperinsulinemic hypoglycemia, familial, 1,606176~Diabetes mellitus, permanent neonatal,610374~Diabetes mellitus, transient neonatal 2,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Diabetes mellitus,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette transporter sub- family C member 8,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208561_at, 208462_s_at, 208562_s_at	ATP binding cassette subfamily C member 9(ABCC9)	Homo sapiens			Defense mechanisms,	GO:0006813~potassium ion transport,GO:0007165~signal transduction,GO:0010107~potassium ion import,GO:0051607~defense response to virus,GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0008282~ATP-sensitive potassium channel complex,GO:0016021~integral component of membrane,GO:0030017~sarcomere,GO:0042383~sarcolemma,	GO:0005215~transporter activity,GO:0005267~potassium channel activity,GO:0005524~ATP binding,GO:0008281~sulfonylurea receptor activity,GO:0015459~potassium channel regulator activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043225~anion transmembrane-transporting ATPase activity,GO:0044325~ion channel binding,	IPR000388:Sulphonylurea receptor,IPR001475:Sulphonylurea receptor, type 2,IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,	239850~Hypertrichotic osteochondrodysplasia,608569~Cardiomyopathy, dilated, 1O,614050~Atrial fibrillation, familial, 12,		SM00382:AAA,	Alternative splicing,ATP-binding,Atrial fibrillation,Cardiomyopathy,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Receptor,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette transporter sub- family C member 9,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205142_x_at	ATP binding cassette subfamily D member 1(ABCD1)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0007031~peroxisome organization,GO:0015910~peroxisomal long-chain fatty acid import,GO:0015919~peroxisomal membrane transport,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0036109~alpha-linolenic acid metabolic process,GO:0042758~long-chain fatty acid catabolic process,GO:0042760~very long-chain fatty acid catabolic process,GO:0043651~linoleic acid metabolic process,GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005779~integral component of peroxisomal membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005215~transporter activity,GO:0005324~long-chain fatty acid transporter activity,GO:0005325~peroxisomal fatty-acyl-CoA transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005283:Peroxysomal long chain fatty acyl transporter,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	300100~Adrenoleukodystrophy,300100~Adrenomyeloneuropathy, adult,		SM00382:AAA,	ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 1,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,sequence conflict,sequence variant,transmembrane region,
207583_at	ATP binding cassette subfamily D member 2(ABCD2)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0000038~very long-chain fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0015909~long-chain fatty acid transport,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0042760~very long-chain fatty acid catabolic process,GO:0055085~transmembrane transport,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,			SM00382:AAA,	ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 2,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,sequence conflict,sequence variant,transmembrane region,
202850_at	ATP binding cassette subfamily D member 3(ABCD3)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006633~fatty acid biosynthetic process,GO:0006635~fatty acid beta-oxidation,GO:0007031~peroxisome organization,GO:0014070~response to organic cyclic compound,GO:0015910~peroxisomal long-chain fatty acid import,GO:0042493~response to drug,GO:0042760~very long-chain fatty acid catabolic process,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005283:Peroxysomal long chain fatty acyl transporter,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	616278~Bile acid synthesis defect, congenital, 5,		SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 3,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,region of interest:Targeting to peroxisomes,sequence conflict,sequence variant,splice variant,transmembrane region,
203981_s_at, 203982_s_at	ATP binding cassette subfamily D member 4(ABCD4)	Homo sapiens				GO:0009235~cobalamin metabolic process,GO:0055085~transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	614857~Methylmalonic aciduria and homocystinuria, cblJ type,		SM00382:AAA,	ATP-binding,Complete proteome,Disease mutation,Membrane,Nucleotide-binding,Peroxisome,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 4,domain:ABC transmembrane type-1,domain:ABC transporter,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,transmembrane region,
201873_s_at, 201872_s_at	ATP binding cassette subfamily E member 1(ABCE1)	Homo sapiens			General function prediction only,	GO:0000054~ribosomal subunit export from nucleus,GO:0006413~translational initiation,GO:0006415~translational termination,GO:0016032~viral process,GO:0055085~transmembrane transport,GO:0060702~negative regulation of endoribonuclease activity,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016020~membrane,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0043024~ribosomal small subunit binding,GO:0060698~endoribonuclease inhibitor activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR007209:RNase L inhibitor RLI, possible metal-binding domain,IPR013283:ABC transporter, ABCE,IPR017871:ABC transporter, conserved site,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	ATP-binding,Chaperone,Complete proteome,Cytoplasm,Host-virus interaction,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:ATP-binding cassette sub-family E member 1,domain:4Fe-4S ferredoxin-type 1,domain:4Fe-4S ferredoxin-type 2,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,
200045_at	ATP binding cassette subfamily F member 1(ABCF1)	Homo sapiens			General function prediction only,	GO:0006412~translation,GO:0006413~translational initiation,GO:0006954~inflammatory response,GO:0045727~positive regulation of translation,GO:0055085~transmembrane transport,	GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008135~translation factor activity, RNA binding,GO:0008494~translation activator activity,GO:0016887~ATPase activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Activator,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:ATP-binding cassette sub-family F member 1,compositionally biased region:Glu-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,
214232_at, 207623_at, 209247_s_at, 207622_s_at, 209246_at	ATP binding cassette subfamily F member 2(ABCF2)	Homo sapiens			General function prediction only,	GO:0006810~transport,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0016020~membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,	GO:0003677~DNA binding,GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR000558:Histone H2B,IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR007125:Histone core,IPR009072:Histone-fold,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,SM00427:H2B,	Acetylation,Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,DNA-binding,Nucleosome core,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:ATP-binding cassette sub-family F member 2,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,
202394_s_at	ATP binding cassette subfamily F member 3(ABCF3)	Homo sapiens			General function prediction only,	GO:0051607~defense response to virus,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,Antiviral defense,ATP-binding,Complete proteome,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:ATP-binding cassette sub-family F member 3,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,
204567_s_at, 211113_s_at	ATP binding cassette subfamily G member 1(ABCG1)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0008203~cholesterol metabolic process,GO:0009720~detection of hormone stimulus,GO:0010033~response to organic substance,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010872~regulation of cholesterol esterification,GO:0010875~positive regulation of cholesterol efflux,GO:0010887~negative regulation of cholesterol storage,GO:0032367~intracellular cholesterol transport,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0033993~response to lipid,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0034436~glycoprotein transport,GO:0042157~lipoprotein metabolic process,GO:0042632~cholesterol homeostasis,GO:0042987~amyloid precursor protein catabolic process,GO:0043691~reverse cholesterol transport,GO:0045542~positive regulation of cholesterol biosynthetic process,GO:0055085~transmembrane transport,GO:0055091~phospholipid homeostasis,GO:0055099~response to high density lipoprotein particle,GO:1901998~toxin transport,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0055037~recycling endosome,	GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0015485~cholesterol binding,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0019534~toxin transporter activity,GO:0034041~sterol-transporting ATPase activity,GO:0034437~glycoprotein transporter activity,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005284:Pigment precursor permease,IPR013525:ABC-2 type transporter,IPR017871:ABC transporter, conserved site,IPR020064:ABC transporter, G1-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Lipid transport,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 1,domain:ABC transmembrane type-2,domain:ABC transporter,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209735_at	ATP binding cassette subfamily G member 2 (Junior blood group)(ABCG2)	Homo sapiens				GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0006879~cellular iron ion homeostasis,GO:0015886~heme transport,GO:0042493~response to drug,GO:0042908~xenobiotic transport,GO:0046415~urate metabolic process,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015232~heme transporter activity,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR013525:ABC-2 type transporter,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,	138900~Uric acid concentration, serum, QTL1,614490~Junior blood group system,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Mitochondrion,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 2,disulfide bond,domain:ABC transmembrane type-2,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,site:Not glycosylated,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207593_at	ATP binding cassette subfamily G member 4(ABCG4)	Homo sapiens				GO:0033344~cholesterol efflux,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0034041~sterol-transporting ATPase activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR013525:ABC-2 type transporter,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 4,domain:ABC transmembrane type-2,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220383_at	ATP binding cassette subfamily G member 5(ABCG5)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0007584~response to nutrient,GO:0007588~excretion,GO:0010212~response to ionizing radiation,GO:0010949~negative regulation of intestinal phytosterol absorption,GO:0015918~sterol transport,GO:0030299~intestinal cholesterol absorption,GO:0033344~cholesterol efflux,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0045796~negative regulation of intestinal cholesterol absorption,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017127~cholesterol transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0046982~protein heterodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR013525:ABC-2 type transporter,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04975:Fat digestion and absorption,hsa04976:Bile secretion,	210250~Sitosterolemia,		SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family G member 5,domain:ABC transmembrane type-2,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201128_s_at, 210337_s_at, 201127_s_at	ATP citrate lyase(ACLY)	Homo sapiens		h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol,	Energy production and conversion,	GO:0006085~acetyl-CoA biosynthetic process,GO:0006101~citrate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009346~citrate lyase complex,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003878~ATP citrate synthase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016829~lyase activity,GO:0046872~metal ion binding,GO:0048037~cofactor binding,	IPR002020:Citrate synthase-like,IPR003781:CoA-binding,IPR005810:Succinyl-CoA ligase, alpha subunit,IPR005811:ATP-citrate lyase/succinyl-CoA ligase,IPR013816:ATP-grasp fold, subdomain 2,IPR014608:ATP-citrate synthase,IPR016040:NAD(P)-binding domain,IPR016102:Succinyl-CoA synthetase-like,IPR016143:Citrate synthase-like, small alpha subdomain,IPR017440:ATP-citrate lyase/succinyl-CoA ligase, active site,IPR017866:Succinyl-CoA synthetase, beta subunit, conserved site,	hsa00020:Citrate cycle (TCA cycle),hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,		PIRSF036511:ATP citrate synthase, fused large and small subunits,	SM00881:SM00881,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Isopeptide bond,Lipid biosynthesis,Lipid metabolism,Lyase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Ubl conjugation,	active site:Tele-phosphohistidine intermediate,chain:ATP-citrate synthase,metal ion-binding site:Magnesium,modified residue,nucleotide phosphate-binding region:ATP,region of interest:CoA-binding,sequence conflict,sequence variant,
213057_at, 214330_at	ATP synthase mitochondrial F1 complex assembly factor 2(ATPAF2)	Homo sapiens				GO:0043461~proton-transporting ATP synthase complex assembly,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016607~nuclear speck,	GO:0005515~protein binding,	IPR011419:ATP12, ATPase F1F0-assembly protein,IPR023335:Orthogonal Bundle domain in ATP12,		604273~Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,			Chaperone,Complete proteome,Disease mutation,Mitochondrion,Proteomics identification,Reference proteome,Transit peptide,	chain:ATP synthase mitochondrial F1 complex assembly factor 2,sequence variant,transit peptide:Mitochondrion,
216954_x_at, 200818_at	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit(ATP5O)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015992~proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000711:ATPase, F1 complex, OSCP/delta subunit,IPR020781:ATPase, F1 complex, OSCP/delta subunit, conserved site,IPR026015:F1F0 ATP synthase OSCP/delta subunit, N-terminal domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,ATP synthesis,Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit O, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
213738_s_at	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle(ATP5A1)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0001937~negative regulation of endothelial cell proliferation,GO:0006629~lipid metabolic process,GO:0006754~ATP biosynthetic process,GO:0009790~embryo development,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0042288~MHC class I protein binding,GO:0044822~poly(A) RNA binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005294:ATPase, F1 complex, alpha subunit,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR023366:ATPase, F1/A1 complex, alpha subunit, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	615228~Mitochondrial complex (ATP synthase) deficiency, nuclear type 4,616045~Combined oxidative phosphorylation deficiency 22,			Acetylation,Alternative splicing,ATP synthesis,ATP-binding,Cell membrane,CF(1),Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Methylation,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit alpha, mitochondrial,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,site:Required for activity,transit peptide:Mitochondrion,
201322_at	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide(ATP5B)	Homo sapiens				GO:0001525~angiogenesis,GO:0001649~osteoblast differentiation,GO:0006091~generation of precursor metabolites and energy,GO:0006629~lipid metabolic process,GO:0006754~ATP biosynthetic process,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007005~mitochondrion organization,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0046034~ATP metabolic process,GO:0051453~regulation of intracellular pH,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005754~mitochondrial proton-transporting ATP synthase, catalytic core,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0031966~mitochondrial membrane,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0042645~mitochondrial nucleoid,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0042288~MHC class I protein binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR003593:AAA+ ATPase domain,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005722:ATPase, F1 complex, beta subunit,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR024034:ATPase, F1 complex beta subunit/V1 complex, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,			SM00382:AAA,	Acetylation,ATP synthesis,ATP-binding,CF(1),Complete proteome,Direct protein sequencing,Glycoprotein,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit beta, mitochondrial,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,transit peptide:Mitochondrion,
203926_x_at, 213041_s_at	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit(ATP5D)	Homo sapiens			Energy production and conversion,	GO:0006119~oxidative phosphorylation,GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0046688~response to copper ion,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005759~mitochondrial matrix,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0043531~ADP binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR001469:ATPase, F1 complex, delta/epsilon subunit,IPR020546:ATPase, F1 complex, delta/epsilon subunit, N-terminal,IPR020547:ATPase, F1 complex, delta/epsilon subunit, C-terminal,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,ATP synthesis,CF(1),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit delta, mitochondrial,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),transit peptide:Mitochondrion,
217801_at	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit(ATP5E)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005759~mitochondrial matrix,	GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR006721:ATPase, F1 complex, epsilon  subunit, mitochondrial,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	614053~Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3,			Acetylation,ATP synthesis,CF(1),Complete proteome,Disease mutation,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transport,	chain:ATP synthase subunit epsilon, mitochondrial,chain:ATP synthase subunit epsilon-like protein, mitochondrial,modified residue,
214132_at, 208870_x_at, 213366_x_at, 205711_x_at	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1(ATP5C1)	Homo sapiens				GO:0006119~oxidative phosphorylation,GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0044822~poly(A) RNA binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000131:ATPase, F1 complex, gamma subunit,IPR023632:ATPase, F1 complex, gamma subunit conserved site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Alternative splicing,ATP synthesis,CF(1),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Transit peptide,Transport,	chain:ATP synthase subunit gamma, mitochondrial,modified residue,sequence conflict,splice variant,transit peptide:Mitochondrion,
211755_s_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit B1(ATP5F1)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0021762~substantia nigra development,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR008688:ATPase, F0 complex, B chain/subunit B/MI25,IPR013837:ATPase, F0 complex, B chain/subunit B,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,CF(0),Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase subunit b, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
208972_s_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit C1 (subunit 9)(ATP5G1)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016021~integral component of membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000454:ATPase, F0 complex, subunit C,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR020537:ATPase, F0 complex, subunit C, DCCD-binding site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Lipid-binding,Membrane,Mitochondrion,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase lipid-binding protein, mitochondrial,sequence conflict,site:Reversibly protonated during proton transport,transit peptide:Mitochondrion,transmembrane region,
208764_s_at, 207552_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit C2 (subunit 9)(ATP5G2)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005741~mitochondrial outer membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0008289~lipid binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000454:ATPase, F0 complex, subunit C,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR020537:ATPase, F0 complex, subunit C, DCCD-binding site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Alternative splicing,CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Lipid-binding,Membrane,Mitochondrion,Polymorphism,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase lipid-binding protein, mitochondrial,sequence conflict,sequence variant,site:Reversibly protonated during proton transport,splice variant,transit peptide:Mitochondrion,transmembrane region,
207507_s_at, 207508_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9)(ATP5G3)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005741~mitochondrial outer membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016021~integral component of membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0005215~transporter activity,GO:0008289~lipid binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR000454:ATPase, F0 complex, subunit C,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR020537:ATPase, F0 complex, subunit C, DCCD-binding site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Lipid-binding,Membrane,Mitochondrion,Polymorphism,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase lipid-binding protein, mitochondrial,sequence variant,site:Reversibly protonated during proton transport,transit peptide:Mitochondrion,transmembrane region,
210149_s_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit D(ATP5H)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000274~mitochondrial proton-transporting ATP synthase, stator stalk,GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0070062~extracellular exosome,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR008689:ATPase, F0 complex, subunit D, mitochondrial,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF005514:F-type ATP synthase, subunit d, mitochondrial,		Acetylation,Alternative splicing,CF(0),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transport,	chain:ATP synthase subunit d, mitochondrial,modified residue,splice variant,
209492_x_at, 207335_x_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit E(ATP5I)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,	IPR008386:ATPase, F0 complex, subunit E, mitochondrial,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,				Acetylation,ATP synthesis,CF(0),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Transport,	chain:ATP synthase subunit e, mitochondrial,modified residue,
202325_s_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit F6(ATP5J)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0019439~aromatic compound catabolic process,GO:0021762~substantia nigra development,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,	GO:0005215~transporter activity,GO:0005506~iron ion binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016708~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR008387:ATPase, F0 complex, subunit F6, mitochondrial,IPR016349:ATPase, F0 complex, subunit F6, mitochondrial subgroup,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF002455:ATP synthase coupling factor 6,		Acetylation,Alternative splicing,CF(0),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,Transport,	chain:ATP synthase-coupling factor 6, mitochondrial,modified residue,sequence conflict,transit peptide:Mitochondrion,
207573_x_at, 210453_x_at, 208746_x_at, 208745_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit G(ATP5L)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0070062~extracellular exosome,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016887~ATPase activity,GO:0022857~transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR006808:ATPase, F0 complex, subunit G, mitochondrial,IPR016702:Mitochondrial ATP synthase subunit g, animal,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,		PIRSF017835:F-type ATP synthase, subunit g, animal mitochondria type,		Acetylation,ATP synthesis,CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transport,	chain:ATP synthase subunit g, mitochondrial,modified residue,sequence conflict,
206992_s_at, 213995_at, 206993_at	ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)(ATP5S)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0015992~proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,	GO:0005743~mitochondrial inner membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046872~metal ion binding,	IPR026063:ATP synthase subunit s, mitochondrial,					Alternative splicing,ATP synthesis,CF(0),Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Leucine-rich repeat,Magnesium,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transit peptide,Transport,	chain:ATP synthase subunit s, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
204499_at, 204500_s_at	ATP/GTP binding protein 1(AGTPBP1)	Homo sapiens				GO:0001754~eye photoreceptor cell differentiation,GO:0006508~proteolysis,GO:0007005~mitochondrion organization,GO:0007628~adult walking behavior,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021772~olfactory bulb development,GO:0035609~C-terminal protein deglutamylation,GO:0035610~protein side chain deglutamylation,GO:0042133~neurotransmitter metabolic process,GO:0050905~neuromuscular process,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,	IPR000834:Peptidase M14, carboxypeptidase A,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Metalloprotease,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Zinc,	active site:Nucleophile,chain:Cytosolic carboxypeptidase 1,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,splice variant,
220390_at	ATP/GTP binding protein like 2(AGBL2)	Homo sapiens				GO:0006508~proteolysis,GO:0035610~protein side chain deglutamylation,	GO:0005814~centriole,GO:0005829~cytosol,GO:0036064~ciliary basal body,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase M14, carboxypeptidase A,					Alternative splicing,Carboxypeptidase,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Zinc,	active site:Nucleophile,chain:Cytosolic carboxypeptidase 2,metal ion-binding site:Zinc,sequence variant,splice variant,
220649_at	ATP/GTP binding protein like 3(AGBL3)	Homo sapiens				GO:0006508~proteolysis,GO:0035610~protein side chain deglutamylation,	GO:0005829~cytosol,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase M14, carboxypeptidase A,					Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Zinc,	active site:Nucleophile,chain:Cytosolic carboxypeptidase 3,metal ion-binding site:Zinc,modified residue,sequence variant,splice variant,
218480_at	ATP/GTP binding protein like 5(AGBL5)	Homo sapiens				GO:0006508~proteolysis,GO:0035608~protein deglutamylation,GO:0035611~protein branching point deglutamylation,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030496~midbody,GO:0072686~mitotic spindle,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,	IPR000834:Peptidase M14, carboxypeptidase A,					Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Metal-binding,Metalloprotease,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Zinc,	chain:Cytosolic carboxypeptidase-like protein 5,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,sequence conflict,sequence variant,splice variant,
218956_s_at	ATP5J2-PTCD1 readthrough(ATP5J2-PTCD1)	Homo sapiens							IPR002885:Pentatricopeptide repeat,IPR019344:Mitochondrial F1-F0 ATP synthase subunit F, predicted,					Complete proteome,Reference proteome,
45828_at, 218038_at	ATP5S like(ATP5SL)	Homo sapiens					GO:0005739~mitochondrion,		IPR026303:ATP synthase subunit s-like protein,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATP synthase subunit s-like protein,sequence variant,splice variant,
212384_at, 200041_s_at	ATP6V1G2-DDX39B readthrough (NMD candidate)(ATP6V1G2-DDX39B)	Homo sapiens				GO:0015992~proton transport,	GO:0016471~vacuolar proton-transporting V-type ATPase complex,	GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,	IPR005124:Vacuolar (H+)-ATPase G subunit,					Coiled coil,Complete proteome,Reference proteome,
218052_s_at	ATPase 13A1(ATP13A1)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0071421~manganese ion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005524~ATP binding,GO:0015410~manganese-transporting ATPase activity,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR006544:Cation-transporting P-type ATPase, subfamily  V,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Acetylation,Alternative splicing,ATP-binding,Complete proteome,Endoplasmic reticulum,Glycoprotein,Hydrolase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable cation-transporting ATPase 13A1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Magnesium,modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218608_at	ATPase 13A2(ATP13A2)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0010821~regulation of mitochondrion organization,GO:0016241~regulation of macroautophagy,GO:0016243~regulation of autophagosome size,GO:0030003~cellular cation homeostasis,GO:0033157~regulation of intracellular protein transport,GO:0034220~ion transmembrane transport,GO:0034599~cellular response to oxidative stress,GO:0046777~protein autophosphorylation,GO:0050714~positive regulation of protein secretion,GO:0052548~regulation of endopeptidase activity,GO:0055069~zinc ion homeostasis,GO:0071287~cellular response to manganese ion,GO:0071294~cellular response to zinc ion,GO:0098655~cation transmembrane transport,GO:1901215~negative regulation of neuron death,GO:1903146~regulation of mitophagy,GO:1903543~positive regulation of exosomal secretion,GO:1904714~regulation of chaperone-mediated autophagy,GO:1905037~autophagosome organization,GO:1905122~polyamine import,GO:1905123~regulation of glucosylceramidase activity,GO:1905165~regulation of lysosomal protein catabolic process,GO:1905166~negative regulation of lysosomal protein catabolic process,GO:1990938~peptidyl-aspartic acid autophosphorylation,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005776~autophagosome,GO:0005887~integral component of plasma membrane,GO:0012506~vesicle membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0031982~vesicle,GO:0032585~multivesicular body membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043202~lysosomal lumen,GO:1905103~integral component of lysosomal membrane,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,GO:1903135~cupric ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR006544:Cation-transporting P-type ATPase, subfamily  V,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,		606693~Ceroid lipofuscinosis, neuronal, 12,606693~Kufor-Rakeb syndrome,			Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Hydrolase,Lysosome,Magnesium,Membrane,Metal-binding,Neurodegeneration,Neuronal ceroid lipofuscinosis,Nucleotide-binding,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable cation-transporting ATPase 13A2,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212297_at, 219558_at	ATPase 13A3(ATP13A3)	Homo sapiens				GO:0006812~cation transport,GO:0006874~cellular calcium ion homeostasis,GO:0098655~cation transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019829~cation-transporting ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006544:Cation-transporting P-type ATPase, subfamily  V,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Hydrolase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable cation-transporting ATPase 13A3,compositionally biased region:Poly-Tyr,metal ion-binding site:Magnesium,modified residue,sequence conflict,splice variant,transmembrane region,
212383_at, 205095_s_at	ATPase H+ transporting V0 subunit a1(ATP6V0A1)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,GO:0090383~phagosome acidification,GO:1901998~toxin transport,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0005623~cell,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0051117~ATPase binding,	IPR002490:ATPase, V0 complex, subunit 116kDa,IPR026028:ATPase, V0 complex, subunit 116kDa, eukaryotic,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,		PIRSF001293:V-type proton ATPase 116 kda subunit a isoform 1,		Alternative splicing,Coiled coil,Complete proteome,Cytoplasmic vesicle,Hydrogen ion transport,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase 116 kDa subunit a isoform 1,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
205704_s_at, 217603_at	ATPase H+ transporting V0 subunit a2(ATP6V0A2)	Homo sapiens				GO:0006955~immune response,GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,GO:0090383~phagosome acidification,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0001669~acrosomal vesicle,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0051117~ATPase binding,	IPR002490:ATPase, V0 complex, subunit 116kDa,IPR026028:ATPase, V0 complex, subunit 116kDa, eukaryotic,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,	219200~Cutis laxa, autosomal recessive, type IIA,278250~Wrinkly skin syndrome,	PIRSF001293:V-type proton ATPase 116 kda subunit a isoform 1,		Cell membrane,Coiled coil,Complete proteome,Endosome,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase 116 kDa subunit a isoform 2,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
220197_at	ATPase H+ transporting V0 subunit a4(ATP6V0A4)	Homo sapiens				GO:0001503~ossification,GO:0006885~regulation of pH,GO:0007035~vacuolar acidification,GO:0007588~excretion,GO:0007605~sensory perception of sound,GO:0008286~insulin receptor signaling pathway,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,GO:0090383~phagosome acidification,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0031526~brush border membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0051117~ATPase binding,	IPR002490:ATPase, V0 complex, subunit 116kDa,IPR026028:ATPase, V0 complex, subunit 116kDa, eukaryotic,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,	602722~Renal tubular acidosis, distal, autosomal recessive,	PIRSF001293:V-type proton ATPase 116 kda subunit a isoform 1,		Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrogen ion transport,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase 116 kDa subunit a isoform 4,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200078_s_at	ATPase H+ transporting V0 subunit b(ATP6V0B)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0005768~endosome,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,	GO:0005215~transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000245:V-ATPase proteolipid subunit,IPR002379:V-ATPase proteolipid subunit C-like domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,				Alternative splicing,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Vacuole,	chain:V-type proton ATPase 21 kDa proteolipid subunit,sequence variant,site:Essential for proton translocation,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200954_at, 36994_at	ATPase H+ transporting V0 subunit c(ATP6V0C)	Homo sapiens				GO:0007042~lysosomal lumen acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016032~viral process,GO:0016241~regulation of macroautophagy,GO:0030177~positive regulation of Wnt signaling pathway,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0005765~lysosomal membrane,GO:0005774~vacuolar membrane,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0031625~ubiquitin protein ligase binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000245:V-ATPase proteolipid subunit,IPR002379:V-ATPase proteolipid subunit C-like domain,IPR011555:V-ATPase proteolipid subunit C, eukaryotic,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,				Complete proteome,Host-virus interaction,Hydrogen ion transport,Ion transport,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Vacuole,	chain:V-type proton ATPase 16 kDa proteolipid subunit,site:Essential for proton translocation,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
212041_at	ATPase H+ transporting V0 subunit d1(ATP6V0D1)	Homo sapiens				GO:0007034~vacuolar transport,GO:0007035~vacuolar acidification,GO:0007420~brain development,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0036498~IRE1-mediated unfolded protein response,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0090383~phagosome acidification,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005813~centrosome,GO:0008021~synaptic vesicle,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,GO:0033181~plasma membrane proton-transporting V-type ATPase complex,GO:0043679~axon terminus,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0032403~protein complex binding,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002843:ATPase, V0 complex,  c/d subunit,IPR016727:ATPase, V0 complex, subunit d,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05203:Viral carcinogenesis,hsa05323:Rheumatoid arthritis,		PIRSF018497:V-type ATPase, subunit d,		Cilium biogenesis/degradation,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit d 1,modified residue,sequence conflict,
214150_x_at, 201172_x_at, 200096_s_at, 214149_s_at, 214244_s_at, 201171_at	ATPase H+ transporting V0 subunit e1(ATP6V0E1)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016049~cell growth,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,	GO:0005215~transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0042625~ATPase coupled ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR008389:ATPase, V0 complex, subunit e1/e2,IPR017385:ATPase, V0 complex, subunit e1/e2, metazoa,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,		PIRSF038097:V-type ATPase, subunits e1/e2,		Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase subunit E 1,transmembrane region,
213587_s_at	ATPase H+ transporting V0 subunit e2(ATP6V0E2)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016049~cell growth,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0042625~ATPase coupled ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR008389:ATPase, V0 complex, subunit e1/e2,IPR017385:ATPase, V0 complex, subunit e1/e2, metazoa,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,		PIRSF038097:V-type ATPase, subunits e1/e2,		Alternative splicing,Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase subunit E 2,splice variant,transmembrane region,
201971_s_at, 201972_at	ATPase H+ transporting V1 subunit A(ATP6V1A)	Homo sapiens				GO:0006810~transport,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0046034~ATP metabolic process,GO:0090383~phagosome acidification,	GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005902~microvillus,GO:0016324~apical plasma membrane,GO:0016469~proton-transporting two-sector ATPase complex,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005725:ATPase, V1 complex, subunit A,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR022878:V-type ATP synthase catalytic subunit A/alpha,IPR024034:ATPase, F1 complex beta subunit/V1 complex, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Acetylation,Alternative splicing,ATP-binding,Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase catalytic subunit A,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
205473_at	ATPase H+ transporting V1 subunit B1(ATP6V1B1)	Homo sapiens				GO:0001503~ossification,GO:0006885~regulation of pH,GO:0007588~excretion,GO:0007605~sensory perception of sound,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0042472~inner ear morphogenesis,GO:0045851~pH reduction,GO:0046034~ATP metabolic process,GO:0055074~calcium ion homeostasis,GO:0090383~phagosome acidification,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005902~microvillus,GO:0012505~endomembrane system,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0032403~protein complex binding,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005723:ATPase, V1 complex, subunit B,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR022879:V-type ATP synthase regulatory subunit B/beta,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,	267300~Renal tubular acidosis with deafness,			Complete proteome,Deafness,Disease mutation,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit B, kidney isoform,mutagenesis site,sequence conflict,sequence variant,short sequence motif:PDZ-binding,
201089_at	ATPase H+ transporting V1 subunit B2(ATP6V1B2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0046034~ATP metabolic process,GO:0090383~phagosome acidification,	GO:0001726~ruffle,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005723:ATPase, V1 complex, subunit B,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR022879:V-type ATP synthase regulatory subunit B/beta,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,	616455~Zimmermann-Laband syndrome 2,			Complete proteome,Disease mutation,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit B, brain isoform,modified residue,sequence conflict,
202872_at, 202873_at, 202874_s_at	ATPase H+ transporting V1 subunit C1(ATP6V1C1)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016469~proton-transporting two-sector ATPase complex,GO:0031410~cytoplasmic vesicle,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR004907:ATPase, V1 complex, subunit C,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Acetylation,Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit C 1,modified residue,
214923_at, 208898_at, 208899_x_at	ATPase H+ transporting V1 subunit D(ATP6V1D)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,GO:0090383~phagosome acidification,	GO:0005765~lysosomal membrane,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005929~cilium,GO:0016020~membrane,GO:0033176~proton-transporting V-type ATPase complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR002699:ATPase, V1 complex, subunit D,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Cilium biogenesis/degradation,Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit D,sequence conflict,
208678_at	ATPase H+ transporting V1 subunit E1(ATP6V1E1)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005829~cytosol,GO:0005902~microvillus,GO:0016324~apical plasma membrane,GO:0016469~proton-transporting two-sector ATPase complex,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0051117~ATPase binding,	IPR002842:ATPase, V1/A1 complex, subunit E,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Hydrogen ion transport,Hydrolase,Ion transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit E 1,modified residue,sequence conflict,sequence variant,
208737_at	ATPase H+ transporting V1 subunit G1(ATP6V1G1)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,GO:1902600~hydrogen ion transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0051117~ATPase binding,	IPR005124:Vacuolar (H+)-ATPase G subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Hydrogen ion transport,Ion transport,Reference proteome,Transport,	chain:V-type proton ATPase subunit G 1,modified residue,
214762_at	ATPase H+ transporting V1 subunit G2(ATP6V1G2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0005829~cytosol,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030285~integral component of synaptic vesicle membrane,GO:0042470~melanosome,	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,	IPR005124:Vacuolar (H+)-ATPase G subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Alternative splicing,Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit G 2,
221504_s_at	ATPase H+ transporting V1 subunit H(ATP6V1H)	Homo sapiens				GO:0006897~endocytosis,GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016032~viral process,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0050690~regulation of defense response to virus by virus,GO:0050790~regulation of catalytic activity,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016887~ATPase activity,GO:0030234~enzyme regulator activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR004908:ATPase, V1 complex, subunit H,IPR011987:ATPase, V1 complex, subunit H, C-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,		PIRSF032184:V-type ATPase, subunit H,		Alternative splicing,Complete proteome,Host-virus interaction,Hydrogen ion transport,Ion transport,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit H,modified residue,sequence conflict,splice variant,
207809_s_at	ATPase H+ transporting accessory protein 1(ATP6AP1)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0045669~positive regulation of osteoblast differentiation,GO:0045780~positive regulation of bone resorption,GO:0045851~pH reduction,GO:0045921~positive regulation of exocytosis,GO:0051656~establishment of organelle localization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2001206~positive regulation of osteoclast development,	GO:0005774~vacuolar membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016469~proton-transporting two-sector ATPase complex,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0017137~Rab GTPase binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR008388:ATPase, V1 complex, subunit S1,IPR024722:BIG/ATPase V1 complex, subunit S1,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05323:Rheumatoid arthritis,				ATP-binding,Complete proteome,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,Vacuole,	chain:V-type proton ATPase subunit S1,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,transmembrane region,
201443_s_at, 201444_s_at, 201442_s_at	ATPase H+ transporting accessory protein 2(ATP6AP2)	Homo sapiens				GO:0002003~angiotensin maturation,GO:0008152~metabolic process,GO:0021903~rostrocaudal neural tube patterning,GO:0030177~positive regulation of Wnt signaling pathway,GO:0032914~positive regulation of transforming growth factor beta1 production,GO:0043408~regulation of MAPK cascade,GO:0048069~eye pigmentation,GO:0060323~head morphogenesis,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004872~receptor activity,GO:0005515~protein binding,	IPR012493:Renin receptor-like,IPR017850:Alkaline-phosphatase-like, core domain,	hsa04614:Renin-angiotensin system,	300423~Mental retardation, X-linked, syndromic, Hedera type,300911~Parkinsonism with spasticity, X-linked,			3D-structure,Alternative splicing,Complete proteome,Epilepsy,Membrane,Mental retardation,Neurodegeneration,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Renin receptor,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207139_at	ATPase H+/K+ transporting alpha subunit(ATP4A)	Homo sapiens				GO:0006810~transport,GO:0006883~cellular sodium ion homeostasis,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR015127:Gastric H+/K+-transporter P-type ATPase, N-terminal,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa00190:Oxidative phosphorylation,hsa04966:Collecting duct acid secretion,hsa04971:Gastric acid secretion,			SM00831:SM00831,	ATP-binding,Cell membrane,Coiled coil,Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Potassium-transporting ATPase alpha chain 1,metal ion-binding site:Magnesium,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
207546_at	ATPase H+/K+ transporting beta subunit(ATP4B)	Homo sapiens				GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0007155~cell adhesion,GO:0010243~response to organonitrogen compound,GO:0032496~response to lipopolysaccharide,GO:0034220~ion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,	GO:0005515~protein binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,	hsa00190:Oxidative phosphorylation,hsa04966:Collecting duct acid secretion,hsa04971:Gastric acid secretion,				Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Potassium,Potassium transport,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Transport,	chain:Potassium-transporting ATPase subunit beta,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207367_at	ATPase H+/K+ transporting non-gastric alpha2 subunit(ATP12A)	Homo sapiens				GO:0006883~cellular sodium ion homeostasis,GO:0006885~regulation of pH,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,	GO:0005886~plasma membrane,GO:0005889~hydrogen:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa00190:Oxidative phosphorylation,			SM00831:SM00831,	Alternative splicing,ATP-binding,Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Potassium-transporting ATPase alpha chain 2,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
220556_at	ATPase Na+/K+ transporting family member beta 4(ATP1B4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005887~integral component of plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,	GO:0015077~monovalent inorganic cation transmembrane transporter activity,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,				Alternative splicing,Coiled coil,Complete proteome,Ion transport,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Transport,	chain:X/potassium-transporting ATPase subunit beta-m,compositionally biased region:Glu-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220948_s_at	ATPase Na+/K+ transporting subunit alpha 1(ATP1A1)	Homo sapiens				GO:0002026~regulation of the force of heart contraction,GO:0002028~regulation of sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0008217~regulation of blood pressure,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016311~dephosphorylation,GO:0030007~cellular potassium ion homeostasis,GO:0031947~negative regulation of glucocorticoid biosynthetic process,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0042493~response to drug,GO:0045822~negative regulation of heart contraction,GO:0045823~positive regulation of heart contraction,GO:0045989~positive regulation of striated muscle contraction,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0060081~membrane hyperpolarization,GO:0071260~cellular response to mechanical stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086004~regulation of cardiac muscle cell contraction,GO:0086009~membrane repolarization,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030315~T-tubule,GO:0042383~sarcolemma,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016791~phosphatase activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0030506~ankyrin binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0043531~ADP binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,			SM00831:SM00831,	Acetylation,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Direct protein sequencing,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-1,metal ion-binding site:Magnesium,modified residue,region of interest:Phosphoinositide-3 kinase binding,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
203295_s_at, 203296_s_at	ATPase Na+/K+ transporting subunit alpha 2(ATP1A2)	Homo sapiens				GO:0001504~neurotransmitter uptake,GO:0002026~regulation of the force of heart contraction,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0006940~regulation of smooth muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0008217~regulation of blood pressure,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0015991~ATP hydrolysis coupled proton transport,GO:0019229~regulation of vasoconstriction,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0035094~response to nicotine,GO:0036376~sodium ion export from cell,GO:0040011~locomotion,GO:0045822~negative regulation of heart contraction,GO:0045988~negative regulation of striated muscle contraction,GO:0046034~ATP metabolic process,GO:0051481~negative regulation of cytosolic calcium ion concentration,GO:0051946~regulation of glutamate uptake involved in transmission of nerve impulse,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0071260~cellular response to mechanical stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:0086004~regulation of cardiac muscle cell contraction,GO:0086009~membrane repolarization,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903170~negative regulation of calcium ion transmembrane transport,GO:1903280~negative regulation of calcium:sodium antiporter activity,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,GO:0043197~dendritic spine,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	104290~Alternating hemiplegia of childhood,602481~Migraine, familial basilar,602481~Migraine, familial hemiplegic, 2,		SM00831:SM00831,	ATP-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-2,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
214432_at	ATPase Na+/K+ transporting subunit alpha 3(ATP1A3)	Homo sapiens				GO:0006883~cellular sodium ion homeostasis,GO:0007613~memory,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036376~sodium ion export from cell,GO:0042493~response to drug,GO:0060048~cardiac muscle contraction,GO:0071383~cellular response to steroid hormone stimulus,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0044326~dendritic spine neck,GO:0044327~dendritic spine head,GO:0045202~synapse,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0031748~D1 dopamine receptor binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:0086037~sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	128235~Dystonia-12,601338~CAPOS syndrome,614820~Alternating hemiplegia of childhood 2,		SM00831:SM00831,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Deafness,Disease mutation,Dystonia,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Parkinsonism,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-3,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
201243_s_at, 201242_s_at	ATPase Na+/K+ transporting subunit beta 1(ATP1B1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006883~cellular sodium ion homeostasis,GO:0007155~cell adhesion,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010468~regulation of gene expression,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0030007~cellular potassium ion homeostasis,GO:0032781~positive regulation of ATPase activity,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0044861~protein transport into plasma membrane raft,GO:0046034~ATP metabolic process,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0055119~relaxation of cardiac muscle,GO:0060048~cardiac muscle contraction,GO:0072659~protein localization to plasma membrane,GO:0086009~membrane repolarization,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903278~positive regulation of sodium ion export from cell,GO:1903281~positive regulation of calcium:sodium antiporter activity,GO:1903288~positive regulation of potassium ion import,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001671~ATPase activator activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008144~drug binding,GO:0016887~ATPase activity,GO:0023026~MHC class II protein complex binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0051117~ATPase binding,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,IPR015565:Sodium/potassium-transporting ATPase subunit beta, chordates,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	145500~Blood pressure regulation QTL,			Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204311_at	ATPase Na+/K+ transporting subunit beta 2(ATP1B2)	Homo sapiens				GO:0006810~transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0007155~cell adhesion,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0030007~cellular potassium ion homeostasis,GO:0032781~positive regulation of ATPase activity,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0086009~membrane repolarization,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903278~positive regulation of sodium ion export from cell,GO:1903288~positive regulation of potassium ion import,GO:1903779~regulation of cardiac conduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016324~apical plasma membrane,	GO:0001671~ATPase activator activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005515~protein binding,GO:0051117~ATPase binding,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,				Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208836_at	ATPase Na+/K+ transporting subunit beta 3(ATP1B3)	Homo sapiens				GO:0006810~transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006883~cellular sodium ion homeostasis,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0030007~cellular potassium ion homeostasis,GO:0032781~positive regulation of ATPase activity,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0050821~protein stabilization,GO:0050900~leukocyte migration,GO:0072659~protein localization to plasma membrane,GO:0086009~membrane repolarization,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1903278~positive regulation of sodium ion export from cell,GO:1903288~positive regulation of potassium ion import,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0001671~ATPase activator activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0051117~ATPase binding,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Potassium,Potassium transport,Proteomics identification,Reference proteome,Signal-anchor,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit beta-3,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205198_s_at, 205197_s_at	ATPase copper transporting alpha(ATP7A)	Homo sapiens				GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001974~blood vessel remodeling,GO:0002082~regulation of oxidative phosphorylation,GO:0006568~tryptophan metabolic process,GO:0006584~catecholamine metabolic process,GO:0006825~copper ion transport,GO:0006878~cellular copper ion homeostasis,GO:0007005~mitochondrion organization,GO:0007595~lactation,GO:0007626~locomotory behavior,GO:0010041~response to iron(III) ion,GO:0010043~response to zinc ion,GO:0010273~detoxification of copper ion,GO:0015677~copper ion import,GO:0015679~plasma membrane copper ion transport,GO:0018205~peptidyl-lysine modification,GO:0019430~removal of superoxide radicals,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021860~pyramidal neuron development,GO:0021954~central nervous system neuron development,GO:0030001~metal ion transport,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0031069~hair follicle morphogenesis,GO:0034220~ion transmembrane transport,GO:0042093~T-helper cell differentiation,GO:0042414~epinephrine metabolic process,GO:0042415~norepinephrine metabolic process,GO:0042417~dopamine metabolic process,GO:0042428~serotonin metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043473~pigmentation,GO:0043588~skin development,GO:0048251~elastic fiber assembly,GO:0048286~lung alveolus development,GO:0048812~neuron projection morphogenesis,GO:0051216~cartilage development,GO:0051353~positive regulation of oxidoreductase activity,GO:0051542~elastin biosynthetic process,GO:0060003~copper ion export,	GO:0005770~late endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030140~trans-Golgi network transport vesicle,GO:0030141~secretory granule,GO:0031526~brush border membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0004008~copper-exporting ATPase activity,GO:0005375~copper ion transmembrane transporter activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016532~superoxide dismutase copper chaperone activity,GO:0019829~cation-transporting ATPase activity,GO:0032767~copper-dependent protein binding,	IPR001757:Cation-transporting P-type ATPase,IPR006121:Heavy metal-associated domain, HMA,IPR006122:Heavy metal-associated domain, copper ion-binding,IPR008250:P-type ATPase, A  domain,IPR017969:Heavy-metal-associated, conserved site,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,IPR027256:Cation-transporting P-type ATPase, subfamily IB,		300489~Spinal muscular atrophy, distal, X-linked 3,304150~Occipital horn syndrome,309400~Menkes disease,			3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Copper,Copper transport,Cytoplasm,Disease mutation,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Neurodegeneration,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Copper-transporting ATPase 1,compositionally biased region:Poly-Ser,domain:HMA 1,domain:HMA 2,domain:HMA 3,domain:HMA 4,domain:HMA 5,domain:HMA 6,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
204624_at	ATPase copper transporting beta(ATP7B)	Homo sapiens				GO:0006825~copper ion transport,GO:0006878~cellular copper ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0007595~lactation,GO:0015677~copper ion import,GO:0015680~intracellular copper ion transport,GO:0030001~metal ion transport,GO:0034220~ion transmembrane transport,GO:0046688~response to copper ion,GO:0051208~sequestering of calcium ion,GO:0060003~copper ion export,	GO:0000139~Golgi membrane,GO:0005739~mitochondrion,GO:0005770~late endosome,GO:0005802~trans-Golgi network,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0004008~copper-exporting ATPase activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019829~cation-transporting ATPase activity,GO:0043682~copper-transporting ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR006121:Heavy metal-associated domain, HMA,IPR006122:Heavy metal-associated domain, copper ion-binding,IPR008250:P-type ATPase, A  domain,IPR017969:Heavy-metal-associated, conserved site,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,IPR027256:Cation-transporting P-type ATPase, subfamily IB,		277900~Wilson disease,			3D-structure,Alternative splicing,ATP-binding,Complete proteome,Copper,Copper transport,Cytoplasm,Disease mutation,Endosome,Golgi apparatus,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Copper-transporting ATPase 2,chain:WND/140 kDa,compositionally biased region:Poly-Ser,domain:HMA 1,domain:HMA 2,domain:HMA 3,domain:HMA 4,domain:HMA 5,domain:HMA 6,helix,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
218782_s_at	ATPase family, AAA domain containing 2(ATAD2)	Homo sapiens				GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031936~negative regulation of chromatin silencing,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042393~histone binding,	IPR001487:Bromodomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR011989:Armadillo-like helical,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00297:BROMO,SM00382:AAA,	3D-structure,Activator,Alternative splicing,ATP-binding,Bromodomain,Coiled coil,Complete proteome,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ATPase family AAA domain-containing protein 2,compositionally biased region:Asp-rich,compositionally biased region:Poly-Ser,domain:Bromo,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,turn,
213387_at	ATPase family, AAA domain containing 2B(ATAD2B)	Homo sapiens				GO:0031936~negative regulation of chromatin silencing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR018359:Bromodomain, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00297:BROMO,SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Bromodomain,Coiled coil,Complete proteome,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATPase family AAA domain-containing protein 2B,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,domain:Bromo,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,turn,
219068_x_at	ATPase family, AAA domain containing 3A(ATAD3A)	Homo sapiens			General function prediction only,	GO:0016049~cell growth,GO:0043066~negative regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0042645~mitochondrial nucleoid,	GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR021911:ATPase family AAA domain-containing protein 3, domain of unknown function DUF3523,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion nucleoid,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:ATPase family AAA domain-containing protein 3A,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
220223_at	ATPase family, AAA domain containing 5(ATAD5)	Homo sapiens				GO:0002377~immunoglobulin production,GO:0006974~cellular response to DNA damage stimulus,GO:0030890~positive regulation of B cell proliferation,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0005634~nucleus,	GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,DNA damage,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATPase family AAA domain-containing protein 5,compositionally biased region:Poly-Ser,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:LXCXE motif,splice variant,
218671_s_at	ATPase inhibitory factor 1(ATPIF1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006091~generation of precursor metabolites and energy,GO:0006783~heme biosynthetic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0030218~erythrocyte differentiation,GO:0032780~negative regulation of ATPase activity,GO:0035999~tetrahydrofolate interconversion,GO:0051260~protein homooligomerization,GO:0051289~protein homotetramerization,GO:0051346~negative regulation of hydrolase activity,GO:0051882~mitochondrial depolarization,GO:0072593~reactive oxygen species metabolic process,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1903052~positive regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:1903578~regulation of ATP metabolic process,	GO:0005739~mitochondrion,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0009986~cell surface,	GO:0004857~enzyme inhibitor activity,GO:0005516~calmodulin binding,GO:0030272~5-formyltetrahydrofolate cyclo-ligase activity,GO:0042030~ATPase inhibitor activity,GO:0042803~protein homodimerization activity,GO:0043532~angiostatin binding,GO:0051117~ATPase binding,	IPR007648:ATPase inhibitor, IATP, mitochondria,					Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	chain:ATPase inhibitor, mitochondrial,transit peptide:Mitochondrion,
214256_at, 214255_at	ATPase phospholipid transporting 10A (putative)(ATP10A)	Homo sapiens				GO:0008360~regulation of cell shape,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase VA,compositionally biased region:Poly-Glu,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214070_s_at, 220920_at	ATPase phospholipid transporting 10B (putative)(ATP10B)	Homo sapiens				GO:0045332~phospholipid translocation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase VB,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
213238_at	ATPase phospholipid transporting 10D (putative)(ATP10D)	Homo sapiens				GO:0006812~cation transport,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase VD,metal ion-binding site:Magnesium,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216488_s_at, 213582_at, 215842_s_at	ATPase phospholipid transporting 11A(ATP11A)	Homo sapiens				GO:0045332~phospholipid translocation,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0055037~recycling endosome,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					ATP-binding,Cell membrane,Coiled coil,Complete proteome,Endoplasmic reticulum,Endosome,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IH,metal ion-binding site:Magnesium,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212536_at	ATPase phospholipid transporting 11B (putative)(ATP11B)	Homo sapiens				GO:0006811~ion transport,GO:0015917~aminophospholipid transport,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005637~nuclear inner membrane,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015075~ion transmembrane transporter activity,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					ATP-binding,Complete proteome,Endoplasmic reticulum,Endosome,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IF,metal ion-binding site:Magnesium,modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210192_at, 213106_at	ATPase phospholipid transporting 8A1(ATP8A1)	Homo sapiens				GO:0007612~learning,GO:0030335~positive regulation of cell migration,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,GO:0048194~Golgi vesicle budding,GO:0061092~positive regulation of phospholipid translocation,GO:0098655~cation transmembrane transport,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042584~chromaffin granule membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019829~cation-transporting ATPase activity,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IA,metal ion-binding site:Magnesium,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219659_at, 219660_s_at	ATPase phospholipid transporting 8A2(ATP8A2)	Homo sapiens				GO:0003011~involuntary skeletal muscle contraction,GO:0007409~axonogenesis,GO:0007568~aging,GO:0008285~negative regulation of cell proliferation,GO:0010842~retina layer formation,GO:0010976~positive regulation of neuron projection development,GO:0010996~response to auditory stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0042472~inner ear morphogenesis,GO:0042755~eating behavior,GO:0043588~skin development,GO:0045332~phospholipid translocation,GO:0048194~Golgi vesicle budding,GO:0048666~neuron development,GO:0050884~neuromuscular process controlling posture,GO:0050908~detection of light stimulus involved in visual perception,GO:0060052~neurofilament cytoskeleton organization,GO:0061092~positive regulation of phospholipid translocation,	GO:0000139~Golgi membrane,GO:0001750~photoreceptor outer segment,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,		615268~Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4,			Alternative splicing,ATP-binding,Cell membrane,Cell projection,Chromosomal rearrangement,Complete proteome,Disease mutation,Endosome,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Mental retardation,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IB,metal ion-binding site:Magnesium,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214594_x_at	ATPase phospholipid transporting 8B1(ATP8B1)	Homo sapiens				GO:0006855~drug transmembrane transport,GO:0007030~Golgi organization,GO:0007605~sensory perception of sound,GO:0008206~bile acid metabolic process,GO:0015721~bile acid and bile salt transport,GO:0021650~vestibulocochlear nerve formation,GO:0032534~regulation of microvillus assembly,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060119~inner ear receptor cell development,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0032420~stereocilium,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:1901612~cardiolipin binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,		147480~Cholestasis, intrahepatic, of pregnancy, 1,211600~Cholestasis, progressive familial intrahepatic 1,243300~Cholestasis, benign recurrent intrahepatic,			ATP-binding,Cell membrane,Cell projection,Complete proteome,Disease mutation,Endoplasmic reticulum,Golgi apparatus,Hearing,Hydrolase,Intrahepatic cholestasis,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IC,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216873_s_at	ATPase phospholipid transporting 8B2(ATP8B2)	Homo sapiens				GO:0007030~Golgi organization,GO:0034220~ion transmembrane transport,GO:0045332~phospholipid translocation,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase ID,metal ion-binding site:Magnesium,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215319_at	ATPase phospholipid transporting 8B3(ATP8B3)	Homo sapiens				GO:0007030~Golgi organization,GO:0007339~binding of sperm to zona pellucida,GO:0045332~phospholipid translocation,	GO:0002080~acrosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IK,metal ion-binding site:Magnesium,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220416_at	ATPase phospholipid transporting 8B4 (putative)(ATP8B4)	Homo sapiens				GO:0007030~Golgi organization,GO:0045332~phospholipid translocation,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					ATP-binding,Cell membrane,Complete proteome,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IM,metal ion-binding site:Magnesium,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212062_at, 216129_at	ATPase phospholipid transporting 9A (putative)(ATP9A)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006897~endocytosis,GO:0045332~phospholipid translocation,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Acetylation,Alternative splicing,ATP-binding,Complete proteome,Endosome,Golgi apparatus,Hydrolase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IIA,metal ion-binding site:Magnesium,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214010_s_at, 214934_at	ATPase phospholipid transporting 9B (putative)(ATP9B)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006897~endocytosis,GO:0045332~phospholipid translocation,GO:0072600~establishment of protein localization to Golgi,	GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Golgi apparatus,Hydrolase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IIB,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212930_at, 215716_s_at, 209281_s_at	ATPase plasma membrane Ca2+ transporting 1(ATP2B1)	Homo sapiens				GO:0003407~neural retina development,GO:0006810~transport,GO:0006874~cellular calcium ion homeostasis,GO:0007420~brain development,GO:0007568~aging,GO:0009409~response to cold,GO:0034220~ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:0071305~cellular response to vitamin D,GO:0071386~cellular response to corticosterone stimulus,GO:1901660~calcium ion export,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0032591~dendritic spine membrane,GO:0032809~neuronal cell body membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005388~calcium-transporting ATPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,			SM00831:SM00831,	Acetylation,Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 1,compositionally biased region:Poly-Glu,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211586_s_at, 216120_s_at, 204685_s_at	ATPase plasma membrane Ca2+ transporting 2(ATP2B2)	Homo sapiens				GO:0006810~transport,GO:0006816~calcium ion transport,GO:0006996~organelle organization,GO:0007595~lactation,GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0008361~regulation of cell size,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021707~cerebellar granule cell differentiation,GO:0030182~neuron differentiation,GO:0034220~ion transmembrane transport,GO:0040011~locomotion,GO:0042428~serotonin metabolic process,GO:0045299~otolith mineralization,GO:0046068~cGMP metabolic process,GO:0048167~regulation of synaptic plasticity,GO:0050808~synapse organization,GO:0050885~neuromuscular process controlling balance,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051928~positive regulation of calcium ion transport,GO:0060088~auditory receptor cell stereocilium organization,GO:0070588~calcium ion transmembrane transport,GO:0090102~cochlea development,GO:1903779~regulation of cardiac conduction,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0030165~PDZ domain binding,GO:0030899~calcium-dependent ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,	601386~Deafness, autosomal recessive 12, modifier of,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell junction,Cell membrane,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 2,compositionally biased region:Poly-Glu,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215911_x_at, 216312_at, 207026_s_at	ATPase plasma membrane Ca2+ transporting 3(ATP2B3)	Homo sapiens				GO:0006810~transport,GO:0006874~cellular calcium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:1903779~regulation of cardiac conduction,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:1903561~extracellular vesicle,	GO:0005388~calcium-transporting ATPase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,	302500~Spinocerebellar ataxia, X-linked 1,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Neurodegeneration,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212135_s_at, 205410_s_at, 212136_at	ATPase plasma membrane Ca2+ transporting 4(ATP2B4)	Homo sapiens				GO:0003407~neural retina development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006874~cellular calcium ion homeostasis,GO:0007283~spermatogenesis,GO:0010751~negative regulation of nitric oxide mediated signal transduction,GO:0021766~hippocampus development,GO:0030317~sperm motility,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034220~ion transmembrane transport,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051001~negative regulation of nitric-oxide synthase activity,GO:0051599~response to hydrostatic pressure,GO:0070588~calcium ion transmembrane transport,GO:0070885~negative regulation of calcineurin-NFAT signaling cascade,GO:0071872~cellular response to epinephrine stimulus,GO:0097553~calcium ion transmembrane import into cytosol,GO:0098703~calcium ion import across plasma membrane,GO:0098736~negative regulation of the force of heart contraction,GO:1900082~negative regulation of arginine catabolic process,GO:1901205~negative regulation of adrenergic receptor signaling pathway involved in heart process,GO:1901660~calcium ion export,GO:1902083~negative regulation of peptidyl-cysteine S-nitrosylation,GO:1902305~regulation of sodium ion transmembrane transport,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903243~negative regulation of cardiac muscle hypertrophy in response to stress,GO:1903249~negative regulation of citrulline biosynthetic process,GO:1903779~regulation of cardiac conduction,GO:2000481~positive regulation of cAMP-dependent protein kinase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0036126~sperm flagellum,GO:0043005~neuron projection,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0097228~sperm principal piece,	GO:0005388~calcium-transporting ATPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0017080~sodium channel regulator activity,GO:0030165~PDZ domain binding,GO:0030346~protein phosphatase 2B binding,GO:0036487~nitric-oxide synthase inhibitor activity,GO:0046872~metal ion binding,GO:0050998~nitric-oxide synthase binding,GO:0097110~scaffold protein binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,			SM00831:SM00831,	3D-structure,Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 4,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,helix,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205444_at	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1(ATP2A1)	Homo sapiens				GO:0006816~calcium ion transport,GO:0006942~regulation of striated muscle contraction,GO:0008637~apoptotic mitochondrial changes,GO:0031448~positive regulation of fast-twitch skeletal muscle fiber contraction,GO:0032470~positive regulation of endoplasmic reticulum calcium ion concentration,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0034220~ion transmembrane transport,GO:0034976~response to endoplasmic reticulum stress,GO:0045988~negative regulation of striated muscle contraction,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0051659~maintenance of mitochondrion location,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070509~calcium ion import,GO:0070588~calcium ion transmembrane transport,GO:0090076~relaxation of skeletal muscle,GO:1903779~regulation of cardiac conduction,	GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0031095~platelet dense tubular network membrane,GO:0031673~H zone,GO:0031674~I band,GO:0033017~sarcoplasmic reticulum membrane,GO:0034704~calcium channel complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005782:Calcium-transporting P-type ATPase, subfamily  IIA, SERCA-type,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,	601003~Brody myopathy,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,disulfide bond,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Magnesium,region of interest:Interacts with phospholamban 1,region of interest:Interacts with phospholamban 2,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
209186_at, 212361_s_at, 212362_at	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2(ATP2A2)	Homo sapiens				GO:0002026~regulation of the force of heart contraction,GO:0006874~cellular calcium ion homeostasis,GO:0006984~ER-nucleus signaling pathway,GO:0006996~organelle organization,GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0010460~positive regulation of heart rate,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0014883~transition between fast and slow fiber,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032470~positive regulation of endoplasmic reticulum calcium ion concentration,GO:0033292~T-tubule organization,GO:0034220~ion transmembrane transport,GO:0034599~cellular response to oxidative stress,GO:0034976~response to endoplasmic reticulum stress,GO:0043434~response to peptide hormone,GO:0045822~negative regulation of heart contraction,GO:0055119~relaxation of cardiac muscle,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0070588~calcium ion transmembrane transport,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0098909~regulation of cardiac muscle cell action potential involved in regulation of contraction,GO:1903233~regulation of calcium ion-dependent exocytosis of neurotransmitter,GO:1903515~calcium ion transport from cytosol to endoplasmic reticulum,GO:1903779~regulation of cardiac conduction,GO:1990036~calcium ion import into sarcoplasmic reticulum,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0012506~vesicle membrane,GO:0014801~longitudinal sarcoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0031095~platelet dense tubular network membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0090534~calcium ion-transporting ATPase complex,GO:0097470~ribbon synapse,	GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0019899~enzyme binding,GO:0031775~lutropin-choriogonadotropic hormone receptor binding,GO:0044548~S100 protein binding,GO:0046872~metal ion binding,GO:0086039~calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005782:Calcium-transporting P-type ATPase, subfamily  IIA, SERCA-type,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,	101900~Acrokeratosis verruciformis,124200~Darier disease,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Complete proteome,Disease mutation,Endoplasmic reticulum,Epilepsy,Hydrolase,Ion transport,Isopeptide bond,Magnesium,Membrane,Metal-binding,Nitration,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Magnesium,modified residue,region of interest:Interacts with HAX1,region of interest:Interacts with phospholamban 1,region of interest:Interacts with phospholamban 2,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
213042_s_at, 207521_s_at, 207522_s_at, 213036_x_at	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3(ATP2A3)	Homo sapiens				GO:0006810~transport,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:1903779~regulation of cardiac conduction,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0031095~platelet dense tubular network membrane,GO:0031965~nuclear membrane,GO:0033017~sarcoplasmic reticulum membrane,	GO:0005388~calcium-transporting ATPase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005782:Calcium-transporting P-type ATPase, subfamily  IIA, SERCA-type,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,			SM00831:SM00831,	Acetylation,Alternative splicing,ATP-binding,Calcium,Calcium transport,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,binding site:ATP,chain:Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
209935_at, 209934_s_at, 212255_s_at, 211137_s_at	ATPase secretory pathway Ca2+ transporting 1(ATP2C1)	Homo sapiens				GO:0006816~calcium ion transport,GO:0006828~manganese ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0007165~signal transduction,GO:0008544~epidermis development,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0030026~cellular manganese ion homeostasis,GO:0031532~actin cytoskeleton reorganization,GO:0032468~Golgi calcium ion homeostasis,GO:0032472~Golgi calcium ion transport,GO:0034220~ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0070588~calcium ion transmembrane transport,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0015410~manganese-transporting ATPase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006413:Calcium-transporting P-type ATPase, subfamily IIA, PMR1-type,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,		169600~Hailey-Hailey disease,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Complete proteome,Disease mutation,Golgi apparatus,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Calcium-transporting ATPase type 2C member 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Magnesium,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
206043_s_at, 214798_at	ATPase secretory pathway Ca2+ transporting 2(ATP2C2)	Homo sapiens				GO:0006874~cellular calcium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0061180~mammary gland epithelium development,GO:0070588~calcium ion transmembrane transport,GO:0071421~manganese ion transmembrane transport,GO:0072661~protein targeting to plasma membrane,GO:0090280~positive regulation of calcium ion import,	GO:0000139~Golgi membrane,GO:0005887~integral component of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0005388~calcium-transporting ATPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015410~manganese-transporting ATPase activity,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006413:Calcium-transporting P-type ATPase, subfamily IIA, PMR1-type,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,				SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Complete proteome,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Calcium-transporting ATPase type 2C member 2,compositionally biased region:Poly-Leu,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Magnesium,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209902_at, 209903_s_at	ATR serine/threonine kinase(ATR)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_plk3Pathway:Regulation of cell cycle progression by Plk3,		GO:0000077~DNA damage checkpoint,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0008156~negative regulation of DNA replication,GO:0018105~peptidyl-serine phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0034644~cellular response to UV,GO:0036297~interstrand cross-link repair,GO:0042493~response to drug,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0046777~protein autophosphorylation,GO:0070198~protein localization to chromosome, telomeric region,GO:0071480~cellular response to gamma radiation,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0032405~MutLalpha complex binding,GO:0032407~MutSalpha complex binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR012993:UME,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021133:HEAT, type 2,IPR026683:Serine/threonine-protein kinase TOR/Smg1,	hsa03460:Fanconi anemia pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,	210600~Seckel syndrome 1,614564~Cutaneous telangiectasia and cancer syndrome, familial,		SM00146:PI3Kc,SM00802:UME,SM01343:SM01343,	Alternative splicing,ATP-binding,Chromosome,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Kinase,Manganese,Mental retardation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	chain:Serine/threonine-protein kinase ATR,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,repeat:HEAT 1,repeat:HEAT 2,sequence conflict,sequence variant,splice variant,
208860_s_at, 208861_s_at, 208859_s_at, 211022_s_at	ATRX, chromatin remodeler(ATRX)	Homo sapiens				GO:0006281~DNA repair,GO:0006306~DNA methylation,GO:0006310~DNA recombination,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0016569~covalent chromatin modification,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030900~forebrain development,GO:0031297~replication fork processing,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0035128~post-embryonic forelimb morphogenesis,GO:0035264~multicellular organism growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060009~Sertoli cell development,GO:0070198~protein localization to chromosome, telomeric region,GO:0072520~seminiferous tubule development,GO:0072711~cellular response to hydroxyurea,GO:1900112~regulation of histone H3-K9 trimethylation,GO:1901581~negative regulation of telomeric RNA transcription from RNA pol II promoter,GO:1901582~positive regulation of telomeric RNA transcription from RNA pol II promoter,GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,GO:0016605~PML body,GO:0031933~telomeric heterochromatin,GO:0070603~SWI/SNF superfamily-type complex,GO:1990707~nuclear subtelomeric heterochromatin,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR025766:ADD domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		300448~Alpha-thalassemia myelodysplasia syndrome, somatic,301040~Alpha-thalassemia/mental retardation syndrome,309580~Mental retardation-hypotonic facies syndrome, X-linked,Mental retardation, X-linked 52~Mental retardation, X-linked 52,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional regulator ATRX,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,short sequence motif:PxVxL motif,splice variant,strand,turn,zinc finger region:GATA-type; atypical,zinc finger region:PHD-type,
216404_at	ATXN8 opposite strand (non-protein coding)(ATXN8OS)	Homo sapiens					GO:0005737~cytoplasm,				608768~Spinocerebellar ataxia 8,			Complete proteome,Cytoplasm,Reference proteome,
205052_at	AU RNA binding methylglutaconyl-CoA hydratase(AUH)	Homo sapiens			Lipid metabolism,	GO:0006552~leucine catabolic process,GO:0006635~fatty acid beta-oxidation,GO:0008152~metabolic process,GO:0009083~branched-chain amino acid catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003730~mRNA 3'-UTR binding,GO:0003824~catalytic activity,GO:0004300~enoyl-CoA hydratase activity,GO:0004490~methylglutaconyl-CoA hydratase activity,	IPR001753:Crotonase superfamily,IPR014748:Crontonase, C-terminal,IPR018376:Enoyl-CoA hydratase/isomerase, conserved site,	hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,	250950~3-methylglutaconic aciduria, type I,			3D-structure,Acetylation,Alternative splicing,Branched-chain amino acid catabolism,Complete proteome,Direct protein sequencing,Disease mutation,Lyase,Mitochondrion,Reference proteome,RNA-binding,Transit peptide,	chain:Methylglutaconyl-CoA hydratase, mitochondrial,helix,mutagenesis site,region of interest:RNA-binding,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
212475_at, 212474_at, 212471_at	AVL9 cell migration associated(AVL9)	Homo sapiens				GO:0016477~cell migration,	GO:0016021~integral component of membrane,GO:0055037~recycling endosome,		IPR018307:Late secretory pathway protein AVL9,					Alternative splicing,Complete proteome,Endosome,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Late secretory pathway protein AVL9 homolog,sequence variant,splice variant,transmembrane region,
202685_s_at, 202686_s_at	AXL receptor tyrosine kinase(AXL)	Homo sapiens				GO:0001764~neuron migration,GO:0001779~natural killer cell differentiation,GO:0001961~positive regulation of cytokine-mediated signaling pathway,GO:0001974~blood vessel remodeling,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021885~forebrain cell migration,GO:0030168~platelet activation,GO:0031100~organ regeneration,GO:0031668~cellular response to extracellular stimulus,GO:0032689~negative regulation of interferon-gamma production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032825~positive regulation of natural killer cell differentiation,GO:0032940~secretion by cell,GO:0034101~erythrocyte homeostasis,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035457~cellular response to interferon-alpha,GO:0042698~ovulation cycle,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048469~cell maturation,GO:0048549~positive regulation of pinocytosis,GO:0051250~negative regulation of lymphocyte activation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060068~vagina development,GO:0070301~cellular response to hydrogen peroxide,GO:0071222~cellular response to lipopolysaccharide,GO:0097028~dendritic cell differentiation,GO:2000669~negative regulation of dendritic cell apoptotic process,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0044228~host cell surface,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001786~phosphatidylserine binding,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032036~myosin heavy chain binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0046982~protein heterodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,				SM00060:FN3,SM00219:TyrKc,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Differentiation,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Immunoglobulin domain,Innate immunity,Kinase,Membrane,Nucleotide-binding,Oncogene,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase receptor UFO,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with SKP1 and GAS6,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220842_at, 221569_at, 220841_s_at	Abelson helper integration site 1(AHI1)	Homo sapiens				GO:0001738~morphogenesis of a polarized epithelium,GO:0001947~heart looping,GO:0002092~positive regulation of receptor internalization,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007417~central nervous system development,GO:0010842~retina layer formation,GO:0016192~vesicle-mediated transport,GO:0030862~positive regulation of polarized epithelial cell differentiation,GO:0030902~hindbrain development,GO:0034613~cellular protein localization,GO:0035844~cloaca development,GO:0035845~photoreceptor cell outer segment organization,GO:0039008~pronephric nephron tubule morphogenesis,GO:0039023~pronephric duct morphogenesis,GO:0042384~cilium assembly,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050795~regulation of behavior,GO:0060271~cilium morphogenesis,GO:0065001~specification of axis polarity,GO:0070121~Kupffer's vesicle development,GO:0070986~left/right axis specification,GO:0071599~otic vesicle development,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005929~cilium,GO:0031513~nonmotile primary cilium,GO:0036038~MKS complex,GO:0036064~ciliary basal body,GO:0072372~primary cilium,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR001452:Src homology-3 domain,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		608629~Joubert syndrome-3,		SM00320:WD40,SM00326:SH3,	3D-structure,Alternative splicing,Cell junction,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Disease mutation,Joubert syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,WD repeat,	chain:Jouberin,compositionally biased region:Poly-Lys,domain:SH3,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
204976_s_at	Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1(AMMECR1)	Homo sapiens						GO:0005515~protein binding,	IPR002733:AMMECR1 domain,IPR023473:AMMECR1,IPR027485:AMMECR1, N-terminal,					Alport syndrome,Alternative splicing,Complete proteome,Deafness,Elliptocytosis,Hereditary hemolytic anemia,Mental retardation,Phosphoprotein,Reference proteome,	chain:AMME syndrome candidate gene 1 protein,compositionally biased region:Gly/Ser-rich,compositionally biased region:Ser-rich,domain:AMMECR1,splice variant,
213926_s_at, 218091_at, 218092_s_at, 213928_s_at	ArfGAP with FG repeats 1(AGFG1)	Homo sapiens				GO:0001675~acrosome assembly,GO:0006406~mRNA export from nucleus,GO:0007275~multicellular organism development,GO:0007289~spermatid nucleus differentiation,GO:0043547~positive regulation of GTPase activity,GO:0045109~intermediate filament organization,	GO:0005643~nuclear pore,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,	hsa05164:Influenza A,			SM00105:ArfGap,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Developmental protein,Differentiation,DNA-binding,Glycoprotein,Metal-binding,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,Transport,Zinc,Zinc-finger,	chain:Arf-GAP domain and FG repeats-containing protein 1,domain:Arf-GAP,glycosylation site:O-linked (GlcNAc),helix,modified residue,sequence conflict,splice variant,strand,turn,zinc finger region:C4-type,
222362_at, 206821_x_at, 206820_at, 222126_at, 217450_at	ArfGAP with FG repeats 2(AGFG2)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,				SM00105:ArfGap,	Acetylation,Alternative splicing,Complete proteome,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP domain and FG repeats-containing protein 2,compositionally biased region:Pro-rich,domain:Arf-GAP,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
204066_s_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 1(AGAP1)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001806:Small GTPase superfamily,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	Acetylation,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,GTP-binding,GTPase activation,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1,domain:Arf-GAP,domain:PH,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Small GTPase-like,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
206152_at, 215080_s_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0015031~protein transport,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0060749~mammary gland alveolus development,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0030295~protein kinase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001806:Small GTPase superfamily,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,GTP-binding,GTPase activation,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,Tumor suppressor,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,domain:Arf-GAP,domain:PH,helix,modified residue,nucleotide phosphate-binding region:GTP,region of interest:G domain,region of interest:Interaction with EPB41L1,region of interest:Interaction with PLCG1,region of interest:Interactions with HOMER1 and NF2,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
221850_x_at, 221971_x_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4(AGAP4)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,		GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00105:ArfGap,SM00233:PH,SM00248:ANK,	ANK repeat,Complete proteome,GTPase activation,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6,domain:Arf-GAP,domain:PH,repeat:ANK 1,repeat:ANK 2,sequence variant,zinc finger region:C4-type,
34206_at, 212516_at	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1(ARAP1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0001921~positive regulation of receptor recycling,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0030037~actin filament reorganization involved in cell cycle,GO:0043547~positive regulation of GTPase activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051270~regulation of cellular component movement,GO:0051491~positive regulation of filopodium assembly,GO:0051497~negative regulation of stress fiber assembly,	GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0032580~Golgi cisterna membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0031702~type 1 angiotensin receptor binding,GO:0046872~metal ion binding,	IPR000159:Ras-association,IPR000198:Rho GTPase-activating protein domain,IPR001164:Arf GTPase activating protein,IPR001660:Sterile alpha motif domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00324:RhoGAP,SM00454:SAM,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,domain:Arf-GAP,domain:PH 1,domain:PH 2,domain:PH 3,domain:PH 4,domain:Ras-associating,domain:Rho-GAP,domain:SAM,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
213618_at	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2(ARAP2)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0007165~signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0046872~metal ion binding,	IPR000159:Ras-association,IPR000198:Rho GTPase-activating protein domain,IPR001164:Arf GTPase activating protein,IPR001660:Sterile alpha motif domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00324:RhoGAP,SM00454:SAM,	3D-structure,Complete proteome,Cytoplasm,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2,domain:Arf-GAP,domain:PH 1,domain:PH 2,domain:PH 3,domain:PH 4,domain:PH 5,domain:Ras-associating,domain:Rho-GAP,domain:SAM,helix,modified residue,sequence conflict,sequence variant,strand,turn,zinc finger region:C4-type,
218950_at	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3(ARAP3)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0016192~vesicle-mediated transport,GO:0030336~negative regulation of cell migration,GO:0035021~negative regulation of Rac protein signal transduction,GO:0035024~negative regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030027~lamellipodium,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0046872~metal ion binding,	IPR000159:Ras-association,IPR000198:Rho GTPase-activating protein domain,IPR001164:Arf GTPase activating protein,IPR001660:Sterile alpha motif domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00324:RhoGAP,SM00454:SAM,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,compositionally biased region:Pro-rich,domain:Arf-GAP,domain:PH 1,domain:PH 2,domain:PH 3,domain:Ras-associating,domain:Rho-GAP,domain:SAM,modified residue,mutagenesis site,sequence variant,zinc finger region:C4-type,
221039_s_at	ArfGAP with SH3 domain, ankyrin repeat and PH domain 1(ASAP1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0043547~positive regulation of GTPase activity,GO:0060271~cilium morphogenesis,GO:0061000~negative regulation of dendritic spine development,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043197~dendritic spine,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001164:Arf GTPase activating protein,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,SM00326:SH3,	3D-structure,Alternative splicing,ANK repeat,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,compositionally biased region:Pro-rich,domain:Arf-GAP,domain:PH,domain:SH3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
206414_s_at	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2(ASAP2)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0043547~positive regulation of GTPase activity,	GO:0005886~plasma membrane,GO:0032580~Golgi cisterna membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,SM00326:SH3,	Alternative splicing,ANK repeat,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3 domain,Zinc,	chain:Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,compositionally biased region:Pro-rich,domain:Arf-GAP,domain:PH,domain:SH3,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,
219103_at, 222236_s_at	ArfGAP with SH3 domain, ankyrin repeat and PH domain 3(ASAP3)	Homo sapiens				GO:0016477~cell migration,GO:0043547~positive regulation of GTPase activity,GO:0051492~regulation of stress fiber assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005925~focal adhesion,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,compositionally biased region:Poly-Ser,domain:Arf-GAP,domain:PH,helix,modified residue,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:C4-type,
205213_at, 205212_s_at	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1(ACAP1)	Homo sapiens				GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,	GO:0016020~membrane,GO:0055038~recycling endosome membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000909:Phospholipase C, phosphatidylinositol-specific , X domain,IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	3D-structure,ANK repeat,Complete proteome,Endosome,GTPase activation,Membrane,Metal-binding,Nitration,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,Zinc,Zinc-finger,	chain:Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,domain:Arf-GAP,domain:BAR,domain:PH,modified residue,mutagenesis site,region of interest:Required for formation of endosomal tubules when overexpressed with PIP5K1C,region of interest:Required for interaction with GULP1,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,zinc finger region:C4-type,
212476_at, 212477_at	ArfGAP with coiled-coil, ankyrin repeat and PH domains 2(ACAP2)	Homo sapiens				GO:0036010~protein localization to endosome,GO:0043547~positive regulation of GTPase activity,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0010008~endosome membrane,GO:0016020~membrane,	GO:0005096~GTPase activator activity,GO:0017137~Rab GTPase binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00233:PH,SM00248:ANK,	ANK repeat,Coiled coil,Complete proteome,Endosome,GTPase activation,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2,domain:Arf-GAP,domain:BAR,domain:PH,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,zinc finger region:C4-type,
90265_at, 219150_s_at	ArfGAP with dual PH domains 1(ADAP1)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0043533~inositol 1,3,4,5 tetrakisphosphate binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00105:ArfGap,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with dual PH domain-containing protein 1,domain:Arf-GAP,domain:PH 1,domain:PH 2,helix,modified residue,mutagenesis site,sequence variant,strand,turn,zinc finger region:C4-type,
219358_s_at	ArfGAP with dual PH domains 2(ADAP2)	Homo sapiens				GO:0007507~heart development,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005740~mitochondrial envelope,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0030674~protein binding, bridging,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0043533~inositol 1,3,4,5 tetrakisphosphate binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00105:ArfGap,SM00233:PH,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,GTPase activation,Membrane,Metal-binding,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with dual PH domain-containing protein 2,domain:Arf-GAP,domain:PH 1,domain:PH 2,sequence conflict,splice variant,zinc finger region:C4-type,
207712_at	B melanoma antigen(BAGE)	Homo sapiens					GO:0005576~extracellular region,		IPR012530:B melanoma antigen,					Alternative splicing,Complete proteome,Reference proteome,Secreted,Signal,	chain:B melanoma antigen 1,signal peptide,
209430_at	B-TFIID TATA-box binding protein associated factor 1(BTAF1)	Homo sapiens			Transcription / DNA replication, recombination, and repair,	GO:0035562~negative regulation of chromatin binding,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005654~nucleoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011989:Armadillo-like helical,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016024:Armadillo-type fold,IPR022707:Domain of unknown function DUF3535,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,DNA-binding,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:TATA-binding protein-associated factor 172,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,short sequence motif:DEGH box,short sequence motif:Nuclear localization signal,
218792_s_at	B-box and SPRY domain containing(BSPRY)	Homo sapiens				GO:0006816~calcium ion transport,	GO:0016020~membrane,GO:0031252~cell leading edge,GO:0048471~perinuclear region of cytoplasm,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,SM00589:PRY,	Alternative splicing,Calcium,Calcium transport,Complete proteome,Cytoplasm,Ion transport,Membrane,Metal-binding,Polymorphism,Reference proteome,Transport,Zinc,Zinc-finger,	chain:B box and SPRY domain-containing protein,domain:B30.2/SPRY,sequence conflict,sequence variant,splice variant,zinc finger region:B box-type,
205263_at	B-cell CLL/lymphoma 10(BCL10)	Homo sapiens				GO:0001783~B cell apoptotic process,GO:0001843~neural tube closure,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002224~toll-like receptor signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002250~adaptive immune response,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006915~apoptotic process,GO:0006968~cellular defense response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0008219~cell death,GO:0009620~response to fungus,GO:0016064~immunoglobulin mediated immune response,GO:0031398~positive regulation of protein ubiquitination,GO:0032094~response to food,GO:0032765~positive regulation of mast cell cytokine production,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042109~lymphotoxin A biosynthetic process,GO:0042226~interleukin-6 biosynthetic process,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050852~T cell receptor signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,GO:0070231~T cell apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0032449~CBM complex,GO:0042101~T cell receptor complex,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0046696~lipopolysaccharide receptor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0002020~protease binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0019209~kinase activator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0043422~protein kinase B binding,GO:0043621~protein self-association,GO:0051059~NF-kappaB binding,	IPR001315:Caspase Recruitment,IPR011029:Death-like domain,	hsa04064:NF-kappa B signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa05152:Tuberculosis,	137245~Lymphoma, MALT, somatic,156240~Mesothelioma, somatic,605027~Lymphoma, follicular, somatic,616098~Immunodeficiency 37,Male germ cell tumor, somatic, 273300,~Male germ cell tumor, somatic, 273300,,Sezary syndrome, somatic,~Sezary syndrome, somatic,,			3D-structure,Acetylation,Apoptosis,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Immunity,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Tumor suppressor,	chain:B-cell lymphoma/leukemia 10,domain:CARD,modified residue,mutagenesis site,sequence variant,
219497_s_at, 210347_s_at, 219498_s_at	B-cell CLL/lymphoma 11A(BCL11A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0010977~negative regulation of neuron projection development,GO:0016925~protein sumoylation,GO:0030517~negative regulation of axon extension,GO:0032463~negative regulation of protein homooligomerization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048671~negative regulation of collateral sprouting,GO:0048672~positive regulation of collateral sprouting,GO:0050773~regulation of dendrite development,GO:2000171~negative regulation of dendrite development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:B-cell lymphoma/leukemia 11A,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
219528_s_at	B-cell CLL/lymphoma 11B(BCL11B)	Homo sapiens				GO:0003334~keratinocyte development,GO:0003382~epithelial cell morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0010837~regulation of keratinocyte proliferation,GO:0019216~regulation of lipid metabolic process,GO:0021773~striatal medium spiny neuron differentiation,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0022008~neurogenesis,GO:0031077~post-embryonic camera-type eye development,GO:0033077~T cell differentiation in thymus,GO:0033153~T cell receptor V(D)J recombination,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043066~negative regulation of apoptotic process,GO:0043368~positive T cell selection,GO:0045664~regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046632~alpha-beta T cell differentiation,GO:0048538~thymus development,GO:0071678~olfactory bulb axon guidance,	GO:0005634~nucleus,GO:0043005~neuron projection,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:B-cell lymphoma/leukemia 11B,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,modified residue,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
203140_at, 215990_s_at	B-cell CLL/lymphoma 6(BCL6)	Homo sapiens	80.T_cell_Activation,			GO:0000060~protein import into nucleus, translocation,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002467~germinal center formation,GO:0002634~regulation of germinal center formation,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007266~Rho protein signal transduction,GO:0007283~spermatogenesis,GO:0008285~negative regulation of cell proliferation,GO:0030036~actin cytoskeleton organization,GO:0030099~myeloid cell differentiation,GO:0030183~B cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030890~positive regulation of B cell proliferation,GO:0031065~positive regulation of histone deacetylation,GO:0032764~negative regulation of mast cell cytokine production,GO:0035024~negative regulation of Rho protein signal transduction,GO:0042092~type 2 immune response,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043380~regulation of memory T cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048294~negative regulation of isotype switching to IgE isotypes,GO:0048821~erythrocyte development,GO:0050727~regulation of inflammatory response,GO:0050767~regulation of neurogenesis,GO:0050776~regulation of immune response,GO:0051272~positive regulation of cellular component movement,GO:2000773~negative regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001161~intronic transcription regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04068:FoxO signaling pathway,hsa05202:Transcriptional misregulation in cancer,	Lymphoma, B-cell~Lymphoma, B-cell,		SM00225:BTB,SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,DNA-binding,Immunity,Inflammatory response,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:B-cell lymphoma 6 protein,domain:BTB,helix,mutagenesis site,sequence conflict,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
204129_at	B-cell CLL/lymphoma 9(BCL9)	Homo sapiens				GO:0014908~myotube differentiation involved in skeletal muscle regeneration,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR015668:B Cell Lymphoma 9,IPR024670:B-cell lymphoma 9, beta-catenin binding domain,					3D-structure,Acetylation,Chromosomal rearrangement,Complete proteome,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Wnt signaling pathway,	chain:B-cell CLL/lymphoma 9 protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,helix,modified residue,region of interest:CTNNB1-binding,sequence conflict,sequence variant,strand,
207655_s_at	B-cell linker(BLNK)	Homo sapiens		h_bcrPathway:BCR Signaling Pathway,		GO:0006954~inflammatory response,GO:0006959~humoral immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009967~positive regulation of signal transduction,GO:0030183~B cell differentiation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613502~Agammaglobulinemia 4,		SM00252:SH2,	Alternative splicing,B-cell activation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH2 domain,	chain:B-cell linker protein,compositionally biased region:Pro-rich,domain:SH2,modified residue,mutagenesis site,sequence conflict,splice variant,
205084_at	B-cell receptor associated protein 29(BCAP29)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006915~apoptotic process,GO:0070973~protein localization to endoplasmic reticulum exit site,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR008417:B-cell receptor-associated 31-like,					3D-structure,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Protein transport,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:B-cell receptor-associated protein 29,sequence conflict,short sequence motif:Di-lysine motif,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200837_at	B-cell receptor-associated protein 31(BCAP31)	Homo sapiens				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007283~spermatogenesis,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0070973~protein localization to endoplasmic reticulum exit site,GO:1903071~positive regulation of ER-associated ubiquitin-dependent protein catabolic process,GO:1904154~positive regulation of retrograde protein transport, ER to cytosol,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005784~Sec61 translocon complex,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0032580~Golgi cisterna membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,GO:0097038~perinuclear endoplasmic reticulum,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0042288~MHC class I protein binding,	IPR008417:B-cell receptor-associated 31-like,	hsa04141:Protein processing in endoplasmic reticulum,	300475~Deafness, dystonia, and cerebral hypomyelination,			3D-structure,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Deafness,Direct protein sequencing,Dystonia,Endoplasmic reticulum,ER-Golgi transport,Membrane,Mental retardation,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:B-cell receptor-associated protein 31,mutagenesis site,sequence conflict,short sequence motif:Di-lysine motif,site:Cleavage; by caspase-8,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
219667_s_at	B-cell scaffold protein with ankyrin repeats 1(BANK1)	Homo sapiens				GO:0042113~B cell activation,GO:0043410~positive regulation of MAPK cascade,GO:0045947~negative regulation of translational initiation,GO:0050869~negative regulation of B cell activation,GO:0051898~negative regulation of protein kinase B signaling,GO:1900165~negative regulation of interleukin-6 secretion,			IPR017893:DBB domain,IPR020683:Ankyrin repeat-containing domain,				SM01282:SM01282,	Alternative splicing,ANK repeat,B-cell activation,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Systemic lupus erythematosus,	chain:B-cell scaffold protein with ankyrin repeats,domain:DBB,region of interest:Interaction with ITPR2,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,splice variant,
205662_at, 210535_at, 210534_s_at	B9 domain containing 1(B9D1)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001944~vasculature development,GO:0007224~smoothened signaling pathway,GO:0032880~regulation of protein localization,GO:0042384~cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0060271~cilium morphogenesis,GO:0060563~neuroepithelial cell differentiation,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0036064~ciliary basal body,	GO:0008158~hedgehog receptor activity,	IPR010796:B9 domain,		614209~Meckel syndrome 9,			Alternative splicing,Cell projection,Ciliopathy,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Meckel syndrome,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:B9 domain-containing protein 1,domain:B9,splice variant,
219766_at	B9 protein domain 2(B9D2)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0043015~gamma-tubulin binding,	IPR010796:B9 domain,		614175~Meckel syndrome 10,			Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Meckel syndrome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:B9 domain-containing protein 2,domain:B9,sequence variant,
219218_at	BAH domain and coiled-coil containing 1(BAHCC1)	Homo sapiens				GO:0006342~chromatin silencing,GO:0031507~heterochromatin assembly,	GO:0000785~chromatin,GO:0005677~chromatin silencing complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003682~chromatin binding,	IPR001025:Bromo adjacent homology (BAH) domain,				SM00439:BAH,	Acetylation,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:BAH and coiled-coil domain-containing protein 1,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:BAH,modified residue,sequence conflict,sequence variant,
221178_at	BAI1 associated protein 2 like 2(BAIAP2L2)	Homo sapiens				GO:0007009~plasma membrane organization,GO:0008286~insulin receptor signaling pathway,GO:0030838~positive regulation of actin filament polymerization,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,GO:0061024~membrane organization,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012506~vesicle membrane,GO:0015629~actin cytoskeleton,GO:0030659~cytoplasmic vesicle membrane,GO:0044291~cell-cell contact zone,GO:0071439~clathrin complex,	GO:0005543~phospholipid binding,GO:0008093~cytoskeletal adaptor activity,	IPR001452:Src homology-3 domain,IPR013606:IRSp53/MIM homology domain (IMD),				SM00326:SH3,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Brain-specific angiogenesis inhibitor 1- associated protein 2-like protein 2,domain:IMD,domain:SH3,sequence conflict,splice variant,
209502_s_at, 205293_x_at, 205294_at, 207832_at	BAI1 associated protein 2(BAIAP2)	Homo sapiens		h_rhoPathway:Rho cell motility signaling pathway,		GO:0007009~plasma membrane organization,GO:0007409~axonogenesis,GO:0008286~insulin receptor signaling pathway,GO:0008360~regulation of cell shape,GO:0009617~response to bacterium,GO:0016358~dendrite development,GO:0030838~positive regulation of actin filament polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048167~regulation of synaptic plasticity,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0098609~cell-cell adhesion,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030141~secretory granule,GO:0030175~filopodium,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008093~cytoskeletal adaptor activity,GO:0030165~PDZ domain binding,GO:0042802~identical protein binding,GO:0070064~proline-rich region binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR013606:IRSp53/MIM homology domain (IMD),	hsa04520:Adherens junction,hsa04810:Regulation of actin cytoskeleton,			SM00326:SH3,	3D-structure,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Brain-specific angiogenesis inhibitor 1- associated protein 2,domain:IMD,domain:SH3,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
216356_x_at, 204874_x_at	BAI1 associated protein 3(BAIAP3)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007269~neurotransmitter secretion,	GO:0098793~presynapse,	GO:0008022~protein C-terminus binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR014770:Munc13 homology 1,IPR014772:Mammalian uncoordinated homology 13, domain 2,IPR019558:Mammalian uncoordinated homology 13, subgroup, domain 2,	hsa05202:Transcriptional misregulation in cancer,			SM00239:C2,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:BAI1-associated protein 3,domain:C2 1,domain:C2 2,domain:MHD1,domain:MHD2,sequence variant,splice variant,
219845_at	BARX homeobox 1(BARX1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0009888~tissue development,GO:0009952~anterior/posterior pattern specification,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030855~epithelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048513~animal organ development,GO:0048536~spleen development,GO:0055123~digestive system development,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein BarH-like 1,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox,helix,sequence conflict,sequence variant,splice variant,
210419_at	BARX homeobox 2(BARX2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001502~cartilage condensation,GO:0006366~transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0014902~myotube differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,DNA-binding,Homeobox,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein BarH-like 2,DNA-binding region:Homeobox,modified residue,
213220_at, 213224_s_at	BBSome interacting protein 1(BBIP1)	Homo sapiens				GO:0015031~protein transport,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0097500~receptor localization to nonmotile primary cilium,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034464~BBSome,	GO:0005515~protein binding,			615995~Bardet-Biedl syndrome 18,			Alternative splicing,Bardet-Biedl syndrome,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Obesity,Protein transport,Reference proteome,Transport,
213016_at, 213015_at	BBX, HMG-box containing(BBX)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0060348~bone development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR019102:HMG box transcription factor BBX, domain of unknown function DUF2028,				SM00398:HMG,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:HMG box transcription factor BBX,compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,DNA-binding region:HMG box,modified residue,sequence variant,splice variant,
220488_s_at	BCAS3, microtubule associated cell migration factor(BCAS3)	Homo sapiens				GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0007030~Golgi organization,GO:0010595~positive regulation of endothelial cell migration,GO:0016192~vesicle-mediated transport,GO:0031023~microtubule organizing center organization,GO:0034260~negative regulation of GTPase activity,GO:0035148~tube formation,GO:0042594~response to starvation,GO:0043085~positive regulation of catalytic activity,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051491~positive regulation of filopodium assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0071391~cellular response to estrogen stimulus,GO:0090316~positive regulation of intracellular protein transport,GO:0090630~activation of GTPase activity,GO:2000114~regulation of establishment of cell polarity,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005881~cytoplasmic microtubule,GO:0031252~cell leading edge,GO:0035327~transcriptionally active chromatin,GO:0045111~intermediate filament cytoskeleton,GO:0071944~cell periphery,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0010698~acetyltransferase activator activity,GO:0035035~histone acetyltransferase binding,GO:0035257~nuclear hormone receptor binding,GO:0042393~histone binding,GO:0048487~beta-tubulin binding,	IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR022175:Breast carcinoma amplified sequence 3,					Acetylation,Alternative splicing,Angiogenesis,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,WD repeat,	chain:Breast carcinoma-amplified sequence 3,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,sequence conflict,sequence variant,site:Breakpoint for translocation to form BCAS4-BCAS3,splice variant,
203796_s_at, 203795_s_at	BCL tumor suppressor 7A(BCL7A)	Homo sapiens				GO:0045892~negative regulation of transcription, DNA-templated,		GO:0005515~protein binding,	IPR006804:BCL7,		B-cell non-Hodgkin lymphoma, high-grade~B-cell non-Hodgkin lymphoma, high-grade,			Alternative splicing,Chromosomal rearrangement,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:B-cell CLL/lymphoma 7 protein family member A,modified residue,sequence variant,splice variant,
202518_at	BCL tumor suppressor 7B(BCL7B)	Homo sapiens				GO:0006915~apoptotic process,GO:0016055~Wnt signaling pathway,GO:0030154~cell differentiation,		GO:0003779~actin binding,GO:0005515~protein binding,	IPR006804:BCL7,					Allergen,Alternative splicing,Apoptosis,Complete proteome,Differentiation,Phosphoprotein,Proteomics identification,Reference proteome,Williams-Beuren syndrome,Wnt signaling pathway,	chain:B-cell CLL/lymphoma 7 protein family member B,modified residue,sequence conflict,splice variant,
219072_at	BCL tumor suppressor 7C(BCL7C)	Homo sapiens				GO:0006915~apoptotic process,			IPR006804:BCL7,					Alternative splicing,Apoptosis,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:B-cell CLL/lymphoma 7 protein family member C,compositionally biased region:Pro-rich,modified residue,sequence conflict,splice variant,
203728_at	BCL2 antagonist/killer 1(BAK1)	Homo sapiens		h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001836~release of cytochrome c from mitochondria,GO:0001974~blood vessel remodeling,GO:0002262~myeloid cell homeostasis,GO:0002352~B cell negative selection,GO:0006987~activation of signaling protein activity involved in unfolded protein response,GO:0007420~brain development,GO:0007568~aging,GO:0008053~mitochondrial fusion,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0009620~response to fungus,GO:0010046~response to mycotoxin,GO:0010225~response to UV-C,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010332~response to gamma radiation,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0010629~negative regulation of gene expression,GO:0014070~response to organic cyclic compound,GO:0019835~cytolysis,GO:0031018~endocrine pancreas development,GO:0031100~organ regeneration,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0034644~cellular response to UV,GO:0035108~limb morphogenesis,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0044346~fibroblast apoptotic process,GO:0045471~response to ethanol,GO:0045862~positive regulation of proteolysis,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048597~post-embryonic camera-type eye morphogenesis,GO:0051726~regulation of cell cycle,GO:0051881~regulation of mitochondrial membrane potential,GO:0060068~vagina development,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070242~thymocyte apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097190~apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097202~activation of cysteine-type endopeptidase activity,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1902262~apoptotic process involved in patterning of blood vessels,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0046930~pore complex,	GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0051087~chaperone binding,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,IPR026308:Apoptosis regulator BAK,	hsa04141:Protein processing in endoplasmic reticulum,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,				3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Membrane,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	chain:Bcl-2 homologous antagonist/killer,chain:Putative Bcl-2 homologous antagonist/killer 2,helix,metal ion-binding site:Zinc; shared with dimeric partner,modified residue,mutagenesis site,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,transmembrane region,turn,
211833_s_at, 208478_s_at	BCL2 associated X, apoptosis regulator(BAX)	Homo sapiens	127.Mito-stress,152.altered_synaptic_signalling-neurodegenerative_disorders,46.P13K_PTEN,	h_badPathway:Regulation of BAD phosphorylation,h_ceramidePathway:Ceramide Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,		GO:0001541~ovarian follicle development,GO:0001764~neuron migration,GO:0001777~T cell homeostatic proliferation,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001822~kidney development,GO:0001836~release of cytochrome c from mitochondria,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0001974~blood vessel remodeling,GO:0002262~myeloid cell homeostasis,GO:0002352~B cell negative selection,GO:0002358~B cell homeostatic proliferation,GO:0002904~positive regulation of B cell apoptotic process,GO:0006687~glycosphingolipid metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006987~activation of signaling protein activity involved in unfolded protein response,GO:0007281~germ cell development,GO:0008053~mitochondrial fusion,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008637~apoptotic mitochondrial changes,GO:0009566~fertilization,GO:0009636~response to toxic substance,GO:0009651~response to salt stress,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010332~response to gamma radiation,GO:0016032~viral process,GO:0021854~hypothalamus development,GO:0021987~cerebral cortex development,GO:0032091~negative regulation of protein binding,GO:0032461~positive regulation of protein oligomerization,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0032976~release of matrix enzymes from mitochondria,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0033599~regulation of mammary gland epithelial cell proliferation,GO:0034644~cellular response to UV,GO:0035234~ectopic germ cell programmed cell death,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045136~development of secondary sexual characteristics,GO:0046666~retinal cell programmed cell death,GO:0048087~positive regulation of developmental pigmentation,GO:0048147~negative regulation of fibroblast proliferation,GO:0048515~spermatid differentiation,GO:0048597~post-embryonic camera-type eye morphogenesis,GO:0048678~response to axon injury,GO:0048873~homeostasis of number of cells within a tissue,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051402~neuron apoptotic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0060011~Sertoli cell proliferation,GO:0060041~retina development in camera-type eye,GO:0060058~positive regulation of apoptotic process involved in mammary gland involution,GO:0060068~vagina development,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070242~thymocyte apoptotic process,GO:0070584~mitochondrion morphogenesis,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1902262~apoptotic process involved in patterning of blood vessels,GO:1902263~apoptotic process involved in embryonic digit morphogenesis,GO:1902445~regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,GO:1902512~positive regulation of apoptotic DNA fragmentation,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,GO:1990117~B cell receptor apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005757~mitochondrial permeability transition pore complex,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0046930~pore complex,GO:0070062~extracellular exosome,GO:0097136~Bcl-2 family protein complex,GO:0097144~BAX complex,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0015267~channel activity,GO:0030544~Hsp70 protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051087~chaperone binding,GO:0051434~BH3 domain binding,	IPR002475:Bcl2-like,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,IPR026304:Apoptosis regulator BAX,	hsa04071:Sphingolipid signaling pathway,hsa04115:p53 signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04210:Apoptosis,hsa04722:Neurotrophin signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05020:Prion diseases,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05210:Colorectal cancer,	114500~Colorectal cancer, somatic,613065~T-cell acute lymphoblastic leukemia, somatic,			3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Host-virus interaction,Membrane,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Apoptosis regulator BAX,helix,modified residue,mutagenesis site,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,splice variant,strand,transmembrane region,turn,
1861_at, 209364_at	BCL2 associated agonist of cell death(BAD)	Homo sapiens	103.Ca2-calmodulin_PK_cascade,159.14-3-3_Apoptosis,46.P13K_PTEN,69.Survival_signaling_BH3-Bad,83.Growth_factors_Survival_factors_Mitogens,86.Apoptosis_Nematode&_Vert,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_badPathway:Regulation of BAD phosphorylation,h_ceramidePathway:Ceramide Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_rasPathway:Ras Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		GO:0001666~response to hypoxia,GO:0001836~release of cytochrome c from mitochondria,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0006007~glucose catabolic process,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007283~spermatogenesis,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009749~response to glucose,GO:0010508~positive regulation of autophagy,GO:0010918~positive regulation of mitochondrial membrane potential,GO:0019050~suppression by virus of host apoptotic process,GO:0019221~cytokine-mediated signaling pathway,GO:0021987~cerebral cortex development,GO:0032024~positive regulation of insulin secretion,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0033133~positive regulation of glucokinase activity,GO:0033574~response to testosterone,GO:0034201~response to oleic acid,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042593~glucose homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043200~response to amino acid,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044342~type B pancreatic cell proliferation,GO:0045471~response to ethanol,GO:0045579~positive regulation of B cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045862~positive regulation of proteolysis,GO:0045918~negative regulation of cytolysis,GO:0046031~ADP metabolic process,GO:0046034~ATP metabolic process,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046931~pore complex assembly,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051384~response to glucocorticoid,GO:0051592~response to calcium ion,GO:0060139~positive regulation of apoptotic process by virus,GO:0060154~cellular process regulating host cell cycle in response to virus,GO:0071247~cellular response to chromate,GO:0071260~cellular response to mechanical stimulus,GO:0071316~cellular response to nicotine,GO:0071396~cellular response to lipid,GO:0071456~cellular response to hypoxia,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097202~activation of cysteine-type endopeptidase activity,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901216~positive regulation of neuron death,GO:2000078~positive regulation of type B pancreatic cell development,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0019901~protein kinase binding,GO:0030346~protein phosphatase 2B binding,GO:0043422~protein kinase B binding,GO:0046982~protein heterodimerization activity,GO:0071889~14-3-3 protein binding,	IPR018868:Pro-apoptotic Bcl-2 protein, BAD,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,				3D-structure,Acetylation,Apoptosis,Complete proteome,Cytoplasm,Membrane,Methylation,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Bcl2 antagonist of cell death,helix,modified residue,sequence variant,short sequence motif:BH3,strand,
202387_at, 211475_s_at	BCL2 associated athanogene 1(BAG1)	Homo sapiens				GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0050790~regulation of catalytic activity,GO:0070389~chaperone cofactor-dependent protein refolding,GO:1900034~regulation of cellular response to heat,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0051087~chaperone binding,	IPR000626:Ubiquitin,IPR003103:BAG domain,	hsa04141:Protein processing in endoplasmic reticulum,			SM00213:UBQ,SM00264:BAG,	3D-structure,Alternative initiation,Alternative splicing,Apoptosis,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:BAG family molecular chaperone regulator 1,compositionally biased region:Arg-rich,domain:BAG,domain:Ubiquitin-like,helix,region of interest:7 X 6 AA tandem repeat of E-E-X(4),region of interest:Interaction with HSPA8,region of interest:Interaction with PPP1R15A,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,sequence conflict,splice variant,strand,turn,
209406_at	BCL2 associated athanogene 2(BAG2)	Homo sapiens				GO:0006457~protein folding,GO:0019538~protein metabolic process,GO:0050790~regulation of catalytic activity,GO:1900034~regulation of cellular response to heat,	GO:0005829~cytosol,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0051087~chaperone binding,	IPR003103:BAG domain,	hsa04141:Protein processing in endoplasmic reticulum,			SM00264:BAG,	Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Reference proteome,	chain:BAG family molecular chaperone regulator 2,domain:BAG,modified residue,sequence conflict,
217911_s_at	BCL2 associated athanogene 3(BAG3)	Homo sapiens				GO:0006457~protein folding,GO:0007420~brain development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010664~negative regulation of striated muscle cell apoptotic process,GO:0021510~spinal cord development,GO:0043066~negative regulation of apoptotic process,GO:0050790~regulation of catalytic activity,GO:0050821~protein stabilization,GO:0071260~cellular response to mechanical stimulus,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0098609~cell-cell adhesion,GO:1900034~regulation of cellular response to heat,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0030018~Z disc,GO:0043005~neuron projection,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0051087~chaperone binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001202:WW domain,IPR003103:BAG domain,		612954~Myopathy, myofibrillar, 6,613881~Cardiomyopathy, dilated, 1HH,		SM00264:BAG,SM00456:WW,	Acetylation,Apoptosis,Cardiomyopathy,Chaperone,Complete proteome,Disease mutation,Isopeptide bond,Methylation,Myofibrillar myopathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:BAG family molecular chaperone regulator 3,compositionally biased region:Poly-Ser,domain:BAG,domain:WW 1,domain:WW 2,modified residue,sequence conflict,sequence variant,
219624_at	BCL2 associated athanogene 4(BAG4)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006457~protein folding,GO:0010763~positive regulation of fibroblast migration,GO:0030838~positive regulation of actin filament polymerization,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0045785~positive regulation of cell adhesion,GO:0051291~protein heterooligomerization,GO:0051496~positive regulation of stress fiber assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0072659~protein localization to plasma membrane,GO:0090367~negative regulation of mRNA modification,GO:0097178~ruffle assembly,GO:1900034~regulation of cellular response to heat,GO:1903215~negative regulation of protein targeting to mitochondrion,GO:2001145~negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0051087~chaperone binding,	IPR003103:BAG domain,	hsa04668:TNF signaling pathway,			SM00264:BAG,	3D-structure,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:BAG family molecular chaperone regulator 4,domain:BAG,helix,mutagenesis site,
202984_s_at, 202985_s_at	BCL2 associated athanogene 5(BAG5)	Homo sapiens				GO:0006457~protein folding,GO:0007030~Golgi organization,GO:0010977~negative regulation of neuron projection development,GO:0031397~negative regulation of protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0051438~regulation of ubiquitin-protein transferase activity,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0061084~negative regulation of protein refolding,GO:0070997~neuron death,GO:0090083~regulation of inclusion body assembly,GO:1900034~regulation of cellular response to heat,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0016234~inclusion body,GO:0048471~perinuclear region of cytoplasm,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0051087~chaperone binding,	IPR003103:BAG domain,				SM00264:BAG,	3D-structure,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:BAG family molecular chaperone regulator 5,domain:BAG 1,domain:BAG 2,domain:BAG 3,domain:BAG 4,helix,modified residue,sequence variant,splice variant,turn,
201255_x_at, 213318_s_at, 210208_x_at	BCL2 associated athanogene 6(BAG6)	Homo sapiens				GO:0001822~kidney development,GO:0002376~immune system process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006810~transport,GO:0007130~synaptonemal complex assembly,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0009790~embryo development,GO:0016569~covalent chromatin modification,GO:0018393~internal peptidyl-lysine acetylation,GO:0030154~cell differentiation,GO:0030324~lung development,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043066~negative regulation of apoptotic process,GO:0045861~negative regulation of proteolysis,GO:0050821~protein stabilization,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071816~tail-anchored membrane protein insertion into ER membrane,GO:1904294~positive regulation of ERAD pathway,GO:1904378~maintenance of unfolded protein involved in ERAD pathway,GO:1904379~protein localization to cytosolic proteasome complex involved in ERAD pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0071818~BAT3 complex,	GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0031593~polyubiquitin binding,GO:0031625~ubiquitin protein ligase binding,GO:0043022~ribosome binding,GO:0051787~misfolded protein binding,GO:0070628~proteasome binding,GO:1990381~ubiquitin-specific protease binding,	IPR000626:Ubiquitin,IPR019954:Ubiquitin conserved site,IPR021925:Protein of unknown function DUF3538,				SM00213:UBQ,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Chaperone,Chromatin regulator,Complete proteome,Cytoplasm,Differentiation,Immunity,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Spermatogenesis,Transport,Ubl conjugation,	chain:Large proline-rich protein BAT3,compositionally biased region:Pro-rich,domain:Ubiquitin-like,helix,modified residue,mutagenesis site,region of interest:4 X 29 AA approximate repeats,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,sequence variant,site:Cleavage; by caspase-3,splice variant,strand,turn,
201101_s_at, 214499_s_at, 201084_s_at, 201083_s_at	BCL2 associated transcription factor 1(BCLAF1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0045892~negative regulation of transcription, DNA-templated,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2001022~positive regulation of response to DNA damage stimulus,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR018545:Btz domain,IPR026668:Bcl-2-associated transcription factor 1,					Acetylation,Alternative splicing,Citrullination,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Bcl-2-associated transcription factor 1,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,splice variant,
214057_at, 200796_s_at, 200797_s_at, 200798_x_at, 214056_at	BCL2 family apoptosis regulator(MCL1)	Homo sapiens				GO:0001709~cell fate determination,GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0010507~negative regulation of autophagy,GO:0019725~cellular homeostasis,GO:0034097~response to cytokine,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0071806~protein transmembrane transport,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:2000811~negative regulation of anoikis,GO:2001020~regulation of response to DNA damage stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016459~myosin complex,GO:0097136~Bcl-2 family protein complex,	GO:0005515~protein binding,GO:0015266~protein channel activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051434~BH3 domain binding,	IPR002475:Bcl2-like,IPR011992:EF-hand-like domain,IPR013281:Apoptosis regulator, Mcl-1,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,	hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,				3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Isopeptide bond,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Induced myeloid leukemia cell differentiation protein Mcl-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,region of interest:PEST-like,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,site:Cleavage; by caspase-3,splice variant,transmembrane region,turn,
205780_at	BCL2 interacting killer(BIK)	Homo sapiens	86.Apoptosis_Nematode&_Vert,	h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0006915~apoptotic process,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0008637~apoptotic mitochondrial changes,GO:0032464~positive regulation of protein homooligomerization,GO:0042981~regulation of apoptotic process,GO:0090200~positive regulation of release of cytochrome c from mitochondria,	GO:0005740~mitochondrial envelope,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,GO:0051400~BH domain binding,	IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR024579:Bcl-2-interacting killer,					3D-structure,Apoptosis,Complete proteome,Membrane,Mitochondrion,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Bcl-2-interacting killer,domain:Leucine-zipper,sequence conflict,sequence variant,short sequence motif:BH3,transmembrane region,
204930_s_at, 37226_at, 207829_s_at	BCL2 interacting protein 1(BNIP1)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007029~endoplasmic reticulum organization,GO:0016320~endoplasmic reticulum membrane fusion,GO:0043066~negative regulation of apoptotic process,GO:0097194~execution phase of apoptosis,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031201~SNARE complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0005484~SNAP receptor activity,GO:0005515~protein binding,	IPR005606:Sec20,	hsa04130:SNARE interactions in vesicular transport,				Alternative splicing,Apoptosis,Autophagy,Coiled coil,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Mitochondrion,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Vesicle transport protein SEC20,mutagenesis site,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
209308_s_at	BCL2 interacting protein 2(BNIP2)	Homo sapiens				GO:0001824~blastocyst development,GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043547~positive regulation of GTPase activity,GO:0045666~positive regulation of neuron differentiation,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051146~striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051297~centrosome organization,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031616~spindle pole centrosome,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR001251:CRAL-TRIO domain,IPR022181:Bcl2-/adenovirus E1B 19kDa-interacting protein 2,				SM00516:SEC14,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:BCL2/adenovirus E1B 19 kDa protein- interacting protein 2,domain:CRAL-TRIO,modified residue,sequence variant,
221478_at, 221479_s_at	BCL2 interacting protein 3 like(BNIP3L)	Homo sapiens				GO:0016239~positive regulation of macroautophagy,GO:0035694~mitochondrial protein catabolic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0051607~defense response to virus,GO:0060548~negative regulation of cell death,GO:0071456~cellular response to hypoxia,GO:0097345~mitochondrial outer membrane permeabilization,GO:1903146~regulation of mitophagy,GO:1903214~regulation of protein targeting to mitochondrion,	GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031224~intrinsic component of membrane,	GO:0005515~protein binding,GO:0005521~lamin binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR010548:BNIP3,					Alternative splicing,Apoptosis,Complete proteome,Endoplasmic reticulum,Host-virus interaction,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:BCL2/adenovirus E1B 19 kDa protein- interacting protein 3-like,modified residue,sequence conflict,transmembrane region,
201848_s_at, 201849_at	BCL2 interacting protein 3(BNIP3)	Homo sapiens				GO:0000422~mitophagy,GO:0001666~response to hypoxia,GO:0006915~apoptotic process,GO:0008219~cell death,GO:0008626~granzyme-mediated apoptotic signaling pathway,GO:0010508~positive regulation of autophagy,GO:0010637~negative regulation of mitochondrial fusion,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0016239~positive regulation of macroautophagy,GO:0035694~mitochondrial protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043068~positive regulation of programmed cell death,GO:0043243~positive regulation of protein complex disassembly,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045837~negative regulation of membrane potential,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048102~autophagic cell death,GO:0050873~brown fat cell differentiation,GO:0051402~neuron apoptotic process,GO:0051607~defense response to virus,GO:0055093~response to hyperoxia,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,GO:0071260~cellular response to mechanical stimulus,GO:0071279~cellular response to cobalt ion,GO:0071456~cellular response to hypoxia,GO:0072593~reactive oxygen species metabolic process,GO:0090141~positive regulation of mitochondrial fission,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097345~mitochondrial outer membrane permeabilization,GO:1901998~toxin transport,GO:1903715~regulation of aerobic respiration,GO:1990144~intrinsic apoptotic signaling pathway in response to hypoxia,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0031307~integral component of mitochondrial outer membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051020~GTPase binding,	IPR010548:BNIP3,	hsa04068:FoxO signaling pathway,hsa05134:Legionellosis,				3D-structure,Apoptosis,Complete proteome,Host-virus interaction,Membrane,Mitochondrion,Mitochondrion outer membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:BCL2/adenovirus E1B 19 kDa protein- interacting protein 3,helix,modified residue,sequence conflict,transmembrane region,
212312_at, 206665_s_at, 215037_s_at	BCL2 like 1(BCL2L1)	Homo sapiens	127.Mito-stress,152.altered_synaptic_signalling-neurodegenerative_disorders,159.14-3-3_Apoptosis,69.Survival_signaling_BH3-Bad,72.IAP_interaction_with_cell_death_pathways,	h_aifPathway:Opposing roles of AIF in Apoptosis and Cell Survival,h_badPathway:Regulation of BAD phosphorylation,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_rasPathway:Ras Signaling Pathway,		GO:0000910~cytokinesis,GO:0001541~ovarian follicle development,GO:0001701~in utero embryonic development,GO:0001836~release of cytochrome c from mitochondria,GO:0006897~endocytosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008637~apoptotic mitochondrial changes,GO:0009566~fertilization,GO:0010507~negative regulation of autophagy,GO:0019050~suppression by virus of host apoptotic process,GO:0034097~response to cytokine,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0046898~response to cycloheximide,GO:0046902~regulation of mitochondrial membrane permeability,GO:0051402~neuron apoptotic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0060154~cellular process regulating host cell cycle in response to virus,GO:0070584~mitochondrion morphogenesis,GO:0071230~cellular response to amino acid stimulus,GO:0071312~cellular response to alkaloid,GO:0071480~cellular response to gamma radiation,GO:0071839~apoptotic process in bone marrow,GO:0090005~negative regulation of establishment of protein localization to plasma membrane,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097284~hepatocyte apoptotic process,GO:1900118~negative regulation of execution phase of apoptosis,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:2000811~negative regulation of anoikis,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031965~nuclear membrane,GO:0097136~Bcl-2 family protein complex,	GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051434~BH3 domain binding,	IPR002475:Bcl2-like,IPR003093:Apoptosis regulator, Bcl-2 protein, BH4,IPR004725:Apoptosis regulator, Bcl-2/ BclX,IPR013279:Apoptosis regulator, Bcl-X,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR020731:Apoptosis regulator, Bcl-2, BH4 motif, conserved site,IPR026298:Blc2 family,	hsa04014:Ras signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04630:Jak-STAT signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05145:Toxoplasmosis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,			SM00265:BH4,	3D-structure,Alternative splicing,Apoptosis,Cell junction,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endocytosis,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Bcl-2-like protein 1,helix,mutagenesis site,sequence conflict,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,site:Cleavage; by caspase-1,splice variant,transmembrane region,turn,
221320_at	BCL2 like 10(BCL2L10)	Homo sapiens				GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0089720~caspase binding,	IPR002475:Bcl2-like,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR026298:Blc2 family,					3D-structure,Apoptosis,Complete proteome,Membrane,Mitochondrion,Nucleus,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Bcl-2-like protein 10,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,transmembrane region,
222343_at, 208536_s_at	BCL2 like 11(BCL2L11)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001822~kidney development,GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:0002262~myeloid cell homeostasis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007127~meiosis I,GO:0007160~cell-matrix adhesion,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030879~mammary gland development,GO:0032464~positive regulation of protein homooligomerization,GO:0034976~response to endoplasmic reticulum stress,GO:0035148~tube formation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043583~ear development,GO:0045787~positive regulation of cell cycle,GO:0046620~regulation of organ growth,GO:0048066~developmental pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048563~post-embryonic organ morphogenesis,GO:0060139~positive regulation of apoptotic process by virus,GO:0060154~cellular process regulating host cell cycle in response to virus,GO:0070242~thymocyte apoptotic process,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902263~apoptotic process involved in embryonic digit morphogenesis,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,GO:2000271~positive regulation of fibroblast apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005868~cytoplasmic dynein complex,GO:0012505~endomembrane system,GO:0019898~extrinsic component of membrane,GO:0097140~BIM-BCL-xl complex,GO:0097141~BIM-BCL-2 complex,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0045502~dynein binding,	IPR014771:Apoptosis, Bim N-terminal,IPR015040:Bcl-x interacting,IPR017288:Bcl-2-like protein 11,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05206:MicroRNAs in cancer,		PIRSF037827:Bcl-2-like protein 11,		3D-structure,Alternative splicing,Apoptosis,Complete proteome,Membrane,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Bcl-2-like protein 11,helix,modified residue,sequence conflict,short sequence motif:BH3,splice variant,
217955_at	BCL2 like 13(BCL2L13)	Homo sapiens				GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0042981~regulation of apoptotic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,	IPR002475:Bcl2-like,IPR026298:Blc2 family,	hsa05134:Legionellosis,				3D-structure,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Bcl-2-like protein 13,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,modified residue,repeat:A,repeat:A; approximate,repeat:B,repeat:B; approximate,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,splice variant,transmembrane region,
221241_s_at	BCL2 like 14(BCL2L14)	Homo sapiens				GO:0006915~apoptotic process,GO:0042981~regulation of apoptotic process,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0043229~intracellular organelle,	GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR002475:Bcl2-like,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Apoptosis facilitator Bcl-2-like protein 14,modified residue,short sequence motif:BH2,short sequence motif:BH3,splice variant,
209311_at	BCL2 like 2(BCL2L2)	Homo sapiens				GO:0007283~spermatogenesis,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0060011~Sertoli cell proliferation,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR003093:Apoptosis regulator, Bcl-2 protein, BH4,IPR013280:Apoptosis regulator, Bcl-W,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020731:Apoptosis regulator, Bcl-2, BH4 motif, conserved site,IPR026298:Blc2 family,	hsa05206:MicroRNAs in cancer,			SM00265:BH4,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Membrane,Methylation,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Bcl-2-like protein 2,helix,modified residue,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH4,strand,
205681_at	BCL2 related protein A1(BCL2A1)	Homo sapiens				GO:0001836~release of cytochrome c from mitochondria,GO:0007568~aging,GO:0008053~mitochondrial fusion,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0021987~cerebral cortex development,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0055085~transmembrane transport,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005741~mitochondrial outer membrane,	GO:0005515~protein binding,GO:0015267~channel activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR013282:Bcl-2-related protein A1,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR026298:Blc2 family,	hsa04064:NF-kappa B signaling pathway,hsa05202:Transcriptional misregulation in cancer,				3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,	chain:Bcl-2-related protein A1,compositionally biased region:Ala/Pro-rich,helix,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,
207005_s_at, 203684_s_at, 203685_at, 207004_at	BCL2, apoptosis regulator(BCL2)	Homo sapiens	127.Mito-stress,152.altered_synaptic_signalling-neurodegenerative_disorders,38.Cell_cycle_arrest_and_apoptosis_ceramide,46.P13K_PTEN,83.Growth_factors_Survival_factors_Mitogens,86.Apoptosis_Nematode&_Vert,99.NF-kB_activation,	h_badPathway:Regulation of BAD phosphorylation,h_ceramidePathway:Ceramide Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_keratinocytePathway:Keratinocyte Differentiation,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_p53Pathway:p53 Signaling Pathway,h_prionPathway:Prion Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000209~protein polyubiquitination,GO:0001503~ossification,GO:0001541~ovarian follicle development,GO:0001656~metanephros development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001662~behavioral fear response,GO:0001782~B cell homeostasis,GO:0001836~release of cytochrome c from mitochondria,GO:0001952~regulation of cell-matrix adhesion,GO:0002320~lymphoid progenitor cell differentiation,GO:0002326~B cell lineage commitment,GO:0002931~response to ischemia,GO:0003014~renal system process,GO:0006470~protein dephosphorylation,GO:0006582~melanin metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0006974~cellular response to DNA damage stimulus,GO:0007015~actin filament organization,GO:0007409~axonogenesis,GO:0007565~female pregnancy,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0009314~response to radiation,GO:0009636~response to toxic substance,GO:0009791~post-embryonic development,GO:0010039~response to iron ion,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010468~regulation of gene expression,GO:0010507~negative regulation of autophagy,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0014031~mesenchymal cell development,GO:0014042~positive regulation of neuron maturation,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016049~cell growth,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021747~cochlear nucleus development,GO:0022612~gland morphogenesis,GO:0022898~regulation of transmembrane transporter activity,GO:0030279~negative regulation of ossification,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0030318~melanocyte differentiation,GO:0030336~negative regulation of cell migration,GO:0030890~positive regulation of B cell proliferation,GO:0031069~hair follicle morphogenesis,GO:0031103~axon regeneration,GO:0031647~regulation of protein stability,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032835~glomerulus development,GO:0032848~negative regulation of cellular pH reduction,GO:0032880~regulation of protein localization,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033077~T cell differentiation in thymus,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033689~negative regulation of osteoblast proliferation,GO:0034097~response to cytokine,GO:0035094~response to nicotine,GO:0035265~organ growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043029~T cell homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043583~ear development,GO:0045069~regulation of viral genome replication,GO:0045636~positive regulation of melanocyte differentiation,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048041~focal adhesion assembly,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048546~digestive tract morphogenesis,GO:0048599~oocyte development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048753~pigment granule organization,GO:0048873~homeostasis of number of cells within a tissue,GO:0050853~B cell receptor signaling pathway,GO:0051384~response to glucocorticoid,GO:0051402~neuron apoptotic process,GO:0051607~defense response to virus,GO:0051881~regulation of mitochondrial membrane potential,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051924~regulation of calcium ion transport,GO:0055085~transmembrane transport,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071310~cellular response to organic substance,GO:0071456~cellular response to hypoxia,GO:0072593~reactive oxygen species metabolic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000811~negative regulation of anoikis,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0031966~mitochondrial membrane,GO:0043209~myelin sheath,GO:0046930~pore complex,	GO:0002020~protease binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015267~channel activity,GO:0016248~channel inhibitor activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0051434~BH3 domain binding,GO:0051721~protein phosphatase 2A binding,	IPR002475:Bcl2-like,IPR003093:Apoptosis regulator, Bcl-2 protein, BH4,IPR004725:Apoptosis regulator, Bcl-2/ BclX,IPR013278:Apoptosis regulator, Bcl-2,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR020731:Apoptosis regulator, Bcl-2, BH4 motif, conserved site,IPR026298:Blc2 family,	hsa04064:NF-kappa B signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,	Leukemia/lymphoma, B-cell, 2~Leukemia/lymphoma, B-cell, 2,		SM00265:BH4,	3D-structure,Alternative splicing,Apoptosis,Chromosomal rearrangement,Complete proteome,Disease mutation,Endoplasmic reticulum,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Apoptosis regulator Bcl-2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,site:Cleavage; by caspase-3,splice variant,strand,transmembrane region,turn,
201544_x_at, 201545_s_at	BCL2L2-PABPN1 readthrough(BCL2L2-PABPN1)	Homo sapiens		h_cpsfPathway:Polyadenylation of mRNA,						hsa03015:mRNA surveillance pathway,hsa05164:Influenza A,
219433_at	BCL6 corepressor(BCOR)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000415~negative regulation of histone H3-K36 methylation,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0030502~negative regulation of bone mineralization,GO:0035518~histone H2A monoubiquitination,GO:0042476~odontogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0060021~palate development,GO:0065001~specification of axis polarity,GO:0070171~negative regulation of tooth mineralization,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0031519~PcG protein complex,	GO:0003714~transcription corepressor activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031072~heat shock protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,		300166~Microphthalmia, syndromic 2,		SM00248:ANK,	3D-structure,Acetylation,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Disease mutation,Microphthalmia,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:BCL-6 corepressor,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,modified residue,mutagenesis site,region of interest:Interaction with BCL6,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,strand,
219444_at	BCL6 corepressor-like 1(BCORL1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BCL-6 corepressor-like protein 1,compositionally biased region:Pro-rich,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
217223_s_at, 202315_s_at	BCR, RhoGEF and GTPase activating protein(BCR)	Homo sapiens	150.caspase_and_NFKB_activation,158.14-3-3_signal_transduction,81.Structure_of_Caps_and_SMACs,	h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_integrinPathway:Integrin Signaling Pathway,		GO:0002692~negative regulation of cellular extravasation,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007420~brain development,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030036~actin cytoskeleton organization,GO:0032496~response to lipopolysaccharide,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0042472~inner ear morphogenesis,GO:0043114~regulation of vascular permeability,GO:0043314~negative regulation of neutrophil degranulation,GO:0043547~positive regulation of GTPase activity,GO:0046777~protein autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0050766~positive regulation of phagocytosis,GO:0050885~neuromuscular process controlling balance,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051726~regulation of cell cycle,GO:0060313~negative regulation of blood vessel remodeling,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030054~cell junction,GO:0043234~protein complex,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,	GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000198:Rho GTPase-activating protein domain,IPR000219:Dbl homology (DH) domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001810:F-box domain, cyclin-like,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR015123:Bcr-Abl oncoprotein oligomerisation,	hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,	608232~Leukemia, chronic myeloid, somatic,613065~Leukemia, acute lymphocytic, somatic,		SM00233:PH,SM00239:C2,SM00324:RhoGAP,SM00325:RhoGEF,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Chromosomal rearrangement,Complete proteome,GTPase activation,Guanine-nucleotide releasing factor,Kinase,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Synapse,Transferase,	chain:Breakpoint cluster region protein,compositionally biased region:Poly-Leu,domain:C2,domain:DH,domain:PH,domain:Rho-GAP,helix,modified residue,mutagenesis site,region of interest:Binding to ABL SH2-domain,region of interest:Kinase,sequence conflict,sequence variant,site:Breakpoint for translocation to form BCR- ABL oncogene,splice variant,
207618_s_at	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone(BCS1L)	Homo sapiens				GO:0007005~mitochondrion organization,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033617~mitochondrial respiratory chain complex IV assembly,GO:0034551~mitochondrial respiratory chain complex III assembly,	GO:0005739~mitochondrion,GO:0005750~mitochondrial respiratory chain complex III,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR014851:BCS1, N-terminal,IPR027243:Mitochondrial chaperone BCS1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		124000~Mitochondrial complex III deficiency, nuclear type 1,256000~Leigh syndrome,262000~Bjornstad syndrome,603358~GRACILE syndrome,		SM00382:AAA,SM01024:SM01024,	ATP-binding,Chaperone,Complete proteome,Deafness,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Mitochondrial chaperone BCS1,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
219670_at	BEN domain containing 5(BEND5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005794~Golgi apparatus,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR018379:BEN domain,				SM01025:SM01025,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BEN domain-containing protein 5,domain:BEN,modified residue,sequence conflict,splice variant,
211725_s_at, 204493_at	BH3 interacting domain death agonist(BID)	Homo sapiens	127.Mito-stress,150.caspase_and_NFKB_activation,46.P13K_PTEN,	h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0001836~release of cytochrome c from mitochondria,GO:0006626~protein targeting to mitochondrion,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007420~brain development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008637~apoptotic mitochondrial changes,GO:0032355~response to estradiol,GO:0032461~positive regulation of protein oligomerization,GO:0032464~positive regulation of protein homooligomerization,GO:0034349~glial cell apoptotic process,GO:0042127~regulation of cell proliferation,GO:0042770~signal transduction in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0051260~protein homooligomerization,GO:0051402~neuron apoptotic process,GO:0090150~establishment of protein localization to membrane,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097284~hepatocyte apoptotic process,GO:0097345~mitochondrial outer membrane permeabilization,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0032592~integral component of mitochondrial membrane,GO:0070062~extracellular exosome,	GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR010479:BH3 interacting,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,	hsa04071:Sphingolipid signaling pathway,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05416:Viral myocarditis,		PIRSF038018:BH3-interacting domain death agonist,		3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:BH3-interacting domain death agonist,chain:BH3-interacting domain death agonist p11,chain:BH3-interacting domain death agonist p13,chain:BH3-interacting domain death agonist p15,helix,modified residue,sequence variant,short sequence motif:BH3,site:Cleavage,splice variant,strand,turn,
204741_at, 214806_at	BICD cargo adaptor 1(BICD1)	Homo sapiens				GO:0006396~RNA processing,GO:0006810~transport,GO:0008298~intracellular mRNA localization,GO:0009653~anatomical structure morphogenesis,GO:0016032~viral process,GO:0033365~protein localization to organelle,GO:0034063~stress granule assembly,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0072385~minus-end-directed organelle transport along microtubule,GO:0072393~microtubule anchoring at microtubule organizing center,GO:1900275~negative regulation of phospholipase C activity,GO:1900276~regulation of proteinase activated receptor activity,GO:1900737~negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,	GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0045298~tubulin complex,GO:0048471~perinuclear region of cytoplasm,GO:0072517~host cell viral assembly compartment,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0017137~Rab GTPase binding,GO:0031871~proteinase activated receptor binding,GO:0034452~dynactin binding,GO:0045502~dynein binding,	IPR018477:Bicaudal-D protein, microtubule-associated,					Alternative splicing,Coiled coil,Complete proteome,Golgi apparatus,Host-virus interaction,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein bicaudal D homolog 1,region of interest:Interacts with RAB6A,sequence conflict,splice variant,
213154_s_at, 209203_s_at, 212702_s_at	BICD cargo adaptor 2(BICD2)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0051642~centrosome localization,GO:0072385~minus-end-directed organelle transport along microtubule,GO:0072393~microtubule anchoring at microtubule organizing center,	GO:0005635~nuclear envelope,GO:0005642~annulate lamellae,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0034452~dynactin binding,GO:0045502~dynein binding,GO:0051959~dynein light intermediate chain binding,	IPR018477:Bicaudal-D protein, microtubule-associated,		615290~Spinal muscular atrophy, lower extremity-predominant, 2, AD,			Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Golgi apparatus,Neurodegeneration,Phosphoprotein,Reference proteome,	chain:Protein bicaudal D homolog 2,modified residue,region of interest:Interacts with RAB6A,splice variant,
215015_at	BICD family like cargo adaptor 1(BICDL1)	Homo sapiens				GO:0031175~neuron projection development,GO:0055107~Golgi to secretory granule transport,	GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0017137~Rab GTPase binding,GO:0034452~dynactin binding,	IPR006933:HAP1, N-terminal,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Neurogenesis,Proteomics identification,Reference proteome,Transport,	chain:Coiled-coil domain-containing protein 64A,
206255_at, 210934_at	BLK proto-oncogene, Src family tyrosine kinase(BLK)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0030154~cell differentiation,GO:0032024~positive regulation of insulin secretion,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045087~innate immune response,GO:0050764~regulation of phagocytosis,GO:0050853~B cell receptor signaling pathway,GO:0071801~regulation of podosome assembly,	GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613375~Maturity-onset diabetes of the young, type 11,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	ATP-binding,Cell membrane,Complete proteome,Diabetes mellitus,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase Blk,domain:Protein kinase,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
219417_s_at	BLOC-1 related complex subunit 6(BORCS6)	Homo sapiens				GO:0032418~lysosome localization,	GO:0005765~lysosomal membrane,GO:0043234~protein complex,	GO:0005515~protein binding,	IPR019314:Protein of unknown function DUF2365,					Complete proteome,Lysosome,Membrane,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C17orf59,compositionally biased region:Pro-rich,modified residue,sequence conflict,
209926_at	BLOC-1 related complex subunit 8(BORCS8)	Homo sapiens				GO:0007507~heart development,	GO:0005765~lysosomal membrane,GO:0043234~protein complex,	GO:0005515~protein binding,	IPR019320:Uncharacterised protein family UPF0402,					Alternative splicing,Complete proteome,Lysosome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:UPF0402 protein,splice variant,
221253_s_at	BLOC1S5-TXNDC5 readthrough (NMD candidate)(BLOC1S5-TXNDC5)	Homo sapiens				GO:0016197~endosomal transport,	GO:0030133~transport vesicle,GO:0031083~BLOC-1 complex,		IPR017243:BLOC-1 complex, muted subunit,			PIRSF037610:BLOC-1 complex, muted subunit,		Complete proteome,Reference proteome,
203304_at	BMP and activin membrane bound inhibitor(BAMBI)	Homo sapiens				GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0035413~positive regulation of catenin import into nucleus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005109~frizzled binding,GO:0005114~type II transforming growth factor beta receptor binding,	IPR009345:BMP/activin membrane-bound inhibitor,	hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,		PIRSF037456:BMP and activin membrane-bound inhibitor,		Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:BMP and activin membrane-bound inhibitor homolog,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205818_at	BMP/retinoic acid inducible neural specific 1(BRINP1)	Homo sapiens				GO:0001662~behavioral fear response,GO:0007050~cell cycle arrest,GO:0007614~short-term memory,GO:0008219~cell death,GO:0035176~social behavior,GO:0035640~exploration behavior,GO:0042711~maternal behavior,GO:0045666~positive regulation of neuron differentiation,GO:0045786~negative regulation of cell cycle,GO:0045930~negative regulation of mitotic cell cycle,GO:0050768~negative regulation of neurogenesis,GO:0071300~cellular response to retinoic acid,GO:0071625~vocalization behavior,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0005515~protein binding,	IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Cytoplasm,Glycoprotein,Growth arrest,Polymorphism,Reference proteome,Signal,	chain:Deleted in bladder cancer protein 1,domain:MACPF,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
214822_at	BMP/retinoic acid inducible neural specific 2(BRINP2)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0045666~positive regulation of neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0071300~cellular response to retinoic acid,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,		IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Glycoprotein,Growth arrest,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein FAM5B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
217562_at	BMP/retinoic acid inducible neural specific 3(BRINP3)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0045666~positive regulation of neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0071300~cellular response to retinoic acid,	GO:0005576~extracellular region,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,		IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Glycoprotein,Growth arrest,Mitochondrion,Reference proteome,Secreted,Signal,	chain:Protein FAM5C,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
219546_at, 59644_at, 37170_at, 214716_at	BMP2 inducible kinase(BMP2K)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0030500~regulation of bone mineralization,GO:0050790~regulation of catalytic activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0019208~phosphatase regulator activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR026105:BMP-2-inducible protein kinase,	hsa05202:Transcriptional misregulation in cancer,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:BMP-2-inducible protein kinase,compositionally biased region:Gln/His-rich,compositionally biased region:Gly-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
203082_at	BMS1, ribosome biogenesis factor(BMS1)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000479~endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042255~ribosome assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0030686~90S preribosome,	GO:0003924~GTPase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0034511~U3 snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR007034:Ribosome biogenesis protein BMS1/TSR1, C-terminal,IPR012948:AARP2CN,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,	107600~Aplasia cutis congenita, nonsyndromic,		SM00785:AARP2CN,SM01362:SM01362,	ATP-binding,Complete proteome,Disease mutation,Ectodermal dysplasia,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ribosome biogenesis,Ubl conjugation,	chain:Ribosome biogenesis protein BMS1 homolog,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
206464_at	BMX non-receptor tyrosine kinase(BMX)	Homo sapiens				GO:0001865~NK T cell differentiation,GO:0006468~protein phosphorylation,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007498~mesoderm development,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0046777~protein autophosphorylation,	GO:0005829~cytosol,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032587~ruffle membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0004871~signal transducer activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001562:Zinc finger, Btk motif,IPR001849:Pleckstrin homology domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,				SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,	3D-structure,Apoptosis,ATP-binding,Cell adhesion,Complete proteome,Cytoplasm,Direct protein sequencing,Kinase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,Stress response,Transferase,Tyrosine-protein kinase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Cytoplasmic tyrosine-protein kinase BMX,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,domain:PH,domain:Protein kinase,domain:SH2,helix,metal ion-binding site:Zinc,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,zinc finger region:Btk-type,
220542_s_at	BPI fold containing family A member 1(BPIFA1)	Homo sapiens				GO:0019731~antibacterial humoral response,GO:0045087~innate immune response,GO:0050828~regulation of liquid surface tension,GO:0050891~multicellular organismal water homeostasis,GO:1900229~negative regulation of single-species biofilm formation in or on host organism,GO:1902305~regulation of sodium ion transmembrane transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008289~lipid binding,	IPR017942:Lipid-binding serum glycoprotein, N-terminal,IPR017943:Bactericidal permeability-increasing protein, alpha/beta domain,					3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Reference proteome,Secreted,Signal,	chain:Protein Plunc,sequence conflict,signal peptide,
215010_s_at	BR serine/threonine kinase 2(BRSK2)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0006887~exocytosis,GO:0007067~mitotic nuclear division,GO:0007409~axonogenesis,GO:0018105~peptidyl-serine phosphorylation,GO:0030010~establishment of cell polarity,GO:0030182~neuron differentiation,GO:0031532~actin cytoskeleton reorganization,GO:0036503~ERAD pathway,GO:0043462~regulation of ATPase activity,GO:0051301~cell division,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:1904152~regulation of retrograde protein transport, ER to cytosol,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0048471~perinuclear region of cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0050321~tau-protein kinase activity,GO:0051117~ATPase binding,GO:0060590~ATPase regulator activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Endoplasmic reticulum,Exocytosis,Kinase,Magnesium,Metal-binding,Mitosis,Neurogenesis,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:BR serine/threonine-protein kinase 2,compositionally biased region:Pro-rich,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
205345_at	BRCA1 associated RING domain 1(BARD1)	Homo sapiens		h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001894~tissue homeostasis,GO:0006260~DNA replication,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006974~cellular response to DNA damage stimulus,GO:0007050~cell cycle arrest,GO:0016567~protein ubiquitination,GO:0031441~negative regulation of mRNA 3'-end processing,GO:0042325~regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045732~positive regulation of protein catabolic process,GO:0046826~negative regulation of protein export from nucleus,GO:0085020~protein K6-linked ubiquitination,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031436~BRCA1-BARD1 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070531~BRCA1-A complex,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR002110:Ankyrin repeat,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR020683:Ankyrin repeat-containing domain,		114480~Breast cancer, susceptibility to,		SM00248:ANK,SM00292:BRCT,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,DNA damage,DNA repair,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:BRCA1-associated RING domain protein 1,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:BRCT 1,domain:BRCT 2,helix,modified residue,region of interest:Interaction with BRCA1,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
201419_at	BRCA1 associated protein 1(BAP1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016579~protein deubiquitination,GO:0035520~monoubiquitinated protein deubiquitination,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0051726~regulation of cell cycle,GO:0071108~protein K48-linked deubiquitination,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035517~PR-DUB complex,	GO:0003682~chromatin binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,		614327~Tumor predisposition syndrome,			Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase BAP1,modified residue,mutagenesis site,region of interest:Interaction with BRCA1,sequence variant,
209923_s_at, 213473_at, 41512_at, 209922_at	BRCA1 associated protein(BRAP)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007265~Ras protein signal transduction,GO:0009968~negative regulation of signal transduction,GO:0016567~protein ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0061630~ubiquitin protein ligase activity,	IPR001607:Zinc finger, UBP-type,IPR001841:Zinc finger, RING-type,IPR011422:BRCA1-associated 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR013083:Zinc finger, RING/FYVE/PHD-type,	hsa04014:Ras signaling pathway,			SM00184:RING,SM00290:ZnF_UBP,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:BRCA1-associated protein,modified residue,mutagenesis site,sequence conflict,zinc finger region:RING-type,zinc finger region:UBP-type,
221703_at	BRCA1 interacting protein C-terminal helicase 1(BRIP1)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006139~nucleobase-containing compound metabolic process,GO:0006260~DNA replication,GO:0006302~double-strand break repair,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0032508~DNA duplex unwinding,GO:0071295~cellular response to vitamin,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03460:Fanconi anemia pathway,	114480~Breast cancer, early-onset,609054~Fanconi anemia, complementation group J,		SM00487:DEXDc,SM00488:DEXDc2,SM00491:HELICc2,	3D-structure,4Fe-4S,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Helicase,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia group J protein,domain:Helicase ATP-binding,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,sequence conflict,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,splice variant,
211851_x_at, 204531_s_at	BRCA1, DNA repair associated(BRCA1)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_g2Pathway:Cell Cycle: G2/M Checkpoint,	Signal transduction mechanisms,	GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006633~fatty acid biosynthetic process,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010212~response to ionizing radiation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0030521~androgen receptor signaling pathway,GO:0031052~chromosome breakage,GO:0031398~positive regulation of protein ubiquitination,GO:0031572~G2 DNA damage checkpoint,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035066~positive regulation of histone acetylation,GO:0035067~negative regulation of histone acetylation,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043009~chordate embryonic development,GO:0043627~response to estrogen,GO:0044030~regulation of DNA methylation,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046600~negative regulation of centriole replication,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051865~protein autoubiquitination,GO:0070512~positive regulation of histone H4-K20 methylation,GO:0071158~positive regulation of cell cycle arrest,GO:0071356~cellular response to tumor necrosis factor,GO:0071681~cellular response to indole-3-methanol,GO:0085020~protein K6-linked ubiquitination,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0000151~ubiquitin ligase complex,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0008274~gamma-tubulin ring complex,GO:0016021~integral component of membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0043234~protein complex,GO:0070531~BRCA1-A complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0050681~androgen receptor binding,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR011364:Breast cancer type 1 susceptibility protein (BRCA1),IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR025994:BRCA1, serine-rich domain,IPR027370:RING-type zinc-finger, LisH dimerisation motif,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,	604370~Breast-ovarian cancer, familial, 1,614320~Pancreatic cancer, susceptibility to, 4,	PIRSF001734:transcriptional regulator, BRCA1 type,	SM00184:RING,SM00292:BRCT,	3D-structure,Acetylation,Activator,Alternative initiation,Alternative splicing,Cell cycle,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fatty acid biosynthesis,Fatty acid metabolism,Isopeptide bond,Ligase,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Breast cancer type 1 susceptibility protein,compositionally biased region:Poly-Lys,domain:BRCT 1,domain:BRCT 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:RING-type,
221196_x_at, 216521_s_at	BRCA1/BRCA2-containing complex subunit 3(BRCC3)	Homo sapiens				GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007067~mitotic nuclear division,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0031572~G2 DNA damage checkpoint,GO:0045739~positive regulation of DNA repair,GO:0050790~regulation of catalytic activity,GO:0051301~cell division,GO:0070536~protein K63-linked deubiquitination,GO:0070537~histone H2A K63-linked deubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0000152~nuclear ubiquitin ligase complex,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0030234~enzyme regulator activity,GO:0031593~polyubiquitin binding,GO:0046872~metal ion binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,				SM00232:JAB_MPN,	Acetylation,Alternative splicing,Cell cycle,Cell division,Chromatin regulator,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,DNA damage,DNA repair,Hydrolase,Metal-binding,Metalloprotease,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation pathway,Zinc,	chain:Lys-63-specific deubiquitinase BRCC36,metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:JAMM motif,splice variant,
218264_at	BRCA2 and CDKN1A interacting protein(BCCIP)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006281~DNA repair,GO:0007049~cell cycle,GO:0061101~neuroendocrine cell differentiation,	GO:0005634~nucleus,GO:0019908~nuclear cyclin-dependent protein kinase holoenzyme complex,	GO:0005515~protein binding,GO:0019207~kinase regulator activity,GO:0044822~poly(A) RNA binding,	IPR025602:BCP1 family,			PIRSF028983:protein BCP1,		Alternative splicing,Cell cycle,Complete proteome,DNA damage,DNA repair,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:BRCA2 and CDKN1A-interacting protein,modified residue,region of interest:Interaction with BRCA2,region of interest:Interaction with CDKN1A,sequence conflict,sequence variant,splice variant,
208368_s_at, 214727_at	BRCA2, DNA repair associated(BRCA2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000910~cytokinesis,GO:0001556~oocyte maturation,GO:0001833~inner cell mass cell proliferation,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0007569~cell aging,GO:0008585~female gonad development,GO:0010165~response to X-ray,GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0030097~hemopoiesis,GO:0031052~chromosome breakage,GO:0032465~regulation of cytokinesis,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0048478~replication fork protection,GO:0051298~centrosome duplication,GO:0070200~establishment of protein localization to telomere,GO:1990426~mitotic recombination-dependent replication fork processing,	GO:0000784~nuclear chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016021~integral component of membrane,GO:0030141~secretory granule,GO:0033593~BRCA2-MAGE-D1 complex,GO:0043234~protein complex,	GO:0002020~protease binding,GO:0003697~single-stranded DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0010484~H3 histone acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0043015~gamma-tubulin binding,	IPR002093:BRCA2 repeat,IPR012340:Nucleic acid-binding, OB-fold,IPR015187:BRCA2, oligonucleotide/oligosaccharide-binding 1,IPR015188:BRCA2, oligonucleotide/oligosaccharide-binding 3,IPR015205:Tower,IPR015252:DNA recombination/repair protein BRCA2, helical domain,IPR015525:Breast cancer type 2 susceptibility protein,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,	114480~Breast cancer, male, susceptibility to,155255~Medulloblastoma,176807~Prostate cancer,194070~Wilms tumor,605724~Fanconi anemia, complementation group D1,612555~Breast-ovarian cancer, familial, 2,613029~Glioblastoma 3,613347~Pancreatic cancer 2,	PIRSF002397:DNA recombination repair protein, BRCA2 type,	SM01341:SM01341,	3D-structure,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fanconi anemia,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Breast cancer type 2 susceptibility protein,helix,modified residue,region of interest:Interaction with FANCD2,region of interest:Interaction with PALB2,repeat:BRCA2 1,repeat:BRCA2 2,repeat:BRCA2 3,repeat:BRCA2 4,repeat:BRCA2 5,repeat:BRCA2 6,repeat:BRCA2 7,repeat:BRCA2 8,sequence conflict,sequence variant,turn,
215676_at, 215677_s_at, 203754_s_at	BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit(BRF1)	Homo sapiens		h_RNApol3Pathway:RNA polymerase III transcription,	Transcription,	GO:0006355~regulation of transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0009303~rRNA transcription,GO:0009304~tRNA transcription,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,	GO:0000126~transcription factor TFIIIB complex,GO:0005654~nucleoplasm,	GO:0003743~translation initiation factor activity,GO:0008270~zinc ion binding,GO:0017025~TBP-class protein binding,	IPR000812:Transcription factor TFIIB,IPR011665:Brf1-like TBP-binding,IPR013137:Zinc finger, TFIIB-type,IPR013150:Transcription factor TFIIB, cyclin-like domain,IPR013763:Cyclin-like,		616202~Cerebellofaciodental syndrome,		SM00385:CYCLIN,	Activator,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Dwarfism,Initiation factor,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor IIIB 90 kDa subunit,metal ion-binding site:Zinc,modified residue,repeat:1,repeat:2,sequence conflict,sequence variant,splice variant,zinc finger region:TFIIB-type,
218955_at, 218954_s_at	BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit(BRF2)	Homo sapiens			Transcription,	GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0034599~cellular response to oxidative stress,	GO:0005654~nucleoplasm,	GO:0001007~transcription factor activity, RNA polymerase III transcription factor binding,GO:0001032~RNA polymerase III type 3 promoter DNA binding,GO:0008270~zinc ion binding,	IPR000812:Transcription factor TFIIB,IPR013137:Zinc finger, TFIIB-type,IPR013763:Cyclin-like,					3D-structure,Activator,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor IIIB 50 kDa subunit,metal ion-binding site:Zinc,repeat:1,repeat:2,sequence conflict,zinc finger region:TFIIB-type,
221711_s_at	BRISC and BRCA1 A complex member 1(BABAM1)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007067~mitotic nuclear division,GO:0010212~response to ionizing radiation,GO:0016569~covalent chromatin modification,GO:0031572~G2 DNA damage checkpoint,GO:0045739~positive regulation of DNA repair,GO:0051301~cell division,GO:0070536~protein K63-linked deubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,	GO:0005515~protein binding,	IPR002035:von Willebrand factor, type A,IPR026126:BRISC and BRCA1-A complex member 1,					Acetylation,Alternative splicing,Cell cycle,Cell division,Chromatin regulator,Complete proteome,Cytoplasm,DNA damage,DNA repair,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:BRCA1-A complex subunit MERIT40,modified residue,region of interest:VWFA-like,sequence conflict,splice variant,
219177_at	BRX1, biogenesis of ribosomes(BRIX1)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,IPR026532:Ribosome biogenesis protein BRX1,				SM00879:SM00879,	Acetylation,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Ribosome biogenesis,Ubl conjugation,	chain:Brix domain-containing protein 2,domain:Brix,modified residue,sequence conflict,
218004_at, 222200_s_at	BSD domain containing 1(BSDC1)	Homo sapiens							IPR005607:BSD,				SM00751:BSD,	Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:BSD domain-containing protein 1,domain:BSD,sequence conflict,splice variant,
204194_at	BTB domain and CNC homolog 1(BACH1)	Homo sapiens				GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000117~regulation of transcription involved in G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0016567~protein ubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0001206~transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0020037~heme binding,GO:0043565~sequence-specific DNA binding,	IPR000210:BTB/POZ-like,IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR011333:BTB/POZ fold,				SM00225:BTB,SM00338:BRLZ,	3D-structure,Activator,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription regulator protein BACH1,DNA-binding region:Basic motif,domain:BTB,domain:Leucine-zipper,helix,modified residue,sequence conflict,sequence variant,strand,turn,
221234_s_at	BTB domain and CNC homolog 2(BACH2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0016567~protein ubiquitination,GO:1902593~single-organism nuclear import,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001206~transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR011333:BTB/POZ fold,				SM00225:BTB,SM00338:BRLZ,	3D-structure,Activator,Complete proteome,Cytoplasm,Disulfide bond,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription regulator protein BACH2,compositionally biased region:Poly-Glu,DNA-binding region:Basic motif,domain:BTB,domain:Leucine-zipper,sequence conflict,sequence variant,
217945_at	BTB domain containing 1(BTBD1)	Homo sapiens				GO:0030162~regulation of proteolysis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043393~regulation of protein binding,	GO:0000932~cytoplasmic mRNA processing body,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR012983:PHR,				SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Cytoplasm,Methylation,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:BTB/POZ domain-containing protein 1,compositionally biased region:Poly-Pro,domain:BTB,sequence conflict,
215349_at	BTB domain containing 18(BTBD18)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,				SM00225:BTB,	Complete proteome,Polymorphism,Reference proteome,
207722_s_at	BTB domain containing 2(BTBD2)	Homo sapiens				GO:0030162~regulation of proteolysis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000932~cytoplasmic mRNA processing body,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR012983:PHR,				SM00225:BTB,SM00875:SM00875,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,	chain:BTB/POZ domain-containing protein 2,compositionally biased region:Poly-Ala,domain:BTB,sequence conflict,splice variant,
202946_s_at	BTB domain containing 3(BTBD3)	Homo sapiens				GO:0021987~cerebral cortex development,GO:0030162~regulation of proteolysis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048813~dendrite morphogenesis,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,	GO:0031625~ubiquitin protein ligase binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR012983:PHR,				SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Cytoplasm,Neurogenesis,Nucleus,Proteomics identification,Reference proteome,	chain:BTB/POZ domain-containing protein 3,compositionally biased region:Poly-Ser,domain:BTB,
217141_at, 220297_at	BTB domain containing 7(BTBD7)	Homo sapiens				GO:0007275~multicellular organism development,GO:0060693~regulation of branching involved in salivary gland morphogenesis,	GO:0005634~nucleus,		IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,				SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Developmental protein,Lipoprotein,Myristate,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:BTB/POZ domain-containing protein 7,compositionally biased region:Poly-Ala,compositionally biased region:Pro-rich,domain:BTB 1,domain:BTB 2,modified residue,sequence conflict,splice variant,
200921_s_at, 200920_s_at	BTG anti-proliferation factor 1(BTG1)	Homo sapiens		h_btg2Pathway:BTG family proteins and cell cycle regulation,		GO:0006355~regulation of transcription, DNA-templated,GO:0006479~protein methylation,GO:0006979~response to oxidative stress,GO:0007283~spermatogenesis,GO:0008285~negative regulation of cell proliferation,GO:0016477~cell migration,GO:0030308~negative regulation of cell growth,GO:0043434~response to peptide hormone,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:2000271~positive regulation of fibroblast apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,	IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	Chromosomal rearrangement,Complete proteome,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,	chain:Protein BTG1,sequence variant,
201236_s_at, 201235_s_at	BTG anti-proliferation factor 2(BTG2)	Homo sapiens		h_btg2Pathway:BTG family proteins and cell cycle regulation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006479~protein methylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0008306~associative learning,GO:0009612~response to mechanical stimulus,GO:0009952~anterior/posterior pattern specification,GO:0014070~response to organic cyclic compound,GO:0017148~negative regulation of translation,GO:0021542~dentate gyrus development,GO:0021954~central nervous system neuron development,GO:0031175~neuron projection development,GO:0035914~skeletal muscle cell differentiation,GO:0043434~response to peptide hormone,GO:0043524~negative regulation of neuron apoptotic process,GO:0051602~response to electrical stimulus,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,	IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	3D-structure,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Protein BTG2,helix,sequence variant,strand,
205548_s_at, 213134_x_at, 215425_at	BTG anti-proliferation factor 3(BTG3)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,GO:0045930~negative regulation of mitotic cell cycle,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein BTG3,compositionally biased region:Poly-Ser,sequence conflict,splice variant,
220766_at	BTG anti-proliferation factor 4(BTG4)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0030182~neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,			IPR002087:Anti-proliferative protein,	hsa03018:RNA degradation,			SM00099:btg1,	Alternative splicing,Complete proteome,Reference proteome,	chain:Protein BTG4,
219966_x_at	BTG3 associated nuclear protein(BANP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0016569~covalent chromatin modification,GO:0034504~protein localization to nucleus,GO:0042177~negative regulation of protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR018379:BEN domain,				SM01025:SM01025,	Acetylation,Alternative splicing,Cell cycle,Chromatin regulator,Coiled coil,Complete proteome,Developmental protein,DNA-binding,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Protein BANP,compositionally biased region:Gln-rich,domain:BEN,region of interest:DNA-binding,region of interest:Interaction with CUX1 and HDAC1,region of interest:Necessary and sufficient for TP53 activation,sequence conflict,splice variant,
203755_at	BUB1 mitotic checkpoint serine/threonine kinase B(BUB1B)	Homo sapiens			General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair,	GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007091~metaphase/anaphase transition of mitotic cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008283~cell proliferation,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0034501~protein localization to kinetochore,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000778~condensed nuclear chromosome kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005680~anaphase-promoting complex,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR013212:Mad3/BUB1 homology region 1,IPR015661:Mitotic checkpoint serine/threonine protein kinase Bub1/Mitotic spindle checkpoint component Mad3,	hsa04110:Cell cycle,hsa05166:HTLV-I infection,	114500~Colorectal cancer, somatic,176430~Premature chromatid separation trait,257300~Mosaic variegated aneuploidy syndrome 1,		SM00777:Mad3_BUB1_I,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Kinase,Kinetochore,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitotic checkpoint serine/threonine- protein kinase BUB1 beta,compositionally biased region:Poly-Glu,domain:CD1,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with CASC5,sequence conflict,sequence variant,short sequence motif:D-box,short sequence motif:Nuclear localization signal,site:Cleavage; by caspase-3,splice variant,
209642_at, 216277_at, 215508_at, 216275_at, 215509_s_at	BUB1 mitotic checkpoint serine/threonine kinase(BUB1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007063~regulation of sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0051301~cell division,GO:0051983~regulation of chromosome segregation,GO:0071173~spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000942~condensed nuclear chromosome outer kinetochore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013212:Mad3/BUB1 homology region 1,IPR015661:Mitotic checkpoint serine/threonine protein kinase Bub1/Mitotic spindle checkpoint component Mad3,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,	Colorectal cancer with chromosomal instability, somatic~Colorectal cancer with chromosomal instability, somatic,		SM00220:S_TKc,SM00777:Mad3_BUB1_I,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Complete proteome,Host-virus interaction,Kinase,Kinetochore,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitotic checkpoint serine/threonine- protein kinase BUB1,domain:CD1,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Essential for loading of BUBR1, MAD1L1 and MAD2L1 to kinetochores,region of interest:Necessary for interaction with BUB3,region of interest:Necessary for interaction with CASC5,region of interest:Necessary for kinetochore localization,sequence conflict,sequence variant,short sequence motif:KEN box 1,short sequence motif:KEN box 2,short sequence motif:Nuclear localization signal,strand,turn,
201457_x_at, 201456_s_at, 209974_s_at, 201458_s_at	BUB3, mitotic checkpoint protein(BUB3)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0007062~sister chromatid cohesion,GO:0007094~mitotic spindle assembly checkpoint,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0071173~spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0033597~mitotic checkpoint complex,GO:1990298~bub1-bub3 complex,	GO:0005515~protein binding,GO:0043130~ubiquitin binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,	hsa04110:Cell cycle,hsa05166:HTLV-I infection,			SM00320:WD40,	Acetylation,ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Complete proteome,Isopeptide bond,Kinetochore,Meiosis,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,WD repeat,	chain:Mitotic checkpoint protein bub3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,splice variant,
215815_at, 205690_s_at	BUD31 homolog(BUD31)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:2000825~positive regulation of androgen receptor activity,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005681~spliceosomal complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035257~nuclear hormone receptor binding,	IPR001748:G10 protein,IPR018230:BUD31/G10-related, conserved site,	hsa03040:Spliceosome,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Protein BUD31 homolog,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
218471_s_at	Bardet-Biedl syndrome 1(BBS1)	Homo sapiens				GO:0001895~retina homeostasis,GO:0007601~visual perception,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0043001~Golgi to plasma membrane protein transport,GO:0045494~photoreceptor cell maintenance,GO:0050896~response to stimulus,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0005930~axoneme,GO:0034464~BBSome,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005113~patched binding,GO:0005119~smoothened binding,GO:0005515~protein binding,	IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,		209900~Bardet-Biedl syndrome 1,			Acetylation,Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Sensory transduction,Signal,Transport,Vision,	chain:Bardet-Biedl syndrome 1 protein,modified residue,sequence variant,splice variant,
219487_at	Bardet-Biedl syndrome 10(BBS10)	Homo sapiens				GO:0001895~retina homeostasis,GO:0007601~visual perception,GO:0035058~nonmotile primary cilium assembly,GO:0043254~regulation of protein complex assembly,GO:0045494~photoreceptor cell maintenance,GO:0050896~response to stimulus,GO:0051131~chaperone-mediated protein complex assembly,	GO:0005929~cilium,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR002423:Chaperonin Cpn60/TCP-1,IPR027409:GroEL-like apical domain,IPR027413:GroEL-like equatorial domain,		615987~Bardet-Biedl syndrome 10,			ATP-binding,Bardet-Biedl syndrome,Cell projection,Chaperone,Ciliopathy,Complete proteome,Disease mutation,Mental retardation,Nucleotide-binding,Obesity,Polymorphism,Reference proteome,Sensory transduction,Vision,	chain:Bardet-Biedl syndrome 10 protein,sequence conflict,sequence variant,
212745_s_at, 212744_at	Bardet-Biedl syndrome 4(BBS4)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0001764~neuron migration,GO:0001843~neural tube closure,GO:0001895~retina homeostasis,GO:0001947~heart looping,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0007286~spermatid development,GO:0007601~visual perception,GO:0007608~sensory perception of smell,GO:0010629~negative regulation of gene expression,GO:0015031~protein transport,GO:0016358~dendrite development,GO:0019216~regulation of lipid metabolic process,GO:0021591~ventricular system development,GO:0021756~striatum development,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0030534~adult behavior,GO:0030837~negative regulation of actin filament polymerization,GO:0032402~melanosome transport,GO:0032465~regulation of cytokinesis,GO:0033365~protein localization to organelle,GO:0034260~negative regulation of GTPase activity,GO:0034454~microtubule anchoring at centrosome,GO:0035058~nonmotile primary cilium assembly,GO:0035176~social behavior,GO:0035845~photoreceptor cell outer segment organization,GO:0038108~negative regulation of appetite by leptin-mediated signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042384~cilium assembly,GO:0045444~fat cell differentiation,GO:0045494~photoreceptor cell maintenance,GO:0045724~positive regulation of cilium assembly,GO:0046548~retinal rod cell development,GO:0046907~intracellular transport,GO:0048854~brain morphogenesis,GO:0050893~sensory processing,GO:0051297~centrosome organization,GO:0051457~maintenance of protein location in nucleus,GO:0051492~regulation of stress fiber assembly,GO:0060271~cilium morphogenesis,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,GO:0060324~face development,GO:0060613~fat pad development,GO:0061512~protein localization to cilium,GO:0071539~protein localization to centrosome,GO:1902855~regulation of nonmotile primary cilium assembly,GO:1903546~protein localization to photoreceptor outer segment,	GO:0000242~pericentriolar material,GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005634~nucleus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005929~cilium,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031513~nonmotile primary cilium,GO:0031514~motile cilium,GO:0032391~photoreceptor connecting cilium,GO:0034451~centriolar satellite,GO:0034464~BBSome,GO:0035869~ciliary transition zone,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0034452~dynactin binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		615982~Bardet-Biedl syndrome 4,		SM00028:TPR,	Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Sensory transduction,TPR repeat,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Bardet-Biedl syndrome 4 protein,region of interest:Interaction with PCM1,region of interest:Required for localization to centrosomes,repeat:TPR 1,repeat:TPR 10,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence variant,splice variant,
219688_at	Bardet-Biedl syndrome 7(BBS7)	Homo sapiens				GO:0001654~eye development,GO:0001947~heart looping,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0007368~determination of left/right symmetry,GO:0007420~brain development,GO:0007601~visual perception,GO:0008104~protein localization,GO:0015031~protein transport,GO:0032402~melanosome transport,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0045444~fat cell differentiation,GO:0046907~intracellular transport,GO:0048546~digestive tract morphogenesis,GO:0051877~pigment granule aggregation in cell center,GO:0060021~palate development,GO:0060173~limb development,GO:0060271~cilium morphogenesis,	GO:0001750~photoreceptor outer segment,GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005930~axoneme,GO:0016020~membrane,GO:0034464~BBSome,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005515~protein binding,	IPR015943:WD40/YVTN repeat-like-containing domain,IPR016575:Bardet-Biedl syndrome 7 protein,IPR017986:WD40-repeat-containing domain,		615984~Bardet-Biedl syndrome 7,	PIRSF011091:Bardet-Biedl syndrome 7 protein,		Acetylation,Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Sensory transduction,Transport,Vision,	chain:Bardet-Biedl syndrome 7 protein,sequence conflict,sequence variant,splice variant,
216239_at, 37547_at, 209958_s_at, 37549_g_at	Bardet-Biedl syndrome 9(BBS9)	Homo sapiens			Cell envelope biogenesis, outer membrane,	GO:0007601~visual perception,GO:0015031~protein transport,GO:0030030~cell projection organization,GO:0042384~cilium assembly,GO:0045444~fat cell differentiation,GO:0050896~response to stimulus,GO:0061512~protein localization to cilium,	GO:0000242~pericentriolar material,GO:0005829~cytosol,GO:0005929~cilium,GO:0016020~membrane,GO:0034451~centriolar satellite,GO:0034464~BBSome,GO:0035869~ciliary transition zone,GO:0060170~ciliary membrane,	GO:0005515~protein binding,	IPR026511:Parathyroid hormone-responsive B1,		615986~Bardet-Biedl syndrome 9,			3D-structure,Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Chromosomal rearrangement,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Sensory transduction,Transport,Vision,	chain:Protein PTHB1,sequence conflict,sequence variant,splice variant,
220470_at	Bet1 golgi vesicular membrane trafficking protein like(BET1L)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0061025~membrane fusion,GO:2000156~regulation of retrograde vesicle-mediated transport, Golgi to ER,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031201~SNARE complex,	GO:0005484~SNAP receptor activity,	IPR000727:Target SNARE coiled-coil domain,	hsa04130:SNARE interactions in vesicular transport,				Coiled coil,Complete proteome,Golgi apparatus,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:BET1-like protein,domain:t-SNARE coiled-coil homology,modified residue,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
202710_at	Bet1 golgi vesicular membrane trafficking protein(BET1)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0048208~COPII vesicle coating,GO:0048280~vesicle fusion with Golgi apparatus,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005801~cis-Golgi network,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0031201~SNARE complex,GO:0031985~Golgi cisterna,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005515~protein binding,GO:0019905~syntaxin binding,	IPR000727:Target SNARE coiled-coil domain,	hsa04130:SNARE interactions in vesicular transport,			SM00397:t_SNARE,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:BET1 homolog,domain:t-SNARE coiled-coil homology,modified residue,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
213429_at, 220580_at	BicC family RNA binding protein 1(BICC1)	Homo sapiens				GO:0007368~determination of left/right symmetry,GO:0007507~heart development,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR001660:Sterile alpha motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR013761:Sterile alpha motif/pointed domain,		601331~Renal dysplasia, cystic, susceptibility to,		SM00322:KH,SM00454:SAM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Protein bicaudal C homolog 1,domain:KH 1,domain:KH 2,domain:SAM,modified residue,sequence variant,splice variant,
205733_at	Bloom syndrome RecQ like helicase(BLM)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000733~DNA strand renaturation,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010165~response to X-ray,GO:0016925~protein sumoylation,GO:0031297~replication fork processing,GO:0032508~DNA duplex unwinding,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045910~negative regulation of DNA recombination,GO:0048478~replication fork protection,GO:0051259~protein oligomerization,GO:0051782~negative regulation of cell division,GO:0071479~cellular response to ionizing radiation,GO:0072711~cellular response to hydroxyurea,GO:0072757~cellular response to camptothecin,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,	GO:0000405~bubble DNA binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0009378~four-way junction helicase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0036310~annealing helicase activity,GO:0043140~ATP-dependent 3'-5' DNA helicase activity,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002121:HRDC domain,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR004589:DNA helicase, ATP-dependent, RecQ type,IPR010997:HRDC-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012532:BDHCT,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR018982:RQC domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,	210900~Bloom syndrome,		SM00341:HRDC,SM00487:DEXDc,SM00490:HELICc,SM00956:SM00956,	3D-structure,Acetylation,ATP-binding,Complete proteome,Disease mutation,DNA replication,DNA-binding,Dwarfism,Helicase,Hydrolase,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Bloom syndrome protein,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HRDC,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,
205504_at	Bruton tyrosine kinase(BTK)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,	h_bcrPathway:BCR Signaling Pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0001805~positive regulation of type III hypersensitivity,GO:0001812~positive regulation of type I hypersensitivity,GO:0001818~negative regulation of cytokine production,GO:0002250~adaptive immune response,GO:0002553~histamine secretion by mast cell,GO:0002721~regulation of B cell cytokine production,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002902~regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007498~mesoderm development,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019722~calcium-mediated signaling,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0045579~positive regulation of B cell differentiation,GO:0048469~cell maturation,GO:0050853~B cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0071226~cellular response to molecule of fungal origin,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0042629~mast cell granule,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR001562:Zinc finger, Btk motif,IPR001849:Pleckstrin homology domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04611:Platelet activation,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa05340:Primary immunodeficiency,	300755~Agammaglobulinemia, X-linked 1,307200~Agammaglobulinemia and isolated hormone deficiency,		SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Adaptive immunity,Alternative promoter usage,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Immunity,Innate immunity,Kinase,Lipid-binding,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transcription,Transcription regulation,Transferase,Tyrosine-protein kinase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase BTK,domain:PH,domain:Protein kinase,domain:SH2,domain:SH3,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,zinc finger region:Btk-type,
207533_at	C-C motif chemokine ligand 1(CCL1)	Homo sapiens	109.Chemokine_families,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0016032~viral process,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0051384~response to glucocorticoid,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,signal peptide,strand,turn,
210133_at	C-C motif chemokine ligand 11(CCL11)	Homo sapiens	109.Chemokine_families,	h_ccr3Pathway:CCR3 signaling in Eosinophils,h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,h_il5Pathway:IL 5 Signaling Pathway,		GO:0001938~positive regulation of endothelial cell proliferation,GO:0002544~chronic inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002551~mast cell chemotaxis,GO:0006468~protein phosphorylation,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008360~regulation of cell shape,GO:0009314~response to radiation,GO:0009615~response to virus,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030838~positive regulation of actin filament polymerization,GO:0035962~response to interleukin-13,GO:0043547~positive regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0048245~eosinophil chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060763~mammary duct terminal end bud growth,GO:0070098~chemokine-mediated signaling pathway,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070670~response to interleukin-4,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05310:Asthma,	600807~Asthma, susceptibility to,609423~HIV1, resistance to,		SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:Eotaxin,disulfide bond,glycosylation site:O-linked (GalNAc...),helix,sequence variant,signal peptide,strand,
206407_s_at, 216714_at	C-C motif chemokine ligand 13(CCL13)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 13, long chain,chain:C-C motif chemokine 13, medium chain,chain:C-C motif chemokine 13, short chain,disulfide bond,helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,
207354_at	C-C motif chemokine ligand 16(CCL16)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007154~cell communication,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0050918~positive chemotaxis,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0042056~chemoattractant activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 16,disulfide bond,signal peptide,
207900_at	C-C motif chemokine ligand 17(CCL17)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0045662~negative regulation of myoblast differentiation,GO:0048247~lymphocyte chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0031729~CCR4 chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 17,disulfide bond,helix,sequence variant,signal peptide,strand,turn,
209924_at, 32128_at	C-C motif chemokine ligand 18(CCL18)	Homo sapiens	16.Chemokines-rec-T-cells,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007154~cell communication,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009607~response to biotic stimulus,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 18,chain:CCL18(1-68),chain:CCL18(3-69),chain:CCL18(4-69),disulfide bond,signal peptide,
210072_at	C-C motif chemokine ligand 19(CCL19)	Homo sapiens	109.Chemokine_families,			GO:0001768~establishment of T cell polarity,GO:0001771~immunological synapse formation,GO:0002407~dendritic cell chemotaxis,GO:0002408~myeloid dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007154~cell communication,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007257~activation of JUN kinase activity,GO:0009615~response to virus,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0031295~T cell costimulation,GO:0032735~positive regulation of interleukin-12 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034695~response to prostaglandin E,GO:0042102~positive regulation of T cell proliferation,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045807~positive regulation of endocytosis,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0048247~lymphocyte chemotaxis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048469~cell maturation,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050921~positive regulation of chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0060491~regulation of cell projection assembly,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071731~response to nitric oxide,GO:0072610~interleukin-12 secretion,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0097029~mature conventional dendritic cell differentiation,GO:0098586~cellular response to virus,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000147~positive regulation of cell motility,GO:2000549~positive regulation of dendritic cell dendrite assembly,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0008009~chemokine activity,GO:0031732~CCR7 chemokine receptor binding,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 19,disulfide bond,signal peptide,
216598_s_at	C-C motif chemokine ligand 2(CCL2)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,19.Cytokine_microglia,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,35.Chemokines_EAE_Autoreactive_T_Cells,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_LDLpathway:Low-density lipoprotein (LDL) pathway during atherogenesis,h_mspPathway:Msp/Ron Receptor Signaling Pathway,		GO:0000165~MAPK cascade,GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002693~positive regulation of cellular extravasation,GO:0006468~protein phosphorylation,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009887~organ morphogenesis,GO:0010332~response to gamma radiation,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010759~positive regulation of macrophage chemotaxis,GO:0014823~response to activity,GO:0016525~negative regulation of angiogenesis,GO:0019079~viral genome replication,GO:0019221~cytokine-mediated signaling pathway,GO:0019725~cellular homeostasis,GO:0030593~neutrophil chemotaxis,GO:0031100~organ regeneration,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032570~response to progesterone,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033552~response to vitamin B3,GO:0034351~negative regulation of glial cell apoptotic process,GO:0035684~helper T cell extravasation,GO:0035690~cellular response to drug,GO:0036006~cellular response to macrophage colony-stimulating factor stimulus,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0036499~PERK-mediated unfolded protein response,GO:0043200~response to amino acid,GO:0043491~protein kinase B signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043615~astrocyte cell migration,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045471~response to ethanol,GO:0046677~response to antibiotic,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0050806~positive regulation of synaptic transmission,GO:0050870~positive regulation of T cell activation,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060135~maternal process involved in female pregnancy,GO:0060137~maternal process involved in parturition,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071300~cellular response to retinoic acid,GO:0071318~cellular response to ATP,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071354~cellular response to interleukin-6,GO:0071356~cellular response to tumor necrosis factor,GO:0071403~cellular response to high density lipoprotein particle stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071549~cellular response to dexamethasone stimulus,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:0090280~positive regulation of calcium ion import,GO:0090314~positive regulation of protein targeting to membrane,GO:2000427~positive regulation of apoptotic cell clearance,GO:2000502~negative regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005791~rough endoplasmic reticulum,GO:0030139~endocytic vesicle,GO:0030425~dendrite,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044299~C-fiber,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031727~CCR2 chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05323:Rheumatoid arthritis,	182940~Spina bifida, susceptibility to,607948~Mycobacterium tuberculosis, susceptibility to,609423~HIV-1, resistance to,Coronary artery disease, modifier of~Coronary artery disease, modifier of,		SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,signal peptide,site:Involved in dimerization,site:Involved in dimerization, receptor binding and signaling,site:Involved in GAG binding,site:Involved in GAG binding and receptor binding,strand,
205476_at	C-C motif chemokine ligand 20(CCL20)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030593~neutrophil chemotaxis,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050726~positive regulation of interleukin-1 alpha biosynthetic process,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031731~CCR6 chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 20,chain:CCL20(1-64),chain:CCL20(1-67),chain:CCL20(2-70),disulfide bond,helix,sequence variant,signal peptide,splice variant,strand,turn,
204606_at	C-C motif chemokine ligand 21(CCL21)	Homo sapiens	109.Chemokine_families,16.Chemokines-rec-T-cells,			GO:0001768~establishment of T cell polarity,GO:0001771~immunological synapse formation,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002407~dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0031295~T cell costimulation,GO:0031529~ruffle organization,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0034695~response to prostaglandin E,GO:0035759~mesangial cell-matrix adhesion,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0048247~lymphocyte chemotaxis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048469~cell maturation,GO:0050921~positive regulation of chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051491~positive regulation of filopodium assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0090630~activation of GTPase activity,GO:0097026~dendritic cell dendrite assembly,GO:1903237~negative regulation of leukocyte tethering or rolling,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000147~positive regulation of cell motility,GO:2000406~positive regulation of T cell migration,GO:2000529~positive regulation of myeloid dendritic cell chemotaxis,GO:2000548~negative regulation of dendritic cell dendrite assembly,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0031732~CCR7 chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 21,disulfide bond,region of interest:C-terminal basic extension,signal peptide,
207861_at	C-C motif chemokine ligand 22(CCL22)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 22,chain:MDC(3-69),chain:MDC(5-69),chain:MDC(7-69),disulfide bond,sequence variant,signal peptide,
210548_at, 210549_s_at	C-C motif chemokine ligand 23(CCL23)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008285~negative regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2001264~negative regulation of C-C chemokine binding,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Heparin-binding,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 23,chain:CCL23(19-99),chain:CCL23(22-99),chain:CCL23(27-99),chain:CCL23(30-99),disulfide bond,helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
221463_at	C-C motif chemokine ligand 24(CCL24)	Homo sapiens	109.Chemokine_families,			GO:0001938~positive regulation of endothelial cell proliferation,GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030838~positive regulation of actin filament polymerization,GO:0043547~positive regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0048245~eosinophil chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2000418~positive regulation of eosinophil migration,	GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 24,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
206988_at	C-C motif chemokine ligand 25(CCL25)	Homo sapiens				GO:0001954~positive regulation of cell-matrix adhesion,GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:1903237~negative regulation of leukocyte tethering or rolling,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005179~hormone activity,GO:0008009~chemokine activity,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,			SM00199:SCY,	Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Inflammatory response,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 25,disulfide bond,sequence variant,signal peptide,splice variant,
207955_at	C-C motif chemokine ligand 27(CCL27)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0060326~cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				3D-structure,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 27,disulfide bond,sequence variant,signal peptide,
205114_s_at	C-C motif chemokine ligand 3 like 3(CCL3L3)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05323:Rheumatoid arthritis,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 3-like 1,chain:LD78-beta(3-70),chain:LD78-beta(5-70),disulfide bond,sequence conflict,signal peptide,site:Cleavage; by DPP4,
204103_at	C-C motif chemokine ligand 4(CCL4)	Homo sapiens	109.Chemokine_families,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0002548~monocyte chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0030593~neutrophil chemotaxis,GO:0035690~cellular response to drug,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0050729~positive regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051928~positive regulation of calcium ion transport,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042802~identical protein binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05132:Salmonella infection,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 4,chain:C-C motif chemokine 4-like,chain:MIP-1-beta(3-69),disulfide bond,helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,
204655_at, 1405_i_at	C-C motif chemokine ligand 5(CCL5)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,	h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,		GO:0000165~MAPK cascade,GO:0002407~dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002676~regulation of chronic inflammatory response,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007159~leukocyte cell-cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0010759~positive regulation of macrophage chemotaxis,GO:0010820~positive regulation of T cell chemotaxis,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031584~activation of phospholipase D activity,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0042102~positive regulation of T cell proliferation,GO:0042119~neutrophil activation,GO:0042327~positive regulation of phosphorylation,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0043623~cellular protein complex assembly,GO:0043922~negative regulation by host of viral transcription,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045089~positive regulation of innate immune response,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045785~positive regulation of cell adhesion,GO:0045948~positive regulation of translational initiation,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050796~regulation of insulin secretion,GO:0050863~regulation of T cell activation,GO:0050918~positive chemotaxis,GO:0051262~protein tetramerization,GO:0051928~positive regulation of calcium ion transport,GO:0060326~cell chemotaxis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070098~chemokine-mediated signaling pathway,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:0070233~negative regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0090026~positive regulation of monocyte chemotaxis,GO:1901214~regulation of neuron death,GO:2000110~negative regulation of macrophage apoptotic process,GO:2000406~positive regulation of T cell migration,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0016004~phospholipase activator activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031729~CCR4 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,GO:0046817~chemokine receptor antagonist activity,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04668:TNF signaling pathway,hsa05020:Prion diseases,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05323:Rheumatoid arthritis,	HIV-1 disease, delayed progression of~HIV-1 disease, delayed progression of,HIV-1 disease, rapid progression of~HIV-1 disease, rapid progression of,		SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Oxidation,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 5,chain:RANTES(3-68),chain:RANTES(4-68),disulfide bond,glycosylation site:O-linked (GalNAc...); partial,helix,sequence conflict,sequence variant,signal peptide,site:Cleavage; by DPP4,site:Susceptible to oxidation,strand,
208075_s_at	C-C motif chemokine ligand 7(CCL7)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0010332~response to gamma radiation,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071361~cellular response to ethanol,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,GO:0031727~CCR2 chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Inflammatory response,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,strand,turn,
214038_at	C-C motif chemokine ligand 8(CCL8)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0002687~positive regulation of leukocyte migration,GO:0006468~protein phosphorylation,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070664~negative regulation of leukocyte proliferation,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005615~extracellular space,GO:0005623~cell,	GO:0004672~protein kinase activity,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0016004~phospholipase activator activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Heparin-binding,Inflammatory response,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 8,chain:MCP-2(6-76),disulfide bond,helix,modified residue,sequence variant,signal peptide,strand,turn,
205099_s_at, 205098_at	C-C motif chemokine receptor 1(CCR1)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0002407~dendritic cell chemotaxis,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007267~cell-cell signaling,GO:0009611~response to wounding,GO:0010629~negative regulation of gene expression,GO:0019221~cytokine-mediated signaling pathway,GO:0030335~positive regulation of cell migration,GO:0030502~negative regulation of bone mineralization,GO:0045672~positive regulation of osteoclast differentiation,GO:0051928~positive regulation of calcium ion transport,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090026~positive regulation of monocyte chemotaxis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,GO:0035717~chemokine (C-C motif) ligand 7 binding,GO:0071791~chemokine (C-C motif) ligand 5 binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002236:CC chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220565_at	C-C motif chemokine receptor 10(CCR10)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR005382:CC chemokine receptor 10,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 10,disulfide bond,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206978_at, 207794_at	C-C motif chemokine receptor 2(CCR2)	Homo sapiens				GO:0001974~blood vessel remodeling,GO:0002407~dendritic cell chemotaxis,GO:0002827~positive regulation of T-helper 1 type immune response,GO:0002829~negative regulation of type 2 immune response,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007259~JAK-STAT cascade,GO:0009611~response to wounding,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010820~positive regulation of T cell chemotaxis,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0019221~cytokine-mediated signaling pathway,GO:0019725~cellular homeostasis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0035705~T-helper 17 cell chemotaxis,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043310~negative regulation of eosinophil degranulation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050870~positive regulation of T cell activation,GO:0070098~chemokine-mediated signaling pathway,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:2000439~positive regulation of monocyte extravasation,GO:2000451~positive regulation of CD8-positive, alpha-beta T cell extravasation,GO:2000464~positive regulation of astrocyte chemotaxis,GO:2000473~positive regulation of hematopoietic stem cell migration,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0031727~CCR2 chemokine receptor binding,GO:0042803~protein homodimerization activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002237:CC chemokine receptor 2,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,	HIV infection, susceptibility/resistance to~HIV infection, susceptibility/resistance to,		SM01381:SM01381,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
208304_at	C-C motif chemokine receptor 3(CCR3)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,	h_ccr3Pathway:CCR3 signaling in Eosinophils,h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,h_il5Pathway:IL 5 Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0001938~positive regulation of endothelial cell proliferation,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0016032~viral process,GO:0045766~positive regulation of angiogenesis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002238:CC chemokine receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05203:Viral carcinogenesis,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 3,disulfide bond,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208376_at	C-C motif chemokine receptor 4(CCR4)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0001764~neuron migration,GO:0002507~tolerance induction,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009314~response to radiation,GO:0009617~response to bacterium,GO:0046677~response to antibiotic,GO:0048872~homeostasis of number of cells,GO:0050927~positive regulation of positive chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002239:CC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05203:Viral carcinogenesis,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206991_s_at	C-C motif chemokine receptor 5 (gene/pseudogene)(CCR5)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,		GO:0000165~MAPK cascade,GO:0002407~dendritic cell chemotaxis,GO:0006816~calcium ion transport,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007267~cell-cell signaling,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0019064~fusion of virus membrane with host plasma membrane,GO:0019722~calcium-mediated signaling,GO:0023052~signaling,GO:0030260~entry into host cell,GO:0070098~chemokine-mediated signaling pathway,GO:0070723~response to cholesterol,GO:0071222~cellular response to lipopolysaccharide,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0003779~actin binding,GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,GO:0071791~chemokine (C-C motif) ligand 5 binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002240:CC chemokine receptor 5,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05145:Toxoplasmosis,hsa05203:Viral carcinogenesis,	609532~Hepatitis C virus, resistance to,610379~West nile virus, susceptibility to,612522~Diabetes mellitus, insulin-dependent, 22,HIV infection, susceptibility/resistance to~HIV infection, susceptibility/resistance to,		SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Diabetes mellitus,Disulfide bond,G-protein coupled receptor,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Sulfation,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 5,disulfide bond,glycosylation site:O-linked (GalNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206983_at	C-C motif chemokine receptor 6(CCR6)	Homo sapiens	14.chemokine_receptor-ligand,		Cell division and chromosome partitioning / Transcription / DNA replication, recombination, and repair,	GO:0002407~dendritic cell chemotaxis,GO:0002523~leukocyte migration involved in inflammatory response,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010634~positive regulation of epithelial cell migration,GO:0019722~calcium-mediated signaling,GO:0048290~isotype switching to IgA isotypes,GO:0060326~cell chemotaxis,GO:0060474~positive regulation of sperm motility involved in capacitation,GO:0070098~chemokine-mediated signaling pathway,GO:0072676~lymphocyte migration,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:1904155~DN2 thymocyte differentiation,GO:1904156~DN3 thymocyte differentiation,GO:2000404~regulation of T cell migration,GO:2000510~positive regulation of dendritic cell chemotaxis,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0036126~sperm flagellum,GO:0097225~sperm midpiece,GO:0097228~sperm principal piece,GO:0097524~sperm plasma membrane,	GO:0004872~receptor activity,GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004067:CC chemokine receptor 6,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 6,chain:Cyclin-L2,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Cyclin-like 1,region of interest:Cyclin-like 2,region of interest:RS,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206337_at	C-C motif chemokine receptor 7(CCR7)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0001768~establishment of T cell polarity,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002407~dendritic cell chemotaxis,GO:0002408~myeloid dendritic cell chemotaxis,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0002885~positive regulation of hypersensitivity,GO:0002922~positive regulation of humoral immune response,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0031529~ruffle organization,GO:0032496~response to lipopolysaccharide,GO:0032649~regulation of interferon-gamma production,GO:0032735~positive regulation of interleukin-12 production,GO:0034695~response to prostaglandin E,GO:0038115~chemokine (C-C motif) ligand 19 signaling pathway,GO:0038116~chemokine (C-C motif) ligand 21 signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045060~negative thymic T cell selection,GO:0045785~positive regulation of cell adhesion,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0048872~homeostasis of number of cells,GO:0050706~regulation of interleukin-1 beta secretion,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051491~positive regulation of filopodium assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071345~cellular response to cytokine stimulus,GO:0071731~response to nitric oxide,GO:0072610~interleukin-12 secretion,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0090630~activation of GTPase activity,GO:0097022~lymphocyte migration into lymph node,GO:0097029~mature conventional dendritic cell differentiation,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000147~positive regulation of cell motility,GO:2000510~positive regulation of dendritic cell chemotaxis,GO:2000522~positive regulation of immunological synapse formation,GO:2000525~positive regulation of T cell costimulation,GO:2000526~positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,GO:2000547~regulation of dendritic cell dendrite assembly,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0035757~chemokine (C-C motif) ligand 19 binding,GO:0035758~chemokine (C-C motif) ligand 21 binding,GO:0038117~C-C motif chemokine 19 receptor activity,GO:0038121~C-C motif chemokine 21 receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001718:CC chemokine receptor 7,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208059_at	C-C motif chemokine receptor 8(CCR8)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004950~chemokine receptor activity,GO:0015026~coreceptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004068:CC chemokine receptor 8,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05203:Viral carcinogenesis,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 8,disulfide bond,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207445_s_at	C-C motif chemokine receptor 9(CCR9)	Homo sapiens				GO:0002305~CD8-positive, gamma-delta intraepithelial T cell differentiation,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004069:CC chemokine receptor 9,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 9,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211434_s_at	C-C motif chemokine receptor like 2(CCRL2)	Homo sapiens				GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor-like 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204470_at	C-X-C motif chemokine ligand 1(CXCL1)	Homo sapiens				GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030036~actin cytoskeleton organization,GO:0032496~response to lipopolysaccharide,GO:0035556~intracellular signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008047~enzyme activator activity,GO:0008083~growth factor activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,			SM00199:SCY,	3D-structure,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Growth factor,Inflammatory response,Reference proteome,Secreted,Signal,	chain:GRO-alpha(4-73),chain:GRO-alpha(5-73),chain:GRO-alpha(6-73),chain:Growth-regulated alpha protein,disulfide bond,helix,signal peptide,strand,turn,
204533_at	C-X-C motif chemokine ligand 10(CXCL10)	Homo sapiens	109.Chemokine_families,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,			GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007517~muscle organ development,GO:0008015~blood circulation,GO:0008284~positive regulation of cell proliferation,GO:0009409~response to cold,GO:0010332~response to gamma radiation,GO:0010818~T cell chemotaxis,GO:0010819~regulation of T cell chemotaxis,GO:0010996~response to auditory stimulus,GO:0016525~negative regulation of angiogenesis,GO:0030816~positive regulation of cAMP metabolic process,GO:0032496~response to lipopolysaccharide,GO:0033280~response to vitamin D,GO:0034605~cellular response to heat,GO:0042118~endothelial cell activation,GO:0042127~regulation of cell proliferation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045662~negative regulation of myoblast differentiation,GO:0045859~regulation of protein kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0090026~positive regulation of monocyte chemotaxis,GO:1901509~regulation of endothelial tube morphogenesis,GO:1901740~negative regulation of myoblast fusion,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0048248~CXCR3 chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,IPR027220:CXC chemokine 10,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04668:TNF signaling pathway,hsa05164:Influenza A,			SM00199:SCY,	3D-structure,Chemotaxis,Citrullination,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 10,chain:CXCL10(1-73),disulfide bond,helix,modified residue,sequence conflict,signal peptide,strand,turn,
211122_s_at, 210163_at	C-X-C motif chemokine ligand 11(CXCL11)	Homo sapiens	109.Chemokine_families,			GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0010818~T cell chemotaxis,GO:0030816~positive regulation of cAMP metabolic process,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0070098~chemokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0048248~CXCR3 chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,IPR027221:CXC chemokine 11,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Citrullination,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 11,disulfide bond,helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
203666_at, 209687_at	C-X-C motif chemokine ligand 12(CXCL12)	Homo sapiens	109.Chemokine_families,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cxcr4Pathway:CXCR4 Signaling Pathway,		GO:0001666~response to hypoxia,GO:0001764~neuron migration,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007411~axon guidance,GO:0008015~blood circulation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008344~adult locomotory behavior,GO:0009314~response to radiation,GO:0009408~response to heat,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0022029~telencephalon cell migration,GO:0031100~organ regeneration,GO:0033603~positive regulation of dopamine secretion,GO:0043434~response to peptide hormone,GO:0045785~positive regulation of cell adhesion,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0050918~positive chemotaxis,GO:0050930~induction of positive chemotaxis,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090280~positive regulation of calcium ion import,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1903237~negative regulation of leukocyte tethering or rolling,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000406~positive regulation of T cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,GO:0045236~CXCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04360:Axon guidance,hsa04670:Leukocyte transendothelial migration,hsa04672:Intestinal immune network for IgA production,hsa05200:Pathways in cancer,hsa05323:Rheumatoid arthritis,	609423~AIDS, resistance to,		SM00199:SCY,	3D-structure,Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Growth factor,Reference proteome,Secreted,Signal,	chain:SDF-1-alpha(3-67),chain:SDF-1-beta(3-72),chain:Stromal cell-derived factor 1,disulfide bond,helix,signal peptide,splice variant,strand,turn,
205242_at	C-X-C motif chemokine ligand 13(CXCL13)	Homo sapiens	109.Chemokine_families,			GO:0002467~germinal center formation,GO:0002518~lymphocyte chemotaxis across high endothelial venule,GO:0002544~chronic inflammatory response,GO:0002920~regulation of humoral immune response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007267~cell-cell signaling,GO:0010820~positive regulation of T cell chemotaxis,GO:0032496~response to lipopolysaccharide,GO:0033625~positive regulation of integrin activation,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0035754~B cell chemotaxis,GO:0035768~endothelial cell chemotaxis to fibroblast growth factor,GO:0035769~B cell chemotaxis across high endothelial venule,GO:0042127~regulation of cell proliferation,GO:0042742~defense response to bacterium,GO:0045765~regulation of angiogenesis,GO:0048535~lymph node development,GO:0070098~chemokine-mediated signaling pathway,GO:0090630~activation of GTPase activity,GO:2000545~negative regulation of endothelial cell chemotaxis to fibroblast growth factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0016021~integral component of membrane,	GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0017134~fibroblast growth factor binding,GO:0031724~CXCR5 chemokine receptor binding,GO:0031735~CCR10 chemokine receptor binding,GO:0046982~protein heterodimerization activity,GO:0048018~receptor agonist activity,GO:0048248~CXCR3 chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Inflammatory response,Membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:C-X-C motif chemokine 13,disulfide bond,signal peptide,
218002_s_at	C-X-C motif chemokine ligand 14(CXCL14)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0045662~negative regulation of myoblast differentiation,GO:0048839~inner ear development,GO:0060326~cell chemotaxis,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,	GO:0005515~protein binding,GO:0008009~chemokine activity,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Proteomics identification,Reference proteome,Secreted,Signal,Ubl conjugation,	chain:C-X-C motif chemokine 14,disulfide bond,helix,signal peptide,strand,turn,
209774_x_at	C-X-C motif chemokine ligand 2(CXCL2)	Homo sapiens				GO:0002237~response to molecule of bacterial origin,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Pharmaceutical,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 2,chain:GRO-beta(5-73),disulfide bond,signal peptide,strand,turn,
207850_at	C-X-C motif chemokine ligand 3(CXCL3)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0070098~chemokine-mediated signaling pathway,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 3,chain:GRO-gamma(5-73),disulfide bond,sequence conflict,sequence variant,signal peptide,
207852_at, 215101_s_at, 214974_x_at	C-X-C motif chemokine ligand 5(CXCL5)	Homo sapiens				GO:0002446~neutrophil mediated immunity,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05133:Pertussis,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 5,chain:ENA-78(8-78),chain:ENA-78(9-78),disulfide bond,signal peptide,site:Cleavage; by cathepsin G,
206336_at	C-X-C motif chemokine ligand 6(CXCL6)	Homo sapiens	109.Chemokine_families,			GO:0002446~neutrophil mediated immunity,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0042742~defense response to bacterium,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0045236~CXCR chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05133:Pertussis,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	Antibiotic,Antimicrobial,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Heparin-binding,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 6,chain:Small-inducible cytokine B6, N-processed variant 1,chain:Small-inducible cytokine B6, N-processed variant 2,chain:Small-inducible cytokine B6, N-processed variant 3,disulfide bond,signal peptide,
202859_x_at, 211506_s_at	C-X-C motif chemokine ligand 8(CXCL8)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,58.(CD40L)_immnosurveillance,7.IL17_hematopoesis,	h_cytokinePathway:Cytokine Network,h_freePathway:Free Radical Induced Apoptosis,h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_il17Pathway:IL 17 Signaling Pathway,h_inflamPathway:Cytokines and Inflammatory Response,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,h_stemPathway:Regulation of hematopoiesis by cytokines,		GO:0001525~angiogenesis,GO:0002237~response to molecule of bacterial origin,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0019722~calcium-mediated signaling,GO:0030155~regulation of cell adhesion,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0036499~PERK-mediated unfolded protein response,GO:0042119~neutrophil activation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045091~regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0048566~embryonic digestive tract development,GO:0050930~induction of positive chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090023~positive regulation of neutrophil chemotaxis,GO:2000535~regulation of entry of bacterium into host cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005153~interleukin-8 receptor binding,GO:0005515~protein binding,GO:0008009~chemokine activity,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,			SM00199:SCY,	3D-structure,Chemotaxis,Citrullination,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Proteomics identification,Reference proteome,Secreted,Signal,	chain:IL-8(5-77),chain:IL-8(6-77),chain:IL-8(7-77),chain:IL-8(8-77),chain:IL-8(9-77),chain:Interleukin-8,chain:MDNCF-a,disulfide bond,helix,sequence conflict,signal peptide,site:Cleavage; by MMP9,site:Cleavage; by thrombin,splice variant,strand,
203915_at	C-X-C motif chemokine ligand 9(CXCL9)	Homo sapiens	109.Chemokine_families,			GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030816~positive regulation of cAMP metabolic process,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045663~positive regulation of myoblast differentiation,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:1901741~positive regulation of myoblast fusion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,	GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048248~CXCR3 chemokine receptor binding,	IPR001089:CXC chemokine,IPR001811:Chemokine interleukin-8-like domain,IPR018048:CXC chemokine, conserved site,IPR027225:CXC chemokine 9,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,			SM00199:SCY,	Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Reference proteome,Secreted,Signal,	chain:C-X-C motif chemokine 9,disulfide bond,signal peptide,
207094_at	C-X-C motif chemokine receptor 1(CXCR1)	Homo sapiens				GO:0002407~dendritic cell chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0031623~receptor internalization,GO:0038112~interleukin-8-mediated signaling pathway,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004918~interleukin-8 receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,GO:0019959~interleukin-8 binding,	IPR000174:CXC chemokine receptor 1/2,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001355:CXC chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	609423~AIDS, slow progression to,			3D-structure,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207008_at	C-X-C motif chemokine receptor 2(CXCR2)	Homo sapiens				GO:0002407~dendritic cell chemotaxis,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0030593~neutrophil chemotaxis,GO:0030901~midbrain development,GO:0031623~receptor internalization,GO:0033030~negative regulation of neutrophil apoptotic process,GO:0038112~interleukin-8-mediated signaling pathway,GO:0042119~neutrophil activation,GO:0043117~positive regulation of vascular permeability,GO:0045766~positive regulation of angiogenesis,GO:0070098~chemokine-mediated signaling pathway,GO:0072173~metanephric tubule morphogenesis,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005622~intracellular,GO:0005623~cell,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,	GO:0004871~signal transducer activity,GO:0004918~interleukin-8 receptor activity,GO:0005515~protein binding,GO:0016494~C-X-C chemokine receptor activity,GO:0019959~interleukin-8 binding,	IPR000057:CXC chemokine receptor 2,IPR000174:CXC chemokine receptor 1/2,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,				3D-structure,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
217119_s_at, 207681_at	C-X-C motif chemokine receptor 3(CXCR3)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_mCalpainPathway:mCalpain and friends in Cell motility,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,		GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0002685~regulation of leukocyte migration,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0010818~T cell chemotaxis,GO:0016525~negative regulation of angiogenesis,GO:0019722~calcium-mediated signaling,GO:0030816~positive regulation of cAMP metabolic process,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050921~positive regulation of chemotaxis,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0070098~chemokine-mediated signaling pathway,GO:0071954~chemokine (C-C motif) ligand 11 production,GO:1900118~negative regulation of execution phase of apoptosis,GO:1900119~positive regulation of execution phase of apoptosis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004950~chemokine receptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019956~chemokine binding,GO:0019958~C-X-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004070:CXC chemokine receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Alternative splicing,Angiogenesis,Apoptosis,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211919_s_at, 217028_at, 209201_x_at	C-X-C motif chemokine receptor 4(CXCR4)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_vifPathway:HIV-1 defeats host-mediated resistance by CEM15,		GO:0000187~activation of MAPK activity,GO:0001666~response to hypoxia,GO:0002407~dendritic cell chemotaxis,GO:0006915~apoptotic process,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009615~response to virus,GO:0019064~fusion of virus membrane with host plasma membrane,GO:0019722~calcium-mediated signaling,GO:0030260~entry into host cell,GO:0030334~regulation of cell migration,GO:0043217~myelin maintenance,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050920~regulation of chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071345~cellular response to cytokine stimulus,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0003779~actin binding,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0031625~ubiquitin protein ligase binding,GO:0032027~myosin light chain binding,GO:0043130~ubiquitin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001277:CXC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022726:CXC chemokine receptor 4 N-terminal domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04360:Axon guidance,hsa04670:Leukocyte transendothelial migration,hsa04672:Intestinal immune network for IgA production,hsa05200:Pathways in cancer,	193670~WHIM syndrome,Myelokathexis, isolated~Myelokathexis, isolated,			3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Lysosome,Membrane,Phosphoprotein,Proteoglycan,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:C-X-C chemokine receptor type 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),modified residue,mutagenesis site,short sequence motif:Important for signaling,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216734_s_at, 206126_at	C-X-C motif chemokine receptor 5(CXCR5)	Homo sapiens	16.Chemokines-rec-T-cells,			GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030595~leukocyte chemotaxis,GO:0032467~positive regulation of cytokinesis,GO:0042113~B cell activation,GO:0048535~lymph node development,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0016494~C-X-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001053:CXC chemokine receptor 5,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Alternative splicing,B-cell activation,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 5,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206974_at, 211469_s_at	C-X-C motif chemokine receptor 6(CXCR6)	Homo sapiens				GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0019079~viral genome replication,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0015026~coreceptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019958~C-X-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002235:CXC chemokine receptor 6,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 6,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
823_at, 203687_at	C-X3-C motif chemokine ligand 1(CX3CL1)	Homo sapiens	109.Chemokine_families,			GO:0002523~leukocyte migration involved in inflammatory response,GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0019221~cytokine-mediated signaling pathway,GO:0030336~negative regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0032914~positive regulation of transforming growth factor beta1 production,GO:0033622~integrin activation,GO:0043547~positive regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0050902~leukocyte adhesive activation,GO:0051041~positive regulation of calcium-independent cell-cell adhesion,GO:0060055~angiogenesis involved in wound healing,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031737~CX3C chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,IPR008097:CX3C chemokine ligand 1,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,			SM00199:SCY,	3D-structure,Cell adhesion,Cell membrane,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Fractalkine,chain:Processed fractalkine,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Chemokine,region of interest:Mucin-like stalk,sequence variant,signal peptide,site:Cleavage; to produce soluble form,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205898_at	C-X3-C motif chemokine receptor 1(CX3CR1)	Homo sapiens				GO:0002052~positive regulation of neuroblast proliferation,GO:0002282~microglial cell activation involved in immune response,GO:0002881~negative regulation of chronic inflammatory response to non-antigenic stimulus,GO:0006935~chemotaxis,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007613~memory,GO:0009611~response to wounding,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0021795~cerebral cortex cell migration,GO:0030336~negative regulation of cell migration,GO:0045766~positive regulation of angiogenesis,GO:0048246~macrophage chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900272~negative regulation of long-term synaptic potentiation,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0032809~neuronal cell body membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016495~C-X3-C chemokine receptor activity,GO:0019960~C-X3-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005387:CX3C chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,	607339~Coronary artery disease, resistance to,609423~Rapid progression to AIDS from HIV1 infection,613784~Macular degeneration, age-related, 12,			Age-related macular degeneration,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:CX3C chemokine receptor 1,disulfide bond,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218447_at	C-X9-C motif containing 2(CMC2)	Homo sapiens					GO:0005739~mitochondrion,		IPR013892:Cytochrome c oxidase biogenesis protein Cmc1-like,					Complete proteome,Disulfide bond,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C16orf61,sequence variant,
216862_s_at, 205106_at, 210212_x_at	C-X9-C motif containing 4(CMC4)	Homo sapiens				GO:0008283~cell proliferation,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,		IPR009069:Cysteine alpha-hairpin motif superfamily,IPR027179:Domain of unknown function DUF1903,					3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Disulfide bond,Mitochondrion,Proto-oncogene,Reference proteome,	chain:Protein p13 MTCP-1,chain:Protein p8 MTCP-1,compositionally biased region:Poly-Glu,disulfide bond,helix,strand,turn,
37020_at, 205753_at	C-reactive protein(CRP)	Homo sapiens				GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0008228~opsonization,GO:0010628~positive regulation of gene expression,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010888~negative regulation of lipid storage,GO:0032930~positive regulation of superoxide anion generation,GO:0045908~negative regulation of vasodilation,GO:0050830~defense response to Gram-positive bacterium,GO:2000482~regulation of interleukin-8 secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0001849~complement component C1q binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030169~low-density lipoprotein particle binding,GO:0033265~choline binding,GO:0046790~virion binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR001759:Pentaxin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00159:PTX,	3D-structure,Acute phase,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disulfide bond,Metal-binding,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-reactive protein,chain:C-reactive protein(1-205),disulfide bond,domain:Pentaxin,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,modified residue,sequence conflict,signal peptide,splice variant,strand,turn,
212863_x_at, 203392_s_at, 213980_s_at	C-terminal binding protein 1(CTBP1)	Homo sapiens		h_ctbp1Pathway:SUMOylation as a mechanism to modulate CtBP-dependent gene responses,h_wntPathway:WNT Signaling Pathway,	Energy production and conversion / Coenzyme metabolism / General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0019079~viral genome replication,GO:0031065~positive regulation of histone deacetylation,GO:0035067~negative regulation of histone acetylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050872~white fat cell differentiation,GO:0051726~regulation of cell cycle,GO:0055114~oxidation-reduction process,GO:0090241~negative regulation of histone H4 acetylation,GO:1903758~negative regulation of transcription from RNA polymerase II promoter by histone modification,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0051287~NAD binding,GO:0070491~repressing transcription factor binding,	IPR006139:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,IPR006140:D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding,IPR016040:NAD(P)-binding domain,	hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,				3D-structure,ADP-ribosylation,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Direct protein sequencing,Host-virus interaction,Isopeptide bond,NAD,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	active site:Proton donor,binding site:NAD,chain:C-terminal-binding protein 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NAD,region of interest:Interaction with GLIS2 1,region of interest:Interaction with GLIS2 2,strand,turn,
201218_at, 215377_at, 210835_s_at, 201220_x_at, 210554_s_at, 201219_at	C-terminal binding protein 2(CTBP2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0008285~negative regulation of cell proliferation,GO:0019079~viral genome replication,GO:0035563~positive regulation of chromatin binding,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0050872~white fat cell differentiation,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0017053~transcriptional repressor complex,GO:0030054~cell junction,GO:0097470~ribbon synapse,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042803~protein homodimerization activity,GO:0042974~retinoic acid receptor binding,GO:0051287~NAD binding,	IPR006139:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,IPR006140:D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding,IPR016040:NAD(P)-binding domain,	hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,				3D-structure,Alternative splicing,Cell junction,Complete proteome,Differentiation,Direct protein sequencing,Host-virus interaction,Methylation,NAD,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Synapse,Transcription,Transcription regulation,	active site:Proton donor,binding site:NAD,chain:C-terminal-binding protein 2,helix,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,splice variant,strand,turn,
219761_at	C-type lectin domain family 1 member A(CLEC1A)	Homo sapiens				GO:0006952~defense response,GO:0007166~cell surface receptor signaling pathway,	GO:0005622~intracellular,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 1 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220496_at	C-type lectin domain family 1 member B(CLEC1B)	Homo sapiens				GO:0006952~defense response,GO:0007166~cell surface receptor signaling pathway,GO:0030168~platelet activation,GO:0030220~platelet formation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 1 member B,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206682_at	C-type lectin domain family 10 member A(CLEC10A)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006897~endocytosis,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR005640:Hepatic lectin, N-terminal,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	Adaptive immunity,Alternative splicing,Coiled coil,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 10 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Endocytosis signal,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205131_x_at, 211709_s_at, 210783_x_at	C-type lectin domain family 11 member A(CLEC11A)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-type lectin domain family 11 member A,disulfide bond,domain:C-type lectin,sequence variant,short sequence motif:Cell attachment site,signal peptide,
212786_at	C-type lectin domain family 16 member A(CLEC16A)	Homo sapiens				GO:0006914~autophagy,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:1901098~positive regulation of autophagosome maturation,GO:1901525~negative regulation of macromitophagy,	GO:0036020~endolysosome membrane,		IPR019155:Uncharacterised protein family FPL,					Alternative splicing,Autophagy,Complete proteome,Diabetes mellitus,Endosome,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein CLEC16A,compositionally biased region:Ser-rich,sequence variant,splice variant,
209732_at	C-type lectin domain family 2 member B(CLEC2B)	Homo sapiens				GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 2 member B,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220132_s_at	C-type lectin domain family 2 member D(CLEC2D)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0050776~regulation of immune response,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003676~nucleic acid binding,GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR004301:Nucleoplasmin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR024057:Nucleoplasmin core domain,				SM00034:CLECT,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Lectin,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 2 member D,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219947_at, 221724_s_at	C-type lectin domain family 4 member A(CLEC4A)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:ITIM motif,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219859_at	C-type lectin domain family 4 member E(CLEC4E)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002292~T cell differentiation involved in immune response,GO:0038094~Fc-gamma receptor signaling pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050715~positive regulation of cytokine secretion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa05152:Tuberculosis,			SM00034:CLECT,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Lectin,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member E,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210481_s_at, 207995_s_at	C-type lectin domain family 4 member M(CLEC4M)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006897~endocytosis,GO:0007159~leukocyte cell-cell adhesion,GO:0009988~cell-cell recognition,GO:0010468~regulation of gene expression,GO:0019048~modulation by virus of host morphology or physiology,GO:0019062~virion attachment to host cell,GO:0019079~viral genome replication,GO:0019882~antigen processing and presentation,GO:0030193~regulation of blood coagulation,GO:0035556~intracellular signal transduction,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,GO:0046968~peptide antigen transport,GO:0075733~intracellular transport of virus,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0030369~ICAM-3 receptor activity,GO:0042605~peptide antigen binding,GO:0046790~virion binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,hsa05162:Measles,	SARS infection, protection against~SARS infection, protection against,		SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Calcium,Cell membrane,Coiled coil,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lectin,Mannose-binding,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member M,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,region of interest:7 X approximate tandem repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219890_at	C-type lectin domain family 5 member A(CLEC5A)	Homo sapiens				GO:0002076~osteoblast development,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0030099~myeloid cell differentiation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,GO:0050715~positive regulation of cytokine secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lectin,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 5 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221698_s_at	C-type lectin domain family 7 member A(CLEC7A)	Homo sapiens				GO:0002221~pattern recognition receptor signaling pathway,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002366~leukocyte activation involved in immune response,GO:0006910~phagocytosis, recognition,GO:0006954~inflammatory response,GO:0008037~cell recognition,GO:0009756~carbohydrate mediated signaling,GO:0042110~T cell activation,GO:0042832~defense response to protozoan,GO:0045087~innate immune response,GO:0071226~cellular response to molecule of fungal origin,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0008329~signaling pattern recognition receptor activity,GO:0030246~carbohydrate binding,GO:0042287~MHC protein binding,GO:0046872~metal ion binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04145:Phagosome,hsa05152:Tuberculosis,	613108~Candidiasis, familial, 4, autosomal recessive,614079~Aspergillosis, susceptibility to,		SM00034:CLECT,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Lectin,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 7 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:ITAM-like,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202399_s_at, 213215_at, 202398_at	C15orf38-AP3S2 readthrough(C15orf38-AP3S2)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0030117~membrane coat,GO:0043231~intracellular membrane-bounded organelle,	GO:0008565~protein transporter activity,	IPR000804:Clathrin adaptor complex, small chain,IPR011012:Longin-like domain,IPR016635:Adaptor protein complex, sigma subunit,IPR018889:Uncharacterised protein family UPF0552,IPR022775:AP complex, mu/sigma subunit,					Complete proteome,Protein transport,Reference proteome,Transport,
200056_s_at	C1D nuclear receptor corepressor(C1D)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006915~apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000176~nuclear exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,	IPR007146:Sas10/Utp3/C1D,IPR011082:Exosome-associated factor Rrp47/DNA strand repair C1D,	hsa03018:RNA degradation,				Apoptosis,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-binding,rRNA processing,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear nucleic acid-binding protein C1D,region of interest:Interaction with NCOR1 and NCOR2,region of interest:Interaction with NR1D1,region of interest:Required for transcriptional repression,sequence conflict,sequence variant,
219283_at	C1GALT1 specific chaperone 1(C1GALT1C1)	Homo sapiens				GO:0006493~protein O-linked glycosylation,GO:0016266~O-glycan processing,GO:0016267~O-glycan processing, core 1,GO:0030168~platelet activation,GO:0036344~platelet morphogenesis,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016263~glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,	IPR026731:C1GALT1-specific chaperone 1,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,	300622~Tn polyagglutination syndrome, somatic,			Chaperone,Complete proteome,Disease mutation,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C1GALT1-specific chaperone 1,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
209424_s_at, 209425_at, 209426_s_at	C1QTNF3-AMACR readthrough (NMD candidate)(C1QTNF3-AMACR)	Homo sapiens					GO:0005576~extracellular region,GO:0005581~collagen trimer,		IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,				SM00110:C1Q,	Collagen,Complete proteome,Reference proteome,Secreted,
222277_at	C1QTNF9B antisense RNA 1(C1QTNF9B-AS1)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,						Complete proteome,Cytoplasm,Reference proteome,	chain:Protein PCOTH,compositionally biased region:Pro-rich,
220975_s_at	C1q and tumor necrosis factor related protein 1(C1QTNF1)	Homo sapiens				GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010544~negative regulation of platelet activation,GO:0010628~positive regulation of gene expression,GO:0010906~regulation of glucose metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0051260~protein homooligomerization,GO:0051897~positive regulation of protein kinase B signaling,GO:0070208~protein heterotrimerization,GO:0090331~negative regulation of platelet aggregation,GO:2000860~positive regulation of aldosterone secretion,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,	GO:0005515~protein binding,GO:0005518~collagen binding,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,				SM00110:C1Q,	Alternative splicing,Collagen,Complete proteome,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Complement C1q tumor necrosis factor- related protein 1,domain:C1q,domain:Collagen-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
220988_s_at	C1q and tumor necrosis factor related protein 3(C1QTNF3)	Homo sapiens				GO:0010629~negative regulation of gene expression,GO:0035356~cellular triglyceride homeostasis,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0045444~fat cell differentiation,GO:0045721~negative regulation of gluconeogenesis,GO:0050715~positive regulation of cytokine secretion,GO:0050728~negative regulation of inflammatory response,GO:0070165~positive regulation of adiponectin secretion,GO:0070206~protein trimerization,GO:0071638~negative regulation of monocyte chemotactic protein-1 production,GO:1900165~negative regulation of interleukin-6 secretion,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005623~cell,GO:0016020~membrane,GO:0070062~extracellular exosome,		IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,				SM00110:C1Q,	Alternative splicing,Collagen,Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,	active site:Nucleophile,chain:Alpha-methylacyl-CoA racemase,chain:Complement C1q tumor necrosis factor- related protein 3,domain:C1q,domain:Collagen-like,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,signal peptide,splice variant,
212875_s_at	C2 calcium dependent domain containing 2(C2CD2)	Homo sapiens					GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005829~cytosol,		IPR000008:C2 calcium-dependent membrane targeting,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C2 domain-containing protein 2,domain:C2,modified residue,sequence conflict,sequence variant,signal peptide,
213199_at, 36552_at	C2 calcium dependent domain containing 3(C2CD3)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0007420~brain development,GO:0008589~regulation of smoothened signaling pathway,GO:0016485~protein processing,GO:0021915~neural tube development,GO:0021997~neural plate axis specification,GO:0030162~regulation of proteolysis,GO:0035058~nonmotile primary cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0061511~centriole elongation,GO:0071539~protein localization to centrosome,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0036064~ciliary basal body,	GO:0005515~protein binding,	IPR000008:C2 calcium-dependent membrane targeting,		615948~Orofaciodigital syndrome XIV,		SM00239:C2,	Alternative splicing,Cell projection,Ciliopathy,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:C2 domain-containing protein 3,domain:C2 1,domain:C2 2,modified residue,sequence conflict,sequence variant,splice variant,
212943_at	C2 calcium dependent domain containing 5(C2CD5)	Homo sapiens				GO:0006906~vesicle fusion,GO:0010828~positive regulation of glucose transport,GO:0031340~positive regulation of vesicle fusion,GO:0032869~cellular response to insulin stimulus,GO:0038028~insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0065002~intracellular protein transmembrane transport,GO:0072659~protein localization to plasma membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0030659~cytoplasmic vesicle membrane,GO:0032587~ruffle membrane,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR002765:Uncharacterised protein family UPF0145,				SM00239:C2,	Alternative splicing,Calcium,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Lipid-binding,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Uncharacterized protein KIAA0528,domain:C2,modified residue,splice variant,
204758_s_at, 204757_s_at	C2CD2 like(C2CD2L)	Homo sapiens				GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,	GO:0016021~integral component of membrane,	GO:0043559~insulin binding,	IPR000008:C2 calcium-dependent membrane targeting,					Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:C2 domain-containing protein 2-like,modified residue,sequence variant,splice variant,transmembrane region,
220099_s_at, 217842_at	C7orf55-LUC7L2 readthrough(C7orf55-LUC7L2)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0050995~negative regulation of lipid catabolic process,GO:0061469~regulation of type B pancreatic cell proliferation,	GO:0005685~U1 snRNP,GO:0005739~mitochondrion,	GO:0003729~mRNA binding,	IPR004882:LUC7-related,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,
220038_at	C8orf44-SGK3 readthrough(C8orf44-SGK3)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006468~protein phosphorylation,GO:0006883~cellular sodium ion homeostasis,GO:0006950~response to stress,GO:0010765~positive regulation of sodium ion transport,GO:0018105~peptidyl-serine phosphorylation,GO:0030334~regulation of cell migration,GO:0032411~positive regulation of transporter activity,GO:0034220~ion transmembrane transport,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,	GO:0005769~early endosome,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0055037~recycling endosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0017080~sodium channel regulator activity,GO:0017081~chloride channel regulator activity,GO:0035091~phosphatidylinositol binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001683:Phox homologous domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,			SM00133:S_TK_X,SM00220:S_TKc,SM00312:PX,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasmic vesicle,Endosome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,
215325_x_at	CACN beta subunit associated regulatory protein(CBARP)	Homo sapiens				GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:1901386~negative regulation of voltage-gated calcium channel activity,GO:1903170~negative regulation of calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030141~secretory granule,GO:0030426~growth cone,GO:0030672~synaptic vesicle membrane,	GO:0044325~ion channel binding,						Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Protein Dos,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Thr,compositionally biased region:Thr-rich,modified residue,sequence conflict,splice variant,transmembrane region,
212554_at, 212551_at	CAP, adenylate cyclase-associated protein, 2 (yeast)(CAP2)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0007010~cytoskeleton organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0007190~activation of adenylate cyclase activity,GO:0008154~actin polymerization or depolymerization,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030864~cortical actin cytoskeleton,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008179~adenylate cyclase binding,GO:0042802~identical protein binding,	IPR001837:Adenylate cyclase-associated CAP,IPR006599:CARP motif,IPR013912:Adenylate cyclase-associated CAP, C-terminal,IPR013992:Adenylate cyclase-associated CAP, N-terminal,IPR016098:Cyclase-associated protein CAP/septum formation inhibitor MinC, C-terminal,IPR017901:C-CAP/cofactor C-like domain,IPR018106:CAP, conserved site,				SM00673:CARP,	Acetylation,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Adenylyl cyclase-associated protein 2,compositionally biased region:Poly-Pro,domain:C-CAP/cofactor C-like,modified residue,sequence variant,
201975_at, 210716_s_at	CAP-Gly domain containing linker protein 1(CLIP1)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,		GO:0001578~microtubule bundle formation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0031116~positive regulation of microtubule polymerization,GO:0044861~protein transport into plasma membrane raft,GO:1900006~positive regulation of dendrite development,	GO:0000776~kinetochore,GO:0001726~ruffle,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005882~intermediate filament,GO:0015630~microtubule cytoskeleton,GO:0030659~cytoplasmic vesicle membrane,GO:0035371~microtubule plus-end,GO:0044354~macropinosome,GO:1990752~microtubule end,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051010~microtubule plus-end binding,	IPR000938:CAP Gly-rich domain,				SM01052:SM01052,	3D-structure,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Membrane,Metal-binding,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transport,Zinc,Zinc-finger,	chain:CAP-Gly domain-containing linker protein 1,compositionally biased region:Ser-rich,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,modified residue,sequence conflict,sequence variant,short sequence motif:CCHC-box,splice variant,strand,turn,
211031_s_at	CAP-Gly domain containing linker protein 2(CLIP2)	Homo sapiens			Cell division and chromosome partitioning,		GO:0005875~microtubule associated complex,GO:0005881~cytoplasmic microtubule,GO:0035371~microtubule plus-end,	GO:0008017~microtubule binding,GO:0051010~microtubule plus-end binding,	IPR000938:CAP Gly-rich domain,				SM01052:SM01052,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Williams-Beuren syndrome,	chain:CAP-Gly domain-containing linker protein 2,compositionally biased region:Ser-rich,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,modified residue,sequence variant,splice variant,strand,turn,
212358_at	CAP-Gly domain containing linker protein 3(CLIP3)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010828~positive regulation of glucose transport,GO:0018230~peptidyl-L-cysteine S-palmitoylation,GO:0031115~negative regulation of microtubule polymerization,GO:0043065~positive regulation of apoptotic process,GO:0044091~membrane biogenesis,GO:0045444~fat cell differentiation,GO:0045807~positive regulation of endocytosis,GO:0072321~chaperone-mediated protein transport,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,	GO:0005795~Golgi stack,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031901~early endosome membrane,GO:0032588~trans-Golgi network membrane,GO:0045121~membrane raft,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0035594~ganglioside binding,	IPR000938:CAP Gly-rich domain,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM01052:SM01052,	3D-structure,ANK repeat,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CAP-Gly domain-containing linker protein 3,compositionally biased region:Poly-Glu,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,region of interest:GoLD,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,strand,turn,
219944_at	CAP-Gly domain containing linker protein family member 4(CLIP4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000938:CAP Gly-rich domain,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM01052:SM01052,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:CAP-Gly domain-containing linker protein 4,compositionally biased region:Ser-rich,domain:CAP-Gly 1,domain:CAP-Gly 2,domain:CAP-Gly 3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,
206339_at	CART prepropeptide(CARTPT)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0001678~cellular glucose homeostasis,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~chemical synaptic transmission,GO:0008343~adult feeding behavior,GO:0009267~cellular response to starvation,GO:0032099~negative regulation of appetite,GO:0032812~positive regulation of epinephrine secretion,GO:0032922~circadian regulation of gene expression,GO:0045671~negative regulation of osteoclast differentiation,GO:0045777~positive regulation of blood pressure,GO:0045779~negative regulation of bone resorption,GO:0050796~regulation of insulin secretion,GO:0051971~positive regulation of transmission of nerve impulse,GO:0070093~negative regulation of glucagon secretion,GO:0070253~somatostatin secretion,	GO:0005615~extracellular space,GO:0030141~secretory granule,	GO:0005184~neuropeptide hormone activity,GO:0005515~protein binding,	IPR009106:CART satiety factor,		601665~Obesity, susceptibility to,			3D-structure,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Neuropeptide,Neurotransmitter,Obesity,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Cocaine- and amphetamine-regulated transcript protein,disulfide bond,peptide:CART(1-39),peptide:CART(42-89),sequence variant,signal peptide,strand,turn,
219342_at	CAS1 domain containing 1(CASD1)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0016740~transferase activity,	IPR012419:Cas1p 10 TM acyl transferase domain,IPR013763:Cyclin-like,					Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:CAS1 domain-containing protein 1,sequence conflict,sequence variant,signal peptide,transmembrane region,
221846_s_at, 61297_at	CASK interacting protein 2(CASKIN2)	Homo sapiens			General function prediction only,	GO:0007165~signal transduction,	GO:0005737~cytoplasm,		IPR001452:Src homology-3 domain,IPR001660:Sterile alpha motif domain,IPR002110:Ankyrin repeat,IPR011511:Variant SH3,IPR013761:Sterile alpha motif/pointed domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00326:SH3,SM00454:SAM,	3D-structure,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Caskin-2,compositionally biased region:Pro-rich,domain:SAM 1,domain:SAM 2,domain:SH3,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence variant,
209833_at	CASP2 and RIPK1 domain containing adaptor with death domain(CRADD)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_stressPathway:TNF/Stress Related Signaling,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007165~signal transduction,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0042981~regulation of apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0002020~protease binding,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0070513~death domain binding,	IPR000488:Death domain,IPR001315:Caspase Recruitment,IPR011029:Death-like domain,		614499~Mental retardation, autosomal recessive 34,		SM00005:DEATH,SM00114:CARD,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Disease mutation,Mental retardation,Nucleus,Proteomics identification,Reference proteome,	chain:Death domain-containing protein CRADD,domain:CARD,domain:Death,helix,strand,turn,
211317_s_at, 210563_x_at, 214618_at, 210564_x_at, 209939_x_at, 209508_x_at, 214486_x_at, 208485_x_at, 211316_x_at, 211862_x_at, 217654_at	CASP8 and FADD like apoptosis regulator(CFLAR)	Homo sapiens	36.Death_of_Key_Intracellular_Targets,86.Apoptosis_Nematode&_Vert,	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007519~skeletal muscle tissue development,GO:0014732~skeletal muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014866~skeletal myofibril assembly,GO:0016032~viral process,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043403~skeletal muscle tissue regeneration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060544~regulation of necroptotic process,GO:0097194~execution phase of apoptosis,GO:1901740~negative regulation of myoblast fusion,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0002020~protease binding,GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0032403~protein complex binding,GO:0097200~cysteine-type endopeptidase activity involved in execution phase of apoptosis,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,	hsa04064:NF-kappa B signaling pathway,hsa04210:Apoptosis,hsa04668:TNF signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),			SM00031:DED,SM00115:CASc,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Host-virus interaction,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CASP8 and FADD-like apoptosis regulator subunit p12,chain:CASP8 and FADD-like apoptosis regulator subunit p43,domain:DED 1,domain:DED 2,helix,mutagenesis site,region of interest:Caspase,region of interest:Interaction with caspase-3,region of interest:Interaction with caspase-8,region of interest:Interaction with caspase-8 propeptide,region of interest:Interaction with caspase-8 subunits p18 and p10,region of interest:Interaction with FADD,region of interest:Interaction with TRAF1 and TRAF2,region of interest:Not proteolytically processed and involved in apoptosis inhibition,sequence conflict,sequence variant,splice variant,strand,turn,
211601_at	CATR tumorigenicity conversion 1(CATR1)	Homo sapiens												Complete proteome,Reference proteome,	chain:CATR tumorigenic conversion 1 protein,
205265_s_at	CAVP-target protein-like(LOC100996693)	Homo sapiens							IPR000048:IQ motif, EF-hand binding site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00015:IQ,SM00408:IGc2,SM00409:IG,	Complete proteome,Reference proteome,
209144_s_at, 207625_s_at, 209145_s_at	CBFA2/RUNX1 translocation partner 2(CBFA2T2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010976~positive regulation of neuron projection development,GO:0010977~negative regulation of neuron projection development,GO:0030855~epithelial cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060575~intestinal epithelial cell differentiation,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,IPR003894:TAFH/NHR1,IPR013289:Eight-Twenty-One,IPR013291:Myeloid transforming gene-related protein-1 (MTGR1),IPR014896:NHR2-like,				SM00549:TAFH,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Protein CBFA2T2,compositionally biased region:Pro-rich,domain:TAFH,modified residue,sequence conflict,splice variant,zinc finger region:MYND-type,
208056_s_at	CBFA2/RUNX1 translocation partner 3(CBFA2T3)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006351~transcription, DNA-templated,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0045820~negative regulation of glycolytic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:1903715~regulation of aerobic respiration,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,IPR003894:TAFH/NHR1,IPR013289:Eight-Twenty-One,IPR013292:Myeloid transforming gene on chromosome 16 (MTG16),IPR014896:NHR2-like,				SM00549:TAFH,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Differentiation,Golgi apparatus,Isopeptide bond,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Protein CBFA2T3,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:TAFH,modified residue,mutagenesis site,region of interest:Mediates interaction with PDE7A (in isoform 2),region of interest:Mediates interaction with PRKAR2A,region of interest:Mediates localization to the nucleus,region of interest:Required for nucleolar targeting (in isoform 1),sequence conflict,sequence variant,site:Breakpoint for translocation to form type-1 RUNX1-CBFA2T3 fusion protein,site:Breakpoint for translocation to form type-2 RUNX1-CBFA2T3 fusion protein,splice variant,zinc finger region:MYND-type,
204039_at	CCAAT/enhancer binding protein alpha(CEBPA)	Homo sapiens		h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000050~urea cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006091~generation of precursor metabolites and energy,GO:0006351~transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007219~Notch signaling pathway,GO:0008203~cholesterol metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0030099~myeloid cell differentiation,GO:0030225~macrophage differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042593~glucose homeostasis,GO:0045444~fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048469~cell maturation,GO:0048839~inner ear development,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0055088~lipid homeostasis,GO:0071285~cellular response to lithium ion,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001013~RNA polymerase I regulatory region DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,	601626~Leukemia, acute myeloid,601626~Leukemia, acute myeloid, somatic,	PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Alternative initiation,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein alpha,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,
212501_at	CCAAT/enhancer binding protein beta(CEBPB)	Homo sapiens		h_il6Pathway:IL 6 signaling pathway,		GO:0001541~ovarian follicle development,GO:0001892~embryonic placenta development,GO:0002432~granuloma formation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007613~memory,GO:0030182~neuron differentiation,GO:0032753~positive regulation of interleukin-4 production,GO:0033598~mammary gland epithelial cell proliferation,GO:0034976~response to endoplasmic reticulum stress,GO:0035711~T-helper 1 cell activation,GO:0042130~negative regulation of T cell proliferation,GO:0042742~defense response to bacterium,GO:0043524~negative regulation of neuron apoptotic process,GO:0045408~regulation of interleukin-6 biosynthetic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050873~brown fat cell differentiation,GO:0060644~mammary gland epithelial cell differentiation,GO:0060850~regulation of transcription involved in cell fate commitment,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071222~cellular response to lipopolysaccharide,GO:0071230~cellular response to amino acid stimulus,GO:0071347~cellular response to interleukin-1,GO:0071407~cellular response to organic cyclic compound,GO:0072574~hepatocyte proliferation,GO:0097421~liver regeneration,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0000779~condensed chromosome, centromeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0036488~CHOP-C/EBP complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0035035~histone acetyltransferase binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04668:TNF signaling pathway,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,		PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	3D-structure,Acetylation,Activator,Alternative initiation,Coiled coil,Complete proteome,Cytoplasm,Differentiation,DNA-binding,Glycoprotein,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein beta,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,region of interest:Required for Lys-174 sumoylation,sequence conflict,sequence variant,turn,
213006_at, 203973_s_at	CCAAT/enhancer binding protein delta(CEBPD)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0045444~fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,			PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein delta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,mutagenesis site,sequence conflict,sequence variant,
214523_at	CCAAT/enhancer binding protein epsilon(CEBPE)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0006909~phagocytosis,GO:0006952~defense response,GO:0030225~macrophage differentiation,GO:0042089~cytokine biosynthetic process,GO:0042742~defense response to bacterium,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,	GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa05202:Transcriptional misregulation in cancer,	245480~Specific granule deficiency,	PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	3D-structure,Activator,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:CCAAT/enhancer-binding protein epsilon,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,
204203_at	CCAAT/enhancer binding protein gamma(CEBPG)	Homo sapiens				GO:0001889~liver development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0016071~mRNA metabolic process,GO:0030183~B cell differentiation,GO:0042267~natural killer cell mediated cytotoxicity,GO:0043353~enucleate erythrocyte differentiation,GO:0043388~positive regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044377~RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,	hsa05152:Tuberculosis,			SM00338:BRLZ,	Activator,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:CCAAT/enhancer-binding protein gamma,DNA-binding region:Basic motif,domain:Leucine-zipper,
203341_at	CCAAT/enhancer binding protein zeta(CEBPZ)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR016024:Armadillo-type fold,					Acetylation,Activator,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CCAAT/enhancer-binding protein zeta,modified residue,sequence conflict,sequence variant,
202521_at	CCCTC-binding factor(CTCF)	Homo sapiens		h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,	General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006366~transcription from RNA polymerase II promoter,GO:0007059~chromosome segregation,GO:0010216~maintenance of DNA methylation,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0016584~nucleosome positioning,GO:0031060~regulation of histone methylation,GO:0035065~regulation of histone acetylation,GO:0040029~regulation of gene expression, epigenetic,GO:0040030~regulation of molecular function, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0071459~protein localization to chromosome, centromeric region,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043035~chromatin insulator sequence binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		615502~Mental retardation, autosomal dominant 21,		SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Alternative splicing,Centromere,Chromatin regulator,Chromosome,Chromosome partition,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional repressor CTCF,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,modified residue,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
220129_at	CCDC169-SOHLH2 readthrough(CCDC169-SOHLH2)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0048477~oogenesis,	GO:0005634~nucleus,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,DNA-binding,Nucleus,Oogenesis,Polymorphism,Reference proteome,Spermatogenesis,Transcription,Transcription regulation,
206158_s_at	CCHC-type zinc finger nucleic acid binding protein(CNBP)	Homo sapiens			Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006695~cholesterol biosynthetic process,GO:0008284~positive regulation of cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR001878:Zinc finger, CCHC-type,		602668~Myotonic dystrophy 2,		SM00343:ZnF_C2HC,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Endoplasmic reticulum,Metal-binding,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Cellular nucleic acid-binding protein,modified residue,splice variant,zinc finger region:CCHC-type 1,zinc finger region:CCHC-type 2,zinc finger region:CCHC-type 3,zinc finger region:CCHC-type 4,zinc finger region:CCHC-type 5,zinc finger region:CCHC-type 6,zinc finger region:CCHC-type 7,
200860_s_at, 200861_at	CCR4-NOT transcription complex subunit 1(CNOT1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007275~multicellular organism development,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0017148~negative regulation of translation,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035195~gene silencing by miRNA,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0061014~positive regulation of mRNA catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~cytoplasmic mRNA processing body,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0030331~estrogen receptor binding,GO:0032947~protein complex scaffold,GO:0042974~retinoic acid receptor binding,GO:0044822~poly(A) RNA binding,GO:0070016~armadillo repeat domain binding,	IPR007196:CCR4-Not complex component, Not1, C-terminal,IPR024557:CCR4-Not complex, Not1 subunit, domain of unknown function DUF3819,	hsa03018:RNA degradation,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 1,compositionally biased region:Thr-rich,modified residue,sequence conflict,sequence variant,splice variant,
217798_at, 222181_at, 222182_s_at	CCR4-NOT transcription complex subunit 2(CNOT2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001226~RNA polymerase II transcription corepressor binding,GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,	IPR007282:NOT2/NOT3/NOT5,	hsa03018:RNA degradation,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 2,modified residue,sequence variant,splice variant,
203239_s_at, 211141_s_at	CCR4-NOT transcription complex subunit 3(CNOT3)	Homo sapiens				GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0005515~protein binding,	IPR007207:Not CCR4-Not complex component, N-terminal,IPR007282:NOT2/NOT3/NOT5,IPR012270:CCR4-NOT complex, subunit 3/ 5,	hsa03018:RNA degradation,		PIRSF005290:CCR4-NOT complex, subunits 3 and 5,		3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 3,compositionally biased region:Gly/Ser-rich,compositionally biased region:Pro-rich,modified residue,splice variant,
210204_s_at, 210866_s_at, 203291_at, 210867_at, 210203_at	CCR4-NOT transcription complex subunit 4(CNOT4)	Homo sapiens			Transcription,	GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0051865~protein autoubiquitination,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR001841:Zinc finger, RING-type,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,IPR013083:Zinc finger, RING/FYVE/PHD-type,	hsa03018:RNA degradation,			SM00361:RRM_1,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:CCR4-NOT transcription complex subunit 4,domain:RRM,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,turn,zinc finger region:C3H1-type,zinc finger region:RING-type; degenerate,
217970_s_at	CCR4-NOT transcription complex subunit 6(CNOT6)	Homo sapiens			Function unknown,	GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008284~positive regulation of cell proliferation,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0035195~gene silencing by miRNA,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:2000327~positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,	GO:0003723~RNA binding,GO:0004532~exoribonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR005135:Endonuclease/exonuclease/phosphatase,	hsa03018:RNA degradation,			SM00369:LRR_TYP,	Activator,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Leucine-rich repeat,Magnesium,Metal-binding,Nuclease,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 6,metal ion-binding site:Magnesium,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,
218250_s_at	CCR4-NOT transcription complex subunit 7(CNOT7)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0005975~carbohydrate metabolic process,GO:0006351~transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0031047~gene silencing by RNA,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0035195~gene silencing by miRNA,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0061014~positive regulation of mRNA catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0004532~exoribonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,	hsa03018:RNA degradation,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Nucleus,Proteomics identification,Reference proteome,Repressor,RNA-binding,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 7,helix,sequence conflict,strand,turn,
202162_s_at, 202163_s_at, 202164_s_at	CCR4-NOT transcription complex subunit 8(CNOT8)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0035195~gene silencing by miRNA,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0061014~positive regulation of mRNA catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,IPR027212:CCR4-NOT transcription complex subunit 8,	hsa03018:RNA degradation,				Alternative splicing,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Metal-binding,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-binding,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 8,sequence conflict,sequence variant,
213098_at, 213179_at, 213903_s_at	CCR4-NOT transcription complex subunit 9(CNOT9)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006402~mRNA catabolic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007548~sex differentiation,GO:0017148~negative regulation of translation,GO:0019221~cytokine-mediated signaling pathway,GO:0031047~gene silencing by RNA,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:2000327~positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,	IPR007216:Rcd1,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa03018:RNA degradation,				3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:Cell differentiation protein RCD1 homolog,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,turn,
215024_at, 208310_s_at, 201973_s_at	CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated(CCZ1B)	Homo sapiens				GO:0016192~vesicle-mediated transport,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0016235~aggresome,GO:0031988~membrane-bounded vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR013176:Protein of unknown function DUF1712, fungi,					Acetylation,Complete proteome,Guanine-nucleotide releasing factor,Lysosome,Membrane,Phosphoprotein,Reference proteome,	chain:UPF0550 protein C7orf28,modified residue,sequence conflict,
201974_s_at	CCZ1 homolog, vacuolar protein trafficking and biogenesis associated(CCZ1)	Homo sapiens				GO:0016192~vesicle-mediated transport,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0016235~aggresome,GO:0031988~membrane-bounded vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR013176:Protein of unknown function DUF1712, fungi,					Acetylation,Complete proteome,Guanine-nucleotide releasing factor,Lysosome,Membrane,Phosphoprotein,Reference proteome,	chain:UPF0550 protein C7orf28,modified residue,sequence conflict,
207167_at	CD101 molecule(CD101)	Homo sapiens				GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0007166~cell surface receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0016812~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,	IPR002195:Dihydroorotase, conserved site,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Immunoglobulin superfamily member 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:EWI motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201743_at	CD14 molecule(CD14)	Homo sapiens	136.CG1,137.Apoptotic_and_Phagocytotic_cell surfaces,73.Integrins_and_other_cell-surface_receptors,8.MonocytesIFNF_IL4,88.Alternatively_Activated_APC,	H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_tollPathway:Toll-Like Receptor Pathway,		GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002756~MyD88-independent toll-like receptor signaling pathway,GO:0006898~receptor-mediated endocytosis,GO:0006909~phagocytosis,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0009408~response to heat,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032026~response to magnesium ion,GO:0032481~positive regulation of type I interferon production,GO:0032729~positive regulation of interferon-gamma production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034128~negative regulation of MyD88-independent toll-like receptor signaling pathway,GO:0034142~toll-like receptor 4 signaling pathway,GO:0034612~response to tumor necrosis factor,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway,GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway,GO:0045087~innate immune response,GO:0045471~response to ethanol,GO:0045807~positive regulation of endocytosis,GO:0050715~positive regulation of cytokine secretion,GO:0051602~response to electrical stimulus,GO:0070266~necroptotic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071726~cellular response to diacyl bacterial lipopeptide,GO:0071727~cellular response to triacyl bacterial lipopeptide,GO:0097190~apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0031362~anchored component of external side of plasma membrane,GO:0045121~membrane raft,GO:0046696~lipopolysaccharide receptor complex,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0001847~opsonin receptor activity,GO:0005515~protein binding,GO:0016019~peptidoglycan receptor activity,GO:0070891~lipoteichoic acid binding,	IPR001611:Leucine-rich repeat,IPR016337:Monocyte differentiation antigen CD14,	hsa04010:MAPK signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04145:Phagosome,hsa04620:Toll-like receptor signaling pathway,hsa04640:Hematopoietic cell lineage,hsa05130:Pathogenic Escherichia coli infection,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,		PIRSF002017:monocyte differentiation antigen CD14,		3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Golgi apparatus,GPI-anchor,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Monocyte differentiation antigen CD14, membrane-bound form,chain:Monocyte differentiation antigen CD14, urinary form,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,
204306_s_at	CD151 molecule (Raph blood group)(CD151)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0016477~cell migration,GO:0031581~hemidesmosome assembly,GO:0042098~T cell proliferation,	GO:0005604~basement membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,		179620~Blood group, Raph,609057~Nephropathy with pretibial epidermolysis bullosa and deafness,	PIRSF002419:tetraspanin,		Blood group antigen,Complete proteome,Deafness,Epidermolysis bullosa,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CD151 antigen,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207840_at	CD160 molecule(CD160)	Homo sapiens				GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0050776~regulation of immune response,GO:0050829~defense response to Gram-negative bacterium,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032393~MHC class I receptor activity,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,	chain:CD160 antigen,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,
203645_s_at, 216233_at, 215049_x_at	CD163 molecule(CD163)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006953~acute-phase response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,	GO:0005044~scavenger receptor activity,GO:0005515~protein binding,	IPR001190:Speract/scavenger receptor,IPR017448:Speract/scavenger receptor-related,				SM00202:SR,	Acute phase,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Inflammatory response,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Scavenger receptor cysteine-rich type 1 protein M130,chain:Soluble CD163,disulfide bond,domain:SRCR 1,domain:SRCR 2,domain:SRCR 3,domain:SRCR 4,domain:SRCR 5,domain:SRCR 6,domain:SRCR 7,domain:SRCR 8,domain:SRCR 9,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence variant,short sequence motif:Internalization signal,signal peptide,site:Cleavage; in calcium-free condition,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208653_s_at, 208405_s_at, 208654_s_at	CD164 molecule(CD164)	Homo sapiens				GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007162~negative regulation of cell adhesion,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0007517~muscle organ development,GO:0008285~negative regulation of cell proliferation,GO:0030097~hemopoiesis,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR007947:CD164-related protein,	hsa04142:Lysosome,				Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Endosome,Glycoprotein,Lysosome,Membrane,Myogenesis,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Sialomucin core protein 24,compositionally biased region:Thr-rich,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),region of interest:Required for endosomal and lysosomal localization,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219669_at	CD177 molecule(CD177)	Homo sapiens				GO:0007596~blood coagulation,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR016054:Ly-6 antigen / uPA receptor -like,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:CD177 antigen,domain:UPAR/Ly6 1,domain:UPAR/Ly6 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,
206206_at	CD180 molecule(CD180)	Homo sapiens				GO:0002224~toll-like receptor signaling pathway,GO:0002322~B cell proliferation involved in immune response,GO:0006954~inflammatory response,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0045087~innate immune response,GO:0071222~cellular response to lipopolysaccharide,	GO:0005887~integral component of plasma membrane,	GO:0004872~receptor activity,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD180 antigen,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206398_s_at	CD19 molecule(CD19)	Homo sapiens	78.B_Cell_Development,			GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0031052~chromosome breakage,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050776~regulation of immune response,GO:0050853~B cell receptor signaling pathway,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05340:Primary immunodeficiency,	613493~Immunodeficiency, common variable, 3,		SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:B-lymphocyte antigen CD19,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210325_at	CD1a molecule(CD1A)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Adaptive immunity,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:Glycolipid,chain:T-cell surface glycoprotein CD1a,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Glycolipid binding,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206749_at	CD1b molecule(CD1B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0050776~regulation of immune response,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Immunity,Immunoglobulin domain,Lysosome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD1b,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,short sequence motif:Internalization signal,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205987_at	CD1c molecule(CD1C)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002286~T cell activation involved in immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0050776~regulation of immune response,	GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,	GO:0030881~beta-2-microglobulin binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0051861~glycolipid binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Adaptive immunity,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Immunity,Immunoglobulin domain,Lipid-binding,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD1c,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Internalization signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205789_at	CD1d molecule(CD1D)	Homo sapiens				GO:0016032~viral process,GO:0016045~detection of bacterium,GO:0034113~heterotypic cell-cell adhesion,GO:0042102~positive regulation of T cell proliferation,GO:0045058~T cell selection,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016323~basolateral plasma membrane,	GO:0004872~receptor activity,GO:0030881~beta-2-microglobulin binding,GO:0030882~lipid antigen binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0042393~histone binding,GO:0050839~cell adhesion molecule binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Host-virus interaction,Immunity,Immunoglobulin domain,Innate immunity,Lysosome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:Glycolipid,chain:T-cell surface glycoprotein CD1d,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence variant,short sequence motif:Internalization signal,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
215784_at, 208592_s_at	CD1e molecule(CD1E)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043202~lysosomal lumen,	GO:0030881~beta-2-microglobulin binding,GO:0030883~endogenous lipid antigen binding,GO:0030884~exogenous lipid antigen binding,GO:0071723~lipopeptide binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00407:IGc1,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Immunity,Immunoglobulin domain,Lipid-binding,Lysosome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:T-cell surface glycoprotein CD1e, membrane-associated,chain:T-cell surface glycoprotein CD1e, soluble,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),propeptide:Removed in sCD1e,sequence conflict,sequence variant,signal peptide,splice variant,transmembrane region,
203593_at	CD2 associated protein(CD2AP)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006930~substrate-dependent cell migration, cell extension,GO:0007010~cytoskeleton organization,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0016050~vesicle organization,GO:0016337~single organismal cell-cell adhesion,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:1900182~positive regulation of protein localization to nucleus,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0030139~endocytic vesicle,GO:0031941~filamentous actin,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,	hsa05100:Bacterial invasion of epithelial cells,	607832~Glomerulosclerosis, focal segmental, 3,		SM00326:SH3,	3D-structure,Cell cycle,Cell division,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mitosis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3 domain,SH3-binding,Ubl conjugation,	chain:CD2-associated protein,compositionally biased region:Pro-rich,domain:SH3 1; truncated,domain:SH3 2,domain:SH3 3,helix,modified residue,region of interest:Interaction with ANLN and localization to the midbody,sequence variant,short sequence motif:SH3-binding,strand,turn,
202257_s_at, 202256_at	CD2 cytoplasmic tail binding protein 2(CD2BP2)	Homo sapiens				GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0010923~negative regulation of phosphatase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,	IPR003169:GYF,				SM00444:GYF,	3D-structure,Acetylation,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:CD2 antigen cytoplasmic tail-binding protein 2,domain:GYF,helix,modified residue,sequence variant,strand,
205831_at	CD2 molecule(CD2)	Homo sapiens	150.caspase_and_NFKB_activation,7.IL17_hematopoesis,81.Structure_of_Caps_and_SMACs,90.IB_and-cat-Arm_processing_of_Ci,99.NF-kB_activation,	h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,		GO:0001766~membrane raft polarization,GO:0006915~apoptotic process,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0030101~natural killer cell activation,GO:0030887~positive regulation of myeloid dendritic cell activation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034113~heterotypic cell-cell adhesion,GO:0042110~T cell activation,GO:0045580~regulation of T cell differentiation,GO:0050900~leukocyte migration,GO:1902715~positive regulation of interferon-gamma secretion,GO:2000484~positive regulation of interleukin-8 secretion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR007110:Immunoglobulin-like domain,IPR008424:Immunoglobulin C2-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR015632:T-cell adhesion molecule CD2,	hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,				3D-structure,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface antigen CD2,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,region of interest:LFA-3 (CD58) binding region 1,region of interest:LFA-3 (CD58) binding region 2,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
209583_s_at, 209582_s_at	CD200 molecule(CD200)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0043031~negative regulation of macrophage activation,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:OX-2 membrane glycoprotein,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220428_at	CD207 molecule(CD207)	Homo sapiens				GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006898~receptor-mediated endocytosis,GO:0051607~defense response to virus,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030139~endocytic vesicle,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031901~early endosome membrane,	GO:0005537~mannose binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,		613393~Birbeck granule deficiency,		SM00034:CLECT,	3D-structure,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member K,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
207278_s_at, 207277_at	CD209 molecule(CD209)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0006897~endocytosis,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0009988~cell-cell recognition,GO:0019048~modulation by virus of host morphology or physiology,GO:0019062~virion attachment to host cell,GO:0019079~viral genome replication,GO:0019882~antigen processing and presentation,GO:0035556~intracellular signal transduction,GO:0042129~regulation of T cell proliferation,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,GO:0046968~peptide antigen transport,GO:0075733~intracellular transport of virus,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0005515~protein binding,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0042605~peptide antigen binding,GO:0046790~virion binding,GO:0046872~metal ion binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,hsa05162:Measles,	607948~Mycobacterium tuberculosis, susceptibility to,609423~HIV type 1, susceptibility to,614371~Dengue fever, protection against,		SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Calcium,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lectin,Mannose-binding,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:CD209 antigen,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,mutagenesis site,region of interest:7 X approximate tandem repeats,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,sequence variant,short sequence motif:Endocytosis signal,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
220674_at, 38521_at, 204581_at, 217422_s_at	CD22 molecule(CD22)	Homo sapiens				GO:0006955~immune response,GO:0007155~cell adhesion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Isopeptide bond,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	binding site:Sialic acid,chain:B-cell receptor CD22,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207315_at	CD226 molecule(CD226)	Homo sapiens				GO:0001816~cytokine production,GO:0002729~positive regulation of natural killer cell cytokine production,GO:0002860~positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0002891~positive regulation of immunoglobulin mediated immune response,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0008037~cell recognition,GO:0032729~positive regulation of interferon-gamma production,GO:0033005~positive regulation of mast cell activation,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,GO:0060369~positive regulation of Fc receptor mediated stimulatory signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0004872~receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD226 antigen,compositionally biased region:Poly-Arg,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209771_x_at, 209772_s_at, 216379_x_at, 208650_s_at, 266_s_at, 208651_x_at	CD24 molecule(CD24)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001775~cell activation,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0007155~cell adhesion,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0016055~Wnt signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0030856~regulation of epithelial cell differentiation,GO:0031295~T cell costimulation,GO:0032597~B cell receptor transport into membrane raft,GO:0032600~chemokine receptor transport out of membrane raft,GO:0032913~negative regulation of transforming growth factor beta3 production,GO:0042104~positive regulation of activated T cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042632~cholesterol homeostasis,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPK cascade,GO:0043627~response to estrogen,GO:0045730~respiratory burst,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072139~glomerular parietal epithelial cell differentiation,GO:0097193~intrinsic apoptotic signaling pathway,GO:2000768~positive regulation of nephron tubule epithelial cell differentiation,	GO:0005622~intracellular,GO:0009986~cell surface,GO:0016020~membrane,GO:0031362~anchored component of external side of plasma membrane,GO:0045121~membrane raft,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030296~protein tyrosine kinase activator activity,		hsa04640:Hematopoietic cell lineage,				Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Reference proteome,Signal,	glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,peptide:Signal transducer CD24,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
220307_at	CD244 molecule(CD244)	Homo sapiens				GO:0001773~myeloid dendritic cell activation,GO:0002250~adaptive immune response,GO:0002323~natural killer cell activation involved in immune response,GO:0007165~signal transduction,GO:0032819~positive regulation of natural killer cell proliferation,GO:0045087~innate immune response,GO:0050900~leukocyte migration,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0071663~positive regulation of granzyme B production,GO:1902715~positive regulation of interferon-gamma secretion,GO:2000484~positive regulation of interleukin-8 secretion,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0042288~MHC class I protein binding,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR024303:Natural killer cell receptor 2B4 immunoglobulin domain,IPR024304:Natural killer cell receptor 2B4,	hsa04650:Natural killer cell mediated cytotoxicity,	180300~Rheumatoid arthritis, susceptibility to,			Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Natural killer cell receptor 2B4,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210031_at	CD247 molecule(CD247)	Homo sapiens		h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrmolecule:T Cell Receptor and CD3 Complex,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0007166~cell surface receptor signaling pathway,GO:0016032~viral process,GO:0031295~T cell costimulation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0042105~alpha-beta T cell receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR021663:T-cell surface glycoprotein CD3 zeta/eta subunit/High affinity IgE receptor gamma subunit,IPR024128:T-cell surface glycoprotein CD3 zeta/eta subunit,	hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),	610163~Immunodeficiency 25,		SM00077:ITAM,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Host-virus interaction,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 zeta chain,disulfide bond,domain:ITAM 1,domain:ITAM 2,domain:ITAM 3,helix,modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219025_at	CD248 molecule(CD248)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,			GO:0008284~positive regulation of cell proliferation,GO:0016477~cell migration,GO:0048535~lymph node development,GO:0060033~anatomical structure regression,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005578~proteinaceous extracellular matrix,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0050840~extracellular matrix binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018097:EGF-like calcium-binding, conserved site,				SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Endosialin,compositionally biased region:Pro-rich,disulfide bond,domain:C-type lectin,domain:EGF-like; calcium-binding,domain:Sushi,glycosylation site:O-linked (GalNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206150_at	CD27 molecule(CD27)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007420~brain development,GO:0008588~release of cytoplasmic sequestered NF-kappaB,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016064~immunoglobulin mediated immune response,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045471~response to ethanol,GO:0045579~positive regulation of B cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0046330~positive regulation of JNK cascade,GO:0070233~negative regulation of T cell apoptotic process,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022328:Tumour necrosis factor receptor 7,	hsa04060:Cytokine-cytokine receptor interaction,	615122~Lymphoproliferative syndrome 2,		SM00208:TNFR,	Apoptosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD27 antigen,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206545_at, 211856_x_at, 211861_x_at	CD28 molecule(CD28)	Homo sapiens	3.T_cell_receptor,50.Hypothesis_of_bronchial_asthma,55.Allergen_recognition_by_Th2_or_Th0_cell,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_th1th2Pathway:Th1/Th2 Differentiation,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0002863~positive regulation of inflammatory response to antigenic stimulus,GO:0006959~humoral immune response,GO:0007166~cell surface receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0031295~T cell costimulation,GO:0032733~positive regulation of interleukin-10 production,GO:0032753~positive regulation of interleukin-4 production,GO:0042089~cytokine biosynthetic process,GO:0042102~positive regulation of T cell proliferation,GO:0045060~negative thymic T cell selection,GO:0045066~regulatory T cell differentiation,GO:0045070~positive regulation of viral genome replication,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045589~regulation of regulatory T cell differentiation,GO:0045727~positive regulation of translation,GO:0045840~positive regulation of mitotic nuclear division,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0050690~regulation of defense response to virus by virus,GO:0050852~T cell receptor signaling pathway,GO:0051897~positive regulation of protein kinase B signaling,GO:0097190~apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0098636~protein complex involved in cell adhesion,	GO:0002020~protease binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR007110:Immunoglobulin-like domain,IPR008093:T cell antigen CD28,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05162:Measles,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00406:IGv,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell-specific surface glycoprotein CD28,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209933_s_at, 217078_s_at, 217072_at	CD300a molecule(CD300A)	Homo sapiens				GO:0002376~immune system process,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0030889~negative regulation of B cell proliferation,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0033007~negative regulation of mast cell activation involved in immune response,GO:0043305~negative regulation of mast cell degranulation,GO:0043407~negative regulation of MAP kinase activity,GO:0048147~negative regulation of fibroblast proliferation,GO:0050776~regulation of immune response,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050859~negative regulation of B cell receptor signaling pathway,GO:0051134~negative regulation of NK T cell activation,GO:0060101~negative regulation of phagocytosis, engulfment,GO:1902564~negative regulation of neutrophil activation,GO:1902567~negative regulation of eosinophil activation,GO:1902569~negative regulation of activation of JAK2 kinase activity,GO:2000417~negative regulation of eosinophil migration,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001786~phosphatidylserine binding,GO:0005515~protein binding,GO:0008429~phosphatidylethanolamine binding,GO:0038023~signaling receptor activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CMRF35-like molecule 8,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207270_x_at	CD300c molecule(CD300C)	Homo sapiens				GO:0002376~immune system process,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004888~transmembrane signaling receptor activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CMRF35-like molecule 6,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218529_at	CD320 molecule(CD320)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0009235~cobalamin metabolic process,GO:0015889~cobalamin transport,GO:0030656~regulation of vitamin metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008083~growth factor activity,GO:0015235~cobalamin transporter activity,GO:0031419~cobalamin binding,	IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,		613646~Methylmalonic aciduria due to transcobalamin receptor defect,		SM00192:LDLa,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth factor,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD320 antigen,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Pro,disulfide bond,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206120_at	CD33 molecule(CD33)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,		GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008285~negative regulation of cell proliferation,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	binding site:Sialic acid,chain:Myeloid cell surface antigen CD33,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209543_s_at	CD34 molecule(CD34)	Homo sapiens	7.IL17_hematopoesis,	h_il17Pathway:IL 17 Signaling Pathway,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,		GO:0001894~tissue homeostasis,GO:0001935~endothelial cell proliferation,GO:0003094~glomerular filtration,GO:0003158~endothelium development,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016337~single organismal cell-cell adhesion,GO:0030097~hemopoiesis,GO:0030195~negative regulation of blood coagulation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032733~positive regulation of interleukin-10 production,GO:0035759~mesangial cell-matrix adhesion,GO:0038001~paracrine signaling,GO:0042482~positive regulation of odontogenesis,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0048870~cell motility,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0060290~transdifferentiation,GO:0061042~vascular wound healing,GO:0071425~hematopoietic stem cell proliferation,GO:0071636~positive regulation of transforming growth factor beta production,GO:0071657~positive regulation of granulocyte colony-stimulating factor production,GO:0071971~extracellular exosome assembly,GO:0072011~glomerular endothelium development,GO:0072089~stem cell proliferation,GO:0072254~metanephric glomerular mesangial cell differentiation,GO:1900035~negative regulation of cellular response to heat,GO:1900038~negative regulation of cellular response to hypoxia,GO:1900041~negative regulation of interleukin-2 secretion,GO:1900168~positive regulation of glial cell-derived neurotrophic factor secretion,GO:1901215~negative regulation of neuron death,GO:2001214~positive regulation of vasculogenesis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009925~basal plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0036053~glomerular endothelium fenestra,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,	GO:0008134~transcription factor binding,GO:0030246~carbohydrate binding,GO:0043199~sulfate binding,	IPR008083:CD34 antigen,IPR013836:CD34/Podocalyxin,	hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,				Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Hematopoietic progenitor cell antigen CD34,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209555_s_at, 206488_s_at, 209554_at	CD36 molecule(CD36)	Homo sapiens		h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002576~platelet degranulation,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006629~lipid metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0006910~phagocytosis, recognition,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007263~nitric oxide mediated signal transduction,GO:0007596~blood coagulation,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010886~positive regulation of cholesterol storage,GO:0019915~lipid storage,GO:0019934~cGMP-mediated signaling,GO:0030194~positive regulation of blood coagulation,GO:0030299~intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0031623~receptor internalization,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033993~response to lipid,GO:0034197~triglyceride transport,GO:0034381~plasma lipoprotein particle clearance,GO:0034383~low-density lipoprotein particle clearance,GO:0035634~response to stilbenoid,GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway,GO:0042953~lipoprotein transport,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043277~apoptotic cell clearance,GO:0044130~negative regulation of growth of symbiont in host,GO:0044539~long-chain fatty acid import,GO:0050702~interleukin-1 beta secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050830~defense response to Gram-positive bacterium,GO:0050892~intestinal absorption,GO:0050909~sensory perception of taste,GO:0055096~low-density lipoprotein particle mediated signaling,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060907~positive regulation of macrophage cytokine production,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070508~cholesterol import,GO:0070542~response to fatty acid,GO:0070543~response to linoleic acid,GO:0071221~cellular response to bacterial lipopeptide,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0071447~cellular response to hydroperoxide,GO:0071726~cellular response to diacyl bacterial lipopeptide,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,GO:1990000~amyloid fibril formation,GO:2000121~regulation of removal of superoxide radicals,GO:2000334~positive regulation of blood microparticle formation,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000505~regulation of energy homeostasis,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030666~endocytic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0031526~brush border membrane,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0045335~phagocytic vesicle,	GO:0005041~low-density lipoprotein receptor activity,GO:0005515~protein binding,GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0030169~low-density lipoprotein particle binding,GO:0050431~transforming growth factor beta binding,GO:0070053~thrombospondin receptor activity,GO:0070892~lipoteichoic acid receptor activity,GO:0071813~lipoprotein particle binding,	IPR002159:CD36 antigen,IPR005428:Adhesion molecule CD36,	hsa03320:PPAR signaling pathway,hsa04145:Phagosome,hsa04152:AMPK signaling pathway,hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa04975:Fat digestion and absorption,hsa05144:Malaria,	608404~Platelet glycoprotein IV deficiency,610938~Coronary heart disease, susceptibility to, 7,611162~Malaria, cerebral, reduced risk of,611162~Malaria, cerebral, susceptibility to,Macrothrombocytopenia~Macrothrombocytopenia,			3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Isopeptide bond,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Platelet glycoprotein 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204192_at	CD37 molecule(CD37)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0007166~cell surface receptor signaling pathway,	GO:0001772~immunological synapse,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04640:Hematopoietic cell lineage,		PIRSF002419:tetraspanin,		Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leukocyte antigen CD37,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205692_s_at	CD38 molecule(CD38)	Homo sapiens				GO:0001666~response to hypoxia,GO:0007165~signal transduction,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007565~female pregnancy,GO:0030307~positive regulation of cell growth,GO:0030890~positive regulation of B cell proliferation,GO:0032024~positive regulation of insulin secretion,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032570~response to progesterone,GO:0033194~response to hydroperoxide,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0045779~negative regulation of bone resorption,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045907~positive regulation of vasoconstriction,GO:0050853~B cell receptor signaling pathway,GO:0060292~long term synaptic depression,GO:0070555~response to interleukin-1,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003953~NAD+ nucleosidase activity,GO:0016740~transferase activity,GO:0016849~phosphorus-oxygen lyase activity,GO:0050135~NAD(P)+ nucleosidase activity,	IPR003193:ADP-ribosyl cyclase (CD38/157),IPR016040:NAD(P)-binding domain,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04921:Oxytocin signaling pathway,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,				3D-structure,Alternative splicing,Complete proteome,Diabetes mellitus,Disulfide bond,Glycoprotein,Hydrolase,Membrane,NAD,NADP,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:ADP-ribosyl cyclase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
213539_at	CD3d molecule(CD3D)	Homo sapiens		h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrmolecule:T Cell Receptor and CD3 Complex,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,	General function prediction only,	GO:0007166~cell surface receptor signaling pathway,GO:0030217~T cell differentiation,GO:0031295~T cell costimulation,GO:0045059~positive thymic T cell selection,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0042105~alpha-beta T cell receptor complex,	GO:0003713~transcription coactivator activity,GO:0004888~transmembrane signaling receptor activity,GO:0046982~protein heterodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015484:CD3 protein, gamma/delta subunit,IPR015485:CD3 signaling complex delta subunit,	hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05162:Measles,hsa05166:HTLV-I infection,hsa05340:Primary immunodeficiency,	615617~Immunodeficiency 19,		SM00077:ITAM,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,SCID,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 delta chain,disulfide bond,domain:ITAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205264_at	CD3e molecule associated protein(CD3EAP)	Homo sapiens				GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009303~rRNA transcription,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0000120~RNA polymerase I transcription factor complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003899~DNA-directed RNA polymerase activity,GO:0044822~poly(A) RNA binding,	IPR013240:DNA-directed RNA polymerase I, subunit RPA34.5,					Acetylation,Alternative splicing,Chromosome,Complete proteome,DNA-directed RNA polymerase,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Ubl conjugation,	chain:DNA-directed RNA polymerase I subunit RPA34,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Lys,modified residue,sequence conflict,sequence variant,splice variant,
205456_at	CD3e molecule(CD3E)	Homo sapiens		h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrmolecule:T Cell Receptor and CD3 Complex,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0002669~positive regulation of T cell anergy,GO:0006461~protein complex assembly,GO:0007166~cell surface receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007172~signal complex assembly,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007584~response to nutrient,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0031295~T cell costimulation,GO:0032729~positive regulation of interferon-gamma production,GO:0032753~positive regulation of interleukin-4 production,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0042981~regulation of apoptotic process,GO:0045060~negative thymic T cell selection,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045879~negative regulation of smoothened signaling pathway,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050776~regulation of immune response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0097190~apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0042105~alpha-beta T cell receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0030159~receptor signaling complex scaffold activity,GO:0042608~T cell receptor binding,GO:0046982~protein heterodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003598:Immunoglobulin subtype 2,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015484:CD3 protein, gamma/delta subunit,	hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05162:Measles,hsa05166:HTLV-I infection,hsa05340:Primary immunodeficiency,	615615~Immunodeficiency 18,615615~Immunodeficiency 18, SCID variant,		SM00077:ITAM,SM00408:IGc2,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 epsilon chain,disulfide bond,domain:Ig-like,domain:ITAM,helix,modified residue,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206804_at	CD3g molecule(CD3G)	Homo sapiens		h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il17Pathway:IL 17 Signaling Pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrmolecule:T Cell Receptor and CD3 Complex,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0006461~protein complex assembly,GO:0007163~establishment or maintenance of cell polarity,GO:0007166~cell surface receptor signaling pathway,GO:0015031~protein transport,GO:0031295~T cell costimulation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042110~T cell activation,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,GO:0070228~regulation of lymphocyte apoptotic process,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0042105~alpha-beta T cell receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0030159~receptor signaling complex scaffold activity,GO:0042608~T cell receptor binding,GO:0046982~protein heterodimerization activity,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003598:Immunoglobulin subtype 2,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015484:CD3 protein, gamma/delta subunit,	hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05162:Measles,hsa05166:HTLV-I infection,	615607~Immunodeficiency 17, CD3 gamma deficient,		SM00077:ITAM,SM00408:IGc2,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD3 gamma chain,disulfide bond,domain:Ig-like,domain:ITAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence variant,short sequence motif:Di-leucine motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203547_at, 216424_at	CD4 molecule(CD4)	Homo sapiens	124.GH-IGF1_thymopoiesis,125.T_Cells_CNS-APCs,3.T_cell_receptor,50.Hypothesis_of_bronchial_asthma,54.T-cell_anergy,55.Allergen_recognition_by_Th2_or_Th0_cell,59.L-type_Ca2+_Tat_immune_cells,62.G1-phase_progression_by_Myc,63.LAT_couples_T-cell_receptor,67.Ikaros_and_signaling_inhibitors,7.IL17_hematopoesis,78.B_Cell_Development,81.Structure_of_Caps_and_SMACs,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_il17Pathway:IL 17 Signaling Pathway,h_il5Pathway:IL 5 Signaling Pathway,h_inflamPathway:Cytokines and Inflammatory Response,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stemPathway:Regulation of hematopoiesis by cytokines,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_thelperPathway:T Helper Cell Surface Molecules,h_vifPathway:HIV-1 defeats host-mediated resistance by CEM15,		GO:0001816~cytokine production,GO:0002250~adaptive immune response,GO:0006948~induction by virus of host cell-cell fusion,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0019064~fusion of virus membrane with host plasma membrane,GO:0030217~T cell differentiation,GO:0030260~entry into host cell,GO:0031295~T cell costimulation,GO:0032355~response to estradiol,GO:0032507~maintenance of protein location in cell,GO:0033280~response to vitamin D,GO:0035397~helper T cell enhancement of adaptive immune response,GO:0042102~positive regulation of T cell proliferation,GO:0045058~T cell selection,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045860~positive regulation of protein kinase activity,GO:0050690~regulation of defense response to virus by virus,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,	GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,GO:0045121~membrane raft,	GO:0001618~virus receptor activity,GO:0001948~glycoprotein binding,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015026~coreceptor activity,GO:0019865~immunoglobulin binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0042289~MHC class II protein binding,GO:0042803~protein homodimerization activity,GO:1990782~protein tyrosine kinase binding,	IPR000973:T-cell surface antigen CD4,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008424:Immunoglobulin C2-set,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR015274:CD4, extracellular,IPR021963:T cell CD4 receptor C-terminal region,	hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613949~OKT4 epitope deficiency,		SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Immunoglobulin domain,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD4,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,region of interest:HIV-1 Vpu-susceptibility domain,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
207892_at	CD40 ligand(CD40LG)	Homo sapiens	50.Hypothesis_of_bronchial_asthma,51.CD40_and_EBV,55.Allergen_recognition_by_Th2_or_Th0_cell,58.(CD40L)_immnosurveillance,76.Sig_trans_Ca2_Calcineurin_NF-AT,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_cd40Pathway:CD40L Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007159~leukocyte cell-cell adhesion,GO:0007257~activation of JUN kinase activity,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0031295~T cell costimulation,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032753~positive regulation of interleukin-4 production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042100~B cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045190~isotype switching,GO:0048305~immunoglobulin secretion,GO:0050776~regulation of immune response,GO:0051023~regulation of immunoglobulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005174~CD40 receptor binding,GO:0005515~protein binding,	IPR003263:Tumour necrosis factor ligand 5,IPR006052:Tumour necrosis factor,IPR008983:Tumour necrosis factor-like domain,IPR021184:Tumour necrosis factor, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05340:Primary immunodeficiency,hsa05416:Viral myocarditis,	308230~Immunodeficiency, X-linked, with hyper-IgM,	PIRSF016527:tumor necrosis factor ligand superfamily protein, CD40 ligand type,	SM00207:TNF,	3D-structure,Cell membrane,Complete proteome,Cytokine,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:CD40 ligand, membrane form,chain:CD40 ligand, soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...) (high mannose and complex),helix,modified residue,sequence variant,site:Cleavage,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
222292_at, 205153_s_at, 35150_at, 215346_at	CD40 molecule(CD40)	Homo sapiens	125.T_Cells_CNS-APCs,15.T-cell_polarization-chemokine_receptors,19.Cytokine_microglia,5.B7_CD40_B-cell_activa,50.Hypothesis_of_bronchial_asthma,55.Allergen_recognition_by_Th2_or_Th0_cell,58.(CD40L)_immnosurveillance,99.NF-kB_activation,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_cd40Pathway:CD40L Signaling Pathway,h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0001934~positive regulation of protein phosphorylation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006461~protein complex assembly,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007275~multicellular organism development,GO:0030168~platelet activation,GO:0030890~positive regulation of B cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0032735~positive regulation of interleukin-12 production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042832~defense response to protozoan,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0050776~regulation of immune response,GO:0051023~regulation of immunoglobulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,GO:0090037~positive regulation of protein kinase C signaling,GO:0097190~apoptotic signaling pathway,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0035631~CD40 receptor complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR020435:Tumour necrosis factor receptor 5,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04620:Toll-like receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05202:Transcriptional misregulation in cancer,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05340:Primary immunodeficiency,hsa05416:Viral myocarditis,	606843~Immunodeficiency with hyper-IgM, type 3,		SM00208:TNFR,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 5,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212014_x_at, 216056_at, 217523_at, 212063_at, 210916_s_at, 209835_x_at, 204490_s_at, 204489_s_at	CD44 molecule (Indian blood group)(CD44)	Homo sapiens	124.GH-IGF1_thymopoiesis,160.abT-cell_development,	h_lymphocytePathway:Adhesion Molecules on Lymphocyte,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,		GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030214~hyaluronan catabolic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033674~positive regulation of kinase activity,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0051216~cartilage development,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070487~monocyte aggregation,GO:1900625~positive regulation of monocyte aggregation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0035692~macrophage migration inhibitory factor receptor complex,GO:0070062~extracellular exosome,	GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0005540~hyaluronic acid binding,	IPR000538:Link,IPR001231:CD44 antigen,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa05131:Shigellosis,hsa05169:Epstein-Barr virus infection,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,	609027~Blood group, Indian system,		SM00445:LINK,	3D-structure,Alternative splicing,Blood group antigen,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Pyrrolidone carboxylic acid,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD44 antigen,compositionally biased region:Arg/Lys-rich (basic),disulfide bond,domain:Link,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Stem,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
211574_s_at, 207549_x_at, 208783_s_at	CD46 molecule(CD46)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002456~T cell mediated immunity,GO:0006508~proteolysis,GO:0006958~complement activation, classical pathway,GO:0007338~single fertilization,GO:0008593~regulation of Notch signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030449~regulation of complement activation,GO:0032613~interleukin-10 production,GO:0032733~positive regulation of interleukin-10 production,GO:0035581~sequestering of extracellular ligand from receptor,GO:0042102~positive regulation of T cell proliferation,GO:0043086~negative regulation of catalytic activity,GO:0043382~positive regulation of memory T cell differentiation,GO:0045087~innate immune response,GO:0045591~positive regulation of regulatory T cell differentiation,GO:0045916~negative regulation of complement activation,GO:0046718~viral entry into host cell,GO:0071636~positive regulation of transforming growth factor beta production,	GO:0002079~inner acrosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001848~complement binding,GO:0004175~endopeptidase activity,GO:0004857~enzyme inhibitor activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0045296~cadherin binding,	IPR000436:Sushi/SCR/CCP,IPR017341:Membrane cofactor protein, CD46,	hsa04610:Complement and coagulation cascades,hsa05162:Measles,	612922~Hemolytic uremic syndrome, atypical, susceptibility to, 2,	PIRSF037971:membrane cofactor protein, CD46 type,	SM00032:CCP,	3D-structure,Alternative splicing,Complement pathway,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Disulfide bond,Fertilization,Glycoprotein,Hemolytic uremic syndrome,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Membrane cofactor protein,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
213857_s_at, 211075_s_at, 213856_at, 213055_at	CD47 molecule(CD47)	Homo sapiens	66.Prot_Interac_w_integrin_domains,72.IAP_interaction_with_cell_death_pathways,74.CD47-IAP_with_avB3,83.Growth_factors_Survival_factors_Mitogens,			GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008228~opsonization,GO:0008284~positive regulation of cell proliferation,GO:0009617~response to bacterium,GO:0022409~positive regulation of cell-cell adhesion,GO:0030198~extracellular matrix organization,GO:0050729~positive regulation of inflammatory response,GO:0050766~positive regulation of phagocytosis,GO:0050870~positive regulation of T cell activation,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0070053~thrombospondin receptor activity,	IPR006704:Leukocyte surface antigen CD47,IPR007110:Immunoglobulin-like domain,IPR013147:CD47 transmembrane,IPR013270:CD47 immunoglobulin-like,IPR013783:Immunoglobulin-like fold,	hsa04512:ECM-receptor interaction,				3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Leukocyte surface antigen CD47,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204118_at	CD48 molecule(CD48)	Homo sapiens				GO:0002819~regulation of adaptive immune response,GO:0006952~defense response,GO:0007165~signal transduction,GO:0042110~T cell activation,GO:0045576~mast cell activation,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004872~receptor activity,GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04650:Natural killer cell mediated cytotoxicity,			SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD48 antigen,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,strand,turn,
206680_at	CD5 molecule like(CD5L)	Homo sapiens				GO:0002376~immune system process,GO:0006898~receptor-mediated endocytosis,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006968~cellular defense response,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005044~scavenger receptor activity,	IPR001190:Speract/scavenger receptor,IPR017448:Speract/scavenger receptor-related,				SM00202:SR,	Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Inflammatory response,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:CD5 antigen-like,disulfide bond,domain:SRCR 1,domain:SRCR 2,domain:SRCR 3,sequence conflict,sequence variant,signal peptide,
206485_at	CD5 molecule(CD5)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,		GO:0006898~receptor-mediated endocytosis,GO:0008037~cell recognition,GO:0008283~cell proliferation,GO:0031295~T cell costimulation,GO:0097190~apoptotic signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,	IPR001190:Speract/scavenger receptor,IPR003566:T-cell surface glycoprotein CD5,IPR017448:Speract/scavenger receptor-related,	hsa04640:Hematopoietic cell lineage,			SM00202:SR,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD5,disulfide bond,domain:SRCR 1,domain:SRCR 2,domain:SRCR 3,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
34210_at, 204661_at	CD52 molecule(CD52)	Homo sapiens				GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0045730~respiratory burst,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,		IPR026643:CAMPATH-1 antigen  (CD52),					Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,peptide:CAMPATH-1 antigen,propeptide:Removed in mature form,sequence variant,signal peptide,
203416_at	CD53 molecule(CD53)	Homo sapiens				GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:1901741~positive regulation of myoblast fusion,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,			PIRSF002419:tetraspanin,		Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Leukocyte surface antigen CD53,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201925_s_at, 201926_s_at	CD55 molecule (Cromer blood group)(CD55)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006958~complement activation, classical pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007283~spermatogenesis,GO:0030449~regulation of complement activation,GO:0031664~regulation of lipopolysaccharide-mediated signaling pathway,GO:0035743~CD4-positive, alpha-beta T cell cytokine production,GO:0043434~response to peptide hormone,GO:0045087~innate immune response,GO:0045730~respiratory burst,GO:0045916~negative regulation of complement activation,GO:0046718~viral entry into host cell,GO:0060137~maternal process involved in parturition,GO:2000516~positive regulation of CD4-positive, alpha-beta T cell activation,GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0030133~transport vesicle,GO:0031225~anchored component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa05416:Viral myocarditis,	613793~Blood group Cromer,		SM00032:CCP,	3D-structure,Alternative splicing,Blood group antigen,Cell membrane,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement decay-accelerating factor,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
216942_s_at, 205173_x_at, 222061_at, 216322_at, 211744_s_at	CD58 molecule(CD58)	Homo sapiens	7.IL17_hematopoesis,	h_il17Pathway:IL 17 Signaling Pathway,		GO:0007155~cell adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0034113~heterotypic cell-cell adhesion,GO:0050900~leukocyte migration,GO:0071346~cellular response to interferon-gamma,GO:0071356~cellular response to tumor necrosis factor,GO:2000484~positive regulation of interleukin-8 secretion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015714:Lymphocyte function associated antigen 3,	hsa04514:Cell adhesion molecules (CAMs),hsa05169:Epstein-Barr virus infection,				3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Lymphocyte function-associated antigen 3,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
200984_s_at, 212463_at, 200985_s_at, 200983_x_at	CD59 molecule(CD59)	Homo sapiens				GO:0001775~cell activation,GO:0001971~negative regulation of activation of membrane attack complex,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007166~cell surface receptor signaling pathway,GO:0007596~blood coagulation,GO:0030449~regulation of complement activation,GO:0042102~positive regulation of T cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0031362~anchored component of external side of plasma membrane,GO:0031982~vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0042383~sarcolemma,GO:0043218~compact myelin,GO:0070062~extracellular exosome,	GO:0001848~complement binding,GO:0005515~protein binding,	IPR016054:Ly-6 antigen / uPA receptor -like,IPR018363:CD59 antigen, conserved site,IPR027101:CD59 glycoprotein,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,	612300~Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy,		SM00134:LU,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycation,Glycoprotein,GPI-anchor,Hereditary hemolytic anemia,Lipoprotein,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,	chain:CD59 glycoprotein,disulfide bond,domain:UPAR/Ly6,glycosylation site:N-linked (Glc) (glycation),glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated asparagine,modified residue,mutagenesis site,propeptide:Removed in mature form,signal peptide,strand,
211900_x_at, 211893_x_at, 208602_x_at, 213958_at	CD6 molecule(CD6)	Homo sapiens				GO:0001771~immunological synapse formation,GO:0002250~adaptive immune response,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0006898~receptor-mediated endocytosis,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0042102~positive regulation of T cell proliferation,GO:0045087~innate immune response,GO:1900017~positive regulation of cytokine production involved in inflammatory response,	GO:0001772~immunological synapse,GO:0005576~extracellular region,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0042101~T cell receptor complex,	GO:0001530~lipopolysaccharide binding,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0070891~lipoteichoic acid binding,	IPR001190:Speract/scavenger receptor,IPR017448:Speract/scavenger receptor-related,	hsa04514:Cell adhesion molecules (CAMs),			SM00202:SR,	3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:T-cell differentiation antigen CD6,disulfide bond,domain:SRCR 1,domain:SRCR 2,domain:SRCR 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
200663_at	CD63 molecule(CD63)	Homo sapiens	57.Post-Golgi&endo_trans_MHC_class_II,73.Integrins_and_other_cell-surface_receptors,			GO:0002092~positive regulation of receptor internalization,GO:0002576~platelet degranulation,GO:0007160~cell-matrix adhesion,GO:0015031~protein transport,GO:0016477~cell migration,GO:0034613~cellular protein localization,GO:0035646~endosome to melanosome transport,GO:0048757~pigment granule maturation,GO:0050931~pigment cell differentiation,GO:1900746~regulation of vascular endothelial growth factor signaling pathway,GO:2000680~regulation of rubidium ion transport,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031088~platelet dense granule membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031902~late endosome membrane,GO:0031904~endosome lumen,GO:0032585~multivesicular body membrane,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:0097487~multivesicular body, internal vesicle,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04142:Lysosome,hsa05205:Proteoglycans in cancer,		PIRSF002419:tetraspanin,		Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Endosome,Glycoprotein,Lipoprotein,Lysosome,Membrane,Palmitate,Protein transport,Proteomics identification,Reference proteome,Secreted,Transmembrane,Transmembrane helix,Transport,	chain:CD63 antigen,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209795_at	CD69 molecule(CD69)	Homo sapiens	60.IL-15_rheumatoid-arthritis_synovitis,			GO:0007165~signal transduction,GO:0035690~cellular response to drug,	GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Early activation antigen CD69,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214551_s_at, 214049_x_at	CD7 molecule(CD7)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,		GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0042110~T cell activation,GO:0048873~homeostasis of number of cells within a tissue,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04640:Hematopoietic cell lineage,			SM00406:IGv,SM00409:IG,	Adaptive immunity,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell antigen CD7,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,region of interest:4 X 9 AA tandem repeats, potential spacer function,repeat:1,repeat:2,repeat:3,repeat:4,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206508_at	CD70 molecule(CD70)	Homo sapiens				GO:0006955~immune response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008283~cell proliferation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,	IPR006052:Tumour necrosis factor,IPR008983:Tumour necrosis factor-like domain,IPR021184:Tumour necrosis factor, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,			SM00207:TNF,	Alternative splicing,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:CD70 antigen,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215925_s_at	CD72 molecule(CD72)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04662:B cell receptor signaling pathway,			SM00034:CLECT,	Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:B-cell differentiation antigen CD72,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209619_at	CD74 molecule(CD74)	Homo sapiens		h_mhcPathway:Antigen Processing and Presentation,		GO:0000187~activation of MAPK activity,GO:0001516~prostaglandin biosynthetic process,GO:0001961~positive regulation of cytokine-mediated signaling pathway,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0002792~negative regulation of peptide secretion,GO:0002830~positive regulation of type 2 immune response,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006461~protein complex assembly,GO:0006886~intracellular protein transport,GO:0006952~defense response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0016064~immunoglobulin mediated immune response,GO:0019882~antigen processing and presentation,GO:0019883~antigen processing and presentation of endogenous antigen,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030890~positive regulation of B cell proliferation,GO:0035691~macrophage migration inhibitory factor signaling pathway,GO:0043030~regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045058~T cell selection,GO:0045059~positive thymic T cell selection,GO:0045060~negative thymic T cell selection,GO:0045581~negative regulation of T cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0048146~positive regulation of fibroblast proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0060907~positive regulation of macrophage cytokine production,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090023~positive regulation of neutrophil chemotaxis,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005765~lysosomal membrane,GO:0005771~multivesicular body,GO:0005773~vacuole,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0035692~macrophage migration inhibitory factor receptor complex,GO:0035693~NOS2-CD74 complex,GO:0042613~MHC class II protein complex,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0001540~beta-amyloid binding,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0019955~cytokine binding,GO:0023026~MHC class II protein complex binding,GO:0035718~macrophage migration inhibitory factor binding,GO:0042289~MHC class II protein binding,GO:0042658~MHC class II protein binding, via antigen binding groove,GO:0042802~identical protein binding,GO:0044183~protein binding involved in protein folding,GO:0050998~nitric-oxide synthase binding,	IPR000716:Thyroglobulin type-1,IPR011988:MHC class II-associated invariant chain, trimerisation,IPR015386:MHC class II-associated invariant chain/CLIP, MHC II-interacting,IPR022339:MHC class II-associated invariant chain,	hsa04612:Antigen processing and presentation,hsa05152:Tuberculosis,hsa05168:Herpes simplex infection,		PIRSF001992:HLA class II histocompatibility antigen, gamma subunit,	SM00211:TY,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Chaperone,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Lysosome,Membrane,Phosphoprotein,Proteoglycan,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen gamma chain,disulfide bond,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (glycosaminoglycan),helix,modified residue,region of interest:CLIP,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205049_s_at	CD79a molecule(CD79A)	Homo sapiens	5.B7_CD40_B-cell_activa,79.B_cell_Activation,	h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0030183~B cell differentiation,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0050853~B cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005771~multivesicular body,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0019815~B cell receptor complex,GO:0045121~membrane raft,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613501~Agammaglobulinemia 3,		SM00077:ITAM,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein alpha chain,disulfide bond,domain:Ig-like C2-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,signal peptide,site:Required for binding to BLNK,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205297_s_at	CD79b molecule(CD79B)	Homo sapiens		h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0030183~B cell differentiation,GO:0050853~B cell receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0019815~B cell receptor complex,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,	612692~Agammaglobulinemia 6,		SM00077:ITAM,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein beta chain,disulfide bond,domain:Ig-like V-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207176_s_at	CD80 molecule(CD80)	Homo sapiens	3.T_cell_receptor,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,		GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0031295~T cell costimulation,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045425~positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0046718~viral entry into host cell,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0071222~cellular response to lipopolysaccharide,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0098636~protein complex involved in cell adhesion,	GO:0001618~virus receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04620:Toll-like receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:T-lymphocyte activation antigen CD80,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
200675_at	CD81 molecule(CD81)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0000187~activation of MAPK activity,GO:0007166~cell surface receptor signaling pathway,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0031623~receptor internalization,GO:0031647~regulation of protein stability,GO:0043128~positive regulation of 1-phosphatidylinositol 4-kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046718~viral entry into host cell,GO:0046813~receptor-mediated virion attachment to host cell,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050776~regulation of immune response,GO:0061462~protein localization to lysosome,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:1904352~positive regulation of protein catabolic process in the vacuole,GO:2000145~regulation of cell motility,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0023026~MHC class II protein complex binding,GO:1990459~transferrin receptor binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04662:B cell receptor signaling pathway,hsa05144:Malaria,hsa05160:Hepatitis C,	613496~Immunodeficiency, common variable, 6,	PIRSF002419:tetraspanin,		3D-structure,Complete proteome,Disulfide bond,Host-virus interaction,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD81 antigen,disulfide bond,helix,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203904_x_at	CD82 molecule(CD82)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0007166~cell surface receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04115:p53 signaling pathway,	176807~Prostate cancer, susceptibility to,	PIRSF002419:tetraspanin,		Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD82 antigen,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204440_at	CD83 molecule(CD83)	Homo sapiens				GO:0001817~regulation of cytokine production,GO:0006952~defense response,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0014070~response to organic cyclic compound,GO:0032713~negative regulation of interleukin-4 production,GO:0032733~positive regulation of interleukin-10 production,GO:0032743~positive regulation of interleukin-2 production,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD83 antigen,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211190_x_at, 211191_at, 211189_x_at, 211192_s_at, 211188_at, 205988_at	CD84 molecule(CD84)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006952~defense response,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0032685~negative regulation of granulocyte macrophage colony-stimulating factor production,GO:0032701~negative regulation of interleukin-18 production,GO:0033004~negative regulation of mast cell activation,GO:0043305~negative regulation of mast cell degranulation,GO:0045087~innate immune response,GO:0050900~leukocyte migration,GO:2001256~regulation of store-operated calcium entry,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 5,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:ITSM motif 1,short sequence motif:ITSM motif 2,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
210895_s_at, 205686_s_at, 205685_at	CD86 molecule(CD86)	Homo sapiens	3.T_cell_receptor,97.Immune_injury_MS-lesions_MS_antigen,	h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_th1th2Pathway:Th1/Th2 Differentiation,		GO:0001878~response to yeast,GO:0002250~adaptive immune response,GO:0002309~T cell proliferation involved in immune response,GO:0002668~negative regulation of T cell anergy,GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0031295~T cell costimulation,GO:0034138~toll-like receptor 3 signaling pathway,GO:0034341~response to interferon-gamma,GO:0042104~positive regulation of activated T cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042493~response to drug,GO:0043011~myeloid dendritic cell differentiation,GO:0043017~positive regulation of lymphotoxin A biosynthetic process,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045404~positive regulation of interleukin-4 biosynthetic process,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046718~viral entry into host cell,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0051607~defense response to virus,GO:0071222~cellular response to lipopolysaccharide,GO:0071248~cellular response to metal ion,GO:0071345~cellular response to cytokine stimulus,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04620:Toll-like receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05202:Transcriptional misregulation in cancer,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00406:IGv,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:T-lymphocyte activation antigen CD86,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205758_at	CD8a molecule(CD8A)	Homo sapiens	124.GH-IGF1_thymopoiesis,58.(CD40L)_immnosurveillance,59.L-type_Ca2+_Tat_immune_cells,67.Ikaros_and_signaling_inhibitors,7.IL17_hematopoesis,78.B_Cell_Development,81.Structure_of_Caps_and_SMACs,97.Immune_injury_MS-lesions_MS_antigen,	h_il17Pathway:IL 17 Signaling Pathway,h_stemPathway:Regulation of hematopoiesis by cytokines,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,		GO:0002456~T cell mediated immunity,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0019882~antigen processing and presentation,GO:0042110~T cell activation,GO:0045065~cytotoxic T cell differentiation,GO:0050776~regulation of immune response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0042101~T cell receptor complex,	GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0019901~protein kinase binding,GO:0042288~MHC class I protein binding,GO:0042803~protein homodimerization activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR015468:CD8 alpha subunit,	hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	608957~CD8 deficiency, familial,		SM00406:IGv,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Immunity,Immunoglobulin domain,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD8 alpha chain,disulfide bond,domain:Ig-like V-type,helix,mutagenesis site,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
215332_s_at, 207979_s_at	CD8b molecule(CD8B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0042110~T cell activation,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0042101~T cell receptor complex,	GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0042288~MHC class I protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,			SM00406:IGv,SM00409:IG,	Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD8 beta chain,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201005_at	CD9 molecule(CD9)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0002576~platelet degranulation,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007342~fusion of sperm to egg plasma membrane,GO:0007420~brain development,GO:0008285~negative regulation of cell proliferation,GO:0009414~response to water deprivation,GO:0014003~oligodendrocyte development,GO:0030168~platelet activation,GO:0030913~paranodal junction assembly,GO:0031623~receptor internalization,GO:0071404~cellular response to low-density lipoprotein particle stimulus,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04640:Hematopoietic cell lineage,		PIRSF002419:tetraspanin,		Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Fertilization,Glycoprotein,Lipoprotein,Membrane,Palmitate,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CD9 antigen,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202878_s_at, 202877_s_at	CD93 molecule(CD93)	Homo sapiens				GO:0006909~phagocytosis,GO:0016032~viral process,GO:0016337~single organismal cell-cell adhesion,GO:0042116~macrophage activation,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031012~extracellular matrix,	GO:0001849~complement component C1q binding,GO:0004872~receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,	Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Host-virus interaction,Lectin,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:C1q receptor protein,chain:Complement component C1q receptor,disulfide bond,domain:C-type lectin,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206761_at	CD96 molecule(CD96)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0002534~cytokine production involved in inflammatory response,GO:0002728~negative regulation of natural killer cell cytokine production,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0032496~response to lipopolysaccharide,GO:0032689~negative regulation of interferon-gamma production,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,		211750~C syndrome,		SM00409:IG,	Alternative splicing,Cell adhesion,Chromosomal rearrangement,Complete proteome,Craniosynostosis,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface protein tactile,compositionally biased region:Pro-rich,compositionally biased region:Pro/Ser/Thr-rich,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201029_s_at, 201028_s_at	CD99 molecule(CD99)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,		IPR022078:CD99 antigen-like protein 2,	hsa04514:Cell adhesion molecules (CAMs),hsa04670:Leukocyte transendothelial migration,				Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:CD99 antigen,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214683_s_at	CDC like kinase 1(CLK1)	Homo sapiens				GO:0008283~cell proliferation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase CLK1,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
203229_s_at	CDC like kinase 2(CLK2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0010212~response to ionizing radiation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032526~response to retinoic acid,GO:0043484~regulation of RNA splicing,GO:0045721~negative regulation of gluconeogenesis,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase CLK2,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
202140_s_at	CDC like kinase 3(CLK3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0045111~intermediate filament cytoskeleton,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase CLK3,compositionally biased region:Arg-rich,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
210346_s_at	CDC like kinase 4(CLK4)	Homo sapiens				GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,	GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase CLK4,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,
201897_s_at	CDC28 protein kinase regulatory subunit 1B(CKS1B)	Homo sapiens		h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,		GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0044772~mitotic cell cycle phase transition,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005654~nucleoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR000789:Cyclin-dependent kinase, regulatory subunit,	hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,			SM01084:SM01084,	3D-structure,Acetylation,Cell cycle,Cell division,Complete proteome,Kinase,Proteomics identification,Reference proteome,Transferase,	chain:Cyclin-dependent kinases regulatory subunit 1,helix,strand,
204170_s_at	CDC28 protein kinase regulatory subunit 2(CKS2)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007127~meiosis I,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0044772~mitotic cell cycle phase transition,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0019005~SCF ubiquitin ligase complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR000789:Cyclin-dependent kinase, regulatory subunit,	hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,			SM01084:SM01084,	3D-structure,Acetylation,Cell cycle,Cell division,Complete proteome,Reference proteome,	chain:Cyclin-dependent kinases regulatory subunit 2,helix,modified residue,strand,
215296_at, 203794_at, 214464_at, 213595_s_at	CDC42 binding protein kinase alpha(CDC42BPA)	Homo sapiens			DNA replication, recombination, and repair,Function unknown,	GO:0006468~protein phosphorylation,GO:0016477~cell migration,GO:0031032~actomyosin structure organization,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005911~cell-cell junction,GO:0031252~cell leading edge,GO:0042641~actomyosin,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000095:PAK-box/P21-Rho-binding,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001180:Citron-like,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR014930:Myotonic dystrophy protein kinase, coiled coil,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,IPR020454:Diacylglycerol/phorbol-ester binding,IPR026611:Serine/threonine-protein kinase MRCK,				SM00036:CNH,SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,SM00285:PBD,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase MRCK alpha,domain:AGC-kinase C-terminal,domain:CNH,domain:CRIB,domain:PH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
217849_s_at	CDC42 binding protein kinase beta(CDC42BPB)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0016477~cell migration,GO:0031032~actomyosin structure organization,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0031252~cell leading edge,GO:0042641~actomyosin,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017048~Rho GTPase binding,GO:0046872~metal ion binding,	IPR000095:PAK-box/P21-Rho-binding,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001180:Citron-like,IPR001849:Pleckstrin homology domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR014930:Myotonic dystrophy protein kinase, coiled coil,IPR017441:Protein kinase, ATP binding site,IPR020454:Diacylglycerol/phorbol-ester binding,				SM00036:CNH,SM00109:C1,SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,SM00285:PBD,	3D-structure,ATP-binding,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Kinase,Magnesium,Membrane,Metal-binding,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase MRCK beta,domain:AGC-kinase C-terminal,domain:CNH,domain:CRIB,domain:PH,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
204693_at	CDC42 effector protein 1(CDC42EP1)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0043547~positive regulation of GTPase activity,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017049~GTP-Rho binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000095:PAK-box/P21-Rho-binding,				SM00285:PBD,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Cdc42 effector protein 1,domain:CRIB,modified residue,mutagenesis site,region of interest:8 X 7 AA tandem repeats of [PT]-[AT]-A- [ENT]-[PT]-[PTS]-[AG],repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,splice variant,
214014_at, 209850_s_at	CDC42 effector protein 2(CDC42EP2)	Homo sapiens				GO:0007015~actin filament organization,GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030036~actin cytoskeleton organization,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0031334~positive regulation of protein complex assembly,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,	GO:0001515~opioid peptide activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017049~GTP-Rho binding,	IPR000095:PAK-box/P21-Rho-binding,IPR017363:Cdc42 effector protein 2,			PIRSF038036:Cdc42 effector protein 2 (Binder of Rho GTPases 1),	SM00285:PBD,	Acetylation,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Reference proteome,	chain:Cdc42 effector protein 2,domain:CRIB,modified residue,mutagenesis site,sequence conflict,sequence variant,
209288_s_at, 209286_at, 209287_s_at	CDC42 effector protein 3(CDC42EP3)	Homo sapiens				GO:0007165~signal transduction,GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0015629~actin cytoskeleton,	GO:0005096~GTPase activator activity,GO:0005519~cytoskeletal regulatory protein binding,GO:0017049~GTP-Rho binding,	IPR000095:PAK-box/P21-Rho-binding,				SM00285:PBD,	Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cdc42 effector protein 3,domain:CRIB,modified residue,sequence conflict,
214721_x_at, 218062_x_at, 218063_s_at	CDC42 effector protein 4(CDC42EP4)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030838~positive regulation of actin filament polymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0012505~endomembrane system,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017049~GTP-Rho binding,GO:0044822~poly(A) RNA binding,	IPR000095:PAK-box/P21-Rho-binding,				SM00285:PBD,	Alternative splicing,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cdc42 effector protein 4,compositionally biased region:Poly-Ser,domain:CRIB,modified residue,sequence conflict,
218157_x_at	CDC42 small effector 1(CDC42SE1)	Homo sapiens				GO:0006909~phagocytosis,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0034260~negative regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005095~GTPase inhibitor activity,GO:0005198~structural molecule activity,	IPR000095:PAK-box/P21-Rho-binding,					Alternative splicing,Cell membrane,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,Lipoprotein,Membrane,Palmitate,Phagocytosis,Reference proteome,	chain:CDC42 small effector protein 1,domain:CRIB,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,region of interest:Mediates phosphoinositide-binding,splice variant,
218597_s_at	CDGSH iron sulfur domain 1(CISD1)	Homo sapiens				GO:0043457~regulation of cellular respiration,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR018967:Iron sulphur-containing domain, CDGSH-type,IPR019610:Iron sulphur domain-containing, mitoNEET, N-terminal,				SM00704:ZnF_CDGSH,	2Fe-2S,3D-structure,Acetylation,Complete proteome,Iron,Iron-sulfur,Isopeptide bond,Membrane,Metal-binding,Mitochondrion,Mitochondrion outer membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:CDGSH iron sulfur domain-containing protein 1,helix,metal ion-binding site:Iron-sulfur (2Fe-2S),metal ion-binding site:Iron-sulfur (2Fe-2S); via pros nitrogen,modified residue,mutagenesis site,strand,topological domain:Cytoplasmic,transmembrane region,turn,
214877_at, 220039_s_at	CDK5 regulatory subunit associated protein 1 like 1(CDKAL1)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0006400~tRNA modification,GO:0035600~tRNA methylthiolation,GO:1990145~maintenance of translational fidelity,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0035598~N6-threonylcarbomyladenosine methylthiotransferase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0061712~tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,	IPR002792:TRAM domain,IPR005839:Methylthiotransferase,IPR006466:MiaB-like tRNA modifying enzyme, archaeal-type,IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR013848:Methylthiotransferase, N-terminal,IPR020612:Methylthiotransferase, conserved site,IPR023404:Radical SAM, alpha/beta horseshoe,IPR023970:Methylthiotransferase/radical SAM-type protein,		125853~Diabetes mellitus, noninsulin-dependent, susceptibility to,		SM00729:Elp3,	4Fe-4S,Alternative splicing,Complete proteome,Diabetes mellitus,Endoplasmic reticulum,Iron,Iron-sulfur,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,S-adenosyl-L-methionine,Transferase,Transmembrane,Transmembrane helix,tRNA processing,	chain:CDK5 regulatory subunit-associated protein 1-like 1,domain:MTTase N-terminal,domain:TRAM,metal ion-binding site:Iron-sulfur (4Fe-4S),metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
218315_s_at	CDK5 regulatory subunit associated protein 1(CDK5RAP1)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006400~tRNA modification,GO:0007420~brain development,GO:0009451~RNA modification,GO:0035600~tRNA methylthiolation,GO:0045664~regulation of neuron differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045903~positive regulation of translational fidelity,GO:0070131~positive regulation of mitochondrial translation,GO:0070900~mitochondrial tRNA modification,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0016740~transferase activity,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,GO:0035596~methylthiotransferase activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR002792:TRAM domain,IPR005839:Methylthiotransferase,IPR006463:tRNA-i(6)A37 modification enzyme MiaB,IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR013848:Methylthiotransferase, N-terminal,IPR020612:Methylthiotransferase, conserved site,IPR023404:Radical SAM, alpha/beta horseshoe,IPR023970:Methylthiotransferase/radical SAM-type protein,				SM00729:Elp3,	4Fe-4S,Alternative splicing,Complete proteome,Iron,Iron-sulfur,Metal-binding,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,	chain:CDK5 regulatory subunit-associated protein 1,domain:MTTase N-terminal,domain:TRAM,metal ion-binding site:Iron-sulfur (4Fe-4S),metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),region of interest:CDK5 activation inhibition,region of interest:CDK5R1-binding,sequence conflict,splice variant,
220935_s_at	CDK5 regulatory subunit associated protein 2(CDK5RAP2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000132~establishment of mitotic spindle orientation,GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0007059~chromosome segregation,GO:0007099~centriole replication,GO:0007420~brain development,GO:0022008~neurogenesis,GO:0031023~microtubule organizing center organization,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046600~negative regulation of centriole replication,GO:0051297~centrosome organization,GO:0090231~regulation of spindle checkpoint,	GO:0000242~pericentriolar material,GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0035371~microtubule plus-end,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097431~mitotic spindle pole,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,	IPR012943:Spindle associated,		604804~Microcephaly 3, primary, autosomal recessive,			Alternative splicing,Calmodulin-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Membrane,Mental retardation,Microtubule,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CDK5 regulatory subunit-associated protein 2,modified residue,region of interest:Interaction with CDK5R1,sequence conflict,sequence variant,splice variant,
218740_s_at	CDK5 regulatory subunit associated protein 3(CDK5RAP3)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0001933~negative regulation of protein phosphorylation,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0010921~regulation of phosphatase activity,GO:0030262~apoptotic nuclear changes,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031398~positive regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0043407~negative regulation of MAP kinase activity,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0044818~mitotic G2/M transition checkpoint,GO:0045664~regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071569~protein ufmylation,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1903363~negative regulation of cellular protein catabolic process,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005874~microtubule,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030332~cyclin binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0051019~mitogen-activated protein kinase binding,GO:0051059~NF-kappaB binding,GO:0097371~MDM2/MDM4 family protein binding,	IPR008491:Protein of unknown function DUF773,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:CDK5 regulatory subunit-associated protein 3,sequence conflict,sequence variant,splice variant,
213976_at, 211358_s_at, 213977_s_at, 205516_x_at	CDKN1A interacting zinc finger protein 1(CIZ1)	Homo sapiens				GO:0032298~positive regulation of DNA-dependent DNA replication initiation,GO:0051457~maintenance of protein location in nucleus,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR022755:Zinc finger, double-stranded RNA binding,IPR026811:Cip1-interacting zinc finger protein,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Dystonia,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Cip1-interacting zinc finger protein,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:Matrin-type,
220505_at	CDKN2A antisense RNA 1 (head to head)(CDKN2A-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Susceptibility protein NSG-x,modified residue,
218929_at	CDKN2A interacting protein(CDKN2AIP)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0009967~positive regulation of signal transduction,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031647~regulation of protein stability,	GO:0001652~granular component,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0002039~p53 binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR014720:Double-stranded RNA-binding-like domain,IPR021859:Protein of unknown function DUF3469,					Acetylation,Complete proteome,Direct protein sequencing,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:CDKN2A-interacting protein,compositionally biased region:Ser-rich,domain:DRBM,modified residue,sequence conflict,
205709_s_at, 222063_s_at	CDP-diacylglycerol synthase 1(CDS1)	Homo sapiens				GO:0006655~phosphatidylglycerol biosynthetic process,GO:0006657~CDP-choline pathway,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0007602~phototransduction,GO:0016024~CDP-diacylglycerol biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0004142~diacylglycerol cholinephosphotransferase activity,GO:0004605~phosphatidate cytidylyltransferase activity,	IPR000374:Phosphatidate cytidylyltransferase,IPR016720:Phosphatidate cytidylyltransferase, eukaryota,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,		PIRSF018269:phosphatidate cytidylyltransferase, eukaryotic type,		Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Magnesium,Membrane,Methylation,Nucleotidyltransferase,Phospholipid biosynthesis,Phospholipid metabolism,Phosphoprotein,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Phosphatidate cytidylyltransferase 1,sequence conflict,sequence variant,transmembrane region,
212864_at, 212862_at	CDP-diacylglycerol synthase 2(CDS2)	Homo sapiens				GO:0006655~phosphatidylglycerol biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,	GO:0005743~mitochondrial inner membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004605~phosphatidate cytidylyltransferase activity,	IPR000374:Phosphatidate cytidylyltransferase,IPR016720:Phosphatidate cytidylyltransferase, eukaryota,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,		PIRSF018269:phosphatidate cytidylyltransferase, eukaryotic type,		Alternative splicing,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotidyltransferase,Phospholipid biosynthesis,Phospholipid metabolism,Phosphoprotein,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Phosphatidate cytidylyltransferase 2,modified residue,splice variant,transmembrane region,
201253_s_at	CDP-diacylglycerol--inositol 3-phosphatidyltransferase(CDIPT)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0046341~CDP-diacylglycerol metabolic process,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003881~CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0019992~diacylglycerol binding,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,GO:0043178~alcohol binding,	IPR000462:CDP-alcohol phosphatidyltransferase,IPR014387:CDP-diacylglycerol-inositol 3-phosphatidyltransferase, eukaryote,	hsa00562:Inositol phosphate metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,		PIRSF000848:CDP-diacylglycerol--inositol 3-phosphatidyltransferase,		Alternative splicing,Cell membrane,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Lipid biosynthesis,Lipid metabolism,Magnesium,Manganese,Membrane,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:CDP-diacylglycerol--inositol 3- phosphatidyltransferase,sequence variant,splice variant,transmembrane region,
213554_s_at, 212010_s_at, 213548_s_at	CDV3 homolog(CDV3)	Homo sapiens				GO:0008283~cell proliferation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR026806:Protein CDV3,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein CDV3 homolog,compositionally biased region:Ala-rich,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,modified residue,splice variant,
206861_s_at	CGG triplet repeat binding protein 1(CGGBP1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,						Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CGG triplet repeat-binding protein 1,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
203899_s_at, 203898_at	CGRP receptor component(CRCP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0007218~neuropeptide signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0001669~acrosomal vesicle,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009360~DNA polymerase III complex,	GO:0000166~nucleotide binding,GO:0001056~RNA polymerase III activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,	IPR005574:RNA polymerase II, Rpb4,IPR006590:RNA polymerase II, Rpb4, core,IPR010997:HRDC-like,				SM00657:RPOL4c,	Alternative splicing,Antiviral defense,Cell membrane,Complete proteome,DNA-directed RNA polymerase,Immunity,Innate immunity,Membrane,Nucleus,Receptor,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase III subunit RPC9,modified residue,splice variant,
206079_at	CHM like, Rab escort protein 2(CHML)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0007264~small GTPase mediated signal transduction,GO:0018344~protein geranylgeranylation,GO:0043547~positive regulation of GTPase activity,GO:0055114~oxidation-reduction process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005968~Rab-protein geranylgeranyltransferase complex,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0016491~oxidoreductase activity,GO:0017137~Rab GTPase binding,	IPR001738:Rab escort (choroideraemia) protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,			PIRSF016550:Rab protein geranylgeranyltransferase, component A, eukaryotic type,		Complete proteome,Cytoplasm,GTPase activation,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Rab proteins geranylgeranyltransferase component A 2,modified residue,sequence conflict,
207099_s_at	CHM, Rab escort protein 1(CHM)	Homo sapiens			Energy production and conversion,	GO:0006612~protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0007264~small GTPase mediated signal transduction,GO:0007601~visual perception,GO:0018344~protein geranylgeranylation,GO:0042981~regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,GO:0005968~Rab-protein geranylgeranyltransferase complex,	GO:0004663~Rab geranylgeranyltransferase activity,GO:0005092~GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0016491~oxidoreductase activity,GO:0016740~transferase activity,GO:0017137~Rab GTPase binding,	IPR001738:Rab escort (choroideraemia) protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,		303100~Choroideremia,	PIRSF016550:Rab protein geranylgeranyltransferase, component A, eukaryotic type,		Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,GTPase activation,Reference proteome,Sensory transduction,Signal,Transferase,Vision,	chain:Rab proteins geranylgeranyltransferase component A 1,modified residue,sequence conflict,sequence variant,
210123_s_at	CHRNA7-FAM7A fusion protein(LOC101929970)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005230~extracellular ligand-gated ion channel activity,	IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
1773_at, 204764_at	CHURC1-FNTB readthrough(CHURC1-FNTB)	Homo sapiens				GO:0007275~multicellular organism development,GO:0018343~protein farnesylation,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005829~cytosol,GO:0005875~microtubule associated complex,GO:0005965~protein farnesyltransferase complex,	GO:0004660~protein farnesyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,	IPR001330:Prenyltransferase/squalene oxidase,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR009508:Transcription activator, Churchill,IPR026872:Protein farnesyltransferase subunit beta,					3D-structure,Alternative splicing,Complete proteome,Metal-binding,Phosphoprotein,Prenyltransferase,Reference proteome,Repeat,Transferase,Zinc,
217947_at	CKLF like MARVEL transmembrane domain containing 6(CMTM6)	Homo sapiens				GO:0006935~chemotaxis,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,	IPR008253:Marvel,					Acetylation,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:CKLF-like MARVEL transmembrane domain- containing protein 6,domain:MARVEL,modified residue,sequence variant,transmembrane region,
219161_s_at	CKLF-CMTM1 readthrough(CKLF-CMTM1)	Homo sapiens					GO:0016021~integral component of membrane,		IPR008253:Marvel,					Complete proteome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,
204978_at	CLK4 associating serine/arginine rich protein(CLASRP)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,		IPR019147:Suppressor of white apricot N-terminal domain,				SM01141:SM01141,	Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Splicing factor, arginine/serine-rich 16,compositionally biased region:Arg-rich,compositionally biased region:Ser-rich,modified residue,sequence variant,splice variant,
210859_x_at, 209275_s_at	CLN3, battenin(CLN3)	Homo sapiens				GO:0001508~action potential,GO:0001575~globoside metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006672~ceramide metabolic process,GO:0006678~glucosylceramide metabolic process,GO:0006681~galactosylceramide metabolic process,GO:0006684~sphingomyelin metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0007034~vacuolar transport,GO:0007040~lysosome organization,GO:0007042~lysosomal lumen acidification,GO:0008306~associative learning,GO:0010468~regulation of gene expression,GO:0015809~arginine transport,GO:0016236~macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016485~protein processing,GO:0030163~protein catabolic process,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035752~lysosomal lumen pH elevation,GO:0042133~neurotransmitter metabolic process,GO:0042987~amyloid precursor protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0045861~negative regulation of proteolysis,GO:0047496~vesicle transport along microtubule,GO:0050885~neuromuscular process controlling balance,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0061024~membrane organization,GO:0097352~autophagosome maturation,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043005~neuron projection,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR003492:Batten's disease protein Cln3,IPR018460:Batten's disease protein Cln3, subgroup,IPR020846:Major facilitator superfamily domain,	hsa04142:Lysosome,	204200~Ceroid lipofuscinosis, neuronal, 3,	PIRSF015974:CLN3 protein/Battenin (Batten disease protein),		Alternative splicing,Complete proteome,Disease mutation,Endosome,Glycoprotein,Lipoprotein,Lysosome,Membrane,Methylation,Neurodegeneration,Neuronal ceroid lipofuscinosis,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Battenin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,splice variant,transmembrane region,
201640_x_at, 211136_s_at	CLPTM1, transmembrane protein(CLPTM1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0033081~regulation of T cell differentiation in thymus,	GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR008429:Cleft lip and palate transmembrane 1,					Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cleft lip and palate transmembrane protein 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215999_at, 208279_s_at, 208280_at	CMT1A duplicated region transcript 1(CDRT1)	Homo sapiens					GO:0005622~intracellular,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR006574:SPRY-associated,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,SM00336:BBOX,SM00589:PRY,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:CMT1A duplicated region transcript 1 protein,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence conflict,sequence variant,
217752_s_at	CNDP dipeptidase 2 (metallopeptidase M20 family)(CNDP2)	Homo sapiens			Amino acid transport and metabolism,	GO:0000096~sulfur amino acid metabolic process,GO:0006508~proteolysis,GO:0006750~glutathione biosynthetic process,GO:0008152~metabolic process,GO:0043171~peptide catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004180~carboxypeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016805~dipeptidase activity,GO:0070573~metallodipeptidase activity,GO:0102008~cytosolic dipeptidase activity,	IPR001261:ArgE/DapE/ACY1/CPG2/YscS, conserved site,IPR002933:Peptidase M20,IPR011650:Peptidase M20, dimerisation domain,IPR017153:Glutathione degradosome, DUG1,	hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00410:beta-Alanine metabolism,hsa01100:Metabolic pathways,		PIRSF037242:CNDP dipeptidase,		3D-structure,Acetylation,Alternative splicing,Carboxypeptidase,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Manganese,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:Substrate,binding site:Substrate; shared with homodimeric partner,binding site:Substrate; via amide nitrogen and carbonyl oxygen,binding site:Substrate; via carbonyl oxygen,chain:Cytosolic non-specific dipeptidase,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,site:Important for catalytic activity,splice variant,
220175_s_at	COBW domain containing 2(CBWD2)	Homo sapiens			General function prediction only,			GO:0005524~ATP binding,	IPR003495:CobW/HypB/UreG domain,IPR011629:Cobalamin (vitamin B12) biosynthesis CobW-like, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					ATP-binding,Complete proteome,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:COBW domain-containing protein 2,compositionally biased region:Poly-Glu,domain:CobW C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,
218439_s_at	COMM domain containing 10(COMMD10)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR017920:COMM domain,					Acetylation,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation pathway,	chain:COMM domain-containing protein 10,domain:COMM,sequence variant,
218048_at	COMM domain containing 3(COMMD3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006814~sodium ion transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR017920:COMM domain,				SM00184:RING,	Coiled coil,Complete proteome,Cytoplasm,Ion transport,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transcription,Transcription regulation,Transport,Ubl conjugation pathway,	chain:COMM domain-containing protein 3,domain:COMM,modified residue,sequence variant,
209133_s_at, 206441_s_at, 209132_s_at	COMM domain containing 4(COMMD4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR017920:COMM domain,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation pathway,	chain:COMM domain-containing protein 4,domain:COMM,modified residue,splice variant,
218351_at	COMM domain containing 8(COMMD8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR017920:COMM domain,					Complete proteome,Cytoplasm,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:COMM domain-containing protein 8,domain:COMM,sequence conflict,sequence variant,
218072_at	COMM domain containing 9(COMMD9)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006814~sodium ion transport,	GO:0005634~nucleus,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,	IPR017920:COMM domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Ion transport,Nucleus,Proteomics identification,Reference proteome,Sodium,Sodium transport,Transcription,Transcription regulation,Transport,Ubl conjugation pathway,	chain:COMM domain-containing protein 9,domain:COMM,sequence conflict,
202265_at	COMMD3-BMI1 readthrough(COMMD3-BMI1)	Homo sapiens		h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007379~segment specification,GO:0010468~regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0016925~protein sumoylation,GO:0030097~hemopoiesis,GO:0045814~negative regulation of gene expression, epigenetic,GO:0048146~positive regulation of fibroblast proliferation,GO:0051443~positive regulation of ubiquitin-protein transferase activity,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,	GO:0008270~zinc ion binding,GO:0071535~RING-like zinc finger domain binding,GO:1990841~promoter-specific chromatin binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,			SM00184:RING,	3D-structure,Chromatin regulator,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Polymorphism,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,
202467_s_at, 209838_at	COP9 signalosome subunit 2(COPS2)	Homo sapiens		h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,	Posttranslational modification, protein turnover, chaperones,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0010388~cullin deneddylation,GO:0022008~neurogenesis,GO:0030182~neuron differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0003714~transcription corepressor activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR000717:Proteasome component (PCI) domain,IPR011990:Tetratricopeptide-like helical,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00088:PINT,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 2,domain:PCI,sequence conflict,splice variant,
202078_at	COP9 signalosome subunit 3(COPS3)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0001701~in utero embryonic development,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007165~signal transduction,GO:0009416~response to light stimulus,GO:0010388~cullin deneddylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,	IPR000717:Proteasome component (PCI) domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00088:PINT,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 3,domain:PCI,modified residue,
218042_at	COP9 signalosome subunit 4(COPS4)	Homo sapiens				GO:0000338~protein deneddylation,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0010388~cullin deneddylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0008021~synaptic vesicle,GO:0008180~COP9 signalosome,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019784~NEDD8-specific protease activity,	IPR000717:Proteasome component (PCI) domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00088:PINT,	3D-structure,Acetylation,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Nucleus,Proteomics identification,Reference proteome,Signalosome,Synapse,	chain:COP9 signalosome complex subunit 4,domain:PCI,modified residue,sequence conflict,
201652_at	COP9 signalosome subunit 5(COPS5)	Homo sapiens		h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,		GO:0000338~protein deneddylation,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006366~transcription from RNA polymerase II promoter,GO:0006412~translation,GO:0006413~translational initiation,GO:0010388~cullin deneddylation,GO:0016579~protein deubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046328~regulation of JNK cascade,GO:0051726~regulation of cell cycle,GO:1903894~regulation of IRE1-mediated unfolded protein response,GO:1990182~exosomal secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0008021~synaptic vesicle,GO:0008180~COP9 signalosome,GO:0030054~cell junction,GO:0048471~perinuclear region of cytoplasm,	GO:0003713~transcription coactivator activity,GO:0003743~translation initiation factor activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,				SM00232:JAB_MPN,	3D-structure,Acetylation,Cell junction,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Hydrolase,Metal-binding,Metalloprotease,Nucleus,Protease,Proteomics identification,Reference proteome,Signalosome,Synapse,	chain:COP9 signalosome complex subunit 5,domain:MPN,metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,sequence conflict,short sequence motif:JAMM motif,
201405_s_at, 213504_at	COP9 signalosome subunit 6(COPS6)	Homo sapiens				GO:0000338~protein deneddylation,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0010388~cullin deneddylation,GO:0016032~viral process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR024969:Rpn11/EIF3F C-terminal domain,				SM00232:JAB_MPN,	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Nucleus,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 6,domain:MPN,region of interest:Interaction with Vpr,
209029_at	COP9 signalosome subunit 7A(COPS7A)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0010388~cullin deneddylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,	IPR000717:Proteasome component (PCI) domain,				SM00088:PINT,	3D-structure,Acetylation,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 7a,domain:PCI,modified residue,sequence conflict,
219997_s_at	COP9 signalosome subunit 7B(COPS7B)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0010388~cullin deneddylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,	IPR000717:Proteasome component (PCI) domain,IPR027530:COP9 signalosome complex subunit 7,				SM00088:PINT,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 7b,domain:PCI,modified residue,splice variant,
214260_at, 202141_s_at, 202142_at, 202143_s_at	COP9 signalosome subunit 8(COPS8)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0008285~negative regulation of cell proliferation,GO:0010387~COP9 signalosome assembly,GO:0010388~cullin deneddylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,						3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 8,domain:PCI,modified residue,
203858_s_at	COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor(COX10)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0006783~heme biosynthetic process,GO:0006784~heme a biosynthetic process,GO:0008535~respiratory chain complex IV assembly,GO:0009060~aerobic respiration,GO:0045333~cellular respiration,GO:0048034~heme O biosynthetic process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070069~cytochrome complex,	GO:0004129~cytochrome-c oxidase activity,GO:0004311~farnesyltranstransferase activity,GO:0008495~protoheme IX farnesyltransferase activity,	IPR000537:UbiA prenyltransferase family,IPR006369:Protohaem IX farnesyltransferase,IPR016315:Protohaem IX farnesyltransferase, mitochondria,	hsa00190:Oxidative phosphorylation,hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,	220110~Mitochondrial complex IV deficiency,256000~Leigh syndrome due to mitochondrial COX4 deficiency,	PIRSF001773:protoheme IX farnesyltransferase, mitochondrial type,		Alternative splicing,Complete proteome,Disease mutation,Heme biosynthesis,Leigh syndrome,Membrane,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,Transmembrane,Transmembrane helix,	chain:Protoheme IX farnesyltransferase, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,transmembrane region,
203551_s_at, 211727_s_at, 214277_at	COX11, cytochrome c oxidase copper chaperone(COX11)	Homo sapiens				GO:0007585~respiratory gaseous exchange,GO:0008535~respiratory chain complex IV assembly,GO:0009060~aerobic respiration,GO:0033132~negative regulation of glucokinase activity,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0004129~cytochrome-c oxidase activity,GO:0005507~copper ion binding,GO:0009055~electron carrier activity,	IPR007533:Cytochrome c oxidase assembly protein CtaG/Cox11,IPR023471:Cytochrome c oxidase assembly protein CtaG/Cox11, domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,		PIRSF005413:cytochrome c oxidase assembly protein, COX11 type,		Alternative splicing,Complete proteome,Copper,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:Cytochrome c oxidase assembly protein COX11, mitochondrial,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transit peptide:Mitochondrion,transmembrane region,
221550_at, 219547_at	COX15, cytochrome c oxidase assembly homolog(COX15)	Homo sapiens				GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:0006783~heme biosynthetic process,GO:0006784~heme a biosynthetic process,GO:0007585~respiratory gaseous exchange,GO:0008535~respiratory chain complex IV assembly,GO:0045333~cellular respiration,GO:0055114~oxidation-reduction process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0016021~integral component of membrane,GO:0070069~cytochrome complex,	GO:0004129~cytochrome-c oxidase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0016653~oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,	IPR003780:Heme A synthase,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR023754:Heme A synthase, type 2,	hsa00190:Oxidative phosphorylation,hsa00860:Porphyrin and chlorophyll metabolism,hsa01100:Metabolic pathways,	256000~Leigh syndrome due to cytochrome c oxidase deficiency,615119~Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2,			Alternative splicing,Complete proteome,Disease mutation,Leigh syndrome,Membrane,Mitochondrion,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cytochrome c oxidase assembly protein COX15 homolog,sequence conflict,sequence variant,splice variant,transmembrane region,
203880_at	COX17, cytochrome c oxidase copper chaperone(COX17)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006825~copper ion transport,GO:0007420~brain development,GO:0007507~heart development,GO:0033617~mitochondrial respiratory chain complex IV assembly,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,	GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0016531~copper chaperone activity,	IPR007745:Cytochrome c oxidase copper chaperone,IPR009069:Cysteine alpha-hairpin motif superfamily,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,				3D-structure,Chaperone,Complete proteome,Copper,Disulfide bond,Metal-binding,Mitochondrion,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Cytochrome c oxidase copper chaperone,compositionally biased region:Ala/Pro-rich,disulfide bond,helix,metal ion-binding site:Copper,turn,
206848_at	COX20, cytochrome c oxidase assembly factor(COX20)	Homo sapiens				GO:0009060~aerobic respiration,GO:0033617~mitochondrial respiratory chain complex IV assembly,	GO:0005739~mitochondrion,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,		IPR022533:Cox20/FAM36A,IPR023242:FAM36A,		220110~Mitochondrial complex IV deficiency,			Acetylation,Alternative splicing,Complete proteome,Membrane,Mitochondrion,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM36A,splice variant,transmembrane region,
202160_at, 211808_s_at	CREB binding protein(CREBBP)	Homo sapiens	139.Fig1CD_Eukaryotic_transcriptional_control,140.Fig2_assembly_model_transcription,141.Fig3_pre-assembly_model_initiation,142.Fig4AB_signal-mediated_transfer_model,143.Fig4CD_signal-mediated_transfer_model,85.Nuc_Rec-Coact_Complex,99.NF-kB_activation,	h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_huntingtonPathway:Inhibition of Huntington's disease neurodegeneration by histone deacetylase inhibitors,h_il7Pathway:IL-7 Signal Transduction,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_pmlPathway:Regulation of transcriptional activity by PML,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_PPARgPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_setPathway:Granzyme A mediated Apoptosis Pathway,h_tgfbPathway:TGF beta signaling pathway,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006473~protein acetylation,GO:0007165~signal transduction,GO:0007219~Notch signaling pathway,GO:0008589~regulation of smoothened signaling pathway,GO:0016032~viral process,GO:0016573~histone acetylation,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0032481~positive regulation of type I interferon production,GO:0034644~cellular response to UV,GO:0042592~homeostatic process,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0044255~cellular lipid metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:1900034~regulation of cellular response to heat,GO:1904837~beta-catenin-TCF complex assembly,	GO:0000123~histone acetyltransferase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0034212~peptide N-acetyltransferase activity,GO:0043426~MRF binding,	IPR000197:Zinc finger, TAZ-type,IPR000433:Zinc finger, ZZ-type,IPR001487:Bromodomain,IPR003101:Coactivator CBP, KIX domain,IPR009110:Nuclear receptor coactivator, interlocking,IPR010303:Domain of unknown function DUF902, CREBbp,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013178:Histone H3-K56 acetyltransferase, RTT109,IPR014744:Nuclear receptor coactivator, CREB-bp-like, interlocking,IPR018359:Bromodomain, conserved site,	hsa04024:cAMP signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa04630:Jak-STAT signaling pathway,hsa04720:Long-term potentiation,hsa04916:Melanogenesis,hsa04919:Thyroid hormone signaling pathway,hsa04922:Glucagon signaling pathway,hsa05016:Huntington's disease,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05215:Prostate cancer,	180849~Rubinstein-Taybi syndrome,		SM00291:ZnF_ZZ,SM00297:BROMO,SM00551:ZnF_TAZ,SM01250:SM01250,	3D-structure,Acetylation,Activator,Acyltransferase,Alternative splicing,Biological rhythms,Bromodomain,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Host-virus interaction,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:CREB-binding protein,compositionally biased region:Cys/His-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO-1),domain:Bromo,domain:KIX,helix,modified residue,region of interest:Interaction with SRCAP,region of interest:Interaction with TRERF1,sequence conflict,sequence variant,site:Breakpoint for translocation to form MYST3-CREBBP,site:Breakpoint for translocation to form MYST4-CREBBP,strand,turn,zinc finger region:TAZ-type 1,zinc finger region:TAZ-type 2,zinc finger region:ZZ-type,
213091_at, 207159_x_at	CREB regulated transcription coactivator 1(CRTC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007613~memory,GO:0016032~viral process,GO:0032793~positive regulation of CREB transcription factor activity,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0051289~protein homotetramerization,GO:0060081~membrane hyperpolarization,GO:0097009~energy homeostasis,GO:1900006~positive regulation of dendrite development,GO:1900273~positive regulation of long-term synaptic potentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045202~synapse,	GO:0005515~protein binding,GO:0008140~cAMP response element binding protein binding,	IPR024783:Transducer of regulated CREB activity, N-terminal,IPR024784:Transducer of regulated CREB activity, middle domain,IPR024785:Transducer of regulated CREB activity, C-terminal,IPR024786:Transducer of regulated CREB activity,	hsa05166:HTLV-I infection,	Mucoepidermoid salivary gland carcinoma~Mucoepidermoid salivary gland carcinoma,			Activator,Alternative splicing,Biological rhythms,Chromosomal rearrangement,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CREB-regulated transcription coactivator 1,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear export signal,site:Breakpoint for translocation to form the MECT1-MAML2 and MAML2-MECT1 fusion proteins,site:Required for ubiquitination and degradation,splice variant,
218648_at	CREB regulated transcription coactivator 3(CRTC3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0016032~viral process,GO:0032793~positive regulation of CREB transcription factor activity,GO:0042116~macrophage activation,GO:0043951~negative regulation of cAMP-mediated signaling,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050995~negative regulation of lipid catabolic process,GO:0051289~protein homotetramerization,GO:0097009~energy homeostasis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0008140~cAMP response element binding protein binding,	IPR024783:Transducer of regulated CREB activity, N-terminal,IPR024784:Transducer of regulated CREB activity, middle domain,IPR024785:Transducer of regulated CREB activity, C-terminal,IPR024786:Transducer of regulated CREB activity,	hsa05166:HTLV-I infection,				Activator,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CREB-regulated transcription coactivator 3,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,modified residue,mutagenesis site,region of interest:Required for interaction with HTLV-1 TAX,sequence conflict,sequence variant,splice variant,
213584_s_at, 202978_s_at, 202979_s_at, 202977_s_at	CREB/ATF bZIP transcription factor(CREBZF)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0009615~response to virus,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,	IPR004827:Basic-leucine zipper domain,IPR020850:GTPase effector domain, GED,					Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:CREB/ATF bZIP transcription factor,DNA-binding region:Basic motif,domain:Leucine-zipper,mutagenesis site,sequence conflict,short sequence motif:HCFC1-binding motif (HBM),
212180_at, 206184_at	CRK like proto-oncogene, adaptor protein(CRKL)	Homo sapiens		h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pyk2Pathway:Links between Pyk2 and Map Kinases,		GO:0000186~activation of MAPKK activity,GO:0001568~blood vessel development,GO:0007254~JNK cascade,GO:0007265~Ras protein signal transduction,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0009952~anterior/posterior pattern specification,GO:0035556~intracellular signal transduction,GO:0048538~thymus development,GO:0060017~parathyroid gland development,GO:0098609~cell-cell adhesion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005768~endosome,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05220:Chronic myeloid leukemia,			SM00252:SH2,SM00326:SH3,	3D-structure,Complete proteome,Phosphoprotein,Reference proteome,Repeat,SH2 domain,SH3 domain,	chain:Crk-like protein,domain:SH2,domain:SH3 1,domain:SH3 2,helix,modified residue,strand,
202225_at, 202224_at, 202226_s_at	CRK proto-oncogene, adaptor protein(CRK)	Homo sapiens		h_cxcr4Pathway:CXCR4 Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0000186~activation of MAPKK activity,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009967~positive regulation of signal transduction,GO:0032956~regulation of actin cytoskeleton organization,GO:0035020~regulation of Rac protein signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0043087~regulation of GTPase activity,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042169~SH2 domain binding,GO:0045309~protein phosphorylated amino acid binding,GO:0046875~ephrin receptor binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05220:Chronic myeloid leukemia,			SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,SH2 domain,SH3 domain,	chain:Adapter molecule crk,domain:SH2,domain:SH3 1,domain:SH3 2,helix,modified residue,mutagenesis site,sequence conflict,splice variant,strand,
219435_at	CST telomere replication complex component 1(CTC1)	Homo sapiens				GO:0000723~telomere maintenance,GO:0006974~cellular response to DNA damage stimulus,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0010833~telomere maintenance via telomere lengthening,GO:0035264~multicellular organism growth,GO:0045740~positive regulation of DNA replication,GO:0048146~positive regulation of fibroblast proliferation,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048539~bone marrow development,GO:0051974~negative regulation of telomerase activity,GO:0071425~hematopoietic stem cell proliferation,GO:0090399~replicative senescence,GO:1904356~regulation of telomere maintenance via telomere lengthening,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:1990879~CST complex,	GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0010521~telomerase inhibitor activity,GO:0042162~telomeric DNA binding,GO:0098505~G-rich strand telomeric DNA binding,			612199~Cerebroretinal microangiopathy with calcifications and cysts,			Alternative splicing,Chromosome,Complete proteome,Disease mutation,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,Telomere,	chain:Uncharacterized protein C17orf68,sequence conflict,sequence variant,splice variant,transmembrane region,
214355_x_at, 215549_x_at	CTAGE family member 4(CTAGE4)	Homo sapiens			Cell division and chromosome partitioning,		GO:0016021~integral component of membrane,							Coiled coil,Complete proteome,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cutaneous T-cell lymphoma-associated antigen 4,chain:Cutaneous T-cell lymphoma-associated antigen 5,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
200035_at	CTD nuclear envelope phosphatase 1(CTDNEP1)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0006998~nuclear envelope organization,GO:0007077~mitotic nuclear envelope disassembly,GO:0007276~gamete generation,GO:0007498~mesoderm development,GO:0010867~positive regulation of triglyceride biosynthetic process,GO:0034504~protein localization to nucleus,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0071595~Nem1-Spo7 phosphatase complex,	GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0016791~phosphatase activity,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	Complete proteome,Endoplasmic reticulum,Hydrolase,Membrane,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Serine/threonine-protein phosphatase dullard,domain:FCP1 homology,mutagenesis site,sequence variant,transmembrane region,
205035_at	CTD phosphatase subunit 1(CTDP1)	Homo sapiens	85.Nuc_Rec-Coact_Complex,			GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006470~protein dephosphorylation,GO:0010458~exit from mitosis,GO:0050434~positive regulation of viral transcription,GO:0051301~cell division,GO:0061052~negative regulation of cell growth involved in cardiac muscle cell development,GO:0070940~dephosphorylation of RNA polymerase II C-terminal domain,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0015629~actin cytoskeleton,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030496~midbody,GO:0051233~spindle midzone,	GO:0004721~phosphoprotein phosphatase activity,GO:0005515~protein binding,GO:0008420~CTD phosphatase activity,	IPR001357:BRCT domain,IPR004274:NLI interacting factor,IPR011947:FCP1-like phosphatase, phosphatase domain,IPR015388:FCP1-like phosphatase, C-terminal,IPR023214:HAD-like domain,		604168~Congenital cataracts, facial dysmorphism, and neuropathy,		SM00292:BRCT,SM00577:CPDc,	3D-structure,Acetylation,Alternative splicing,Cataract,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	chain:RNA polymerase II subunit A C-terminal domain phosphatase,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,domain:BRCT,domain:FCP1 homology,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,
217844_at	CTD small phosphatase 1(CTDSP1)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006470~protein dephosphorylation,GO:0045665~negative regulation of neuron differentiation,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008420~CTD phosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Hydrolase,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:4-aspartylphosphate intermediate,active site:Proton donor,chain:Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,domain:FCP1 homology,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,mutagenesis site,sequence conflict,sequence variant,site:Transition state stabilizer,splice variant,strand,turn,
208735_s_at, 203445_s_at	CTD small phosphatase 2(CTDSP2)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0036498~IRE1-mediated unfolded protein response,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008420~CTD phosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	3D-structure,Complete proteome,Hydrolase,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,	active site:4-aspartylphosphate intermediate,active site:Proton donor,chain:Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2,domain:FCP1 homology,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,sequence conflict,site:Transition state stabilizer,strand,turn,
201904_s_at, 201906_s_at, 213597_s_at, 214187_x_at, 201905_s_at	CTD small phosphatase like(CTDSPL)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:4-aspartylphosphate intermediate,active site:Proton donor,chain:CTD small phosphatase-like protein,domain:FCP1 homology,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,sequence variant,site:Transition state stabilizer,splice variant,strand,turn,
202613_at	CTP synthase 1(CTPS1)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006241~CTP biosynthetic process,GO:0006541~glutamine metabolic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0042098~T cell proliferation,GO:0042100~B cell proliferation,GO:0042493~response to drug,GO:0044210~'de novo' CTP biosynthetic process,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0003883~CTP synthase activity,GO:0005524~ATP binding,GO:0042802~identical protein binding,	IPR004468:CTP synthase,IPR017456:CTP synthase, N-terminal,IPR017926:Glutamine amidotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,	615897~Immunodeficiency 24,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Glutamine amidotransferase,Immunity,Ligase,Nucleotide-binding,Phosphoprotein,Polymorphism,Pyrimidine biosynthesis,Reference proteome,	active site:For GATase activity,chain:CTP synthase 1,domain:Glutamine amidotransferase type-1,helix,modified residue,sequence conflict,sequence variant,strand,turn,
219080_s_at	CTP synthase 2(CTPS2)	Homo sapiens				GO:0006220~pyrimidine nucleotide metabolic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006541~glutamine metabolic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0044210~'de novo' CTP biosynthetic process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0003883~CTP synthase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR004468:CTP synthase,IPR017456:CTP synthase, N-terminal,IPR017926:Glutamine amidotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,				3D-structure,ATP-binding,Complete proteome,Glutamine amidotransferase,Ligase,Nucleotide-binding,Phosphoprotein,Proteomics identification,Pyrimidine biosynthesis,Reference proteome,	active site:For GATase activity,chain:CTP synthase 2,domain:Glutamine amidotransferase type-1,helix,modified residue,sequence conflict,strand,turn,
202060_at	CTR9 homolog, Paf1/RNA polymerase II complex component(CTR9)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0001826~inner cell mass cell differentiation,GO:0001829~trophectodermal cell differentiation,GO:0001832~blastocyst growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007259~JAK-STAT cascade,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0080182~histone H3-K4 trimethylation,GO:1900364~negative regulation of mRNA polyadenylation,GO:2000653~regulation of genetic imprinting,GO:2001162~positive regulation of histone H3-K79 methylation,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0016593~Cdc73/Paf1 complex,GO:0016607~nuclear speck,GO:0035327~transcriptionally active chromatin,	GO:0000993~RNA polymerase II core binding,GO:0005515~protein binding,GO:0042169~SH2 domain binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transcription,Transcription regulation,Wnt signaling pathway,	chain:RNA polymerase-associated protein CTR9 homolog,compositionally biased region:Lys-rich,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,compositionally biased region:Ser-rich,modified residue,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 12,repeat:TPR 13,repeat:TPR 14,repeat:TPR 15,repeat:TPR 16,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,
220275_at	CUB and zona pellucida like domains 1(CUZD1)	Homo sapiens		h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,		GO:0006931~substrate-dependent cell migration, cell attachment to substrate,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0032023~trypsinogen activation,GO:0051301~cell division,	GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0042589~zymogen granule membrane,		IPR000859:CUB domain,IPR001507:Zona pellucida domain,				SM00042:CUB,SM00241:ZP,	Alternative splicing,Cell adhesion,Cell cycle,Cell division,Complete proteome,Cytoplasmic vesicle,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CUB and zona pellucida-like domain- containing protein 1,disulfide bond,domain:CUB 1,domain:CUB 2,domain:ZP,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218451_at	CUB domain containing protein 1(CDCP1)	Homo sapiens					GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR000859:CUB domain,					Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:CUB domain-containing protein 1,disulfide bond,domain:CUB,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Cleavage; by ST14/MT-SP1,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219468_s_at	CUE domain containing 1(CUEDC1)	Homo sapiens							IPR003892:Ubiquitin system component Cue,IPR009060:UBA-like,				SM00546:CUE,	3D-structure,Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:CUE domain-containing protein 1,compositionally biased region:Pro-rich,domain:CUE,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
218097_s_at	CUE domain containing 2(CUEDC2)	Homo sapiens				GO:0010936~negative regulation of macrophage cytokine production,GO:1900016~negative regulation of cytokine production involved in inflammatory response,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0005515~protein binding,	IPR003892:Ubiquitin system component Cue,					Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation pathway,	chain:CUE domain-containing protein 2,domain:CUE,sequence conflict,
204113_at, 221742_at, 221743_at, 209489_at	CUGBP, Elav-like family member 1(CELF1)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0007281~germ cell development,GO:0007286~spermatid development,GO:0009790~embryo development,GO:0016246~RNA interference,GO:0017148~negative regulation of translation,GO:0040018~positive regulation of multicellular organism growth,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0000900~translation repressor activity, nucleic acid binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0031369~translation initiation factor binding,GO:0042835~BRE binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:CUG-BP- and ETR-3-like factor 1,compositionally biased region:Ser-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,mutagenesis site,splice variant,strand,turn,
202158_s_at, 202156_s_at, 202157_s_at	CUGBP, Elav-like family member 2(CELF2)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008016~regulation of heart contraction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,	chain:CUG-BP- and ETR-3-like factor 2,compositionally biased region:Ala-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,region of interest:Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion,sequence variant,splice variant,
215045_at, 206817_x_at	CUGBP, Elav-like family member 3(CELF3)	Homo sapiens				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0007283~spermatogenesis,GO:0008380~RNA splicing,GO:0030317~sperm motility,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,mRNA processing,mRNA splicing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:CUG-BP- and ETR-3-like factor 3,compositionally biased region:Gln-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,sequence conflict,splice variant,
218655_s_at	CWC25 spliceosome associated protein homolog(CWC25)	Homo sapiens					GO:0005654~nucleoplasm,		IPR019339:CBF1-interacting co-repressor CIR, N-terminal domain,IPR022209:Pre-mRNA splicing factor,				SM01083:SM01083,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 49,compositionally biased region:Lys-rich,modified residue,splice variant,
218787_x_at	CWF19-like 1, cell cycle control (S. pombe)(CWF19L1)	Homo sapiens						GO:0003824~catalytic activity,	IPR006767:Cwf19-like protein, C-terminal domain-2,IPR006768:Cwf19-like, C-terminal domain-1,IPR011146:HIT-like domain,		616127~Spinocerebellar ataxia, autosomal recessive 17,			Alternative splicing,Complete proteome,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,	chain:CWF19-like protein 1,sequence conflict,sequence variant,splice variant,
48580_at, 218058_at	CXXC finger protein 1(CXXC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0036498~IRE1-mediated unfolded protein response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051568~histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0035097~histone methyltransferase complex,GO:0048188~Set1C/COMPASS complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0045322~unmethylated CpG binding,	IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR022056:CpG binding protein, C-terminal,				SM00249:PHD,	3D-structure,Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:CpG-binding protein,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),modified residue,mutagenesis site,sequence conflict,zinc finger region:CXXC-type,zinc finger region:PHD-type,
220277_at	CXXC finger protein 4(CXXC4)	Homo sapiens				GO:0007352~zygotic specification of dorsal/ventral axis,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0031410~cytoplasmic vesicle,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0030165~PDZ domain binding,	IPR002857:Zinc finger, CXXC-type,	hsa04310:Wnt signaling pathway,				Complete proteome,Cytoplasm,Metal-binding,Reference proteome,Wnt signaling pathway,Zinc,Zinc-finger,	chain:CXXC-type zinc finger protein 4,compositionally biased region:Poly-Ser,region of interest:Interaction with DVL1,zinc finger region:CXXC-type,
218643_s_at	CXXC repeat containing interactor of PDZ3 domain(CRIPT)	Homo sapiens				GO:0031122~cytoplasmic microtubule organization,GO:0035372~protein localization to microtubule,GO:0045184~establishment of protein localization,GO:1902897~regulation of postsynaptic density protein 95 clustering,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0030165~PDZ domain binding,GO:0032403~protein complex binding,GO:0097110~scaffold protein binding,	IPR019367:PDZ-binding protein, CRIPT,		615789~Short stature with microcephaly and distinctive facies,			Cell junction,Cell projection,Complete proteome,Cytoplasm,Dwarfism,Reference proteome,Synapse,	chain:Cysteine-rich PDZ-binding protein,region of interest:PDZ3-binding,region of interest:Sufficient for interaction with DLG4,
221903_s_at, 221905_at, 39582_at, 213295_at, 214272_at, 222142_at, 60084_at	CYLD lysine 63 deubiquitinase(CYLD)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0016055~Wnt signaling pathway,GO:0016579~protein deubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032480~negative regulation of type I interferon production,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0045087~innate immune response,GO:0070266~necroptotic process,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070536~protein K63-linked deubiquitination,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1902017~regulation of cilium assembly,GO:1990108~protein linear deubiquitination,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,	GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0030496~midbody,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0036064~ciliary basal body,GO:0048471~perinuclear region of cytoplasm,GO:0097542~ciliary tip,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0061578~Lys63-specific deubiquitinase activity,GO:0070064~proline-rich region binding,	IPR000938:CAP Gly-rich domain,IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	hsa04380:Osteoclast differentiation,hsa04622:RIG-I-like receptor signaling pathway,	132700~Cylindromatosis, familial,601606~Trichoepithelioma, multiple familial, 1,605041~Brooke-Spiegler syndrome,		SM01052:SM01052,	3D-structure,Alternative splicing,Cell cycle,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Hydrolase,Immunity,Innate immunity,Membrane,Metal-binding,Microtubule,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Tumor suppressor,Ubl conjugation pathway,Wnt signaling pathway,Zinc,	chain:Probable ubiquitin carboxyl-terminal hydrolase CYLD,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,modified residue,mutagenesis site,region of interest:Interaction with NEMO,region of interest:Interaction with TRAF2,region of interest:Interaction with TRIP,sequence variant,splice variant,strand,turn,
211843_x_at, 205939_at	CYP3A7-CYP3A51P readthrough(CYP3A7-CYP3A51P)	Homo sapiens				GO:0002933~lipid hydroxylation,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002402:Cytochrome P450, E-class, group II,IPR008072:Cytochrome P450, E-class, CYP3A,IPR017972:Cytochrome P450, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,
219365_s_at	CaM kinase like vesicle associated(CAMKV)	Homo sapiens				GO:0006468~protein phosphorylation,	GO:0005886~plasma membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0004672~protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,				SM00220:S_TKc,	Alternative splicing,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasmic vesicle,Kinase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:CaM kinase-like vesicle-associated protein,compositionally biased region:Ala-rich,domain:Protein kinase,modified residue,sequence conflict,sequence variant,splice variant,
220888_s_at	Cas scaffolding protein family member 4(CASS4)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,		IPR001452:Src homology-3 domain,IPR014928:Serine rich protein interaction,IPR021901:CAS family, DUF3513,				SM00326:SH3,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,SH3 domain,	chain:Cas scaffolding protein family member 4,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:SH3,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
208348_s_at, 209682_at	Cbl proto-oncogene B(CBLB)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,GO:0006607~NLS-bearing protein import into nucleus,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0023051~regulation of signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0045121~membrane raft,	GO:0001784~phosphotyrosine binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR009060:UBA-like,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,			SM00165:UBA,SM00184:RING,	3D-structure,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:E3 ubiquitin-protein ligase CBL-B,compositionally biased region:Pro-rich,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,domain:UBA,helix,modified residue,mutagenesis site,region of interest:4H,region of interest:Interaction with SH3KBP1,region of interest:Interaction with VAV1,region of interest:Linker,sequence conflict,sequence variant,splice variant,turn,zinc finger region:RING-type,
220638_s_at	Cbl proto-oncogene C(CBLC)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0016567~protein ubiquitination,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043407~negative regulation of MAP kinase activity,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001784~phosphotyrosine binding,GO:0004871~signal transducer activity,GO:0005154~epidermal growth factor receptor binding,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,			SM00184:RING,	3D-structure,Alternative splicing,Calcium,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3-binding,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:Signal transduction protein CBL-C,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,modified residue,region of interest:4H,region of interest:Linker,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:RING-type,
220018_at	Cbl proto-oncogene like 1(CBLL1)	Homo sapiens				GO:0007162~negative regulation of cell adhesion,GO:0016337~single organismal cell-cell adhesion,GO:0016567~protein ubiquitination,GO:0030155~regulation of cell adhesion,GO:0030335~positive regulation of cell migration,GO:0045807~positive regulation of endocytosis,	GO:0000151~ubiquitin ligase complex,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR017907:Zinc finger, RING-type, conserved site,					Alternative splicing,Complete proteome,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase Hakai,compositionally biased region:Pro-rich,modified residue,sequence conflict,zinc finger region:C2H2-type,zinc finger region:RING-type,
206607_at	Cbl proto-oncogene(CBL)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,		GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014823~response to activity,GO:0016567~protein ubiquitination,GO:0023051~regulation of signaling,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042594~response to starvation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045471~response to ethanol,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0070997~neuron death,GO:0090650~cellular response to oxygen-glucose deprivation,GO:0098609~cell-cell adhesion,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016600~flotillin complex,GO:0030426~growth cone,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0001784~phosphotyrosine binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0046875~ephrin receptor binding,GO:0061630~ubiquitin protein ligase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR009060:UBA-like,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,	613563~Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,		SM00165:UBA,SM00184:RING,	3D-structure,Calcium,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Ligase,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:E3 ubiquitin-protein ligase CBL,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Pro-rich,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,domain:UBA,helix,modified residue,mutagenesis site,region of interest:4H,region of interest:Interaction with CD2AP,region of interest:Linker,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
207144_s_at	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1(CITED1)	Homo sapiens				GO:0000578~embryonic axis specification,GO:0001570~vasculogenesis,GO:0001656~metanephros development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001890~placenta development,GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptotic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0010628~positive regulation of gene expression,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030318~melanocyte differentiation,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0032868~response to insulin,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0042438~melanin biosynthetic process,GO:0043473~pigmentation,GO:0043524~negative regulation of neuron apoptotic process,GO:0043627~response to estrogen,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051591~response to cAMP,GO:0060231~mesenchymal to epithelial transition,GO:0060395~SMAD protein signal transduction,GO:0060711~labyrinthine layer development,GO:0060712~spongiotrophoblast layer development,GO:0070555~response to interleukin-1,GO:0070669~response to interleukin-2,GO:0070670~response to interleukin-4,GO:0070741~response to interleukin-6,GO:0071104~response to interleukin-9,GO:0071105~response to interleukin-11,GO:0071107~response to parathyroid hormone,GO:0071559~response to transforming growth factor beta,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0050693~LBD domain binding,GO:0070410~co-SMAD binding,	IPR007576:CITED,					Activator,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Cbp/p300-interacting transactivator 1,compositionally biased region:Asp/Glu-rich (acidic),sequence variant,
207980_s_at, 209357_at	Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2(CITED2)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001829~trophectodermal cell differentiation,GO:0001843~neural tube closure,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0001947~heart looping,GO:0002089~lens morphogenesis in camera-type eye,GO:0002244~hematopoietic progenitor cell differentiation,GO:0003151~outflow tract morphogenesis,GO:0003156~regulation of organ formation,GO:0003197~endocardial cushion development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007368~determination of left/right symmetry,GO:0007417~central nervous system development,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007530~sex determination,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009612~response to mechanical stimulus,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021602~cranial nerve morphogenesis,GO:0022409~positive regulation of cell-cell adhesion,GO:0030154~cell differentiation,GO:0030336~negative regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030851~granulocyte differentiation,GO:0034405~response to fluid shear stress,GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035802~adrenal cortex formation,GO:0035914~skeletal muscle cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0043627~response to estrogen,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046697~decidualization,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048821~erythrocyte development,GO:0060136~embryonic process involved in female pregnancy,GO:0060349~bone morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060971~embryonic heart tube left/right pattern formation,GO:0060972~left/right pattern formation,GO:0061156~pulmonary artery morphogenesis,GO:0061308~cardiac neural crest cell development involved in heart development,GO:0061428~negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070986~left/right axis specification,GO:1900164~nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,GO:2000020~positive regulation of male gonad development,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0035035~histone acetyltransferase binding,GO:0050693~LBD domain binding,	IPR007576:CITED,		614431~Ventricular septal defect 2,614433~Atrial septal defect 8,			3D-structure,Activator,Alternative splicing,Atrial septal defect,Complete proteome,Developmental protein,Differentiation,Disease mutation,Nucleus,Proteomics identification,Reference proteome,Repressor,Stress response,Transcription,Transcription regulation,	chain:Cbp/p300-interacting transactivator 2,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Gly-rich,compositionally biased region:His-rich,helix,splice variant,
203263_s_at, 203264_s_at	Cdc42 guanine nucleotide exchange factor 9(ARHGEF9)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR013315:Spectrin alpha chain, SH3 domain,		300607~Epileptic encephalopathy, early infantile, 8,		SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Epilepsy,Guanine-nucleotide releasing factor,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Rho guanine nucleotide exchange factor 9,domain:DH,domain:PH,domain:SH3,helix,region of interest:Interaction with GPHN,sequence variant,strand,
219270_at	ChaC glutathione specific gamma-glutamylcyclotransferase 1(CHAC1)	Homo sapiens				GO:0006750~glutathione biosynthetic process,GO:0006751~glutathione catabolic process,GO:0006986~response to unfolded protein,GO:0007219~Notch signaling pathway,GO:0010955~negative regulation of protein processing,GO:0022008~neurogenesis,GO:0045746~negative regulation of Notch signaling pathway,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005802~trans-Golgi network,GO:0005829~cytosol,	GO:0003839~gamma-glutamylcyclotransferase activity,GO:0005112~Notch binding,GO:0005515~protein binding,	IPR006840:ChaC-like protein,IPR013024:Butirosin biosynthesis, BtrG-like,					Acyltransferase,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Golgi apparatus,Neurogenesis,Notch signaling pathway,Proteomics identification,Reference proteome,Transferase,Unfolded protein response,	chain:Cation transport regulator-like protein 1,
206207_at	Charcot-Leyden crystal galectin(CLC)	Homo sapiens				GO:0002667~regulation of T cell anergy,GO:0002724~regulation of T cell cytokine production,GO:0007275~multicellular organism development,GO:0046006~regulation of activated T cell proliferation,GO:0070231~T cell apoptotic process,	GO:0005829~cytosol,	GO:0004622~lysophospholipase activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Lectin,Polymorphism,Reference proteome,	chain:Eosinophil lysophospholipase,domain:Galectin,helix,modified residue,sequence variant,site:Not glycosylated,strand,turn,
221845_s_at	ClpB homolog, mitochondrial AAA ATPase chaperonin(CLPB)	Homo sapiens				GO:0034605~cellular response to heat,	GO:0005739~mitochondrion,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR001270:Chaperonin ClpA/B,IPR002110:Ankyrin repeat,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR019489:Clp ATPase, C-terminal,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		616271~3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia,		SM00248:ANK,SM00382:AAA,SM01086:SM01086,	Acetylation,Alternative splicing,ANK repeat,ATP-binding,Cataract,Complete proteome,Disease mutation,Epilepsy,Hydrolase,Mitochondrion,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transit peptide,	chain:Caseinolytic peptidase B protein homolog,modified residue,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence variant,splice variant,
201913_s_at	Coenzyme A synthase(COASY)	Homo sapiens			Coenzyme metabolism,	GO:0009108~coenzyme biosynthetic process,GO:0015937~coenzyme A biosynthetic process,GO:0016310~phosphorylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005759~mitochondrial matrix,GO:0070062~extracellular exosome,	GO:0004140~dephospho-CoA kinase activity,GO:0004595~pantetheine-phosphate adenylyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001977:Dephospho-CoA kinase,IPR004821:Cytidyltransferase-like domain,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00770:Pantothenate and CoA biosynthesis,hsa01100:Metabolic pathways,	615643~Neurodegeneration with brain iron accumulation 6,			Alternative splicing,ATP-binding,Coenzyme A biosynthesis,Complete proteome,Cytoplasm,Disease mutation,Kinase,Mitochondrion,Multifunctional enzyme,Neurodegeneration,Nucleotide-binding,Nucleotidyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Bifunctional coenzyme A synthase,domain:DPCK,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Phosphopantetheine adenylyltransferase,sequence conflict,sequence variant,splice variant,
206878_at	D-amino acid oxidase(DAO)	Homo sapiens				GO:0006562~proline catabolic process,GO:0036088~D-serine catabolic process,GO:0042416~dopamine biosynthetic process,GO:0046416~D-amino acid metabolic process,GO:0046487~glyoxylate metabolic process,GO:0055114~oxidation-reduction process,GO:0055130~D-alanine catabolic process,GO:0070178~D-serine metabolic process,	GO:0005741~mitochondrial outer membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,	GO:0003884~D-amino-acid oxidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,GO:0071949~FAD binding,	IPR006076:FAD dependent oxidoreductase,IPR006181:D-amino acid oxidase, conserved site,IPR016040:NAD(P)-binding domain,IPR023209:D-amino-acid oxidase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa00330:Arginine and proline metabolism,hsa00472:D-Arginine and D-ornithine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa04146:Peroxisome,	181500~Schizophrenia,	PIRSF000189:D-amino-acid oxidase,		3D-structure,Complete proteome,FAD,Flavoprotein,Oxidoreductase,Peroxisome,Proteomics identification,Reference proteome,	binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:D-amino-acid oxidase,helix,nucleotide phosphate-binding region:FAD,sequence conflict,short sequence motif:Microbody targeting signal,strand,turn,
222134_at, 207418_s_at	D-aspartate oxidase(DDO)	Homo sapiens				GO:0006531~aspartate metabolic process,GO:0006533~aspartate catabolic process,GO:0007320~insemination,GO:0007625~grooming behavior,GO:0019478~D-amino acid catabolic process,GO:0042445~hormone metabolic process,GO:0046416~D-amino acid metabolic process,GO:0046487~glyoxylate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,	GO:0003884~D-amino-acid oxidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008445~D-aspartate oxidase activity,GO:0048037~cofactor binding,GO:0071949~FAD binding,	IPR006076:FAD dependent oxidoreductase,IPR006181:D-amino acid oxidase, conserved site,IPR016040:NAD(P)-binding domain,IPR023209:D-amino-acid oxidase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa04146:Peroxisome,		PIRSF000189:D-amino-acid oxidase,		Alternative splicing,Complete proteome,FAD,Flavoprotein,Oxidoreductase,Peroxisome,Polymorphism,Proteomics identification,Reference proteome,	binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:D-aspartate oxidase,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,short sequence motif:Microbody targeting signal,splice variant,
209782_s_at, 209783_at	D-box binding PAR bZIP transcription factor(DBP)	Homo sapiens				GO:0001889~liver development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0007623~circadian rhythm,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR004827:Basic-leucine zipper domain,				SM00338:BRLZ,	Activator,Biological rhythms,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:D site-binding protein,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich (proline/acidic region (PAR)),DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,
202929_s_at	D-dopachrome tautomerase-like(DDTL)	Homo sapiens					GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0016829~lyase activity,	IPR001398:Macrophage migration inhibitory factor,IPR014347:Tautomerase/MIF superfamily,IPR019829:Macrophage migration inhibitory factor, conserved site,					Complete proteome,Cytoplasm,Lyase,Reference proteome,	chain:D-dopachrome decarboxylase-like protein,modified residue,
220611_at	DAB1, reelin adaptor protein(DAB1)	Homo sapiens		h_reelinPathway:Reelin Signaling Pathway,		GO:0007162~negative regulation of cell adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0007494~midgut development,GO:0007628~adult walking behavior,GO:0016358~dendrite development,GO:0021517~ventral spinal cord development,GO:0021589~cerebellum structural organization,GO:0021813~cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,GO:0021942~radial glia guided migration of Purkinje cell,GO:0042493~response to drug,GO:0045666~positive regulation of neuron differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048712~negative regulation of astrocyte differentiation,GO:0050771~negative regulation of axonogenesis,GO:0051645~Golgi localization,GO:0097477~lateral motor column neuron migration,	GO:0005730~nucleolus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005903~brush border,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0043548~phosphatidylinositol 3-kinase binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Disabled homolog 1,domain:PID,modified residue,sequence conflict,sequence variant,splice variant,
201280_s_at, 201279_s_at, 201278_at, 210757_x_at	DAB2, clathrin adaptor protein(DAB2)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0006898~receptor-mediated endocytosis,GO:0006915~apoptotic process,GO:0007229~integrin-mediated signaling pathway,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0015031~protein transport,GO:0016055~Wnt signaling pathway,GO:0030335~positive regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0035026~leading edge cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045807~positive regulation of endocytosis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1903077~negative regulation of protein localization to plasma membrane,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,GO:2000370~positive regulation of clathrin-mediated endocytosis,GO:2000643~positive regulation of early endosome to late endosome transport,	GO:0005730~nucleolus,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0005925~focal adhesion,GO:0030136~clathrin-coated vesicle,GO:0030665~clathrin-coated vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070022~transforming growth factor beta receptor homodimeric complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0035615~clathrin adaptor activity,GO:0038024~cargo receptor activity,GO:0046332~SMAD binding,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04144:Endocytosis,			SM00462:PTB,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Coated pit,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Developmental protein,Differentiation,Endocytosis,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Tumor suppressor,Wnt signaling pathway,	chain:Disabled homolog 2,domain:PID,modified residue,mutagenesis site,region of interest:Required for interaction with MYO6,sequence conflict,sequence variant,splice variant,
218808_at, 221934_s_at	DALR anticodon binding domain containing 3(DALRD3)	Homo sapiens				GO:0006418~tRNA aminoacylation for protein translation,GO:0006420~arginyl-tRNA aminoacylation,		GO:0004812~aminoacyl-tRNA ligase activity,GO:0004814~arginine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR008909:DALR anticodon binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,				SM00836:SM00836,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:DALR anticodon-binding domain-containing protein 3,sequence conflict,sequence variant,splice variant,
218443_s_at	DAZ associated protein 1(DAZAP1)	Homo sapiens				GO:0001893~maternal placenta development,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0035613~RNA stem-loop binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03015:mRNA surveillance pathway,			SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Methylation,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spermatogenesis,	chain:DAZ-associated protein 1,compositionally biased region:Pro-rich,domain:RRM 1,domain:RRM 2,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
214334_x_at, 212595_s_at, 200794_x_at	DAZ associated protein 2(DAZAP2)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0050699~WW domain binding,	IPR022730:DAZ associated protein 2,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:DAZ-associated protein 2,compositionally biased region:Pro-rich,sequence conflict,sequence variant,
204556_s_at, 204557_s_at	DAZ interacting zinc finger protein 1(DZIP1)	Homo sapiens				GO:0007224~smoothened signaling pathway,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0042384~cilium assembly,GO:0045184~establishment of protein localization,GO:0051220~cytoplasmic sequestering of protein,GO:0060271~cilium morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005815~microtubule organizing center,GO:0036064~ciliary basal body,GO:0043234~protein complex,GO:0097539~ciliary transition fiber,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Metal-binding,Nucleus,Polymorphism,Reference proteome,Spermatogenesis,Zinc,Zinc-finger,	chain:Zinc finger protein DZIP1,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type,
207232_s_at, 213186_at, 207231_at	DAZ interacting zinc finger protein 3(DZIP3)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019902~phosphatase binding,GO:0031593~polyubiquitin binding,GO:0044822~poly(A) RNA binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase DZIP3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,mutagenesis site,sequence conflict,splice variant,zinc finger region:RING-type; atypical,
206661_at	DBF4 zinc finger B(DBF4B)	Homo sapiens				GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0032147~activation of protein kinase activity,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016235~aggresome,GO:0043231~intracellular membrane-bounded organelle,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,	IPR001357:BRCT domain,IPR006572:Zinc finger, DBF-type,				SM00586:ZnF_DBF,	Alternative splicing,Cell cycle,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Zinc,Zinc-finger,	chain:Protein DBF4 homolog B,domain:BRCT,modified residue,sequence conflict,splice variant,zinc finger region:DBF4-type,
204244_s_at	DBF4 zinc finger(DBF4)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0043085~positive regulation of catalytic activity,	GO:0005654~nucleoplasm,	GO:0003676~nucleic acid binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,	IPR001357:BRCT domain,IPR006572:Zinc finger, DBF-type,	hsa04110:Cell cycle,			SM00586:ZnF_DBF,	3D-structure,Alternative splicing,Cell cycle,Complete proteome,DNA replication,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Protein DBF4 homolog A,domain:BRCT 1,domain:BRCT 2,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:DBF4-type,
206939_at	DCC netrin 1 receptor(DCC)	Homo sapiens				GO:0001764~neuron migration,GO:0006915~apoptotic process,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0010977~negative regulation of neuron projection development,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0033563~dorsal/ventral axon guidance,GO:0033564~anterior/posterior axon guidance,GO:0038007~netrin-activated signaling pathway,GO:0048671~negative regulation of collateral sprouting,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1901214~regulation of neuron death,GO:2000171~negative regulation of dendrite development,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,	GO:0004888~transmembrane signaling receptor activity,GO:0005042~netrin receptor activity,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010560:Neogenin, C-terminal,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	114500~Colorectal cancer, somatic,157600~Mirror movements 1,Esophageal carcinoma, somatic 133239~Esophageal carcinoma, somatic 133239,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Apoptosis,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Netrin receptor DCC,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
204377_s_at, 204376_at	DDB1 and CUL4 associated factor 1(DCAF1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0030183~B cell differentiation,GO:0033151~V(D)J recombination,GO:0035212~cell competition in a multicellular organism,GO:1990245~histone H2A-T120 phosphorylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:1990244~histone kinase activity (H2A-T120 specific),	IPR006594:LisH dimerisation motif,IPR011989:Armadillo-like helical,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,				SM00667:LisH,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Ubl conjugation pathway,WD repeat,	chain:Protein VPRBP,compositionally biased region:Asp/Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:LisH,modified residue,region of interest:WD repeat-like region,sequence variant,splice variant,
219001_s_at	DDB1 and CUL4 associated factor 10(DCAF10)	Homo sapiens			General function prediction only,	GO:0016567~protein ubiquitination,	GO:0080008~Cul4-RING E3 ubiquitin ligase complex,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 10,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
216389_s_at, 201886_at	DDB1 and CUL4 associated factor 11(DCAF11)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005654~nucleoplasm,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017399:WD repeat protein 23,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,			PIRSF038135:WD repeat protein 23 ,	SM00320:WD40,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 11,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
220843_s_at	DDB1 and CUL4 associated factor 13(DCAF13)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030054~cell junction,GO:0032040~small-subunit processome,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR007287:Sof1-like protein,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 13,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
222012_at, 91952_at, 221851_at, 221849_s_at	DDB1 and CUL4 associated factor 15(DCAF15)	Homo sapiens				GO:0016567~protein ubiquitination,								Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:DDB1- and CUL4-associated factor 15,modified residue,
219717_at	DDB1 and CUL4 associated factor 16(DCAF16)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,						Acetylation,Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:DDB1- and CUL4-associated factor 16,compositionally biased region:Poly-Glu,modified residue,sequence variant,
220172_at	DDB1 and CUL4 associated factor 17(DCAF17)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,				241080~Woodhouse-Sakati syndrome,			Alternative splicing,Complete proteome,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:DDB1- and CUL4-associated factor 17,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,splice variant,transmembrane region,
214758_at	DDB1 and CUL4 associated factor 4(DCAF4)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0080008~Cul4-RING E3 ubiquitin ligase complex,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	3D-structure,Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 4,repeat:WD 1,repeat:WD 2,sequence conflict,sequence variant,splice variant,
217908_s_at	DDB1 and CUL4 associated factor 6(DCAF6)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR000048:IQ motif, EF-hand binding site,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	3D-structure,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 6,domain:IQ,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,splice variant,
221745_at, 209592_s_at, 221744_at	DDB1 and CUL4 associated factor 7(DCAF7)	Homo sapiens				GO:0007275~multicellular organism development,GO:0016567~protein ubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0043234~protein complex,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 7,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,
202250_s_at, 202249_s_at, 216885_s_at	DDB1 and CUL4 associated factor 8(DCAF8)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		610100~Giant axonal neuropathy 2, autosomal dominant,		SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DDB1- and CUL4-associated factor 8,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
212690_at	DDHD domain containing 2(DDHD2)	Homo sapiens				GO:0006654~phosphatidic acid biosynthetic process,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007626~locomotory behavior,GO:0008542~visual learning,GO:0019433~triglyceride catabolic process,GO:0034389~lipid particle organization,GO:0090141~positive regulation of mitochondrial fission,	GO:0005737~cytoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0016020~membrane,GO:0030134~ER to Golgi transport vesicle,	GO:0004620~phospholipase activity,GO:0004806~triglyceride lipase activity,GO:0046872~metal ion binding,	IPR001660:Sterile alpha motif domain,IPR004170:WWE domain,IPR004177:DDHD,IPR013761:Sterile alpha motif/pointed domain,		615033~Spastic paraplegia 54, autosomal recessive,		SM00454:SAM,SM01127:SM01127,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Golgi apparatus,Hereditary spastic paraplegia,Hydrolase,Lipid degradation,Lipid metabolism,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Phospholipase DDHD2,domain:DDHD,domain:SAM,domain:WWE,modified residue,mutagenesis site,sequence conflict,sequence variant,
218159_at	DDRGK domain containing 1(DDRGK1)	Homo sapiens				GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1903721~positive regulation of I-kappaB phosphorylation,GO:1990592~protein K69-linked ufmylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0044389~ubiquitin-like protein ligase binding,	IPR011991:Winged helix-turn-helix DNA-binding domain,IPR019153:DDRGK domain containing protein,				SM01128:SM01128,	Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Ubl conjugation,	chain:DDRGK domain-containing protein 1,domain:PCI,sequence variant,signal peptide,splice variant,
201241_at	DEAD-box helicase 1(DDX1)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006446~regulation of translational initiation,GO:0007275~multicellular organism development,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0043330~response to exogenous dsRNA,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071920~cleavage body,GO:0072669~tRNA-splicing ligase complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008143~poly(A) binding,GO:0033677~DNA/RNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00449:SPRY,SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Exonuclease,Helicase,Hydrolase,mRNA processing,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,tRNA processing,	chain:ATP-dependent RNA helicase DDX1,domain:B30.2/SPRY,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,
204977_at	DEAD-box helicase 10(DDX10)	Homo sapiens			DNA replication, recombination, and repair / Transcription / Translation, ribosomal structure and biogenesis,	GO:0010501~RNA secondary structure unwinding,		GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01178:SM01178,	3D-structure,Acetylation,ATP-binding,Coiled coil,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX10,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,strand,turn,
208151_x_at, 208719_s_at, 213998_s_at, 208718_at	DEAD-box helicase 17(DDX17)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006396~RNA processing,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0030331~estrogen receptor binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative initiation,Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Isopeptide bond,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX17,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
208897_s_at, 208896_at, 205763_s_at, 208895_s_at	DEAD-box helicase 18(DDX18)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:0071392~cellular response to estradiol stimulus,	GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01178:SM01178,	3D-structure,ATP-binding,Chromosome,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX18,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
202577_s_at, 202578_s_at	DEAD-box helicase 19A(DDX19A)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0010501~RNA secondary structure unwinding,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Isopeptide bond,Membrane,mRNA transport,Nuclear pore complex,Nucleotide-binding,Nucleus,Protein transport,Proteomics identification,Reference proteome,RNA-binding,Translocation,Transport,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX19A,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
202576_s_at	DEAD-box helicase 19B(DDX19B)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0010501~RNA secondary structure unwinding,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Membrane,mRNA transport,Nuclear pore complex,Nucleotide-binding,Nucleus,Polymorphism,Protein transport,Proteomics identification,Reference proteome,RNA-binding,Translocation,Transport,	chain:ATP-dependent RNA helicase DDX19B,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,strand,
201440_at, 40465_at	DEAD-box helicase 23(DDX23)	Homo sapiens				GO:0000354~cis assembly of pre-catalytic spliceosome,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005730~nucleolus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,	3D-structure,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Spliceosome,	chain:Probable ATP-dependent RNA helicase DDX23,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
200702_s_at, 200694_s_at	DEAD-box helicase 24(DDX24)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:0016070~RNA metabolic process,	GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX24,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
219945_at	DEAD-box helicase 25(DDX25)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0007286~spermatid development,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0033391~chromatoid body,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,Alternative initiation,ATP-binding,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Helicase,Hydrolase,mRNA transport,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spermatogenesis,Translation regulation,Transport,	chain:ATP-dependent RNA helicase DDX25,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,short sequence motif:Q motif,splice variant,strand,turn,
221780_s_at, 215693_x_at, 219108_x_at	DEAD-box helicase 27(DDX27)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Chromosome,Coiled coil,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,	chain:Probable ATP-dependent RNA helicase DDX27,compositionally biased region:Asp/Glu/Lys-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Nuclear localization signal,short sequence motif:Q motif,
40255_at, 214025_at, 203784_s_at, 203785_s_at	DEAD-box helicase 28(DDX28)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Complete proteome,Helicase,Hydrolase,Mitochondrion,Mitochondrion nucleoid,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA-binding,	chain:Probable ATP-dependent RNA helicase DDX28,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAD,short sequence motif:Mitochondrial targeting signal,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,short sequence motif:Q motif,
212515_s_at, 201210_at, 207617_at, 212514_x_at, 201211_s_at	DEAD-box helicase 3, X-linked(DDX3X)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007059~chromosome segregation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0017148~negative regulation of translation,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031333~negative regulation of protein complex assembly,GO:0032508~DNA duplex unwinding,GO:0032728~positive regulation of interferon-beta production,GO:0034063~stress granule assembly,GO:0035556~intracellular signal transduction,GO:0042256~mature ribosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045070~positive regulation of viral genome replication,GO:0045087~innate immune response,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0071243~cellular response to arsenic-containing substance,GO:0071470~cellular response to osmotic stress,GO:0071651~positive regulation of chemokine (C-C motif) ligand 5 production,GO:0097193~intrinsic apoptotic signaling pathway,GO:0098609~cell-cell adhesion,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903608~protein localization to cytoplasmic stress granule,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016607~nuclear speck,GO:0022627~cytosolic small ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008143~poly(A) binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031369~translation initiation factor binding,GO:0035613~RNA stem-loop binding,GO:0043024~ribosomal small subunit binding,GO:0043273~CTPase activity,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04622:RIG-I-like receptor signaling pathway,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,	300958~Mental retardation, X-linked 102,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Chromosome partition,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Helicase,Host-virus interaction,Hydrolase,Immunity,Innate immunity,Isopeptide bond,Membrane,Mental retardation,Methylation,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX3X,compositionally biased region:Gly/Ser-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with XPO1,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,strand,
205001_s_at, 205000_at	DEAD-box helicase 3, Y-linked(DDX3Y)	Homo sapiens				GO:0006413~translational initiation,GO:0007059~chromosome segregation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX3Y,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
219328_at	DEAD-box helicase 31(DDX31)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01178:SM01178,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX31,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
221630_s_at	DEAD-box helicase 4(DDX4)	Homo sapiens				GO:0007140~male meiosis,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0010501~RNA secondary structure unwinding,GO:0030154~cell differentiation,GO:0030317~sperm motility,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,	GO:0005737~cytoplasm,GO:0043186~P granule,GO:0048471~perinuclear region of cytoplasm,GO:0071546~pi-body,GO:0071547~piP-body,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Helicase,Hydrolase,Meiosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Spermatogenesis,	chain:Probable ATP-dependent RNA helicase DDX4,compositionally biased region:Gly-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
217840_at	DEAD-box helicase 41(DDX41)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006915~apoptotic process,GO:0008283~cell proliferation,GO:0010501~RNA secondary structure unwinding,GO:0030154~cell differentiation,GO:0032479~regulation of type I interferon production,GO:0032481~positive regulation of type I interferon production,GO:0035458~cellular response to interferon-beta,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,ATP-binding,Coiled coil,Complete proteome,Disease mutation,Helicase,Hydrolase,Metal-binding,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Zinc,Zinc-finger,	chain:Probable ATP-dependent RNA helicase DDX41,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,strand,zinc finger region:CCHC-type,
201788_at	DEAD-box helicase 42(DDX42)	Homo sapiens				GO:0008104~protein localization,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX42,compositionally biased region:Gly-rich,compositionally biased region:His-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,short sequence motif:Q motif,splice variant,
220004_at	DEAD-box helicase 43(DDX43)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,	GO:0005622~intracellular,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00322:KH,SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Polymorphism,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX43,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:KH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
202462_s_at	DEAD-box helicase 46(DDX46)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Coiled coil,Complete proteome,Helicase,Hydrolase,Isopeptide bond,Lipoprotein,Membrane,mRNA processing,mRNA splicing,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX46,compositionally biased region:Arg-rich,compositionally biased region:Poly-Asp,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
220890_s_at	DEAD-box helicase 47(DDX47)	Homo sapiens				GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010501~RNA secondary structure unwinding,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,	chain:Probable ATP-dependent RNA helicase DDX47,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,strand,
31807_at, 210811_s_at	DEAD-box helicase 49(DDX49)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005654~nucleoplasm,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX49,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
214968_at	DEAD-box helicase 51(DDX51)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA processing,	chain:ATP-dependent RNA helicase DDX51,compositionally biased region:Arg-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
219111_s_at	DEAD-box helicase 54(DDX54)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0010501~RNA secondary structure unwinding,GO:0016070~RNA metabolic process,GO:0030520~intracellular estrogen receptor signaling pathway,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0030331~estrogen receptor binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012541:DBP10CT,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM01123:SM01123,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,	chain:ATP-dependent RNA helicase DDX54,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with nuclear receptors,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
217754_at	DEAD-box helicase 56(DDX56)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,GO:0010976~positive regulation of neuron projection development,	GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA processing,	chain:Probable ATP-dependent RNA helicase DDX56,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,
204909_at	DEAD-box helicase 6(DDX6)	Homo sapiens				GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0010501~RNA secondary structure unwinding,GO:0019074~viral RNA genome packaging,GO:0019827~stem cell population maintenance,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045665~negative regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0000792~heterochromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0001520~outer dense fiber,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016442~RISC complex,GO:0043186~P granule,GO:0043231~intracellular membrane-bounded organelle,GO:0097227~sperm annulus,	GO:0003676~nucleic acid binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03018:RNA degradation,			SM00487:DEXDc,SM00490:HELICc,	3D-structure,ATP-binding,Chromosomal rearrangement,Complete proteome,Cytoplasm,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,RNA-binding,Ubl conjugation,	chain:Probable ATP-dependent RNA helicase DDX6,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAD box,short sequence motif:Q motif,strand,turn,
210206_s_at, 208149_x_at, 208159_x_at, 213378_s_at	DEAD/H-box helicase 11(DDX11)	Homo sapiens				GO:0006139~nucleobase-containing compound metabolic process,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007275~multicellular organism development,GO:0016032~viral process,GO:0031297~replication fork processing,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0032091~negative regulation of protein binding,GO:0032508~DNA duplex unwinding,GO:0035563~positive regulation of chromatin binding,GO:0036498~IRE1-mediated unfolded protein response,GO:0044806~G-quadruplex DNA unwinding,GO:0045876~positive regulation of sister chromatid cohesion,GO:0072711~cellular response to hydroxyurea,GO:0072719~cellular response to cisplatin,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1904976~cellular response to bleomycin,GO:1990700~nucleolar chromatin organization,GO:2000781~positive regulation of double-strand break repair,	GO:0000790~nuclear chromatin,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,GO:0030892~mitotic cohesin complex,GO:0031390~Ctf18 RFC-like complex,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003688~DNA replication origin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008186~RNA-dependent ATPase activity,GO:0033680~ATP-dependent DNA/RNA helicase activity,GO:0045142~triplex DNA binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0051880~G-quadruplex DNA binding,	IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		613398~Warsaw breakage syndrome,		SM00488:DEXDc2,SM00491:HELICc2,	4Fe-4S,Activator,Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Disease mutation,DNA damage,DNA repair,DNA replication,DNA-binding,Helicase,Host-virus interaction,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,	chain:Probable ATP-dependent RNA helicase DDX11,compositionally biased region:Glu-rich,domain:Helicase ATP-binding,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH,splice variant,
209407_s_at	DEAF1, transcription factor(DEAF1)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001843~neural tube closure,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007281~germ cell development,GO:0008542~visual learning,GO:0009653~anatomical structure morphogenesis,GO:0033599~regulation of mammary gland epithelial cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048706~embryonic skeletal system development,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000770:SAND domain,IPR002893:Zinc finger, MYND-type,IPR010919:SAND domain-like,IPR024119:Transcription factor DEAF-1,		615828~Mental retardation, autosomal dominant 24,		SM00258:SAND,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Deformed epidermal autoregulatory factor 1 homolog,compositionally biased region:Ala-rich,compositionally biased region:Pro-rich,domain:SAND,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:MYND-type,
201386_s_at, 201385_at	DEAH-box helicase 15(DHX15)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009636~response to toxic substance,GO:0043279~response to alkaloid,	GO:0005634~nucleus,GO:0005689~U12-type spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0071008~U2-type post-mRNA release spliceosomal complex,	GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,	chain:Putative pre-mRNA-splicing factor ATP- dependent RNA helicase DHX15,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAH box,
203694_s_at	DEAH-box helicase 16(DHX16)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	ATP-binding,Coiled coil,Complete proteome,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative pre-mRNA-splicing factor ATP- dependent RNA helicase DHX16,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,
218198_at	DEAH-box helicase 32 (putative)(DHX32)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000398~mRNA splicing, via spliceosome,	GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR007502:Helicase-associated domain,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00847:SM00847,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Mitochondrion,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Putative pre-mRNA-splicing factor ATP- dependent RNA helicase DHX32,domain:Helicase ATP-binding,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
218579_s_at	DEAH-box helicase 35(DHX35)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,	GO:0005737~cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,	chain:Probable ATP-dependent RNA helicase DHX35,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,
209178_at	DEAH-box helicase 38(DHX38)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,Ubl conjugation,	chain:Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,
218277_s_at	DEAH-box helicase 40(DHX40)	Homo sapiens				GO:0006396~RNA processing,GO:0006810~transport,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001482:Type II secretion system protein E,IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Probable ATP-dependent RNA helicase DHX40,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAH box,splice variant,
203334_at	DEAH-box helicase 8(DHX8)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR003029:Ribosomal protein S1, RNA-binding domain,IPR007502:Helicase-associated domain,IPR011709:Domain of unknown function DUF1605,IPR012340:Nucleic acid-binding, OB-fold,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR022967:RNA-binding domain, S1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03040:Spliceosome,			SM00316:SM00316,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,ATP-binding,Complete proteome,Helicase,Hydrolase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Spliceosome,	chain:ATP-dependent RNA helicase DHX8,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Poly-Lys,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:S1 motif,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,strand,turn,
221293_s_at	DEF6, guanine nucleotide exchange factor(DEF6)	Homo sapiens					GO:0005634~nucleus,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030175~filopodium,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011992:EF-hand-like domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Acetylation,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Differentially expressed in FDCP 6 homolog,compositionally biased region:Glu-rich,compositionally biased region:Poly-Asp,domain:PH,modified residue,mutagenesis site,sequence variant,
200934_at	DEK proto-oncogene(DEK)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0016569~covalent chromatin modification,GO:0019079~viral genome replication,GO:0045815~positive regulation of gene expression, epigenetic,GO:2000779~regulation of double-strand break repair,GO:2001032~regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043292~contractile fiber,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,	IPR003034:SAP domain,IPR009057:Homeodomain-like,IPR014876:DEK, C-terminal,		Leukemia, acute nonlymphocytic~Leukemia, acute nonlymphocytic,		SM00513:SAP,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Chromosomal rearrangement,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Protein DEK,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Asp/Glu-rich (highly acidic),domain:SAP,helix,modified residue,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
219763_at	DENN domain containing 1A(DENND1A)	Homo sapiens				GO:0006897~endocytosis,GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0032483~regulation of Rab protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0048488~synaptic vesicle endocytosis,	GO:0030054~cell junction,GO:0030136~clathrin-coated vesicle,GO:0030425~dendrite,GO:0030665~clathrin-coated vesicle membrane,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017124~SH3 domain binding,GO:0017137~Rab GTPase binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Guanine-nucleotide releasing factor,Lipid-binding,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Synapse,Transport,	chain:DENN domain-containing protein 1A,compositionally biased region:Pro-rich,domain:dDENN,domain:DENN,domain:uDENN,modified residue,sequence conflict,splice variant,
219696_at	DENN domain containing 1B(DENND1B)	Homo sapiens				GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0035745~T-helper 2 cell cytokine production,GO:0043547~positive regulation of GTPase activity,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005829~cytosol,GO:0030136~clathrin-coated vesicle,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	3D-structure,Alternative splicing,Asthma,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:DENN domain-containing protein 1B,domain:dDENN,domain:DENN,domain:uDENN,sequence conflict,sequence variant,splice variant,
221080_s_at	DENN domain containing 1C(DENND1C)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0030136~clathrin-coated vesicle,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DENN domain-containing protein 1C,domain:dDENN,domain:DENN,domain:uDENN,modified residue,sequence conflict,sequence variant,
221886_at, 221885_at, 53991_at	DENN domain containing 2A(DENND2A)	Homo sapiens				GO:0015031~protein transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0015629~actin cytoskeleton,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:DENN domain-containing protein 2A,domain:dDENN,domain:DENN,domain:uDENN,modified residue,sequence conflict,sequence variant,splice variant,
221081_s_at	DENN domain containing 2D(DENND2D)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Polymorphism,Reference proteome,	chain:DENN domain-containing protein 2D,domain:dDENN,domain:DENN,domain:uDENN,sequence conflict,sequence variant,splice variant,
212975_at, 212974_at	DENN domain containing 3(DENND3)	Homo sapiens				GO:0008333~endosome to lysosome transport,GO:0043547~positive regulation of GTPase activity,GO:0044257~cellular protein catabolic process,	GO:0005622~intracellular,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR001680:WD40 repeat,IPR005112:dDENN domain,IPR005113:uDENN domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,SM00799:DENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:DENN domain-containing protein 3,domain:dDENN,domain:DENN,domain:uDENN,repeat:WD 1,repeat:WD 2,repeat:WD 3,sequence variant,splice variant,
214787_at	DENN domain containing 4A(DENND4A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR002885:Pentatricopeptide repeat,IPR005112:dDENN domain,IPR005113:uDENN domain,IPR023341:MABP domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,DNA-binding,Guanine-nucleotide releasing factor,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:C-myc promoter-binding protein,compositionally biased region:Poly-Glu,domain:dDENN,domain:DENN,domain:uDENN,modified residue,repeat:PPR 1,repeat:PPR 2,sequence conflict,sequence variant,short sequence motif:Bipartite nuclear localization signal,
202860_at	DENN domain containing 4B(DENND4B)	Homo sapiens				GO:0032483~regulation of Rab protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005794~Golgi apparatus,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR002885:Pentatricopeptide repeat,IPR005112:dDENN domain,IPR005113:uDENN domain,IPR023341:MABP domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Coiled coil,Complete proteome,Golgi apparatus,Guanine-nucleotide releasing factor,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:DENN domain-containing protein 4B,compositionally biased region:Gln-rich,compositionally biased region:Ser-rich,domain:dDENN,domain:DENN,domain:uDENN,modified residue,repeat:PPR 1,repeat:PPR 2,
205684_s_at	DENN domain containing 4C(DENND4C)	Homo sapiens				GO:0015031~protein transport,GO:0032869~cellular response to insulin stimulus,GO:0043547~positive regulation of GTPase activity,GO:0072659~protein localization to plasma membrane,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030904~retromer complex,GO:0032593~insulin-responsive compartment,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,IPR023341:MABP domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:DENN domain-containing protein 4C,compositionally biased region:Poly-Ser,domain:dDENN,domain:DENN,domain:uDENN,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:PPR,sequence conflict,sequence variant,splice variant,transmembrane region,
212561_at	DENN domain containing 5A(DENND5A)	Homo sapiens				GO:0042147~retrograde transport, endosome to Golgi,GO:0043547~positive regulation of GTPase activity,GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0030904~retromer complex,	GO:0005262~calcium channel activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0017137~Rab GTPase binding,	IPR001024:Lipoxygenase, LH2,IPR001194:DENN domain,IPR004012:RUN,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00593:RUN,SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:DENN domain-containing protein 5A,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gly,domain:dDENN,domain:DENN,domain:PLAT,domain:RUN 1,domain:RUN 2,domain:uDENN,modified residue,sequence conflict,sequence variant,
215058_at	DENN domain containing 5B(DENND5B)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001024:Lipoxygenase, LH2,IPR001194:DENN domain,IPR004012:RUN,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00593:RUN,SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Acetylation,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:DENN domain-containing protein 5B,domain:dDENN,domain:DENN,domain:PLAT,domain:RUN 1,domain:RUN 2,domain:uDENN,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
220713_at	DENN domain containing 6B(DENND6B)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,	GO:0055037~recycling endosome,	GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR018307:Late secretory pathway protein AVL9,IPR024224:Uncharacterised protein family FAM116,					Complete proteome,Cytoplasm,Endosome,Guanine-nucleotide releasing factor,Reference proteome,	chain:Protein FAM116B,
220295_x_at	DEP domain containing 1(DEPDC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000198:Rho GTPase-activating protein domain,IPR000591:DEP domain,IPR008936:Rho GTPase activation protein,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00049:DEP,	3D-structure,Alternative splicing,Complete proteome,GTPase activation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DEP domain-containing protein 1A,domain:DEP,domain:Rho-GAP,helix,modified residue,sequence variant,splice variant,strand,
205223_at	DEP domain containing 5(DEPDC5)	Homo sapiens				GO:0010506~regulation of autophagy,GO:0032007~negative regulation of TOR signaling,GO:0034198~cellular response to amino acid starvation,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:1904262~negative regulation of TORC1 signaling,	GO:0005622~intracellular,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:1990130~Iml1 complex,	GO:0005096~GTPase activator activity,GO:0032403~protein complex binding,	IPR000591:DEP domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR027244:Vacuolar membrane-associated protein Iml1,		604364~Epilepsy, familial focal, with variable foci,		SM00049:DEP,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Epilepsy,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DEP domain-containing protein 5,domain:DEP,sequence conflict,sequence variant,splice variant,
218858_at	DEP domain containing MTOR-interacting protein(DEPTOR)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0032007~negative regulation of TOR signaling,GO:0035556~intracellular signal transduction,GO:0045792~negative regulation of cell size,GO:2001236~regulation of extrinsic apoptotic signaling pathway,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR000591:DEP domain,IPR001478:PDZ domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00049:DEP,SM00228:PDZ,	Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:DEP domain-containing mTOR-interacting protein,compositionally biased region:Poly-Arg,compositionally biased region:Ser-rich,domain:DEP 1,domain:DEP 2,domain:PDZ,modified residue,sequence conflict,sequence variant,
218260_at	DET1 and DDB1 associated 1(DDA1)	Homo sapiens				GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,		GO:0005515~protein binding,	IPR018276:Ubiquitin ligase, Det1/DDB1-complexing,					Acetylation,Complete proteome,Phosphoprotein,Reference proteome,Ubl conjugation pathway,	chain:DET1- and DDB1-associated protein 1,modified residue,
208152_s_at	DExD-box helicase 21(DDX21)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0043330~response to exogenous dsRNA,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0097322~7SK snRNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Helicase,Hydrolase,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,rRNA processing,Transcription,Ubl conjugation,	chain:Nucleolar RNA helicase 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,region of interest:3 X 5 AA repeats,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,short sequence motif:DEVD box,short sequence motif:Q motif,splice variant,
201584_s_at	DExD-box helicase 39A(DDX39A)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006974~cellular response to DNA damage stimulus,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0031124~mRNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX39,compositionally biased region:Poly-Glu,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DECD box,short sequence motif:Q motif,
221699_s_at	DExD-box helicase 50(DDX50)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:ATP-dependent RNA helicase DDX50,compositionally biased region:Arg-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEVD box,short sequence motif:Q motif,strand,
210320_s_at, 212834_at, 213637_at	DExD-box helicase 52(DDX52)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX52,compositionally biased region:Lys-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,strand,
218943_s_at	DExD/H-box helicase 58(DDX58)	Homo sapiens			DNA replication, recombination, and repair,	GO:0002230~positive regulation of defense response to virus by host,GO:0009597~detection of virus,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0030334~regulation of cell migration,GO:0032480~negative regulation of type I interferon production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0034344~regulation of type III interferon production,GO:0039528~cytoplasmic pattern recognition receptor signaling pathway in response to virus,GO:0039529~RIG-I signaling pathway,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043330~response to exogenous dsRNA,GO:0045087~innate immune response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005923~bicellular tight junction,GO:0015629~actin cytoskeleton,GO:0032587~ruffle membrane,	GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0042802~identical protein binding,	IPR001650:Helicase, C-terminal,IPR011029:Death-like domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR021673:C-terminal domain of RIG-I,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04064:NF-kappa B signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,	616298~Singleton-Merten syndrome 2,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,Antiviral defense,ATP-binding,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Helicase,Host-virus interaction,Hydrolase,Immunity,Innate immunity,Isopeptide bond,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Tight junction,Ubl conjugation,Zinc,	chain:Probable ATP-dependent RNA helicase DDX58,domain:CARD 1,domain:CARD 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Repressor domain,sequence variant,short sequence motif:DECH box,splice variant,strand,turn,
218986_s_at	DExD/H-box helicase 60(DDX60)	Homo sapiens			DNA replication, recombination, and repair,	GO:0009615~response to virus,GO:0045087~innate immune response,GO:0051607~defense response to virus,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0005737~cytoplasm,GO:0045111~intermediate filament cytoskeleton,	GO:0003690~double-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Immunity,Innate immunity,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX60,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEVH box,
212648_at	DExH-box helicase 29(DHX29)	Homo sapiens				GO:0006396~RNA processing,GO:0006413~translational initiation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0016282~eukaryotic 43S preinitiation complex,	GO:0003676~nucleic acid binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Helicase,Hydrolase,Initiation factor,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:ATP-dependent RNA helicase DHX29,compositionally biased region:Ala-rich,compositionally biased region:Poly-Glu,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,
204355_at, 212674_s_at	DExH-box helicase 30(DHX30)	Homo sapiens				GO:0006396~RNA processing,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Mitochondrion,Mitochondrion nucleoid,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,	chain:Putative ATP-dependent RNA helicase DHX30,compositionally biased region:Poly-Glu,domain:DRBM,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DEAH box,splice variant,strand,turn,
214017_s_at, 204815_s_at, 204816_s_at	DExH-box helicase 34(DHX34)	Homo sapiens				GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006396~RNA processing,GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DHX34,domain:Helicase ATP-binding,domain:Helicase C-terminal,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEIH box,
213420_at	DExH-box helicase 57(DHX57)	Homo sapiens				GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR006575:RWD domain,IPR007502:Helicase-associated domain,IPR009060:UBA-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00356:ZnF_C3H1,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Helicase,Hydrolase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Zinc,Zinc-finger,	chain:Putative ATP-dependent RNA helicase DHX57,compositionally biased region:Gly-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:UBA,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEVH box,splice variant,zinc finger region:C3H1-type,
219364_at	DExH-box helicase 58(DHX58)	Homo sapiens			DNA replication, recombination, and repair,	GO:0009615~response to virus,GO:0032480~negative regulation of type I interferon production,GO:0032481~positive regulation of type I interferon production,GO:0039534~negative regulation of MDA-5 signaling pathway,GO:0039536~negative regulation of RIG-I signaling pathway,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045824~negative regulation of innate immune response,GO:0051607~defense response to virus,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,	IPR001650:Helicase, C-terminal,IPR006935:Helicase/UvrB domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR021673:C-terminal domain of RIG-I,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04622:RIG-I-like receptor signaling pathway,			SM00487:DEXDc,SM00490:HELICc,	3D-structure,Antiviral defense,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Helicase,Host-virus interaction,Hydrolase,Immunity,Innate immunity,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Zinc,	chain:Probable ATP-dependent RNA helicase DHX58,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,metal ion-binding site:Zinc,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:RNA-binding,sequence conflict,sequence variant,short sequence motif:DECH box,strand,turn,
212107_s_at, 212105_s_at, 202420_s_at	DExH-box helicase 9(DHX9)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006396~RNA processing,GO:0032481~positive regulation of type I interferon production,GO:0032508~DNA duplex unwinding,GO:0048511~rhythmic process,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0097165~nuclear stress granule,	GO:0001085~RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003724~RNA helicase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014720:Double-stranded RNA-binding-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00358:DSRM,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Biological rhythms,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Helicase,Hydrolase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,	chain:ATP-dependent RNA helicase A,domain:DRBM 1,domain:DRBM 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,region of interest:Interaction with CREBBP,region of interest:MTAD,region of interest:NTD,sequence conflict,sequence variant,short sequence motif:DEIH box,short sequence motif:Nuclear localization signal,
203695_s_at	DFNA5, deafness associated tumor suppressor(DFNA5)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0008285~negative regulation of cell proliferation,GO:0012501~programmed cell death,GO:0060113~inner ear receptor cell differentiation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,		IPR007677:Gasdermin,		600994~Deafness, autosomal dominant 5,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Deafness,Disulfide bond,Membrane,Necrosis,Non-syndromic deafness,Polymorphism,Proteomics identification,Reference proteome,Signal,Tumor suppressor,	chain:Non-syndromic hearing impairment protein 5,sequence variant,splice variant,
217050_at, 217245_at	DIAPH2 antisense RNA 1(DIAPH2-AS1)	Homo sapiens				GO:0007165~signal transduction,		GO:0004871~signal transducer activity,						Complete proteome,Reference proteome,	chain:Early lymphoid activation gene protein,sequence conflict,
210801_at, 204405_x_at, 210802_s_at, 217106_x_at	DIM1 dimethyladenosine transferase 1 homolog(DIMT1)	Homo sapiens				GO:0031167~rRNA methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,	GO:0000179~rRNA (adenine-N6,N6-)-dimethyltransferase activity,GO:0044822~poly(A) RNA binding,GO:0052909~18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,	IPR001737:Ribosomal RNA adenine methylase transferase,IPR011530:Ribosomal RNA adenine dimethylase,IPR020596:Ribosomal RNA adenine methylase transferase, conserved site,IPR020598:Ribosomal RNA adenine methylase transferase, N-terminal,				SM00650:rADc,	3D-structure,Complete proteome,Methyltransferase,Nucleus,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via amide nitrogen,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,chain:Probable dimethyladenosine transferase,helix,sequence conflict,strand,turn,
219619_at	DIRAS family GTPase 2(DIRAS2)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043406~positive regulation of MAP kinase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,	GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,	chain:GTP-binding protein Di-Ras2,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
215506_s_at	DIRAS family GTPase 3(DIRAS3)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:GTP-binding protein Di-Ras3,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,
214194_at, 218362_s_at	DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease(DIS3)	Homo sapiens			Transcription,	GO:0006364~rRNA processing,GO:0006402~mRNA catabolic process,GO:0016075~rRNA catabolic process,GO:0043488~regulation of mRNA stability,GO:0043547~positive regulation of GTPase activity,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0071034~CUT catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003723~RNA binding,GO:0004519~endonuclease activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR002716:PIN domain,IPR012340:Nucleic acid-binding, OB-fold,IPR022966:Ribonuclease II/R, conserved site,	hsa03018:RNA degradation,			SM00670:PINc,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Endonuclease,Exonuclease,Exosome,Hydrolase,Magnesium,Manganese,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,	chain:Exosome complex exonuclease RRP44,domain:PINc,modified residue,sequence conflict,sequence variant,splice variant,
214724_at	DIX domain containing 1(DIXDC1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007049~cell cycle,GO:0016055~Wnt signaling pathway,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021869~forebrain ventricular zone progenitor cell division,GO:0032956~regulation of actin cytoskeleton organization,GO:0045665~negative regulation of neuron differentiation,GO:0060070~canonical Wnt signaling pathway,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0043015~gamma-tubulin binding,	IPR001158:DIX domain,IPR001715:Calponin homology domain,IPR015506:Dishevelled-related protein,				SM00021:DAX,SM00033:CH,	3D-structure,Actin-binding,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Lipoprotein,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Wnt signaling pathway,	chain:Dixin,domain:CH,domain:DIX,modified residue,region of interest:Actin-binding,sequence conflict,sequence variant,splice variant,
220512_at, 220511_s_at, 210762_s_at	DLC1 Rho GTPase activating protein(DLC1)	Homo sapiens				GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0021575~hindbrain morphogenesis,GO:0030036~actin cytoskeleton organization,GO:0030336~negative regulation of cell migration,GO:0030900~forebrain development,GO:0032956~regulation of actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0035024~negative regulation of Rho protein signal transduction,GO:0035307~positive regulation of protein dephosphorylation,GO:0043547~positive regulation of GTPase activity,GO:0048041~focal adhesion assembly,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:1900119~positive regulation of execution phase of apoptosis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005901~caveola,GO:0005925~focal adhesion,GO:0030864~cortical actin cytoskeleton,GO:0032587~ruffle membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0042169~SH2 domain binding,	IPR000198:Rho GTPase-activating protein domain,IPR001660:Sterile alpha motif domain,IPR002913:START domain,IPR008936:Rho GTPase activation protein,IPR013761:Sterile alpha motif/pointed domain,IPR023393:START-like domain,		114500~Colorectal cancer, somatic,		SM00234:START,SM00324:RhoGAP,	3D-structure,Alternative promoter usage,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,GTPase activation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Rho GTPase-activating protein 7,compositionally biased region:Poly-Ser,domain:Rho-GAP,domain:SAM,domain:START,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
210750_s_at, 206489_s_at, 206490_at	DLG associated protein 1(DLGAP1)	Homo sapiens				GO:0007268~chemical synaptic transmission,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,	hsa04724:Glutamatergic synapse,				Alternative splicing,Cell junction,Cell membrane,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Synapse,	chain:Disks large-associated protein 1,compositionally biased region:Poly-Thr,modified residue,region of interest:Interaction with DYL2,sequence conflict,sequence variant,short sequence motif:PDZ-binding,splice variant,
216916_s_at, 210227_at	DLG associated protein 2(DLGAP2)	Homo sapiens				GO:0007270~neuron-neuron synaptic transmission,	GO:0005883~neurofilament,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,					Alternative splicing,Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Synapse,	chain:Disks large-associated protein 2,modified residue,sequence conflict,sequence variant,splice variant,
202570_s_at, 202571_s_at, 202572_s_at	DLG associated protein 4(DLGAP4)	Homo sapiens				GO:0023052~signaling,	GO:0016020~membrane,GO:0045202~synapse,	GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,					Alternative splicing,Complete proteome,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Disks large-associated protein 4,compositionally biased region:Poly-Pro,modified residue,sequence conflict,sequence variant,splice variant,
203764_at	DLG associated protein 5(DLGAP5)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007079~mitotic chromosome movement towards spindle pole,GO:0008283~cell proliferation,GO:0023052~signaling,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0031616~spindle pole centrosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,					Alternative splicing,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Disks large-associated protein 5,modified residue,sequence conflict,sequence variant,splice variant,
209804_at	DNA cross-link repair 1A(DCLRE1A)	Homo sapiens				GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007067~mitotic nuclear division,GO:0031848~protection from non-homologous end joining at telomere,GO:0036297~interstrand cross-link repair,GO:0051301~cell division,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003684~damaged DNA binding,GO:0035312~5'-3' exodeoxyribonuclease activity,	IPR001279:Beta-lactamase-like,IPR011084:DNA repair metallo-beta-lactamase,					3D-structure,Cell cycle,Cell division,Complete proteome,DNA damage,DNA repair,Isopeptide bond,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:DNA cross-link repair 1A protein,modified residue,mutagenesis site,region of interest:Nuclear focus formation,region of interest:Nuclear localization region,sequence variant,
219490_s_at	DNA cross-link repair 1B(DCLRE1B)	Homo sapiens				GO:0000075~cell cycle checkpoint,GO:0000723~telomere maintenance,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0031627~telomeric loop formation,GO:0031848~protection from non-homologous end joining at telomere,GO:0031860~telomeric 3' overhang formation,GO:0036297~interstrand cross-link repair,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0035312~5'-3' exodeoxyribonuclease activity,	IPR001279:Beta-lactamase-like,IPR011084:DNA repair metallo-beta-lactamase,					3D-structure,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA repair,Dyskeratosis congenita,Exonuclease,Hydrolase,Nuclease,Nucleus,Polymorphism,Reference proteome,Telomere,Ubl conjugation,	chain:DNA cross-link repair 1B protein,helix,modified residue,sequence conflict,sequence variant,
222233_s_at, 219678_x_at	DNA cross-link repair 1C(DCLRE1C)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0010212~response to ionizing radiation,GO:0030183~B cell differentiation,GO:0031848~protection from non-homologous end joining at telomere,GO:0033151~V(D)J recombination,GO:0036297~interstrand cross-link repair,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0070419~nonhomologous end joining complex,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003684~damaged DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0035312~5'-3' exodeoxyribonuclease activity,	IPR001279:Beta-lactamase-like,IPR011084:DNA repair metallo-beta-lactamase,	hsa03450:Non-homologous end-joining,hsa05340:Primary immunodeficiency,	602450~Severe combined immunodeficiency, Athabascan type,603554~Omenn syndrome,			3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disease mutation,DNA damage,DNA recombination,DNA repair,Endonuclease,Exonuclease,Hydrolase,Immunity,Magnesium,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SCID,	chain:Protein artemis,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
209383_at	DNA damage inducible transcript 3(DDIT3)	Homo sapiens		h_p38mapkPathway:p38 MAPK Signaling Pathway ,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001955~blood vessel maturation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006983~ER overload response,GO:0006986~response to unfolded protein,GO:0007050~cell cycle arrest,GO:0016055~Wnt signaling pathway,GO:0032757~positive regulation of interleukin-8 production,GO:0032792~negative regulation of CREB transcription factor activity,GO:0034976~response to endoplasmic reticulum stress,GO:0036499~PERK-mediated unfolded protein response,GO:0036500~ATF6-mediated unfolded protein response,GO:0042594~response to starvation,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043525~positive regulation of neuron apoptotic process,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0044324~regulation of transcription involved in anterior/posterior axis specification,GO:0045454~cell redox homeostasis,GO:0045599~negative regulation of fat cell differentiation,GO:0045662~negative regulation of myoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051898~negative regulation of protein kinase B signaling,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0072655~establishment of protein localization to mitochondrion,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903026~negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990442~intrinsic apoptotic signaling pathway in response to nitrosative stress,GO:2000016~negative regulation of determination of dorsal identity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005829~cytosol,GO:0032993~protein-DNA complex,GO:0035976~AP1 complex,GO:0036488~CHOP-C/EBP complex,GO:1990617~CHOP-ATF4 complex,GO:1990622~CHOP-ATF3 complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008140~cAMP response element binding protein binding,GO:0042803~protein homodimerization activity,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016670:DNA damage-inducible transcript 3,	hsa04010:MAPK signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05202:Transcriptional misregulation in cancer,	613488~Myxoid liposarcoma,	PIRSF016571:C/EBP-zeta (C/EBP-homologous protein),	SM00338:BRLZ,	Activator,Alternative splicing,Apoptosis,Cell cycle,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Growth arrest,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Repressor,Stress response,Transcription,Transcription regulation,Ubl conjugation,Unfolded protein response,Wnt signaling pathway,	chain:DNA damage-inducible transcript 3,compositionally biased region:Poly-Glu,domain:Leucine-zipper,sequence conflict,sequence variant,
202887_s_at	DNA damage inducible transcript 4(DDIT4)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001764~neuron migration,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0030182~neuron differentiation,GO:0032007~negative regulation of TOR signaling,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043241~protein complex disassembly,GO:0045820~negative regulation of glycolytic process,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0051607~defense response to virus,GO:0071549~cellular response to dexamethasone stimulus,GO:0072593~reactive oxygen species metabolic process,GO:1901216~positive regulation of neuron death,GO:1902532~negative regulation of intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0071889~14-3-3 protein binding,	IPR012918:RTP801-like,	hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,				3D-structure,Antiviral defense,Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,Mitochondrion,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:DNA-damage-inducible transcript 4 protein,sequence conflict,
218627_at	DNA damage regulated autophagy modulator 1(DRAM1)	Homo sapiens				GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0010506~regulation of autophagy,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR019402:Frag1/DRAM/Sfk1,					Alternative splicing,Apoptosis,Autophagy,Complete proteome,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DNA damage-regulated autophagy modulator protein 1,transmembrane region,
203277_at	DNA fragmentation factor subunit alpha(DFFA)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_setPathway:Granzyme A mediated Apoptosis Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006309~apoptotic DNA fragmentation,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0070242~thymocyte apoptotic process,GO:1900118~negative regulation of execution phase of apoptosis,GO:1902511~negative regulation of apoptotic DNA fragmentation,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR000488:Death domain,IPR003508:Caspase-activated nuclease CIDE-N,IPR015121:DNA fragmentation factor 45kDa, middle domain,IPR017299:DNA fragmentation factor, alpha subunit,IPR027296:DNA fragmentation factor 45kDa C-terminal domain,	hsa04210:Apoptosis,		PIRSF037865:DNA fragmentation factor, alpha subunit,	SM00266:CAD,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DNA fragmentation factor subunit alpha,domain:CIDE-N,helix,modified residue,sequence conflict,site:Cleavage; by caspase-3,splice variant,strand,turn,
206752_s_at	DNA fragmentation factor subunit beta(DFFB)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_setPathway:Granzyme A mediated Apoptosis Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006309~apoptotic DNA fragmentation,GO:0006915~apoptotic process,GO:0030263~apoptotic chromosome condensation,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004536~deoxyribonuclease activity,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,	IPR003508:Caspase-activated nuclease CIDE-N,IPR015311:Apoptosis, DNA fragmentation factor 40kDa,	hsa04210:Apoptosis,			SM00266:CAD,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Hydrolase,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA fragmentation factor subunit beta,domain:CIDE-N,helix,sequence variant,splice variant,strand,turn,
202726_at	DNA ligase 1(LIG1)	Homo sapiens				GO:0000722~telomere maintenance via recombination,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006471~protein ADP-ribosylation,GO:0009653~anatomical structure morphogenesis,GO:0033151~V(D)J recombination,GO:0051103~DNA ligation involved in DNA repair,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,GO:1903461~Okazaki fragment processing involved in mitotic DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000977:DNA ligase, ATP-dependent,IPR012308:DNA ligase, ATP-dependent, N-terminal,IPR012309:DNA ligase, ATP-dependent, C-terminal,IPR012310:DNA ligase, ATP-dependent, central,IPR012340:Nucleic acid-binding, OB-fold,IPR016059:DNA ligase, ATP-dependent, conserved site,	hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,	DNA ligase I deficiency~DNA ligase I deficiency,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Coiled coil,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA replication,Isopeptide bond,Ligase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:N6-AMP-lysine intermediate,binding site:ATP,chain:DNA ligase 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,region of interest:Interaction with target DNA,sequence variant,site:Interaction with target DNA,strand,turn,
207348_s_at, 204123_at	DNA ligase 3(LIG3)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006266~DNA ligation,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006288~base-excision repair, DNA ligation,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0033151~V(D)J recombination,GO:0043504~mitochondrial DNA repair,GO:0051103~DNA ligation involved in DNA repair,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,GO:0090298~negative regulation of mitochondrial DNA replication,GO:0097681~double-strand break repair via alternative nonhomologous end joining,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0070421~DNA ligase III-XRCC1 complex,	GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000977:DNA ligase, ATP-dependent,IPR001357:BRCT domain,IPR001510:Zinc finger, PARP-type,IPR012308:DNA ligase, ATP-dependent, N-terminal,IPR012309:DNA ligase, ATP-dependent, C-terminal,IPR012310:DNA ligase, ATP-dependent, central,IPR012340:Nucleic acid-binding, OB-fold,IPR016059:DNA ligase, ATP-dependent, conserved site,	hsa03410:Base excision repair,			SM00292:BRCT,SM01336:SM01336,	3D-structure,Alternative initiation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA replication,Ligase,Magnesium,Metal-binding,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Zinc,Zinc-finger,	active site:N6-AMP-lysine intermediate,binding site:ATP,chain:DNA ligase 3,domain:BRCT,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,sequence variant,splice variant,strand,turn,zinc finger region:PARP-type,
206235_at	DNA ligase 4(LIG4)	Homo sapiens				GO:0000012~single strand break repair,GO:0001701~in utero embryonic development,GO:0002328~pro-B cell differentiation,GO:0006260~DNA replication,GO:0006266~DNA ligation,GO:0006273~lagging strand elongation,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0007049~cell cycle,GO:0007417~central nervous system development,GO:0008283~cell proliferation,GO:0010165~response to X-ray,GO:0010332~response to gamma radiation,GO:0033077~T cell differentiation in thymus,GO:0033151~V(D)J recombination,GO:0033152~immunoglobulin V(D)J recombination,GO:0033153~T cell receptor V(D)J recombination,GO:0035019~somatic stem cell population maintenance,GO:0043524~negative regulation of neuron apoptotic process,GO:0045190~isotype switching,GO:0048146~positive regulation of fibroblast proliferation,GO:0050769~positive regulation of neurogenesis,GO:0051102~DNA ligation involved in DNA recombination,GO:0051103~DNA ligation involved in DNA repair,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051402~neuron apoptotic process,GO:0071285~cellular response to lithium ion,GO:0071897~DNA biosynthetic process,GO:0075713~establishment of integrated proviral latency,GO:0097680~double-strand break repair via classical nonhomologous end joining,GO:2001252~positive regulation of chromosome organization,	GO:0000784~nuclear chromosome, telomeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005958~DNA-dependent protein kinase-DNA ligase 4 complex,GO:0032807~DNA ligase IV complex,GO:0070419~nonhomologous end joining complex,	GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000977:DNA ligase, ATP-dependent,IPR001357:BRCT domain,IPR012308:DNA ligase, ATP-dependent, N-terminal,IPR012309:DNA ligase, ATP-dependent, C-terminal,IPR012310:DNA ligase, ATP-dependent, central,IPR012340:Nucleic acid-binding, OB-fold,IPR016059:DNA ligase, ATP-dependent, conserved site,IPR021536:DNA ligase IV,	hsa03450:Non-homologous end-joining,	254500~Multiple myeloma, resistance to,606593~LIG4 syndrome,		SM00292:BRCT,	3D-structure,ATP-binding,Cell cycle,Cell division,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA replication,Ligase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,SCID,	active site:N6-AMP-lysine intermediate,binding site:ATP,chain:DNA ligase 4,domain:BRCT 1,domain:BRCT 2,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,sequence conflict,sequence variant,strand,turn,
208382_s_at, 208386_x_at	DNA meiotic recombinase 1(DMC1)	Homo sapiens				GO:0000730~DNA recombinase assembly,GO:0001541~ovarian follicle development,GO:0001556~oocyte maturation,GO:0006281~DNA repair,GO:0006312~mitotic recombination,GO:0007126~meiotic nuclear division,GO:0007129~synapsis,GO:0007131~reciprocal meiotic recombination,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007292~female gamete generation,GO:0010212~response to ionizing radiation,GO:0042148~strand invasion,GO:0070192~chromosome organization involved in meiotic cell cycle,	GO:0000781~chromosome, telomeric region,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0000150~recombinase activity,GO:0000166~nucleotide binding,GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,	IPR003593:AAA+ ATPase domain,IPR010995:DNA repair Rad51/transcription factor NusA, alpha-helical,IPR011940:Meiotic recombinase Dmc1,IPR013632:DNA recombination and repair protein Rad51, C-terminal,IPR016467:DNA recombination and repair protein, RecA-like,IPR020587:DNA recombination/repair protein RecA, monomer-monomer interface,IPR020588:DNA recombination/repair protein RecA/RadB, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF005856:DNA repair and recombination protein, Rad51 type,	SM00382:AAA,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Chromosome,Complete proteome,DNA-binding,Meiosis,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	binding site:ssDNA,binding site:ssDNA or dsDNA,chain:Meiotic recombination protein DMC1/LIM15 homolog,helix,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
201697_s_at	DNA methyltransferase 1(DNMT1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0010216~maintenance of DNA methylation,GO:0010628~positive regulation of gene expression,GO:0016458~gene silencing,GO:0016569~covalent chromatin modification,GO:0042127~regulation of cell proliferation,GO:0043045~DNA methylation involved in embryo development,GO:0045814~negative regulation of gene expression, epigenetic,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0071230~cellular response to amino acid stimulus,GO:0090116~C-5 methylation of cytosine,GO:0090309~positive regulation of methylation-dependent chromatin silencing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005721~pericentric heterochromatin,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0009008~DNA-methyltransferase activity,GO:1990841~promoter-specific chromatin binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001525:C-5 cytosine methyltransferase,IPR002857:Zinc finger, CXXC-type,IPR010506:DMAP1-binding,IPR017198:DNA (cytosine-5)-methyltransferase 1, eukaryote,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR022702:DNA (cytosine-5)-methyltransferase 1, replication foci domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	604121~Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant,614116~Neuropathy, hereditary sensory, type IE,	PIRSF037404:DNA (cytosine-5)-methyltransferase 1, DNMT1 type,	SM00439:BAH,SM01137:SM01137,	3D-structure,Acetylation,Activator,Alternative splicing,Chromatin regulator,Complete proteome,Deafness,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Methylation,Methyltransferase,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 1,domain:BAH 1,domain:BAH 2,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:6 X 2 AA tandem repeats of K-G,region of interest:Catalytic,region of interest:DNA replication foci-targeting sequence,region of interest:Homodimerization,region of interest:Interaction with DMAP1,region of interest:Interaction with DNMT3A,region of interest:Interaction with DNMT3B,region of interest:Interaction with PCNA,region of interest:Interaction with the PRC2/EED-EZH2 complex,region of interest:Required for activity,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6; approximate,sequence variant,short sequence motif:Nuclear localization signal,site:Important for activity,splice variant,strand,turn,zinc finger region:CXXC-type,
218457_s_at	DNA methyltransferase 3 alpha(DNMT3A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007283~spermatogenesis,GO:0007568~aging,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010288~response to lead ion,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030182~neuron differentiation,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0043046~DNA methylation involved in gamete generation,GO:0044027~hypermethylation of CpG island,GO:0045814~negative regulation of gene expression, epigenetic,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0071230~cellular response to amino acid stimulus,GO:0071361~cellular response to ethanol,GO:0071456~cellular response to hypoxia,GO:0090116~C-5 methylation of cytosine,GO:0097284~hepatocyte apoptotic process,	GO:0000775~chromosome, centromeric region,GO:0000791~euchromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0009008~DNA-methyltransferase activity,GO:0042802~identical protein binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,	IPR000313:PWWP,IPR001525:C-5 cytosine methyltransferase,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR025766:ADD domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	615879~Tatton-Brown-Rahman syndrome,		SM00293:PWWP,	3D-structure,Alternative promoter usage,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-adenosyl-L-methionine,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3A,domain:PWWP,helix,modified residue,mutagenesis site,region of interest:Interaction with DNMT1 and DNMT3B,region of interest:Interaction with the PRC2/EED-EZH2 complex,splice variant,strand,turn,zinc finger region:ADD-type,
220668_s_at	DNA methyltransferase 3 beta(DNMT3B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0006306~DNA methylation,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0014823~response to activity,GO:0031000~response to caffeine,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0045666~positive regulation of neuron differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0071455~cellular response to hyperoxia,GO:0071549~cellular response to dexamethasone stimulus,GO:0090116~C-5 methylation of cytosine,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0009008~DNA-methyltransferase activity,GO:0042826~histone deacetylase binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,	IPR000313:PWWP,IPR001525:C-5 cytosine methyltransferase,IPR011011:Zinc finger, FYVE/PHD-type,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR025766:ADD domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	242860~Immunodeficiency-centromeric instability-facial anomalies syndrome 1,		SM00293:PWWP,	3D-structure,Activator,Alternative splicing,Citrullination,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,S-adenosyl-L-methionine,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3B,domain:PWWP,helix,region of interest:Interaction with DNMT1 and DNMT3A,region of interest:Interaction with the PRC2/EED-EZH2 complex,sequence variant,splice variant,strand,turn,zinc finger region:ADD-type,
220139_at	DNA methyltransferase 3 like(DNMT3L)	Homo sapiens				GO:0006306~DNA methylation,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007283~spermatogenesis,GO:0043085~positive regulation of catalytic activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0019899~enzyme binding,GO:0030234~enzyme regulator activity,GO:0046872~metal ion binding,	IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR025766:ADD domain,					3D-structure,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3- like,helix,mutagenesis site,sequence conflict,sequence variant,strand,turn,zinc finger region:ADD-type,
210487_at	DNA nucleotidylexotransferase(DNTT)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0033198~response to ATP,GO:0071897~DNA biosynthetic process,	GO:0000790~nuclear chromatin,GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003912~DNA nucleotidylexotransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001726:DNA nucleotidylexotransferase (TdT) / DNA-directed DNA/RNA polymerase mu,IPR002054:DNA-directed DNA polymerase X,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027292:DNA nucleotidylexotransferase (TdT),IPR027421:DNA polymerase family X lyase domain,	hsa03450:Non-homologous end-joining,hsa04640:Hematopoietic cell lineage,		PIRSF000817:DNA nucleotidyltransferase,PIRSF501175:DNA nucleotidylexotransferase [Parent=PIRSF000817],	SM00292:BRCT,SM00483:POLXc,	3D-structure,Alternative splicing,Complete proteome,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Terminal addition,Transferase,	chain:DNA nucleotidylexotransferase,domain:BRCT,helix,metal ion-binding site:Magnesium,metal ion-binding site:Sodium; via carbonyl oxygen,region of interest:Involved in ssDNA binding,region of interest:Mediates interaction with DNTTIP2,sequence conflict,sequence variant,splice variant,strand,turn,
204835_at	DNA polymerase alpha 1, catalytic subunit(POLA1)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006270~DNA replication initiation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006272~leading strand elongation,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003896~DNA primase activity,GO:0005515~protein binding,GO:0008408~3'-5' exonuclease activity,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR015088:Zinc finger, DNA-directed DNA polymerase, family B, alpha,IPR017964:DNA-directed DNA polymerase, family B, conserved site,IPR023211:DNA polymerase, palm domain,IPR024647:DNA polymerase alpha catalytic subunit, N-terminal domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,	310465~N syndrome,		SM00486:POLBc,	3D-structure,4Fe-4S,Acetylation,Complete proteome,Direct protein sequencing,DNA replication,DNA-binding,DNA-directed DNA polymerase,Host-virus interaction,Iron,Iron-sulfur,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:DNA polymerase alpha catalytic subunit,compositionally biased region:Asp-rich,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,helix,modified residue,sequence conflict,sequence variant,site:Cleavage,strand,zinc finger region:C4-type,
204441_s_at	DNA polymerase alpha 2, accessory subunit(POLA2)	Homo sapiens				GO:0000060~protein import into nucleus, translocation,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0071897~DNA biosynthetic process,	GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0046982~protein heterodimerization activity,	IPR007185:DNA polymerase alpha/epsilon, subunit B,IPR013627:DNA polymerase alpha, subunit B N-terminal,IPR016722:DNA polymerase alpha, subunit B,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,		PIRSF018300:DNA polymerase alpha, subunit B,		3D-structure,Alternative splicing,Complete proteome,DNA replication,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA polymerase alpha subunit B,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro/Ser/Thr-rich,modified residue,sequence conflict,sequence variant,
203616_at	DNA polymerase beta(POLB)	Homo sapiens				GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006286~base-excision repair, base-free sugar-phosphate removal,GO:0006287~base-excision repair, gap-filling,GO:0006288~base-excision repair, DNA ligation,GO:0006290~pyrimidine dimer repair,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007435~salivary gland morphogenesis,GO:0007568~aging,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010332~response to gamma radiation,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0045471~response to ethanol,GO:0048535~lymph node development,GO:0048536~spleen development,GO:0048872~homeostasis of number of cells,GO:0051402~neuron apoptotic process,GO:0055093~response to hyperoxia,GO:0071707~immunoglobulin heavy chain V-D-J recombination,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0016829~lyase activity,GO:0019899~enzyme binding,GO:0034061~DNA polymerase activity,GO:0046872~metal ion binding,	IPR002008:DNA polymerase, family X, beta-like,IPR002054:DNA-directed DNA polymerase X,IPR003583:Helix-hairpin-helix DNA-binding motif, class 1,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027420:DNA polymerase beta, N-terminal domain,	hsa03410:Base excision repair,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,			SM00278:HhH1,SM00483:POLXc,	3D-structure,Acetylation,Complete proteome,Cytoplasm,DNA damage,DNA repair,DNA replication,DNA synthesis,DNA-binding,DNA-directed DNA polymerase,Isopeptide bond,Lyase,Magnesium,Metal-binding,Methylation,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Sodium,Transferase,Ubl conjugation,	active site:Schiff-base intermediate with DNA,chain:DNA polymerase beta,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Sodium; via carbonyl oxygen,modified residue,mutagenesis site,region of interest:DNA binding,sequence conflict,sequence variant,strand,turn,
203422_at	DNA polymerase delta 1, catalytic subunit(POLD1)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006287~base-excision repair, gap-filling,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0033683~nucleotide-excision repair, DNA incision,GO:0034644~cellular response to UV,GO:0042769~DNA damage response, detection of DNA damage,GO:0045004~DNA replication proofreading,GO:0055089~fatty acid homeostasis,	GO:0000109~nucleotide-excision repair complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016235~aggresome,GO:0043625~delta DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008296~3'-5'-exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0019899~enzyme binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR017964:DNA-directed DNA polymerase, family B, conserved site,IPR023211:DNA polymerase, palm domain,IPR025687:C4-type zinc-finger of DNA polymerase delta,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,hsa05166:HTLV-I infection,	612591~Colorectal cancer, susceptibility to, 10,615381~Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome,		SM00486:POLBc,	4Fe-4S,Complete proteome,Disease mutation,DNA replication,DNA-binding,DNA-directed DNA polymerase,Exonuclease,Hydrolase,Iron,Iron-sulfur,Metal-binding,Methylation,Nuclease,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:DNA polymerase delta catalytic subunit,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,zinc finger region:C4-type,
201115_at	DNA polymerase delta 2, accessory subunit(POLD2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0019985~translesion synthesis,GO:0033683~nucleotide-excision repair, DNA incision,GO:0042769~DNA damage response, detection of DNA damage,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043625~delta DNA polymerase complex,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,	IPR007185:DNA polymerase alpha/epsilon, subunit B,IPR024826:DNA polymerase delta/II small subunit family,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,hsa05166:HTLV-I infection,				3D-structure,Acetylation,Complete proteome,DNA replication,DNA-directed DNA polymerase,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:DNA polymerase delta subunit 2,helix,modified residue,sequence variant,strand,turn,
212836_at	DNA polymerase delta 3, accessory subunit(POLD3)	Homo sapiens				GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0019985~translesion synthesis,GO:0033683~nucleotide-excision repair, DNA incision,GO:0042769~DNA damage response, detection of DNA damage,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0043625~delta DNA polymerase complex,	GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,	IPR019038:DNA polymerase subunit Cdc27,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,hsa05166:HTLV-I infection,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA replication,DNA-directed DNA polymerase,Isopeptide bond,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Ubl conjugation,	chain:DNA polymerase delta subunit 3,helix,modified residue,
202996_at	DNA polymerase delta 4, accessory subunit(POLD4)	Homo sapiens				GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0019985~translesion synthesis,GO:0033683~nucleotide-excision repair, DNA incision,GO:0042769~DNA damage response, detection of DNA damage,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043625~delta DNA polymerase complex,	GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,	IPR007218:DNA polymerase delta, subunit 4,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,hsa05166:HTLV-I infection,				Alternative splicing,Complete proteome,DNA replication,DNA-directed DNA polymerase,Nucleotidyltransferase,Nucleus,Polymorphism,Reference proteome,Transferase,	chain:DNA polymerase delta subunit 4,mutagenesis site,sequence variant,
217806_s_at	DNA polymerase delta interacting protein 2(POLDIP2)	Homo sapiens				GO:0016242~negative regulation of macroautophagy,GO:0045931~positive regulation of mitotic cell cycle,GO:0070584~mitochondrion morphogenesis,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0042645~mitochondrial nucleoid,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR007474:ApaG domain,IPR011722:Hemimethylated DNA-binding domain,				SM00992:SM00992,	Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Polymerase delta-interacting protein 2,domain:ApaG,modified residue,sequence conflict,
210583_at, 215357_s_at, 212100_s_at, 210584_s_at	DNA polymerase delta interacting protein 3(POLDIP3)	Homo sapiens			General function prediction only,	GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,GO:0045727~positive regulation of translation,	GO:0000346~transcription export complex,GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,Transport,Ubl conjugation,	chain:Polymerase delta-interacting protein 3,domain:RRM,modified residue,splice variant,
205909_at	DNA polymerase epsilon 2, accessory subunit(POLE2)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006270~DNA replication initiation,GO:0006281~DNA repair,GO:0042276~error-prone translesion synthesis,	GO:0005654~nucleoplasm,GO:0008622~epsilon DNA polymerase complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,	IPR007185:DNA polymerase alpha/epsilon, subunit B,IPR016266:DNA polymerase epsilon, subunit B,IPR024639:DNA polymerase epsilon subunit B, N-terminal,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa05166:HTLV-I infection,		PIRSF000799:DNA polymerase epsilon, subunit B,		3D-structure,Alternative splicing,Complete proteome,DNA replication,DNA-binding,DNA-directed DNA polymerase,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:DNA polymerase epsilon subunit 2,helix,modified residue,sequence conflict,sequence variant,strand,turn,
208828_at	DNA polymerase epsilon 3, accessory subunit(POLE3)	Homo sapiens				GO:0006260~DNA replication,GO:0043966~histone H3 acetylation,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0008622~epsilon DNA polymerase complex,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa05166:HTLV-I infection,				Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,DNA-directed DNA polymerase,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transferase,	chain:DNA polymerase epsilon subunit 3,modified residue,sequence conflict,sequence variant,
216026_s_at	DNA polymerase epsilon, catalytic subunit(POLE)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006272~leading strand elongation,GO:0006281~DNA repair,GO:0006287~base-excision repair, gap-filling,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0045004~DNA replication proofreading,GO:0048568~embryonic organ development,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0008622~epsilon DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008270~zinc ion binding,GO:0008310~single-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR013697:DNA polymerase epsilon, catalytic subunit A, C-terminal,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa05166:HTLV-I infection,	615083~Colorectal cancer, susceptibility to, 12,615139~FILS syndrome,		SM00486:POLBc,SM01159:SM01159,	4Fe-4S,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA replication,DNA-binding,DNA-directed DNA polymerase,Iron,Iron-sulfur,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:DNA polymerase epsilon catalytic subunit A,modified residue,sequence conflict,sequence variant,zinc finger region:C4-type,
219380_x_at	DNA polymerase eta(POLH)	Homo sapiens				GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006290~pyrimidine dimer repair,GO:0006301~postreplication repair,GO:0010225~response to UV-C,GO:0019985~translesion synthesis,GO:0070987~error-free translesion synthesis,GO:0071494~cellular response to UV-C,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001126:DNA-repair protein, UmuC-like,IPR017061:DNA polymerase eta,IPR017961:DNA polymerase, Y-family, little finger domain,	hsa03460:Fanconi anemia pathway,	278750~Xeroderma pigmentosum, variant type,	PIRSF036603:DNA polymerase eta,		3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA replication,DNA synthesis,DNA-binding,DNA-directed DNA polymerase,Isopeptide bond,Magnesium,Metal-binding,Mutator protein,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Schiff base,Transferase,Ubl conjugation,Xeroderma pigmentosum,	chain:DNA polymerase eta,domain:UmuC,helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,
205811_at	DNA polymerase gamma 2, accessory subunit(POLG2)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006426~glycyl-tRNA aminoacylation,GO:0007005~mitochondrion organization,GO:0022904~respiratory electron transport chain,GO:0032042~mitochondrial DNA metabolic process,GO:0070584~mitochondrion morphogenesis,GO:0071897~DNA biosynthetic process,	GO:0000262~mitochondrial chromosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0004820~glycine-tRNA ligase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004154:Anticodon-binding,IPR027030:DNA polymerase subunit gamma-2, mitochondrial,IPR027031:Glycyl-tRNA synthetase/DNA polymerase subunit gamma-2,		610131~Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4,			3D-structure,Complete proteome,Disease mutation,DNA replication,DNA-binding,DNA-directed DNA polymerase,Mitochondrion,Nucleotidyltransferase,Phosphoprotein,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:DNA polymerase subunit gamma-2, mitochondrial,helix,modified residue,sequence conflict,sequence variant,strand,transit peptide:Mitochondrion,turn,
217636_at, 217635_s_at, 203366_at	DNA polymerase gamma, catalytic subunit(POLG)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006264~mitochondrial DNA replication,GO:0006287~base-excision repair, gap-filling,GO:0007568~aging,GO:0009416~response to light stimulus,GO:0010332~response to gamma radiation,GO:0055093~response to hyperoxia,GO:0071333~cellular response to glucose stimulus,GO:0071897~DNA biosynthetic process,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005739~mitochondrion,GO:0005760~gamma DNA polymerase complex,GO:0042645~mitochondrial nucleoid,GO:0043195~terminal bouton,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008408~3'-5' exonuclease activity,	IPR001098:DNA-directed DNA polymerase, family A, palm domain,IPR002297:DNA-directed DNA-polymerase, family A, mitochondria,IPR012337:Ribonuclease H-like domain,IPR019760:DNA-directed DNA polymerase, family A, conserved site,		157640~Progressive external ophthalmoplegia, autosomal dominant 1,203700~Mitochondrial DNA depletion syndrome 4A (Alpers type),258450~Progressive external ophthalmoplegia, autosomal recessive 1,607459~Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE),613662~Mitochondrial DNA depletion syndrome 4B (MNGIE type),	PIRSF000797:DNA-directed DNA polymerase, mitochondrial type,	SM00482:POLAc,	3D-structure,Coiled coil,Complete proteome,Disease mutation,DNA replication,DNA-binding,DNA-directed DNA polymerase,Epilepsy,Leigh syndrome,Magnesium,Mitochondrion,Mitochondrion nucleoid,Neurodegeneration,Neuropathy,Nucleotidyltransferase,Polymorphism,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,Transferase,	chain:DNA polymerase subunit gamma-1,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,sequence variant,
219317_at	DNA polymerase iota(POLI)	Homo sapiens				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0019985~translesion synthesis,GO:0042276~error-prone translesion synthesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001126:DNA-repair protein, UmuC-like,IPR017961:DNA polymerase, Y-family, little finger domain,	hsa03460:Fanconi anemia pathway,				3D-structure,Complete proteome,DNA damage,DNA repair,DNA replication,DNA synthesis,DNA-binding,DNA-directed DNA polymerase,Magnesium,Metal-binding,Mutator protein,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Schiff base,Transferase,	active site:Proton acceptor,binding site:dNTP,chain:DNA polymerase iota,compositionally biased region:Ser-rich,domain:UmuC,helix,metal ion-binding site:Magnesium,region of interest:DNA binding,sequence conflict,sequence variant,strand,turn,
221049_s_at	DNA polymerase lambda(POLL)	Homo sapiens				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016829~lyase activity,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR002008:DNA polymerase, family X, beta-like,IPR002054:DNA-directed DNA polymerase X,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027421:DNA polymerase family X lyase domain,	hsa03410:Base excision repair,hsa03450:Non-homologous end-joining,			SM00483:POLXc,	3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA replication,DNA synthesis,DNA-binding,DNA-directed DNA polymerase,Lyase,Manganese,Metal-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,	active site:Schiff-base intermediate with DNA,chain:DNA polymerase lambda,domain:BRCT,helix,metal ion-binding site:Manganese,modified residue,mutagenesis site,region of interest:DNA binding,region of interest:Involved in primer binding,sequence conflict,sequence variant,strand,turn,
222238_s_at	DNA polymerase mu(POLM)	Homo sapiens				GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0030183~B cell differentiation,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0034061~DNA polymerase activity,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001726:DNA nucleotidylexotransferase (TdT) / DNA-directed DNA/RNA polymerase mu,IPR002054:DNA-directed DNA polymerase X,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027249:DNA-directed DNA/RNA polymerase mu,IPR027421:DNA polymerase family X lyase domain,	hsa03450:Non-homologous end-joining,		PIRSF000817:DNA nucleotidyltransferase,PIRSF501176:DNA polymerase mu [Parent=PIRSF000817],	SM00483:POLXc,	3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA-directed DNA polymerase,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:DNA polymerase mu,domain:BRCT,helix,metal ion-binding site:Magnesium,modified residue,region of interest:Involved in ssDNA binding,sequence variant,strand,turn,
219510_at, 207746_at	DNA polymerase theta(POLQ)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000724~double-strand break repair via homologous recombination,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0051260~protein homooligomerization,GO:0071897~DNA biosynthetic process,GO:0097681~double-strand break repair via alternative nonhomologous end joining,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR001098:DNA-directed DNA polymerase, family A, palm domain,IPR001650:Helicase, C-terminal,IPR002298:DNA polymerase A,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012337:Ribonuclease H-like domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR019760:DNA-directed DNA polymerase, family A, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00482:POLAc,SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,DNA damage,DNA repair,DNA-directed DNA polymerase,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,
219000_s_at, 216646_at	DNA replication and sister chromatid cohesion 1(DSCC1)	Homo sapiens				GO:0006260~DNA replication,GO:0006275~regulation of DNA replication,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034421~post-translational protein acetylation,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005515~protein binding,GO:0043142~single-stranded DNA-dependent ATPase activity,	IPR019128:Sister chromatid cohesion protein Dcc1,					Cell cycle,Complete proteome,DNA replication,DNA-binding,Nucleus,Polymorphism,Reference proteome,	chain:Sister chromatid cohesion protein DCC1,sequence variant,
213647_at	DNA replication helicase/nuclease 2(DNA2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000076~DNA replication checkpoint,GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006264~mitochondrial DNA replication,GO:0006284~base-excision repair,GO:0032508~DNA duplex unwinding,GO:0033567~DNA replication, Okazaki fragment processing,GO:0043137~DNA replication, removal of RNA primer,GO:0043504~mitochondrial DNA repair,GO:0045740~positive regulation of DNA replication,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902990~mitotic telomere maintenance via semi-conservative replication,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005760~gamma DNA polymerase complex,GO:0042645~mitochondrial nucleoid,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0016890~site-specific endodeoxyribonuclease activity, specific for altered base,GO:0017108~5'-flap endonuclease activity,GO:0043139~5'-3' DNA helicase activity,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR014808:DNA replication factor Dna2, N-terminal,IPR026851:Dna2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03030:DNA replication,	615156~Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6,615807~Seckel syndrome 8,			3D-structure,4Fe-4S,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA replication,DNA-binding,Dwarfism,Endonuclease,Helicase,Hydrolase,Iron,Iron-sulfur,Mental retardation,Metal-binding,Mitochondrion,Multifunctional enzyme,Nuclease,Nucleotide-binding,Nucleus,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,	chain:DNA2-like helicase,nucleotide phosphate-binding region:ATP,splice variant,
218393_s_at	DNA replication regulator and spliceosomal factor(SMU1)	Homo sapiens			Amino acid transport and metabolism,		GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00320:WD40,SM00667:LisH,SM00668:CTLH,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Reference proteome,Repeat,WD repeat,	chain:WD40 repeat-containing protein SMU1,domain:CTLH,domain:LisH,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,
218016_s_at	DNA-directed RNA polymerase III subunit RPC5(LOC101060521)	Homo sapiens				GO:0006383~transcription from RNA polymerase III promoter,GO:0032481~positive regulation of type I interferon production,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,	GO:0003899~DNA-directed RNA polymerase activity,	IPR006886:DNA-directed RNA polymerase III subunit Rpc5,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03020:RNA polymerase,hsa04623:Cytosolic DNA-sensing pathway,				Alternative splicing,Antiviral defense,Complete proteome,DNA-directed RNA polymerase,Immunity,Innate immunity,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Ubl conjugation,
222070_at, 57739_at	DND microRNA-mediated repression inhibitor 1(DND1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0060965~negative regulation of gene silencing by miRNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0017091~AU-rich element binding,GO:0035198~miRNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Complete proteome,Cytoplasm,Developmental protein,Nucleus,Reference proteome,Repeat,RNA-binding,	chain:Dead end protein homolog 1,domain:RRM 1,domain:RRM 2,
214865_at	DOT1 like histone lysine methyltransferase(DOT1L)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006348~chromatin silencing at telomere,GO:0008284~positive regulation of cell proliferation,GO:0032200~telomere organization,GO:0034729~histone H3-K79 methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046425~regulation of JAK-STAT cascade,GO:0051726~regulation of cell cycle,GO:2000677~regulation of transcription regulatory region DNA binding,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0031151~histone methyltransferase activity (H3-K79 specific),GO:0042054~histone methyltransferase activity,	IPR021169:Histone H3-K79 methyltransferase, metazoa,IPR025789:Histone H3-K79 methyltransferase,	hsa00310:Lysine degradation,hsa05202:Transcriptional misregulation in cancer,		PIRSF037123:histone H3-K79 methyltransferase, animal type,		3D-structure,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,chain:Histone-lysine N-methyltransferase, H3 lysine-79 specific,helix,modified residue,mutagenesis site,region of interest:Required for interaction with nucleosomes and DNA,region of interest:S-adenosyl-L-methionine binding,sequence conflict,sequence variant,short sequence motif:SAM-binding motif 1,short sequence motif:SAM-binding motif 2,short sequence motif:SAM-binding motif 3,splice variant,strand,turn,
204514_at	DPH2 homolog(DPH2)	Homo sapiens				GO:0017183~peptidyl-diphthamide biosynthetic process from peptidyl-histidine,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0090560~2-(3-amino-3-carboxypropyl)histidine synthase activity,	IPR010014:Diphthamide synthesis DHP2, eukaryotic,IPR016435:Diphthamide synthesis, eukaryotic DPH1/archaeal DPH2,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Diphthamide biosynthesis protein 2,modified residue,sequence conflict,
215143_at	DPY19L2 pseudogene 2(DPY19L2P2)	Homo sapiens				GO:0007286~spermatid development,GO:0018406~protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,	GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,	GO:0000030~mannosyltransferase activity,	IPR018732:Dpy-19,					Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,
203258_at	DR1 associated protein 1(DRAP1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,					3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Dr1-associated corepressor,compositionally biased region:Poly-Lys,compositionally biased region:Pro-rich,domain:Histone-fold,helix,sequence conflict,splice variant,
211484_s_at	DS cell adhesion molecule(DSCAM)	Homo sapiens				GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007162~negative regulation of cell adhesion,GO:0007399~nervous system development,GO:0007416~synapse assembly,GO:0007626~locomotory behavior,GO:0010842~retina layer formation,GO:0042327~positive regulation of phosphorylation,GO:0048813~dendrite morphogenesis,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0060060~post-embryonic retina morphogenesis in camera-type eye,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0070593~dendrite self-avoidance,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030426~growth cone,GO:0045202~synapse,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Down syndrome cell adhesion molecule,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Ig-like C2-type 1,domain:Ig-like C2-type 10,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,domain:Ig-like C2-type 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
217309_s_at, 203635_at	DSCR3 arrestin fold containing(DSCR3)	Homo sapiens				GO:0006886~intracellular protein transport,	GO:0005634~nucleus,GO:0005768~endosome,	GO:0008565~protein transporter activity,	IPR014756:Immunoglobulin E-set,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Down syndrome critical region protein 3,modified residue,
219512_at	DSN1 homolog, MIS12 kinetochore complex component(DSN1)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0051301~cell division,GO:0051456~attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,	GO:0000444~MIS12/MIND type complex,GO:0000818~nuclear MIS12/MIND complex,GO:0000922~spindle pole,GO:0000941~condensed nuclear chromosome inner kinetochore,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR013218:Mtw1 kinetochore complex, DSN1,					Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Kinetochore-associated protein DSN1 homolog,modified residue,sequence conflict,splice variant,
219291_at	DTW domain containing 1(DTWD1)	Homo sapiens							IPR005636:DTW,				SM01144:SM01144,	Acetylation,Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:DTW domain-containing protein 1,sequence variant,short sequence motif:DXTW,splice variant,
203733_at	Dexi homolog(DEXI)	Homo sapiens							IPR023259:Dexamethasone-induced protein,					Complete proteome,Reference proteome,	chain:Dexamethasone-induced protein,
214198_s_at, 202099_s_at	DiGeorge syndrome critical region gene 2(DGCR2)	Homo sapiens				GO:0007155~cell adhesion,GO:0009887~organ morphogenesis,GO:0050890~cognition,	GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001007:von Willebrand factor, type C,IPR001304:C-type lectin,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00034:CLECT,SM00192:LDLa,SM00214:VWC,	Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Integral membrane protein DGCR2/IDD,disulfide bond,domain:C-type lectin,domain:LDL-receptor class A,domain:VWFC,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208024_s_at	DiGeorge syndrome critical region gene 6(DGCR6)	Homo sapiens				GO:0007155~cell adhesion,GO:0009887~organ morphogenesis,	GO:0005578~proteinaceous extracellular matrix,GO:0005634~nucleus,		IPR010849:DiGeorge syndrome critical 6,					Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein DGCR6,sequence conflict,sequence variant,
214024_s_at	DiGeorge syndrome critical region gene 6-like(DGCR6L)	Homo sapiens					GO:0005634~nucleus,	GO:0005515~protein binding,	IPR010849:DiGeorge syndrome critical 6,					Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein DGCR6L,sequence conflict,sequence variant,
203791_at	Dmx like 1(DMXL1)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,	GO:0043291~RAVE complex,		IPR001680:WD40 repeat,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR022033:RAVE complex protein Rav1 C-terminal,				SM00320:WD40,	Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:DmX-like protein 1,compositionally biased region:Poly-Asp,modified residue,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 14,repeat:WD 15,repeat:WD 16,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence variant,
212820_at, 215761_at	Dmx like 2(DMXL2)	Homo sapiens				GO:0007035~vacuolar acidification,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,	GO:0005615~extracellular space,GO:0008021~synaptic vesicle,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0043291~RAVE complex,	GO:0017137~Rab GTPase binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR022033:RAVE complex protein Rav1 C-terminal,		616113~Polyendocrine-polyneuropathy syndrome,		SM00320:WD40,	Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasmic vesicle,Diabetes mellitus,Direct protein sequencing,Disease mutation,Hypogonadotropic hypogonadism,Membrane,Neuropathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Synapse,WD repeat,	chain:DmX-like protein 2,modified residue,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 15,repeat:WD 16,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,
200880_at, 200881_s_at	DnaJ heat shock protein family (Hsp40) member A1(DNAJA1)	Homo sapiens				GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0007283~spermatogenesis,GO:0009408~response to heat,GO:0030317~sperm motility,GO:0030521~androgen receptor signaling pathway,GO:0031397~negative regulation of protein ubiquitination,GO:0042769~DNA damage response, detection of DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043508~negative regulation of JUN kinase activity,GO:0051223~regulation of protein transport,GO:0070585~protein localization to mitochondrion,GO:1901998~toxin transport,GO:1903748~negative regulation of establishment of protein localization to mitochondrion,GO:1905259~negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098554~cytoplasmic side of endoplasmic reticulum membrane,	GO:0001664~G-protein coupled receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030544~Hsp70 protein binding,GO:0030957~Tat protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,GO:0055131~C3HC4-type RING finger domain binding,	IPR001305:Heat shock protein DnaJ, cysteine-rich domain,IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR012724:Chaperone DnaJ,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,	3D-structure,Acetylation,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Endoplasmic reticulum,Lipoprotein,Membrane,Metal-binding,Methylation,Microsome,Mitochondrion,Nucleus,Phosphoprotein,Prenylation,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily A member 1,compositionally biased region:Gly-rich,domain:J,lipid moiety-binding region:S-farnesyl cysteine,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,repeat:CXXCXGXG motif,sequence conflict,zinc finger region:CR-type,
209157_at	DnaJ heat shock protein family (Hsp40) member A2(DNAJA2)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0008284~positive regulation of cell proliferation,GO:0009408~response to heat,GO:0042026~protein refolding,	GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031072~heat shock protein binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001305:Heat shock protein DnaJ, cysteine-rich domain,IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR012724:Chaperone DnaJ,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,	Acetylation,Chaperone,Complete proteome,Lipoprotein,Membrane,Metal-binding,Methylation,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily A member 2,domain:J,lipid moiety-binding region:S-farnesyl cysteine,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,repeat:CXXCXGXG motif,sequence conflict,zinc finger region:CR-type,
205963_s_at	DnaJ heat shock protein family (Hsp40) member A3(DNAJA3)	Homo sapiens		h_tidPathway:Chaperones modulate interferon Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006264~mitochondrial DNA replication,GO:0006457~protein folding,GO:0006469~negative regulation of protein kinase activity,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006924~activation-induced cell death of T cells,GO:0007005~mitochondrion organization,GO:0007264~small GTPase mediated signal transduction,GO:0007528~neuromuscular junction development,GO:0007569~cell aging,GO:0008285~negative regulation of cell proliferation,GO:0009408~response to heat,GO:0031398~positive regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033077~T cell differentiation in thymus,GO:0034341~response to interferon-gamma,GO:0042102~positive regulation of T cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043069~negative regulation of programmed cell death,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0050790~regulation of catalytic activity,GO:0050821~protein stabilization,GO:0060336~negative regulation of interferon-gamma-mediated signaling pathway,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005884~actin filament,GO:0019897~extrinsic component of plasma membrane,GO:0030054~cell junction,GO:0031594~neuromuscular junction,GO:0042645~mitochondrial nucleoid,GO:0043231~intracellular membrane-bounded organelle,GO:0045211~postsynaptic membrane,	GO:0005133~interferon-gamma receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0030695~GTPase regulator activity,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,GO:0051082~unfolded protein binding,	IPR001305:Heat shock protein DnaJ, cysteine-rich domain,IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR012724:Chaperone DnaJ,IPR018253:DnaJ domain, conserved site,	hsa05203:Viral carcinogenesis,			SM00271:DnaJ,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell junction,Cell membrane,Chaperone,Complete proteome,Cytoplasm,Membrane,Metal-binding,Methylation,Mitochondrion,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Synapse,Transit peptide,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily A member 3, mitochondrial,domain:J,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,mutagenesis site,repeat:CXXCXGXG motif,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,zinc finger region:CR-type,
220395_at	DnaJ heat shock protein family (Hsp40) member A4(DNAJA4)	Homo sapiens				GO:0006457~protein folding,GO:0009408~response to heat,GO:0042026~protein refolding,GO:0090084~negative regulation of inclusion body assembly,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031072~heat shock protein binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001305:Heat shock protein DnaJ, cysteine-rich domain,IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR012724:Chaperone DnaJ,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Alternative splicing,Chaperone,Complete proteome,Lipoprotein,Membrane,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily A member 4,compositionally biased region:Gly-rich,domain:J,lipid moiety-binding region:S-farnesyl cysteine,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,repeat:CXXCXGXG motif,sequence conflict,zinc finger region:CR-type,
200664_s_at, 200666_s_at	DnaJ heat shock protein family (Hsp40) member B1(DNAJB1)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_prionPathway:Prion Pathway,	Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0032781~positive regulation of ATPase activity,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0070389~chaperone cofactor-dependent protein refolding,GO:0090084~negative regulation of inclusion body assembly,GO:0098609~cell-cell adhesion,GO:1900034~regulation of cellular response to heat,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,GO:0051117~ATPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,hsa05164:Influenza A,			SM00271:DnaJ,	3D-structure,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Stress response,	chain:DnaJ homolog subfamily B member 1,domain:J,helix,modified residue,sequence conflict,turn,
202865_at, 214338_at, 202866_at, 202867_s_at	DnaJ heat shock protein family (Hsp40) member B12(DNAJB12)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,		GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR001623:DnaJ domain,IPR015399:Domain of unknown function DUF1977, DnaJ-like,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,	3D-structure,Acetylation,Alternative splicing,Chaperone,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily B member 12,domain:J,helix,sequence conflict,sequence variant,transmembrane region,turn,
219237_s_at	DnaJ heat shock protein family (Hsp40) member B14(DNAJB14)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR001623:DnaJ domain,IPR015399:Domain of unknown function DUF1977, DnaJ-like,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Alternative splicing,Chaperone,Complete proteome,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily B member 14,domain:J,sequence conflict,splice variant,transmembrane region,
202500_at	DnaJ heat shock protein family (Hsp40) member B2(DNAJB2)	Homo sapiens				GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0008285~negative regulation of cell proliferation,GO:0030308~negative regulation of cell growth,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032781~positive regulation of ATPase activity,GO:0032880~regulation of protein localization,GO:0042026~protein refolding,GO:0061077~chaperone-mediated protein folding,GO:0090084~negative regulation of inclusion body assembly,GO:0090086~negative regulation of protein deubiquitination,GO:1903644~regulation of chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016234~inclusion body,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0031593~polyubiquitin binding,GO:0031625~ubiquitin protein ligase binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,GO:0070628~proteasome binding,	IPR001623:DnaJ domain,IPR003903:Ubiquitin interacting motif,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,	614881~Spinal muscular atrophy, distal, autosomal recessive, 5,616233~Charcot-Marie-Tooth disease, axonal, type 2T,		SM00271:DnaJ,SM00726:UIM,	3D-structure,Acetylation,Alternative splicing,Chaperone,Complete proteome,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:DnaJ homolog subfamily B member 2,domain:J,repeat:UIM 1,repeat:UIM 2,sequence conflict,sequence variant,splice variant,
203811_s_at, 203810_at	DnaJ heat shock protein family (Hsp40) member B4(DNAJB4)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0009408~response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Cell membrane,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Stress response,	chain:DnaJ homolog subfamily B member 4,domain:J,modified residue,
207453_s_at, 212817_at	DnaJ heat shock protein family (Hsp40) member B5(DNAJB5)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006457~protein folding,GO:0006986~response to unfolded protein,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001623:DnaJ domain,IPR002939:Chaperone DnaJ, C-terminal,IPR008971:HSP40/DnaJ peptide-binding,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Alternative splicing,Chaperone,Complete proteome,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily B member 5,domain:J,sequence conflict,splice variant,
209015_s_at, 208811_s_at, 208810_at	DnaJ heat shock protein family (Hsp40) member B6(DNAJB6)	Homo sapiens		h_prionPathway:Prion Pathway,		GO:0006457~protein folding,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0032781~positive regulation of ATPase activity,GO:0032880~regulation of protein localization,GO:0034504~protein localization to nucleus,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045109~intermediate filament organization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060710~chorio-allantoic fusion,GO:0060715~syncytiotrophoblast cell differentiation involved in labyrinthine layer development,GO:0060717~chorion development,GO:0090084~negative regulation of inclusion body assembly,GO:1900034~regulation of cellular response to heat,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030018~Z disc,GO:0048471~perinuclear region of cytoplasm,	GO:0001671~ATPase activator activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,		603511~Muscular dystrophy, limb-girdle, type 1E,		SM00271:DnaJ,	Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Limb-girdle muscular dystrophy,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily B member 6,compositionally biased region:Gly/Phe-rich,domain:J,modified residue,region of interest:Interaction with HSP70,region of interest:Interaction with KRT18,sequence conflict,splice variant,
202842_s_at, 202843_at	DnaJ heat shock protein family (Hsp40) member B9(DNAJB9)	Homo sapiens				GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0036498~IRE1-mediated unfolded protein response,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	3D-structure,Chaperone,Complete proteome,Endoplasmic reticulum,Phosphoprotein,Polymorphism,Reference proteome,Signal,	chain:DnaJ homolog subfamily B member 9,domain:J,helix,sequence variant,strand,turn,
218409_s_at	DnaJ heat shock protein family (Hsp40) member C1(DNAJC1)	Homo sapiens				GO:0006417~regulation of translation,GO:0006457~protein folding,GO:0032781~positive regulation of ATPase activity,GO:0045861~negative regulation of proteolysis,GO:0050708~regulation of protein secretion,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0001671~ATPase activator activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0051087~chaperone binding,	IPR001005:SANT/Myb domain,IPR001623:DnaJ domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,IPR018253:DnaJ domain, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,SM00717:SANT,	3D-structure,Chaperone,Complete proteome,DNA-binding,Endoplasmic reticulum,Membrane,Microsome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 1,domain:J,domain:SANT 1,domain:SANT 2,helix,modified residue,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
221782_at, 221781_s_at	DnaJ heat shock protein family (Hsp40) member C10(DNAJC10)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0032781~positive regulation of ATPase activity,GO:0034975~protein folding in endoplasmic reticulum,GO:0034976~response to endoplasmic reticulum stress,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005623~cell,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0034663~endoplasmic reticulum chaperone complex,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0030544~Hsp70 protein binding,GO:0051087~chaperone binding,GO:0051117~ATPase binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ domain,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,IPR021170:DnaJ homolog, subfamily C,	hsa04141:Protein processing in endoplasmic reticulum,		PIRSF037293:ER-resident protein ERdj5,	SM00271:DnaJ,	Alternative splicing,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Membrane,Oxidoreductase,Polymorphism,Proteomics identification,Redox-active center,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 10,domain:J,domain:Thioredoxin 1,domain:Thioredoxin 2,domain:Thioredoxin 3,domain:Thioredoxin 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
215792_s_at	DnaJ heat shock protein family (Hsp40) member C11(DNAJC11)	Homo sapiens					GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,IPR024586:DnaJ-like protein C11, C-terminal,				SM00271:DnaJ,	Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 11,domain:J,sequence conflict,sequence variant,splice variant,
218976_at	DnaJ heat shock protein family (Hsp40) member C12(DNAJC12)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,				IPR001623:DnaJ domain,				SM00271:DnaJ,	3D-structure,Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 12,domain:J,helix,sequence variant,splice variant,turn,
212467_at	DnaJ heat shock protein family (Hsp40) member C13(DNAJC13)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0007032~endosome organization,GO:0015031~protein transport,GO:1902954~regulation of early endosome to recycling endosome transport,GO:2000641~regulation of early endosome to late endosome transport,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,GO:0071203~WASH complex,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR003169:GYF,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR025640:Domain of unknown function DUF4339,		616361~Parkinson disease 21,		SM00271:DnaJ,	Acetylation,Chaperone,Complete proteome,Disease mutation,Endosome,Membrane,Neurodegeneration,Parkinson disease,Parkinsonism,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:DnaJ homolog subfamily C member 13,domain:J,modified residue,sequence conflict,sequence variant,
218435_at	DnaJ heat shock protein family (Hsp40) member C15(DNAJC15)	Homo sapiens				GO:0009267~cellular response to starvation,GO:0015031~protein transport,GO:0019216~regulation of lipid metabolic process,GO:0031333~negative regulation of protein complex assembly,GO:1902957~negative regulation of mitochondrial electron transport, NADH to ubiquinone,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR001623:DnaJ domain,				SM00271:DnaJ,	Chaperone,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:DnaJ homolog subfamily C member 15,domain:J,modified residue,sequence conflict,sequence variant,transmembrane region,
212908_at, 217358_at, 212911_at	DnaJ heat shock protein family (Hsp40) member C16(DNAJC16)	Homo sapiens				GO:0045454~cell redox homeostasis,	GO:0005623~cell,GO:0016021~integral component of membrane,		IPR001623:DnaJ domain,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 16,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,domain:J,domain:Thioredoxin,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219861_at	DnaJ heat shock protein family (Hsp40) member C17(DNAJC17)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:1901998~toxin transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR001623:DnaJ domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00271:DnaJ,	3D-structure,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transcription,Transcription regulation,	chain:DnaJ homolog subfamily C member 17,compositionally biased region:Poly-Glu,domain:J,domain:RRM,helix,modified residue,strand,
213097_s_at	DnaJ heat shock protein family (Hsp40) member C2(DNAJC2)	Homo sapiens			Translation, ribosomal structure and biogenesis / Posttranslational modification, protein turnover, chaperones,	GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0032781~positive regulation of ATPase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051083~'de novo' cotranslational protein folding,GO:1900034~regulation of cellular response to heat,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0001671~ATPase activator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0030544~Hsp70 protein binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0044822~poly(A) RNA binding,	IPR001005:SANT/Myb domain,IPR001623:DnaJ domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,SM00717:SANT,	3D-structure,Acetylation,Activator,Alternative splicing,Chaperone,Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:DnaJ homolog subfamily C member 2,domain:J,domain:SANT 1,domain:SANT 2,modified residue,sequence conflict,splice variant,
220441_at	DnaJ heat shock protein family (Hsp40) member C22(DNAJC22)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001623:DnaJ domain,IPR007829:TM2,				SM00271:DnaJ,	Chaperone,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 22,domain:J,transmembrane region,
213853_at	DnaJ heat shock protein family (Hsp40) member C24(DNAJC24)	Homo sapiens				GO:0017183~peptidyl-diphthamide biosynthetic process from peptidyl-histidine,GO:0032781~positive regulation of ATPase activity,GO:0055114~oxidation-reduction process,GO:0061077~chaperone-mediated protein folding,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016021~integral component of membrane,	GO:0001671~ATPase activator activity,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,	IPR001623:DnaJ domain,IPR007872:Zinc finger, DPH-type,				SM00271:DnaJ,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Electron transport,Iron,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Zinc,Zinc-finger,	chain:DnaJ homolog subfamily C member 24,domain:J,sequence variant,zinc finger region:DPH-type,
220372_at	DnaJ heat shock protein family (Hsp40) member C28(DNAJC28)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000301~retrograde transport, vesicle recycling within Golgi,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0007030~Golgi organization,GO:0048213~Golgi vesicle prefusion complex stabilization,	GO:0017119~Golgi transport complex,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR018961:DnaJ homologue, subfamily C, member 28, conserved domain,				SM00271:DnaJ,	Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Reference proteome,	chain:DnaJ homolog subfamily C member 28,compositionally biased region:Poly-Glu,domain:J,modified residue,sequence conflict,
208499_s_at	DnaJ heat shock protein family (Hsp40) member C3(DNAJC3)	Homo sapiens		h_rnaPathway:Double Stranded RNA Induced Gene Expression,		GO:0006469~negative regulation of protein kinase activity,GO:0036494~positive regulation of translation initiation in response to endoplasmic reticulum stress,GO:0036498~IRE1-mediated unfolded protein response,GO:0043066~negative regulation of apoptotic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051607~defense response to virus,GO:0070417~cellular response to cold,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0031205~endoplasmic reticulum Sec complex,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0004860~protein kinase inhibitor activity,GO:0019901~protein kinase binding,GO:0051087~chaperone binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR018704:Uncharacterised domain UPF0070, N-terminal,IPR019734:Tetratricopeptide repeat,IPR023114:Elongated TPR repeat-containing domain,IPR026901:DnaJ homologue subfamily C member 3,	hsa04141:Protein processing in endoplasmic reticulum,hsa05164:Influenza A,	616192~Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus,		SM00028:TPR,SM00271:DnaJ,	3D-structure,Antiviral defense,Chaperone,Complete proteome,Deafness,Diabetes mellitus,Disulfide bond,Endoplasmic reticulum,Neurodegeneration,Neuropathy,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Signal,Stress response,TPR repeat,Translation regulation,Unfolded protein response,	chain:DnaJ homolog subfamily C member 3,domain:J,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,signal peptide,
206782_s_at, 206781_at, 213919_at	DnaJ heat shock protein family (Hsp40) member C4(DNAJC4)	Homo sapiens				GO:0006457~protein folding,GO:0006986~response to unfolded protein,	GO:0005739~mitochondrion,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR001623:DnaJ domain,				SM00271:DnaJ,	Chaperone,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:DnaJ homolog subfamily C member 4,domain:J,transmembrane region,
204720_s_at, 204721_s_at	DnaJ heat shock protein family (Hsp40) member C6(DNAJC6)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0072318~clathrin coat disassembly,GO:2000369~regulation of clathrin-mediated endocytosis,	GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0031982~vesicle,GO:0045202~synapse,	GO:0004725~protein tyrosine phosphatase activity,GO:0017124~SH3 domain binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001623:DnaJ domain,IPR014020:Tensin phosphatase, C2 domain,	hsa04144:Endocytosis,	615528~Parkinson disease 19, juvenile-onset,		SM00271:DnaJ,SM01326:SM01326,	Acetylation,Alternative splicing,Chaperone,Complete proteome,Hydrolase,Neurodegeneration,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,SH3-binding,	active site:Phosphocysteine intermediate,chain:Putative tyrosine-protein phosphatase auxilin,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:C2 tensin-type,domain:J,domain:Phosphatase tensin-type,modified residue,region of interest:3 X 4 AA approximate tandem repeats,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,
202416_at	DnaJ heat shock protein family (Hsp40) member C7(DNAJC7)	Homo sapiens				GO:0006457~protein folding,GO:0032781~positive regulation of ATPase activity,GO:0070389~chaperone cofactor-dependent protein refolding,GO:1900034~regulation of cellular response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0001671~ATPase activator activity,GO:0005515~protein binding,GO:0031072~heat shock protein binding,	IPR001440:Tetratricopeptide TPR-1,IPR001623:DnaJ domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00271:DnaJ,	Acetylation,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:DnaJ homolog subfamily C member 7,domain:J,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,
212490_at, 212491_s_at, 205545_x_at	DnaJ heat shock protein family (Hsp40) member C8(DNAJC8)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0045171~intercellular bridge,		IPR001623:DnaJ domain,				SM00271:DnaJ,	Acetylation,Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 8,domain:J,modified residue,sequence conflict,
213092_x_at, 213088_s_at	DnaJ heat shock protein family (Hsp40) member C9(DNAJC9)	Homo sapiens			Translation, ribosomal structure and biogenesis / Posttranslational modification, protein turnover, chaperones,	GO:0032781~positive regulation of ATPase activity,GO:0035176~social behavior,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0031072~heat shock protein binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,				SM00271:DnaJ,	Cell membrane,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Reference proteome,	chain:DnaJ homolog subfamily C member 9,domain:J,modified residue,
207258_at	Down syndrome critical region 4(DSCR4)	Homo sapiens												Complete proteome,Reference proteome,	chain:Down syndrome critical region protein 4,
202221_s_at, 213579_s_at	E1A binding protein p300(EP300)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_il7Pathway:IL-7 Signal Transduction,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_PPARgPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_tgfbPathway:TGF beta signaling pathway,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006473~protein acetylation,GO:0006475~internal protein amino acid acetylation,GO:0006915~apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006990~positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007507~heart development,GO:0007519~skeletal muscle tissue development,GO:0007623~circadian rhythm,GO:0009887~organ morphogenesis,GO:0010506~regulation of autophagy,GO:0010742~macrophage derived foam cell differentiation,GO:0016032~viral process,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0018393~internal peptidyl-lysine acetylation,GO:0030183~B cell differentiation,GO:0030220~platelet formation,GO:0030324~lung development,GO:0032092~positive regulation of protein binding,GO:0032481~positive regulation of type I interferon production,GO:0034644~cellular response to UV,GO:0035855~megakaryocyte development,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043627~response to estrogen,GO:0043923~positive regulation by host of viral transcription,GO:0043967~histone H4 acetylation,GO:0043969~histone H2B acetylation,GO:0045444~fat cell differentiation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051726~regulation of cell cycle,GO:0060765~regulation of androgen receptor signaling pathway,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0090043~regulation of tubulin deacetylation,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904837~beta-catenin-TCF complex assembly,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0031490~chromatin DNA binding,GO:0033613~activating transcription factor binding,GO:0034212~peptide N-acetyltransferase activity,GO:0035257~nuclear hormone receptor binding,GO:0050681~androgen receptor binding,GO:0097157~pre-mRNA intronic binding,	IPR000197:Zinc finger, TAZ-type,IPR000433:Zinc finger, ZZ-type,IPR001487:Bromodomain,IPR003101:Coactivator CBP, KIX domain,IPR009110:Nuclear receptor coactivator, interlocking,IPR010303:Domain of unknown function DUF902, CREBbp,IPR013178:Histone H3-K56 acetyltransferase, RTT109,IPR014744:Nuclear receptor coactivator, CREB-bp-like, interlocking,IPR018359:Bromodomain, conserved site,	hsa04024:cAMP signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa04630:Jak-STAT signaling pathway,hsa04720:Long-term potentiation,hsa04916:Melanogenesis,hsa04919:Thyroid hormone signaling pathway,hsa04922:Glucagon signaling pathway,hsa05016:Huntington's disease,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05215:Prostate cancer,	114500~Colorectal cancer, somatic,613684~Rubinstein-Taybi syndrome 2,		SM00291:ZnF_ZZ,SM00297:BROMO,SM00551:ZnF_TAZ,SM01250:SM01250,	3D-structure,Acetylation,Acyltransferase,Biological rhythms,Bromodomain,Cell cycle,Chromosomal rearrangement,Citrullination,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Host-virus interaction,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:Histone acetyltransferase p300,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,domain:Bromo,domain:KIX,helix,modified residue,mutagenesis site,region of interest:Binding region for E1A adenovirus,region of interest:Interaction with HTLV-1 Tax,region of interest:Interaction with NCOA2,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MYST3-EP300 and EP300-MYST3,site:Interaction with NCOA2,strand,turn,zinc finger region:TAZ-type 1,zinc finger region:TAZ-type 2,zinc finger region:ZZ-type,
212375_at, 212376_s_at	E1A binding protein p400(EP400)	Homo sapiens			Transcription / DNA replication, recombination, and repair,	GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,	GO:0000812~Swr1 complex,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:1990405~protein antigen binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014012:Helicase/SANT-associated, DNA binding,IPR017877:Myb-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,SM00573:HSA,	Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:E1A-binding protein p400,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HSA,domain:Myb-like,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with ZNF42,region of interest:Interactions with RUVBL1 and RUVBL2,sequence conflict,sequence variant,short sequence motif:DEAH box-like,splice variant,
202623_at	E2F associated phosphoprotein(EAPP)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,		IPR019370:E2F-associated phosphoprotein,					Acetylation,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:E2F-associated phosphoprotein,compositionally biased region:Poly-Lys,modified residue,sequence conflict,sequence variant,
204947_at, 2028_s_at	E2F transcription factor 1(E2F1)	Homo sapiens	1.RBphosphoE2F,84.Ubiquitination_Pathways_Cell_Cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_etsPathway:METS affect on Macrophage Differentiation,h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_skp2e2fPathway:E2F1 Destruction Pathway,		GO:0000077~DNA damage checkpoint,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007283~spermatogenesis,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010628~positive regulation of gene expression,GO:0030900~forebrain development,GO:0043276~anoikis,GO:0043392~negative regulation of DNA binding,GO:0045599~negative regulation of fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0048255~mRNA stabilization,GO:0070345~negative regulation of fat cell proliferation,GO:0071398~cellular response to fatty acid,GO:0071456~cellular response to hypoxia,GO:0071466~cellular response to xenobiotic stimulus,GO:0071930~negative regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1990086~lens fiber cell apoptotic process,GO:1990090~cellular response to nerve growth factor stimulus,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0035189~Rb-E2F complex,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,			SM01372:SM01372,	3D-structure,Acetylation,Activator,Apoptosis,Cell cycle,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor E2F1,domain:Leucine-zipper,helix,modified residue,mutagenesis site,region of interest:Cyclin A/CDK2 binding,region of interest:Dimerization,region of interest:Retinoblastoma protein RB1 binding,region of interest:Transactivation,sequence conflict,sequence variant,short sequence motif:DEF box,strand,turn,
207042_at	E2F transcription factor 2(E2F2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0051726~regulation of cell cycle,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:1990086~lens fiber cell apoptotic process,	GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,			SM01372:SM01372,	3D-structure,Activator,Cell cycle,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor E2F2,compositionally biased region:Poly-Pro,domain:Leucine-zipper,helix,region of interest:Cyclin A/CDK2 binding,region of interest:Dimerization,region of interest:Retinoblastoma protein binding,region of interest:Transactivation,sequence variant,short sequence motif:DEF box,
203692_s_at, 203693_s_at	E2F transcription factor 3(E2F3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0070345~negative regulation of fat cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,			SM01372:SM01372,	Activator,Alternative splicing,Cell cycle,Coiled coil,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor E2F3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,domain:Leucine-zipper,region of interest:Cyclin A/CDK2 binding,region of interest:Dimerization,region of interest:Retinoblastoma protein binding,region of interest:Transactivation,sequence variant,short sequence motif:DEF box,
38707_r_at, 202248_at	E2F transcription factor 4(E2F4)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,		GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0002064~epithelial cell development,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006884~cell volume homeostasis,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008015~blood circulation,GO:0009887~organ morphogenesis,GO:0042127~regulation of cell proliferation,GO:0044458~motile cilium assembly,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0098534~centriole assembly,GO:1903251~multi-ciliated epithelial cell differentiation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0046983~protein dimerization activity,GO:1990841~promoter-specific chromatin binding,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,	hsa04110:Cell cycle,hsa04350:TGF-beta signaling pathway,			SM01372:SM01372,	3D-structure,Acetylation,Activator,Cell cycle,Cilium biogenesis/degradation,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor E2F4,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:Leucine-zipper,helix,modified residue,region of interest:Dimerization,region of interest:Interaction with RBL1 and RBL2,region of interest:Transactivation,sequence variant,short sequence motif:DEF box,short sequence motif:HCFC1-binding-motif (HBM),strand,turn,
221586_s_at	E2F transcription factor 5(E2F5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0009887~organ morphogenesis,GO:0030030~cell projection organization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,	hsa04110:Cell cycle,hsa04350:TGF-beta signaling pathway,			SM01372:SM01372,	Activator,Alternative splicing,Cilium biogenesis/degradation,Coiled coil,Complete proteome,DNA-binding,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Transcription factor E2F5,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:Leucine-zipper,region of interest:Dimerization,region of interest:RBL2 association,region of interest:Transactivation,sequence conflict,sequence variant,short sequence motif:DEF box,
203957_at	E2F transcription factor 6(E2F6)	Homo sapiens				GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,IPR015635:Transcription factor E2F6,				SM01372:SM01372,	Alternative splicing,Cell cycle,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor E2F6,compositionally biased region:Poly-Glu,domain:Leucine-zipper,modified residue,mutagenesis site,region of interest:Dimerization,region of interest:Transcription repression,sequence conflict,short sequence motif:DEF box,splice variant,
219990_at	E2F transcription factor 8(E2F8)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001890~placenta development,GO:0002040~sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0008283~cell proliferation,GO:0032466~negative regulation of cytokinesis,GO:0032877~positive regulation of DNA endoreduplication,GO:0033301~cell cycle comprising mitosis without cytokinesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060707~trophoblast giant cell differentiation,GO:0060718~chorionic trophoblast cell differentiation,GO:0070365~hepatocyte differentiation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015633:E2F Family,				SM01372:SM01372,	3D-structure,Activator,Cell cycle,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor E2F8,modified residue,mutagenesis site,sequence conflict,sequence variant,
218524_at	E4F transcription factor 1(E4F1)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0009794~regulation of mitotic cell cycle, embryonic,GO:0010564~regulation of cell cycle process,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0040008~regulation of growth,GO:0051301~cell division,GO:0071850~mitotic cell cycle arrest,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0035497~cAMP response element binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Cell cycle,Cell division,Complete proteome,Cytoplasm,DNA-binding,Growth regulation,Host-virus interaction,Ligase,Metal-binding,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Transcription factor E4F1,modified residue,mutagenesis site,region of interest:Interaction with BMI1,region of interest:Mediates dimerization, DNA-binding, transcription repression of CCNA2 and interaction with HMGA2,region of interest:Mediates interaction with CDKN2A,region of interest:Mediates interaction with RASSF1,region of interest:Mediates interaction with TP53,region of interest:Required for ubiquitin ligase activity,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3; degenerate,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9; degenerate,
212420_at, 212418_at	E74 like ETS transcription factor 1(ELF1)	Homo sapiens				GO:0001817~regulation of cytokine production,GO:0006366~transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050860~negative regulation of T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022084:Transcription factor Elf, N-terminal,				SM00413:ETS,	Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-1,compositionally biased region:Poly-Asp,DNA-binding region:ETS,modified residue,sequence variant,
203822_s_at, 210361_s_at	E74 like ETS transcription factor 2(ELF2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022084:Transcription factor Elf, N-terminal,				SM00413:ETS,	Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS-related transcription factor Elf-2,DNA-binding region:ETS,modified residue,splice variant,
201510_at, 210827_s_at	E74 like ETS transcription factor 3(ELF3)	Homo sapiens				GO:0001824~blastocyst development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060056~mammary gland involution,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Inflammatory response,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-3,DNA-binding region:ETS,domain:PNT,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
31845_at, 203490_at	E74 like ETS transcription factor 4(ELF4)	Homo sapiens				GO:0001787~natural killer cell proliferation,GO:0001866~NK T cell proliferation,GO:0006366~transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0045087~innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0016605~PML body,GO:0031965~nuclear membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022084:Transcription factor Elf, N-terminal,				SM00413:ETS,	Activator,Chromosomal rearrangement,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-4,DNA-binding region:ETS,modified residue,region of interest:RUNX1-binding,sequence conflict,
220624_s_at, 220625_s_at	E74 like ETS transcription factor 5(ELF5)	Homo sapiens				GO:0001712~ectodermal cell fate commitment,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0035019~somatic stem cell population maintenance,GO:0045596~negative regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060644~mammary gland epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04917:Prolactin signaling pathway,			SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-5,DNA-binding region:ETS,domain:PNT,helix,sequence conflict,splice variant,strand,turn,
218225_at	ECSIT signalling integrator(ECSIT)	Homo sapiens		h_il1rPathway:Signal transduction through IL1R,h_tollPathway:Toll-Like Receptor Pathway,		GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0045087~innate immune response,GO:0051341~regulation of oxidoreductase activity,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0005515~protein binding,GO:0016651~oxidoreductase activity, acting on NAD(P)H,	IPR010418:ECSIT,	hsa04010:MAPK signaling pathway,			SM01284:SM01284,	Alternative splicing,Complete proteome,Cytoplasm,Immunity,Innate immunity,Mitochondrion,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,	chain:Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial,sequence variant,splice variant,transit peptide:Mitochondrion,
220006_at	EF-hand and coiled-coil domain containing 1(EFCC1)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 48,compositionally biased region:Poly-Ala,sequence variant,
220156_at	EF-hand calcium binding domain 1(EFCAB1)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:EF-hand calcium-binding domain-containing protein 1,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,
214264_s_at, 210525_x_at	EF-hand calcium binding domain 11(EFCAB11)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,			GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,chain:EF-hand domain-containing protein C14orf143,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,sequence variant,splice variant,
201775_s_at, 201778_s_at, 201777_s_at, 201776_s_at	EF-hand calcium binding domain 14(EFCAB14)	Homo sapiens			Cell division and chromosome partitioning,			GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,					Calcium,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:EF-hand domain-containing protein KIAA0494,domain:EF-hand 1,domain:EF-hand 2,modified residue,sequence variant,
211200_s_at, 207572_at	EF-hand calcium binding domain 2(EFCAB2)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Alternative splicing,Complete proteome,Reference proteome,Repeat,	chain:EF-hand calcium-binding domain-containing protein 2,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,splice variant,
220271_x_at	EF-hand calcium binding domain 6(EFCAB6)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR015070:EF-hand calcium-binding domain-containing protein 6,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	3D-structure,Alternative splicing,Calcium,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:EF-hand calcium-binding domain-containing protein 6,domain:EF-hand 1,domain:EF-hand 10,domain:EF-hand 11,domain:EF-hand 12,domain:EF-hand 13,domain:EF-hand 14,domain:EF-hand 15,domain:EF-hand 16,domain:EF-hand 17,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,domain:EF-hand 5,domain:EF-hand 6,domain:EF-hand 7,domain:EF-hand 8,domain:EF-hand 9,helix,modified residue,region of interest:Interaction with AR,region of interest:Interaction with PARK7,sequence conflict,sequence variant,splice variant,
219833_s_at	EF-hand domain containing 1(EFHC1)	Homo sapiens				GO:0021795~cerebral cortex cell migration,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005930~axoneme,GO:0043025~neuronal cell body,GO:0072686~mitotic spindle,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR002048:EF-hand domain,IPR006602:Uncharacterised domain DM10,IPR010554:Protein of unknown function DUF1126,IPR011992:EF-hand-like domain,		254770~Myoclonic epilepsy, juvenile, susceptibility to, 1,607631~Epilepsy, juvenile absence, susceptibility to, 1,		SM00676:DM10,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Epilepsy,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:EF-hand domain-containing protein 1,domain:DM10 1,domain:DM10 2,domain:DM10 3,domain:EF-hand,sequence conflict,sequence variant,splice variant,
220591_s_at, 220523_at	EF-hand domain containing 2(EFHC2)	Homo sapiens						GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR006602:Uncharacterised domain DM10,IPR010554:Protein of unknown function DUF1126,IPR011992:EF-hand-like domain,				SM00676:DM10,	3D-structure,Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:EF-hand domain-containing family member C2,domain:DM10 1,domain:DM10 2,domain:DM10 3,domain:EF-hand,helix,sequence conflict,sequence variant,splice variant,strand,turn,
209343_at	EF-hand domain family member D1(EFHD1)	Homo sapiens				GO:0031175~neuron projection development,	GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing protein D1,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
217992_s_at	EF-hand domain family member D2(EFHD2)	Homo sapiens				GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0045121~membrane raft,	GO:0005509~calcium ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Acetylation,Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing protein D2,domain:EF-hand 1,domain:EF-hand 2,modified residue,
212150_at, 212149_at	EFR3 homolog A(EFR3A)	Homo sapiens				GO:0046854~phosphatidylinositol phosphorylation,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Autism,Autism spectrum disorder,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein EFR3 homolog A,modified residue,sequence conflict,sequence variant,splice variant,
215328_at, 215334_at	EFR3 homolog B(EFR3B)	Homo sapiens				GO:0046854~phosphatidylinositol phosphorylation,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein EFR3 homolog B,modified residue,splice variant,
201842_s_at, 201843_s_at	EGF containing fibulin like extracellular matrix protein 1(EFEMP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007601~visual perception,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032331~negative regulation of chondrocyte differentiation,GO:0043010~camera-type eye development,GO:0048048~embryonic eye morphogenesis,GO:0048050~post-embryonic eye morphogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005006~epidermal growth factor-activated receptor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,		126600~Doyne honeycomb degeneration of retina,		SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Growth factor,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:EGF-containing fibulin-like extracellular matrix protein 1,disulfide bond,domain:EGF-like 1; atypical,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
206580_s_at, 209356_x_at	EGF containing fibulin like extracellular matrix protein 2(EFEMP2)	Homo sapiens					GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,IPR026824:EGF-containing fibulin-like extracellular matrix protein 1/2,		614437~Cutis laxa, autosomal recessive, type IB,		SM00179:EGF_CA,SM00181:EGF,	3D-structure,Calcium,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:EGF-containing fibulin-like extracellular matrix protein 2,disulfide bond,domain:EGF-like 1; atypical,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,strand,
221935_s_at	EGF domain specific O-linked N-acetylglucosamine transferase(EOGT)	Homo sapiens				GO:0006493~protein O-linked glycosylation,	GO:0005788~endoplasmic reticulum lumen,	GO:0016262~protein N-acetylglucosaminyltransferase activity,	IPR007657:Glycosyltransferase AER61, uncharacterised,	hsa00514:Other types of O-glycan biosynthesis,	615297~Adams-Oliver syndrome 4,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Uncharacterized glycosyltransferase AER61,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
219454_at	EGF like domain multiple 6(EGFL6)	Homo sapiens				GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,	GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0016020~membrane,	GO:0005178~integrin binding,GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000998:MAM domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR018097:EGF-like calcium-binding, conserved site,IPR023413:Green fluorescent protein-like,				SM00137:MAM,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Basement membrane,Calcium,Cell adhesion,Coiled coil,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Epidermal growth factor-like protein 6,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:MAM,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
218825_at	EGF like domain multiple 7(EGFL7)	Homo sapiens				GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0007155~cell adhesion,GO:0045746~negative regulation of Notch signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005509~calcium ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Angiogenesis,Calcium,Cell adhesion,Coiled coil,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Epidermal growth factor-like protein 7,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EMI,sequence variant,signal peptide,
209490_s_at	EGF like domain multiple 8(EGFL8)	Homo sapiens				GO:0001701~in utero embryonic development,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Epidermal growth factor-like protein 8,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EMI,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
207379_at	EGF like repeats and discoidin domains 3(EDIL3)	Homo sapiens				GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0010811~positive regulation of cell-substrate adhesion,	GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005178~integrin binding,GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR008979:Galactose-binding domain-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,SM00231:FA58C,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Complete proteome,Developmental protein,Disulfide bond,EGF-like domain,Glycoprotein,Metal-binding,Reference proteome,Repeat,Secreted,Signal,	chain:EGF-like repeat and discoidin I-like domain-containing protein 3,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:F5/8 type C 1,domain:F5/8 type C 2,short sequence motif:Cell attachment site,signal peptide,splice variant,
91703_at, 221755_at	EH domain binding protein 1 like 1(EHBP1L1)	Homo sapiens					GO:0016020~membrane,		IPR001715:Calponin homology domain,IPR019448:EEIG1/EHBP1 N-terminal domain,IPR022735:Domain of unknown function DUF3585,				SM00033:CH,	Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:EH domain-binding protein 1-like protein 1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:CH,modified residue,sequence conflict,sequence variant,
212653_s_at, 212650_at	EH domain binding protein 1(EHBP1)	Homo sapiens					GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR001715:Calponin homology domain,IPR019448:EEIG1/EHBP1 N-terminal domain,IPR022735:Domain of unknown function DUF3585,		611868~Prostate cancer, hereditary, 12,		SM00033:CH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:EH domain-binding protein 1,compositionally biased region:Poly-Glu,domain:CH,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
209039_x_at, 209038_s_at, 222221_x_at, 208112_x_at, 209037_s_at	EH domain containing 1(EHD1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0007596~blood coagulation,GO:0010886~positive regulation of cholesterol storage,GO:0031175~neuron projection development,GO:0032456~endocytic recycling,GO:0034383~low-density lipoprotein particle clearance,GO:0042384~cilium assembly,GO:0042632~cholesterol homeostasis,GO:0051260~protein homooligomerization,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,GO:0098609~cell-cell adhesion,GO:1901741~positive regulation of myoblast fusion,GO:1990090~cellular response to nerve growth factor stimulus,GO:2001137~positive regulation of endocytic recycling,	GO:0005769~early endosome,GO:0005811~lipid particle,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0020018~ciliary pocket membrane,GO:0030139~endocytic vesicle,GO:0031095~platelet dense tubular network membrane,GO:0031901~early endosome membrane,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0017137~Rab GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00027:EH,	3D-structure,Acetylation,ATP-binding,Calcium,Cell membrane,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Direct protein sequencing,Endosome,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	binding site:ATP,chain:EH domain-containing protein 1,domain:EF-hand,domain:EH,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,strand,
45297_at, 205341_at, 221870_at	EH domain containing 2(EHD2)	Homo sapiens				GO:0006897~endocytosis,GO:0007596~blood coagulation,GO:0030866~cortical actin cytoskeleton organization,GO:0032456~endocytic recycling,GO:0072659~protein localization to plasma membrane,GO:0097320~membrane tubulation,GO:1901741~positive regulation of myoblast fusion,GO:2001137~positive regulation of endocytic recycling,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0010008~endosome membrane,GO:0019898~extrinsic component of membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00027:EH,	Alternative splicing,ATP-binding,Calcium,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Endosome,Hydrolase,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	binding site:ATP,chain:EH domain-containing protein 2,domain:EF-hand,domain:EH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
218935_at	EH domain containing 3(EHD3)	Homo sapiens				GO:0001881~receptor recycling,GO:0007596~blood coagulation,GO:0032456~endocytic recycling,GO:0034498~early endosome to Golgi transport,GO:0042384~cilium assembly,GO:0051260~protein homooligomerization,GO:0055117~regulation of cardiac muscle contraction,GO:0060271~cilium morphogenesis,GO:0072661~protein targeting to plasma membrane,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0090160~Golgi to lysosome transport,GO:1901387~positive regulation of voltage-gated calcium channel activity,GO:1903358~regulation of Golgi organization,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0010008~endosome membrane,GO:0020018~ciliary pocket membrane,GO:0030139~endocytic vesicle,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,	GO:0003676~nucleic acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00027:EH,	Acetylation,Alternative splicing,ATP-binding,Calcium,Cell membrane,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Direct protein sequencing,Endosome,Isopeptide bond,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Protein transport,Reference proteome,Transport,Ubl conjugation,	binding site:ATP,chain:EH domain-containing protein 3,domain:EF-hand,domain:EH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,
209536_s_at	EH domain containing 4(EHD4)	Homo sapiens				GO:0006907~pinocytosis,GO:0030100~regulation of endocytosis,GO:0032456~endocytic recycling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051260~protein homooligomerization,GO:0071363~cellular response to growth factor stimulus,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031901~early endosome membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000261:EPS15 homology (EH),IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,			SM00027:EH,	Acetylation,ATP-binding,Calcium,Cell membrane,Complete proteome,Endosome,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	binding site:ATP,chain:EH domain-containing protein 4,domain:EF-hand,domain:EH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
216396_s_at, 208289_s_at	EI24, autophagy associated transmembrane protein(EI24)	Homo sapiens				GO:0006915~apoptotic process,GO:0016236~macroautophagy,GO:0030308~negative regulation of cell growth,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,		IPR009890:Etoposide-induced 2.4,	hsa04115:p53 signaling pathway,				Acetylation,Alternative splicing,Apoptosis,Autophagy,Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Etoposide-induced protein 2.4 homolog,compositionally biased region:Poly-Arg,modified residue,sequence conflict,transmembrane region,
201727_s_at, 201726_at	ELAV like RNA binding protein 1(ELAVL1)	Homo sapiens		h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000398~mRNA splicing, via spliceosome,GO:0007275~multicellular organism development,GO:0043488~regulation of mRNA stability,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0060965~negative regulation of gene silencing by miRNA,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:2000036~regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:1990904~ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0017091~AU-rich element binding,GO:0019901~protein kinase binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa04152:AMPK signaling pathway,			SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 1,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,
208427_s_at	ELAV like RNA binding protein 2(ELAVL2)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006355~regulation of transcription, DNA-templated,	GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 2,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,splice variant,
206338_at	ELAV like RNA binding protein 3(ELAVL3)	Homo sapiens				GO:0007399~nervous system development,GO:0030154~cell differentiation,		GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR003954:RNA recognition motif domain, eukaryote,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00361:RRM_1,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Neurogenesis,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 3,domain:RRM 1,domain:RRM 2,domain:RRM 3,sequence conflict,splice variant,
206051_at	ELAV like RNA binding protein 4(ELAVL4)	Homo sapiens				GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0048813~dendrite morphogenesis,		GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0017091~AU-rich element binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,		Neuropathy, paraneoplastic sensory~Neuropathy, paraneoplastic sensory,		SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:ELAV-like protein 4,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,modified residue,sequence variant,splice variant,strand,turn,
210376_x_at, 203617_x_at, 210850_s_at	ELK1, ETS transcription factor(ELK1)	Homo sapiens	67.Ikaros_and_signaling_inhibitors,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_igf1Pathway:IGF-1 Signaling Pathway,h_il2Pathway:IL 2 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,		GO:0006366~transcription from RNA polymerase II promoter,GO:0009416~response to light stimulus,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071394~cellular response to testosterone stimulus,GO:0071480~cellular response to gamma radiation,GO:0071774~response to fibroblast growth factor,GO:1901216~positive regulation of neuron death,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043679~axon terminus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04510:Focal adhesion,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05020:Prion diseases,hsa05140:Leishmaniasis,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05205:Proteoglycans in cancer,hsa05213:Endometrial cancer,			SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS domain-containing protein Elk-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:ETS,helix,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,
221773_at, 206127_at	ELK3, ETS transcription factor(ELK3)	Homo sapiens				GO:0001525~angiogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0030154~cell differentiation,GO:0042060~wound healing,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0032422~purine-rich negative regulatory element binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Activator,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS domain-containing protein Elk-3,compositionally biased region:Poly-Ala,DNA-binding region:ETS,modified residue,sequence conflict,sequence variant,short sequence motif:CTBP-binding motif,
206919_at, 205994_at, 214831_at	ELK4, ETS transcription factor(ELK4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0070932~histone H3 deacetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa04010:MAPK signaling pathway,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS domain-containing protein Elk-4,DNA-binding region:ETS,helix,sequence conflict,splice variant,strand,turn,
215606_s_at	ELKS/RAB6-interacting/CAST family member 1(ERC1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007252~I-kappaB phosphorylation,GO:0007275~multicellular organism development,GO:0015031~protein transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0098609~cell-cell adhesion,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0008385~IkappaB kinase complex,GO:0042734~presynaptic membrane,GO:0045202~synapse,GO:0048786~presynaptic active zone,	GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0030165~PDZ domain binding,GO:0043522~leucine zipper domain binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR019018:Rab-binding domain FIP-RBD,IPR019323:CAZ complex, RIM-binding protein,	hsa04064:NF-kappa B signaling pathway,				Acetylation,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:ELKS/RAB6-interacting/CAST family member 1,domain:RBD-FIP,modified residue,sequence conflict,sequence variant,site:Breakpoint for translocation to form ERC1-RET oncogene,splice variant,
213938_at	ELKS/RAB6-interacting/CAST family member 2(ERC2)	Homo sapiens					GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0030054~cell junction,GO:0030426~growth cone,GO:0042734~presynaptic membrane,GO:0048786~presynaptic active zone,	GO:0005515~protein binding,	IPR019323:CAZ complex, RIM-binding protein,					Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,Synaptosome,	chain:ERC protein 2,compositionally biased region:Poly-Gly,compositionally biased region:Poly-His,compositionally biased region:Poly-Lys,modified residue,sequence variant,
219551_at	ELL associated factor 2(EAF2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0030308~negative regulation of cell growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,	GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0016607~nuclear speck,GO:0032783~ELL-EAF complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,	IPR019194:Transcription elognation factor  Eaf, N-terminal,IPR027093:EAF family,					Activator,Alternative splicing,Apoptosis,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ELL-associated factor 2,compositionally biased region:Poly-Gln,compositionally biased region:Ser-rich,modified residue,region of interest:Necessary for interaction with ELL,region of interest:Necessary for interaction with TCEA1 and transactivation activity,region of interest:Necessary for transactivation activity,splice variant,
213712_at, 220029_at	ELOVL fatty acid elongase 2(ELOVL2)	Homo sapiens				GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0036109~alpha-linolenic acid metabolic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0043651~linoleic acid metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0009922~fatty acid elongase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 2,sequence conflict,sequence variant,short sequence motif:Di-lysine motif,transmembrane region,
219532_at	ELOVL fatty acid elongase 4(ELOVL4)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0009584~detection of visible light,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0009922~fatty acid elongase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	hsa00062:Fatty acid elongation,	133190~Spinocerebellar ataxia 34,600110~Stargardt disease 3,614457~Ichthyosis, spastic quadriplegia, and mental retardation,			Complete proteome,Disease mutation,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Ichthyosis,Lipid biosynthesis,Lipid metabolism,Membrane,Mental retardation,Neurodegeneration,Polymorphism,Reference proteome,Spinocerebellar ataxia,Stargardt disease,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Di-lysine motif,transmembrane region,
214153_at, 215082_at, 208788_at	ELOVL fatty acid elongase 5(ELOVL5)	Homo sapiens				GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0036109~alpha-linolenic acid metabolic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0043651~linoleic acid metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0097447~dendritic tree,	GO:0005515~protein binding,GO:0009922~fatty acid elongase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,	615957~Spinocerebellar ataxia 38,			Acetylation,Alternative splicing,Cell projection,Complete proteome,Disease mutation,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Membrane,Neurodegeneration,Phosphoprotein,Proteomics identification,Reference proteome,Spinocerebellar ataxia,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 5,modified residue,sequence conflict,transmembrane region,
210868_s_at, 204256_at	ELOVL fatty acid elongase 6(ELOVL6)	Homo sapiens				GO:0006636~unsaturated fatty acid biosynthetic process,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042759~long-chain fatty acid biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0009922~fatty acid elongase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Complete proteome,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Membrane,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 6,sequence conflict,transmembrane region,
209233_at	EMG1, N1-specific pseudouridine methyltransferase(EMG1)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042274~ribosomal small subunit biogenesis,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0070037~rRNA (pseudouridine) methyltransferase activity,	IPR005304:Ribosomal biogenesis, methyltransferase, EMG1/NEP1,	hsa03008:Ribosome biogenesis in eukaryotes,	211180~Bowen-Conradi syndrome,			3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Disease mutation,Methyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA processing,rRNA-binding,S-adenosyl-L-methionine,Transferase,	chain:Probable ribosome biogenesis protein NEP1,modified residue,sequence variant,
213779_at	EMI domain containing 1(EMID1)	Homo sapiens					GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,		IPR008160:Collagen triple helix repeat,IPR011489:EMI domain,					Alternative splicing,Collagen,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:EMI domain-containing protein 1,disulfide bond,domain:Collagen-like,domain:EMI,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
219012_s_at	EMSY, BRCA2 interacting transcriptional repressor(EMSY)	Homo sapiens				GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR005491:EMSY N-terminal,				SM01191:SM01191,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,DNA damage,DNA repair,Glycoprotein,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Protein EMSY,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,compositionally biased region:Thr-rich,domain:ENT,glycosylation site:O-linked (GlcNAc),helix,modified residue,mutagenesis site,region of interest:Interaction with BRCA2,region of interest:Interaction with ZMYND11,splice variant,strand,
218482_at	ENY2, transcription and export complex 2 subunit(ENY2)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006406~mRNA export from nucleus,GO:0015031~protein transport,GO:0016578~histone deubiquitination,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,	GO:0000124~SAGA complex,GO:0005643~nuclear pore,GO:0070390~transcription export complex 2,GO:0071819~DUBm complex,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,	IPR018783:Transcription factor, enhancer of yellow 2,					3D-structure,Acetylation,Activator,Alternative splicing,Chromatin regulator,Complete proteome,mRNA transport,Nuclear pore complex,Nucleus,Protein transport,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Translocation,Transport,	chain:Enhancer of yellow 2 transcription factor homolog,
211698_at, 208669_s_at, 208670_s_at	EP300 interacting inhibitor of differentiation 1(EID1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0030154~cell differentiation,GO:0035065~regulation of histone acetylation,GO:0045595~regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016235~aggresome,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0035034~histone acetyltransferase regulator activity,GO:0035035~histone acetyltransferase binding,						Alternative splicing,Cell cycle,Complete proteome,Cytoplasm,Differentiation,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:EP300-interacting inhibitor of differentiation 1,modified residue,mutagenesis site,region of interest:Interaction with NR0B2,short sequence motif:LXCXE motif,splice variant,
205977_s_at, 215804_at	EPH receptor A1(EPHA1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001954~positive regulation of cell-matrix adhesion,GO:0006469~negative regulation of protein kinase activity,GO:0007166~cell surface receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035019~somatic stem cell population maintenance,GO:0043087~regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0051496~positive regulation of stress fiber assembly,GO:0090630~activation of GTPase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004672~protein kinase activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,Angiogenesis,ATP-binding,Cell adhesion,Cell membrane,Complete proteome,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 1,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203499_at	EPH receptor A2(EPHA2)	Homo sapiens				GO:0001501~skeletal system development,GO:0001570~vasculogenesis,GO:0001649~osteoblast differentiation,GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010591~regulation of lamellipodium assembly,GO:0014028~notochord formation,GO:0016032~viral process,GO:0016477~cell migration,GO:0016525~negative regulation of angiogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021915~neural tube development,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030316~osteoclast differentiation,GO:0032682~negative regulation of chemokine production,GO:0033598~mammary gland epithelial cell proliferation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0036342~post-anal tail morphogenesis,GO:0043491~protein kinase B signaling,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0045765~regulation of angiogenesis,GO:0046058~cAMP metabolic process,GO:0046849~bone remodeling,GO:0048013~ephrin receptor signaling pathway,GO:0048320~axial mesoderm formation,GO:0048870~cell motility,GO:0050830~defense response to Gram-positive bacterium,GO:0051898~negative regulation of protein kinase B signaling,GO:0060035~notochord cell development,GO:0060326~cell chemotaxis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0070309~lens fiber cell morphogenesis,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070848~response to growth factor,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090630~activation of GTPase activity,GO:0098609~cell-cell adhesion,GO:1901491~negative regulation of lymphangiogenesis,GO:1904238~pericyte cell differentiation,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0030027~lamellipodium,GO:0031256~leading edge membrane,GO:0031258~lamellipodium membrane,GO:0032587~ruffle membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,	116600~Cataract 6, multiple types,	PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,Angiogenesis,Apoptosis,ATP-binding,Cataract,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Host-virus interaction,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 2,compositionally biased region:Cys-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206071_s_at, 206070_s_at, 211164_at	EPH receptor A3(EPHA3)	Homo sapiens				GO:0007155~cell adhesion,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0071300~cellular response to retinoic acid,GO:0097155~fasciculation of sensory neuron axon,GO:0097156~fasciculation of motor neuron axon,	GO:0005576~extracellular region,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 3,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206114_at	EPH receptor A4(EPHA4)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0007155~cell adhesion,GO:0007628~adult walking behavior,GO:0008045~motor neuron axon guidance,GO:0008347~glial cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021957~corticospinal tract morphogenesis,GO:0043087~regulation of GTPase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0048681~negative regulation of axon regeneration,GO:0048710~regulation of astrocyte differentiation,GO:0050770~regulation of axonogenesis,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061001~regulation of dendritic spine morphogenesis,GO:0072178~nephric duct morphogenesis,GO:0097155~fasciculation of sensory neuron axon,GO:0097156~fasciculation of motor neuron axon,GO:2001108~positive regulation of Rho guanyl-nucleotide exchange factor activity,	GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0031901~early endosome membrane,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044295~axonal growth cone,GO:0045211~postsynaptic membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042731~PH domain binding,GO:0042802~identical protein binding,GO:0046875~ephrin receptor binding,GO:0097161~DH domain binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00220:S_TKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Developmental protein,Endosome,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Synapse,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 4,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216837_at, 215664_s_at	EPH receptor A5(EPHA5)	Homo sapiens				GO:0007411~axon guidance,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019933~cAMP-mediated signaling,GO:0021766~hippocampus development,GO:0032793~positive regulation of CREB transcription factor activity,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0048666~neuron development,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:1904322~cellular response to forskolin,	GO:0005791~rough endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Cell projection,Complete proteome,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 5,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206852_at	EPH receptor A7(EPHA7)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0006915~apoptotic process,GO:0007420~brain development,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0022407~regulation of cell-cell adhesion,GO:0031290~retinal ganglion cell axon guidance,GO:0031952~regulation of protein autophosphorylation,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0048013~ephrin receptor signaling pathway,GO:0048671~negative regulation of collateral sprouting,GO:0048755~branching morphogenesis of a nerve,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050919~negative chemotaxis,GO:0051964~negative regulation of synapse assembly,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0072178~nephric duct morphogenesis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,	GO:0004713~protein tyrosine kinase activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,GO:0045499~chemorepellent activity,GO:0046875~ephrin receptor binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Developmental protein,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-A receptor 7,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
210753_s_at, 211898_s_at	EPH receptor B1(EPHB1)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0001525~angiogenesis,GO:0001771~immunological synapse formation,GO:0007411~axon guidance,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021631~optic nerve morphogenesis,GO:0021952~central nervous system projection neuron axonogenesis,GO:0022008~neurogenesis,GO:0030010~establishment of cell polarity,GO:0031290~retinal ganglion cell axon guidance,GO:0031589~cell-substrate adhesion,GO:0046328~regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0048593~camera-type eye morphogenesis,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0051965~positive regulation of synapse assembly,GO:0060326~cell chemotaxis,GO:0060996~dendritic spine development,GO:0060997~dendritic spine morphogenesis,GO:0061351~neural precursor cell proliferation,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1901214~regulation of neuron death,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031901~early endosome membrane,GO:0032433~filopodium tip,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005003~ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,GO:0032403~protein complex binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Endosome,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-B receptor 1,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
209588_at, 211165_x_at, 210651_s_at, 209589_s_at	EPH receptor B2(EPHB2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001655~urogenital system development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007612~learning,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021631~optic nerve morphogenesis,GO:0021952~central nervous system projection neuron axonogenesis,GO:0022038~corpus callosum development,GO:0031290~retinal ganglion cell axon guidance,GO:0042472~inner ear morphogenesis,GO:0048013~ephrin receptor signaling pathway,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048593~camera-type eye morphogenesis,GO:0050771~negative regulation of axonogenesis,GO:0050878~regulation of body fluid levels,GO:0051965~positive regulation of synapse assembly,GO:0060021~palate development,GO:0060996~dendritic spine development,GO:0060997~dendritic spine morphogenesis,GO:0071679~commissural neuron axon guidance,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0004713~protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,	603688~Prostate cancer/brain cancer susceptibility, somatic,	PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Cell projection,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-B receptor 2,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding (in isoform 2),signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
1438_at, 204600_at	EPH receptor B3(EPHB3)	Homo sapiens				GO:0001525~angiogenesis,GO:0001655~urogenital system development,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021952~central nervous system projection neuron axonogenesis,GO:0022038~corpus callosum development,GO:0022407~regulation of cell-cell adhesion,GO:0031290~retinal ganglion cell axon guidance,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043087~regulation of GTPase activity,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0048538~thymus development,GO:0048546~digestive tract morphogenesis,GO:0050770~regulation of axonogenesis,GO:0051965~positive regulation of synapse assembly,GO:0060021~palate development,GO:0060996~dendritic spine development,GO:0060997~dendritic spine morphogenesis,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0030425~dendrite,	GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0008046~axon guidance receptor activity,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Angiogenesis,ATP-binding,Cell membrane,Cell projection,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-B receptor 3,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202894_at, 216680_s_at	EPH receptor B4(EPHB4)	Homo sapiens				GO:0001525~angiogenesis,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0003007~heart morphogenesis,GO:0007155~cell adhesion,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	3D-structure,Alternative splicing,Angiogenesis,ATP-binding,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Ephrin type-B receptor 4,compositionally biased region:Cys-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
204718_at	EPH receptor B6(EPHB6)	Homo sapiens				GO:0001806~type IV hypersensitivity,GO:0006468~protein phosphorylation,GO:0032092~positive regulation of protein binding,GO:0048013~ephrin receptor signaling pathway,GO:0050663~cytokine secretion,GO:0050798~activated T cell proliferation,GO:2000525~positive regulation of T cell costimulation,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0004872~receptor activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001090:Ephrin receptor ligand binding domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001426:Tyrosine-protein kinase, receptor class V, conserved site,IPR001660:Sterile alpha motif domain,IPR003961:Fibronectin, type III,IPR008979:Galactose-binding domain-like,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013761:Sterile alpha motif/pointed domain,IPR013783:Immunoglobulin-like fold,IPR016257:Tyrosine-protein kinase, ephrin receptor,	hsa04360:Axon guidance,		PIRSF000666:tyrosine-protein kinase, ephrin receptor type,	SM00060:FN3,SM00454:SAM,SM00615:EPH_lbd,SM01411:SM01411,	Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Ephrin type-B receptor 6,compositionally biased region:Cys-rich,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Protein kinase,domain:SAM,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202909_at	EPM2A interacting protein 1(EPM2AIP1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032868~response to insulin,GO:0045725~positive regulation of glycogen biosynthetic process,GO:2000467~positive regulation of glycogen (starch) synthase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR026630:EPM2A-interacting protein 1,					Complete proteome,Endoplasmic reticulum,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:EPM2A-interacting protein 1,modified residue,sequence conflict,sequence variant,
206318_at, 206319_s_at	EPPIN-WFDC6 readthrough(EPPIN-WFDC6)	Homo sapiens				GO:0010466~negative regulation of peptidase activity,GO:0042742~defense response to bacterium,GO:0051259~protein oligomerization,GO:0090281~negative regulation of calcium ion import,GO:1901318~negative regulation of sperm motility,	GO:0005615~extracellular space,GO:0009986~cell surface,GO:0043234~protein complex,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR008197:Whey acidic protein-type  4-disulphide core,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,				SM00131:KU,SM00217:WAP,	Alternative splicing,Antimicrobial,Complete proteome,Disulfide bond,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Serine protease inhibitor,Signal,
218779_x_at, 221665_s_at, 218778_x_at, 221655_x_at, 91826_at	EPS8 like 1(EPS8L1)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0098609~cell-cell adhesion,GO:1900029~positive regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0032587~ruffle membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0042608~T cell receptor binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,				SM00326:SH3,SM00462:PTB,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Kinase,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,SH3 domain,Signal,Transferase,	chain:Epidermal growth factor receptor kinase substrate 8-like protein 1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Leu,compositionally biased region:Pro-rich,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
218180_s_at	EPS8 like 2(EPS8L2)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0098609~cell-cell adhesion,GO:1900029~positive regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0031982~vesicle,GO:0032587~ruffle membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,				SM00326:SH3,SM00462:PTB,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Epidermal growth factor receptor kinase substrate 8-like protein 2,domain:PID,domain:SH3,helix,modified residue,sequence conflict,splice variant,strand,turn,
219404_at	EPS8 like 3(EPS8L3)	Homo sapiens					GO:0005737~cytoplasm,		IPR001452:Src homology-3 domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,				SM00326:SH3,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:Epidermal growth factor receptor kinase substrate 8-like protein 3,compositionally biased region:Pro-rich,domain:SH3,helix,sequence variant,splice variant,strand,
203279_at	ER degradation enhancing alpha-mannosidase like protein 1(EDEM1)	Homo sapiens		h_eradPathway:ERassociated degradation (ERAD) Pathway,		GO:0006491~N-glycan processing,GO:0008152~metabolic process,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0036498~IRE1-mediated unfolded protein response,GO:0036510~trimming of terminal mannose on C branch,GO:0097466~glycoprotein ERAD pathway,GO:1904154~positive regulation of retrograde protein transport, ER to cytosol,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0001948~glycoprotein binding,GO:0004559~alpha-mannosidase activity,GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0051787~misfolded protein binding,	IPR001382:Glycoside hydrolase, family 47,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosidase,Hydrolase,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Unfolded protein response,	chain:ER degradation-enhancing alpha- mannosidase-like 1,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
218282_at	ER degradation enhancing alpha-mannosidase like protein 2(EDEM2)	Homo sapiens				GO:0006491~N-glycan processing,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0036509~trimming of terminal mannose on B branch,GO:0097466~glycoprotein ERAD pathway,GO:1904154~positive regulation of retrograde protein transport, ER to cytosol,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0001948~glycoprotein binding,GO:0004559~alpha-mannosidase activity,GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Polymorphism,Reference proteome,Signal,Unfolded protein response,	chain:ER degradation-enhancing alpha- mannosidase-like 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
220342_x_at, 220926_s_at	ER degradation enhancing alpha-mannosidase like protein 3(EDEM3)	Homo sapiens				GO:0006491~N-glycan processing,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0004559~alpha-mannosidase activity,GO:0004569~glycoprotein endo-alpha-1,2-mannosidase activity,GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,	IPR001382:Glycoside hydrolase, family 47,IPR003137:Protease-associated domain, PA,	hsa04141:Protein processing in endoplasmic reticulum,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosidase,Hydrolase,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Unfolded protein response,	chain:ER degradation-enhancing alpha- mannosidase-like 3,domain:PA,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,
202444_s_at, 202441_at	ER lipid raft associated 1(ERLIN1)	Homo sapiens				GO:0008203~cholesterol metabolic process,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0032933~SREBP signaling pathway,GO:0045541~negative regulation of cholesterol biosynthetic process,GO:0045717~negative regulation of fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0015485~cholesterol binding,GO:0031625~ubiquitin protein ligase binding,	IPR001107:Band 7 protein,				SM00244:PHB,	Acetylation,Cholesterol metabolism,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Lipid metabolism,Lipid-binding,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Erlin-1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
221543_s_at, 221542_s_at	ER lipid raft associated 2(ERLIN2)	Homo sapiens				GO:0008203~cholesterol metabolic process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0032933~SREBP signaling pathway,GO:0045541~negative regulation of cholesterol biosynthetic process,GO:0045717~negative regulation of fatty acid biosynthetic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0015485~cholesterol binding,GO:0031625~ubiquitin protein ligase binding,	IPR001107:Band 7 protein,		611225~Spastic paraplegia 18, autosomal recessive,		SM00244:PHB,	Alternative splicing,Cholesterol metabolism,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Hereditary spastic paraplegia,Lipid metabolism,Membrane,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Erlin-2,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Interaction with ERLIN1,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
212394_at, 212395_s_at, 215991_s_at, 212396_s_at	ER membrane protein complex subunit 1(EMC1)	Homo sapiens			Function unknown,	GO:0034975~protein folding in endoplasmic reticulum,	GO:0016021~integral component of membrane,GO:0072546~ER membrane protein complex,		IPR002372:Pyrrolo-quinoline quinone repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR011678:Domain of unknown function DUF1620,IPR026895:ER membrane protein complex subunit 1,IPR027295:Quinonprotein alcohol dehydrogenase-like domain,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0090,domain:DUF1620,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
222345_at	ER membrane protein complex subunit 10(EMC10)	Homo sapiens					GO:0005576~extracellular region,GO:0016021~integral component of membrane,GO:0072546~ER membrane protein complex,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:UPF0510 protein INM02,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203584_at	ER membrane protein complex subunit 2(EMC2)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,		GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0072546~ER membrane protein complex,	GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Acetylation,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 35,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,
215250_at, 217882_at	ER membrane protein complex subunit 3(EMC3)	Homo sapiens				GO:0034975~protein folding in endoplasmic reticulum,	GO:0016021~integral component of membrane,GO:0072546~ER membrane protein complex,		IPR002809:Protein of unknown function DUF106, transmembrane,IPR008568:Uncharacterised conserved protein UCP010045, transmembrane eukaryotic,			PIRSF010045:transmembrane protein, pob type,	SM01415:SM01415,	Alternative splicing,Complete proteome,Direct protein sequencing,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 111,sequence conflict,splice variant,transmembrane region,
221255_s_at	ER membrane protein complex subunit 6(EMC6)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0034975~protein folding in endoplasmic reticulum,	GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0072546~ER membrane protein complex,GO:0097631~integral component of omegasome membrane,	GO:0005515~protein binding,	IPR008504:Transmembrane protein 93,					Acetylation,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 93,transmembrane region,
217898_at	ER membrane protein complex subunit 7(EMC7)	Homo sapiens					GO:0016021~integral component of membrane,GO:0072546~ER membrane protein complex,	GO:0030246~carbohydrate binding,	IPR013784:Carbohydrate-binding-like fold,IPR019008:Domain of unknown function DUF2012,					3D-structure,Complete proteome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:UPF0480 protein C15orf24,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218057_x_at	ER membrane protein complex subunit 8(EMC8)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0072546~ER membrane protein complex,	GO:0005515~protein binding,	IPR005366:Uncharacterised protein family UPF0172,					Alternative splicing,Complete proteome,Cytoplasm,Proteomics identification,Reference proteome,	chain:Neighbor of COX4,modified residue,
219203_at	ER membrane protein complex subunit 9(EMC9)	Homo sapiens					GO:0005737~cytoplasm,GO:0072546~ER membrane protein complex,	GO:0005515~protein binding,	IPR005366:Uncharacterised protein family UPF0172,					Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:UPF0172 protein FAM158A,sequence conflict,sequence variant,
208247_at	ERC2 intronic transcript 1(ERC2-IT1)	Homo sapiens												Complete proteome,Reference proteome,
203719_at, 203720_s_at	ERCC excision repair 1, endonuclease non-catalytic subunit(ERCC1)	Homo sapiens				GO:0000710~meiotic mismatch repair,GO:0000720~pyrimidine dimer repair by nucleotide-excision repair,GO:0001302~replicative cell aging,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006312~mitotic recombination,GO:0006949~syncytium formation,GO:0006979~response to oxidative stress,GO:0007283~spermatogenesis,GO:0007584~response to nutrient,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009650~UV protection,GO:0009744~response to sucrose,GO:0010165~response to X-ray,GO:0010259~multicellular organism aging,GO:0032205~negative regulation of telomere maintenance,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035166~post-embryonic hemopoiesis,GO:0035264~multicellular organism growth,GO:0036297~interstrand cross-link repair,GO:0045190~isotype switching,GO:0048477~oogenesis,GO:0048568~embryonic organ development,GO:0070911~global genome nucleotide-excision repair,GO:0070914~UV-damage excision repair,GO:0090656~t-circle formation,GO:1904431~positive regulation of t-circle formation,	GO:0000109~nucleotide-excision repair complex,GO:0000110~nucleotide-excision repair factor 1 complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,GO:0070522~ERCC4-ERCC1 complex,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0001094~TFIID-class transcription factor binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019904~protein domain specific binding,GO:0043566~structure-specific DNA binding,	IPR004579:DNA repair protein rad10,IPR010994:RuvA domain 2-like,IPR011335:Restriction endonuclease  type II-like,	hsa03420:Nucleotide excision repair,hsa03460:Fanconi anemia pathway,	610758~Cerebrooculofacioskeletal syndrome 4,			3D-structure,Acetylation,Alternative splicing,Cataract,Complete proteome,Cytoplasm,DNA damage,DNA repair,DNA-binding,Endonuclease,Hydrolase,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA excision repair protein ERCC-1,helix,sequence variant,short sequence motif:Nuclear localization signal,strand,
213468_at	ERCC excision repair 2, TFIIH core complex helicase subunit(ERCC2)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0006139~nucleobase-containing compound metabolic process,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0007059~chromosome segregation,GO:0007568~aging,GO:0008283~cell proliferation,GO:0009650~UV protection,GO:0009791~post-embryonic development,GO:0016032~viral process,GO:0021510~spinal cord development,GO:0030198~extracellular matrix organization,GO:0030282~bone mineralization,GO:0032289~central nervous system myelin formation,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035264~multicellular organism growth,GO:0035315~hair cell differentiation,GO:0040016~embryonic cleavage,GO:0043249~erythrocyte maturation,GO:0043388~positive regulation of DNA binding,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048820~hair follicle maturation,GO:0060218~hematopoietic stem cell differentiation,GO:0070911~global genome nucleotide-excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0019907~cyclin-dependent protein kinase activating kinase holoenzyme complex,GO:0071817~MMXD complex,	GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0043139~5'-3' DNA helicase activity,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001945:Xeroderma pigmentosum group D protein,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR010643:Domain of unknown function DUF1227,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,	278730~Xeroderma pigmentosum, group D,601675~Trichothiodystrophy 1, photosensitive,610756~Cerebrooculofacioskeletal syndrome 2,		SM00488:DEXDc2,SM00491:HELICc2,	3D-structure,4Fe-4S,Alternative splicing,ATP-binding,Cataract,Chromosome partition,Cockayne syndrome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Helicase,Host-virus interaction,Hydrolase,Ichthyosis,Iron,Iron-sulfur,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Xeroderma pigmentosum,	chain:TFIIH basal transcription factor complex helicase subunit,domain:Helicase ATP-binding,metal ion-binding site:Iron-sulfur (4Fe-4S),mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,
202176_at	ERCC excision repair 3, TFIIH core complex helicase subunit(ERCC3)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,		GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0001666~response to hypoxia,GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0008104~protein localization,GO:0009411~response to UV,GO:0009650~UV protection,GO:0016032~viral process,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035315~hair cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048568~embryonic organ development,GO:0070911~global genome nucleotide-excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016887~ATPase activity,GO:0032564~dATP binding,GO:0042277~peptide binding,GO:0043138~3'-5' DNA helicase activity,GO:0047485~protein N-terminus binding,	IPR001161:Helicase Ercc3,IPR001650:Helicase, C-terminal,IPR006935:Helicase/UvrB domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,	610651~Xeroderma pigmentosum, group B,616390~Trichothiodystrophy 2, photosensitive,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,ATP-binding,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Helicase,Host-virus interaction,Hydrolase,Ichthyosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Xeroderma pigmentosum,	chain:TFIIH basal transcription factor complex helicase XPB subunit,compositionally biased region:Asp/Glu-rich (acidic),domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEVH box,short sequence motif:Nuclear localization signal,
210158_at	ERCC excision repair 4, endonuclease catalytic subunit(ERCC4)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0009411~response to UV,GO:0009650~UV protection,GO:0032205~negative regulation of telomere maintenance,GO:0033683~nucleotide-excision repair, DNA incision,GO:0034644~cellular response to UV,GO:0036297~interstrand cross-link repair,GO:0070911~global genome nucleotide-excision repair,GO:1901255~nucleotide-excision repair involved in interstrand cross-link repair,	GO:0000109~nucleotide-excision repair complex,GO:0000110~nucleotide-excision repair factor 1 complex,GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0070522~ERCC4-ERCC1 complex,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0001094~TFIID-class transcription factor binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0043566~structure-specific DNA binding,GO:0047485~protein N-terminus binding,	IPR006166:ERCC4 domain,IPR006167:DNA repair protein,IPR010994:RuvA domain 2-like,IPR011335:Restriction endonuclease  type II-like,IPR020819:DNA repair nuclease, XPF-type/Helicase,	hsa03420:Nucleotide excision repair,hsa03460:Fanconi anemia pathway,	278760~Xeroderma pigmentosum, group F,278760~Xeroderma pigmentosum, type F/Cockayne syndrome,610965~XFE progeroid syndrome,615272~Fanconi anemia, complementation group Q,		SM00891:SM00891,	3D-structure,Acetylation,Alternative splicing,Cockayne syndrome,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Endonuclease,Fanconi anemia,Hydrolase,Magnesium,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Xeroderma pigmentosum,	chain:DNA repair endonuclease XPF,domain:ERCC4,domain:Leucine-zipper 1,domain:Leucine-zipper 2,helix,modified residue,region of interest:Interaction with EME1 and ERCC1,sequence variant,short sequence motif:Nuclear localization signal,strand,
202414_at	ERCC excision repair 5, endonuclease(ERCC5)	Homo sapiens				GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0009411~response to UV,GO:0009650~UV protection,GO:0010225~response to UV-C,GO:0033683~nucleotide-excision repair, DNA incision,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005675~holo TFIIH complex,GO:0016021~integral component of membrane,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,	GO:0000405~bubble DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004518~nuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,	IPR001044:XPG/Rad2 endonuclease, eukaryotes,IPR006084:XPG/Rad2 endonuclease,IPR006085:XPG N-terminal,IPR006086:XPG-I domain,IPR008918:Helix-hairpin-helix motif, class 2,IPR019974:XPG conserved site,IPR020045:5'-3' exonuclease, C-terminal domain,	hsa03420:Nucleotide excision repair,	278780~Xeroderma pigmentosum, group G,278780~Xeroderma pigmentosum, group G/Cockayne syndrome,616570~Cerebrooculofacioskeletal syndrome 3,		SM00279:HhH2,SM00484:XPGI,SM00485:XPGN,	3D-structure,Acetylation,Alternative splicing,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Endonuclease,Hydrolase,Magnesium,Membrane,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Xeroderma pigmentosum,	chain:DNA repair protein complementing XP-G cells,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,region of interest:I-domain,region of interest:Interaction with PCNA,region of interest:N-domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
219650_at	ERCC excision repair 6 like, spindle assembly checkpoint helicase(ERCC6L)	Homo sapiens			Transcription / DNA replication, recombination, and repair,	GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA-binding,Helicase,Hydrolase,Kinetochore,Mitosis,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:DNA excision repair protein ERCC-6-like,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,repeat:TPR 1,repeat:TPR 2,sequence conflict,short sequence motif:DEAH box,
207347_at	ERCC excision repair 6, chromatin remodeling factor(ERCC6)	Homo sapiens				GO:0000303~response to superoxide,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006290~pyrimidine dimer repair,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0007256~activation of JNKK activity,GO:0007257~activation of JUN kinase activity,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009411~response to UV,GO:0009636~response to toxic substance,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0035264~multicellular organism growth,GO:0045494~photoreceptor cell maintenance,GO:0045815~positive regulation of gene expression, epigenetic,GO:0061098~positive regulation of protein tyrosine kinase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0008023~transcription elongation factor complex,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0030296~protein tyrosine kinase activator activity,GO:0032403~protein complex binding,GO:0047485~protein N-terminus binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03420:Nucleotide excision repair,	133540~Cockayne syndrome, type B,211980~Lung cancer, susceptibility to,214150~Cerebrooculofacioskeletal syndrome 1,278800~De Sanctis-Cacchione syndrome,600630~UV-sensitive syndrome 1,613761~Macular degeneration, age-related, susceptibility to 5,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Age-related macular degeneration,ATP-binding,Cataract,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Helicase,Hydrolase,Mental retardation,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Xeroderma pigmentosum,	chain:DNA excision repair protein ERCC-6,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Gly-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEGH box,short sequence motif:Nuclear localization signal,
220716_at, 205162_at	ERCC excision repair 8, CSA ubiquitin ligase complex subunit(ERCC8)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0009411~response to UV,GO:0010165~response to X-ray,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045739~positive regulation of DNA repair,GO:0051865~protein autoubiquitination,	GO:0000109~nucleotide-excision repair complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0043234~protein complex,	GO:0003678~DNA helicase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0032403~protein complex binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa03420:Nucleotide excision repair,hsa04120:Ubiquitin mediated proteolysis,	216400~Cockayne syndrome, type A,614621~UV-sensitive syndrome 2,		SM00320:WD40,	3D-structure,Alternative splicing,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,Dwarfism,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:DNA excision repair protein ERCC-8,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence variant,splice variant,
213541_s_at, 211626_x_at, 222079_at	ERG, ETS transcription factor(ERG)	Homo sapiens				GO:0003197~endocardial cushion development,GO:0003199~endocardial cushion to mesenchymal transition involved in heart valve formation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:2000504~positive regulation of blood vessel remodeling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa05202:Transcriptional misregulation in cancer,			SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Transcriptional regulator ERG,DNA-binding region:ETS,domain:PNT,helix,modified residue,splice variant,strand,turn,
218135_at	ERGIC and golgi 2(ERGIC2)	Homo sapiens				GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,	IPR012936:Endoplasmic reticulum vesicle transporter, C-terminal,					Complete proteome,Cytoplasm,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Membrane,Nucleus,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Endoplasmic reticulum-Golgi intermediate compartment protein 2,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
216032_s_at, 215257_at	ERGIC and golgi 3(ERGIC3)	Homo sapiens				GO:0016192~vesicle-mediated transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,		IPR012936:Endoplasmic reticulum vesicle transporter, C-terminal,					Acetylation,Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Endoplasmic reticulum-Golgi intermediate compartment protein 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
213365_at	ERI1 exoribonuclease family member 2(ERI2)	Homo sapiens				GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),		GO:0003676~nucleic acid binding,GO:0004527~exonuclease activity,GO:0008270~zinc ion binding,	IPR010666:Zinc finger, GRF-type,IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,				SM00479:EXOIII,	Alternative splicing,Complete proteome,Exonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Polymorphism,Reference proteome,	active site:Proton acceptor,binding site:AMP,chain:ERI1 exoribonuclease 2,domain:Exonuclease,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,sequence conflict,sequence variant,splice variant,
208973_at	ERI1 exoribonuclease family member 3(ERI3)	Homo sapiens				GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),		GO:0003676~nucleic acid binding,GO:0004527~exonuclease activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,				SM00479:EXOIII,	3D-structure,Alternative splicing,Amyloid,Complete proteome,Exonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Prion,Proteomics identification,Reference proteome,	active site:Proton acceptor,binding site:AMP,chain:ERI1 exoribonuclease 3,domain:Exonuclease,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,splice variant,
218859_s_at	ESF1 nucleolar pre-rRNA processing protein homolog(ESF1)	Homo sapiens			Function unknown,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR012580:NUC153,					Acetylation,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ESF1 homolog,compositionally biased region:Asp-rich,compositionally biased region:Lys-rich,modified residue,sequence conflict,sequence variant,
204034_at	ETHE1, persulfide dioxygenase(ETHE1)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0070221~sulfide oxidation, using sulfide:quinone oxidoreductase,GO:0070813~hydrogen sulfide metabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005506~iron ion binding,GO:0050313~sulfur dioxygenase activity,	IPR001279:Beta-lactamase-like,	hsa00920:Sulfur metabolism,	602473~Ethylmalonic encephalopathy,		SM00849:SM00849,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Dioxygenase,Disease mutation,Metal-binding,Mitochondrion,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	chain:Protein ETHE1, mitochondrial,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,sequence variant,transit peptide:Mitochondrion,
219850_s_at	ETS homologous factor(EHF)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0030855~epithelial cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050673~epithelial cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ETS homologous factor,DNA-binding region:ETS,domain:PNT,modified residue,sequence conflict,sequence variant,splice variant,
214447_at	ETS proto-oncogene 1, transcription factor(ETS1)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,h_keratinocytePathway:Keratinocyte Differentiation,		GO:0001666~response to hypoxia,GO:0006366~transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007565~female pregnancy,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0010595~positive regulation of endothelial cell migration,GO:0010715~regulation of extracellular matrix disassembly,GO:0021854~hypothalamus development,GO:0021983~pituitary gland development,GO:0030578~PML body organization,GO:0032355~response to estradiol,GO:0034616~response to laminar fluid shear stress,GO:0042981~regulation of apoptotic process,GO:0044849~estrous cycle,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045786~negative regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0048870~cell motility,GO:0050728~negative regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0051272~positive regulation of cellular component movement,GO:0060055~angiogenesis involved in wound healing,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:0070301~cellular response to hydrogen peroxide,GO:0070555~response to interleukin-1,GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016311:Transforming protein C-ets,	hsa04014:Ras signaling pathway,hsa04320:Dorso-ventral axis formation,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,		PIRSF001698:transforming factor C-ets,	SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Immunity,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Protein C-ets-1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:ETS,domain:PNT,helix,modified residue,sequence conflict,splice variant,strand,turn,
201328_at, 201329_s_at	ETS proto-oncogene 2, transcription factor(ETS2)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,h_keratinocytePathway:Keratinocyte Differentiation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001712~ectodermal cell fate commitment,GO:0006351~transcription, DNA-templated,GO:0007498~mesoderm development,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0090009~primitive streak formation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0035259~glucocorticoid receptor binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016311:Transforming protein C-ets,IPR027276:Transforming protein C-ets-2,	hsa04014:Ras signaling pathway,hsa04320:Dorso-ventral axis formation,hsa05166:HTLV-I infection,		PIRSF001698:transforming factor C-ets,PIRSF501032:transforming protein C-ets-2 [Parent=PIRSF001698],	SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Protein C-ets-2,DNA-binding region:ETS,domain:PNT,modified residue,
206501_x_at, 221910_at, 221911_at, 217053_x_at, 217061_s_at	ETS variant 1(ETV1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007411~axon guidance,GO:0007517~muscle organ development,GO:0007638~mechanosensory behavior,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048935~peripheral nervous system neuron development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR006715:PEA3-type ETS-domain transcription factor, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS translocation variant 1,DNA-binding region:ETS,sequence conflict,sequence variant,splice variant,
215510_at	ETS variant 2(ETV2)	Homo sapiens				GO:0001824~blastocyst development,GO:0001890~placenta development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007219~Notch signaling pathway,GO:0016055~Wnt signaling pathway,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048514~blood vessel morphogenesis,GO:0060803~BMP signaling pathway involved in mesodermal cell fate specification,GO:2000382~positive regulation of mesoderm development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,
214480_at	ETS variant 3(ETV3)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0030154~cell differentiation,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0090571~RNA polymerase II transcription repressor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0017151~DEAD/H-box RNA helicase binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS translocation variant 3,DNA-binding region:ETS,modified residue,splice variant,
211603_s_at	ETS variant 4(ETV4)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0008045~motor neuron axon guidance,GO:0030154~cell differentiation,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060762~regulation of branching involved in mammary gland duct morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR006715:PEA3-type ETS-domain transcription factor, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS translocation variant 4,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Gln-rich,DNA-binding region:ETS,modified residue,sequence conflict,sequence variant,
203348_s_at, 216375_s_at, 203349_s_at	ETS variant 5(ETV5)	Homo sapiens		h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,		GO:0006366~transcription from RNA polymerase II promoter,GO:0007274~neuromuscular synaptic transmission,GO:0007626~locomotory behavior,GO:0030154~cell differentiation,GO:0034599~cellular response to oxidative stress,GO:0045666~positive regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048133~male germ-line stem cell asymmetric division,GO:0050807~regulation of synapse organization,GO:0060252~positive regulation of glial cell proliferation,GO:0060762~regulation of branching involved in mammary gland duct morphogenesis,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR000418:Ets domain,IPR006715:PEA3-type ETS-domain transcription factor, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:ETS translocation variant 5,DNA-binding region:ETS,sequence variant,
205585_at	ETS variant 6(ETV6)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007296~vitellogenesis,GO:0022008~neurogenesis,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071425~hematopoietic stem cell proliferation,GO:0097152~mesenchymal cell apoptotic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04320:Dorso-ventral axis formation,hsa05202:Transcriptional misregulation in cancer,	601626~Leukemia, acute myeloid, somatic,616216~Thrombocytopenia 5,		SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Acetylation,Chromosomal rearrangement,Complete proteome,Disease mutation,DNA-binding,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Transcription factor ETV6,DNA-binding region:ETS,domain:PNT,helix,modified residue,mutagenesis site,sequence variant,site:Breakpoint for translocation to form CHIC2-ETV6 in AML,site:Breakpoint for translocation to form ETV6-AML1 in ALL,site:Breakpoint for translocation to form ETV6-MDS2 in MDS,site:Breakpoint for translocation to form PAX5-ETV6,strand,turn,
221680_s_at	ETS variant 7(ETV7)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009887~organ morphogenesis,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04320:Dorso-ventral axis formation,hsa05202:Transcriptional misregulation in cancer,			SM00251:SAM_PNT,SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor ETV7,DNA-binding region:ETS,domain:PNT,sequence conflict,sequence variant,splice variant,
203643_at	ETS2 repressor factor(ERF)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,		600775~Craniosynostosis 4,		SM00413:ETS,	Alternative splicing,Complete proteome,Craniosynostosis,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:ETS domain-containing transcription factor ERF,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,DNA-binding region:ETS,modified residue,mutagenesis site,sequence conflict,sequence variant,
209214_s_at, 210012_s_at, 210011_s_at	EWS RNA binding protein 1(EWSR1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa05202:Transcriptional misregulation in cancer,	612219~Ewing sarcoma,612219~Neuroepithelioma,		SM00360:RRM,SM00547:ZnF_RBZ,	3D-structure,Acetylation,Alternative splicing,Calmodulin-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:RNA-binding protein EWS,compositionally biased region:Arg/Gly/Pro-rich,domain:IQ,domain:RRM,helix,modified residue,region of interest:31 X approximate tandem repeats,region of interest:EAD (Gln/Pro/Thr-rich),repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,site:Breakpoint for insertion to form EWSR1- FEV fusion protein,site:Breakpoint for translocation to form chimeric EWSR1/ATF1 protein,splice variant,strand,turn,zinc finger region:RanBP2-type,
214608_s_at	EYA transcriptional coactivator and phosphatase 1(EYA1)	Homo sapiens				GO:0000132~establishment of mitotic spindle orientation,GO:0001656~metanephros development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007389~pattern specification process,GO:0007501~mesodermal cell fate specification,GO:0007605~sensory perception of sound,GO:0009653~anatomical structure morphogenesis,GO:0010212~response to ionizing radiation,GO:0014706~striated muscle tissue development,GO:0016576~histone dephosphorylation,GO:0016925~protein sumoylation,GO:0030154~cell differentiation,GO:0034613~cellular protein localization,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035909~aorta morphogenesis,GO:0042471~ear morphogenesis,GO:0042473~outer ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0045664~regulation of neuron differentiation,GO:0045739~positive regulation of DNA repair,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048665~neuron fate specification,GO:0048704~embryonic skeletal system morphogenesis,GO:0048752~semicircular canal morphogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0060037~pharyngeal system development,GO:0060487~lung epithelial cell differentiation,GO:0071600~otic vesicle morphogenesis,GO:0072513~positive regulation of secondary heart field cardioblast proliferation,GO:0090103~cochlea morphogenesis,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032993~protein-DNA complex,GO:0043234~protein complex,	GO:0003723~RNA binding,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006545:EYA,	hsa05202:Transcriptional misregulation in cancer,	113650~Anterior segment anomalies with or without cataract,113650~Branchiootorenal syndrome 1, with or without cataracts,166780~Otofaciocervical syndrome,602588~Branchiootic syndrome 1,			Activator,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Deafness,Developmental protein,Disease mutation,DNA damage,DNA repair,Hydrolase,Magnesium,Mental retardation,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	active site:Nucleophile,active site:Proton donor,chain:Eyes absent homolog 1,metal ion-binding site:Magnesium,mutagenesis site,sequence variant,splice variant,
209692_at	EYA transcriptional coactivator and phosphatase 2(EYA2)	Homo sapiens				GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007501~mesodermal cell fate specification,GO:0014706~striated muscle tissue development,GO:0016576~histone dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0045739~positive regulation of DNA repair,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097345~mitochondrial outer membrane permeabilization,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006545:EYA,IPR023214:HAD-like domain,					3D-structure,Activator,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Developmental protein,DNA damage,DNA repair,Hydrolase,Magnesium,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	active site:Nucleophile,active site:Proton donor,chain:Eyes absent homolog 2,helix,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
206379_at	EYA transcriptional coactivator and phosphatase 3(EYA3)	Homo sapiens				GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007601~visual perception,GO:0009653~anatomical structure morphogenesis,GO:0010212~response to ionizing radiation,GO:0016576~histone dephosphorylation,GO:0030154~cell differentiation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0045739~positive regulation of DNA repair,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006545:EYA,					Acetylation,Activator,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Developmental protein,DNA damage,DNA repair,Hydrolase,Magnesium,Metal-binding,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	active site:Nucleophile,active site:Proton donor,chain:Eyes absent homolog 3,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence conflict,splice variant,
207327_at	EYA transcriptional coactivator and phosphatase 4(EYA4)	Homo sapiens				GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0009653~anatomical structure morphogenesis,GO:0016576~histone dephosphorylation,GO:0030154~cell differentiation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0045739~positive regulation of DNA repair,GO:0048839~inner ear development,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006545:EYA,IPR023214:HAD-like domain,		601316~Deafness, autosomal dominant 10,605362~Cardiomyopathy, dilated, 1J,			Acetylation,Activator,Alternative splicing,Cardiomyopathy,Chromatin regulator,Complete proteome,Cytoplasm,Deafness,Developmental protein,Disease mutation,DNA damage,DNA repair,Hydrolase,Magnesium,Metal-binding,Non-syndromic deafness,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	active site:Nucleophile,active site:Proton donor,chain:Eyes absent homolog 4,metal ion-binding site:Magnesium,modified residue,sequence conflict,sequence variant,splice variant,
217838_s_at	Enah/Vasp-like(EVL)	Homo sapiens				GO:0007015~actin filament organization,GO:0007166~cell surface receptor signaling pathway,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0008154~actin polymerization or depolymerization,GO:0009887~organ morphogenesis,GO:0010633~negative regulation of epithelial cell migration,GO:0030838~positive regulation of actin filament polymerization,GO:0051289~protein homotetramerization,GO:0051496~positive regulation of stress fiber assembly,GO:1900028~negative regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0017124~SH3 domain binding,	IPR000697:EVH1,IPR011993:Pleckstrin homology-like domain,IPR014885:VASP tetramerisation,IPR017354:Vasodilator-stimulated phosphoprotein,			PIRSF038010:vasodilator-stimulated phosphoprotein,	SM00461:WH1,	Actin-binding,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3-binding,	chain:Ena/VASP-like protein,compositionally biased region:Pro-rich,domain:WH1,modified residue,region of interest:EVH2,region of interest:EVH2 block A,region of interest:EVH2 block B,region of interest:EVH2 block C,sequence conflict,sequence variant,short sequence motif:KLKR,splice variant,
219424_at	Epstein-Barr virus induced 3(EBI3)	Homo sapiens				GO:0006959~humoral immune response,GO:0019221~cytokine-mediated signaling pathway,GO:0042088~T-helper 1 type immune response,GO:0042098~T cell proliferation,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0046641~positive regulation of alpha-beta T cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,	GO:0004896~cytokine receptor activity,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0045523~interleukin-27 receptor binding,	IPR003530:Long hematopoietin receptor, soluble alpha chain, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Complete proteome,Cytokine,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Interleukin-27 subunit beta,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
212087_s_at	Era like 12S mitochondrial rRNA chaperone 1(ERAL1)	Homo sapiens				GO:0000028~ribosomal small subunit assembly,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0015629~actin cytoskeleton,GO:0045111~intermediate filament cytoskeleton,	GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019843~rRNA binding,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,	IPR005225:Small GTP-binding protein domain,IPR005662:GTP-binding protein Era,IPR006073:GTP binding domain,IPR009019:K homology domain, prokaryotic type,IPR015946:K homology domain-like, alpha/beta,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA-binding,Transit peptide,	chain:GTP-binding protein era homolog,domain:KH type-2,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
210887_s_at, 219432_at	EvC ciliary complex subunit 1(EVC)	Homo sapiens				GO:0001501~skeletal system development,GO:0003416~endochondral bone growth,GO:0007224~smoothened signaling pathway,GO:0007517~muscle organ development,GO:0045880~positive regulation of smoothened signaling pathway,GO:0051216~cartilage development,	GO:0005737~cytoplasm,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,		IPR026501:Limbin/Ellis-van Creveld protein,IPR026582:Ellis-van Creveld protein,		193530~Weyers acrodental dysostosis,225500~Ellis-van Creveld syndrome,			Cell membrane,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Dwarfism,Ectodermal dysplasia,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ellis-van Creveld syndrome protein,sequence conflict,sequence variant,transmembrane region,
219216_at	Ewing tumor associated antigen 1(ETAA1)	Homo sapiens					GO:0005737~cytoplasm,							Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Ewing's tumor-associated antigen 1,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
209455_at, 209456_s_at	F-box and WD repeat domain containing 11(FBXW11)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006470~protein dephosphorylation,GO:0016055~Wnt signaling pathway,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031648~protein destabilization,GO:0038061~NIK/NF-kappaB signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0042753~positive regulation of circadian rhythm,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0050852~T cell receptor signaling pathway,GO:0051403~stress-activated MAPK cascade,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,GO:0061630~ubiquitin protein ligase activity,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR021977:D domain of beta-TrCP,	hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04390:Hippo signaling pathway,hsa04710:Circadian rhythm,hsa05131:Shigellosis,			SM00256:FBOX,SM00320:WD40,SM01028:SM01028,	Alternative splicing,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,Nucleus,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,Wnt signaling pathway,	chain:F-box/WD repeat-containing protein 11,domain:F-box,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,splice variant,
215600_x_at	F-box and WD repeat domain containing 12(FBXW12)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001810:F-box domain, cyclin-like,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00256:FBOX,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 12,domain:F-box,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,
209630_s_at, 218941_at	F-box and WD repeat domain containing 2(FBXW2)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0016567~protein ubiquitination,		GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,				SM00256:FBOX,SM00320:WD40,	Acetylation,Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 2,domain:F-box,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence conflict,splice variant,
221519_at	F-box and WD repeat domain containing 4(FBXW4)	Homo sapiens				GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016055~Wnt signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0042733~embryonic digit morphogenesis,GO:0051216~cartilage development,	GO:0000151~ubiquitin ligase complex,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00320:WD40,	Complete proteome,Developmental protein,Reference proteome,Repeat,Ubl conjugation pathway,WD repeat,Wnt signaling pathway,	chain:F-box/WD repeat-containing protein 4,domain:F-box,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence conflict,
218751_s_at	F-box and WD repeat domain containing 7(FBXW7)	Homo sapiens		h_fbw7Pathway:Cyclin E Destruction Pathway,		GO:0000209~protein polyubiquitination,GO:0001944~vasculature development,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0010868~negative regulation of triglyceride biosynthetic process,GO:0010883~regulation of lipid storage,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0032876~negative regulation of DNA endoreduplication,GO:0032880~regulation of protein localization,GO:0034644~cellular response to UV,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0050821~protein stabilization,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0055088~lipid homeostasis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903146~regulation of mitophagy,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000346~negative regulation of hepatocyte proliferation,GO:2000639~negative regulation of SREBP signaling pathway,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0030674~protein binding, bridging,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050816~phosphothreonine binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04120:Ubiquitin mediated proteolysis,			SM00256:FBOX,SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 7,domain:F-box,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,strand,turn,
220127_s_at	F-box and leucine rich repeat protein 12(FBXL12)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,				SM00256:FBOX,	Alternative splicing,Complete proteome,Leucine-rich repeat,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 12,domain:F-box,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,splice variant,
213145_at	F-box and leucine rich repeat protein 14(FBXL14)	Homo sapiens				GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00367:LRR_CC,	Complete proteome,Cytoplasm,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 14,domain:F-box,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence variant,
218938_at	F-box and leucine rich repeat protein 15(FBXL15)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0009953~dorsal/ventral pattern formation,GO:0016567~protein ubiquitination,GO:0030282~bone mineralization,GO:0030513~positive regulation of BMP signaling pathway,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00367:LRR_CC,	Acetylation,Complete proteome,Cytoplasm,Leucine-rich repeat,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box only protein 37,domain:F-box,sequence conflict,
220896_at, 216395_at, 215068_s_at	F-box and leucine rich repeat protein 18(FBXL18)	Homo sapiens							IPR001810:F-box domain, cyclin-like,					Alternative splicing,Complete proteome,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 18,domain:F-box,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,sequence variant,splice variant,
214436_at	F-box and leucine rich repeat protein 2(FBXL2)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0006513~protein monoubiquitination,GO:0010506~regulation of autophagy,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019903~protein phosphatase binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00256:FBOX,SM00367:LRR_CC,	Alternative splicing,Calcium,Calmodulin-binding,Complete proteome,Host-virus interaction,Leucine-rich repeat,Lipoprotein,Membrane,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 2,domain:F-box,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,
209943_at	F-box and leucine rich repeat protein 4(FBXL4)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,	GO:0000151~ubiquitin ligase complex,GO:0005654~nucleoplasm,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,	IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,		615471~Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type),		SM00367:LRR_CC,	Complete proteome,Cytoplasm,Disease mutation,Leucine-rich repeat,Methylation,Mitochondrion,Nucleus,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 4,domain:F-box,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,sequence conflict,
209005_at, 209004_s_at	F-box and leucine rich repeat protein 5(FBXL5)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0055072~iron ion homeostasis,GO:1903364~positive regulation of cellular protein catabolic process,	GO:0000151~ubiquitin ligase complex,GO:0019005~SCF ubiquitin ligase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,IPR012312:Haemerythrin/HHE cation-binding motif,				SM00256:FBOX,SM00367:LRR_CC,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Iron,Leucine-rich repeat,Metal-binding,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 5,domain:F-box,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,mutagenesis site,region of interest:Hemerythrin-like,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,splice variant,
219189_at	F-box and leucine rich repeat protein 6(FBXL6)	Homo sapiens				GO:0006508~proteolysis,GO:0016567~protein ubiquitination,		GO:0004842~ubiquitin-protein transferase activity,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00367:LRR_CC,	Alternative splicing,Complete proteome,Leucine-rich repeat,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 6,domain:F-box,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,splice variant,
213249_at	F-box and leucine rich repeat protein 7(FBXL7)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0051301~cell division,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR001611:Leucine-rich repeat,IPR001810:F-box domain, cyclin-like,IPR006553:Leucine-rich repeat, cysteine-containing subtype,				SM00256:FBOX,SM00367:LRR_CC,	Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Leucine-rich repeat,Mitosis,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 7,domain:F-box,repeat:LRR 1,repeat:LRR 10,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,
220080_at	F-box and leucine rich repeat protein 8(FBXL8)	Homo sapiens				GO:0000209~protein polyubiquitination,	GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,				SM00256:FBOX,	Complete proteome,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box/LRR-repeat protein 8,domain:F-box,sequence conflict,
203255_at, 219208_at, 222119_s_at	F-box protein 11(FBXO11)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007605~sensory perception of sound,GO:0016567~protein ubiquitination,GO:0035246~peptidyl-arginine N-methylation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016274~protein-arginine N-methyltransferase activity,	IPR001810:F-box domain, cyclin-like,IPR003126:Zinc finger, N-recognin,IPR006626:Parallel beta-helix repeat,IPR006633:Carbohydrate-binding/sugar hydrolysis domain,IPR007742:Periplasmic copper-binding protein NosD, beta helix domain,IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,IPR022441:Parallel beta-helix repeat-2,				SM00256:FBOX,SM00396:ZnF_UBR1,SM00710:PbH1,SM00722:CASH,	Alternative splicing,Chromosome,Complete proteome,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:F-box only protein 11,domain:F-box,repeat:PbH1 1,repeat:PbH1 10,repeat:PbH1 11,repeat:PbH1 12,repeat:PbH1 13,repeat:PbH1 14,repeat:PbH1 15,repeat:PbH1 16,repeat:PbH1 17,repeat:PbH1 18,repeat:PbH1 19,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,splice variant,zinc finger region:UBR-type,
221123_x_at	F-box protein 16(FBXO16)	Homo sapiens							IPR001810:F-box domain, cyclin-like,				SM00256:FBOX,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 16,domain:F-box,modified residue,sequence variant,
220233_at	F-box protein 17(FBXO17)	Homo sapiens					GO:0019005~SCF ubiquitin ligase complex,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR007397:F-box associated (FBA) domain,IPR008979:Galactose-binding domain-like,				SM00256:FBOX,SM01198:SM01198,	Complete proteome,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 17,domain:F-box,domain:FBA,
219305_x_at	F-box protein 2(FBXO2)	Homo sapiens		h_eradPathway:ERassociated degradation (ERAD) Pathway,		GO:0000209~protein polyubiquitination,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0006516~glycoprotein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031090~organelle membrane,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0001948~glycoprotein binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001810:F-box domain, cyclin-like,IPR007397:F-box associated (FBA) domain,IPR008979:Galactose-binding domain-like,	hsa04120:Ubiquitin mediated proteolysis,hsa04141:Protein processing in endoplasmic reticulum,			SM01198:SM01198,	Complete proteome,Cytoplasm,Endoplasmic reticulum,Lectin,Membrane,Microsome,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 2,domain:F-box,domain:FBA,sequence conflict,sequence variant,
212229_s_at, 212231_at, 214891_at	F-box protein 21(FBXO21)	Homo sapiens			Function unknown,	GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,	GO:0000151~ubiquitin ligase complex,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,	IPR001810:F-box domain, cyclin-like,IPR011722:Hemimethylated DNA-binding domain,				SM00992:SM00992,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 21,domain:F-box,sequence variant,splice variant,
219638_at	F-box protein 22(FBXO22)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006913~nucleocytoplasmic transport,GO:0009267~cellular response to starvation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0048742~regulation of skeletal muscle fiber development,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0030018~Z disc,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR019494:FIST C domain,				SM01204:SM01204,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 22,domain:F-box,modified residue,sequence conflict,splice variant,
221157_s_at	F-box protein 24(FBXO24)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0016567~protein ubiquitination,	GO:0000151~ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR001810:F-box domain, cyclin-like,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,				SM00256:FBOX,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 24,domain:F-box,repeat:RCC1,sequence variant,splice variant,
202271_at, 202272_s_at	F-box protein 28(FBXO28)	Homo sapiens					GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,					Alternative splicing,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 28,domain:F-box,modified residue,
218432_at	F-box protein 3(FBXO3)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR007474:ApaG domain,IPR018958:Cell wall assembly/cell proliferation coordinating protein, KNR4-like,				SM00256:FBOX,SM00860:SM00860,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 3,compositionally biased region:Asp/Glu-rich (highly acidic),compositionally biased region:Poly-Arg,domain:ApaG,domain:F-box,sequence conflict,sequence variant,splice variant,
222352_at	F-box protein 31(FBXO31)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0008054~negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031571~mitotic G1 DNA damage checkpoint,	GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043025~neuronal cell body,	GO:0004842~ubiquitin-protein transferase activity,GO:0030332~cyclin binding,	IPR001810:F-box domain, cyclin-like,IPR026941:F-box only protein 31,		615979~Mental retardation, autosomal recessive 45,		SM00256:FBOX,	Alternative splicing,Cell cycle,Complete proteome,DNA damage,Mental retardation,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 31,compositionally biased region:Poly-Pro,domain:F-box,modified residue,mutagenesis site,sequence conflict,splice variant,
218539_at	F-box protein 34(FBXO34)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,					Complete proteome,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 34,chain:Protein CGI-301,domain:F-box,modified residue,sequence variant,
219608_s_at, 221257_x_at	F-box protein 38(FBXO38)	Homo sapiens				GO:0010976~positive regulation of neuron projection development,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR001810:F-box domain, cyclin-like,		615575~Neuronopathy, distal hereditary motor, type IID,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 38,domain:F-box,modified residue,region of interest:Interaction with KLF7,sequence conflict,sequence variant,splice variant,
220550_at	F-box protein 4(FBXO4)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0000723~telomere maintenance,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007568~aging,GO:0010608~posttranscriptional regulation of gene expression,GO:0016567~protein ubiquitination,GO:0019725~cellular homeostasis,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0031648~protein destabilization,GO:0035726~common myeloid progenitor cell proliferation,GO:0048147~negative regulation of fibroblast proliferation,GO:0071479~cellular response to ionizing radiation,GO:1900181~negative regulation of protein localization to nucleus,GO:1902916~positive regulation of protein polyubiquitination,GO:2000001~regulation of DNA damage checkpoint,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0061630~ubiquitin protein ligase activity,	IPR001810:F-box domain, cyclin-like,	hsa04120:Ubiquitin mediated proteolysis,			SM00256:FBOX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 4,domain:F-box,modified residue,sequence conflict,splice variant,
220164_s_at	F-box protein 40(FBXO40)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0042692~muscle cell differentiation,	GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001293:Zinc finger, TRAF-type,IPR001810:F-box domain, cyclin-like,IPR008974:TRAF-like,IPR013323:SIAH-type domain,					Complete proteome,Cytoplasm,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:F-box only protein 40,domain:F-box,sequence conflict,sequence variant,zinc finger region:TRAF-type,
221945_at, 44040_at	F-box protein 41(FBXO41)	Homo sapiens							IPR001810:F-box domain, cyclin-like,					Coiled coil,Complete proteome,Methylation,Phosphoprotein,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 41,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,compositionally biased region:Poly-His,domain:F-box,modified residue,
221813_at, 221812_at, 47773_at	F-box protein 42(FBXO42)	Homo sapiens						GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR011498:Kelch repeat type 2,IPR015915:Kelch-type beta propeller,				SM00256:FBOX,	Complete proteome,Kelch repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:F-box only protein 42,domain:F-box,modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,sequence conflict,sequence variant,
205310_at	F-box protein 46(FBXO46)	Homo sapiens						GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,				SM00256:FBOX,	Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 46,domain:F-box,modified residue,
218875_s_at	F-box protein 5(FBXO5)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0001556~oocyte maturation,GO:0007057~spindle assembly involved in female meiosis I,GO:0007067~mitotic nuclear division,GO:0007088~regulation of mitotic nuclear division,GO:0007346~regulation of mitotic cell cycle,GO:0016050~vesicle organization,GO:0045835~negative regulation of meiotic nuclear division,GO:0046785~microtubule polymerization,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR001810:F-box domain, cyclin-like,	hsa04114:Oocyte meiosis,				3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Metal-binding,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:F-box only protein 5,domain:F-box,mutagenesis site,region of interest:Interaction with EVI5,sequence variant,zinc finger region:IBR-type,
201178_at	F-box protein 7(FBXO7)	Homo sapiens				GO:0000422~mitophagy,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006626~protein targeting to mitochondrion,GO:0010975~regulation of neuron projection development,GO:0016567~protein ubiquitination,GO:0031647~regulation of protein stability,GO:0040012~regulation of locomotion,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903599~positive regulation of mitophagy,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,GO:0097409~glial cytoplasmic inclusion,GO:0097414~classical Lewy body,GO:0097462~Lewy neurite,GO:1990037~Lewy body core,GO:1990038~Lewy body corona,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0043130~ubiquitin binding,GO:0046982~protein heterodimerization activity,	IPR001810:F-box domain, cyclin-like,IPR021625:Proteasome Inhibitor PI31,		260300~Parkinson disease 15, autosomal recessive,		SM00256:FBOX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Methylation,Mitochondrion,Neurodegeneration,Nucleus,Parkinsonism,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:F-box only protein 7,domain:F-box,sequence conflict,sequence variant,
212991_at, 212987_at, 210638_s_at	F-box protein 9(FBXO9)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0032006~regulation of TOR signaling,GO:0045087~innate immune response,GO:0045444~fat cell differentiation,	GO:0000151~ubiquitin ligase complex,GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR007330:MIT,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,TPR repeat,Ubl conjugation pathway,	chain:F-box only protein 9,domain:F-box,repeat:TPR,splice variant,
222354_at, 221664_s_at	F11 receptor(F11R)	Homo sapiens				GO:0001817~regulation of cytokine production,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0009314~response to radiation,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0031032~actomyosin structure organization,GO:0034260~negative regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0045777~positive regulation of blood pressure,GO:0046718~viral entry into host cell,GO:0050892~intestinal absorption,GO:0050900~leukocyte migration,GO:0070830~bicellular tight junction assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:0090557~establishment of endothelial intestinal barrier,GO:0090559~regulation of membrane permeability,GO:0098609~cell-cell adhesion,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005923~bicellular tight junction,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0036057~slit diaphragm,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,			SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Tight junction,Transmembrane,Transmembrane helix,	chain:Junctional adhesion molecule A,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
207221_at	F2R like thrombin/trypsin receptor 3(F2RL3)	Homo sapiens		h_par1pathway:Thrombin signaling and protease-activated receptors,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,		GO:0007165~signal transduction,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007596~blood coagulation,GO:0009611~response to wounding,GO:0030168~platelet activation,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060155~platelet dense granule organization,GO:0070493~thrombin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0015057~thrombin receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR003912:Protease-activated receptor,IPR003944:Protease-activated receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04015:Rap1 signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04611:Platelet activation,hsa05200:Pathways in cancer,				3D-structure,Blood coagulation,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Hemostasis,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Proteinase-activated receptor 4,compositionally biased region:Poly-Leu,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,propeptide:Removed for receptor activation,sequence variant,signal peptide,site:Cleavage; by thrombin or trypsin,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206429_at, 213506_at	F2R like trypsin receptor 1(F2RL1)	Homo sapiens				GO:0002286~T cell activation involved in immune response,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0002741~positive regulation of cytokine secretion involved in immune response,GO:0003104~positive regulation of glomerular filtration,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007596~blood coagulation,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030193~regulation of blood coagulation,GO:0030335~positive regulation of cell migration,GO:0030836~positive regulation of actin filament depolymerization,GO:0031274~positive regulation of pseudopodium assembly,GO:0032930~positive regulation of superoxide anion generation,GO:0034137~positive regulation of toll-like receptor 2 signaling pathway,GO:0034140~negative regulation of toll-like receptor 3 signaling pathway,GO:0034141~positive regulation of toll-like receptor 3 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035926~chemokine (C-C motif) ligand 2 secretion,GO:0042119~neutrophil activation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043311~positive regulation of eosinophil degranulation,GO:0045087~innate immune response,GO:0045909~positive regulation of vasodilation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0046330~positive regulation of JNK cascade,GO:0050702~interleukin-1 beta secretion,GO:0050900~leukocyte migration,GO:0050921~positive regulation of chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051607~defense response to virus,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0061028~establishment of endothelial barrier,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070493~thrombin receptor signaling pathway,GO:0070661~leukocyte proliferation,GO:0070963~positive regulation of neutrophil mediated killing of gram-negative bacterium,GO:0072608~interleukin-10 secretion,GO:0072643~interferon-gamma secretion,GO:0090195~chemokine secretion,GO:0090198~negative regulation of chemokine secretion,GO:0097029~mature conventional dendritic cell differentiation,GO:1900135~positive regulation of renin secretion into blood stream,GO:2000484~positive regulation of interleukin-8 secretion,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031143~pseudopodium,	GO:0001965~G-protein alpha-subunit binding,GO:0004872~receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0015057~thrombin receptor activity,GO:0031681~G-protein beta-subunit binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002281:Protease-activated receptor 2,IPR003912:Protease-activated receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa05143:African trypanosomiasis,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Proteinase-activated receptor 2,compositionally biased region:Poly-Ser,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,propeptide:Removed for receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by trypsin,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220707_s_at	FAD dependent oxidoreductase domain containing 2(FOXRED2)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0055114~oxidation-reduction process,	GO:0005788~endoplasmic reticulum lumen,	GO:0001948~glycoprotein binding,GO:0004497~monooxygenase activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,					Alternative splicing,Complete proteome,Endoplasmic reticulum,FAD,Flavoprotein,Glycoprotein,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:FAD-dependent oxidoreductase domain- containing protein 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
202916_s_at, 202915_s_at	FAM20B, glycosaminoglycan xylosylkinase(FAM20B)	Homo sapiens				GO:0016310~phosphorylation,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0046872~metal ion binding,	IPR009581:Domain of unknown function DUF1193,IPR024869:FAM20,					ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Kinase,Manganese,Membrane,Metal-binding,Nucleotide-binding,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Protein FAM20B,glycosylation site:N-linked (GlcNAc...),short sequence motif:Microbody targeting signal,signal peptide,
203678_at	FANCD2/FANCI-associated nuclease 1(FAN1)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0033683~nucleotide-excision repair, DNA incision,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0045171~intercellular bridge,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004528~phosphodiesterase I activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0017108~5'-flap endonuclease activity,GO:0043130~ubiquitin binding,GO:0070336~flap-structured DNA binding,	IPR006642:Zinc finger, Rad18-type putative,IPR014883:VRR-NUC domain,	hsa03460:Fanconi anemia pathway,	614817~Interstitial nephritis, karyomegalic,		SM00734:ZnF_Rad18,SM00990:SM00990,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,Endonuclease,Exonuclease,Hydrolase,Magnesium,Manganese,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Coiled-coil domain-containing protein MTMR15,sequence conflict,sequence variant,splice variant,zinc finger region:Rad18-type,
219002_at	FAST kinase domains 1(FASTKD1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,	GO:0004672~protein kinase activity,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,				SM00952:SM00952,	Acetylation,Alternative splicing,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:FAST kinase domain-containing protein 1,domain:RAP,modified residue,sequence conflict,sequence variant,splice variant,
216996_s_at, 205976_at	FAST kinase domains 2(FASTKD2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0004672~protein kinase activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,		220110~Mitochondrial complex IV deficiency,		SM00952:SM00952,	Alternative splicing,Complete proteome,Mitochondrion,Mitochondrion nucleoid,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA-binding,Transit peptide,	chain:FAST kinase domain-containing protein 2,domain:RAP,sequence variant,splice variant,
219200_at	FAST kinase domains 3(FASTKD3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,				SM00952:SM00952,	Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:FAST kinase domain-containing protein 3,domain:RAP,sequence variant,
219016_at	FAST kinase domains 5(FASTKD5)	Homo sapiens				GO:0000963~mitochondrial RNA processing,GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0045333~cellular respiration,	GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,				SM00952:SM00952,	Acetylation,Complete proteome,Mitochondrion,Mitochondrion nucleoid,mRNA processing,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,rRNA-binding,Transit peptide,	chain:FAST kinase domain-containing protein 5,domain:RAP,modified residue,sequence variant,
201579_at	FAT atypical cadherin 1(FAT1)	Homo sapiens				GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007163~establishment or maintenance of cell polarity,GO:0007267~cell-cell signaling,GO:0009653~anatomical structure morphogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR018097:EGF-like calcium-binding, conserved site,IPR020894:Cadherin conserved site,				SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 1,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 33,domain:Cadherin 34,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:Laminin G-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208153_s_at	FAT atypical cadherin 2(FAT2)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0010631~epithelial cell migration,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Calcium,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 2,compositionally biased region:Poly-Ser,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2,domain:Laminin G-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219427_at	FAT atypical cadherin 4(FAT4)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0003007~heart morphogenesis,GO:0007009~plasma membrane organization,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007219~Notch signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0035329~hippo signaling,GO:0043931~ossification involved in bone maturation,GO:0048565~digestive tract development,GO:0060122~inner ear receptor stereocilium organization,GO:0072137~condensed mesenchymal cell proliferation,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR018097:EGF-like calcium-binding, conserved site,IPR020894:Cadherin conserved site,		615546~Van Maldergem syndrome 2,616006~Hennekam lymphangiectasia-lymphedema syndrome 2,		SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Alternative splicing,Calcium,Cell adhesion,Complete proteome,Deafness,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 4,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 33,domain:Cadherin 34,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
200019_s_at	FAU, ubiquitin like and ribosomal protein S30 fusion(FAU)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002227~innate immune response in mucosa,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0019731~antibacterial humoral response,GO:0050830~defense response to Gram-positive bacterium,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000626:Ubiquitin,IPR006846:Ribosomal protein S30,IPR019954:Ubiquitin conserved site,IPR019956:Ubiquitin subgroup,	hsa03010:Ribosome,			SM00213:UBQ,	3D-structure,Complete proteome,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,	chain:40S ribosomal protein S30,chain:Ubiquitin-like protein FUBI,sequence variant,
215567_at, 219927_at, 212499_s_at	FCF1 rRNA-processing protein(FCF1)	Homo sapiens				GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR002716:PIN domain,IPR006984:Protein of unknown function DUF652,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00670:PINc,	Complete proteome,Nucleus,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,	chain:rRNA-processing protein FCF1 homolog,domain:PINc,
203620_s_at	FCH and double SH3 domains 2(FCHSD2)	Homo sapiens				GO:0007274~neuromuscular synaptic transmission,GO:0030833~regulation of actin filament polymerization,	GO:0031594~neuromuscular junction,GO:0055037~recycling endosome,	GO:0005515~protein binding,	IPR001060:FCH domain,IPR001452:Src homology-3 domain,				SM00055:FCH,SM00326:SH3,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:FCH and double SH3 domains protein 2,compositionally biased region:Poly-Pro,domain:FCH,domain:SH3 1,domain:SH3 2,modified residue,splice variant,strand,turn,
213669_at	FCH domain only 1(FCHO1)	Homo sapiens				GO:0048268~clathrin coat assembly,GO:0072583~clathrin-mediated endocytosis,	GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0030136~clathrin-coated vesicle,	GO:0005515~protein binding,GO:0035612~AP-2 adaptor complex binding,	IPR001060:FCH domain,IPR018808:Muniscin C-terminal mu homology domain,IPR022023:U1 small nuclear ribonucleoprotein of 70kDa N-terminal,				SM00055:FCH,	Alternative splicing,Coated pit,Coiled coil,Complete proteome,Endocytosis,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:FCH domain only protein 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:FCH,modified residue,splice variant,
206412_at	FER tyrosine kinase(FER)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001932~regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0010591~regulation of lamellipodium assembly,GO:0010762~regulation of fibroblast migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030838~positive regulation of actin filament polymerization,GO:0031532~actin cytoskeleton reorganization,GO:0032496~response to lipopolysaccharide,GO:0032869~cellular response to insulin stimulus,GO:0033007~negative regulation of mast cell activation involved in immune response,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034614~cellular response to reactive oxygen species,GO:0035426~extracellular matrix-cell signaling,GO:0035556~intracellular signal transduction,GO:0036006~cellular response to macrophage colony-stimulating factor stimulus,GO:0036119~response to platelet-derived growth factor,GO:0038028~insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042503~tyrosine phosphorylation of Stat3 protein,GO:0043304~regulation of mast cell degranulation,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0045087~innate immune response,GO:0046777~protein autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0050904~diapedesis,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070102~interleukin-6-mediated signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0042995~cell projection,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008157~protein phosphatase 1 binding,GO:0008289~lipid binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001060:FCH domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016250:Tyrosine-protein kinase, non-receptor Fes, subgroup,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,			PIRSF000632:tyrosine-protein kinase, Fes/Fps type,	SM00055:FCH,SM00219:TyrKc,SM00252:SH2,	3D-structure,Alternative promoter usage,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Lipid-binding,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Fer,domain:FCH,domain:Protein kinase,domain:SH2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,
206774_at	FERM and PDZ domain containing 1(FRMPD1)	Homo sapiens					GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000299:FERM domain,IPR001478:PDZ domain,IPR011993:Pleckstrin homology-like domain,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00228:PDZ,SM00295:B41,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Polymorphism,Reference proteome,	chain:FERM and PDZ domain-containing protein 1,domain:FERM,domain:PDZ,helix,modified residue,sequence conflict,sequence variant,strand,turn,
215052_at	FERM and PDZ domain containing 4(FRMPD4)	Homo sapiens				GO:0051835~positive regulation of synapse structural plasticity,	GO:0005856~cytoskeleton,GO:0043197~dendritic spine,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,	IPR000299:FERM domain,IPR001202:WW domain,IPR001478:PDZ domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00228:PDZ,SM00295:B41,	3D-structure,Cell projection,Complete proteome,Lipid-binding,Reference proteome,	chain:FERM and PDZ domain-containing protein 4,domain:FERM,domain:PDZ,domain:WW,modified residue,mutagenesis site,sequence conflict,
220819_at	FERM domain containing 1(FRMD1)	Homo sapiens					GO:0005856~cytoskeleton,		IPR000299:FERM domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	hsa04390:Hippo signaling pathway,			SM00295:B41,SM01196:SM01196,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:FERM domain-containing protein 1,domain:FERM,sequence variant,
208476_s_at, 208475_at	FERM domain containing 4A(FRMD4A)	Homo sapiens				GO:0090162~establishment of epithelial cell polarity,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005923~bicellular tight junction,	GO:0030674~protein binding, bridging,	IPR000299:FERM domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR021774:Protein of unknown function DUF3338,				SM00295:B41,SM01196:SM01196,	Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:FERM domain-containing protein 4A,compositionally biased region:Ser-rich,domain:FERM,modified residue,sequence conflict,sequence variant,
213056_at, 216131_at, 216134_at	FERM domain containing 4B(FRMD4B)	Homo sapiens				GO:0090162~establishment of epithelial cell polarity,	GO:0001726~ruffle,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,		IPR000299:FERM domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR021774:Protein of unknown function DUF3338,				SM00295:B41,SM01196:SM01196,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Proteomics identification,Reference proteome,	chain:FERM domain-containing protein 4B,domain:FERM,modified residue,
210043_at	FERM domain containing 8(FRMD8)	Homo sapiens					GO:0005856~cytoskeleton,	GO:0005515~protein binding,	IPR000299:FERM domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00295:B41,	Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:FERM domain-containing protein 8,domain:FERM,modified residue,sequence conflict,splice variant,
201910_at, 201911_s_at	FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1)	Homo sapiens				GO:0007416~synapse assembly,GO:0010923~negative regulation of phosphatase activity,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0048813~dendrite morphogenesis,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0043197~dendritic spine,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:SM01195,SM01196:SM01196,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Synapse,Synaptosome,	chain:FERM, RhoGEF and pleckstrin domain- containing protein 1,compositionally biased region:Poly-Glu,domain:DH,domain:FERM,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,
204511_at	FERM, ARH/RhoGEF and pleckstrin domain protein 2(FARP2)	Homo sapiens				GO:0007155~cell adhesion,GO:0016322~neuron remodeling,GO:0016601~Rac protein signal transduction,GO:0030316~osteoclast differentiation,GO:0031532~actin cytoskeleton reorganization,GO:0033623~regulation of integrin activation,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0071526~semaphorin-plexin signaling pathway,GO:0071800~podosome assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0019898~extrinsic component of membrane,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	hsa04015:Rap1 signaling pathway,hsa04520:Adherens junction,			SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:SM01195,SM01196:SM01196,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:FERM, RhoGEF and pleckstrin domain- containing protein 2,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:DH,domain:FERM,domain:PH 1,domain:PH 2,modified residue,sequence variant,splice variant,
205418_at	FES proto-oncogene, tyrosine kinase(FES)	Homo sapiens				GO:0001578~microtubule bundle formation,GO:0006468~protein phosphorylation,GO:0006935~chemotaxis,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0010976~positive regulation of neuron projection development,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030155~regulation of cell adhesion,GO:0031116~positive regulation of microtubule polymerization,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0043304~regulation of mast cell degranulation,GO:0045087~innate immune response,GO:0045595~regulation of cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0046777~protein autophosphorylation,GO:0051297~centrosome organization,GO:0060627~regulation of vesicle-mediated transport,GO:2000145~regulation of cell motility,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0034987~immunoglobulin receptor binding,GO:0035091~phosphatidylinositol binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001060:FCH domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016250:Tyrosine-protein kinase, non-receptor Fes, subgroup,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04360:Axon guidance,		PIRSF000632:tyrosine-protein kinase, Fes/Fps type,	SM00055:FCH,SM00219:TyrKc,SM00252:SH2,	3D-structure,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Golgi apparatus,Kinase,Lipid-binding,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Fes/Fps,domain:FCH,domain:Protein kinase,domain:SH2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
207260_at	FEV, ETS transcription factor(FEV)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0042551~neuron maturation,GO:0048665~neuron fate specification,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa05202:Transcriptional misregulation in cancer,			SM00413:ETS,	3D-structure,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,DNA-binding,Neurogenesis,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Protein FEV,compositionally biased region:Ala-rich,DNA-binding region:ETS,region of interest:May mediate active transcriptional repression,site:Breakpoint for insertion to form EWS-FEV fusion protein,
221086_s_at	FEZ family zinc finger 2(FEZF2)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007626~locomotory behavior,GO:0008285~negative regulation of cell proliferation,GO:0016358~dendrite development,GO:0021542~dentate gyrus development,GO:0021797~forebrain anterior/posterior pattern specification,GO:0021853~cerebral cortex GABAergic interneuron migration,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048664~neuron fate determination,GO:1902667~regulation of axon guidance,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,DNA-binding,Metal-binding,Neurogenesis,Nucleus,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Fez family zinc finger protein 2,compositionally biased region:Gly-rich,sequence conflict,sequence variant,short sequence motif:Engrailed homology 1 repressor,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
202041_s_at	FGF1 intracellular binding protein(FIBP)	Homo sapiens				GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0070527~platelet aggregation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0017134~fibroblast growth factor binding,	IPR008614:Acidic fibroblast growth factor binding,					Acetylation,Alternative splicing,Complete proteome,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Acidic fibroblast growth factor intracellular-binding protein,modified residue,sequence variant,splice variant,
214124_x_at, 205588_s_at, 205587_at	FGFR1 oncogene partner(FGFR1OP)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006469~negative regulation of protein kinase activity,GO:0008284~positive regulation of cell proliferation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030307~positive regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0034453~microtubule anchoring,GO:0061099~negative regulation of protein tyrosine kinase activity,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030292~protein tyrosine kinase inhibitor activity,GO:0042803~protein homodimerization activity,	IPR006594:LisH dimerisation motif,IPR018993:FGFR1 oncogene partner (FOP), N-terminal dimerisation domain,		Myeloproliferative disorder~Myeloproliferative disorder,			3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:FGFR1 oncogene partner,domain:LisH,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,site:Breakpoint for translocation to form FGFR1OP-FGFR1 or FGFR1-FGFR1OP fusion proteins,splice variant,turn,
219718_at	FGGY carbohydrate kinase domain containing(FGGY)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0016310~phosphorylation,GO:0070050~neuron cellular homeostasis,	GO:0005737~cytoplasm,	GO:0016301~kinase activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,	IPR006003:Carbohydrate kinase, FGGY-related,IPR018484:Carbohydrate kinase, FGGY, N-terminal,IPR018485:Carbohydrate kinase, FGGY, C-terminal,			PIRSF000538:keto-sugar kinase,		Alternative splicing,Amyotrophic lateral sclerosis,Complete proteome,Kinase,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:FGGY carbohydrate kinase domain- containing protein,sequence variant,splice variant,
208438_s_at	FGR proto-oncogene, Src family tyrosine kinase(FGR)	Homo sapiens		h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,		GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0008360~regulation of cell shape,GO:0009615~response to virus,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042127~regulation of cell proliferation,GO:0043306~positive regulation of mast cell degranulation,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045859~regulation of protein kinase activity,GO:0046777~protein autophosphorylation,GO:0050715~positive regulation of cytokine secretion,GO:0050764~regulation of phagocytosis,GO:0050830~defense response to Gram-positive bacterium,	GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,	GO:0001784~phosphotyrosine binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0034987~immunoglobulin receptor binding,GO:0034988~Fc-gamma receptor I complex binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04062:Chemokine signaling pathway,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	ATP-binding,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Immunity,Innate immunity,Kinase,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Fgr,domain:Protein kinase,domain:SH2,domain:SH3,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
219910_at	FIC domain containing(FICD)	Homo sapiens				GO:0006269~DNA replication, synthesis of RNA primer,GO:0006278~RNA-dependent DNA biosynthetic process,GO:0018117~protein adenylylation,GO:0034260~negative regulation of GTPase activity,	GO:0016021~integral component of membrane,	GO:0003720~telomerase activity,GO:0003724~RNA helicase activity,GO:0003896~DNA primase activity,GO:0004779~sulfate adenylyltransferase activity,GO:0005524~ATP binding,GO:0008193~tRNA guanylyltransferase activity,GO:0008905~mannose-phosphate guanylyltransferase activity,GO:0033677~DNA/RNA helicase activity,GO:0043338~CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity,GO:0043814~phospholactate guanylyltransferase activity,GO:0043910~ATP:coenzyme F420 adenylyltransferase activity,GO:0052630~UDP-N-acetylgalactosamine diphosphorylase activity,GO:0070733~protein adenylyltransferase activity,	IPR003812:Fido domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,					3D-structure,ATP-binding,Complete proteome,Membrane,Nucleotide-binding,Nucleotidyltransferase,Reference proteome,Repeat,TPR repeat,Transferase,Transmembrane,Transmembrane helix,	chain:Adenosine monophosphate-protein transferase FICD,domain:Fido,modified residue,mutagenesis site,repeat:TPR 1,repeat:TPR 2,transmembrane region,
203656_at	FIG4 phosphoinositide 5-phosphatase(FIG4)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0007033~vacuole organization,GO:0007626~locomotory behavior,GO:0010976~positive regulation of neuron projection development,GO:0016311~dephosphorylation,GO:0031642~negative regulation of myelination,GO:0032288~myelin assembly,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043473~pigmentation,GO:0048666~neuron development,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,GO:0055037~recycling endosome,	GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0005515~protein binding,GO:0042578~phosphoric ester hydrolase activity,GO:0043812~phosphatidylinositol-4-phosphate phosphatase activity,GO:0043813~phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,	IPR002013:Synaptojanin, N-terminal,		216340~Yunis-Varon syndrome,611228~Charcot-Marie-Tooth disease, type 4J,612577~Amyotrophic lateral sclerosis 11,612691~Polymicrogyria, bilateral temporooccipital,			Amyotrophic lateral sclerosis,Charcot-Marie-Tooth disease,Complete proteome,Disease mutation,Endosome,Hydrolase,Membrane,Neurodegeneration,Neuropathy,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Polyphosphoinositide phosphatase,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:SAC,mutagenesis site,sequence conflict,sequence variant,
219249_s_at	FK506 binding protein 10(FKBP10)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,		259450~Bruck syndrome 1,610968~Osteogenesis imperfecta, type XI,		SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Isomerase,Metal-binding,Osteogenesis imperfecta,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Rotamase,Signal,	calcium-binding region:1,calcium-binding region:2,chain:FK506-binding protein 10,domain:EF-hand 1,domain:EF-hand 2,domain:PPIase FKBP-type 1,domain:PPIase FKBP-type 2,domain:PPIase FKBP-type 3,domain:PPIase FKBP-type 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,
219117_s_at, 219118_at	FK506 binding protein 11(FKBP11)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					Alternative splicing,Complete proteome,Isomerase,Membrane,Proteomics identification,Reference proteome,Rotamase,Signal,Transmembrane,Transmembrane helix,	chain:FK506-binding protein 11,domain:PPIase FKBP-type,signal peptide,transmembrane region,
219390_at	FK506 binding protein 14(FKBP14)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0036498~IRE1-mediated unfolded protein response,GO:0061077~chaperone-mediated protein folding,	GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,		614557~Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss,			3D-structure,Calcium,Complete proteome,Deafness,Direct protein sequencing,Ehlers-Danlos syndrome,Endoplasmic reticulum,Glycoprotein,Isomerase,Metal-binding,Proteomics identification,Reference proteome,Repeat,Rotamase,Signal,	calcium-binding region:1,calcium-binding region:2,chain:FK506-binding protein 14,domain:EF-hand 1,domain:EF-hand 2,domain:PPIase FKBP-type,glycosylation site:N-linked (GlcNAc...),short sequence motif:Prevents secretion from ER,signal peptide,
76897_s_at, 212663_at, 31826_at	FK506 binding protein 15(FKBP15)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006457~protein folding,GO:0006897~endocytosis,GO:0010923~negative regulation of phosphatase activity,	GO:0005769~early endosome,GO:0005884~actin filament,GO:0016020~membrane,GO:0030424~axon,GO:0030426~growth cone,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR011993:Pleckstrin homology-like domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					Acetylation,Actin-binding,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Endocytosis,Endosome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:FK506-binding protein 15,compositionally biased region:Poly-Asp,domain:PPIase FKBP-type,modified residue,region of interest:Important for function in growth cone organization,sequence variant,splice variant,
214119_s_at, 210187_at, 200709_at, 210186_s_at	FK506 binding protein 1A(FKBP1A)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0000413~protein peptidyl-prolyl isomerization,GO:0001933~negative regulation of protein phosphorylation,GO:0003007~heart morphogenesis,GO:0006457~protein folding,GO:0006458~'de novo' protein folding,GO:0006936~muscle contraction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0010039~response to iron ion,GO:0019221~cytokine-mediated signaling pathway,GO:0022417~protein maturation by protein folding,GO:0031000~response to caffeine,GO:0031398~positive regulation of protein ubiquitination,GO:0032092~positive regulation of protein binding,GO:0032513~negative regulation of protein phosphatase type 2B activity,GO:0032880~regulation of protein localization,GO:0032925~regulation of activin receptor signaling pathway,GO:0042026~protein refolding,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043206~extracellular fibril organization,GO:0050776~regulation of immune response,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051280~negative regulation of release of sequestered calcium ion into cytosol,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060347~heart trabecula formation,GO:0061077~chaperone-mediated protein folding,GO:0070588~calcium ion transmembrane transport,GO:1902991~regulation of amyloid precursor protein catabolic process,GO:1990000~amyloid fibril formation,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0014802~terminal cisterna,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0031012~extracellular matrix,GO:0033017~sarcoplasmic reticulum membrane,GO:0043679~axon terminus,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0004871~signal transducer activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0005527~macrolide binding,GO:0005528~FK506 binding,GO:0019855~calcium channel inhibitor activity,GO:0019899~enzyme binding,GO:0030544~Hsp70 protein binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0046332~SMAD binding,GO:0048185~activin binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Isomerase,Membrane,Proteomics identification,Reference proteome,Rotamase,Transmembrane,Transmembrane helix,	chain:Peptidyl-prolyl cis-trans isomerase FKBP1A,domain:PPIase FKBP-type,helix,modified residue,sequence conflict,strand,turn,
209931_s_at, 206857_s_at	FK506 binding protein 1B(FKBP1B)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0006458~'de novo' protein folding,GO:0006939~smooth muscle contraction,GO:0009749~response to glucose,GO:0010459~negative regulation of heart rate,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0019227~neuronal action potential propagation,GO:0022417~protein maturation by protein folding,GO:0030073~insulin secretion,GO:0032513~negative regulation of protein phosphatase type 2B activity,GO:0033197~response to vitamin E,GO:0034220~ion transmembrane transport,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042026~protein refolding,GO:0042098~T cell proliferation,GO:0042542~response to hydrogen peroxide,GO:0048680~positive regulation of axon regeneration,GO:0051280~negative regulation of release of sequestered calcium ion into cytosol,GO:0051284~positive regulation of sequestering of calcium ion,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051775~response to redox state,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0061077~chaperone-mediated protein folding,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903779~regulation of cardiac conduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030018~Z disc,GO:0033017~sarcoplasmic reticulum membrane,GO:0034704~calcium channel complex,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005102~receptor binding,GO:0005219~ryanodine-sensitive calcium-release channel activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0019855~calcium channel inhibitor activity,GO:0030551~cyclic nucleotide binding,GO:0044325~ion channel binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Isomerase,Proteomics identification,Reference proteome,Rotamase,Sarcoplasmic reticulum,	chain:Peptidyl-prolyl cis-trans isomerase FKBP1B,domain:PPIase FKBP-type,helix,splice variant,strand,turn,
203391_at	FK506 binding protein 2(FKBP2)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					3D-structure,Complete proteome,Endoplasmic reticulum,Isomerase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Rotamase,Signal,	chain:FK506-binding protein 2,domain:PPIase FKBP-type,helix,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,strand,turn,
218003_s_at	FK506 binding protein 3(FKBP3)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0044822~poly(A) RNA binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,					3D-structure,Acetylation,Complete proteome,Isomerase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Rotamase,	chain:FK506-binding protein 3,domain:PPIase FKBP-type,helix,modified residue,sequence conflict,strand,turn,
200894_s_at, 200895_s_at	FK506 binding protein 4(FKBP4)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0006463~steroid hormone receptor complex assembly,GO:0006825~copper ion transport,GO:0007566~embryo implantation,GO:0010977~negative regulation of neuron projection development,GO:0030521~androgen receptor signaling pathway,GO:0030850~prostate gland development,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031115~negative regulation of microtubule polymerization,GO:0031503~protein complex localization,GO:0046661~male sex differentiation,GO:0061077~chaperone-mediated protein folding,GO:1900034~regulation of cellular response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005874~microtubule,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0005528~FK506 binding,GO:0030674~protein binding, bridging,GO:0031072~heat shock protein binding,GO:0032767~copper-dependent protein binding,GO:0035259~glucocorticoid receptor binding,GO:0044822~poly(A) RNA binding,GO:0048156~tau protein binding,GO:0051219~phosphoprotein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,	hsa04915:Estrogen signaling pathway,			SM00028:TPR,	3D-structure,Acetylation,Cell projection,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Isomerase,Isopeptide bond,Methylation,Microtubule,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Rotamase,TPR repeat,Ubl conjugation,	chain:FK506-binding protein 4,chain:FK506-binding protein 4, N-terminally processed,domain:PPIase FKBP-type 1,domain:PPIase FKBP-type 2,helix,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence variant,strand,turn,
204560_at	FK506 binding protein 5(FKBP5)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0031072~heat shock protein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR023114:Elongated TPR repeat-containing domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,	hsa04915:Estrogen signaling pathway,	608516~Major depressive disorder and accelerated response to antidepressant drug treatment,		SM00028:TPR,	3D-structure,Acetylation,Alternative splicing,Chaperone,Complete proteome,Cytoplasm,Isomerase,Nucleus,Phosphoprotein,Reference proteome,Repeat,Rotamase,TPR repeat,	chain:FK506-binding protein 5,domain:PPIase FKBP-type 1,domain:PPIase FKBP-type 2,helix,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,strand,turn,
206763_at	FK506 binding protein 6(FKBP6)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0007126~meiotic nuclear division,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,GO:0045070~positive regulation of viral genome replication,GO:0061077~chaperone-mediated protein folding,	GO:0000795~synaptonemal complex,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0042802~identical protein binding,GO:0051879~Hsp90 protein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,				SM00028:TPR,	3D-structure,Alternative splicing,Chromosome,Complete proteome,Cytoplasm,Differentiation,Meiosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Spermatogenesis,TPR repeat,Williams-Beuren syndrome,	chain:FK506-binding protein 6,domain:PPIase FKBP-type,helix,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,strand,turn,
40850_at, 208255_s_at, 222007_s_at	FK506 binding protein 8(FKBP8)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0001708~cell fate specification,GO:0006457~protein folding,GO:0006915~apoptotic process,GO:0007224~smoothened signaling pathway,GO:0016032~viral process,GO:0021904~dorsal/ventral neural tube patterning,GO:0030513~positive regulation of BMP signaling pathway,GO:0035264~multicellular organism growth,GO:0035556~intracellular signal transduction,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0061077~chaperone-mediated protein folding,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0031966~mitochondrial membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,IPR023114:Elongated TPR repeat-containing domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,				SM00028:TPR,	3D-structure,Alternative splicing,Apoptosis,Calcium,Complete proteome,Host-virus interaction,Isomerase,Isopeptide bond,Membrane,Metal-binding,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Rotamase,TPR repeat,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:FK506-binding protein 8,compositionally biased region:Glu-rich,domain:PPIase FKBP-type,helix,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,splice variant,strand,transmembrane region,turn,
212169_at	FK506 binding protein 9(FKBP9)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005509~calcium ion binding,GO:0005528~FK506 binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Endoplasmic reticulum,Glycoprotein,Isomerase,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Rotamase,Signal,	calcium-binding region:1,calcium-binding region:2,chain:FK506-binding protein 9,domain:EF-hand 1,domain:EF-hand 2,domain:PPIase FKBP-type 1,domain:PPIase FKBP-type 2,domain:PPIase FKBP-type 3,domain:PPIase FKBP-type 4,glycosylation site:N-linked (GlcNAc...),short sequence motif:Prevents secretion from ER,signal peptide,
219187_at	FK506 binding protein like(FKBPL)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0009314~response to radiation,GO:0050821~protein stabilization,GO:0061077~chaperone-mediated protein folding,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,	IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,				SM00028:TPR,	Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,TPR repeat,	chain:FK506-binding protein-like,modified residue,mutagenesis site,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,
212025_s_at, 212024_x_at, 222065_s_at	FLII, actin remodeling protein(FLII)	Homo sapiens			Function unknown,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0030036~actin cytoskeleton organization,GO:0051014~actin filament severing,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005903~brush border,GO:0005925~focal adhesion,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR007122:Villin/Gelsolin,IPR007123:Gelsolin domain,IPR025875:Leucine rich repeat 4,				SM00262:GEL,SM00369:LRR_TYP,	Acetylation,Actin-binding,Activator,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Direct protein sequencing,Leucine-rich repeat,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Protein flightless-1 homolog,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ala,modified residue,mutagenesis site,region of interest:Interaction with ACTL6A,region of interest:Interaction with LRRFIP1 and LRRFIP2,repeat:Gelsolin-like 1,repeat:Gelsolin-like 2,repeat:Gelsolin-like 3,repeat:Gelsolin-like 4,repeat:Gelsolin-like 5,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,
201637_s_at, 201636_at, 201635_s_at	FMR1 autosomal homolog 1(FXR1)	Homo sapiens				GO:0006915~apoptotic process,GO:0007517~muscle organ development,GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0030424~axon,GO:0035770~ribonucleoprotein granule,GO:0043034~costamere,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0002151~G-quadruplex RNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0033592~RNA strand annealing activity,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	hsa03013:RNA transport,			SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Myogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Signal,	chain:Fragile X mental retardation syndrome- related protein 1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Pro,domain:KH 1,domain:KH 2,helix,modified residue,region of interest:RNA-binding RGG-box,sequence conflict,sequence variant,splice variant,strand,turn,
35265_at, 203172_at	FMR1 autosomal homolog 2(FXR2)	Homo sapiens				GO:0017148~negative regulation of translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	hsa03013:RNA transport,			SM00322:KH,	3D-structure,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Fragile X mental retardation syndrome- related protein 2,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Ser,domain:KH 1,domain:KH 2,helix,modified residue,sequence conflict,sequence variant,strand,
204420_at	FOS like 1, AP-1 transcription factor subunit(FOSL1)	Homo sapiens		h_ranklPathway:Bone Remodelling,		GO:0001701~in utero embryonic development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006935~chemotaxis,GO:0006968~cellular defense response,GO:0007296~vitellogenesis,GO:0007565~female pregnancy,GO:0007612~learning,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0009629~response to gravity,GO:0031668~cellular response to extracellular stimulus,GO:0032570~response to progesterone,GO:0034097~response to cytokine,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0045787~positive regulation of cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051412~response to corticosterone,GO:0051591~response to cAMP,GO:0060674~placenta blood vessel development,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:2000144~positive regulation of DNA-templated transcription, initiation,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04310:Wnt signaling pathway,hsa04380:Osteoclast differentiation,hsa05166:HTLV-I infection,			SM00338:BRLZ,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Fos-related antigen 1,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,DNA-binding region:Basic motif,domain:Leucine-zipper,
205409_at, 218880_at, 218881_s_at	FOS like 2, AP-1 transcription factor subunit(FOSL2)	Homo sapiens		h_ranklPathway:Bone Remodelling,		GO:0003334~keratinocyte development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008219~cell death,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04380:Osteoclast differentiation,			SM00338:BRLZ,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Fos-related antigen 2,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
220852_at	FOXN3 antisense RNA 2(FOXN3-AS2)	Homo sapiens													chain:Uncharacterized protein PRO1768,
220415_at	FPGT-TNNI3K readthrough(FPGT-TNNI3K)	Homo sapiens				GO:0002027~regulation of heart rate,GO:0006468~protein phosphorylation,GO:0055117~regulation of cardiac muscle contraction,GO:0086069~bundle of His cell to Purkinje myocyte communication,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0031013~troponin I binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002110:Ankyrin repeat,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,ATP-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,
212546_s_at, 212548_s_at	FRY like transcription coactivator(FRYL)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031175~neuron projection development,GO:0090527~actin filament reorganization,	GO:0005938~cell cortex,GO:0030427~site of polarized growth,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR025481:Cell morphogenesis protein C-terminal,IPR025614:Cell morphogenesis protein N-terminal,					Acetylation,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Protein furry homolog-like,modified residue,sequence variant,site:Breakpoint for insertion to form MLL-AFF4 fusion protein,splice variant,
204072_s_at, 214319_at, 214318_s_at	FRY microtubule binding protein(FRY)	Homo sapiens				GO:0000902~cell morphogenesis,GO:0031175~neuron projection development,GO:0043086~negative regulation of catalytic activity,GO:0090527~actin filament reorganization,GO:1904428~negative regulation of tubulin deacetylation,	GO:0000922~spindle pole,GO:0005815~microtubule organizing center,GO:0005938~cell cortex,GO:0030427~site of polarized growth,	GO:0004857~enzyme inhibitor activity,	IPR016024:Armadillo-type fold,IPR025481:Cell morphogenesis protein C-terminal,IPR025614:Cell morphogenesis protein N-terminal,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein furry homolog,modified residue,sequence variant,transmembrane region,
209702_at	FTO, alpha-ketoglutarate dependent dioxygenase(FTO)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0006307~DNA dealkylation involved in DNA repair,GO:0010883~regulation of lipid storage,GO:0035552~oxidative single-stranded DNA demethylation,GO:0035553~oxidative single-stranded RNA demethylation,GO:0040014~regulation of multicellular organism growth,GO:0042245~RNA repair,GO:0044065~regulation of respiratory system process,GO:0060612~adipose tissue development,GO:0070350~regulation of white fat cell proliferation,GO:0070989~oxidative demethylation,GO:0080111~DNA demethylation,GO:0090335~regulation of brown fat cell differentiation,	GO:0005634~nucleus,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0008198~ferrous iron binding,GO:0035515~oxidative RNA demethylase activity,GO:0035516~oxidative DNA demethylase activity,GO:0043734~DNA-N1-methyladenine dioxygenase activity,GO:1990931~RNA N6-methyladenosine dioxygenase activity,	IPR024366:Alpha-ketoglutarate-dependent dioxygenase FTO, C-terminal,IPR024367:Alpha-ketoglutarate-dependent dioxygenase FTO, catalytic domain,		612460~Obesity, susceptibility to, BMIQ14,612938~Growth retardation, developmental delay, facial dysmorphism,		SM01223:SM01223,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Dioxygenase,Disease mutation,DNA damage,DNA repair,Iron,Membrane,Metal-binding,Nucleus,Obesity,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA repair,Transmembrane,Transmembrane helix,	chain:Protein fto,modified residue,sequence conflict,sequence variant,splice variant,
215744_at, 200959_at, 217370_x_at	FUS RNA binding protein(FUS)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0071277~cellular response to calcium ion,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005844~polysome,GO:0043204~perikaryon,GO:0044327~dendritic spine head,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0030331~estrogen receptor binding,GO:0031489~myosin V binding,GO:0035255~ionotropic glutamate receptor binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa05202:Transcriptional misregulation in cancer,	608030~Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia,614782~Tremor, hereditary essential, 4,		SM00360:RRM,SM00547:ZnF_RBZ,	3D-structure,Alternative splicing,Amyotrophic lateral sclerosis,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Metal-binding,Methylation,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:RNA-binding protein FUS,compositionally biased region:Arg/Gly-rich,compositionally biased region:Gln/Gly/Ser/Tyr-rich,compositionally biased region:Gly-rich,domain:RRM,modified residue,sequence conflict,sequence variant,site:Breakpoint for translocation to form chimeric FUS/ATF1 protein,site:Breakpoint for translocation to form FUS/TLS-CHOP oncogene,splice variant,zinc finger region:RanBP2-type,
205384_at	FXYD domain containing ion transport regulator 1(FXYD1)	Homo sapiens				GO:0006821~chloride transport,GO:0006936~muscle contraction,GO:0008016~regulation of heart contraction,GO:0034220~ion transmembrane transport,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:1902476~chloride transmembrane transport,GO:1903278~positive regulation of sodium ion export from cell,GO:1903779~regulation of cardiac conduction,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0034707~chloride channel complex,GO:0042383~sarcolemma,	GO:0005216~ion channel activity,GO:0005254~chloride channel activity,GO:0017080~sodium channel regulator activity,GO:0044325~ion channel binding,	IPR000272:Ion-transport regulator, FXYD motif,	hsa04024:cAMP signaling pathway,				3D-structure,Chloride,Chloride channel,Complete proteome,Ion channel,Ion transport,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Phospholemman,helix,modified residue,sequence conflict,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205674_x_at	FXYD domain containing ion transport regulator 2(FXYD2)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001558~regulation of cell growth,GO:0006810~transport,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0042127~regulation of cell proliferation,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005216~ion channel activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0017080~sodium channel regulator activity,	IPR000272:Ion-transport regulator, FXYD motif,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	154020~Hypomagnesemia 2, renal,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Ion transport,Membrane,Potassium,Potassium transport,Primary hypomagnesemia,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit gamma,sequence variant,splice variant,transmembrane region,
202489_s_at, 202488_s_at	FXYD domain containing ion transport regulator 3(FXYD3)	Homo sapiens				GO:0006821~chloride transport,GO:0034220~ion transmembrane transport,GO:0050790~regulation of catalytic activity,GO:1902476~chloride transmembrane transport,GO:1903779~regulation of cardiac conduction,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0034707~chloride channel complex,GO:0070062~extracellular exosome,	GO:0005216~ion channel activity,GO:0005254~chloride channel activity,GO:0017080~sodium channel regulator activity,GO:0051117~ATPase binding,	IPR000272:Ion-transport regulator, FXYD motif,					Alternative splicing,Chloride,Chloride channel,Complete proteome,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 3,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218084_x_at	FXYD domain containing ion transport regulator 5(FXYD5)	Homo sapiens				GO:0030033~microvillus assembly,GO:0034220~ion transmembrane transport,GO:0046588~negative regulation of calcium-dependent cell-cell adhesion,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003779~actin binding,GO:0005216~ion channel activity,GO:0017080~sodium channel regulator activity,GO:0045296~cadherin binding,	IPR000272:Ion-transport regulator, FXYD motif,					Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 5,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
217897_at	FXYD domain containing ion transport regulator 6(FXYD6)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005515~protein binding,	IPR000272:Ion-transport regulator, FXYD motif,					Alternative splicing,Complete proteome,Ion channel,Ion transport,Membrane,Reference proteome,Schizophrenia,Signal,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 6,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220131_at	FXYD domain containing ion transport regulator 7(FXYD7)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0043269~regulation of ion transport,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005515~protein binding,GO:0051117~ATPase binding,	IPR000272:Ion-transport regulator, FXYD motif,					Complete proteome,Ion channel,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 7,modified residue,transmembrane region,
207434_s_at	FXYD6-FXYD2 readthrough(FXYD6-FXYD2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,	IPR000272:Ion-transport regulator, FXYD motif,					Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,
211795_s_at, 211794_at, 205285_s_at	FYN binding protein(FYB)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006607~NLS-bearing protein import into nucleus,GO:0006955~immune response,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0050852~T cell receptor signaling pathway,GO:0072659~protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032403~protein complex binding,	IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	hsa04015:Rap1 signaling pathway,			SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:FYN-binding protein,compositionally biased region:Poly-Pro,domain:SH3,helix,modified residue,region of interest:Interaction with SKAP1,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:SH2-binding,short sequence motif:SH2-binding; to FYN,short sequence motif:SH2-binding; to LCP2,strand,turn,
212486_s_at, 216033_s_at, 210105_s_at	FYN proto-oncogene, Src family tyrosine kinase(FYN)	Homo sapiens	67.Ikaros_and_signaling_inhibitors,81.Structure_of_Caps_and_SMACs,	h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,h_il7Pathway:IL-7 Signal Transduction,h_integrinPathway:Integrin Signaling Pathway,h_reelinPathway:Reelin Signaling Pathway,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0000165~MAPK cascade,GO:0001764~neuron migration,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0006468~protein phosphorylation,GO:0006816~calcium ion transport,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007596~blood coagulation,GO:0007612~learning,GO:0007631~feeding behavior,GO:0008360~regulation of cell shape,GO:0010629~negative regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030900~forebrain development,GO:0031295~T cell costimulation,GO:0031397~negative regulation of protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0042493~response to drug,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0045471~response to ethanol,GO:0046854~phosphatidylinositol phosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048813~dendrite morphogenesis,GO:0050690~regulation of defense response to virus by virus,GO:0050798~activated T cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0050966~detection of mechanical stimulus involved in sensory perception of pain,GO:0071375~cellular response to peptide hormone stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900182~positive regulation of protein localization to nucleus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0045121~membrane raft,	GO:0001664~G-protein coupled receptor binding,GO:0001948~glycoprotein binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015631~tubulin binding,GO:0019899~enzyme binding,GO:0042608~T cell receptor binding,GO:0042609~CD4 receptor binding,GO:0042610~CD8 receptor binding,GO:0042802~identical protein binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0046875~ephrin receptor binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0051428~peptide hormone receptor binding,GO:0070851~growth factor receptor binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04071:Sphingolipid signaling pathway,hsa04360:Axon guidance,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04611:Platelet activation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04725:Cholinergic synapse,hsa05020:Prion diseases,hsa05130:Pathogenic Escherichia coli infection,hsa05162:Measles,hsa05416:Viral myocarditis,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Adaptive immunity,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Host-virus interaction,Immunity,Kinase,Lipoprotein,Manganese,Membrane,Metal-binding,Myristate,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Fyn,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
218204_s_at	FYVE and coiled-coil domain containing 1(FYCO1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006810~transport,GO:0072383~plus-end-directed vesicle transport along microtubule,GO:1901098~positive regulation of autophagosome maturation,	GO:0005764~lysosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000306:Zinc finger, FYVE-type,IPR004012:RUN,IPR009038:GOLD,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,		610019~Cataract 18, autosomal recessive,		SM00064:FYVE,	3D-structure,Acetylation,Alternative splicing,Cataract,Coiled coil,Complete proteome,Cytoplasmic vesicle,Disease mutation,Endosome,Lysosome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:FYVE and coiled-coil domain-containing protein 1,domain:GOLD,domain:RUN,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
204819_at	FYVE, RhoGEF and PH domain containing 1(FGD1)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008360~regulation of cell shape,GO:0009887~organ morphogenesis,GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,	IPR000219:Dbl homology (DH) domain,IPR000306:Zinc finger, FYVE-type,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,	hsa04810:Regulation of actin cytoskeleton,	305400~Aarskog-Scott syndrome,305400~Mental retardation, X-linked syndromic 16,		SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,	Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Guanine-nucleotide releasing factor,Metal-binding,Phosphoprotein,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:FYVE, RhoGEF and PH domain-containing protein 1,compositionally biased region:Pro-rich,domain:DH,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,short sequence motif:SH3-binding,zinc finger region:FYVE-type,
215602_at	FYVE, RhoGEF and PH domain containing 2(FGD2)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,GO:0031901~early endosome membrane,GO:0032587~ruffle membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR000219:Dbl homology (DH) domain,IPR000306:Zinc finger, FYVE-type,IPR001849:Pleckstrin homology domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR011993:Pleckstrin homology-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,Guanine-nucleotide releasing factor,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:FYVE, RhoGEF and PH domain-containing protein 2,domain:DH,domain:PH 1,domain:PH 2,sequence variant,splice variant,zinc finger region:FYVE-type,
219901_at	FYVE, RhoGEF and PH domain containing 6(FGD6)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0046847~filopodium assembly,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0031267~small GTPase binding,GO:0046872~metal ion binding,	IPR000219:Dbl homology (DH) domain,IPR000306:Zinc finger, FYVE-type,IPR001849:Pleckstrin homology domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR011993:Pleckstrin homology-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00064:FYVE,SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Guanine-nucleotide releasing factor,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:FYVE, RhoGEF and PH domain-containing protein 6,compositionally biased region:Poly-Ser,domain:DH,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:FYVE-type,
203805_s_at, 203806_s_at, 215530_at	Fanconi anemia complementation group A(FANCA)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0006461~protein complex assembly,GO:0007140~male meiosis,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,GO:0045589~regulation of regulatory T cell differentiation,GO:0050727~regulation of inflammatory response,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:2000348~regulation of CD40 signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,	IPR003516:Fanconi anaemia group A protein,	hsa03460:Fanconi anemia pathway,	227650~Fanconi anemia, complementation group A,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Fanconi anemia group A protein,modified residue,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
205189_s_at	Fanconi anemia complementation group C(FANCC)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006461~protein complex assembly,GO:0034599~cellular response to oxidative stress,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,	IPR000686:Fanconi anaemia group C protein,	hsa03460:Fanconi anemia pathway,	227645~Fanconi anemia, complementation group C,	PIRSF018417:Fanconi anemia group C protein,		Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia group C protein,sequence conflict,sequence variant,
220255_at	Fanconi anemia complementation group E(FANCE)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043240~Fanconi anaemia nuclear complex,		IPR021025:Fanconi Anaemia group E protein, C-terminal,	hsa03460:Fanconi anemia pathway,	600901~Fanconi anemia, complementation group E,			3D-structure,Complete proteome,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group E protein,helix,modified residue,region of interest:Interaction with FANCC,sequence variant,strand,
218689_at	Fanconi anemia complementation group F(FANCF)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0001541~ovarian follicle development,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0016567~protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,		hsa03460:Fanconi anemia pathway,	603467~Fanconi anemia, complementation group F,			3D-structure,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Fanconi anemia,Nucleus,Polymorphism,Reference proteome,	chain:Fanconi anemia group F protein,helix,mutagenesis site,sequence variant,strand,turn,
203564_at	Fanconi anemia complementation group G(FANCG)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0000075~cell cycle checkpoint,GO:0001541~ovarian follicle development,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007286~spermatid development,GO:0009314~response to radiation,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0043240~Fanconi anaemia nuclear complex,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR019734:Tetratricopeptide repeat,	hsa03460:Fanconi anemia pathway,	614082~Fanconi anemia, complementation group G,		SM00028:TPR,	Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Fanconi anemia group G protein,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence variant,
213007_at, 213008_at	Fanconi anemia complementation group I(FANCI)	Homo sapiens				GO:0006281~DNA repair,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0031398~positive regulation of protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0070182~DNA polymerase binding,	IPR026171:Fanconi anemia group I protein,	hsa03460:Fanconi anemia pathway,	609053~Fanconi anemia, complementation group I,			Alternative splicing,Cell cycle,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group I protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,
218397_at	Fanconi anemia complementation group L(FANCL)	Homo sapiens				GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0007276~gamete generation,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,	GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019162:Fanconi anemia complex, subunit FancL, WD-repeat containing domain,IPR026848:E3 ubiquitin-protein ligase FANCL,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,	614083~Fanconi anemia, complementation group L,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA repair,Fanconi anemia,Ligase,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase FANCL,mutagenesis site,sequence conflict,sequence variant,zinc finger region:RING-type,
221800_s_at	Fanconi anemia core complex associated protein 100(FAAP100)	Homo sapiens				GO:0006281~DNA repair,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,GO:0045111~intermediate filament cytoskeleton,	GO:0003677~DNA binding,GO:0005515~protein binding,		hsa03460:Fanconi anemia pathway,				Alternative splicing,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia-associated protein of 100 kDa,sequence conflict,sequence variant,splice variant,
214816_x_at	Fanconi anemia core complex associated protein 24(FAAP24)	Homo sapiens				GO:0006281~DNA repair,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0043231~intracellular membrane-bounded organelle,GO:0043240~Fanconi anaemia nuclear complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR010994:RuvA domain 2-like,IPR026985:Fanconi anemia-associated protein of 24kDa,	hsa03460:Fanconi anemia pathway,				3D-structure,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia-associated protein of 24 kDa,region of interest:RuvA domain 2-like,sequence variant,
202676_x_at, 214114_x_at, 210975_x_at	Fas activated serine/threonine kinase(FASTK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0043484~regulation of RNA splicing,GO:0097190~apoptotic signaling pathway,	GO:0005759~mitochondrial matrix,	GO:0003723~RNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0033867~Fas-activated serine/threonine kinase activity,	IPR010622:FAST kinase leucine-rich,IPR013579:FAST kinase-like protein, subdomain 2,IPR013584:RAP domain,IPR015715:Fas activated serine/threonine kinase FAST,				SM00952:SM00952,	Alternative initiation,Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Kinase,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Serine/threonine-protein kinase,Transferase,	chain:Fas-activated serine/threonine kinase,compositionally biased region:Poly-Pro,domain:RAP,sequence variant,
203618_at, 203619_s_at	Fas apoptotic inhibitory molecule 2(FAIM2)	Homo sapiens				GO:0002931~response to ischemia,GO:0006915~apoptotic process,GO:0021549~cerebellum development,GO:0021680~cerebellar Purkinje cell layer development,GO:0021681~cerebellar granular layer development,GO:0021702~cerebellar Purkinje cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0045121~membrane raft,GO:0045211~postsynaptic membrane,		IPR006214:Bax inhibitor 1-related,					Alternative splicing,Apoptosis,Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Fas apoptotic inhibitory molecule 2,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
220643_s_at	Fas apoptotic inhibitory molecule(FAIM)	Homo sapiens				GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR010695:Fas apoptotic inhibitory molecule,					3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,	chain:Fas apoptotic inhibitory molecule 1,sequence conflict,sequence variant,splice variant,
218080_x_at	Fas associated factor 1(FAF1)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),		GO:0006915~apoptotic process,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0008219~cell death,GO:0010942~positive regulation of cell death,GO:0030155~regulation of cell adhesion,GO:0031334~positive regulation of protein complex assembly,GO:0042176~regulation of protein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045859~regulation of protein kinase activity,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031265~CD95 death-inducing signaling complex,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0043130~ubiquitin binding,GO:0051059~NF-kappaB binding,	IPR001012:UBX,IPR006577:UAS,IPR012336:Thioredoxin-like fold,				SM00166:UBX,SM00594:UAS,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:FAS-associated factor 1,domain:UBX,helix,modified residue,sequence conflict,splice variant,strand,turn,
212108_at, 212106_at	Fas associated factor family member 2(FAF2)	Homo sapiens				GO:0006986~response to unfolded protein,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030970~retrograde protein transport, ER to cytosol,GO:0034389~lipid particle organization,GO:0043086~negative regulation of catalytic activity,	GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0035473~lipase binding,GO:0043130~ubiquitin binding,GO:0055102~lipase inhibitor activity,	IPR001012:UBX,IPR006577:UAS,IPR009060:UBA-like,IPR012336:Thioredoxin-like fold,				SM00594:UAS,	3D-structure,Acetylation,Coiled coil,Complete proteome,Cytoplasm,Endoplasmic reticulum,Lipid droplet,Proteomics identification,Reference proteome,Unfolded protein response,	chain:FAS-associated factor 2,domain:UBA,domain:UBX,helix,modified residue,
202535_at	Fas associated via death domain(FADD)	Homo sapiens	150.caspase_and_NFKB_activation,39.Deg_of_Chromosomal_DNA,40.Deg_of_Chrom_DNA_TNF-ind_apoptosis,44.Sig_Trans_TNFR1-DR3-DR4_DR5,46.P13K_PTEN,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,99.NF-kB_activation,	h_ceramidePathway:Ceramide Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_nfkbPathway:NF-kB Signaling Pathway,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002821~positive regulation of adaptive immune response,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032729~positive regulation of interferon-gamma production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033077~T cell differentiation in thymus,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0036462~TRAIL-activated apoptotic signaling pathway,GO:0042104~positive regulation of activated T cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045651~positive regulation of macrophage differentiation,GO:0045862~positive regulation of proteolysis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048535~lymph node development,GO:0048536~spleen development,GO:0048538~thymus development,GO:0051291~protein heterooligomerization,GO:0051607~defense response to virus,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,GO:0060546~negative regulation of necroptotic process,GO:0070236~negative regulation of activation-induced cell death of T cells,GO:0071260~cellular response to mechanical stimulus,GO:0071550~death-inducing signaling complex assembly,GO:0097049~motor neuron apoptotic process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:0097527~necroptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000454~positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0002020~protease binding,GO:0005123~death receptor binding,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0032813~tumor necrosis factor receptor superfamily binding,GO:0035877~death effector domain binding,GO:0042802~identical protein binding,GO:0089720~caspase binding,	IPR000488:Death domain,IPR001875:Death effector domain,IPR011029:Death-like domain,IPR016729:FADD,	hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05010:Alzheimer's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,	613759~Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations,	PIRSF018586:FADD protein,	SM00005:DEATH,SM00031:DED,	3D-structure,Apoptosis,Complete proteome,Disease mutation,Host-virus interaction,Immunity,Innate immunity,Phosphoprotein,Reference proteome,	chain:Protein FADD,domain:Death,domain:DED,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
204780_s_at, 204781_s_at, 215719_x_at, 216252_x_at	Fas cell surface death receptor(FAS)	Homo sapiens	38.Cell_cycle_arrest_and_apoptosis_ceramide,39.Deg_of_Chromosomal_DNA,46.P13K_PTEN,58.(CD40L)_immnosurveillance,72.IAP_interaction_with_cell_death_pathways,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_keratinocytePathway:Keratinocyte Differentiation,h_pmlPathway:Regulation of transcriptional activity by PML,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,		GO:0002377~immunoglobulin production,GO:0003014~renal system process,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006924~activation-induced cell death of T cells,GO:0006925~inflammatory cell apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007623~circadian rhythm,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009636~response to toxic substance,GO:0010467~gene expression,GO:0019724~B cell mediated immunity,GO:0032464~positive regulation of protein homooligomerization,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045060~negative thymic T cell selection,GO:0045619~regulation of lymphocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0048536~spleen development,GO:0050869~negative regulation of B cell activation,GO:0051260~protein homooligomerization,GO:0051384~response to glucocorticoid,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:0071285~cellular response to lithium ion,GO:0071455~cellular response to hyperoxia,GO:0097049~motor neuron apoptotic process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097284~hepatocyte apoptotic process,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:0097527~necroptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0042802~identical protein binding,	IPR000488:Death domain,IPR001368:TNFR/NGFR cysteine-rich region,IPR008063:Fas receptor,IPR011029:Death-like domain,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,	601859~Autoimmune lymphoproliferative syndrome,601859~Autoimmune lymphoproliferative syndrome, type IA,Squamous cell carcinoma, burn scar-related, somatic~Squamous cell carcinoma, burn scar-related, somatic,		SM00005:DEATH,SM00208:TNFR,	3D-structure,Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 6,disulfide bond,domain:Death,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Interaction with HIPK3,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
211333_s_at, 210865_at	Fas ligand(FASLG)	Homo sapiens	76.Sig_trans_Ca2_Calcineurin_NF-AT,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_keratinocytePathway:Keratinocyte Differentiation,h_pmlPathway:Regulation of transcriptional activity by PML,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006925~inflammatory cell apoptotic process,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016525~negative regulation of angiogenesis,GO:0030644~cellular chloride ion homeostasis,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043525~positive regulation of neuron apoptotic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0046666~retinal cell programmed cell death,GO:0048388~endosomal lumen acidification,GO:0070231~T cell apoptotic process,GO:0070266~necroptotic process,GO:0070848~response to growth factor,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:0097527~necroptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0043202~lysosomal lumen,GO:0048471~perinuclear region of cytoplasm,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005123~death receptor binding,GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,	IPR006052:Tumour necrosis factor,IPR006053:Tumour necrosis factor alpha/beta/c,IPR008983:Tumour necrosis factor-like domain,IPR021184:Tumour necrosis factor, conserved site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04722:Neurotrophin signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,	211980~Lung cancer, susceptibility to,601859~Autoimmune lymphoproliferative syndrome, type IB,		SM00207:TNF,	3D-structure,Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Cytokine,Cytoplasmic vesicle,Disulfide bond,Glycoprotein,Lysosome,Membrane,Nucleus,Polymorphism,Reference proteome,Repressor,Secreted,Signal-anchor,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Tumor necrosis factor ligand superfamily member 6, membrane form,chain:Tumor necrosis factor ligand superfamily member 6, soluble form,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence variant,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211306_s_at, 211307_s_at, 211305_x_at, 211816_x_at, 207674_at	Fc fragment of IgA receptor(FCAR)	Homo sapiens				GO:0006955~immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0019862~IgA binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa05150:Staphylococcus aureus infection,			SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,IgA-binding protein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Immunoglobulin alpha Fc receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
206760_s_at, 206759_at	Fc fragment of IgE receptor II(FCER2)	Homo sapiens	6.CD23_engagement,8.MonocytesIFNF_IL4,			GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin,GO:0007219~Notch signaling pathway,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051712~positive regulation of killing of cells of other organism,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0019863~IgE binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04640:Hematopoietic cell lineage,hsa05169:Epstein-Barr virus infection,			SM00034:CLECT,	3D-structure,Calcium,Cell membrane,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgE-binding protein,Lectin,Lipoprotein,Membrane,Metal-binding,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin epsilon Fc receptor membrane-bound form,chain:Low affinity immunoglobulin epsilon Fc receptor soluble form,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
211734_s_at	Fc fragment of IgE receptor Ia(FCER1A)	Homo sapiens		h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,		GO:0001812~positive regulation of type I hypersensitivity,GO:0001820~serotonin secretion,GO:0007257~activation of JUN kinase activity,GO:0019370~leukotriene biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043306~positive regulation of mast cell degranulation,GO:0045401~positive regulation of interleukin-3 biosynthetic process,GO:0045425~positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050850~positive regulation of calcium-mediated signaling,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0019767~IgE receptor activity,GO:0019863~IgE binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04071:Sphingolipid signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa05310:Asthma,			SM00408:IGc2,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgE-binding protein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin epsilon receptor subunit alpha,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204232_at	Fc fragment of IgE receptor Ig(FCER1G)	Homo sapiens		h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,		GO:0001798~positive regulation of type IIa hypersensitivity,GO:0001805~positive regulation of type III hypersensitivity,GO:0001812~positive regulation of type I hypersensitivity,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002283~neutrophil activation involved in immune response,GO:0002292~T cell differentiation involved in immune response,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002554~serotonin secretion by platelet,GO:0006911~phagocytosis, engulfment,GO:0007229~integrin-mediated signaling pathway,GO:0007596~blood coagulation,GO:0010543~regulation of platelet activation,GO:0016064~immunoglobulin mediated immune response,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030168~platelet activation,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0032733~positive regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032765~positive regulation of mast cell cytokine production,GO:0033026~negative regulation of mast cell apoptotic process,GO:0038094~Fc-gamma receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0042742~defense response to bacterium,GO:0043306~positive regulation of mast cell degranulation,GO:0045087~innate immune response,GO:0045576~mast cell activation,GO:0050766~positive regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0072659~protein localization to plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0032998~Fc-epsilon receptor I complex,	GO:0005515~protein binding,GO:0019767~IgE receptor activity,GO:0019863~IgE binding,GO:0019864~IgG binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR021663:T-cell surface glycoprotein CD3 zeta/eta subunit/High affinity IgE receptor gamma subunit,	hsa04071:Sphingolipid signaling pathway,hsa04611:Platelet activation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04664:Fc epsilon RI signaling pathway,hsa05152:Tuberculosis,hsa05310:Asthma,			SM00077:ITAM,	Cell membrane,Complete proteome,Disulfide bond,IgE-binding protein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin epsilon receptor subunit gamma,disulfide bond,domain:ITAM,modified residue,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203240_at	Fc fragment of IgG binding protein(FCGBP)	Homo sapiens					GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR001007:von Willebrand factor, type C,IPR001846:von Willebrand factor, type D domain,IPR002919:Trypsin Inhibitor-like, cysteine rich domain,IPR003645:Follistatin-like, N-terminal,IPR014853:Uncharacterised domain, cysteine-rich,IPR025615:TILa domain,				SM00181:EGF,SM00214:VWC,SM00215:VWC_out,SM00216:VWD,SM00274:FOLN,SM00832:SM00832,	Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:IgGFc-binding protein,compositionally biased region:Cys-rich,disulfide bond,domain:TIL 1,domain:TIL 10,domain:TIL 11,domain:TIL 12,domain:TIL 2,domain:TIL 3,domain:TIL 4,domain:TIL 5,domain:TIL 6,domain:TIL 7,domain:TIL 8,domain:TIL 9,domain:VWFD 1,domain:VWFD 10,domain:VWFD 11,domain:VWFD 12,domain:VWFD 13,domain:VWFD 2,domain:VWFD 3,domain:VWFD 4,domain:VWFD 5,domain:VWFD 6,domain:VWFD 7,domain:VWFD 8,domain:VWFD 9,glycosylation site:N-linked (GlcNAc...),region of interest:IgGFc-binding,sequence conflict,sequence variant,signal peptide,
204006_s_at	Fc fragment of IgG receptor IIIa(FCGR3A)	Homo sapiens	56.Macrophage_regulation_of_CD4+T_cells,			GO:0006955~immune response,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0019864~IgG binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	615707~Immunodeficiency 20,		SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,IgG-binding protein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor III-A,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204007_at	Fc fragment of IgG receptor IIIb(FCGR3B)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0006955~immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0019864~IgG binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	Neutropenia, alloimmune neonatal~Neutropenia, alloimmune neonatal,		SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,IgG-binding protein,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor III-B,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,strand,
203561_at	Fc fragment of IgG receptor IIa(FCGR2A)	Homo sapiens				GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04611:Platelet activation,hsa04666:Fc gamma R-mediated phagocytosis,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05322:Systemic lupus erythematosus,	152700~Lupus nephritis, susceptibility to,219700~Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis,611162~Malaria, severe, susceptibility to,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgG-binding protein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-a,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210889_s_at	Fc fragment of IgG receptor IIb(FCGR2B)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0006955~immune response,GO:0007165~signal transduction,GO:0016032~viral process,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05162:Measles,	152700~Systemic lupus erythematosus, susceptibility to,611162~Malaria, resistance to,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Host-virus interaction,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-b,chain:Low affinity immunoglobulin gamma Fc region receptor II-c,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211395_x_at, 210992_x_at, 211396_at	Fc fragment of IgG receptor IIc (gene/pseudogene)(FCGR2C)	Homo sapiens				GO:0006955~immune response,GO:0007165~signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,	188030~Thrombocytopenic purpura, autoimmune,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-b,chain:Low affinity immunoglobulin gamma Fc region receptor II-c,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216951_at	Fc fragment of IgG receptor Ia(FCGR1A)	Homo sapiens				GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006898~receptor-mediated endocytosis,GO:0006911~phagocytosis, engulfment,GO:0006955~immune response,GO:0007165~signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0050776~regulation of immune response,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031901~early endosome membrane,	GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04640:Hematopoietic cell lineage,hsa04666:Fc gamma R-mediated phagocytosis,hsa05140:Leishmaniasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,	IgG receptor I, phagocytic, familial deficiency of~IgG receptor I, phagocytic, familial deficiency of,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgG-binding protein,Immunity,Immunoglobulin domain,Innate immunity,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin gamma Fc receptor I,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Interaction with EPB41L2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214511_x_at	Fc fragment of IgG receptor Ib(FCGR1B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0038093~Fc receptor signaling pathway,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031901~early endosome membrane,	GO:0019763~immunoglobulin receptor activity,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,IgG-binding protein,Immunity,Immunoglobulin domain,Membrane,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:High affinity immunoglobulin gamma Fc receptor IB,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
216950_s_at	Fc fragment of IgG receptor Ic, pseudogene(FCGR1CP)	Homo sapiens													chain:High affinity immunoglobulin gamma Fc receptor I,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Interaction with EPB41L2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218831_s_at	Fc fragment of IgG receptor and transporter(FCGRT)	Homo sapiens				GO:0002416~IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,GO:0019882~antigen processing and presentation,GO:0038094~Fc-gamma receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0003823~antigen binding,GO:0019770~IgG receptor activity,GO:0019864~IgG binding,GO:0030881~beta-2-microglobulin binding,GO:0042605~peptide antigen binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:IgG receptor FcRn large subunit p51,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,sequence conflict,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
221601_s_at, 221602_s_at	Fc fragment of IgM receptor(FCMR)	Homo sapiens				GO:0002376~immune system process,GO:0006968~cellular defense response,GO:0043066~negative regulation of apoptotic process,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Fas apoptotic inhibitory molecule 3,compositionally biased region:Arg-rich,disulfide bond,domain:Ig-like,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221239_s_at	Fc receptor like 2(FCRL2)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204236_at, 210786_s_at, 211825_s_at	Fli-1 proto-oncogene, ETS transcription factor(FLI1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007599~hemostasis,GO:0008015~blood circulation,GO:0009887~organ morphogenesis,GO:0030154~cell differentiation,GO:0035855~megakaryocyte development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa05202:Transcriptional misregulation in cancer,			SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Friend leukemia integration 1 transcription factor,DNA-binding region:ETS,domain:PNT,helix,modified residue,sequence conflict,splice variant,strand,
209189_at	Fos proto-oncogene, AP-1 transcription factor subunit(FOS)	Homo sapiens	3.T_cell_receptor,67.Ikaros_and_signaling_inhibitors,92.Ancient_Host_Defense_Pathways,	h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_bcellsurvivalPathway:B Cell Survival Pathway,h_bcrPathway:BCR Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_igf1Pathway:IGF-1 Signaling Pathway,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_ngfPathway:Nerve growth factor pathway (NGF),h_pdgfPathway:PDGF Signaling Pathway,h_ranklPathway:Bone Remodelling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_tpoPathway:TPO Signaling Pathway,h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0001661~conditioned taste aversion,GO:0006306~DNA methylation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007399~nervous system development,GO:0007565~female pregnancy,GO:0007568~aging,GO:0009409~response to cold,GO:0009416~response to light stimulus,GO:0009629~response to gravity,GO:0009636~response to toxic substance,GO:0030431~sleep,GO:0031668~cellular response to extracellular stimulus,GO:0032496~response to lipopolysaccharide,GO:0032570~response to progesterone,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0034614~cellular response to reactive oxygen species,GO:0035902~response to immobilization stress,GO:0035914~skeletal muscle cell differentiation,GO:0035994~response to muscle stretch,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042493~response to drug,GO:0045672~positive regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051412~response to corticosterone,GO:0051591~response to cAMP,GO:0060395~SMAD protein signal transduction,GO:0071277~cellular response to calcium ion,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0043005~neuron projection,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0070412~R-SMAD binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04010:MAPK signaling pathway,hsa04024:cAMP signaling pathway,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04713:Circadian entrainment,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05031:Amphetamine addiction,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05231:Choline metabolism in cancer,hsa05323:Rheumatoid arthritis,			SM00338:BRLZ,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Endoplasmic reticulum,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,	chain:Proto-oncogene protein c-fos,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,mutagenesis site,sequence conflict,
202768_at	FosB proto-oncogene, AP-1 transcription factor subunit(FOSB)	Homo sapiens		h_fosbPathway:FOSB gene expression and drug abuse,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007565~female pregnancy,GO:0009612~response to mechanical stimulus,GO:0032570~response to progesterone,GO:0032870~cellular response to hormone stimulus,GO:0042493~response to drug,GO:0043278~response to morphine,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051412~response to corticosterone,GO:0051591~response to cAMP,GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04380:Osteoclast differentiation,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,			SM00338:BRLZ,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein fosB,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,sequence variant,
220910_at	Fraser extracellular matrix complex subunit 1(FRAS1)	Homo sapiens				GO:0002009~morphogenesis of an epithelium,GO:0003338~metanephros morphogenesis,GO:0007154~cell communication,GO:0015031~protein transport,GO:0030326~embryonic limb morphogenesis,GO:0043588~skin development,GO:0060021~palate development,	GO:0005604~basement membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0061618~sublamina densa,	GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001007:von Willebrand factor, type C,IPR003644:Na-Ca exchanger/integrin-beta4,IPR006212:Furin-like repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,		219000~Fraser syndrome,		SM00181:EGF,SM00214:VWC,SM00215:VWC_out,SM00237:Calx_beta,SM00261:FU,	Alternative splicing,Calcium,Cell membrane,Complete proteome,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Extracellular matrix protein FRAS1,domain:Calx-beta 1,domain:Calx-beta 2,domain:Calx-beta 3,domain:Calx-beta 4,domain:Calx-beta 5,domain:VWFC 1,domain:VWFC 2,domain:VWFC 3,domain:VWFC 4,domain:VWFC 5,domain:VWFC 6,glycosylation site:N-linked (GlcNAc...),repeat:CSPG 1,repeat:CSPG 10,repeat:CSPG 11,repeat:CSPG 12,repeat:CSPG 2,repeat:CSPG 3,repeat:CSPG 4,repeat:CSPG 5,repeat:CSPG 6,repeat:CSPG 7,repeat:CSPG 8,repeat:CSPG 9,repeat:FU 1,repeat:FU 10,repeat:FU 11,repeat:FU 12,repeat:FU 13,repeat:FU 14,repeat:FU 2,repeat:FU 3,repeat:FU 4,repeat:FU 5,repeat:FU 6,repeat:FU 7,repeat:FU 8,repeat:FU 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
213937_s_at, 205324_s_at	FtsJ RNA methyltransferase homolog 1 (E. coli)(FTSJ1)	Homo sapiens				GO:0001510~RNA methylation,GO:0002128~tRNA nucleoside ribose methylation,GO:0002181~cytoplasmic translation,GO:0030488~tRNA methylation,	GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0008175~tRNA methyltransferase activity,	IPR002877:Ribosomal RNA methyltransferase FtsJ domain,IPR015507:Ribosomal RNA large subunit methyltransferase E,IPR025786:RNA-directed RNA polymerase L,		309549~Mental retardation, X-linked 9,			Alternative splicing,Complete proteome,Cytoplasm,Mental retardation,Methyltransferase,Phosphoprotein,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,tRNA processing,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via amide nitrogen,chain:Putative ribosomal RNA methyltransferase 1,modified residue,sequence conflict,
218103_at	FtsJ homolog 3(FTSJ3)	Homo sapiens				GO:0000453~enzyme-directed rRNA 2'-O-methylation,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0031167~rRNA methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0005515~protein binding,GO:0008649~rRNA methyltransferase activity,GO:0008650~rRNA (uridine-2'-O-)-methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0044822~poly(A) RNA binding,	IPR002877:Ribosomal RNA methyltransferase FtsJ domain,IPR012920:Ribosomal RNA methyltransferase, Spb1, C-terminal,IPR015507:Ribosomal RNA large subunit methyltransferase E,IPR024576:Ribosomal RNA methyltransferase Spb1, domain of unknown function DUF3381,			PIRSF005461:23S ribosomal RNA methyltransferase,		Citrullination,Coiled coil,Complete proteome,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,S-adenosyl-L-methionine,Transferase,	chain:Putative rRNA methyltransferase 3,modified residue,sequence conflict,sequence variant,
208283_at	G antigen 1(GAGE1)	Homo sapiens				GO:0006968~cellular defense response,		GO:0005515~protein binding,	IPR008625:GAGE,				SM01379:SM01379,	Complete proteome,Reference proteome,	chain:G antigen 1,chain:G antigen 12C/D/E,chain:G antigen 12F/G/I,chain:G antigen 2A/2B,chain:G antigen 3,chain:G antigen 4,chain:G antigen 5,chain:G antigen 6,chain:G antigen 7,chain:G antigen 8,modified residue,sequence conflict,
207086_x_at, 207739_s_at, 208235_x_at, 208155_x_at, 206640_x_at	G antigen 12F(GAGE12F)	Homo sapiens											SM01379:SM01379,	Alternative splicing,Complete proteome,Reference proteome,	chain:G antigen 1,chain:G antigen 12C/D/E,chain:G antigen 12F/G/I,chain:G antigen 2A/2B,chain:G antigen 3,chain:G antigen 4,chain:G antigen 5,chain:G antigen 6,chain:G antigen 7,chain:G antigen 8,modified residue,sequence conflict,
207663_x_at	G antigen 3(GAGE3)	Homo sapiens							IPR008625:GAGE,				SM01379:SM01379,	Complete proteome,Reference proteome,	chain:G antigen 1,chain:G antigen 12C/D/E,chain:G antigen 12F/G/I,chain:G antigen 2A/2B,chain:G antigen 3,chain:G antigen 4,chain:G antigen 5,chain:G antigen 6,chain:G antigen 7,chain:G antigen 8,modified residue,sequence conflict,
220903_at	G elongation factor mitochondrial 1(GFM1)	Homo sapiens				GO:0070125~mitochondrial translational elongation,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR004540:Translation elongation factor EFG/EF2,IPR005225:Small GTP-binding protein domain,IPR005517:Translation elongation factor EFG/EF2, domain IV,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009022:Elongation factor G, III-V domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		609060~Combined oxidative phosphorylation deficiency 1,		SM00838:SM00838,SM00889:SM00889,	Acetylation,Alternative splicing,Complete proteome,Elongation factor,GTP-binding,Mitochondrion,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Transit peptide,	chain:Elongation factor G, mitochondrial,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
203307_at	G protein nucleolar 1 (putative)(GNL1)	Homo sapiens			General function prediction only,	GO:0002456~T cell mediated immunity,GO:0006974~cellular response to DNA damage stimulus,GO:0007165~signal transduction,GO:0042254~ribosome biogenesis,	GO:0005615~extracellular space,GO:0005634~nucleus,	GO:0003924~GTPase activity,GO:0005198~structural molecule activity,GO:0005525~GTP binding,	IPR006073:GTP binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Guanine nucleotide-binding protein-like 1,compositionally biased region:Asp/Glu-rich (highly acidic),modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
201948_at	G protein nucleolar 2(GNL2)	Homo sapiens				GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR012971:Nucleolar GTP-binding protein 2, N-terminal domain,IPR023179:GTP-binding protein, orthogonal bundle domain,IPR024929:Nucleolar GTP-binding protein 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,				Acetylation,Coiled coil,Complete proteome,GTP-binding,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,Transmembrane,Transmembrane helix,	chain:Nucleolar GTP-binding protein 2,compositionally biased region:Poly-Glu,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
222109_at, 46947_at, 217632_at, 205010_at	G protein nucleolar 3 like(GNL3L)	Homo sapiens				GO:0031397~negative regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0032091~negative regulation of protein binding,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0033234~negative regulation of protein sumoylation,GO:0042254~ribosome biogenesis,GO:0090073~positive regulation of protein homodimerization activity,GO:1904816~positive regulation of protein localization to chromosome, telomeric region,	GO:0005634~nucleus,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,				Coiled coil,Complete proteome,GTP-binding,Isopeptide bond,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,Ribosome biogenesis,Ubl conjugation,	chain:Guanine nucleotide-binding protein-like 3-like protein,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,region of interest:Required for nucleolar localization,sequence variant,
217782_s_at	G protein pathway suppressor 1(GPS1)	Homo sapiens				GO:0000188~inactivation of MAPK activity,GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0007049~cell cycle,GO:0007254~JNK cascade,GO:0010387~COP9 signalosome assembly,GO:0010388~cullin deneddylation,GO:0034260~negative regulation of GTPase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0005095~GTPase inhibitor activity,GO:0005515~protein binding,	IPR000717:Proteasome component (PCI) domain,IPR011990:Tetratricopeptide-like helical,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR019585:26S proteasome, regulatory subunit Rpn7,				SM00088:PINT,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Signalosome,	chain:COP9 signalosome complex subunit 1,domain:PCI,modified residue,sequence conflict,splice variant,
209350_s_at	G protein pathway suppressor 2(GPS2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000188~inactivation of MAPK activity,GO:0007049~cell cycle,GO:0007254~JNK cascade,GO:0034260~negative regulation of GTPase activity,GO:0046329~negative regulation of JNK cascade,	GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0003714~transcription corepressor activity,GO:0005095~GTPase inhibitor activity,GO:0005515~protein binding,	IPR026094:G protein pathway suppressor 2,	hsa05166:HTLV-I infection,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Methylation,Polymorphism,Proteomics identification,Reference proteome,	chain:G protein pathway suppressor 2,compositionally biased region:Poly-Glu,sequence variant,
206747_at	G protein regulated inducer of neurite outgrowth 2(GPRIN2)	Homo sapiens						GO:0005515~protein binding,	IPR026646:G protein-regulated inducer of neurite outgrowth,					Complete proteome,Polymorphism,Reference proteome,	chain:G protein-regulated inducer of neurite outgrowth 2,sequence conflict,sequence variant,
213766_x_at, 213944_x_at, 564_at, 214679_x_at, 204248_at, 40562_at	G protein subunit alpha 11(GNA11)	Homo sapiens		h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,		GO:0001501~skeletal system development,GO:0001508~action potential,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007507~heart development,GO:0007603~phototransduction, visible light,GO:0009649~entrainment of circadian clock,GO:0030168~platelet activation,GO:0045634~regulation of melanocyte differentiation,GO:0048066~developmental pigmentation,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,GO:0071467~cellular response to pH,	GO:0001750~photoreceptor outer segment,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031826~type 2A serotonin receptor binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04725:Cholinergic synapse,hsa04730:Long-term depression,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05200:Pathways in cancer,	145981~Hypocalciuric hypercalcemia, type II,615361~Hypocalcemia, autosomal dominant 2,		SM00275:SM00275,	ADP-ribosylation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-11,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
221737_at	G protein subunit alpha 12(GNA12)	Homo sapiens		h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,		GO:0001701~in utero embryonic development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007266~Rho protein signal transduction,GO:0007596~blood coagulation,GO:0008360~regulation of cell shape,GO:0010762~regulation of fibroblast migration,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0032006~regulation of TOR signaling,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042493~response to drug,GO:0042733~embryonic digit morphogenesis,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0031526~brush border membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031752~D5 dopamine receptor binding,GO:0046872~metal ion binding,	IPR000469:G-protein alpha subunit, group 12,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,			SM00275:SM00275,	Alternative initiation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-12,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
206917_at	G protein subunit alpha 13(GNA13)	Homo sapiens		h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,		GO:0001569~patterning of blood vessels,GO:0001701~in utero embryonic development,GO:0006928~movement of cell or subcellular component,GO:0007165~signal transduction,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007266~Rho protein signal transduction,GO:0008360~regulation of cell shape,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0031584~activation of phospholipase D activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031526~brush border membrane,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031702~type 1 angiotensin receptor binding,GO:0031752~D5 dopamine receptor binding,GO:0046872~metal ion binding,	IPR000469:G-protein alpha subunit, group 12,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04611:Platelet activation,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,			SM00275:SM00275,	Alternative splicing,Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-13,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence variant,
220108_at	G protein subunit alpha 14(GNA14)	Homo sapiens				GO:0007165~signal transduction,GO:0030168~platelet activation,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,			SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Magnesium,Metal-binding,Nucleotide-binding,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-14,modified residue,nucleotide phosphate-binding region:GTP,
205349_at	G protein subunit alpha 15(GNA15)	Homo sapiens		h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,		GO:0007186~G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007207~phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,GO:0030168~platelet activation,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,			SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-15,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,
213924_at, 206356_s_at, 206355_at, 214071_at	G protein subunit alpha L(GNAL)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,	GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR000367:G-protein alpha subunit, group S,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa05012:Parkinson's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,	615073~Dystonia 25,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Complete proteome,Disease mutation,Dystonia,GTP-binding,Isopeptide bond,Lipoprotein,Magnesium,Metal-binding,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transducer,Ubl conjugation,	chain:Guanine nucleotide-binding protein G(olf) subunit alpha,lipid moiety-binding region:N-palmitoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,
209576_at	G protein subunit alpha i1(GNAI1)	Homo sapiens		h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_edg1Pathway:Phospholipids as signalling intermediaries,h_gpcrPathway:Signaling Pathway from G-Protein Families,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_par1pathway:Thrombin signaling and protease-activated receptors,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,		GO:0006457~protein folding,GO:0007049~cell cycle,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0043434~response to peptide hormone,GO:0043949~regulation of cAMP-mediated signaling,GO:0050805~negative regulation of synaptic transmission,GO:0051301~cell division,GO:1904322~cellular response to forskolin,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005813~centrosome,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030496~midbody,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0019003~GDP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0032794~GTPase activating protein binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04360:Axon guidance,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04971:Gastric acid secretion,hsa05012:Parkinson's disease,hsa05030:Cocaine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,			SM00275:SM00275,	3D-structure,ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Nucleus,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(i) subunit alpha-1,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,strand,turn,
201040_at	G protein subunit alpha i2(GNAI2)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0001973~adenosine receptor signaling pathway,GO:0006457~protein folding,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007584~response to nutrient,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0035556~intracellular signal transduction,GO:0043434~response to peptide hormone,GO:0050805~negative regulation of synaptic transmission,GO:0051301~cell division,GO:0051924~regulation of calcium ion transport,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0030496~midbody,GO:0044297~cell body,GO:0045121~membrane raft,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04360:Axon guidance,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04971:Gastric acid secretion,hsa05012:Parkinson's disease,hsa05030:Cocaine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,	192605~Ventricular tachycardia, idiopathic,Pituitary ACTH-secreting adenoma~Pituitary ACTH-secreting adenoma,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(i) subunit alpha-2,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,splice variant,
201180_s_at, 201181_at, 201179_s_at	G protein subunit alpha i3(GNAI3)	Homo sapiens				GO:0006457~protein folding,GO:0006810~transport,GO:0006906~vesicle fusion,GO:0007049~cell cycle,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007212~dopamine receptor signaling pathway,GO:0046039~GTP metabolic process,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0042588~zymogen granule,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0032794~GTPase activating protein binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04360:Axon guidance,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04971:Gastric acid secretion,hsa05012:Parkinson's disease,hsa05030:Cocaine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05200:Pathways in cancer,	602483~Auriculocondylar syndrome 1,		SM00275:SM00275,	3D-structure,ADP-ribosylation,Cell cycle,Cell division,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(k) subunit alpha,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,strand,turn,
204763_s_at, 215912_at, 204762_s_at	G protein subunit alpha o1(GNAO1)	Homo sapiens				GO:0006457~protein folding,GO:0006936~muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007568~aging,GO:0007626~locomotory behavior,GO:0008016~regulation of heart contraction,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0034097~response to cytokine,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043278~response to morphine,GO:0043547~positive regulation of GTPase activity,GO:0051926~negative regulation of calcium ion transport,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0043209~myelin sheath,GO:0044297~cell body,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0032794~GTPase activating protein binding,GO:0046872~metal ion binding,GO:0051430~corticotropin-releasing hormone receptor 1 binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,	615473~Epileptic encephalopathy, early infantile, 17,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Epilepsy,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(o) subunit alpha,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
202615_at, 211426_x_at	G protein subunit alpha q(GNAQ)	Homo sapiens		h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pkcPathway:Activation of PKC through G protein coupled receptor,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0001501~skeletal system development,GO:0001508~action potential,GO:0006469~negative regulation of protein kinase activity,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0007603~phototransduction, visible light,GO:0009649~entrainment of circadian clock,GO:0009791~post-embryonic development,GO:0016322~neuron remodeling,GO:0021884~forebrain neuron development,GO:0030168~platelet activation,GO:0035412~regulation of catenin import into nucleus,GO:0042711~maternal behavior,GO:0042733~embryonic digit morphogenesis,GO:0043547~positive regulation of GTPase activity,GO:0045634~regulation of melanocyte differentiation,GO:0048066~developmental pigmentation,GO:0050821~protein stabilization,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0001750~photoreceptor outer segment,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031826~type 2A serotonin receptor binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,	163000~Capillary malformations, congenital, 1, somatic, mosaic,185300~Sturge-Weber syndrome, somatic, mosaic,		SM00275:SM00275,	ADP-ribosylation,Coiled coil,Complete proteome,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(q) subunit alpha,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
214286_at, 207514_s_at	G protein subunit alpha transducin 1(GNAT1)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0007603~phototransduction, visible light,GO:0008283~cell proliferation,GO:0009416~response to light stimulus,GO:0009642~response to light intensity,GO:0016056~rhodopsin mediated signaling pathway,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0042462~eye photoreceptor cell development,GO:0050908~detection of light stimulus involved in visual perception,GO:0050917~sensory perception of umami taste,GO:0051343~positive regulation of cyclic-nucleotide phosphodiesterase activity,GO:0051344~negative regulation of cyclic-nucleotide phosphodiesterase activity,GO:0060041~retina development in camera-type eye,GO:0071257~cellular response to electrical stimulus,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0032391~photoreceptor connecting cilium,GO:0042622~photoreceptor outer segment membrane,GO:0043025~neuronal cell body,GO:0097381~photoreceptor disc membrane,	GO:0000035~acyl binding,GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0019003~GDP binding,GO:0019901~protein kinase binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04744:Phototransduction,	610444~Night blindness, congenital stationary, autosomal dominant 3,616389~Night blindness, congenital stationary, type 1G,		SM00275:SM00275,	3D-structure,ADP-ribosylation,Complete proteome,Congenital stationary night blindness,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Metal-binding,Myristate,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Sensory transduction,Transducer,Vision,	chain:Guanine nucleotide-binding protein G(t) subunit alpha-1,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
210604_at	G protein subunit alpha transducin 2(GNAT2)	Homo sapiens				GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0006457~protein folding,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007601~visual perception,GO:0007602~phototransduction,GO:0009642~response to light intensity,GO:0046549~retinal cone cell development,GO:0050908~detection of light stimulus involved in visual perception,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0042622~photoreceptor outer segment membrane,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04744:Phototransduction,	613856~Achromatopsia-4,		SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Metal-binding,Myristate,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Sensory transduction,Transducer,Vision,	chain:Guanine nucleotide-binding protein G(t) subunit alpha-2,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
216590_at	G protein subunit alpha transducin 3(GNAT3)	Homo sapiens				GO:0006457~protein folding,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0035094~response to nicotine,GO:0050913~sensory perception of bitter taste,GO:0050916~sensory perception of sweet taste,GO:0050917~sensory perception of umami taste,	GO:0001669~acrosomal vesicle,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005930~axoneme,GO:0016324~apical plasma membrane,GO:0043234~protein complex,	GO:0001664~G-protein coupled receptor binding,GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04744:Phototransduction,			SM00275:SM00275,	Complete proteome,Cytoplasm,GTP-binding,Lipoprotein,Magnesium,Metal-binding,Myristate,Nucleotide-binding,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(t) subunit alpha-3,lipid moiety-binding region:N-myristoyl glycine,nucleotide phosphate-binding region:GTP,
204993_at	G protein subunit alpha z(GNAZ)	Homo sapiens				GO:0006457~protein folding,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,	GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005057~receptor signaling protein activity,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04730:Long-term depression,			SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(z) subunit alpha,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
219560_at, 220762_s_at	G protein subunit beta 1 like(GNB1L)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0035176~social behavior,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0009898~cytoplasmic side of plasma membrane,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Guanine nucleotide-binding protein subunit beta-like protein 1,compositionally biased region:Poly-Pro,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence variant,splice variant,
200744_s_at, 200746_s_at, 200745_s_at	G protein subunit beta 1(GNB1)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_bArr-mapkPathway:Role of -arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:-arrestins in GPCR Desensitization,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_edg1Pathway:Phospholipids as signalling intermediaries,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,		GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007265~Ras protein signal transduction,GO:0008283~cell proliferation,GO:0010659~cardiac muscle cell apoptotic process,GO:0016056~rhodopsin mediated signaling pathway,GO:0030168~platelet activation,GO:0050909~sensory perception of taste,GO:0060041~retina development in camera-type eye,GO:0070208~protein heterotrimerization,GO:0071377~cellular response to glucagon stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071456~cellular response to hypoxia,GO:0071870~cellular response to catecholamine stimulus,	GO:0001917~photoreceptor inner segment,GO:0005622~intracellular,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0042622~photoreceptor outer segment membrane,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,GO:0097381~photoreceptor disc membrane,GO:1903561~extracellular vesicle,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030507~spectrin binding,GO:0031702~type 1 angiotensin receptor binding,GO:0032403~protein complex binding,GO:0047391~alkylglycerophosphoethanolamine phosphodiesterase activity,GO:0051020~GTPase binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04744:Phototransduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Mental retardation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,strand,turn,
200852_x_at	G protein subunit beta 2(GNB2)	Homo sapiens				GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0051020~GTPase binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00320:WD40,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,
206047_at	G protein subunit beta 3(GNB3)	Homo sapiens				GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008217~regulation of blood pressure,GO:0071377~cellular response to glucagon stimulus,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030507~spectrin binding,GO:0051020~GTPase binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04742:Taste transduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,	145500~Hypertension, essential, susceptibility to,		SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,
211871_x_at, 207124_s_at, 204000_at	G protein subunit beta 5(GNB5)	Homo sapiens				GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:1901386~negative regulation of voltage-gated calcium channel activity,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043209~myelin sheath,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0031682~G-protein gamma-subunit binding,GO:0051087~chaperone binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein subunit beta-5,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,splice variant,
201921_at	G protein subunit gamma 10(GNG10)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:DnaJ homolog subfamily C member 25,chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,domain:J,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,splice variant,transmembrane region,
204115_at	G protein subunit gamma 11(GNG11)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Coiled coil,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11,lipid moiety-binding region:S-farnesyl cysteine,modified residue,propeptide:Removed in mature form,
212294_at	G protein subunit gamma 12(GNG12)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0021987~cerebral cortex development,GO:0032496~response to lipopolysaccharide,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,GO:0042301~phosphate ion binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04810:Regulation of actin cytoskeleton,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Phosphoprotein,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,sequence conflict,
220806_x_at	G protein subunit gamma 13(GNG13)	Homo sapiens				GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0050909~sensory perception of taste,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,	GO:0004871~signal transducer activity,GO:0031681~G-protein beta-subunit binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04742:Taste transduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13,lipid moiety-binding region:S-farnesyl cysteine,propeptide:Removed in mature form,
222005_s_at	G protein subunit gamma 3(GNG3)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030425~dendrite,GO:0044297~cell body,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0031702~type 1 angiotensin receptor binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Phosphoprotein,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
205184_at	G protein subunit gamma 4(GNG4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0030308~negative regulation of cell growth,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
207157_s_at	G protein subunit gamma 5(GNG5)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,GO:0072513~positive regulation of secondary heart field cardioblast proliferation,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005739~mitochondrion,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031680~G-protein beta/gamma-subunit complex,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030165~PDZ domain binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Direct protein sequencing,Lipoprotein,Membrane,Methylation,Phosphoprotein,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
206896_s_at	G protein subunit gamma 7(GNG7)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
207166_at	G protein subunit gamma transducin 1(GNGT1)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_bArr-mapkPathway:Role of -arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:-arrestins in GPCR Desensitization,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_edg1Pathway:Phospholipids as signalling intermediaries,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,		GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008104~protein localization,GO:0010659~cardiac muscle cell apoptotic process,GO:0016056~rhodopsin mediated signaling pathway,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0042462~eye photoreceptor cell development,GO:0071456~cellular response to hypoxia,	GO:0001917~photoreceptor inner segment,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0097381~photoreceptor disc membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04744:Phototransduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(T) subunit gamma-T1,disulfide bond,lipid moiety-binding region:S-farnesyl cysteine,propeptide:Removed in mature form,sequence variant,
211829_s_at, 210640_s_at	G protein-coupled estrogen receptor 1(GPER1)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0001956~positive regulation of neurotransmitter secretion,GO:0002695~negative regulation of leukocyte activation,GO:0006954~inflammatory response,GO:0007049~cell cycle,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010579~positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010948~negative regulation of cell cycle process,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0019228~neuronal action potential,GO:0030263~apoptotic chromosome condensation,GO:0030264~nuclear fragmentation involved in apoptotic nuclear change,GO:0030335~positive regulation of cell migration,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0031959~mineralocorticoid receptor signaling pathway,GO:0032024~positive regulation of insulin secretion,GO:0032962~positive regulation of inositol trisphosphate biosynthetic process,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043401~steroid hormone mediated signaling pathway,GO:0043410~positive regulation of MAPK cascade,GO:0045087~innate immune response,GO:0045599~negative regulation of fat cell differentiation,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0045909~positive regulation of vasodilation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050728~negative regulation of inflammatory response,GO:0050769~positive regulation of neurogenesis,GO:0051053~negative regulation of DNA metabolic process,GO:0051055~negative regulation of lipid biosynthetic process,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051898~negative regulation of protein kinase B signaling,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070474~positive regulation of uterine smooth muscle contraction,GO:0071157~negative regulation of cell cycle arrest,GO:0071333~cellular response to glucose stimulus,GO:0071356~cellular response to tumor necrosis factor,GO:0071375~cellular response to peptide hormone stimulus,GO:0071389~cellular response to mineralocorticoid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:2000353~positive regulation of endothelial cell apoptotic process,GO:2000724~positive regulation of cardiac vascular smooth muscle cell differentiation,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0031966~mitochondrial membrane,GO:0032591~dendritic spine membrane,GO:0042734~presynaptic membrane,GO:0043198~dendritic shaft,GO:0043679~axon terminus,GO:0044327~dendritic spine head,GO:0045095~keratin filament,GO:0048471~perinuclear region of cytoplasm,GO:0048786~presynaptic active zone,GO:0055037~recycling endosome,	GO:0003682~chromatin binding,GO:0004930~G-protein coupled receptor activity,GO:0005496~steroid binding,GO:0005515~protein binding,GO:0017082~mineralocorticoid receptor activity,GO:0030284~estrogen receptor activity,GO:1990239~steroid hormone binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04915:Estrogen signaling pathway,				Acetylation,Apoptosis,Cell cycle,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Differentiation,Disulfide bond,Endoplasmic reticulum,Endosome,G-protein coupled receptor,Glycoprotein,Golgi apparatus,Immunity,Inflammatory response,Innate immunity,Membrane,Mitochondrion,Neurogenesis,Nucleus,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:G-protein coupled estrogen receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214605_x_at	G protein-coupled receptor 1(GPR1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007218~neuropeptide signaling pathway,GO:0007268~chemical synaptic transmission,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0042923~neuropeptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002275:G protein-coupled receptor 1 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211979_at, 220264_s_at, 220265_at, 211977_at	G protein-coupled receptor 107(GPR107)	Homo sapiens				GO:0072583~clathrin-mediated endocytosis,	GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,	GO:0032050~clathrin heavy chain binding,	IPR009637:Transmembrane receptor, eukaryota,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein GPR107,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,transmembrane region,
214558_at	G protein-coupled receptor 12(GPR12)	Homo sapiens				GO:0006874~cellular calcium ion homeostasis,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005623~cell,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0031210~phosphatidylcholine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000599:G protein-coupled receptor 12,IPR000723:G protein-coupled receptor 3/6/12 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 12,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221140_s_at	G protein-coupled receptor 132(GPR132)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005388:G2A lysophosphatidylcholine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Stress response,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 132,compositionally biased region:Poly-Arg,disulfide bond,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211659_at, 214503_x_at, 217641_at	G protein-coupled receptor 135(GPR135)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 135,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221966_at, 219430_at, 43934_at	G protein-coupled receptor 137(GPR137)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR137,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204137_at	G protein-coupled receptor 137B(GPR137B)	Homo sapiens					GO:0005765~lysosomal membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR137B,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206696_at	G protein-coupled receptor 143(GPR143)	Homo sapiens				GO:0006726~eye pigment biosynthetic process,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007601~visual perception,GO:0032400~melanosome localization,GO:0032402~melanosome transport,GO:0032438~melanosome organization,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050848~regulation of calcium-mediated signaling,GO:1902908~regulation of melanosome transport,GO:1903056~regulation of melanosome organization,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0033162~melanosome membrane,GO:0042470~melanosome,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0035240~dopamine binding,GO:0035643~L-DOPA receptor activity,GO:0072544~L-DOPA binding,GO:0072545~tyrosine binding,	IPR001414:Ocular albinism protein, type 1,		300500~Ocular albinism, type I, Nettleship-Falls type,300814~Nystagmus 6, congenital, X-linked,			Albinism,Cell membrane,Complete proteome,Disease mutation,G-protein coupled receptor,Glycoprotein,Lysosome,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 143,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208524_at	G protein-coupled receptor 15(GPR15)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0072678~T cell migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 15,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
64942_at, 221902_at	G protein-coupled receptor 153(GPR153)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022335:G protein-coupled receptor 153,IPR022347:G protein-coupled receptor 153/162,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 153,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220901_at	G protein-coupled receptor 157(GPR157)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000832:GPCR, family 2, secretin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR017981:GPCR, family 2-like,IPR022343:GCR1-cAMP receptor,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 157,compositionally biased region:Poly-Cys,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206971_at, 206972_s_at, 214104_at	G protein-coupled receptor 161(GPR161)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0030819~positive regulation of cAMP biosynthetic process,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,	GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,GO:0055037~recycling endosome,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Cell projection,Cilium,Complete proteome,Developmental protein,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 161,disulfide bond,glycosylation site:N-linked (GlcNAc...),splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205056_s_at	G protein-coupled receptor 162(GPR162)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022347:G protein-coupled receptor 153/162,IPR022348:G protein-coupled receptor 162,					Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 162,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206190_at, 215225_s_at	G protein-coupled receptor 17(GPR17)	Homo sapiens				GO:0002376~immune system process,GO:0002862~negative regulation of inflammatory response to antigenic stimulus,GO:0007186~G-protein coupled receptor signaling pathway,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004950~chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Uracil nucleotide/cysteinyl leukotriene receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207651_at	G protein-coupled receptor 171(GPR171)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0035589~G-protein coupled purinergic nucleotide receptor signaling pathway,GO:0045638~negative regulation of myeloid cell differentiation,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0045028~G-protein coupled purinergic nucleotide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 171,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221299_at	G protein-coupled receptor 173(GPR173)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0097211~cellular response to gonadotropin-releasing hormone,GO:2001223~negative regulation of neuron migration,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004968~gonadotropin-releasing hormone receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 173,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206673_at	G protein-coupled receptor 176(GPR176)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007268~chemical synaptic transmission,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 176,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210279_at	G protein-coupled receptor 18(GPR18)	Homo sapiens				GO:0002300~CD8-positive, alpha-beta intraepithelial T cell differentiation,GO:0002305~CD8-positive, gamma-delta intraepithelial T cell differentiation,GO:0002689~negative regulation of leukocyte chemotaxis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030217~T cell differentiation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:N-arachidonyl glycine receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214506_at	G protein-coupled receptor 182(GPR182)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001350:G10D orphan receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 182,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205419_at	G protein-coupled receptor 183(GPR183)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002312~B cell activation involved in immune response,GO:0002313~mature B cell differentiation involved in immune response,GO:0002407~dendritic cell chemotaxis,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010818~T cell chemotaxis,GO:0030316~osteoclast differentiation,GO:0030595~leukocyte chemotaxis,GO:0030890~positive regulation of B cell proliferation,GO:0036145~dendritic cell homeostasis,GO:0061470~T follicular helper cell differentiation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2000458~regulation of astrocyte chemotaxis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008142~oxysterol binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Adaptive immunity,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Immunity,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 183,disulfide bond,modified residue,region of interest:Interaction with G proteins,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207183_at	G protein-coupled receptor 19(GPR19)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 19,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214510_at	G protein-coupled receptor 20(GPR20)	Homo sapiens				GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 20,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221294_at	G protein-coupled receptor 21(GPR21)	Homo sapiens				GO:0001963~synaptic transmission, dopaminergic,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007612~learning,GO:0040018~positive regulation of multicellular organism growth,GO:0042593~glucose homeostasis,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0001588~dopamine neurotransmitter receptor activity, coupled via Gs,GO:0004930~G-protein coupled receptor activity,GO:0035240~dopamine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 21,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221288_at	G protein-coupled receptor 22(GPR22)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0032870~cellular response to hormone stimulus,GO:1901652~response to peptide,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 22,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221363_x_at	G protein-coupled receptor 25(GPR25)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 25,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221306_at	G protein-coupled receptor 27(GPR27)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:1900738~positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 27,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214613_at	G protein-coupled receptor 3(GPR3)	Homo sapiens				GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0040020~regulation of meiotic nuclear division,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000723:G protein-coupled receptor 3/6/12 orphan,IPR000984:G protein-coupled receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208556_at	G protein-coupled receptor 31(GPR31)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 31,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221469_at	G protein-coupled receptor 32(GPR32)	Homo sapiens				GO:0002430~complement receptor mediated signaling pathway,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0050900~leukocyte migration,GO:0060326~cell chemotaxis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004875~complement receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004982~N-formyl peptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000826:Formyl peptide receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 32,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210264_at	G protein-coupled receptor 35(GPR35)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:1901386~negative regulation of voltage-gated calcium channel activity,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016494~C-X-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 35,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
207055_at	G protein-coupled receptor 37 like 1(GPR37L1)	Homo sapiens				GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0021940~positive regulation of cerebellar granule cell precursor proliferation,GO:0043410~positive regulation of MAPK cascade,GO:0045665~negative regulation of neuron differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048712~negative regulation of astrocyte differentiation,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0036505~prosaposin receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR003909:G protein-coupled receptor 37 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Endothelin B receptor-like protein 2,compositionally biased region:Cys-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209631_s_at, 214586_at	G protein-coupled receptor 37(GPR37)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,		GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0031987~locomotion involved in locomotory behavior,GO:0042416~dopamine biosynthetic process,GO:0043410~positive regulation of MAPK cascade,GO:0045964~positive regulation of dopamine metabolic process,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0000151~ubiquitin ligase complex,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0043235~receptor complex,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0030544~Hsp70 protein binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0036505~prosaposin receptor activity,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR003909:G protein-coupled receptor 37 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa05012:Parkinson's disease,				Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Probable G-protein coupled receptor 37,compositionally biased region:Poly-Cys,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208600_s_at	G protein-coupled receptor 39(GPR39)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0046872~metal ion binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Zinc,	chain:G-protein coupled receptor 39,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc,modified residue,mutagenesis site,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206236_at, 211266_s_at	G protein-coupled receptor 4(GPR4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0010447~response to acidic pH,GO:0016525~negative regulation of angiogenesis,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060055~angiogenesis involved in wound healing,GO:0072144~glomerular mesangial cell development,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002276:G protein-coupled receptor 4 orphan,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211175_at	G protein-coupled receptor 45(GPR45)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 45,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208311_at	G protein-coupled receptor 50(GPR50)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008502~melatonin receptor activity,GO:0042802~identical protein binding,	IPR000025:Melatonin receptor family,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002280:Melatonin-related receptor 1X,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Melatonin-related receptor,compositionally biased region:Pro-rich,disulfide bond,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221313_at	G protein-coupled receptor 52(GPR52)	Homo sapiens				GO:0001963~synaptic transmission, dopaminergic,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007612~learning,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001588~dopamine neurotransmitter receptor activity, coupled via Gs,GO:0004930~G-protein coupled receptor activity,GO:0035240~dopamine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 52,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214655_at	G protein-coupled receptor 6(GPR6)	Homo sapiens				GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0038036~sphingosine-1-phosphate receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000723:G protein-coupled receptor 3/6/12 orphan,IPR001151:G protein-coupled receptor 6,IPR017452:GPCR, rhodopsin-like, 7TM,					Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 6,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Val,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220993_s_at	G protein-coupled receptor 63(GPR63)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 63,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214467_at	G protein-coupled receptor 65(GPR65)	Homo sapiens				GO:0006915~apoptotic process,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0010447~response to acidic pH,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0031532~actin cytoskeleton reorganization,GO:0035025~positive regulation of Rho protein signal transduction,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0051496~positive regulation of stress fiber assembly,GO:0090630~activation of GTPase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005464:Psychosine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Apoptosis,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Psychosine receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211249_at	G protein-coupled receptor 68(GPR68)	Homo sapiens				GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0045656~negative regulation of monocyte differentiation,GO:0071467~cellular response to pH,GO:2001206~positive regulation of osteoclast development,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005389:OGR1 sphingosylphosphorylcholine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Ovarian cancer G-protein coupled receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220481_at	G protein-coupled receptor 75(GPR75)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:1901214~regulation of neuron death,	GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 75,compositionally biased region:Phe-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
211062_s_at	G protein-coupled receptor 78(GPR78)	Homo sapiens				GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 78,disulfide bond,mutagenesis site,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219898_at	G protein-coupled receptor 85(GPR85)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 85,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219936_s_at	G protein-coupled receptor 87(GPR87)	Homo sapiens				GO:0007194~negative regulation of adenylate cyclase activity,GO:0035589~G-protein coupled purinergic nucleotide receptor signaling pathway,	GO:0005887~integral component of plasma membrane,	GO:0045028~G-protein coupled purinergic nucleotide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR008109:P2Y13 purinoceptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 87,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220313_at	G protein-coupled receptor 88(GPR88)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007626~locomotory behavior,GO:0019228~neuronal action potential,GO:0050885~neuromuscular process controlling balance,GO:0061743~motor learning,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0003774~motor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Cytoplasm,G-protein coupled receptor,Glycoprotein,Membrane,Mental retardation,Nucleus,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 88,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
222140_s_at, 220642_x_at	G protein-coupled receptor 89B(GPR89B)	Homo sapiens				GO:0006811~ion transport,GO:0015031~protein transport,GO:0034765~regulation of ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051452~intracellular pH reduction,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0032580~Golgi cisterna membrane,	GO:0004871~signal transducer activity,GO:0005244~voltage-gated ion channel activity,GO:0008308~voltage-gated anion channel activity,	IPR015672:GPCR 89-related,IPR022535:Golgi pH regulator, conserved domain,IPR025969:Abscisic acid G-protein coupled receptor-like domain,					Alternative splicing,Complete proteome,Glycoprotein,Golgi apparatus,Ion channel,Ion transport,Membrane,Protein transport,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Protein GPR89,chain:Putative protein GPR89C,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
204793_at	G protein-coupled receptor associated sorting protein 1(GPRASP1)	Homo sapiens				GO:0008333~endosome to lysosome transport,GO:1990172~G-protein coupled receptor catabolic process,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR006911:Armadillo repeat-containing domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:G-protein coupled receptor-associated sorting protein 1,compositionally biased region:Glu-rich,region of interest:OPRD1-binding,sequence variant,
212444_at, 203108_at	G protein-coupled receptor class C group 5 member A(GPRC5A)	Homo sapiens				GO:0007165~signal transduction,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0007186~G-protein coupled receptor signaling pathway,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031982~vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR017978:GPCR, family 3, C-terminal,					Cell membrane,Complete proteome,Cytoplasmic vesicle,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Retinoic acid-induced protein 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203631_s_at, 203632_s_at	G protein-coupled receptor class C group 5 member B(GPRC5B)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007626~locomotory behavior,GO:0010976~positive regulation of neuron projection development,GO:0032147~activation of protein kinase activity,GO:0042593~glucose homeostasis,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045666~positive regulation of neuron differentiation,GO:0050729~positive regulation of inflammatory response,GO:0060907~positive regulation of macrophage cytokine production,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001664~G-protein coupled receptor binding,GO:0004930~G-protein coupled receptor activity,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,	IPR017978:GPCR, family 3, C-terminal,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor family C group 5 member B,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219327_s_at	G protein-coupled receptor class C group 5 member C(GPRC5C)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031982~vesicle,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0004930~G-protein coupled receptor activity,	IPR017978:GPCR, family 3, C-terminal,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor family C group 5 member C,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221297_at	G protein-coupled receptor class C group 5 member D(GPRC5D)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR017978:GPCR, family 3, C-terminal,					Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor family C group 5 member D,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208041_at	G protein-coupled receptor kinase 1(GRK1)	Homo sapiens		h_rhodopsinPathway:Visual Signal Transduction,		GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007601~visual perception,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0016056~rhodopsin mediated signaling pathway,GO:0016057~regulation of membrane potential in photoreceptor cell,GO:0016058~maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0046777~protein autophosphorylation,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0097381~photoreceptor disc membrane,	GO:0004672~protein kinase activity,GO:0004703~G-protein coupled receptor kinase activity,GO:0005524~ATP binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0016301~kinase activity,GO:0050254~rhodopsin kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04744:Phototransduction,	613411~Oguchi disease-2,		SM00133:S_TK_X,SM00220:S_TKc,SM00315:RGS,	3D-structure,ATP-binding,Complete proteome,Congenital stationary night blindness,Disease mutation,Kinase,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Receptor,Reference proteome,Sensory transduction,Serine/threonine-protein kinase,Transferase,Vision,	active site:Proton acceptor,binding site:ATP,chain:Rhodopsin kinase,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:RGS,lipid moiety-binding region:S-farnesyl cysteine,modified residue,nucleotide phosphate-binding region:ATP,propeptide:Removed in mature form,region of interest:C-terminal,region of interest:N-terminal,sequence variant,
38447_at, 201401_s_at, 201402_at	G protein-coupled receptor kinase 2(GRK2)	Homo sapiens		h_bArr-mapkPathway:Role of -arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:-arrestins in GPCR Desensitization,		GO:0002026~regulation of the force of heart contraction,GO:0002029~desensitization of G-protein coupled receptor protein signaling pathway,GO:0003108~negative regulation of the force of heart contraction by chemical signal,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007217~tachykinin receptor signaling pathway,GO:0007507~heart development,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0019079~viral genome replication,GO:0031623~receptor internalization,GO:0033605~positive regulation of catecholamine secretion,GO:0045988~negative regulation of striated muscle contraction,GO:0046718~viral entry into host cell,GO:0060048~cardiac muscle contraction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0072372~primary cilium,	GO:0004672~protein kinase activity,GO:0004703~G-protein coupled receptor kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031694~alpha-2A adrenergic receptor binding,GO:0031755~Edg-2 lysophosphatidic acid receptor binding,GO:0047696~beta-adrenergic receptor kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04724:Glutamatergic synapse,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,SM00315:RGS,	3D-structure,ATP-binding,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Beta-adrenergic receptor kinase 1,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,domain:RGS,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence conflict,sequence variant,strand,
204183_s_at, 204184_s_at	G protein-coupled receptor kinase 3(GRK3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0031623~receptor internalization,	GO:0005886~plasma membrane,	GO:0004672~protein kinase activity,GO:0004703~G-protein coupled receptor kinase activity,GO:0005524~ATP binding,GO:0047696~beta-adrenergic receptor kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04724:Glutamatergic synapse,hsa04740:Olfactory transduction,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,SM00315:RGS,	ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Beta-adrenergic receptor kinase 2,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,domain:RGS,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence conflict,sequence variant,
210600_s_at, 208365_s_at	G protein-coupled receptor kinase 4(GRK4)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,		GO:0002031~G-protein coupled receptor internalization,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0031623~receptor internalization,	GO:0005829~cytosol,GO:0005938~cell cortex,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0097381~photoreceptor disc membrane,	GO:0004703~G-protein coupled receptor kinase activity,GO:0005524~ATP binding,GO:0050254~rhodopsin kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00315:RGS,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipoprotein,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:G protein-coupled receptor kinase 4,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:RGS,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence conflict,sequence variant,splice variant,
204395_s_at, 204396_s_at	G protein-coupled receptor kinase 5(GRK5)	Homo sapiens				GO:0006915~apoptotic process,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007217~tachykinin receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0046777~protein autophosphorylation,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0031965~nuclear membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0004703~G-protein coupled receptor kinase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0047696~beta-adrenergic receptor kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR011009:Protein kinase-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00315:RGS,	3D-structure,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Kinase,Lipid-binding,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:G protein-coupled receptor kinase 5,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:RGS,modified residue,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence variant,
202849_x_at, 210981_s_at, 202848_s_at, 211543_s_at	G protein-coupled receptor kinase 6(GRK6)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0016055~Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004703~G-protein coupled receptor kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0047696~beta-adrenergic receptor kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00315:RGS,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:G protein-coupled receptor kinase 6,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:RGS,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence conflict,sequence variant,splice variant,strand,turn,
203776_at	G-patch domain and KOW motifs(GPKOW)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,	IPR000467:G-patch domain,IPR005824:KOW,IPR026822:Protein MOS2,				SM00443:G_patch,SM00739:KOW,	Acetylation,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,Repeat,	chain:G patch domain and KOW motifs-containing protein,domain:G-patch,domain:KOW 1,domain:KOW 2,modified residue,sequence conflict,
219818_s_at	G-patch domain containing 1(GPATCH1)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,	GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,	IPR000467:G-patch domain,IPR011666:Domain of unknown function DUF1604,					Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:G patch domain-containing protein 1,domain:G-patch,modified residue,sequence conflict,sequence variant,
219720_s_at	G-patch domain containing 2 like(GPATCH2L)	Homo sapiens						GO:0005515~protein binding,	IPR026291:G patch domain-containing protein 2,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C14orf118,compositionally biased region:Arg-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
219078_at	G-patch domain containing 2(GPATCH2)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,	IPR000467:G-patch domain,IPR026291:G patch domain-containing protein 2,				SM00443:G_patch,	Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,	chain:G patch domain-containing protein 2,domain:G-patch,modified residue,sequence conflict,splice variant,
218895_at	G-patch domain containing 3(GPATCH3)	Homo sapiens						GO:0003676~nucleic acid binding,	IPR000467:G-patch domain,				SM00443:G_patch,	Complete proteome,Polymorphism,Reference proteome,	chain:G patch domain-containing protein 3,compositionally biased region:Glu-rich,domain:G-patch,sequence conflict,sequence variant,
221733_s_at, 220596_at	G-patch domain containing 4(GPATCH4)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,		GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,				SM00443:G_patch,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:G patch domain-containing protein 4,domain:G-patch,modified residue,splice variant,
212485_at, 212487_at	G-patch domain containing 8(GPATCH8)	Homo sapiens			DNA replication, recombination, and repair,			GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000467:G-patch domain,IPR007087:Zinc finger, C2H2,IPR022755:Zinc finger, double-stranded RNA binding,				SM00443:G_patch,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:G patch domain-containing protein 8,compositionally biased region:Lys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gly,compositionally biased region:Ser-rich,domain:G-patch,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type,
205240_at, 221922_at	G-protein signaling modulator 2(GPSM2)	Homo sapiens				GO:0000132~establishment of mitotic spindle orientation,GO:0007052~mitotic spindle organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050790~regulation of catalytic activity,GO:0051661~maintenance of centrosome location,GO:0060487~lung epithelial cell differentiation,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0045177~apical part of cell,GO:0097431~mitotic spindle pole,	GO:0000166~nucleotide binding,GO:0001965~G-protein alpha-subunit binding,GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,	IPR003109:GoLoco motif,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		604213~Chudley-McCullough syndrome,		SM00028:TPR,SM00390:GoLoco,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:G-protein-signaling modulator 2,domain:GoLoco 1,domain:GoLoco 2,domain:GoLoco 3,domain:GoLoco 4,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,
204265_s_at, 214847_s_at	G-protein signaling modulator 3(GPSM3)	Homo sapiens				GO:0002690~positive regulation of leukocyte chemotaxis,GO:0050790~regulation of catalytic activity,GO:1900017~positive regulation of cytokine production involved in inflammatory response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0030695~GTPase regulator activity,	IPR003109:GoLoco motif,				SM00390:GoLoco,	Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:G-protein-signaling modulator 3,compositionally biased region:Pro-rich,domain:GoLoco 1,domain:GoLoco 2,domain:GoLoco 3,modified residue,mutagenesis site,sequence conflict,
201520_s_at, 201501_s_at, 215030_at, 221917_s_at	G-rich RNA sequence binding factor 1(GRSF1)	Homo sapiens				GO:0006378~mRNA polyadenylation,GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0009952~anterior/posterior pattern specification,GO:0016331~morphogenesis of embryonic epithelium,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Mitochondrion,Mitochondrion nucleoid,mRNA processing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transit peptide,tRNA processing,	chain:G-rich sequence factor 1,compositionally biased region:Ala-rich,domain:RRM 1,domain:RRM 2,domain:RRM 3,modified residue,sequence conflict,sequence variant,
213524_s_at	G0/G1 switch 2(G0S2)	Homo sapiens				GO:0097191~extrinsic apoptotic signaling pathway,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005811~lipid particle,	GO:0005515~protein binding,	IPR016821:G0/G1 switch protein 2, putative,			PIRSF023925:G0/G1 switch protein 2,		Apoptosis,Complete proteome,Mitochondrion,Reference proteome,	chain:G0/G1 switch regulatory protein 2,
201912_s_at, 215438_x_at, 217595_at	G1 to S phase transition 1(GSPT1)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002184~cytoplasmic translational termination,GO:0006479~protein methylation,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0018444~translation release factor complex,	GO:0003747~translation release factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03015:mRNA surveillance pathway,				3D-structure,Alternative splicing,Complete proteome,GTP-binding,Nonsense-mediated mRNA decay,Nucleotide-binding,Protein biosynthesis,Proteomics identification,Reference proteome,	chain:Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,nucleotide phosphate-binding region:GTP,strand,turn,
205541_s_at	G1 to S phase transition 2(GSPT2)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002184~cytoplasmic translational termination,GO:0006415~translational termination,GO:0007049~cell cycle,	GO:0005829~cytosol,GO:0018444~translation release factor complex,	GO:0003747~translation release factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR009818:Ataxin-2, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03015:mRNA surveillance pathway,				3D-structure,Cell cycle,Complete proteome,Cytoplasm,GTP-binding,Nonsense-mediated mRNA decay,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,	chain:Eukaryotic peptide chain release factor GTP-binding subunit ERF3B,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,site:Interacts with GTP/GDP,
204318_s_at, 215942_s_at, 204315_s_at, 204317_at, 211040_x_at	G2 and S-phase expressed 1(GTSE1)	Homo sapiens				GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007017~microtubule-based process,GO:0030335~positive regulation of cell migration,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0046827~positive regulation of protein export from nucleus,GO:0050821~protein stabilization,GO:1900182~positive regulation of protein localization to nucleus,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1904527~negative regulation of microtubule binding,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,	GO:0005515~protein binding,	IPR026657:Proline/serine-rich coiled-coil protein 1/G2 and S phase-expressed protein 1,IPR026659:G2 and S phase-expressed protein 1,	hsa04115:p53 signaling pathway,				Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Phosphoprotein,Polymorphism,Reference proteome,	chain:G2 and S phase-expressed protein 1,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,
201514_s_at, 201503_at, 222187_x_at	G3BP stress granule assembly factor 1(G3BP1)	Homo sapiens				GO:0006810~transport,GO:0007265~Ras protein signal transduction,GO:0032508~DNA duplex unwinding,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,				SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Endonuclease,Helicase,Hydrolase,Membrane,Methylation,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Transport,	chain:Ras GTPase-activating protein-binding protein 1,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,domain:NTF2,domain:RRM,modified residue,mutagenesis site,site:Not acetylated,
208841_s_at, 206383_s_at, 208840_s_at	G3BP stress granule assembly factor 2(G3BP2)	Homo sapiens				GO:0006810~transport,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0007265~Ras protein signal transduction,GO:0051028~mRNA transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0030159~receptor signaling complex scaffold activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,mRNA transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Transport,Ubl conjugation,	chain:Ras GTPase-activating protein-binding protein 2,compositionally biased region:Glu-rich,compositionally biased region:Gly-rich,domain:NTF2,domain:RRM,modified residue,sequence conflict,sequence variant,site:Not acetylated,splice variant,
210188_at	GA binding protein transcription factor alpha subunit(GABPA)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0030154~cell differentiation,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016312:Transcription factor, GA-binding, alpha subunit,IPR024668:GA-binding protein alpha subunit, N-terminal,			PIRSF001703:GA-binding transcription factor,alpha subunit ,	SM00251:SAM_PNT,SM00413:ETS,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:GA-binding protein alpha chain,DNA-binding region:ETS,domain:PNT,sequence conflict,sequence variant,
204618_s_at, 206173_x_at	GA binding protein transcription factor beta subunit 1(GABPB1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Acetylation,Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:GA-binding protein subunit beta-1,mutagenesis site,region of interest:Transcription activation and HCFC1 interaction,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,splice variant,
208869_s_at, 208868_s_at, 211458_s_at	GABA type A receptor associated protein like 1(GABARAPL1)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006914~autophagy,GO:0006995~cellular response to nitrogen starvation,GO:0016236~macroautophagy,	GO:0000421~autophagosome membrane,GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0030659~cytoplasmic vesicle membrane,GO:0032590~dendrite membrane,GO:0032839~dendrite cytoplasm,GO:0044297~cell body,	GO:0005515~protein binding,GO:0030957~Tat protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0048487~beta-tubulin binding,GO:0050811~GABA receptor binding,	IPR004241:Autophagy protein Atg8 ubiquitin-like,	hsa04068:FoxO signaling pathway,hsa04140:Regulation of autophagy,hsa04727:GABAergic synapse,				3D-structure,Alternative splicing,Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endoplasmic reticulum,Golgi apparatus,Lipoprotein,Membrane,Microtubule,Proteomics identification,Receptor,Reference proteome,	chain:Gamma-aminobutyric acid receptor- associated protein-like 1,chain:Gamma-aminobutyric acid receptor- associated protein-like 3,helix,region of interest:Interaction with beta-tubulin,region of interest:Interaction with GABRG2,strand,
209046_s_at	GABA type A receptor associated protein like 2(GABARAPL2)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0006914~autophagy,GO:0006995~cellular response to nitrogen starvation,GO:0015031~protein transport,GO:0016236~macroautophagy,GO:0032781~positive regulation of ATPase activity,GO:1901799~negative regulation of proteasomal protein catabolic process,	GO:0000139~Golgi membrane,GO:0000421~autophagosome membrane,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,	GO:0000149~SNARE binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031625~ubiquitin protein ligase binding,GO:0048487~beta-tubulin binding,GO:0050811~GABA receptor binding,GO:0051117~ATPase binding,	IPR004241:Autophagy protein Atg8 ubiquitin-like,	hsa04068:FoxO signaling pathway,hsa04140:Regulation of autophagy,hsa04727:GABAergic synapse,				3D-structure,Acetylation,Autophagy,Complete proteome,Cytoplasmic vesicle,Golgi apparatus,Lipoprotein,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Receptor,Reference proteome,Transport,	chain:Gamma-aminobutyric acid receptor- associated protein-like 2,modified residue,region of interest:Interaction with beta-tubulin,region of interest:Interaction with GABRG2,sequence conflict,sequence variant,
211457_at	GABA type A receptor associated protein like 3 pseudogene(GABARAPL3)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0006995~cellular response to nitrogen starvation,	GO:0000421~autophagosome membrane,GO:0005829~cytosol,GO:0005874~microtubule,GO:0031410~cytoplasmic vesicle,		IPR004241:Autophagy protein Atg8 ubiquitin-like,					Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Lipoprotein,Membrane,Microtubule,Reference proteome,	chain:Gamma-aminobutyric acid receptor- associated protein-like 1,chain:Gamma-aminobutyric acid receptor- associated protein-like 3,helix,region of interest:Interaction with beta-tubulin,region of interest:Interaction with GABRG2,strand,
200645_at	GABA type A receptor-associated protein(GABARAP)	Homo sapiens		h_gabaPathway:Gamma-aminobutyric Acid Receptor Life Cycle,		GO:0000226~microtubule cytoskeleton organization,GO:0006605~protein targeting,GO:0006914~autophagy,GO:0007268~chemical synaptic transmission,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0015031~protein transport,GO:0016236~macroautophagy,	GO:0000139~Golgi membrane,GO:0000421~autophagosome membrane,GO:0005764~lysosome,GO:0005776~autophagosome,GO:0005790~smooth endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005930~axoneme,GO:0015629~actin cytoskeleton,GO:0031410~cytoplasmic vesicle,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0097225~sperm midpiece,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031625~ubiquitin protein ligase binding,GO:0048487~beta-tubulin binding,GO:0050811~GABA receptor binding,	IPR004241:Autophagy protein Atg8 ubiquitin-like,	hsa04068:FoxO signaling pathway,hsa04140:Regulation of autophagy,hsa04727:GABAergic synapse,				3D-structure,Apoptosis,Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Golgi apparatus,Lipoprotein,Membrane,Microtubule,Protein transport,Proteomics identification,Receptor,Reference proteome,Transport,	chain:Gamma-aminobutyric acid receptor- associated protein,helix,region of interest:Interaction with beta-tubulin,region of interest:Interaction with GABRG2,region of interest:Interaction with GPHN,strand,
212891_s_at, 212889_x_at	GADD45G interacting protein 1(GADD45GIP1)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0016032~viral process,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,GO:0071850~mitotic cell cycle arrest,GO:1903862~positive regulation of oxidative phosphorylation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005761~mitochondrial ribosome,	GO:0005515~protein binding,	IPR018472:Growth arrest/ DNA-damage-inducible protein-interacting protein 1,					3D-structure,Cell cycle,Coiled coil,Complete proteome,Host-virus interaction,Mitochondrion,Nucleus,Reference proteome,	chain:Growth arrest and DNA-damage-inducible proteins-interacting protein 1,compositionally biased region:Poly-Gln,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,
219110_at	GAR1 ribonucleoprotein(GAR1)	Homo sapiens				GO:0000454~snoRNA guided rRNA pseudouridine synthesis,GO:0007004~telomere maintenance via telomerase,GO:0031118~rRNA pseudouridine synthesis,GO:0098655~cation transmembrane transport,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0031429~box H/ACA snoRNP complex,GO:0072589~box H/ACA scaRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0005261~cation channel activity,GO:0005515~protein binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR007504:H/ACA ribonucleoprotein complex, subunit Gar1/Naf1,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR021154:H/ACA ribonucleoprotein complex, subunit Gar1, eukaryote,	hsa03008:Ribosome biogenesis in eukaryotes,				Alternative splicing,Complete proteome,Nucleus,Reference proteome,Repeat,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,	chain:H/ACA ribonucleoprotein complex subunit 1,region of interest:RGG-box 1,region of interest:RGG-box 2,sequence conflict,splice variant,
207615_s_at	GAS8 antisense RNA 1(GAS8-AS1)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Uncharacterized protein C16orf3,sequence variant,
210446_at	GATA binding protein 1(GATA1)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0009887~organ morphogenesis,GO:0009888~tissue development,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010724~regulation of definitive erythrocyte differentiation,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030220~platelet formation,GO:0030221~basophil differentiation,GO:0030222~eosinophil differentiation,GO:0030502~negative regulation of bone mineralization,GO:0033690~positive regulation of osteoblast proliferation,GO:0035162~embryonic hemopoiesis,GO:0035854~eosinophil fate commitment,GO:0043066~negative regulation of apoptotic process,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048821~erythrocyte development,GO:0048873~homeostasis of number of cells within a tissue,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0070527~platelet aggregation,GO:0071733~transcriptional activation by promoter-enhancer looping,GO:0097028~dendritic cell differentiation,GO:0097067~cellular response to thyroid hormone stimulus,GO:2000678~negative regulation of transcription regulatory region DNA binding,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0017053~transcriptional repressor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008301~DNA binding, bending,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,		190685~Leukemia, megakaryoblastic, with or without Down syndrome, somatic,300367~Thrombocytopenia, X-linked, with or without dyserythropoietic anemia,300835~Anemia, X-linked, with/without neutropenia and/or platelet abnormalities,314050~Thrombocytopenia with beta-thalassemia, X-linked,		SM00401:ZnF_GATA,	Acetylation,Activator,Alternative initiation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Erythroid transcription factor,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,mutagenesis site,region of interest:Required for interaction with ZFPM1,sequence variant,splice variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
207954_at, 210358_x_at, 209710_at	GATA binding protein 2(GATA2)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001655~urogenital system development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006909~phagocytosis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0009887~organ morphogenesis,GO:0009888~tissue development,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021533~cell differentiation in hindbrain,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0021954~central nervous system neuron development,GO:0021983~pituitary gland development,GO:0030097~hemopoiesis,GO:0033993~response to lipid,GO:0035019~somatic stem cell population maintenance,GO:0035065~regulation of histone acetylation,GO:0035854~eosinophil fate commitment,GO:0042472~inner ear morphogenesis,GO:0043306~positive regulation of mast cell degranulation,GO:0045599~negative regulation of fat cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048565~digestive tract development,GO:0048873~homeostasis of number of cells within a tissue,GO:0050766~positive regulation of phagocytosis,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060216~definitive hemopoiesis,GO:0060872~semicircular canal development,GO:0070345~negative regulation of fat cell proliferation,GO:0090102~cochlea development,GO:0097154~GABAergic neuron differentiation,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000977~regulation of forebrain neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		601626~Leukemia, acute myeloid, susceptibility to,614038~Emberger syndrome,614172~Immunodeficiency 21,614286~Myelodysplastic syndrome, susceptibility to,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	Activator,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Methylation,Nucleus,Phagocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Endothelial transcription factor GATA-2,sequence conflict,sequence variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
209602_s_at, 209603_at, 209604_s_at	GATA binding protein 3(GATA3)	Homo sapiens	78.B_Cell_Development,80.T_cell_Activation,89.CD4_T_Cell_Differentiation,	h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001806~type IV hypersensitivity,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002088~lens development in camera-type eye,GO:0002572~pro-T cell differentiation,GO:0003180~aortic valve morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003281~ventricular septum development,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0009615~response to virus,GO:0009653~anatomical structure morphogenesis,GO:0009791~post-embryonic development,GO:0009887~organ morphogenesis,GO:0009967~positive regulation of signal transduction,GO:0010332~response to gamma radiation,GO:0010595~positive regulation of endothelial cell migration,GO:0010975~regulation of neuron projection development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0030218~erythrocyte differentiation,GO:0031929~TOR signaling,GO:0032689~negative regulation of interferon-gamma production,GO:0032703~negative regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035162~embryonic hemopoiesis,GO:0035457~cellular response to interferon-alpha,GO:0035799~ureter maturation,GO:0035898~parathyroid hormone secretion,GO:0042035~regulation of cytokine biosynthetic process,GO:0042421~norepinephrine biosynthetic process,GO:0042472~inner ear morphogenesis,GO:0042493~response to drug,GO:0043370~regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043523~regulation of neuron apoptotic process,GO:0043583~ear development,GO:0043627~response to estrogen,GO:0045061~thymic T cell selection,GO:0045064~T-helper 2 cell differentiation,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045471~response to ethanol,GO:0045582~positive regulation of T cell differentiation,GO:0045599~negative regulation of fat cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048485~sympathetic nervous system development,GO:0048538~thymus development,GO:0048565~digestive tract development,GO:0048589~developmental growth,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0050728~negative regulation of inflammatory response,GO:0050852~T cell receptor signaling pathway,GO:0051569~regulation of histone H3-K4 methylation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060017~parathyroid gland development,GO:0060037~pharyngeal system development,GO:0060065~uterus development,GO:0060231~mesenchymal to epithelial transition,GO:0060374~mast cell differentiation,GO:0060676~ureteric bud formation,GO:0061085~regulation of histone H3-K27 methylation,GO:0061290~canonical Wnt signaling pathway involved in metanephric kidney development,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,GO:0071442~positive regulation of histone H3-K14 acetylation,GO:0071599~otic vesicle development,GO:0071773~cellular response to BMP stimulus,GO:0072107~positive regulation of ureteric bud formation,GO:0072178~nephric duct morphogenesis,GO:0072179~nephric duct formation,GO:0072182~regulation of nephron tubule epithelial cell differentiation,GO:0072602~interleukin-4 secretion,GO:0072643~interferon-gamma secretion,GO:0072676~lymphocyte migration,GO:0090102~cochlea development,GO:1901536~negative regulation of DNA demethylation,GO:2000114~regulation of establishment of cell polarity,GO:2000146~negative regulation of cell motility,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000607~negative regulation of cell proliferation involved in mesonephros development,GO:2000611~positive regulation of thyroid hormone generation,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000683~regulation of cellular response to X-ray,GO:2000703~negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,GO:2000734~negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005134~interleukin-2 receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,GO:0071837~HMG box domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		146255~Hypoparathyroidism, sensorineural deafness, and renal dysplasia,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	3D-structure,Activator,Alternative splicing,Complete proteome,Deafness,Disease mutation,DNA-binding,Immunity,Innate immunity,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Trans-acting T-cell-specific transcription factor GATA-3,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
205517_at	GATA binding protein 4(GATA4)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_hopPathway:Hop Pathway in Cardiac Development,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0001947~heart looping,GO:0003197~endocardial cushion development,GO:0003208~cardiac ventricle morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003281~ventricular septum development,GO:0003289~atrial septum primum morphogenesis,GO:0003290~atrial septum secundum morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0007492~endoderm development,GO:0007596~blood coagulation,GO:0008584~male gonad development,GO:0009612~response to mechanical stimulus,GO:0010507~negative regulation of autophagy,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0030513~positive regulation of BMP signaling pathway,GO:0033189~response to vitamin A,GO:0035054~embryonic heart tube anterior/posterior pattern specification,GO:0042493~response to drug,GO:0045165~cell fate commitment,GO:0045766~positive regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048468~cell development,GO:0048617~embryonic foregut morphogenesis,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0051891~positive regulation of cardioblast differentiation,GO:0060290~transdifferentiation,GO:0060413~atrial septum morphogenesis,GO:0060575~intestinal epithelial cell differentiation,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0071333~cellular response to glucose stimulus,GO:0086004~regulation of cardiac muscle cell contraction,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0033613~activating transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0051525~NFAT protein binding,GO:0070410~co-SMAD binding,	IPR000679:Zinc finger, GATA-type,IPR008013:GATA-type transcription activator, N-terminal,IPR013088:Zinc finger, NHR/GATA-type,IPR016375:Transcription factor GATA-4/5/6,	hsa04022:cGMP-PKG signaling pathway,hsa04919:Thyroid hormone signaling pathway,	187500~Tetralogy of Fallot,607941~Atrial septal defect 2,614429~Ventricular septal defect 1,614430~Atrioventricular septal defect 4,615542~Testicular anomalies with or without congenital heart disease,	PIRSF003028:transcription factor GATA-4/5/6 types,	SM00401:ZnF_GATA,	3D-structure,Activator,Alternative splicing,Atrial septal defect,Cardiomyopathy,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Methylation,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor GATA-4,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Thr,modified residue,sequence conflict,sequence variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
210002_at	GATA binding protein 6(GATA6)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001889~liver development,GO:0003148~outflow tract septum morphogenesis,GO:0003309~type B pancreatic cell differentiation,GO:0003310~pancreatic A cell differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006644~phospholipid metabolic process,GO:0007493~endodermal cell fate determination,GO:0007596~blood coagulation,GO:0008584~male gonad development,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0030513~positive regulation of BMP signaling pathway,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0032912~negative regulation of transforming growth factor beta2 production,GO:0035239~tube morphogenesis,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043627~response to estrogen,GO:0044267~cellular protein metabolic process,GO:0045165~cell fate commitment,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048468~cell development,GO:0048645~organ formation,GO:0051145~smooth muscle cell differentiation,GO:0051891~positive regulation of cardioblast differentiation,GO:0055007~cardiac muscle cell differentiation,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060430~lung saccule development,GO:0060486~Clara cell differentiation,GO:0060510~Type II pneumocyte differentiation,GO:0060575~intestinal epithelial cell differentiation,GO:0060947~cardiac vascular smooth muscle cell differentiation,GO:0070848~response to growth factor,GO:0071158~positive regulation of cell cycle arrest,GO:0071371~cellular response to gonadotropin stimulus,GO:0071456~cellular response to hypoxia,GO:0071773~cellular response to BMP stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,	IPR000679:Zinc finger, GATA-type,IPR008013:GATA-type transcription activator, N-terminal,IPR013088:Zinc finger, NHR/GATA-type,		187500~Tetralogy of Fallot,217095~Persistent truncus arteriosus,600001~Pancreatic agenesis and congenital heart defects,614474~Atrioventricular septal defect 5,614475~Atrial septal defect 9,		SM00401:ZnF_GATA,	Activator,Alternative initiation,Atrial septal defect,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor GATA-6,compositionally biased region:Poly-Ala,compositionally biased region:Poly-His,compositionally biased region:Poly-Thr,modified residue,sequence conflict,splice variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
208503_s_at, 213018_at, 214718_at	GATA zinc finger domain containing 1(GATAD1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,		614672~Cardiomyopathy, dilated, 2B,			Cardiomyopathy,Complete proteome,Disease mutation,Isopeptide bond,Metal-binding,Nucleus,Polymorphism,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:GATA zinc finger domain-containing protein 1,compositionally biased region:Gly-rich,sequence conflict,sequence variant,zinc finger region:GATA-type,
218131_s_at	GATA zinc finger domain containing 2A(GATAD2A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016607~nuclear speck,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0030674~protein binding, bridging,GO:0043565~sequence-specific DNA binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional repressor p66-alpha,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:GATA-type,
204965_at	GC, vitamin D binding protein(GC)	Homo sapiens				GO:0042359~vitamin D metabolic process,GO:0051180~vitamin transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003779~actin binding,GO:0005499~vitamin D binding,GO:0051183~vitamin transporter activity,GO:1902118~calcidiol binding,	IPR000213:Vitamin D-binding protein,IPR000264:ALB/AFP/VDB,IPR014760:Serum albumin, N-terminal,IPR015247:Vitamin D binding protein, domain III,IPR020857:Serum albumin, conserved site,IPR020858:Serum albumin-like,				SM00103:ALBUMIN,	3D-structure,Actin-binding,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transport,Vitamin D,	chain:Vitamin D-binding protein,disulfide bond,domain:Albumin 1,domain:Albumin 2,domain:Albumin 3,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
217877_s_at	GC-rich promoter binding protein 1 like 1(GPBP1L1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,						Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Vasculin-like protein 1,modified residue,sequence conflict,sequence variant,
210175_at, 216305_s_at	GC-rich sequence DNA-binding factor 2(GCFC2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000245~spliceosomal complex assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0071008~U2-type post-mRNA release spliceosomal complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR012890:GC-rich sequence DNA-binding factor,IPR022783:GC-rich sequence DNA-binding factor domain,					Alternative splicing,Coiled coil,Complete proteome,DNA-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:GC-rich sequence DNA-binding factor,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,
212139_at, 216232_s_at	GCN1, eIF2 alpha kinase activator homolog(GCN1)	Homo sapiens			Energy production and conversion,	GO:0006412~translation,GO:0006417~regulation of translation,GO:0033674~positive regulation of kinase activity,GO:0034198~cellular response to amino acid starvation,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0045859~regulation of protein kinase activity,GO:0098609~cell-cell adhesion,GO:1990253~cellular response to leucine starvation,	GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0008135~translation factor activity, RNA binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR026827:Proteasome component ECM29/Translational activator GCN1,					Acetylation,Activator,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Stress response,Translation regulation,	chain:Translational activator GCN1,modified residue,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 12,repeat:HEAT 13,repeat:HEAT 14,repeat:HEAT 15,repeat:HEAT 16,repeat:HEAT 17,repeat:HEAT 18,repeat:HEAT 19,repeat:HEAT 2,repeat:HEAT 20,repeat:HEAT 21,repeat:HEAT 22,repeat:HEAT 23,repeat:HEAT 24,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,sequence variant,
205696_s_at	GDNF family receptor alpha 1(GFRA1)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007166~cell surface receptor signaling pathway,GO:0007399~nervous system development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0016167~glial cell-derived neurotrophic factor receptor activity,	IPR003438:Glial cell line-derived neurotrophic factor receptor,IPR003503:Glial cell line-derived neurotrophic factor receptor, alpha 1,IPR016017:GDNF/GAS1,IPR017372:Glial cell line-derived neurotrophic factor receptor, alpha 1/2,			PIRSF038071:GDNF family receptor alpha,	SM00907:SM00907,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,	chain:GDNF family receptor alpha-1,compositionally biased region:Poly-Thr,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,signal peptide,splice variant,
205721_at, 205722_s_at	GDNF family receptor alpha 2(GFRA2)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007399~nervous system development,GO:0031953~negative regulation of protein autophosphorylation,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:1903263~positive regulation of serine phosphorylation of STAT3 protein,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,GO:0031225~anchored component of membrane,	GO:0004872~receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0016167~glial cell-derived neurotrophic factor receptor activity,	IPR003438:Glial cell line-derived neurotrophic factor receptor,IPR003504:Glial cell line-derived neurotrophic factor receptor alpha 2,IPR016017:GDNF/GAS1,IPR017372:Glial cell line-derived neurotrophic factor receptor, alpha 1/2,			PIRSF038071:GDNF family receptor alpha,	SM00907:SM00907,	Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,	chain:GDNF family receptor alpha-2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,
214479_at	GDNF family receptor alpha 3(GFRA3)	Homo sapiens				GO:0000165~MAPK cascade,GO:0001764~neuron migration,GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007422~peripheral nervous system development,GO:0043547~positive regulation of GTPase activity,GO:0048485~sympathetic nervous system development,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0031225~anchored component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0008046~axon guidance receptor activity,	IPR003438:Glial cell line-derived neurotrophic factor receptor,IPR003505:Glial cell line-derived neurotrophic factor receptor, alpha 3,IPR016017:GDNF/GAS1,				SM00907:SM00907,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Receptor,Reference proteome,Signal,	chain:GDNF family receptor alpha-3,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,strand,turn,
221199_at	GDNF family receptor alpha 4(GFRA4)	Homo sapiens				GO:0000165~MAPK cascade,GO:0030279~negative regulation of ossification,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0043547~positive regulation of GTPase activity,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0016167~glial cell-derived neurotrophic factor receptor activity,	IPR003438:Glial cell line-derived neurotrophic factor receptor,IPR016017:GDNF/GAS1,				SM00907:SM00907,	Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Receptor,Reference proteome,Secreted,Signal,	chain:GDNF family receptor alpha-4,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,propeptide:Removed in mature form,signal peptide,splice variant,
201864_at	GDP dissociation inhibitor 1(GDI1)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0032482~Rab protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0050771~negative regulation of axonogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051592~response to calcium ion,GO:0055114~oxidation-reduction process,GO:0090315~negative regulation of protein targeting to membrane,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030496~midbody,GO:0043005~neuron projection,GO:0043209~myelin sheath,GO:0043234~protein complex,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005093~Rab GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0017137~Rab GTPase binding,	IPR000806:Rab GDI protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,		300849~Mental retardation, X-linked 41,			Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Golgi apparatus,GTPase activation,Mental retardation,Proteomics identification,Reference proteome,	chain:Rab GDP dissociation inhibitor alpha,modified residue,sequence conflict,sequence variant,
200008_s_at, 200009_at	GDP dissociation inhibitor 2(GDI2)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0055114~oxidation-reduction process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005093~Rab GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,	IPR000806:Rab GDI protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,GTPase activation,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Rab GDP dissociation inhibitor beta,modified residue,sequence conflict,
204875_s_at, 214106_s_at	GDP-mannose 4,6-dehydratase(GMDS)	Homo sapiens				GO:0007219~Notch signaling pathway,GO:0019673~GDP-mannose metabolic process,GO:0042351~'de novo' GDP-L-fucose biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008446~GDP-mannose 4,6-dehydratase activity,GO:0042802~identical protein binding,GO:0070401~NADP+ binding,	IPR006368:GDP-mannose 4,6-dehydratase,IPR016040:NAD(P)-binding domain,	hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Lyase,NADP,Phosphoprotein,Reference proteome,	active site:Nucleophile,binding site:NADP,chain:GDP-mannose 4,6 dehydratase,helix,modified residue,sequence conflict,strand,turn,
218070_s_at	GDP-mannose pyrophosphorylase A(GMPPA)	Homo sapiens				GO:0009058~biosynthetic process,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,	IPR001451:Bacterial transferase hexapeptide repeat,IPR005835:Nucleotidyl transferase,IPR011004:Trimeric LpxA-like,IPR018357:Hexapeptide transferase, conserved site,	hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,	615510~Alacrima, achalasia, and mental retardation syndrome,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Mental retardation,Polymorphism,Proteomics identification,Reference proteome,	chain:Mannose-1-phosphate guanyltransferase alpha,sequence conflict,sequence variant,splice variant,
219920_s_at	GDP-mannose pyrophosphorylase B(GMPPB)	Homo sapiens				GO:0009058~biosynthetic process,GO:0009298~GDP-mannose biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0004475~mannose-1-phosphate guanylyltransferase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0016779~nucleotidyltransferase activity,	IPR001451:Bacterial transferase hexapeptide repeat,IPR005835:Nucleotidyl transferase,IPR011004:Trimeric LpxA-like,IPR018357:Hexapeptide transferase, conserved site,	hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,	615350~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14,615351~Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14,615352~Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14,			Alternative splicing,Complete proteome,Congenital muscular dystrophy,Cytoplasm,Disease mutation,Dystroglycanopathy,GTP-binding,Limb-girdle muscular dystrophy,Nucleotide-binding,Nucleotidyltransferase,Polymorphism,Reference proteome,Transferase,	chain:Mannose-1-phosphate guanyltransferase beta,sequence variant,splice variant,
218913_s_at	GEM interacting protein(GMIP)	Homo sapiens				GO:0034260~negative regulation of GTPase activity,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000198:Rho GTPase-activating protein domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008936:Rho GTPase activation protein,				SM00109:C1,SM00324:RhoGAP,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,GTPase activation,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:GEM-interacting protein,compositionally biased region:Poly-Arg,compositionally biased region:Pro-rich,domain:Rho-GAP,modified residue,sequence conflict,sequence variant,zinc finger region:Phorbol-ester/DAG-type,
220058_at	GID complex subunit 4 homolog(GID4)	Homo sapiens							IPR018618:Vacuolar import/degradation protein Vid24,					Complete proteome,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C17orf39,compositionally biased region:Pro-rich,sequence conflict,
218448_at	GID complex subunit 8 homolog(GID8)	Homo sapiens					GO:0005654~nucleoplasm,GO:0030054~cell junction,		IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR013144:CRA domain,IPR024964:CTLH/CRA C-terminal to LisH motif domain,				SM00667:LisH,SM00668:CTLH,SM00757:CRA,	Coiled coil,Complete proteome,Nucleus,Reference proteome,	chain:Protein C20orf11,domain:CTLH,domain:LisH,sequence conflict,
218805_at, 215352_at, 64064_at	GIMAP1-GIMAP5 readthrough(GIMAP1-GIMAP5)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005525~GTP binding,	IPR006703:AIG1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
206102_at	GINS complex subunit 1(GINS1)	Homo sapiens				GO:0001833~inner cell mass cell proliferation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0032508~DNA duplex unwinding,GO:1902983~DNA strand elongation involved in mitotic DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0043138~3'-5' DNA helicase activity,	IPR005339:GINS complex, subunit Psf1,					3D-structure,Complete proteome,DNA replication,Nucleus,Polymorphism,Reference proteome,	chain:DNA replication complex GINS protein PSF1,helix,sequence variant,strand,
221521_s_at	GINS complex subunit 2(GINS2)	Homo sapiens				GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,GO:0032508~DNA duplex unwinding,GO:1902975~mitotic DNA replication initiation,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031298~replication fork protection complex,	GO:0005515~protein binding,GO:0043138~3'-5' DNA helicase activity,	IPR007257:GINS complex, subunit Psf2,IPR021151:GINS complex,			PIRSF028998:GINS complex, PSF2 component,		3D-structure,Acetylation,Complete proteome,DNA replication,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DNA replication complex GINS protein psf2,helix,modified residue,strand,
45633_at, 218719_s_at	GINS complex subunit 3(GINS3)	Homo sapiens				GO:0006260~DNA replication,GO:0006271~DNA strand elongation involved in DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,		IPR010492:GINS complex, subunit Psf3,IPR021151:GINS complex,					3D-structure,Alternative splicing,Complete proteome,DNA replication,Nucleus,Reference proteome,	chain:DNA replication complex GINS protein PSF3,helix,region of interest:Not essential for folding and stability of GINS complex, but may regulate accessibility to the central complex pore,splice variant,strand,turn,
211767_at	GINS complex subunit 4(GINS4)	Homo sapiens				GO:0000727~double-strand break repair via break-induced replication,GO:0001833~inner cell mass cell proliferation,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0032508~DNA duplex unwinding,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031298~replication fork protection complex,	GO:0005515~protein binding,GO:0043138~3'-5' DNA helicase activity,	IPR008591:GINS complex, subunit Sld5,IPR021151:GINS complex,			PIRSF007764:GINS complex, Sld5 component,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA replication,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:DNA replication complex GINS protein SLD5,helix,region of interest:Important for GINS complex assembly,splice variant,strand,
207525_s_at	GIPC PDZ domain containing family member 1(GIPC1)	Homo sapiens				GO:0006605~protein targeting,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0014047~glutamate secretion,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0031647~regulation of protein stability,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032467~positive regulation of cytokinesis,GO:0043542~endothelial cell migration,GO:0048167~regulation of synaptic plasticity,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005938~cell cortex,GO:0008021~synaptic vesicle,GO:0012506~vesicle membrane,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0017022~myosin binding,GO:0030165~PDZ domain binding,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,IPR017379:Uncharacterised conserved protein UCP038083, PDZ,			PIRSF038083:uncharacterized protein with PDZ domain, GIPC type,	SM00228:PDZ,	Alternative splicing,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:PDZ domain-containing protein GIPC1,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:PDZ,
219970_at	GIPC PDZ domain containing family member 2(GIPC2)	Homo sapiens					GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR017379:Uncharacterised conserved protein UCP038083, PDZ,			PIRSF038083:uncharacterized protein with PDZ domain, GIPC type,	SM00228:PDZ,	3D-structure,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,	chain:PDZ domain-containing protein GIPC2,domain:PDZ,helix,sequence variant,strand,
218030_at	GIT ArfGAP 1(GIT1)	Homo sapiens				GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0032465~regulation of cytokinesis,GO:0043547~positive regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016235~aggresome,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR002110:Ankyrin repeat,IPR013724:Spa2 homology (SHD) of GIT,IPR020683:Ankyrin repeat-containing domain,IPR022018:G protein-coupled receptor kinase-interacting protein 1 C term,	hsa04144:Endocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,			SM00105:ArfGap,SM00248:ANK,SM00555:GIT,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Cytoplasm,GTPase activation,Kinase,Metal-binding,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Transferase,Zinc,Zinc-finger,	chain:ARF GTPase-activating protein GIT1,domain:Arf-GAP,modified residue,region of interest:ARHGEF6-binding,region of interest:Interaction with PXN and TGFB1I1,region of interest:PTK2-binding,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,splice variant,zinc finger region:C4-type,
204982_at, 209876_at	GIT ArfGAP 2(GIT2)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,		GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:0048266~behavioral response to pain,	GO:0005654~nucleoplasm,GO:0005925~focal adhesion,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR002110:Ankyrin repeat,IPR013724:Spa2 homology (SHD) of GIT,IPR020683:Ankyrin repeat-containing domain,IPR022018:G protein-coupled receptor kinase-interacting protein 1 C term,	hsa04144:Endocytosis,			SM00105:ArfGap,SM00248:ANK,SM00555:GIT,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,GTPase activation,Kinase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Transferase,Zinc,Zinc-finger,	chain:ARF GTPase-activating protein GIT2,domain:Arf-GAP,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,zinc finger region:C4-type,
206920_s_at, 206921_at	GLE1, RNA export mediator(GLE1)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0006446~regulation of translational initiation,GO:0006449~regulation of translational termination,GO:0015031~protein transport,GO:0016973~poly(A)+ mRNA export from nucleus,	GO:0005615~extracellular space,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0044614~nuclear pore cytoplasmic filaments,	GO:0000822~inositol hexakisphosphate binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0031369~translation initiation factor binding,GO:0042802~identical protein binding,	IPR012476:GLE1-like,		253310~Lethal congenital contracture syndrome 1,611890~Arthrogryposis, lethal, with anterior horn cell disease,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transport,	chain:Nucleoporin GLE1,modified residue,region of interest:Interaction with NUP155,region of interest:Interaction with NUPL2,region of interest:Mediates the shuttling between the nucleus and the cytoplasm,sequence conflict,sequence variant,splice variant,
206646_at	GLI family zinc finger 1(GLI1)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0007224~smoothened signaling pathway,GO:0007283~spermatogenesis,GO:0007418~ventral midline development,GO:0008284~positive regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009611~response to wounding,GO:0009913~epidermal cell differentiation,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0021696~cerebellar cortex morphogenesis,GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,GO:0021983~pituitary gland development,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0045667~regulation of osteoblast differentiation,GO:0045740~positive regulation of DNA replication,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048546~digestive tract morphogenesis,GO:0060032~notochord regression,GO:0060070~canonical Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097421~liver regeneration,GO:2000345~regulation of hepatocyte proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005930~axoneme,GO:0043231~intracellular membrane-bounded organelle,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,			SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein GLI1,compositionally biased region:Asp/Glu-rich (acidic),helix,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
208057_s_at, 207034_s_at	GLI family zinc finger 2(GLI2)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,	Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0002062~chondrocyte differentiation,GO:0002076~osteoblast development,GO:0006366~transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0007411~axon guidance,GO:0007418~ventral midline development,GO:0007442~hindgut morphogenesis,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009913~epidermal cell differentiation,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0021508~floor plate formation,GO:0021513~spinal cord dorsal/ventral patterning,GO:0021517~ventral spinal cord development,GO:0021696~cerebellar cortex morphogenesis,GO:0021775~smoothened signaling pathway involved in ventral spinal cord interneuron specification,GO:0021776~smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0021983~pituitary gland development,GO:0030324~lung development,GO:0030879~mammary gland development,GO:0030902~hindbrain development,GO:0032331~negative regulation of chondrocyte differentiation,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0035295~tube development,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045666~positive regulation of neuron differentiation,GO:0045740~positive regulation of DNA replication,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048566~embryonic digestive tract development,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048754~branching morphogenesis of an epithelial tube,GO:0060032~notochord regression,GO:0060513~prostatic bud formation,GO:0060603~mammary gland duct morphogenesis,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0071407~cellular response to organic cyclic compound,GO:0090103~cochlea morphogenesis,GO:0098586~cellular response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005930~axoneme,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0031512~motile primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04340:Hedgehog signaling pathway,hsa04390:Hippo signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	610829~Holoprosencephaly-9,615849~Culler-Jones syndrome,		SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,DNA-binding,Holoprosencephaly,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein GLI2,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
205201_at	GLI family zinc finger 3(GLI3)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,	Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0002052~positive regulation of neuroblast proliferation,GO:0006366~transcription from RNA polymerase II promoter,GO:0007224~smoothened signaling pathway,GO:0007411~axon guidance,GO:0007442~hindgut morphogenesis,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0016485~protein processing,GO:0021631~optic nerve morphogenesis,GO:0021766~hippocampus development,GO:0021775~smoothened signaling pathway involved in ventral spinal cord interneuron specification,GO:0021776~smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,GO:0021798~forebrain dorsal/ventral pattern formation,GO:0021819~layer formation in cerebral cortex,GO:0021861~forebrain radial glial cell differentiation,GO:0022018~lateral ganglionic eminence cell proliferation,GO:0030318~melanocyte differentiation,GO:0030324~lung development,GO:0032332~positive regulation of chondrocyte differentiation,GO:0033077~T cell differentiation in thymus,GO:0035108~limb morphogenesis,GO:0042060~wound healing,GO:0042307~positive regulation of protein import into nucleus,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043585~nose morphogenesis,GO:0043586~tongue development,GO:0043627~response to estrogen,GO:0045060~negative thymic T cell selection,GO:0045665~negative regulation of neuron differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0048557~embryonic digestive tract morphogenesis,GO:0048566~embryonic digestive tract development,GO:0048568~embryonic organ development,GO:0048589~developmental growth,GO:0048593~camera-type eye morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048709~oligodendrocyte differentiation,GO:0060021~palate development,GO:0060364~frontal suture morphogenesis,GO:0060366~lambdoid suture morphogenesis,GO:0060367~sagittal suture morphogenesis,GO:0060594~mammary gland specification,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0060840~artery development,GO:0060873~anterior semicircular canal development,GO:0060875~lateral semicircular canal development,GO:0061005~cell differentiation involved in kidney development,GO:0070242~thymocyte apoptotic process,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1903010~regulation of bone development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005929~cilium,GO:0005930~axoneme,GO:0016592~mediator complex,GO:0016607~nuclear speck,GO:0017053~transcriptional repressor complex,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0035035~histone acetyltransferase binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	146510~Pallister-Hall syndrome,174200~Polydactyly, postaxial, types A1 and B,174700~Polydactyly, preaxial, type IV,175700~Greig cephalopolysyndactyly syndrome,241800~Hypothalamic hamartomas, somatic,		SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Cell projection,Cilium,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein GLI3,compositionally biased region:Asp/Glu-rich (acidic),modified residue,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
204221_x_at, 204222_s_at, 214085_x_at	GLI pathogenesis related 1(GLIPR1)	Homo sapiens					GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR001283:Allergen V5/Tpx-1-related,IPR002413:Ves allergen,IPR014044:CAP domain,IPR018244:Allergen V5/Tpx-1-related, conserved site,				SM00198:SCP,	3D-structure,Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Glioma pathogenesis-related protein 1,sequence conflict,sequence variant,signal peptide,transmembrane region,
213208_at, 38892_at	GLTSCR1 like(GLTSCR1L)	Homo sapiens												Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein KIAA0240,sequence conflict,
215891_s_at, 33646_g_at, 212737_at, 35820_at, 215890_at, 209727_at	GM2 ganglioside activator(GM2A)	Homo sapiens				GO:0006687~glycosphingolipid metabolic process,GO:0006689~ganglioside catabolic process,GO:0006869~lipid transport,GO:0007611~learning or memory,GO:0009313~oligosaccharide catabolic process,GO:0019915~lipid storage,GO:0050885~neuromuscular process controlling balance,GO:0051345~positive regulation of hydrolase activity,	GO:0005739~mitochondrion,GO:0005889~hydrogen:potassium-exchanging ATPase complex,GO:0009898~cytoplasmic side of plasma membrane,GO:0043202~lysosomal lumen,GO:0045179~apical cortex,GO:0070062~extracellular exosome,	GO:0005319~lipid transporter activity,GO:0008047~enzyme activator activity,GO:0016004~phospholipase activator activity,GO:0030290~sphingolipid activator protein activity,GO:0032428~beta-N-acetylgalactosaminidase activity,	IPR003172:MD-2-related lipid-recognition (ML) domain,	hsa04142:Lysosome,	272750~GM2-gangliosidosis, AB variant,		SM00737:ML,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Gangliosidosis,Glycoprotein,Hydrolase,Lipid metabolism,Lysosome,Polymorphism,Proteomics identification,Reference proteome,Signal,Sphingolipid metabolism,	chain:Ganglioside GM2 activator,chain:Ganglioside GM2 activator isoform short,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
214157_at, 217057_s_at, 214548_x_at, 200981_x_at, 217058_at, 200780_x_at, 212273_x_at, 217673_x_at, 211858_x_at	GNAS complex locus(GNAS)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_bArr-mapkPathway:Role of -arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:-arrestins in GPCR Desensitization,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cftrPathway:Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cremPathway:Regulation of Spermatogenesis by CREM,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_plcePathway:Phospholipase C-epsilon pathway,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,		GO:0001894~tissue homeostasis,GO:0001958~endochondral ossification,GO:0003091~renal water homeostasis,GO:0006112~energy reserve metabolic process,GO:0006306~DNA methylation,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007565~female pregnancy,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0009306~protein secretion,GO:0009966~regulation of signal transduction,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0035116~embryonic hindlimb morphogenesis,GO:0035264~multicellular organism growth,GO:0040015~negative regulation of multicellular organism growth,GO:0040032~post-embryonic body morphogenesis,GO:0042493~response to drug,GO:0043547~positive regulation of GTPase activity,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045669~positive regulation of osteoblast differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0046907~intracellular transport,GO:0048589~developmental growth,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0050796~regulation of insulin secretion,GO:0050890~cognition,GO:0051216~cartilage development,GO:0060348~bone development,GO:0060789~hair follicle placode formation,GO:0070527~platelet aggregation,GO:0071107~response to parathyroid hormone,GO:0071377~cellular response to glucagon stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071514~genetic imprinting,GO:0071870~cellular response to catecholamine stimulus,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,GO:2000828~regulation of parathyroid hormone secretion,	GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030133~transport vesicle,GO:0030425~dendrite,GO:0031224~intrinsic component of membrane,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031698~beta-2 adrenergic receptor binding,GO:0031748~D1 dopamine receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0035255~ionotropic glutamate receptor binding,GO:0046872~metal ion binding,GO:0051430~corticotropin-releasing hormone receptor 1 binding,	IPR000367:G-protein alpha subunit, group S,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR009434:Neuroendocrine-specific golgi P55,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04724:Glutamatergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05110:Vibrio cholerae infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05414:Dilated cardiomyopathy,	102200~Acromegaly, somatic,103580~Pseudohypoparathyroidism Ia,166350~Osseous heteroplasia, progressive,219080~ACTH-independent macronodular adrenal hyperplasia,603233~Pseudohypoparathyroidism Ib,612462~Pseudohypoparathyroidism Ic,612463~Pseudopseudohypoparathyroidism,McCune-Albright syndrome, somatic, mosaic 174800~McCune-Albright syndrome, somatic, mosaic 174800,		SM00275:SM00275,	3D-structure,ADP-ribosylation,Alternative splicing,Cell membrane,Cell projection,Cleavage on pair of basic residues,Coiled coil,Complete proteome,Cushing syndrome,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Glycoprotein,GTP-binding,Isopeptide bond,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Obesity,Palmitate,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Proto-oncogene,Reference proteome,Secreted,Signal,Transducer,Ubl conjugation,	chain:alpha subunit of GsGTP binding protein,chain:Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,chain:Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,chain:Neuroendocrine secretory protein 55,chain:Protein ALEX,compositionally biased region:Ala-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),lipid moiety-binding region:N-palmitoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,peptide:GPIPIRRH peptide,peptide:LHAL tetrapeptide,sequence conflict,sequence variant,splice variant,
220171_x_at	GPALPP motifs containing 1(GPALPP1)	Homo sapiens							IPR022226:Protein of unknown function DUF3752,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA1704,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Ser,modified residue,sequence conflict,splice variant,
209313_at	GPN-loop GTPase 1(GPN1)	Homo sapiens				GO:0044376~RNA polymerase II complex import to nucleus,GO:1990022~RNA polymerase III complex localization to nucleus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR003593:AAA+ ATPase domain,IPR004130:Uncharacterised protein family, ATP binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,GTP-binding,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:GPN-loop GTPase 1,modified residue,nucleotide phosphate-binding region:GTP (Pootential),
218799_at	GPN-loop GTPase 2(GPN2)	Homo sapiens				GO:0044376~RNA polymerase II complex import to nucleus,GO:1990022~RNA polymerase III complex localization to nucleus,	GO:0005737~cytoplasm,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR004130:Uncharacterised protein family, ATP binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Complete proteome,GTP-binding,Hydrolase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:GPN-loop GTPase 2,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
218461_at	GPN-loop GTPase 3(GPN3)	Homo sapiens				GO:0044376~RNA polymerase II complex import to nucleus,GO:1990022~RNA polymerase III complex localization to nucleus,	GO:0005622~intracellular,GO:0043234~protein complex,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR004130:Uncharacterised protein family, ATP binding,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Hydrolase,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:GPN-loop GTPase 3,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,
212906_at	GRAM domain containing 1B(GRAMD1B)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR004182:GRAM,				SM00568:GRAM,	Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:GRAM domain-containing protein 1B,domain:GRAM,modified residue,splice variant,transmembrane region,
219313_at	GRAM domain containing 1C(GRAMD1C)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR004182:GRAM,				SM00568:GRAM,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:GRAM domain-containing protein 1C,domain:GRAM,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
218706_s_at	GRAM domain containing 3(GRAMD3)	Homo sapiens					GO:0005881~cytoplasmic microtubule,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004182:GRAM,				SM00568:GRAM,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:GRAM domain-containing protein 3,domain:GRAM,modified residue,sequence conflict,
212856_at	GRAM domain containing 4(GRAMD4)	Homo sapiens				GO:0006915~apoptotic process,	GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,		IPR004182:GRAM,				SM00568:GRAM,	Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:GRAM domain-containing protein 4,chain:TSC22 domain family protein 3,domain:GRAM,domain:Leucine-zipper,modified residue,region of interest:AP1-binding,sequence variant,splice variant,transmembrane region,
212261_at, 212260_at	GRB10 interacting GYF protein 2(GIGYF2)	Homo sapiens				GO:0007631~feeding behavior,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0017148~negative regulation of translation,GO:0021522~spinal cord motor neuron differentiation,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0035264~multicellular organism growth,GO:0044267~cellular protein metabolic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048873~homeostasis of number of cells within a tissue,GO:0050881~musculoskeletal movement,GO:0050885~neuromuscular process controlling balance,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003169:GYF,		607688~Parkinson disease 11,		SM00444:GYF,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Methylation,Neurodegeneration,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:PERQ amino acid-rich with GYF domain- containing protein 2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:GYF,modified residue,region of interest:Required for GRB10-binding,sequence conflict,sequence variant,splice variant,
214987_at, 207112_s_at	GRB2 associated binding protein 1(GAB1)	Homo sapiens		h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0006979~response to oxidative stress,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007257~activation of JUN kinase activity,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0008544~epidermis development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0030334~regulation of cell migration,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038128~ERBB2 signaling pathway,GO:0046854~phosphatidylinositol phosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0060711~labyrinthine layer development,GO:0070102~interleukin-6-mediated signaling pathway,	GO:0005829~cytosol,	GO:0004871~signal transducer activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,			SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GRB2-associated-binding protein 1,compositionally biased region:Pro-rich,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,
203853_s_at	GRB2 associated binding protein 2(GAB2)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0030316~osteoclast differentiation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043306~positive regulation of mast cell degranulation,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,	hsa04014:Ras signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04380:Osteoclast differentiation,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05220:Chronic myeloid leukemia,			SM00233:PH,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GRB2-associated-binding protein 2,domain:PH,helix,modified residue,mutagenesis site,sequence variant,short sequence motif:SH3-binding,splice variant,
219377_at	GRB2 associated regulator of MAPK1 subtype 1(GAREM1)	Homo sapiens				GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0051781~positive regulation of cell division,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071364~cellular response to epidermal growth factor stimulus,	GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0070064~proline-rich region binding,	IPR013761:Sterile alpha motif/pointed domain,IPR025946:CABIT domain,					3D-structure,Alternative splicing,Complete proteome,Mitogen,Phosphoprotein,Polymorphism,Reference proteome,	chain:Protein FAM59A,compositionally biased region:Pro-rich,domain:SAM,helix,modified residue,sequence variant,splice variant,turn,
208406_s_at	GRB2-related adaptor protein 2(GRAP2)	Homo sapiens				GO:0007265~Ras protein signal transduction,GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,GO:0031295~T cell costimulation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0050852~T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,	hsa04660:T cell receptor signaling pathway,			SM00252:SH2,SM00326:SH3,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,	chain:GRB2-related adapter protein 2,domain:SH2,domain:SH3 1,domain:SH3 2,modified residue,sequence variant,
206620_at	GRB2-related adaptor protein(GRAP)	Homo sapiens				GO:0007265~Ras protein signal transduction,GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,				SM00252:SH2,SM00326:SH3,	Complete proteome,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,	chain:GRB2-related adapter protein,domain:SH2,domain:SH3 1,domain:SH3 2,
212244_at, 212243_at	GRINL1A complex locus 1(GCOM1)	Homo sapiens				GO:0035556~intracellular signal transduction,	GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030864~cortical actin cytoskeleton,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031674~I band,		IPR026213:DNA-directed RNA polymerase II subunit GRINL1,					3D-structure,Alternative splicing,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Polymorphism,Reference proteome,Signal,	chain:GRINL1A complex locus protein 1,chain:Protein GRINL1A,chain:Protein GRINL1A, isoforms 4/5,chain:Protein GRINL1B,compositionally biased region:Poly-Arg,modified residue,sequence variant,signal peptide,splice variant,
218912_at	GRIP and coiled-coil domain containing 1(GCC1)	Homo sapiens				GO:0000042~protein targeting to Golgi,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR000237:GRIP,				SM00755:Grip,	Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Polymorphism,Reference proteome,	chain:GRIP and coiled-coil domain-containing protein 1,domain:GRIP,sequence variant,
202832_at	GRIP and coiled-coil domain containing 2(GCC2)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0006622~protein targeting to lysosome,GO:0031023~microtubule organizing center organization,GO:0034067~protein localization to Golgi apparatus,GO:0034453~microtubule anchoring,GO:0034499~late endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,GO:0070861~regulation of protein exit from endoplasmic reticulum,GO:0071955~recycling endosome to Golgi transport,GO:0090161~Golgi ribbon formation,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:GRIP and coiled-coil domain-containing protein 2,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
221072_at	GSN antisense RNA 1(GSN-AS1)	Homo sapiens		h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_rhoPathway:Rho cell motility signaling pathway,										Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C9orf31,
218412_s_at	GTF2I repeat domain containing 1(GTF2IRD1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0014886~transition between slow and fast fiber,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,	IPR004212:GTF2I-like repeat,IPR016659:Transcription factor II-I,	hsa03022:Basal transcription factors,hsa04022:cGMP-PKG signaling pathway,hsa05168:Herpes simplex infection,		PIRSF016441:general transcription factor II-I,		3D-structure,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Williams-Beuren syndrome,	chain:General transcription factor II-I repeat domain-containing protein 1,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,repeat:GTF2I-like 1,repeat:GTF2I-like 2,repeat:GTF2I-like 3,repeat:GTF2I-like 4,repeat:GTF2I-like 5,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
215569_at	GTF2I repeat domain containing 2B(GTF2IRD2B)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,	IPR004212:GTF2I-like repeat,IPR012337:Ribonuclease H-like domain,					3D-structure,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Williams-Beuren syndrome,	chain:General transcription factor II-I repeat domain-containing protein 2B,helix,repeat:GTF2I-like 1,repeat:GTF2I-like 2,sequence conflict,splice variant,strand,turn,
205276_s_at, 205274_at, 219357_at, 205275_at	GTP binding protein 1(GTPBP1)	Homo sapiens			General function prediction only,	GO:0006414~translational elongation,GO:0006955~immune response,GO:0007165~signal transduction,GO:0061014~positive regulation of mRNA catabolic process,	GO:0000177~cytoplasmic exosome (RNase complex),GO:0005622~intracellular,GO:0005829~cytosol,GO:0016020~membrane,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GTP-binding protein 1,compositionally biased region:Poly-Ala,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,
221050_s_at	GTP binding protein 2(GTPBP2)	Homo sapiens			General function prediction only,	GO:0006414~translational elongation,	GO:0005622~intracellular,GO:0043231~intracellular membrane-bounded organelle,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR000795:Elongation factor, GTP-binding domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:GTP-binding protein 2,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
213835_x_at	GTP binding protein 3 (mitochondrial)(GTPBP3)	Homo sapiens				GO:0002098~tRNA wobble uridine modification,GO:0030488~tRNA methylation,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR004520:tRNA modification GTPase MnmE,IPR005225:Small GTP-binding protein domain,IPR006073:GTP binding domain,IPR018948:GTP-binding protein TrmE, N-terminal,IPR025867:tRNA modification GTPase MnmE C-terminal domain,IPR027266:GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1,IPR027368:tRNA modification GTPase MnmE domain 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		616198~Combined oxidative phosphorylation deficiency 23,			Alternative splicing,Cardiomyopathy,Complete proteome,Disease mutation,GTP-binding,Mitochondrion,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,tRNA processing,	chain:tRNA modification GTPase GTPBP3, mitochondrial,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,transit peptide:Mitochondrion,
218238_at, 218239_s_at, 217631_at	GTP binding protein 4(GTPBP4)	Homo sapiens			General function prediction only,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001649~osteoblast differentiation,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0022408~negative regulation of cell-cell adhesion,GO:0030336~negative regulation of cell migration,GO:0031397~negative regulation of protein ubiquitination,GO:0033342~negative regulation of collagen binding,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR005225:Small GTP-binding protein domain,IPR006073:GTP binding domain,IPR010674:Nucleolar GTP-binding protein 1, Rossman-fold domain,IPR012973:NOG, C-terminal,IPR024926:Nucleolar GTP-binding protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF038919:nucleolar GTP-binding protein 1,		Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,GTP-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,	chain:Nucleolar GTP-binding protein 1,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
203314_at	GTP binding protein 6 (putative)(GTPBP6)	Homo sapiens			General function prediction only,		GO:0005737~cytoplasm,	GO:0005525~GTP binding,GO:0043022~ribosome binding,GO:0046872~metal ion binding,	IPR006073:GTP binding domain,IPR016496:GTPase HflX,IPR025121:GTPase HflX N-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Coiled coil,Complete proteome,GTP-binding,Magnesium,Metal-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Putative GTP-binding protein 6,nucleotide phosphate-binding region:GTP,sequence conflict,
221046_s_at	GTP binding protein 8 (putative)(GTPBP8)	Homo sapiens					GO:0005739~mitochondrion,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR006073:GTP binding domain,IPR019987:GTP-binding protein, ribosome biogenesis, YsxC,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:GTP-binding protein 8,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,
204472_at	GTP binding protein overexpressed in skeletal muscle(GEM)	Homo sapiens				GO:0006955~immune response,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0051276~chromosome organization,GO:0051310~metaphase plate congression,	GO:0005634~nucleus,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,	GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR017358:Small GTPase superfamily, GEM/REM/Rad,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF038017:GTP-binding protein, GEM type,		3D-structure,Calmodulin-binding,Cell membrane,Complete proteome,GTP-binding,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GTP-binding protein GEM,helix,nucleotide phosphate-binding region:GTP,region of interest:Calmodulin-binding,sequence conflict,sequence variant,strand,turn,
204224_s_at	GTP cyclohydrolase 1(GCH1)	Homo sapiens				GO:0006729~tetrahydrobiopterin biosynthetic process,GO:0006809~nitric oxide biosynthetic process,GO:0008217~regulation of blood pressure,GO:0014916~regulation of lung blood pressure,GO:0032496~response to lipopolysaccharide,GO:0034341~response to interferon-gamma,GO:0034612~response to tumor necrosis factor,GO:0035998~7,8-dihydroneopterin 3'-triphosphate biosynthetic process,GO:0042311~vasodilation,GO:0042416~dopamine biosynthetic process,GO:0042559~pteridine-containing compound biosynthetic process,GO:0045776~negative regulation of blood pressure,GO:0046654~tetrahydrofolate biosynthetic process,GO:0048265~response to pain,GO:0050884~neuromuscular process controlling posture,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051066~dihydrobiopterin metabolic process,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,GO:2000121~regulation of removal of superoxide radicals,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,GO:0043234~protein complex,	GO:0003934~GTP cyclohydrolase I activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008270~zinc ion binding,GO:0030742~GTP-dependent protein binding,GO:0031369~translation initiation factor binding,GO:0042803~protein homodimerization activity,GO:0050662~coenzyme binding,	IPR001474:GTP cyclohydrolase I,IPR018234:GTP cyclohydrolase I, conserved site,IPR020602:GTP cyclohydrolase I/Nitrile oxidoreductase,	hsa00790:Folate biosynthesis,hsa01100:Metabolic pathways,	128230~Dystonia, DOPA-responsive, with or without hyperphenylalaninemia,233910~Hyperphenylalaninemia, BH4-deficient, B,			3D-structure,Allosteric enzyme,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Dystonia,GTP-binding,Hydrolase,Metal-binding,Nucleotide-binding,Nucleus,Parkinsonism,Phenylketonuria,Phosphoprotein,Polymorphism,Reference proteome,Tetrahydrobiopterin biosynthesis,Zinc,	chain:GTP cyclohydrolase 1,helix,metal ion-binding site:Zinc,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
204867_at	GTP cyclohydrolase I feedback regulator(GCHFR)	Homo sapiens				GO:0006809~nitric oxide biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0042133~neurotransmitter metabolic process,GO:0043105~negative regulation of GTP cyclohydrolase I activity,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051291~protein heterooligomerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0042470~melanosome,GO:0043234~protein complex,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0016597~amino acid binding,GO:0016787~hydrolase activity,GO:0030742~GTP-dependent protein binding,GO:0044549~GTP cyclohydrolase binding,	IPR009112:GTP cyclohydrolase I, feedback regulatory protein,					Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Membrane,Nucleus,Proteomics identification,Reference proteome,	chain:GTP cyclohydrolase 1 feedback regulatory protein,
212802_s_at, 212804_s_at, 214869_x_at	GTPase activating protein and VPS9 domains 1(GAPVD1)	Homo sapiens				GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0051223~regulation of protein transport,GO:0098609~cell-cell adhesion,	GO:0005768~endosome,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0032794~GTPase activating protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001936:Ras GTPase-activating protein,IPR003123:Vacuolar sorting protein 9,IPR008936:Rho GTPase activation protein,				SM00167:VPS9,	Alternative splicing,Complete proteome,Endocytosis,Endosome,GTPase activation,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,	chain:GTPase-activating protein and VPS9 domain-containing protein 1,domain:Ras-GAP,domain:VPS9,modified residue,sequence conflict,splice variant,
219243_at	GTPase, IMAP family member 4(GIMAP4)	Homo sapiens					GO:0005829~cytosol,	GO:0005525~GTP binding,	IPR006703:AIG1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Coiled coil,Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GTPase IMAP family member 4,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,
219777_at	GTPase, IMAP family member 6(GIMAP6)	Homo sapiens					GO:0005829~cytosol,	GO:0005525~GTP binding,	IPR006703:AIG1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:GTPase IMAP family member 6,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,
220577_at	GTPase, very large interferon inducible pseudogene 1(GVINP1)	Homo sapiens					GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005525~GTP binding,	IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Nucleus,Reference proteome,	chain:Interferon-induced very large GTPase 1,nucleotide phosphate-binding region:GTP,sequence conflict,
218884_s_at	GUF1 homolog, GTPase(GUF1)	Homo sapiens				GO:0006412~translation,GO:0045727~positive regulation of translation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0043022~ribosome binding,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR006297:Elongation factor 4,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009022:Elongation factor G, III-V domain,IPR013842:GTP-binding protein LepA, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Hydrolase,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleotide-binding,Polymorphism,Protein biosynthesis,Reference proteome,Transit peptide,	chain:GTP-binding protein GUF1 homolog,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
215913_s_at, 215915_at, 204237_at, 204235_s_at	GULP, engulfment adaptor PTB domain containing 1(GULP1)	Homo sapiens				GO:0006869~lipid transport,GO:0006911~phagocytosis, engulfment,GO:0006915~apoptotic process,GO:0007165~signal transduction,	GO:0005737~cytoplasm,	GO:0004871~signal transducer activity,	IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Lipid transport,Phagocytosis,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:PTB domain-containing engulfment adapter protein 1,domain:PID,modified residue,mutagenesis site,splice variant,
212432_at, 212434_at	GrpE like 1, mitochondrial(GRPEL1)	Homo sapiens				GO:0006457~protein folding,GO:0030150~protein import into mitochondrial matrix,GO:0050790~regulation of catalytic activity,	GO:0001405~presequence translocase-associated import motor,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0042803~protein homodimerization activity,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR000740:GrpE nucleotide exchange factor,IPR009012:GrpE nucleotide exchange factor, head,IPR013805:GrpE nucleotide exchange factor, coiled-coil,					Acetylation,Chaperone,Complete proteome,Mitochondrion,Reference proteome,Transit peptide,	chain:GrpE protein homolog 1, mitochondrial,modified residue,transit peptide:Mitochondrion,
212057_at, 212056_at	Gse1 coiled-coil protein(GSE1)	Homo sapiens						GO:0005515~protein binding,	IPR022207:Genetic suppressor element-like,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Genetic suppressor element 1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,
208886_at	H1 histone family member 0(H1F0)	Homo sapiens				GO:0006309~apoptotic DNA fragmentation,GO:0006334~nucleosome assembly,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005794~Golgi apparatus,GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00526:H15,	Acetylation,Alternative splicing,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,RNA editing,	chain:Histone H1.0,modified residue,region of interest:Globular,sequence conflict,sequence variant,
204805_s_at	H1 histone family member X(H1FX)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0098609~cell-cell adhesion,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005913~cell-cell adherens junction,	GO:0003677~DNA binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00526:H15,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,	chain:Histone H1x,modified residue,
214438_at	H2.0 like homeobox(HLX)	Homo sapiens			Transcription,	GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007519~skeletal muscle tissue development,GO:0008284~positive regulation of cell proliferation,GO:0030154~cell differentiation,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0046622~positive regulation of organ growth,GO:0048484~enteric nervous system development,GO:0048557~embryonic digestive tract morphogenesis,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Differentiation,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:H2.0-like homeobox protein,compositionally biased region:Poly-Gln,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,DNA-binding region:Homeobox,modified residue,sequence conflict,sequence variant,
214412_at	H2A histone family member B2(H2AFB2)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0006397~mRNA processing,	GO:0000788~nuclear nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0035327~transcriptionally active chromatin,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	Chromosome,Complete proteome,DNA-binding,mRNA processing,Nucleosome core,Nucleus,Reference proteome,	chain:Histone H2A-Bbd type 2/3,region of interest:Docking domain,
220936_s_at	H2A histone family member J(H2AFJ)	Homo sapiens				GO:0006342~chromatin silencing,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	3D-structure,Acetylation,Alternative splicing,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H2A.J,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,splice variant,
212205_at, 202487_s_at, 212206_s_at	H2A histone family member V(H2AFV)	Homo sapiens				GO:0006342~chromatin silencing,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	3D-structure,Acetylation,Alternative splicing,Chromosome,Complete proteome,DNA-binding,Nucleosome core,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H2A.v,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence variant,
212525_s_at, 213344_s_at, 212524_x_at, 205436_s_at	H2A histone family member X(H2AFX)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0000724~double-strand break repair via homologous recombination,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0010212~response to ionizing radiation,GO:0016032~viral process,GO:0021987~cerebral cortex development,GO:0045739~positive regulation of DNA repair,GO:0051321~meiotic cell cycle,GO:0071480~cellular response to gamma radiation,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0001673~male germ cell nucleus,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0035861~site of double-strand break,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	3D-structure,Acetylation,Cell cycle,Chromosome,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA-binding,Host-virus interaction,Isopeptide bond,Meiosis,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H2A.x,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,sequence conflict,short sequence motif:[ST]-Q motif,
214501_s_at, 207168_s_at, 214500_at	H2A histone family member Y(H2AFY)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0007549~dosage compensation,GO:0016569~covalent chromatin modification,GO:0019216~regulation of lipid metabolic process,GO:0033128~negative regulation of histone phosphorylation,GO:0034184~positive regulation of maintenance of mitotic sister chromatid cohesion,GO:0040029~regulation of gene expression, epigenetic,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0061086~negative regulation of histone H3-K27 methylation,GO:0061187~regulation of chromatin silencing at rDNA,GO:0071169~establishment of protein localization to chromatin,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902750~negative regulation of cell cycle G2/M phase transition,GO:1904815~negative regulation of protein localization to chromosome, telomeric region,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0001739~sex chromatin,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0035098~ESC/E(Z) complex,GO:0070062~extracellular exosome,	GO:0000182~rDNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0010385~double-stranded methylated DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR002589:Appr-1-p processing,IPR007125:Histone core,IPR009072:Histone-fold,IPR021171:Core histone macro-H2A,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,		PIRSF037942:core histone macro-H2A,	SM00414:H2A,SM00506:A1pp,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Core histone macro-H2A.1,compositionally biased region:Lys-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,domain:Histone H2A,domain:Macro,helix,modified residue,sequence conflict,splice variant,strand,turn,
218445_at	H2A histone family member Y2(H2AFY2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0007420~brain development,GO:0007549~dosage compensation,GO:0016569~covalent chromatin modification,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0071169~establishment of protein localization to chromatin,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0001740~Barr body,GO:0005654~nucleoplasm,GO:0035098~ESC/E(Z) complex,GO:0070062~extracellular exosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0031490~chromatin DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR002589:Appr-1-p processing,IPR007125:Histone core,IPR009072:Histone-fold,IPR021171:Core histone macro-H2A,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,		PIRSF037942:core histone macro-H2A,	SM00414:H2A,SM00506:A1pp,	3D-structure,Chromatin regulator,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Nucleosome core,Nucleus,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Core histone macro-H2A.2,compositionally biased region:Lys-rich,domain:Histone H2A,domain:Macro,modified residue,
213911_s_at, 200853_at	H2A histone family member Z(H2AFZ)	Homo sapiens				GO:0006342~chromatin silencing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071392~cellular response to estradiol stimulus,	GO:0000786~nucleosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,			SM00414:H2A,	3D-structure,Acetylation,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Reference proteome,Ubl conjugation,	chain:Histone H2A.Z,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,region of interest:Required for interaction with INCENP,turn,
208579_x_at	H2B histone family member S(H2BFS)	Homo sapiens				GO:0002227~innate immune response in mucosa,GO:0006334~nucleosome assembly,GO:0019731~antibacterial humoral response,GO:0021762~substantia nigra development,GO:0050830~defense response to Gram-positive bacterium,	GO:0000788~nuclear nucleosome,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,							chain:Histone H2B type F-S,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,
200080_s_at, 213826_s_at, 208755_x_at, 211940_x_at, 213828_x_at	H3 histone family member 3A(H3F3A)	Homo sapiens				GO:0000183~chromatin silencing at rDNA,GO:0001649~osteoblast differentiation,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006997~nucleus organization,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0007596~blood coagulation,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009725~response to hormone,GO:0030307~positive regulation of cell growth,GO:0031047~gene silencing by RNA,GO:0031508~pericentric heterochromatin assembly,GO:0031509~telomeric heterochromatin assembly,GO:0032200~telomere organization,GO:0035264~multicellular organism growth,GO:0042692~muscle cell differentiation,GO:0044267~cellular protein metabolic process,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0048477~oogenesis,GO:0090230~regulation of centromere complex assembly,GO:1902340~negative regulation of chromosome condensation,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0001740~Barr body,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H3.3,modified residue,sequence conflict,
207353_s_at	H6 family homeobox 1(HMX1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,		612109~Oculoauricular syndrome,		SM00389:HOX,	Cataract,Complete proteome,Developmental protein,DNA-binding,Homeobox,Microphthalmia,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeobox protein HMX1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,DNA-binding region:Homeobox,sequence conflict,short sequence motif:HMX family specific domain 1,short sequence motif:HMX family specific domain 2,
220071_x_at	HAUS augmin like complex subunit 2(HAUS2)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007067~mitotic nuclear division,GO:0031023~microtubule organizing center organization,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0070652~HAUS complex,		IPR026242:HAUS augmin-like complex subunit 2,					Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Polymorphism,Proteomics identification,Reference proteome,	chain:HAUS augmin-like complex subunit 2,sequence variant,splice variant,
210054_at	HAUS augmin like complex subunit 3(HAUS3)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007067~mitotic nuclear division,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0070652~HAUS complex,	GO:0005515~protein binding,	IPR026206:HAUS augmin-like complex subunit 3,					Acetylation,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Polymorphism,Proteomics identification,Reference proteome,	chain:HAUS augmin-like complex subunit 3,sequence variant,
213053_at, 213054_at, 36888_at	HAUS augmin like complex subunit 5(HAUS5)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007067~mitotic nuclear division,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0070652~HAUS complex,		IPR026215:HAUS augmin-like complex subunit 5,					Acetylation,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:HAUS augmin-like complex subunit 5,sequence variant,splice variant,
218602_s_at	HAUS augmin like complex subunit 6(HAUS6)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007067~mitotic nuclear division,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0070652~HAUS complex,		IPR026797:HAUS augmin-like complex subunit 6,					Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:HAUS augmin-like complex subunit 6,modified residue,sequence conflict,sequence variant,splice variant,
213334_x_at	HAUS augmin like complex subunit 7(HAUS7)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007067~mitotic nuclear division,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0070652~HAUS complex,	GO:0031996~thioesterase binding,						Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,	chain:HAUS augmin-like complex subunit 7,chain:Three prime repair exonuclease 2,helix,modified residue,sequence variant,splice variant,strand,turn,
209316_s_at, 209315_at, 209314_s_at	HBS1 like translational GTPase(HBS1L)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0006412~translation,GO:0006414~translational elongation,GO:0007165~signal transduction,GO:0032790~ribosome disassembly,	GO:0005622~intracellular,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR015033:Domain of unknown function DUF1916,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03015:mRNA surveillance pathway,hsa05134:Legionellosis,				Acetylation,Alternative splicing,Complete proteome,Elongation factor,GTP-binding,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HBS1-like protein,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,
208018_s_at	HCK proto-oncogene, Src family tyrosine kinase(HCK)	Homo sapiens		h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_vifPathway:HIV-1 defeats host-mediated resistance by CEM15,		GO:0002522~leukocyte migration involved in immune response,GO:0002758~innate immune response-activating signal transduction,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007498~mesoderm development,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0016032~viral process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030154~cell differentiation,GO:0030838~positive regulation of actin filament polymerization,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0043066~negative regulation of apoptotic process,GO:0043299~leukocyte degranulation,GO:0045728~respiratory burst after phagocytosis,GO:0046777~protein autophosphorylation,GO:0050690~regulation of defense response to virus by virus,GO:0050727~regulation of inflammatory response,GO:0050764~regulation of phagocytosis,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0071801~regulation of podosome assembly,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005901~caveola,GO:0005925~focal adhesion,GO:0030133~transport vesicle,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0042995~cell projection,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04062:Chemokine signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative initiation,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Exocytosis,Golgi apparatus,Host-virus interaction,Immunity,Inflammatory response,Innate immunity,Kinase,Lipoprotein,Lysosome,Membrane,Myristate,Nucleotide-binding,Nucleus,Palmitate,Phagocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase HCK,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
201145_at	HCLS1 associated protein X-1(HAX1)	Homo sapiens				GO:0007005~mitochondrion organization,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030833~regulation of actin filament polymerization,GO:0030854~positive regulation of granulocyte differentiation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051897~positive regulation of protein kinase B signaling,GO:0071345~cellular response to cytokine stimulus,GO:1903146~regulation of mitophagy,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0000932~cytoplasmic mRNA processing body,GO:0005635~nuclear envelope,GO:0005667~transcription factor complex,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016529~sarcoplasmic reticulum,GO:0030027~lamellipodium,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,	GO:0005515~protein binding,GO:0019966~interleukin-1 binding,GO:0047485~protein N-terminus binding,	IPR017248:HS1-associating, X-1,		610738~Neutropenia, severe congenital 3, autosomal recessive,	PIRSF037634:HS1-associating protein X-1,		Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,	chain:HCLS1-associated protein X-1,compositionally biased region:Asp/Glu-rich (highly acidic),modified residue,region of interest:Involved in ATP2A2 binding,region of interest:Involved in CASP9 binding,region of interest:Involved in GNA13 binding,region of interest:Involved in HCLS1 binding,region of interest:Involved in PKD2 binding,region of interest:Involved in PLN binding,region of interest:Required for ITGB6 binding,region of interest:Required for localization in mitochondria,region of interest:Required for localization in sarcoplasmic reticulum,sequence conflict,sequence variant,site:Cleavage; by caspase-3,splice variant,
219020_at	HCLS1 binding protein 3(HS1BP3)	Homo sapiens				GO:0042981~regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,	GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,				SM00312:PX,	Acetylation,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:HCLS1-binding protein 3,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:PX,modified residue,sequence variant,
203259_s_at, 203260_at	HD domain containing 2(HDDC2)	Homo sapiens					GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003607:HD/PDEase domain,IPR006674:HD domain,				SM00471:HDc,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:HD domain-containing protein 2,domain:HD,modified residue,sequence conflict,sequence variant,splice variant,
218594_at, 218595_s_at	HEAT repeat containing 1(HEATR1)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030686~90S preribosome,GO:0032040~small-subunit processome,GO:0034455~t-UTP complex,	GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR012954:BP28, C-terminal domain,IPR016024:Armadillo-type fold,IPR022125:U3 small nucleolar RNA-associated protein 10,	hsa03008:Ribosome biogenesis in eukaryotes,			SM01036:SM01036,	Acetylation,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,	chain:HEAT repeat-containing protein 1,modified residue,repeat:HEAT,sequence variant,
219289_at	HEAT repeat containing 3(HEATR3)	Homo sapiens				GO:0006606~protein import into nucleus,GO:0042273~ribosomal large subunit biogenesis,	GO:0005622~intracellular,	GO:0051082~unfolded protein binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,	chain:HEAT repeat-containing protein 3,compositionally biased region:Poly-Ala,repeat:HEAT 1,repeat:HEAT 2,sequence conflict,sequence variant,splice variant,
218991_at, 65493_at	HEAT repeat containing 6(HEATR6)	Homo sapiens						GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR025283:Domain of unknown function DUF4042,					Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:HEAT repeat-containing protein 6,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,sequence conflict,sequence variant,
217902_s_at	HECT and RLD domain containing E3 ubiquitin protein ligase 2(HERC2)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006886~intracellular protein transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005814~centriole,GO:0016020~membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0032183~SUMO binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000433:Zinc finger, ZZ-type,IPR000569:HECT,IPR001199:Cytochrome b5-like heme/steroid binding domain,IPR004939:Anaphase-promoting complex, subunit 10/DOC domain,IPR006624:Beta-propeller repeat TECPR,IPR008979:Galactose-binding domain-like,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR010606:Mib-herc2,IPR014722:Ribosomal protein L2 domain 2,IPR021097:CPH domain,	hsa04120:Ubiquitin mediated proteolysis,	227220~Skin/hair/eye pigmentation 1, blond/brown hair,227220~Skin/hair/eye pigmentation 1, blue/nonblue eyes,615516~Mental retardation, autosomal recessive 38,		SM00119:HECTc,SM00291:ZnF_ZZ,SM00706:TECPR,SM01117:SM01117,SM01337:SM01337,	3D-structure,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA repair,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HERC2,domain:Cytochrome b5 heme-binding,domain:DOC,domain:HECT,domain:MIB/HERC2,helix,modified residue,repeat:RCC1 1,repeat:RCC1 10,repeat:RCC1 11,repeat:RCC1 12,repeat:RCC1 13,repeat:RCC1 14,repeat:RCC1 15,repeat:RCC1 16,repeat:RCC1 17,repeat:RCC1 18,repeat:RCC1 19,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,repeat:RCC1 8,repeat:RCC1 9,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,strand,turn,zinc finger region:ZZ-type,
208055_s_at, 208054_at	HECT and RLD domain containing E3 ubiquitin protein ligase 4(HERC4)	Homo sapiens				GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0016874~ligase activity,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000569:HECT,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Proteomics identification,Reference proteome,Repeat,Spermatogenesis,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HERC4,domain:HECT,modified residue,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,sequence conflict,splice variant,
219863_at	HECT and RLD domain containing E3 ubiquitin protein ligase 5(HERC5)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000209~protein polyubiquitination,GO:0032020~ISG15-protein conjugation,GO:0032480~negative regulation of type I interferon production,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0050688~regulation of defense response to virus,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0042296~ISG15 transferase activity,GO:0044822~poly(A) RNA binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000569:HECT,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,				SM00119:HECTc,	Antiviral defense,Complete proteome,Cytoplasm,Immunity,Innate immunity,Ligase,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HERC5,domain:HECT,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,sequence variant,
218306_s_at	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1(HERC1)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0006810~transport,GO:0010507~negative regulation of autophagy,GO:0016567~protein ubiquitination,GO:0021702~cerebellar Purkinje cell differentiation,GO:0031175~neuron projection development,GO:0043547~positive regulation of GTPase activity,GO:0050885~neuromuscular process controlling balance,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0016874~ligase activity,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000569:HECT,IPR001680:WD40 repeat,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,SM00320:WD40,SM00449:SPRY,	3D-structure,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Transport,Ubl conjugation pathway,WD repeat,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HERC1,compositionally biased region:Glu-rich,domain:B30.2/SPRY,domain:HECT,modified residue,repeat:RCC1 1,repeat:RCC1 10,repeat:RCC1 11,repeat:RCC1 12,repeat:RCC1 13,repeat:RCC1 14,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,repeat:RCC1 7,repeat:RCC1 8,repeat:RCC1 9,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence variant,
219352_at	HECT and RLD domain containing E3 ubiquitin protein ligase family member 6(HERC6)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0000209~protein polyubiquitination,GO:0002244~hematopoietic progenitor cell differentiation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000569:HECT,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,				SM00119:HECTc,	Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HERC6,domain:HECT,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,sequence conflict,sequence variant,splice variant,
218632_at	HECT domain E3 ubiquitin protein ligase 3(HECTD3)	Homo sapiens				GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0019905~syntaxin binding,	IPR000569:HECT,IPR004939:Anaphase-promoting complex, subunit 10/DOC domain,IPR008979:Galactose-binding domain-like,				SM00119:HECTc,SM01337:SM01337,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Ligase,Phosphoprotein,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase HECTD3,domain:DOC,domain:HECT,splice variant,
211034_s_at	HECT domain E3 ubiquitin protein ligase 4(HECTD4)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0042593~glucose homeostasis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0016874~ligase activity,	IPR000569:HECT,				SM00119:HECTc,	Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase KIAA0614,chain:Transmembrane protein C12orf51,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:HECT,modified residue,repeat:LRR 1,repeat:LRR 2,sequence conflict,splice variant,transmembrane region,
215584_at, 210331_at	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1(HECW1)	Homo sapiens				GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0061630~ubiquitin protein ligase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000569:HECT,IPR001202:WW domain,				SM00119:HECTc,SM00239:C2,SM00456:WW,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Repeat,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:E3 ubiquitin-protein ligase HECW1,compositionally biased region:Cys-rich,compositionally biased region:Glu-rich,domain:C2,domain:HECT,domain:WW 1,domain:WW 2,sequence conflict,
214673_s_at, 208599_at, 208598_s_at, 207783_x_at	HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase(HUWE1)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006284~base-excision repair,GO:0006513~protein monoubiquitination,GO:0016574~histone ubiquitination,GO:0030154~cell differentiation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000569:HECT,IPR004170:WWE domain,IPR009060:UBA-like,IPR010309:E3 ubiquitin ligase, domain of unknown function DUF908,IPR010314:E3 ubiquitin ligase, domain of unknown function DUF913,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR016024:Armadillo-type fold,IPR025527:Domain of unknown function DUF4414,	hsa04120:Ubiquitin mediated proteolysis,	300706~Mental retardation, X-linked syndromic, Turner type,		SM00119:HECTc,SM00165:UBA,	3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Differentiation,Disease mutation,DNA damage,DNA repair,DNA-binding,Membrane,Mental retardation,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:E3 ubiquitin-protein ligase HUWE1,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Thr-rich,domain:HECT,domain:UBA,domain:WWE,helix,modified residue,mutagenesis site,repeat:UIM,sequence conflict,sequence variant,splice variant,strand,turn,
221162_at	HERV-H LTR-associating 1(HHLA1)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,
220812_s_at	HERV-H LTR-associating 2(HHLA2)	Homo sapiens				GO:0001819~positive regulation of cytokine production,GO:0031295~T cell costimulation,GO:0042104~positive regulation of activated T cell proliferation,	GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:HERV-H LTR-associating protein 2,disulfide bond,domain:Ig-like C1-type,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,transmembrane region,
220387_s_at	HERV-H LTR-associating 3(HHLA3)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Reference proteome,	chain:HERV-H LTR-associating protein 3,sequence conflict,splice variant,
211267_at	HESX homeobox 1(HESX1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0030916~otic vesicle formation,GO:0043584~nose development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048853~forebrain morphogenesis,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0043565~sequence-specific DNA binding,GO:0047485~protein N-terminus binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,	182230~Growth hormone deficiency with pituitary anomalies,182230~Pituitary hormone deficiency, combined, 5,182230~Septooptic dysplasia,		SM00389:HOX,	3D-structure,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Dwarfism,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox expressed in ES cells 1,DNA-binding region:Homeobox,helix,sequence variant,
220718_at	HEXA antisense RNA 1(HEXA-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C15orf34,
207027_at	HGF activator(HGFAC)	Homo sapiens				GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005791~rough endoplasmic reticulum,	GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,	IPR000001:Kringle,IPR000083:Fibronectin, type I,IPR000562:Fibronectin, type II, collagen-binding,IPR000742:Epidermal growth factor-like domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013032:EGF-like, conserved site,IPR013806:Kringle-like fold,IPR014394:Coagulation factor XIIa/hepatocyte growth factor activator,IPR018056:Kringle, conserved site,IPR018114:Peptidase S1, trypsin family, active site,			PIRSF001146:coagulation factor XII/hepatocyte growth factor activator,	SM00020:Tryp_SPc,SM00058:FN1,SM00059:FN2,SM00130:KR,SM00181:EGF,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Kringle,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Hepatocyte growth factor activator long chain,chain:Hepatocyte growth factor activator short chain,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:Fibronectin type-I,domain:Fibronectin type-II,domain:Kringle,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Removed in mature form,sequence variant,signal peptide,strand,turn,
219071_x_at, 221629_x_at	HGH1 homolog(HGH1)	Homo sapiens							IPR007205:FAM203 N-terminal,IPR007206:FAM203 C-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Acetylation,Complete proteome,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Brain protein 16,compositionally biased region:Ala-rich,modified residue,
220283_at	HHIP like 2(HHIPL2)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0005975~carbohydrate metabolic process,GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,	GO:0005515~protein binding,GO:0016901~oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,GO:0048038~quinone binding,	IPR011041:Soluble quinoprotein glucose/sorbosone dehydrogenase,IPR011042:Six-bladed beta-propeller, TolB-like,IPR012938:Glucose/Sorbosone dehydrogenase,IPR018143:Folate receptor-like,					Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:HHIP-like protein 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
208461_at	HIC ZBTB transcriptional repressor 1(HIC1)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,	General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,	GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Acetylation,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,Zinc,Zinc-finger,	chain:Hypermethylated in cancer 1 protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,domain:BTB,modified residue,mutagenesis site,region of interest:Binding to CtBP,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
212964_at, 212965_at, 212966_at, 216911_s_at	HIC ZBTB transcriptional repressor 2(HIC2)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008022~protein C-terminus binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Hypermethylated in cancer 2 protein,domain:BTB,region of interest:Binding to CtBP,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
221896_s_at, 217845_x_at	HIG1 hypoxia inducible domain family member 1A(HIGD1A)	Homo sapiens				GO:0043066~negative regulation of apoptotic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070469~respiratory chain,		IPR007667:Hypoxia induced protein, domain,					3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Respiratory chain,Stress response,Transmembrane,Transmembrane helix,Transport,	chain:HIG1 domain family member 1A,domain:HIG1,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219719_at	HIG1 hypoxia inducible domain family member 1B(HIGD1B)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007667:Hypoxia induced protein, domain,					3D-structure,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:HIG1 domain family member 1B,domain:HIG1,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
209329_x_at, 209328_x_at	HIG1 hypoxia inducible domain family member 2A(HIGD2A)	Homo sapiens				GO:0043066~negative regulation of apoptotic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,		IPR007667:Hypoxia induced protein, domain,					Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,	chain:HIG1 domain family member 2A,domain:HIG1,modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204504_s_at	HIRA interacting protein 3(HIRIP3)	Homo sapiens				GO:0006333~chromatin assembly or disassembly,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0005515~protein binding,	IPR019098:Histone chaperone domain CHZ,				SM01082:SM01082,	Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:HIRA-interacting protein 3,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,splice variant,
207180_s_at, 209448_at, 210253_at	HIV-1 Tat interactive protein 2(HTATIP2)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0001525~angiogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0016032~viral process,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045765~regulation of angiogenesis,GO:0051170~nuclear import,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,	IPR016040:NAD(P)-binding domain,					3D-structure,Acetylation,Alternative splicing,Angiogenesis,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Host-virus interaction,NADP,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	active site:Proton acceptor,binding site:Substrate,chain:Oxidoreductase HTATIP2,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,splice variant,strand,
202601_s_at, 202602_s_at	HIV-1 Tat specific factor 1(HTATSF1)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0019079~viral genome replication,GO:0032784~regulation of DNA-templated transcription, elongation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Acetylation,Activator,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,	chain:HIV Tat-specific factor 1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Lys,domain:RRM 1,domain:RRM 2,helix,modified residue,mutagenesis site,region of interest:Mediates interaction with the P-TEFb complex,sequence conflict,sequence variant,strand,
206082_at	HLA complex P5 (non-protein coding)(HCP5)	Homo sapiens				GO:0006952~defense response,								Complete proteome,Polymorphism,Reference proteome,	chain:HLA class I histocompatibility antigen protein P5,sequence conflict,sequence variant,
204755_x_at, 204754_at, 204753_s_at	HLF, PAR bZIP transcription factor(HLF)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR004827:Basic-leucine zipper domain,				SM00338:BRLZ,	Alternative splicing,Biological rhythms,Chromosomal rearrangement,Coiled coil,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Hepatic leukemia factor,compositionally biased region:Pro-rich (proline/acidic region (PAR)),DNA-binding region:Basic motif,domain:Leucine-zipper,sequence variant,
212431_at, 34221_at	HMG-box containing 3(HMGXB3)	Homo sapiens				GO:0016310~phosphorylation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0016301~kinase activity,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,	chain:HMG domain-containing protein 3,compositionally biased region:Arg-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,DNA-binding region:HMG box,sequence conflict,
212597_s_at, 212596_s_at	HMG-box containing 4(HMGXB4)	Homo sapiens				GO:0008333~endosome to lysosome transport,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,	GO:0016589~NURF complex,	GO:0003677~DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR025228:Domain of unknown function DUF4171,				SM00398:HMG,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Wnt signaling pathway,	chain:HMG domain-containing protein 4,DNA-binding region:HMG box,sequence conflict,sequence variant,
207361_at, 209102_s_at	HMG-box transcription factor 1(HBP1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007050~cell cycle arrest,GO:0016055~Wnt signaling pathway,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003652:Ataxin, AXH domain,IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,SM00536:AXH,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Wnt signaling pathway,	chain:HMG box-containing protein 1,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Ser,DNA-binding region:HMG box,domain:AXH,helix,sequence conflict,splice variant,
218623_at	HMP19 protein(HMP19)	Homo sapiens				GO:0007212~dopamine receptor signaling pathway,GO:0048268~clathrin coat assembly,	GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0032580~Golgi cisterna membrane,GO:0032585~multivesicular body membrane,	GO:0032051~clathrin light chain binding,	IPR009431:Calcyon neuron-specific vesicular protein,			PIRSF002383:neuron specific protein/calcyon,		Complete proteome,Cytoplasmic vesicle,Endosome,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Neuron-specific protein family member 2,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
216930_at, 210515_at	HNF1 homeobox A(HNF1A)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ghPathway:Growth Hormone Signaling Pathway,h_hesPathway:Segmentation Clock,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001824~blastocyst development,GO:0001889~liver development,GO:0001890~placenta development,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006633~fatty acid biosynthetic process,GO:0006699~bile acid biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006979~response to oxidative stress,GO:0008203~cholesterol metabolic process,GO:0009749~response to glucose,GO:0015721~bile acid and bile salt transport,GO:0015908~fatty acid transport,GO:0016573~histone acetylation,GO:0030073~insulin secretion,GO:0030111~regulation of Wnt signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0031018~endocrine pancreas development,GO:0035565~regulation of pronephros size,GO:0035623~renal glucose absorption,GO:0042593~glucose homeostasis,GO:0043691~reverse cholesterol transport,GO:0045453~bone resorption,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046323~glucose import,GO:0048341~paraxial mesoderm formation,GO:0050796~regulation of insulin secretion,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0060395~SMAD protein signal transduction,	GO:0001750~photoreceptor outer segment,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0045120~pronucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR001356:Homeodomain,IPR006897:Hepatocyte nuclear factor 1, beta isoform, C-terminal,IPR006898:Hepatocyte nuclear factor 1, alpha isoform C-terminal,IPR006899:Hepatocyte nuclear factor 1, N-terminal,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR023219:Hepatocyte nuclear factor 1, dimerisation domain,	hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04950:Maturity onset diabetes of the young,	125853~Diabetes mellitus, noninsulin-dependent, 2,142330~Hepatic adenoma, somatic,144700~Renal cell carcinoma,222100~Diabetes mellitus, insulin-dependent,600496~MODY, type III,612520~Diabetes mellitus, insulin-dependent, 20,		SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Hepatocyte nuclear factor 1-alpha,compositionally biased region:Asp/Glu-rich (acidic; potential involvement with transcription),DNA-binding region:Homeobox; HNF1-type,helix,modified residue,region of interest:Dimerization,sequence variant,short sequence motif:Nuclear localization signal,splice variant,turn,
208135_at, 205313_at	HNF1 homeobox B(HNF1B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001714~endodermal cell fate specification,GO:0001822~kidney development,GO:0001826~inner cell mass cell differentiation,GO:0006351~transcription, DNA-templated,GO:0007219~Notch signaling pathway,GO:0009749~response to glucose,GO:0009952~anterior/posterior pattern specification,GO:0014070~response to organic cyclic compound,GO:0030073~insulin secretion,GO:0030111~regulation of Wnt signaling pathway,GO:0030902~hindbrain development,GO:0031018~endocrine pancreas development,GO:0032922~circadian regulation of gene expression,GO:0035565~regulation of pronephros size,GO:0039020~pronephric nephron tubule development,GO:0042493~response to drug,GO:0042663~regulation of endodermal cell fate specification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048557~embryonic digestive tract morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048793~pronephros development,GO:0048806~genitalia development,GO:0050673~epithelial cell proliferation,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0060677~ureteric bud elongation,GO:0061017~hepatoblast differentiation,GO:0061296~negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,GO:0065004~protein-DNA complex assembly,GO:0070365~hepatocyte differentiation,GO:0072095~regulation of branch elongation involved in ureteric bud branching,GO:0072181~mesonephric duct formation,GO:1900212~negative regulation of mesenchymal cell apoptotic process involved in metanephros development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001159~core promoter proximal region DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR006897:Hepatocyte nuclear factor 1, beta isoform, C-terminal,IPR006899:Hepatocyte nuclear factor 1, N-terminal,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR023219:Hepatocyte nuclear factor 1, dimerisation domain,	hsa04950:Maturity onset diabetes of the young,	125853~Diabetes mellitus, noninsulin-dependent,137920~Renal cysts and diabetes syndrome,144700~Renal cell carcinoma,		SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Hepatocyte nuclear factor 1-beta,DNA-binding region:Homeobox; HNF1-type,helix,modified residue,region of interest:Dimerization,sequence variant,splice variant,turn,
66053_at, 208906_at	HNRNPUL2-BSCL2 readthrough (NMD candidate)(HNRNPUL2-BSCL2)	Homo sapiens							IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00449:SPRY,SM00513:SAP,	Coiled coil,Complete proteome,Reference proteome,
211597_s_at	HOP homeobox(HOPX)	Homo sapiens		h_hopPathway:Hop Pathway in Cardiac Development,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0008016~regulation of heart contraction,GO:0016575~histone deacetylation,GO:0043393~regulation of protein binding,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0045596~negative regulation of cell differentiation,GO:0048286~lung alveolus development,GO:0051155~positive regulation of striated muscle cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,				SM00389:HOX,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Homeobox,Nucleus,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeodomain-only protein,DNA-binding region:Homeobox; atypical,sequence conflict,splice variant,
210112_at, 203309_s_at, 203308_x_at, 217354_s_at	HPS1, biogenesis of lysosomal organelles complex 3 subunit 1(HPS1)	Homo sapiens				GO:0007040~lysosome organization,GO:0007601~visual perception,GO:0043547~positive regulation of GTPase activity,GO:0050896~response to stimulus,GO:1903232~melanosome assembly,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005887~integral component of plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031085~BLOC-3 complex,GO:0031410~cytoplasmic vesicle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR026053:Hermansky-Pudlak syndrome 1 protein,		203300~Hermansky-Pudlak syndrome 1,			Albinism,Alternative splicing,Complete proteome,Disease mutation,Guanine-nucleotide releasing factor,Hermansky-Pudlak syndrome,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Vision,	chain:Hermansky-Pudlak syndrome 1 protein,compositionally biased region:Poly-Glu,repeat:[DE]-X(4)-L-L 1,repeat:[DE]-X(4)-L-L 2,repeat:[DE]-X(4)-L-L 3,repeat:[DE]-X(4)-L-L 4,sequence conflict,sequence variant,short sequence motif:Melanosome targeting signal,splice variant,
54037_at, 218402_s_at	HPS4, biogenesis of lysosomal organelles complex 3 subunit 2(HPS4)	Homo sapiens				GO:0006605~protein targeting,GO:0007040~lysosome organization,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0030318~melanocyte differentiation,GO:0043547~positive regulation of GTPase activity,GO:0048075~positive regulation of eye pigmentation,GO:0050821~protein stabilization,GO:1903232~melanosome assembly,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0016020~membrane,GO:0031085~BLOC-3 complex,GO:0042470~melanosome,GO:0042827~platelet dense granule,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,	IPR026091:Hermansky-Pudlak syndrome 4 protein,		614073~Hermansky-Pudlak syndrome 4,			Albinism,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Hermansky-Pudlak syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Hermansky-Pudlak syndrome 4 protein,modified residue,sequence conflict,sequence variant,splice variant,
204544_at	HPS5, biogenesis of lysosomal organelles complex 2 subunit 2(HPS5)	Homo sapiens				GO:0006996~organelle organization,GO:0007596~blood coagulation,GO:0043473~pigmentation,	GO:0031084~BLOC-2 complex,	GO:0005515~protein binding,	IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		614074~Hermansky-Pudlak syndrome 5,			Albinism,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Hermansky-Pudlak syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Hermansky-Pudlak syndrome 5 protein,compositionally biased region:Poly-Ala,modified residue,sequence conflict,sequence variant,splice variant,
219052_at	HPS6, biogenesis of lysosomal organelles complex 2 subunit 3(HPS6)	Homo sapiens				GO:0006996~organelle organization,GO:0007596~blood coagulation,GO:0030318~melanocyte differentiation,GO:0032418~lysosome localization,GO:0072657~protein localization to membrane,	GO:0005765~lysosomal membrane,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0031084~BLOC-2 complex,GO:0031901~early endosome membrane,	GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0030742~GTP-dependent protein binding,	IPR017218:BLOC-2 complex, Hps6 subunit,		614075~Hermansky-Pudlak syndrome 6,	PIRSF037476:BLOC-2 complex, Hps6 subunit,		Albinism,Complete proteome,Cytoplasm,Endoplasmic reticulum,Endosome,Hermansky-Pudlak syndrome,Membrane,Microsome,Reference proteome,	chain:Hermansky-Pudlak syndrome 6 protein,
216760_at, 221122_at, 216759_at	HRAS like suppressor 2(HRASLS2)	Homo sapiens				GO:0016042~lipid catabolic process,	GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0016746~transferase activity, transferring acyl groups,GO:0016787~hydrolase activity,	IPR007053:LRAT-like domain,					3D-structure,Acyltransferase,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:HRAS-like suppressor 2,
219983_at, 219984_s_at	HRAS like suppressor(HRASLS)	Homo sapiens				GO:0016042~lipid catabolic process,	GO:0016021~integral component of membrane,	GO:0016740~transferase activity,GO:0016787~hydrolase activity,	IPR007053:LRAT-like domain,					Complete proteome,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:HRAS-like suppressor,
212983_at	HRas proto-oncogene, GTPase(HRAS)	Homo sapiens	65.Integrin_affinity_modulation,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArrestin-srcPathway:Roles of -arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_longevityPathway:The IGF-1 Receptor and Longevity,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_mCalpainPathway:mCalpain and friends in Cell motility,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_reckPathway:Inhibition of Matrix Metalloproteinases,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000165~MAPK cascade,GO:0001934~positive regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006897~endocytosis,GO:0006935~chemotaxis,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030335~positive regulation of cell migration,GO:0032729~positive regulation of interferon-gamma production,GO:0034260~negative regulation of GTPase activity,GO:0035176~social behavior,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0042088~T-helper 1 type immune response,GO:0042832~defense response to protozoan,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048013~ephrin receptor signaling pathway,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051291~protein heterooligomerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090303~positive regulation of wound healing,GO:0090398~cellular senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900029~positive regulation of ruffle assembly,GO:2000251~positive regulation of actin cytoskeleton reorganization,GO:2000630~positive regulation of miRNA metabolic process,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	109800~Bladder cancer, somatic,137550~Spitz nevus or nevus spilus, somatic,162900~Nevus sebaceous or woolly hair nevus, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,188470~Thyroid carcinoma, follicular, somatic,218040~Congenital myopathy with excess of muscle spindles,218040~Costello syndrome,			3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Nucleus,Palmitate,Prenylation,Proto-oncogene,Reference proteome,S-nitrosylation,	chain:GTPase HRas,chain:GTPase HRas, N-terminally processed,helix,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,strand,turn,
202415_s_at	HSPA (Hsp70) binding protein 1(HSPBP1)	Homo sapiens				GO:0006457~protein folding,GO:0031398~positive regulation of protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043086~negative regulation of catalytic activity,		GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR013918:Nucleotide exchange factor Fes1,IPR016024:Armadillo-type fold,	hsa04141:Protein processing in endoplasmic reticulum,				3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Hsp70-binding protein 1,compositionally biased region:Gly-rich,helix,modified residue,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,sequence variant,splice variant,turn,
219284_at	HSPB1 associated protein 1(HSPBAP1)	Homo sapiens			Function unknown,		GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR003347:JmjC domain,IPR013296:HSPB1-associated protein 1,				SM00558:JmjC,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Stress response,	chain:HSPB1-associated protein 1,domain:JmjC,region of interest:Interaction with HSPB1,sequence conflict,sequence variant,splice variant,
202918_s_at	HSPE1-MOB4 readthrough(HSPE1-MOB4)	Homo sapiens				GO:0006457~protein folding,	GO:0005737~cytoplasm,	GO:0005524~ATP binding,	IPR005301:Mob1/phocein,IPR011032:GroES-like,IPR018369:Chaperonin Cpn10, conserved site,IPR020818:Chaperonin Cpn10,				SM00883:SM00883,SM01388:SM01388,	Chaperone,Complete proteome,Reference proteome,
204884_s_at, 204883_s_at, 217618_x_at	HUS1 checkpoint clamp component(HUS1)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000077~DNA damage checkpoint,GO:0000724~double-strand break repair via homologous recombination,GO:0001932~regulation of protein phosphorylation,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007093~mitotic cell cycle checkpoint,GO:0008156~negative regulation of DNA replication,GO:0009411~response to UV,GO:0009790~embryo development,GO:0031573~intra-S DNA damage checkpoint,GO:0033314~mitotic DNA replication checkpoint,GO:0044778~meiotic DNA integrity checkpoint,GO:0071479~cellular response to ionizing radiation,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0030896~checkpoint clamp complex,GO:0035861~site of double-strand break,	GO:0005515~protein binding,	IPR007150:Checkpoint protein Hus1/Mec3,IPR016580:Cell cycle checkpoint, Hus1,			PIRSF011312:cell cycle checkpoint protein, HUS1 type,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Checkpoint protein HUS1,helix,sequence variant,strand,
52159_at, 218620_s_at, 218621_at	HemK methyltransferase family member 1(HEMK1)	Homo sapiens				GO:0006306~DNA methylation,GO:0006479~protein methylation,	GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,	IPR002052:DNA methylase, N-6 adenine-specific, conserved site,IPR002295:N6 adenine-specific DNA methyltransferase, D21 class,IPR004556:Modification methylase HemK,IPR007848:Methyltransferase small domain,IPR019874:Protein-(glutamine-N5) methyltransferase, release factor-specific,					Complete proteome,Methyltransferase,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:HemK methyltransferase family member 1,sequence variant,
219979_s_at	Hikeshi, heat shock protein nuclear import factor(HIKESHI)	Homo sapiens				GO:0006606~protein import into nucleus,GO:0015031~protein transport,GO:0034605~cellular response to heat,GO:1900034~regulation of cellular response to heat,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0008565~protein transporter activity,GO:0030544~Hsp70 protein binding,	IPR008493:Protein of unknown function DUF775,					3D-structure,Complete proteome,Cytoplasm,Disease mutation,Leukodystrophy,Nucleus,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Uncharacterized protein C11orf73,sequence conflict,sequence variant,
218726_at	Holliday junction recognition protein(HJURP)	Homo sapiens				GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0043254~regulation of protein complex assembly,GO:0051101~regulation of DNA binding,	GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042393~histone binding,GO:0042802~identical protein binding,	IPR018465:Centromere protein Scm3, N-terminal,IPR021052:Holliday junction recognition protein, HJURP,IPR022102:Holliday junction regulator protein family C-terminal,					3D-structure,Alternative splicing,Cell cycle,Centromere,Chaperone,Chromosome,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Holliday junction recognition protein,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
201185_at	HtrA serine peptidase 1(HTRA1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0001558~regulation of cell growth,GO:0001890~placenta development,GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050687~negative regulation of defense response to virus,GO:0060718~chorionic trophoblast cell differentiation,GO:0097187~dentinogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005520~insulin-like growth factor binding,GO:0008236~serine-type peptidase activity,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR001478:PDZ domain,IPR001940:Peptidase S1C,IPR002350:Kazal domain,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,		600142~CARASIL syndrome,610149~Macular degeneration, age-related, 7,610149~Macular degeneration, age-related, neovascular type,		SM00121:IB,SM00228:PDZ,SM00280:KAZAL,	3D-structure,Age-related macular degeneration,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Growth factor binding,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease HTRA1,domain:IGFBP N-terminal,domain:Kazal-like,domain:PDZ,helix,mutagenesis site,region of interest:Serine protease,sequence conflict,signal peptide,strand,
211152_s_at, 203089_s_at	HtrA serine peptidase 2(HTRA2)	Homo sapiens				GO:0006508~proteolysis,GO:0006672~ceramide metabolic process,GO:0007005~mitochondrion organization,GO:0007568~aging,GO:0007628~adult walking behavior,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009635~response to herbicide,GO:0010942~positive regulation of cell death,GO:0016540~protein autoprocessing,GO:0019742~pentacyclic triterpenoid metabolic process,GO:0030900~forebrain development,GO:0034599~cellular response to oxidative stress,GO:0034605~cellular response to heat,GO:0035458~cellular response to interferon-beta,GO:0040014~regulation of multicellular organism growth,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0044257~cellular protein catabolic process,GO:0045786~negative regulation of cell cycle,GO:0048666~neuron development,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0097194~execution phase of apoptosis,GO:1901215~negative regulation of neuron death,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001269~positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0035631~CD40 receptor complex,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0051082~unfolded protein binding,	IPR001478:PDZ domain,IPR001940:Peptidase S1C,IPR009003:Trypsin-like cysteine/serine peptidase domain,	hsa05012:Parkinson's disease,	610297~Parkinson disease 13,		SM00228:PDZ,	3D-structure,Alternative splicing,Apoptosis,Autocatalytic cleavage,Complete proteome,Direct protein sequencing,Disease mutation,Hydrolase,Membrane,Mitochondrion,Neurodegeneration,Parkinson disease,Parkinsonism,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Transit peptide,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Serine protease HTRA2, mitochondrial,domain:PDZ,helix,mutagenesis site,region of interest:Serine protease,sequence variant,short sequence motif:IAP-binding motif,splice variant,strand,transit peptide:Mitochondrion,transmembrane region,turn,
215490_at	IBA57 homolog, iron-sulfur cluster assembly(IBA57)	Homo sapiens			General function prediction only,	GO:0006783~heme biosynthetic process,GO:0016226~iron-sulfur cluster assembly,	GO:0005759~mitochondrial matrix,	GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR017703:YgfZ/GcvT conserved site,		615330~Multiple mitochondrial dysfunctions syndrome 3,616451~Spastic paraplegia 74, autosomal recessive,			Acetylation,Complete proteome,Disease mutation,Heme biosynthesis,Hereditary spastic paraplegia,Mitochondrion,Neurodegeneration,Polymorphism,Reference proteome,Transferase,Transit peptide,	chain:Putative transferase C1orf69, mitochondrial,sequence variant,transit peptide:Mitochondrion,
220703_at	IDI2 antisense RNA 1(IDI2-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C10orf110,modified residue,
201422_at	IFI30, lysosomal thiol reductase(IFI30)	Homo sapiens				GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0048147~negative regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0055114~oxidation-reduction process,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0043202~lysosomal lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0016667~oxidoreductase activity, acting on a sulfur group of donors,	IPR004911:Gamma interferon inducible lysosomal thiol reductase GILT,	hsa04612:Antigen processing and presentation,				Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Lysosome,Oxidoreductase,Proteomics identification,Redox-active center,Reference proteome,Secreted,Signal,	chain:Gamma-interferon-inducible lysosomal thiol reductase,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,
219690_at	IGF like family receptor 1(IGFLR1)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR011029:Death-like domain,					Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 149,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220561_at	IGF2 antisense RNA(IGF2-AS)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative insulin-like growth factor 2 antisense gene protein,sequence conflict,sequence variant,
200066_at, 213550_s_at	IK cytokine, down-regulator of HLA II(IK)	Homo sapiens				GO:0006955~immune response,GO:0007267~cell-cell signaling,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR012492:Protein RED, C-terminal,IPR012916:RED-like, N-terminal,					Acetylation,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Protein Red,compositionally biased region:Poly-Glu,modified residue,region of interest:17 X 2 AA tandem repeats of R-[ED],repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,
220704_at, 205038_at, 216901_s_at, 205039_s_at	IKAROS family zinc finger 1(IKZF1)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0007498~mesoderm development,GO:0016569~covalent chromatin modification,GO:0030098~lymphocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031618~nuclear pericentric heterochromatin,GO:0043234~protein complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		Leukemia, acute lymphoblastic~Leukemia, acute lymphoblastic,		SM00355:ZnF_C2H2,	Activator,Alternative splicing,Cell cycle,Chromatin regulator,Chromosomal rearrangement,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA-binding protein Ikaros,compositionally biased region:Poly-Leu,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,region of interest:Required for binding PP1CC,region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization,sequence conflict,site:Required for both pericentromeric heterochromatin localization and complete DNA binding,site:Required for both pericentromeric heterochromatin localization and DNA binding,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
220567_at	IKAROS family zinc finger 2(IKZF2)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Helios,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
221092_at	IKAROS family zinc finger 3(IKZF3)	Homo sapiens		h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007498~mesoderm development,GO:0030888~regulation of B cell proliferation,GO:0042113~B cell activation,GO:0042981~regulation of apoptotic process,GO:0045577~regulation of B cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,B-cell activation,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein Aiolos,modified residue,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; atypical,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6; atypical,
208472_at	IKAROS family zinc finger 4(IKZF4)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005813~centrosome,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Eos,mutagenesis site,sequence conflict,short sequence motif:CTBP-binding motif PEDLA,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
220086_at	IKAROS family zinc finger 5(IKZF5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Pegasus,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
211339_s_at	IL2 inducible T-cell kinase(ITK)	Homo sapiens		h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,		GO:0001816~cytokine production,GO:0001865~NK T cell differentiation,GO:0002250~adaptive immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0032609~interferon-gamma production,GO:0032633~interleukin-4 production,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0050852~T cell receptor signaling pathway,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR001562:Zinc finger, Btk motif,IPR001849:Pleckstrin homology domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04062:Chemokine signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,	613011~Lymphoproliferative syndrome 1,		SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,SM00326:SH3,	3D-structure,Adaptive immunity,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Immunity,Kinase,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase ITK/TSK,domain:PH,domain:Protein kinase,domain:SH2,domain:SH3,helix,metal ion-binding site:Zinc,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,zinc finger region:Btk-type,
221548_s_at	ILK associated serine/threonine phosphatase(ILKAP)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007229~integrin-mediated signaling pathway,	GO:0005737~cytoplasm,	GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0043169~cation binding,GO:0046872~metal ion binding,	IPR000222:Protein phosphatase 2C, manganese/magnesium aspartate binding site,IPR001932:Protein phosphatase 2C (PP2C)-like,IPR015655:Protein phosphatase 2C,				SM00332:PP2Cc,	Acetylation,Complete proteome,Cytoplasm,Hydrolase,Integrin,Kinase,Magnesium,Manganese,Metal-binding,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Transferase,	chain:Integrin-linked kinase-associated serine/threonine phosphatase 2C,domain:PP2C-like,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 1; via carbonyl oxygen,metal ion-binding site:Manganese 2,modified residue,mutagenesis site,sequence variant,
221688_s_at	IMP3, U3 small nucleolar ribonucleoprotein(IMP3)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0006364~rRNA processing,GO:0045903~positive regulation of translational fidelity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0015935~small ribosomal subunit,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR001912:Ribosomal protein S4/S9, N-terminal,IPR002942:RNA-binding S4 domain,IPR022801:Ribosomal protein S4/S9,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00363:S4,SM01390:SM01390,	3D-structure,Complete proteome,Nucleus,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,rRNA-binding,	chain:U3 small nucleolar ribonucleoprotein protein imp3,compositionally biased region:Arg-rich,domain:S4 RNA-binding,helix,sequence conflict,strand,
212411_at	IMP4 homolog, U3 small nucleolar ribonucleoprotein(IMP4)	Homo sapiens				GO:0006364~rRNA processing,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0042134~rRNA primary transcript binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,	hsa03008:Ribosome biogenesis in eukaryotes,			SM00879:SM00879,	Coiled coil,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,Signal,	chain:U3 small nucleolar ribonucleoprotein protein IMP4,compositionally biased region:Arg-rich,domain:Brix,
222093_s_at	INO80 complex subunit B(INO80B)	Homo sapiens				GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031011~Ino80 complex,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR006880:PAPA-1-like conserved region,IPR007529:Zinc finger, HIT-type,				SM01406:SM01406,	Coiled coil,Complete proteome,DNA damage,DNA recombination,DNA repair,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:INO80 complex subunit B,compositionally biased region:Lys-rich,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,zinc finger region:HIT-type,
220165_at	INO80 complex subunit D(INO80D)	Homo sapiens				GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,		IPR025927:Potential DNA-binding domain,					Alternative splicing,Complete proteome,DNA damage,DNA recombination,DNA repair,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:INO80 complex subunit D,compositionally biased region:Poly-Asp,sequence conflict,sequence variant,
221251_x_at, 65133_i_at	INO80B-WBP1 readthrough (NMD candidate)(INO80B-WBP1)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,	GO:0031011~Ino80 complex,		IPR006880:PAPA-1-like conserved region,IPR007529:Zinc finger, HIT-type,				SM01406:SM01406,	Coiled coil,Complete proteome,Reference proteome,
206502_s_at	INSM transcriptional repressor 1(INSM1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001933~negative regulation of protein phosphorylation,GO:0003309~type B pancreatic cell differentiation,GO:0003310~pancreatic A cell differentiation,GO:0003323~type B pancreatic cell development,GO:0003358~noradrenergic neuron development,GO:0006351~transcription, DNA-templated,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0030335~positive regulation of cell migration,GO:0031018~endocrine pancreas development,GO:0042421~norepinephrine biosynthetic process,GO:0043254~regulation of protein complex assembly,GO:0045597~positive regulation of cell differentiation,GO:0060290~transdifferentiation,GO:0061104~adrenal chromaffin cell differentiation,GO:0061549~sympathetic ganglion development,GO:0071158~positive regulation of cell cycle arrest,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0030332~cyclin binding,GO:0031490~chromatin DNA binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Cell cycle,Complete proteome,Developmental protein,Differentiation,DNA-binding,Metal-binding,Neurogenesis,Nucleus,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Insulinoma-associated protein 1,compositionally biased region:Ala/Gly/Pro-rich,zinc finger region:C2H2-type 1; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
203907_s_at, 203906_at	IQ motif and Sec7 domain 1(IQSEC1)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,SM00233:PH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Lipid-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 1,domain:IQ,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
214819_at	IQ motif and Sec7 domain 2(IQSEC2)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:1900454~positive regulation of long term synaptic depression,	GO:0005737~cytoplasm,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,	309530~Mental retardation, X-linked 1,		SM00222:Sec7,SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Mental retardation,Methylation,Phosphoprotein,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 2,compositionally biased region:His-rich,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:IQ,domain:PH,domain:SEC7,modified residue,splice variant,
213834_at	IQ motif and Sec7 domain 3(IQSEC3)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:IQ,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
205995_x_at, 211707_s_at	IQ motif containing B1(IQCB1)	Homo sapiens				GO:0042384~cilium assembly,GO:0045494~photoreceptor cell maintenance,GO:0048496~maintenance of organ identity,GO:0060271~cilium morphogenesis,	GO:0001750~photoreceptor outer segment,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0015630~microtubule cytoskeleton,GO:0032391~photoreceptor connecting cilium,GO:0045171~intercellular bridge,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019899~enzyme binding,	IPR000048:IQ motif, EF-hand binding site,IPR016024:Armadillo-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		609254~Senior-Loken syndrome 5,		SM00015:IQ,	Alternative splicing,Calmodulin-binding,Ciliopathy,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Leber congenital amaurosis,Nephronophthisis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Senior-Loken syndrome,	chain:IQ calmodulin-binding motif-containing protein 1,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:IQ 4,modified residue,sequence variant,splice variant,
206650_at	IQ motif containing C(IQCC)	Homo sapiens							IPR000048:IQ motif, EF-hand binding site,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:IQ domain-containing protein C,domain:IQ,sequence conflict,sequence variant,splice variant,
204202_at, 217124_at	IQ motif containing E(IQCE)	Homo sapiens			Cell division and chromosome partitioning,		GO:0005739~mitochondrion,GO:0072372~primary cilium,	GO:0005515~protein binding,	IPR000048:IQ motif, EF-hand binding site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,	Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:IQ domain-containing protein E,compositionally biased region:Poly-Lys,domain:IQ 1,domain:IQ 2,modified residue,sequence conflict,sequence variant,splice variant,
221185_s_at	IQ motif containing G(IQCG)	Homo sapiens				GO:0007286~spermatid development,GO:0007288~sperm axoneme assembly,	GO:0002177~manchette,GO:0005737~cytoplasm,GO:0031514~motile cilium,GO:0036126~sperm flagellum,GO:0070062~extracellular exosome,	GO:0005516~calmodulin binding,GO:0030544~Hsp70 protein binding,	IPR000048:IQ motif, EF-hand binding site,					3D-structure,Alternative splicing,Calmodulin-binding,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Polymorphism,Reference proteome,Spermatogenesis,	chain:IQ domain-containing protein G,domain:IQ,sequence conflict,sequence variant,splice variant,
210840_s_at, 200791_s_at, 213446_s_at	IQ motif containing GTPase activating protein 1(IQGAP1)	Homo sapiens			Cell division and chromosome partitioning / Signal transduction mechanisms,	GO:0001817~regulation of cytokine production,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0034260~negative regulation of GTPase activity,GO:0035305~negative regulation of dephosphorylation,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0043087~regulation of GTPase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0051894~positive regulation of focal adhesion assembly,GO:0071277~cellular response to calcium ion,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0072015~glomerular visceral epithelial cell development,GO:0098609~cell-cell adhesion,GO:1900006~positive regulation of dendrite development,GO:1900086~positive regulation of peptidyl-tyrosine autophosphorylation,GO:1903829~positive regulation of cellular protein localization,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1990138~neuron projection extension,GO:1990776~response to angiotensin,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016328~lateral plasma membrane,GO:0030424~axon,GO:0030426~growth cone,GO:0030496~midbody,GO:0030529~intracellular ribonucleoprotein complex,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031252~cell leading edge,GO:0036057~slit diaphragm,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005095~GTPase inhibitor activity,GO:0005096~GTPase activator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0043539~protein serine/threonine kinase activator activity,GO:0044548~S100 protein binding,GO:0048365~Rac GTPase binding,GO:0051019~mitogen-activated protein kinase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000048:IQ motif, EF-hand binding site,IPR000593:RasGAP protein, C-terminal,IPR001202:WW domain,IPR001715:Calponin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR023152:Ras GTPase-activating protein, conserved site,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04520:Adherens junction,hsa04810:Regulation of actin cytoskeleton,hsa05205:Proteoglycans in cancer,			SM00015:IQ,SM00033:CH,SM00323:RasGAP,SM00456:WW,	3D-structure,Acetylation,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Direct protein sequencing,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Ras GTPase-activating-like protein IQGAP1,domain:CH,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:IQ 4,domain:Ras-GAP,domain:WW,helix,modified residue,mutagenesis site,region of interest:C1,region of interest:C2,sequence variant,strand,turn,
203474_at	IQ motif containing GTPase activating protein 2(IQGAP2)	Homo sapiens				GO:0007165~signal transduction,GO:0034260~negative regulation of GTPase activity,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0043087~regulation of GTPase activity,GO:0070493~thrombin receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005902~microvillus,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0031941~filamentous actin,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005095~GTPase inhibitor activity,GO:0005516~calmodulin binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0017048~Rho GTPase binding,GO:0048365~Rac GTPase binding,GO:0051015~actin filament binding,GO:0071933~Arp2/3 complex binding,	IPR000048:IQ motif, EF-hand binding site,IPR000593:RasGAP protein, C-terminal,IPR001202:WW domain,IPR001715:Calponin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR023152:Ras GTPase-activating protein, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04810:Regulation of actin cytoskeleton,			SM00015:IQ,SM00033:CH,SM00323:RasGAP,	3D-structure,Alternative splicing,Calmodulin-binding,Coiled coil,Complete proteome,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Ras GTPase-activating-like protein IQGAP2,compositionally biased region:Poly-Lys,domain:CH,domain:IQ 1,domain:IQ 2,domain:IQ 3,domain:Ras-GAP,domain:WW,modified residue,sequence variant,splice variant,
220361_at	IQ motif containing H(IQCH)	Homo sapiens							IPR000048:IQ motif, EF-hand binding site,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:IQ domain-containing protein H,domain:IQ,sequence conflict,sequence variant,splice variant,
213392_at, 215130_s_at, 216135_at, 215131_at	IQ motif containing K(IQCK)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:IQ domain-containing protein K,sequence variant,splice variant,
220274_at	IQ motif containing with AAA domain 1(IQCA1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,			GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,	chain:IQ and AAA domain-containing protein 1,compositionally biased region:Lys-rich,domain:IQ,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
204030_s_at	IQCJ-SCHIP1 readthrough(IQCJ-SCHIP1)	Homo sapiens					GO:0005737~cytoplasm,		IPR015649:Schwannomin interacting protein 1,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,
205483_s_at	ISG15 ubiquitin-like modifier(ISG15)	Homo sapiens				GO:0019941~modification-dependent protein catabolic process,GO:0019985~translesion synthesis,GO:0030501~positive regulation of bone mineralization,GO:0031397~negative regulation of protein ubiquitination,GO:0032020~ISG15-protein conjugation,GO:0032480~negative regulation of type I interferon production,GO:0032649~regulation of interferon-gamma production,GO:0034340~response to type I interferon,GO:0042742~defense response to bacterium,GO:0045071~negative regulation of viral genome replication,GO:0045648~positive regulation of erythrocyte differentiation,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0031386~protein tag,	IPR000626:Ubiquitin,IPR019956:Ubiquitin subgroup,	hsa04622:RIG-I-like receptor signaling pathway,	616126~Immunodeficiency 38,		SM00213:UBQ,	3D-structure,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Host-virus interaction,Immunity,Innate immunity,Isopeptide bond,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Secreted,Ubl conjugation pathway,	binding site:Activating enzyme,chain:Interferon-induced 17 kDa protein,chain:Ubiquitin cross-reactive protein,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),domain:Ubiquitin-like 1,domain:Ubiquitin-like 2,helix,propeptide:Removed in mature form,region of interest:Involved in the ligation of specific target proteins,sequence conflict,sequence variant,strand,
206104_at	ISL LIM homeobox 1(ISL1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001755~neural crest cell migration,GO:0003139~secondary heart field specification,GO:0003148~outflow tract septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003266~regulation of secondary heart field cardioblast proliferation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0021520~spinal cord motor neuron cell fate specification,GO:0021522~spinal cord motor neuron differentiation,GO:0021524~visceral motor neuron differentiation,GO:0021559~trigeminal nerve development,GO:0021983~pituitary gland development,GO:0031016~pancreas development,GO:0031103~axon regeneration,GO:0031290~retinal ganglion cell axon guidance,GO:0032024~positive regulation of insulin secretion,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032730~positive regulation of interleukin-1 alpha production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035066~positive regulation of histone acetylation,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0043388~positive regulation of DNA binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0045665~negative regulation of neuron differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048665~neuron fate specification,GO:0048762~mesenchymal cell differentiation,GO:0048880~sensory system development,GO:0048936~peripheral nervous system neuron axonogenesis,GO:0050728~negative regulation of inflammatory response,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060037~pharyngeal system development,GO:0060379~cardiac muscle cell myoblast differentiation,GO:0060384~innervation,GO:0060413~atrial septum morphogenesis,GO:0060913~cardiac cell fate determination,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071657~positive regulation of granulocyte colony-stimulating factor production,GO:0090074~negative regulation of protein homodimerization activity,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1901258~positive regulation of macrophage colony-stimulating factor production,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001158~enhancer sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0030331~estrogen receptor binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00132:LIM,SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Insulin gene enhancer protein ISL-1,compositionally biased region:Gln-rich,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,modified residue,
200851_s_at	IST1, ESCRT-III associated factor(IST1)	Homo sapiens				GO:0000910~cytokinesis,GO:0008104~protein localization,GO:0009838~abscission,GO:0015031~protein transport,GO:0019076~viral release from host cell,GO:0036258~multivesicular body assembly,GO:0045184~establishment of protein localization,GO:0045862~positive regulation of proteolysis,GO:0046745~viral capsid secondary envelopment,GO:0048672~positive regulation of collateral sprouting,GO:0051301~cell division,GO:0098609~cell-cell adhesion,GO:1904903~ESCRT III complex disassembly,	GO:0005635~nuclear envelope,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030496~midbody,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,GO:0090543~Flemming body,	GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0090541~MIT domain binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR005061:Domain of unknown function DUF292, eukaryotic,	hsa04144:Endocytosis,				3D-structure,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:IST1 homolog,helix,modified residue,mutagenesis site,region of interest:Interaction with CHMP1A and CHMP1B,region of interest:Interaction with VPS37B,region of interest:Interaction with VPS4A, VTA1, MITD1 STAMBP and USP8,region of interest:Interaction with VTA1,short sequence motif:MIT-interacting motif,short sequence motif:Type-2 MIT-interacting motif,splice variant,turn,
214296_x_at, 215734_at	IZUMO family member 4(IZUMO4)	Homo sapiens					GO:0005576~extracellular region,GO:0005634~nucleus,							Alternative splicing,Complete proteome,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C19orf36,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
206734_at	JRK-like(JRKL)	Homo sapiens				GO:0007417~central nervous system development,	GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR004875:DDE superfamily endonuclease, CENP-B-like,IPR006600:HTH CenpB-type DNA-binding domain,IPR007889:DNA binding HTH domain, Psq-type,IPR009057:Homeodomain-like,				SM00674:CENPB,	Complete proteome,DNA-binding,Nucleus,Reference proteome,	chain:Jerky protein homolog-like,DNA-binding region:H-T-H motif,domain:DDE,domain:HTH CENPB-type,domain:HTH psq-type,sequence conflict,
201648_at	Janus kinase 1(JAK1)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,48.mice_minus_JAKs_and_STATs,75.Stats_activators_of_Apoptosis,	h_egfPathway:EGF Signaling Pathway,h_ifnaPathway:IFN alpha signaling pathway,h_ifngPathway:IFN gamma signaling pathway ,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_pdgfPathway:PDGF Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0000165~MAPK cascade,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038110~interleukin-2-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0046677~response to antibiotic,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:1903672~positive regulation of sprouting angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005131~growth hormone receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0031625~ubiquitin protein ligase binding,GO:0031730~CCR5 chemokine receptor binding,GO:0046872~metal ion binding,	IPR000299:FERM domain,IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016251:Tyrosine-protein kinase, non-receptor Jak/Tyk2,IPR017441:Protein kinase, ATP binding site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020776:Tyrosine-protein kinase, non-receptor Jak1,	hsa04151:PI3K-Akt signaling pathway,hsa04380:Osteoclast differentiation,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,		PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,	3D-structure,Acetylation,ATP-binding,Coiled coil,Complete proteome,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase JAK1,domain:FERM,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH2,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
205841_at, 205842_s_at	Janus kinase 2(JAK2)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,48.mice_minus_JAKs_and_STATs,75.Stats_activators_of_Apoptosis,	h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_epoPathway:EPO Signaling Pathway,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_ifngPathway:IFN gamma signaling pathway ,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_stat3Pathway:Stat3 Signaling Pathway,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0002250~adaptive immune response,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0007165~signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007259~JAK-STAT cascade,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007262~STAT protein import into nucleus,GO:0007498~mesoderm development,GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010811~positive regulation of cell-substrate adhesion,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0022408~negative regulation of cell-cell adhesion,GO:0030041~actin filament polymerization,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0031103~axon regeneration,GO:0031959~mineralocorticoid receptor signaling pathway,GO:0032024~positive regulation of insulin secretion,GO:0032496~response to lipopolysaccharide,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0033194~response to hydroperoxide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034612~response to tumor necrosis factor,GO:0035409~histone H3-Y41 phosphorylation,GO:0035556~intracellular signal transduction,GO:0035722~interleukin-12-mediated signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0042503~tyrosine phosphorylation of Stat3 protein,GO:0042506~tyrosine phosphorylation of Stat5 protein,GO:0042508~tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0042977~activation of JAK2 kinase activity,GO:0042981~regulation of apoptotic process,GO:0043388~positive regulation of DNA binding,GO:0043392~negative regulation of DNA binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045597~positive regulation of cell differentiation,GO:0045822~negative regulation of heart contraction,GO:0046677~response to antibiotic,GO:0046777~protein autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050867~positive regulation of cell activation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0060399~positive regulation of growth hormone receptor signaling pathway,GO:0061180~mammary gland epithelium development,GO:0070671~response to interleukin-12,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1902728~positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,GO:1904037~positive regulation of epithelial cell apoptotic process,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005901~caveola,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031904~endosome lumen,GO:0045121~membrane raft,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005131~growth hormone receptor binding,GO:0005143~interleukin-12 receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0020037~heme binding,GO:0031702~type 1 angiotensin receptor binding,GO:0033130~acetylcholine receptor binding,GO:0035401~histone kinase activity (H3-Y41 specific),GO:0042169~SH2 domain binding,GO:0042393~histone binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043560~insulin receptor substrate binding,GO:0046872~metal ion binding,GO:0051428~peptide hormone receptor binding,	IPR000299:FERM domain,IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016251:Tyrosine-protein kinase, non-receptor Jak/Tyk2,IPR017441:Protein kinase, ATP binding site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020693:Tyrosine-protein kinase, non-receptor Jak2,	hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa04725:Cholinergic synapse,hsa04917:Prolactin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	133100~Erythrocytosis, somatic,254450~Myelofibrosis, somatic,263300~Polycythemia vera, somatic,600800~Budd-Chiari syndrome, somatic,601626~Leukemia, acute myeloid, somatic,614521~Thrombocythemia 3,	PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,	3D-structure,Adaptive immunity,ATP-binding,Chromatin regulator,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Immunity,Innate immunity,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase JAK2,domain:FERM,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH2; atypical,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,site:Breakpoint for translocation to form PCM1-JAK2 fusion protein,strand,turn,
211108_s_at, 207187_at, 211109_at	Janus kinase 3(JAK3)	Homo sapiens	48.mice_minus_JAKs_and_STATs,	h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0000165~MAPK cascade,GO:0002250~adaptive immune response,GO:0002731~negative regulation of dendritic cell cytokine production,GO:0006468~protein phosphorylation,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007262~STAT protein import into nucleus,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030183~B cell differentiation,GO:0032693~negative regulation of interleukin-10 production,GO:0032695~negative regulation of interleukin-12 production,GO:0035556~intracellular signal transduction,GO:0035771~interleukin-4-mediated signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042102~positive regulation of T cell proliferation,GO:0043029~T cell homeostasis,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0045221~negative regulation of FasL biosynthetic process,GO:0045626~negative regulation of T-helper 1 cell differentiation,GO:0050868~negative regulation of T cell activation,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070232~regulation of T cell apoptotic process,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0070669~response to interleukin-2,GO:0070670~response to interleukin-4,GO:0070672~response to interleukin-15,GO:0071104~response to interleukin-9,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,	IPR000299:FERM domain,IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016251:Tyrosine-protein kinase, non-receptor Jak/Tyk2,IPR017441:Protein kinase, ATP binding site,IPR019749:Band 4.1 domain,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020775:Tyrosine-protein kinase, non-receptor Jak3,	hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,	600802~SCID, autosomal recessive, T-negative/B-positive type,	PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,	3D-structure,Adaptive immunity,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Immunity,Innate immunity,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SCID,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase JAK3,domain:FERM,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH2; atypical,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
201751_at	Josephin domain containing 1(JOSD1)	Homo sapiens				GO:0016579~protein deubiquitination,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,	IPR006155:Machado-Joseph disease protein MJD,				SM01246:SM01246,	Cell membrane,Complete proteome,Cytoplasm,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Josephin-1,domain:Josephin,sequence variant,
214692_s_at, 217146_at, 216309_x_at, 37872_at	Jrk helix-turn-helix protein(JRK)	Homo sapiens					GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR004875:DDE superfamily endonuclease, CENP-B-like,IPR006600:HTH CenpB-type DNA-binding domain,IPR007889:DNA binding HTH domain, Psq-type,IPR009057:Homeodomain-like,				SM00674:CENPB,	Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,
201464_x_at, 201466_s_at, 201465_s_at, 213281_at	Jun proto-oncogene, AP-1 transcription factor subunit(JUN)	Homo sapiens	114.Genomic_reformatting_Brain_Ischemia,3.T_cell_receptor,67.Ikaros_and_signaling_inhibitors,77.IkBa_Kinase_JNK_MEKK1,92.Ancient_Host_Defense_Pathways,	h_41BBPathway:The 4-1BB-dependent immune response,h_agrPathway:Agrin in Postsynaptic Differentiation,h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_atmPathway:ATM Signaling Pathway,h_bcrPathway:BCR Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_d4gdiPathway:D4-GDI Signaling Pathway,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_igf1Pathway:IGF-1 Signaling Pathway,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il1rPathway:Signal transduction through IL1R,h_il2Pathway:IL 2 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_ngfPathway:Nerve growth factor pathway (NGF),h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,h_pdgfPathway:PDGF Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_tpoPathway:TPO Signaling Pathway,h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0001525~angiogenesis,GO:0001774~microglial cell activation,GO:0001836~release of cytochrome c from mitochondria,GO:0001889~liver development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0003151~outflow tract morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007184~SMAD protein import into nucleus,GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009612~response to mechanical stimulus,GO:0010634~positive regulation of epithelial cell migration,GO:0010941~regulation of cell death,GO:0030224~monocyte differentiation,GO:0031103~axon regeneration,GO:0031953~negative regulation of protein autophosphorylation,GO:0032496~response to lipopolysaccharide,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0035026~leading edge cell differentiation,GO:0035994~response to muscle stretch,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043392~negative regulation of DNA binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0043923~positive regulation by host of viral transcription,GO:0045597~positive regulation of cell differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051365~cellular response to potassium ion starvation,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0051899~membrane depolarization,GO:0060395~SMAD protein signal transduction,GO:0061029~eyelid development in camera-type eye,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071277~cellular response to calcium ion,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000144~positive regulation of DNA-templated transcription, initiation,	GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005719~nuclear euchromatin,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0070412~R-SMAD binding,GO:0071837~HMG box domain binding,	IPR002112:Transcription factor Jun,IPR004827:Basic-leucine zipper domain,IPR005643:Jun-like transcription factor,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR015558:c-Jun Transcription Factor,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04024:cAMP signaling pathway,hsa04310:Wnt signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05231:Choline metabolism in cancer,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,			SM00338:BRLZ,	3D-structure,Acetylation,Activator,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor AP-1,DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,sequence conflict,sequence variant,
201473_at	JunB proto-oncogene, AP-1 transcription factor subunit(JUNB)	Homo sapiens	114.Genomic_reformatting_Brain_Ischemia,	h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001649~osteoblast differentiation,GO:0001829~trophectodermal cell differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009314~response to radiation,GO:0009612~response to mechanical stimulus,GO:0010941~regulation of cell death,GO:0030316~osteoclast differentiation,GO:0032496~response to lipopolysaccharide,GO:0032870~cellular response to hormone stimulus,GO:0033687~osteoblast proliferation,GO:0034097~response to cytokine,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0045597~positive regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046697~decidualization,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0060136~embryonic process involved in female pregnancy,GO:0060716~labyrinthine layer blood vessel development,GO:0071277~cellular response to calcium ion,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR001352:Ribonuclease HII/HIII,IPR002112:Transcription factor Jun,IPR004649:Ribonuclease H2, subunit A,IPR004827:Basic-leucine zipper domain,IPR005643:Jun-like transcription factor,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR012337:Ribonuclease H-like domain,IPR023160:Ribonuclease HII, helix-loop-helix cap domain,IPR024567:Ribonuclease HII/HIII domain,	hsa04380:Osteoclast differentiation,hsa04668:TNF signaling pathway,			SM00338:BRLZ,	Acetylation,Coiled coil,Complete proteome,DNA-binding,Endonuclease,Hydrolase,Isopeptide bond,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor jun-B,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,
203752_s_at, 203751_x_at, 214326_x_at	JunD proto-oncogene, AP-1 transcription factor subunit(JUND)	Homo sapiens		h_bcellsurvivalPathway:B Cell Survival Pathway,h_fosbPathway:FOSB gene expression and drug abuse,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002076~osteoblast development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007568~aging,GO:0007623~circadian rhythm,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009612~response to mechanical stimulus,GO:0010941~regulation of cell death,GO:0032496~response to lipopolysaccharide,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043434~response to peptide hormone,GO:0045597~positive regulation of cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0071277~cellular response to calcium ion,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR002112:Transcription factor Jun,IPR004827:Basic-leucine zipper domain,IPR005643:Jun-like transcription factor,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,	hsa04010:MAPK signaling pathway,hsa04380:Osteoclast differentiation,			SM00338:BRLZ,	3D-structure,Activator,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor jun-D,compositionally biased region:Poly-Ala,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,
215046_at	KAT8 regulatory NSL complex subunit 1 like(KANSL1L)	Homo sapiens				GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0044545~NSL complex,	GO:0001047~core promoter binding,GO:0035035~histone acetyltransferase binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR026180:KAT8 regulatory NSL complex subunit 1,				SM01300:SM01300,	Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C2orf67,modified residue,sequence conflict,splice variant,
221821_s_at	KAT8 regulatory NSL complex subunit 2(KANSL2)	Homo sapiens				GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0044545~NSL complex,	GO:0005515~protein binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR025927:Potential DNA-binding domain,IPR026316:KAT8 regulatory NSL complex subunit 2,					3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Uncharacterized protein C12orf41,modified residue,sequence variant,splice variant,
220950_s_at	KAT8 regulatory NSL complex subunit 3(KANSL3)	Homo sapiens				GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR026555:KAT8 regulatory NSL complex subunit 3/Testis-expressed sequence 30 protein,					Alternative splicing,Chromatin regulator,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA1310,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
220629_at	KCNQ1 downstream neighbor (non-protein coding)(KCNQ1DN)	Homo sapiens												Complete proteome,Reference proteome,	chain:KCNQ1 downstream neighbor protein,
204486_at	KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1)	Homo sapiens									130650~Beckwith-Wiedemann syndrome,
200922_at	KDEL endoplasmic reticulum protein retention receptor 1(KDELR1)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006621~protein retention in ER lumen,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005801~cis-Golgi network,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0030663~COPI-coated vesicle membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005046~KDEL sequence binding,GO:0046923~ER retention sequence binding,	IPR000133:ER lumen protein retaining receptor,	hsa05110:Vibrio cholerae infection,				Alternative splicing,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,ER-Golgi transport,Membrane,Phosphoprotein,Protein transport,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ER lumen protein retaining receptor 1,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200700_s_at, 200699_at, 200698_at	KDEL endoplasmic reticulum protein retention receptor 2(KDELR2)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006621~protein retention in ER lumen,GO:0006886~intracellular protein transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0070062~extracellular exosome,	GO:0005046~KDEL sequence binding,GO:0046923~ER retention sequence binding,	IPR000133:ER lumen protein retaining receptor,	hsa05110:Vibrio cholerae infection,				Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Protein transport,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ER lumen protein retaining receptor 2,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
204017_at, 207265_s_at, 207264_at	KDEL endoplasmic reticulum protein retention receptor 3(KDELR3)	Homo sapiens		h_arapPathway:ADP-Ribosylation Factor,		GO:0006621~protein retention in ER lumen,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0015031~protein transport,GO:0036498~IRE1-mediated unfolded protein response,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,	GO:0046923~ER retention sequence binding,	IPR000133:ER lumen protein retaining receptor,	hsa05110:Vibrio cholerae infection,				Alternative splicing,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Membrane,Polymorphism,Protein transport,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ER lumen protein retaining receptor 3,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
219479_at	KDEL motif containing 1(KDELC1)	Homo sapiens				GO:0006664~glycolipid metabolic process,	GO:0005788~endoplasmic reticulum lumen,	GO:0046527~glucosyltransferase activity,	IPR001298:Filamin/ABP280 repeat,IPR006598:Lipopolysaccharide-modifying protein,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,				SM00557:IG_FLMN,SM00672:CAP10,	3D-structure,Complete proteome,Endoplasmic reticulum,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:KDEL motif-containing protein 1,glycosylation site:N-linked (GlcNAc...),repeat:Filamin,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,strand,turn,
200040_at, 201488_x_at, 214185_at	KH RNA binding domain containing, signal transduction associated 1(KHDRBS1)	Homo sapiens		h_sam68Pathway:Regulation of Splicing through Sam68,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0009967~positive regulation of signal transduction,GO:0031647~regulation of protein stability,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070618~Grb2-Sos complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Complete proteome,Direct protein sequencing,Isopeptide bond,Membrane,Methylation,mRNA processing,Nucleus,Phosphoprotein,Reference proteome,RNA-binding,SH3-binding,Transcription,Transcription regulation,Ubl conjugation,	chain:KH domain-containing, RNA-binding, signal transduction-associated protein 1,compositionally biased region:Arg/Gly-rich,compositionally biased region:DMA/Gly-rich,compositionally biased region:Pro-rich,domain:KH,modified residue,splice variant,
215527_at	KH RNA binding domain containing, signal transduction associated 2(KHDRBS2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0042169~SH2 domain binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	Complete proteome,Methylation,mRNA processing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,SH3-binding,Transcription,Transcription regulation,	chain:KH domain-containing, RNA-binding, signal transduction-associated protein 2,compositionally biased region:Pro-rich,domain:KH,modified residue,sequence conflict,sequence variant,
209781_s_at	KH RNA binding domain containing, signal transduction associated 3(KHDRBS3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007283~spermatogenesis,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,SH3-binding,Transcription,Transcription regulation,	chain:KH domain-containing, RNA-binding, signal transduction-associated protein 3,compositionally biased region:Pro-rich,compositionally biased region:Tyr-rich,domain:KH,modified residue,mutagenesis site,region of interest:Interaction with SIAH1,sequence conflict,splice variant,
212356_at, 212355_at	KH and NYN domain containing(KHNYN)	Homo sapiens						GO:0003723~RNA binding,	IPR004088:K Homology domain, type 1,IPR021869:Ribonuclease Zc3h12a-like,					3D-structure,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein KIAA0323,modified residue,sequence variant,
220513_at	KH domain containing 1 like(KHDC1L)	Homo sapiens												Complete proteome,Reference proteome,	chain:KH homology domain-containing protein 1,domain:KH; atypical,sequence conflict,splice variant,transmembrane region,
204372_s_at, 212303_x_at, 204371_s_at	KH-type splicing regulatory protein(KHSRP)	Homo sapiens				GO:0000375~RNA splicing, via transesterification reactions,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,GO:0043488~regulation of mRNA stability,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051028~mRNA transport,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071345~cellular response to cytokine stimulus,GO:2000628~regulation of miRNA metabolic process,	GO:0000178~exosome (RNase complex),GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR009019:K homology domain, prokaryotic type,IPR015096:Domain of unknown function DUF1897,				SM00322:KH,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Transport,Ubl conjugation,	chain:Far upstream element-binding protein 2,compositionally biased region:Ala/Gly/Pro-rich,compositionally biased region:Gly-rich,compositionally biased region:Gly/Pro-rich,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,helix,modified residue,region of interest:4 X 12 AA imperfect repeats,repeat:1,repeat:2,repeat:3,repeat:4,sequence conflict,splice variant,strand,turn,
203143_s_at, 203144_s_at	KIAA0040(KIAA0040)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0040,sequence variant,
207161_at	KIAA0087(KIAA0087)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA0087,modified residue,sequence variant,
201729_s_at, 201728_s_at	KIAA0100(KIAA0100)	Homo sapiens					GO:0005576~extracellular region,		IPR019439:FMP27, N-terminal,IPR019441:FMP27, GFWDK domain,IPR019443:FMP27,  C-terminal,				SM01214:SM01214,	Alternative splicing,Coiled coil,Complete proteome,Glycoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:UPF0378 protein KIAA0100,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
202503_s_at, 211713_x_at	KIAA0101(KIAA0101)	Homo sapiens				GO:0006260~DNA replication,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0051297~centrosome organization,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0003682~chromatin binding,GO:0005515~protein binding,						3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA repair,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:PCNA-associated factor,modified residue,mutagenesis site,sequence variant,
201977_s_at, 201978_s_at	KIAA0141(KIAA0141)	Homo sapiens			General function prediction only,	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR006597:Sel1-like,IPR011990:Tetratricopeptide-like helical,				SM00671:SEL1,	Apoptosis,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transit peptide,	chain:Uncharacterized protein KIAA0141, mitochondrial,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,sequence variant,transit peptide:Mitochondrion,
201985_at	KIAA0196(KIAA0196)	Homo sapiens				GO:0001556~oocyte maturation,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0040038~polar body extrusion after meiotic divisions,GO:0090306~spindle assembly involved in meiosis,	GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0071203~WASH complex,	GO:0005515~protein binding,	IPR019393:WASH complex, subunit strumpellin,	hsa04144:Endocytosis,	220210~Ritscher-Schinzel syndrome 1,603563~Spastic paraplegia 8, autosomal dominant,			Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Endosome,Hereditary spastic paraplegia,Mental retardation,Neurodegeneration,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:WASH complex subunit strumpellin,modified residue,sequence conflict,sequence variant,
212441_at	KIAA0232(KIAA0232)	Homo sapiens						GO:0005524~ATP binding,						ATP-binding,Complete proteome,Nucleotide-binding,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein KIAA0232,compositionally biased region:Poly-Ser,modified residue,nucleotide phosphate-binding region:ATP,
217929_s_at	KIAA0319 like(KIAA0319L)	Homo sapiens					GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000601:PKD domain,IPR013980:Seven cysteines,IPR022409:PKD/Chitinase domain,				SM00089:PKD,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0319-like,domain:MANSC,domain:PKD 1,domain:PKD 2,domain:PKD 3,domain:PKD 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
206017_at	KIAA0319(KIAA0319)	Homo sapiens				GO:0001764~neuron migration,GO:2000171~negative regulation of dendrite development,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,	GO:0005515~protein binding,	IPR000601:PKD domain,IPR002859:PKD/REJ-like protein,IPR003961:Fibronectin, type III,IPR011106:Seven cysteines, N-terminal,IPR013980:Seven cysteines,IPR022409:PKD/Chitinase domain,		600202~Dyslexia, susceptibility to, 2,		SM00060:FN3,SM00089:PKD,SM00765:MANEC,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Endosome,Glycoprotein,Membrane,Neurogenesis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA0319,domain:MANSC,domain:PKD 1,domain:PKD 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203288_at	KIAA0355(KIAA0355)	Homo sapiens												Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0355,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence conflict,
212428_at, 212427_at, 214356_s_at	KIAA0368(KIAA0368)	Homo sapiens				GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0043248~proteasome assembly,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005802~trans-Golgi network,GO:0005813~centrosome,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030134~ER to Golgi transport vesicle,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0032947~protein complex scaffold,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024372:Proteasome stabiliser ECM29,IPR026827:Proteasome component ECM29/Translational activator GCN1,					Acetylation,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Endoplasmic reticulum,Endosome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteasome,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:Proteasome-associated protein ECM29 homolog,modified residue,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 12,repeat:HEAT 13,repeat:HEAT 14,repeat:HEAT 15,repeat:HEAT 16,repeat:HEAT 17,repeat:HEAT 18,repeat:HEAT 19,repeat:HEAT 2,repeat:HEAT 20,repeat:HEAT 21,repeat:HEAT 22,repeat:HEAT 23,repeat:HEAT 24,repeat:HEAT 25,repeat:HEAT 26,repeat:HEAT 27,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,sequence variant,
202714_s_at	KIAA0391(KIAA0391)	Homo sapiens				GO:0001682~tRNA 5'-leader removal,GO:0008033~tRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:0090646~mitochondrial tRNA processing,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,	GO:0004526~ribonuclease P activity,						3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,tRNA processing,	chain:Mitochondrial ribonuclease P protein 3,modified residue,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
205496_at	KIAA0408(KIAA0408)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C6orf174,chain:Uncharacterized protein KIAA0408,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,sequence variant,signal peptide,splice variant,transmembrane region,
202386_s_at	KIAA0430(KIAA0430)	Homo sapiens				GO:0006302~double-strand break repair,GO:0007143~female meiotic division,GO:0010468~regulation of gene expression,GO:0010923~negative regulation of phosphatase activity,GO:0048477~oogenesis,	GO:0005777~peroxisome,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021139:NYN domain, limkain-b1-type,IPR024582:Limkain b1, conserved domain,IPR024768:Limkain-b1,IPR025605:OST-HTH/LOTUS domain,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Differentiation,Meiosis,Oogenesis,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Limkain-b1,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:RRM,helix,modified residue,sequence conflict,splice variant,strand,turn,
204546_at	KIAA0513(KIAA0513)	Homo sapiens					GO:0005737~cytoplasm,		IPR022096:Myotubularin protein,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0513,sequence variant,splice variant,
213185_at	KIAA0556(KIAA0556)	Homo sapiens					GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0042995~cell projection,		IPR026704:Uncharacterised protein KIAA0556,					Cell projection,Ciliopathy,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Joubert syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0556,compositionally biased region:Poly-Arg,modified residue,sequence variant,
37232_at, 205631_at	KIAA0586(KIAA0586)	Homo sapiens				GO:0007224~smoothened signaling pathway,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0070201~regulation of establishment of protein localization,	GO:0001917~photoreceptor inner segment,GO:0005813~centrosome,GO:0005814~centriole,GO:0036064~ciliary basal body,				616490~Joubert syndrome 23,616546~Short-rib thoracic dysplasia 14 with polydactyly,			Alternative splicing,Cell projection,Ciliopathy,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Joubert syndrome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0586,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),
204711_at	KIAA0753(KIAA0753)	Homo sapiens				GO:0007099~centriole replication,GO:0071539~protein localization to centrosome,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0034451~centriolar satellite,	GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein KIAA0753,sequence conflict,sequence variant,splice variant,
215268_at	KIAA0754(KIAA0754)	Homo sapiens					GO:0005886~plasma membrane,							Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Uncharacterized protein KIAA0754,compositionally biased region:Ala-rich,modified residue,region of interest:13 X 13 AA approximate tandem repeat of P-T-S-P-A-A-A-V-P-T-P-E-E,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,
213424_at	KIAA0895(KIAA0895)	Homo sapiens							IPR012548:Protein of unknown function DUF1704,				SM01154:SM01154,	Alternative splicing,Complete proteome,Reference proteome,	chain:Uncharacterized protein KIAA0895,compositionally biased region:Arg-rich,sequence conflict,splice variant,
202220_at	KIAA0907(KIAA0907)	Homo sapiens					GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR004088:K Homology domain, type 1,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:UPF0469 protein KIAA0907,compositionally biased region:Pro-rich,helix,modified residue,splice variant,strand,turn,
209760_at	KIAA0922(KIAA0922)	Homo sapiens				GO:0016055~Wnt signaling pathway,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR022113:Protein of unknown function DUF3651, TMEM131,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Endoplasmic reticulum,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Transmembrane protein 131-like,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212421_at, 217118_s_at	KIAA0930(KIAA0930)	Homo sapiens							IPR019141:Protein of unknown function DUF2045,					Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C22orf9,modified residue,splice variant,
215081_at	KIAA1024(KIAA1024)	Homo sapiens					GO:0016021~integral component of membrane,		IPR009626:Uncharacterised protein family UPF0258,					Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0258 protein KIAA1024,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
215936_s_at, 212794_s_at, 212795_at	KIAA1033(KIAA1033)	Homo sapiens				GO:0007032~endosome organization,GO:0015031~protein transport,GO:0016197~endosomal transport,	GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0031083~BLOC-1 complex,GO:0071203~WASH complex,		IPR027307:WASH complex subunit 7,	hsa04144:Endocytosis,	615817~Mental retardation, autosomal recessive 43,			Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Endosome,Mental retardation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:WASH complex subunit 7,modified residue,sequence conflict,sequence variant,splice variant,
214098_at	KIAA1107(KIAA1107)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1107,modified residue,sequence conflict,sequence variant,splice variant,
216294_s_at, 212779_at, 214929_s_at	KIAA1109(KIAA1109)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0030856~regulation of epithelial cell differentiation,	GO:0005634~nucleus,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR018863:Fragile site-associated protein, C-terminal,				SM01220:SM01220,	Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA1109,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
214134_at	KIAA1211 like(KIAA1211L)	Homo sapiens							IPR026713:Probable exonuclease mut-7 homolog, isoform 5,					Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C2orf55,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,
221874_at	KIAA1324(KIAA1324)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0009267~cellular response to starvation,GO:0044090~positive regulation of vacuole organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0044822~poly(A) RNA binding,	IPR009011:Mannose-6-phosphate receptor binding domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,				SM01411:SM01411,	Alternative splicing,Autophagy,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:UPF0577 protein KIAA1324,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214796_at	KIAA1456(KIAA1456)	Homo sapiens				GO:0002098~tRNA wobble uridine modification,GO:0006400~tRNA modification,GO:0030488~tRNA methylation,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0008175~tRNA methyltransferase activity,GO:0008198~ferrous iron binding,GO:0016300~tRNA (uracil) methyltransferase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,	IPR013216:Methyltransferase type 11,					Alternative splicing,Complete proteome,Methyltransferase,Phosphoprotein,Polymorphism,Reference proteome,S-adenosyl-L-methionine,Transferase,tRNA processing,	chain:Putative methyltransferase KIAA1456,sequence variant,splice variant,
213316_at	KIAA1462(KIAA1462)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005911~cell-cell junction,GO:0005912~adherens junction,							Cell adhesion,Cell junction,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1462,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,
214772_at	KIAA1549 like(KIAA1549L)	Homo sapiens					GO:0016021~integral component of membrane,		IPR024606:Protein of unknown function DUF3827,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0606 protein C11orf41,compositionally biased region:Poly-Ile,compositionally biased region:Poly-Pro,splice variant,transmembrane region,
206044_s_at	KIAA1549(KIAA1549)	Homo sapiens					GO:0016021~integral component of membrane,		IPR024606:Protein of unknown function DUF3827,					Alternative promoter usage,Alternative splicing,Chromosomal rearrangement,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0606 protein KIAA1549,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
218614_at	KIAA1551(KIAA1551)	Homo sapiens												Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C12orf35,modified residue,sequence conflict,sequence variant,
215367_at	KIAA1614(KIAA1614)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA1614,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
221901_at, 52837_at	KIAA1644(KIAA1644)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein KIAA1644,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215681_at, 215680_at	KIAA1654 protein(KIAA1654)	Homo sapiens													chain:Putative uncharacterized protein KIAA1654,
212453_at	KIF1 binding protein(KIF1BP)	Homo sapiens				GO:0006839~mitochondrial transport,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005739~mitochondrion,GO:0005856~cytoskeleton,	GO:0005515~protein binding,GO:0019894~kinesin binding,	IPR011990:Tetratricopeptide-like helical,IPR022083:KIF-1 binding protein,		609460~Goldberg-Shprintzen megacolon syndrome,			Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Hirschsprung disease,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:KIF1-binding protein,sequence conflict,sequence variant,
211350_s_at, 207963_at, 211351_at	KIF25 antisense RNA 1(KIF25-AS1)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Polymorphism,Reference proteome,
207029_at, 211124_s_at	KIT ligand(KITLG)	Homo sapiens	124.GH-IGF1_thymopoiesis,	h_badPathway:Regulation of BAD phosphorylation,h_erythPathway:Erythrocyte Differentiation Pathway,h_il17Pathway:IL 17 Signaling Pathway,h_mcmPathway:CDK Regulation of DNA Replication,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000165~MAPK cascade,GO:0001541~ovarian follicle development,GO:0001755~neural crest cell migration,GO:0002687~positive regulation of leukocyte migration,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0033026~negative regulation of mast cell apoptotic process,GO:0035162~embryonic hemopoiesis,GO:0035234~ectopic germ cell programmed cell death,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0045636~positive regulation of melanocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0070668~positive regulation of mast cell proliferation,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1902035~positive regulation of hematopoietic stem cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005125~cytokine activity,GO:0005173~stem cell factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003452:Stem cell factor,IPR009079:Four-helical cytokine-like, core,IPR012351:Four-helical cytokine, core,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,	145250~Hyperpigmentation with or without hypopigmentation,611664~Skin/hair/eye pigmentation 7, blond/brown hair,616697~Deafness, congenital, unilateral or asymmetric,	PIRSF015599:Kit ligand precursor/stem cell factor,		3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth factor,Membrane,Non-syndromic deafness,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Kit ligand,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,glycosylation site:O-linked (GalNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
205051_s_at	KIT proto-oncogene receptor tyrosine kinase(KIT)	Homo sapiens		h_badPathway:Regulation of BAD phosphorylation,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001541~ovarian follicle development,GO:0002318~myeloid progenitor cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002327~immature B cell differentiation,GO:0002371~dendritic cell cytokine production,GO:0002551~mast cell chemotaxis,GO:0006687~glycosphingolipid metabolic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0008284~positive regulation of cell proliferation,GO:0008354~germ cell migration,GO:0008360~regulation of cell shape,GO:0008542~visual learning,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010863~positive regulation of phospholipase C activity,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell population maintenance,GO:0030032~lamellipodium assembly,GO:0030097~hemopoiesis,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030318~melanocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0031532~actin cytoskeleton reorganization,GO:0032762~mast cell cytokine production,GO:0035019~somatic stem cell population maintenance,GO:0035162~embryonic hemopoiesis,GO:0035234~ectopic germ cell programmed cell death,GO:0035556~intracellular signal transduction,GO:0035701~hematopoietic stem cell migration,GO:0035855~megakaryocyte development,GO:0038093~Fc receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0038162~erythropoietin-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043069~negative regulation of programmed cell death,GO:0043303~mast cell degranulation,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045747~positive regulation of Notch signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048070~regulation of developmental pigmentation,GO:0048103~somatic stem cell division,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048565~digestive tract development,GO:0048863~stem cell differentiation,GO:0050673~epithelial cell proliferation,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060326~cell chemotaxis,GO:0060374~mast cell differentiation,GO:0070662~mast cell proliferation,GO:0097067~cellular response to thyroid hormone stimulus,GO:0097324~melanocyte migration,GO:0097326~melanocyte adhesion,GO:1905065~positive regulation of vascular smooth muscle cell differentiation,	GO:0001669~acrosomal vesicle,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,	GO:0002020~protease binding,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005020~stem cell factor receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019955~cytokine binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR027263:Mast/stem cell growth factor receptor,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	154800~Mast cell disease,172800~Piebaldism,273300~Germ cell tumors,601626~Leukemia, acute myeloid,606764~Gastrointestinal stromal tumor, familial,	PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type,PIRSF500951:mast/stem cell growth factor receptor [Parent=PIRSF000615],	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mast/stem cell growth factor receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,site:Interaction with APS,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
219871_at	KLF3 antisense RNA 1(KLF3-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein FLJ13197,compositionally biased region:Arg/Gly-rich,
205821_at	KLRC4-KLRK1 readthrough(KLRC4-KLRK1)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0007165~signal transduction,GO:0030101~natural killer cell activation,GO:0030154~cell differentiation,GO:0031295~T cell costimulation,GO:0032729~positive regulation of interferon-gamma production,GO:0034260~negative regulation of GTPase activity,GO:0045087~innate immune response,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0071222~cellular response to lipopolysaccharide,GO:2000502~negative regulation of natural killer cell chemotaxis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0032394~MHC class Ib receptor activity,GO:0042288~MHC class I protein binding,GO:0042803~protein homodimerization activity,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04650:Natural killer cell mediated cytotoxicity,hsa05144:Malaria,			SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Differentiation,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,
213005_s_at	KN motif and ankyrin repeat domains 1(KANK1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010977~negative regulation of neuron projection development,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030336~negative regulation of cell migration,GO:0030837~negative regulation of actin filament polymerization,GO:0035024~negative regulation of Rho protein signal transduction,GO:0035413~positive regulation of catenin import into nucleus,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0090303~positive regulation of wound healing,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900028~negative regulation of ruffle assembly,GO:2000114~regulation of establishment of cell polarity,GO:2000393~negative regulation of lamellipodium morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,IPR021939:Kank N-terminal motif,		612900~Cerebral palsy, spastic quadriplegic, 2,		SM00248:ANK,	Alternative promoter usage,ANK repeat,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,	chain:KN motif and ankyrin repeat domain- containing protein 1,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence variant,
218418_s_at, 221068_at	KN motif and ankyrin repeat domains 2(KANK2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0043069~negative regulation of programmed cell death,GO:0070563~negative regulation of vitamin D receptor signaling pathway,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,IPR021939:Kank N-terminal motif,		616099~Palmoplantar keratoderma and woolly hair,		SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Methylation,Mitochondrion,Palmoplantar keratoderma,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:KN motif and ankyrin repeat domain- containing protein 2,compositionally biased region:Poly-Ser,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,splice variant,
213715_s_at	KN motif and ankyrin repeat domains 3(KANK3)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,IPR021939:Kank N-terminal motif,				SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:KN motif and ankyrin repeat domain- containing protein 3,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence variant,splice variant,
206583_at	KRAB box domain containing 4(KRBOX4)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,	GO:0003676~nucleic acid binding,	IPR001909:Krueppel-associated box,IPR026613:KRAB domain C2H2 zinc finger family,				SM00349:KRAB,	Alternative splicing,Complete proteome,Reference proteome,	chain:Protein ZNF673,domain:KRAB,sequence conflict,splice variant,
214352_s_at, 204009_s_at, 204010_s_at	KRAS proto-oncogene, GTPase(KRAS)	Homo sapiens	65.Integrin_affinity_modulation,	h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000165~MAPK cascade,GO:0001889~liver development,GO:0001934~positive regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0010628~positive regulation of gene expression,GO:0019221~cytokine-mediated signaling pathway,GO:0021897~forebrain astrocyte development,GO:0030036~actin cytoskeleton organization,GO:0031647~regulation of protein stability,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0035022~positive regulation of Rac protein signal transduction,GO:0035176~social behavior,GO:0038002~endocrine signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0043406~positive regulation of MAP kinase activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048873~homeostasis of number of cells within a tissue,GO:0050900~leukocyte migration,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051146~striated muscle cell differentiation,GO:0051384~response to glucocorticoid,GO:0051385~response to mineralocorticoid,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:2000774~positive regulation of cellular senescence,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0045121~membrane raft,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019002~GMP binding,GO:0019003~GDP binding,GO:0030275~LRR domain binding,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR020849:Small GTPase superfamily, Ras type,IPR023313:Ubiquitin-conjugating enzyme, active site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	109800~Bladder cancer, somatic,114480~Breast cancer, somatic,137215~Gastric cancer, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,211980~Lung cancer, somatic,260350~Pancreatic carcinoma, somatic,601626~Leukemia, acute myeloid,609942~Noonan syndrome 3,614470~RAS-associated autoimmune leukoproliferative disorder,615278~Cardiofaciocutaneous syndrome 2,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Cardiomyopathy,Cell membrane,Complete proteome,Cytoplasm,Deafness,Direct protein sequencing,Disease mutation,Ectodermal dysplasia,GTP-binding,Lipoprotein,Magnesium,Membrane,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Palmitate,Polymorphism,Prenylation,Proto-oncogene,Reference proteome,S-nitrosylation,Ubl conjugation pathway,	chain:GTPase KRas,chain:GTPase KRas, N-terminally processed,helix,lipid moiety-binding region:S-farnesyl cysteine; in isoform 2A,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,splice variant,strand,turn,
218798_at	KRI1 homolog(KRI1)	Homo sapiens					GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR018034:KRR1 interacting protein 1,IPR024626:Kri1-like, C-terminal,					Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein KRI1 homolog,compositionally biased region:Glu-rich,modified residue,sequence conflict,sequence variant,splice variant,
34031_i_at, 204738_s_at, 216713_at	KRIT1, ankyrin repeat containing(KRIT1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0007264~small GTPase mediated signal transduction,GO:0010596~negative regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0032092~positive regulation of protein binding,GO:0045454~cell redox homeostasis,GO:0050790~regulation of catalytic activity,GO:2000114~regulation of establishment of cell polarity,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008017~microtubule binding,GO:0030695~GTPase regulator activity,GO:0032403~protein complex binding,	IPR000299:FERM domain,IPR002110:Ankyrin repeat,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR020683:Ankyrin repeat-containing domain,	hsa04015:Rap1 signaling pathway,	116860~Cavernous malformations of CNS and retina,116860~Cerebral cavernous malformations-1,116860~Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations,		SM00248:ANK,SM00295:B41,	3D-structure,Alternative splicing,Angiogenesis,ANK repeat,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Proteomics identification,Reference proteome,Repeat,	chain:Krev interaction trapped protein 1,domain:FERM,region of interest:Required for RAP1A binding,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,
203203_s_at, 203202_at	KRR1, small subunit processome component homolog(KRR1)	Homo sapiens			General function prediction only,	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0032040~small-subunit processome,GO:0045171~intercellular bridge,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR024166:Ribosomal RNA assembly KRR1,			PIRSF006515:ribosomal RNA assembly protein KRR1,	SM00322:KH,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,	chain:KRR1 small subunit processome component homolog,compositionally biased region:Lys-rich,domain:KH,modified residue,sequence conflict,sequence variant,
217511_at, 221000_s_at	Kazal type serine peptidase inhibitor domain 1(KAZALD1)	Homo sapiens				GO:0001503~ossification,GO:0001558~regulation of cell growth,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,	GO:0005614~interstitial matrix,	GO:0005520~insulin-like growth factor binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR002350:Kazal domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011390:Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,			PIRSF018239:IGFBP-related protein, MAC25 type,	SM00280:KAZAL,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Immunoglobulin domain,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Kazal-type serine protease inhibitor domain-containing protein 1,compositionally biased region:Cys-rich,disulfide bond,domain:Ig-like C2-type,domain:IGFBP N-terminal,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
206077_at	Kell blood group, metallo-endopeptidase(KEL)	Homo sapiens				GO:0006508~proteolysis,GO:0006874~cellular calcium ion homeostasis,GO:0008361~regulation of cell size,GO:0010961~cellular magnesium ion homeostasis,GO:0031133~regulation of axon diameter,GO:0042310~vasoconstriction,GO:0042552~myelination,GO:0048741~skeletal muscle fiber development,GO:1901380~negative regulation of potassium ion transmembrane transport,	GO:0005623~cell,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,		110900~Blood group, Kell,			Blood group antigen,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,chain:Kell blood group glycoprotein,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); in KEL2 antigen,metal ion-binding site:Zinc; catalytic,mutagenesis site,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205563_at	KiSS-1 metastasis-suppressor(KISS1)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008285~negative regulation of cell proliferation,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0043410~positive regulation of MAPK cascade,GO:0050806~positive regulation of synaptic transmission,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060112~generation of ovulation cycle rhythm,GO:0060124~positive regulation of growth hormone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016324~apical plasma membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0005515~protein binding,GO:0031773~kisspeptin receptor binding,	IPR020207:Metastasis-suppressor KiSS-1,		614842~Hypogonadotropic hypogonadism 13 with or without anosmia,			Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Hypogonadotropic hypogonadism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Metastasis-suppressor KiSS-1,modified residue,peptide:Kisspeptin-10,peptide:Kisspeptin-13,peptide:Kisspeptin-14,peptide:Metastin,region of interest:Essential for receptor binding and receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by MMP2 and MMP9,
205664_at	Kin17 DNA and RNA binding protein(KIN)	Homo sapiens				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0016032~viral process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0046872~metal ion binding,	IPR019447:DNA/RNA-binding protein Kin17, conserved domain,				SM01253:SM01253,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,DNA damage,DNA recombination,DNA repair,DNA replication,DNA-binding,Host-virus interaction,Metal-binding,Methylation,mRNA processing,Nucleus,Proteomics identification,Reference proteome,RNA-binding,Stress response,Zinc,Zinc-finger,	chain:DNA/RNA-binding protein KIN17,helix,mutagenesis site,region of interest:C-terminal subdomain A,region of interest:C-terminal subdomain B,strand,turn,zinc finger region:C2H2-type,
210504_at	Kruppel like factor 1(KLF1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030218~erythrocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060135~maternal process involved in female pregnancy,GO:1901653~cellular response to peptide,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		111150~Blood group--Lutheran inhibitor,613566~Hereditary persistence of fetal hemoglobin,613673~Dyserythropoietic anemia, congenital, type IV,		SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Complete proteome,Congenital dyserythropoietic anemia,Disease mutation,DNA-binding,Hereditary hemolytic anemia,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
202393_s_at	Kruppel like factor 10(KLF10)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0006351~transcription, DNA-templated,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007623~circadian rhythm,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009267~cellular response to starvation,GO:0030282~bone mineralization,GO:0035019~somatic stem cell population maintenance,GO:0042752~regulation of circadian rhythm,GO:0045672~positive regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0001046~core promoter sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Alternative splicing,Biological rhythms,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 10,helix,modified residue,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
218486_at	Kruppel like factor 11(KLF11)	Homo sapiens			General function prediction only,	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0043065~positive regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		610508~Maturity-onset diabetes of the young, type VII,		SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative splicing,Apoptosis,Complete proteome,Diabetes mellitus,Disease mutation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 11,helix,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
214276_at, 206965_at, 206966_s_at, 208467_at	Kruppel like factor 12(KLF12)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 12,modified residue,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
219878_s_at	Kruppel like factor 13(KLF13)	Homo sapiens			General function prediction only,	GO:0006366~transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 13,compositionally biased region:Ala/Pro-rich,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Poly-Ala,compositionally biased region:Ser-rich,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
221302_at	Kruppel like factor 15(KLF15)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006366~transcription from RNA polymerase II promoter,GO:0010001~glial cell differentiation,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0015758~glucose transport,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0072112~glomerular visceral epithelial cell differentiation,GO:1901653~cellular response to peptide,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0005634~nucleus,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 15,helix,strand,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
219371_s_at	Kruppel like factor 2(KLF2)	Homo sapiens			General function prediction only,	GO:0000902~cell morphogenesis,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0032715~negative regulation of interleukin-6 production,GO:0035264~multicellular organism growth,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0040029~regulation of gene expression, epigenetic,GO:0043249~erythrocyte maturation,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051247~positive regulation of protein metabolic process,GO:0060509~Type I pneumocyte differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071409~cellular response to cycloheximide,GO:0071499~cellular response to laminar fluid shear stress,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04068:FoxO signaling pathway,			SM00355:ZnF_C2H2,	Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
219657_s_at	Kruppel like factor 3(KLF3)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa05202:Transcriptional misregulation in cancer,			SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 3,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),modified residue,region of interest:Repressor domain,sequence conflict,sequence variant,short sequence motif:CTBP-binding motif,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
221841_s_at, 220266_s_at	Kruppel like factor 4(KLF4)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007500~mesodermal cell fate determination,GO:0008285~negative regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0014740~negative regulation of muscle hyperplasia,GO:0019827~stem cell population maintenance,GO:0031077~post-embryonic camera-type eye development,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0035019~somatic stem cell population maintenance,GO:0035166~post-embryonic hemopoiesis,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045444~fat cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048679~regulation of axon regeneration,GO:0048730~epidermis morphogenesis,GO:0050728~negative regulation of inflammatory response,GO:0051247~positive regulation of protein metabolic process,GO:0051898~negative regulation of protein kinase B signaling,GO:0051973~positive regulation of telomerase activity,GO:0060070~canonical Wnt signaling pathway,GO:0060761~negative regulation of response to cytokine stimulus,GO:0070301~cellular response to hydrogen peroxide,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0071409~cellular response to cycloheximide,GO:0071499~cellular response to laminar fluid shear stress,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:1901653~cellular response to peptide,GO:1904998~negative regulation of leukocyte adhesion to arterial endothelial cell,GO:2000342~negative regulation of chemokine (C-X-C motif) ligand 2 production,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005737~cytoplasm,GO:0044798~nuclear transcription factor complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001010~transcription factor activity, sequence-specific DNA binding transcription factor recruiting,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001221~transcription cofactor binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008270~zinc ion binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 4,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
209211_at, 209212_s_at	Kruppel like factor 5(KLF5)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0030033~microvillus assembly,GO:0032534~regulation of microvillus assembly,GO:0035914~skeletal muscle cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060576~intestinal epithelial cell development,GO:0071407~cellular response to organic cyclic compound,GO:1901653~cellular response to peptide,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 5,helix,sequence variant,strand,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
208961_s_at, 211610_at, 208960_s_at	Kruppel like factor 6(KLF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		176807~Prostate cancer, somatic,613659~Gastric cancer, somatic,		SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 6,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
204334_at	Kruppel like factor 7(KLF7)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007411~axon guidance,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048813~dendrite morphogenesis,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 7,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
219930_at	Kruppel like factor 8(KLF8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Krueppel-like factor 8,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),mutagenesis site,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
203541_s_at, 203542_s_at, 203543_s_at	Kruppel like factor 9(KLF9)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0010839~negative regulation of keratinocyte proliferation,GO:0071387~cellular response to cortisol stimulus,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Biological rhythms,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 9,compositionally biased region:Asp/Glu-rich (acidic),zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
218054_s_at, 200076_s_at	KxDL motif containing 1(KXD1)	Homo sapiens				GO:0016192~vesicle-mediated transport,GO:0032418~lysosome localization,	GO:0005765~lysosomal membrane,GO:0031083~BLOC-1 complex,GO:0043234~protein complex,	GO:0005515~protein binding,	IPR019371:Uncharacterised domain KxDL,					Acetylation,Complete proteome,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,	chain:UPF0459 protein C19orf50,sequence variant,
219061_s_at	L antigen family member 3(LAGE3)	Homo sapiens				GO:0008033~tRNA processing,	GO:0005634~nucleus,	GO:0005515~protein binding,	IPR015419:EKC/KEOPS complex, subunit Pcc1,					Complete proteome,Nucleus,Reference proteome,tRNA processing,	chain:L antigen family member 3,
220089_at	L-2-hydroxyglutarate dehydrogenase(L2HGDH)	Homo sapiens				GO:0006103~2-oxoglutarate metabolic process,GO:0044267~cellular protein metabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0031305~integral component of mitochondrial inner membrane,	GO:0016491~oxidoreductase activity,GO:0047545~2-hydroxyglutarate dehydrogenase activity,	IPR006076:FAD dependent oxidoreductase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00650:Butanoate metabolism,	236792~L-2-hydroxyglutaric aciduria,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:L-2-hydroxyglutarate dehydrogenase, mitochondrial,modified residue,sequence variant,splice variant,transit peptide:Mitochondrion,
204585_s_at, 204584_at	L1 cell adhesion molecule(L1CAM)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0045773~positive regulation of axon extension,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0044295~axonal growth cone,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules (CAMs),	303350~CRASH syndrome,303350~MASA syndrome,304100~Corpus callosum, partial agenesis of,307000~Hydrocephalus due to aqueductal stenosis,307000~Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,307000~Hydrocephalus with Hirschsprung disease,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hereditary spastic paraplegia,Hirschsprung disease,Immunoglobulin domain,Membrane,Mental retardation,Neurodegeneration,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule L1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
215543_s_at, 204414_at	LARGE xylosyl- and glucuronyltransferase 1(LARGE1)	Homo sapiens				GO:0006044~N-acetylglucosamine metabolic process,GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0006688~glycosphingolipid biosynthetic process,GO:0009101~glycoprotein biosynthetic process,GO:0035269~protein O-linked mannosylation,GO:0043403~skeletal muscle tissue regeneration,GO:0046716~muscle cell cellular homeostasis,GO:0060538~skeletal muscle organ development,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0008375~acetylglucosaminyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0030145~manganese ion binding,GO:0035252~UDP-xylosyltransferase activity,GO:0042285~xylosyltransferase activity,	IPR002495:Glycosyl transferase, family 8,		608840~Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6,613154~Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6,			Alternative splicing,Coiled coil,Complete proteome,Congenital muscular dystrophy,Disease mutation,Dystroglycanopathy,Glycoprotein,Glycosyltransferase,Golgi apparatus,Lissencephaly,Manganese,Membrane,Metal-binding,Multifunctional enzyme,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Glycosyltransferase-like protein LARGE1,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
208117_s_at	LAS1 like, ribosome biogenesis factor(LAS1L)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0000478~endonucleolytic cleavage involved in rRNA processing,GO:0006325~chromatin organization,GO:0006364~rRNA processing,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0071339~MLL1 complex,	GO:0044822~poly(A) RNA binding,	IPR007174:Las1-like,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,rRNA processing,	chain:Protein LAS1 homolog,modified residue,sequence variant,splice variant,
204891_s_at, 204890_s_at	LCK proto-oncogene, Src family tyrosine kinase(LCK)	Homo sapiens	3.T_cell_receptor,54.T-cell_anergy,63.LAT_couples_T-cell_receptor,67.Ikaros_and_signaling_inhibitors,81.Structure_of_Caps_and_SMACs,	h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_il2Pathway:IL 2 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0006468~protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0006882~cellular zinc ion homeostasis,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0030097~hemopoiesis,GO:0030168~platelet activation,GO:0030217~T cell differentiation,GO:0031295~T cell costimulation,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0045087~innate immune response,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050690~regulation of defense response to virus by virus,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0050900~leukocyte migration,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051249~regulation of lymphocyte activation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000242~pericentriolar material,GO:0001772~immunological synapse,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0042169~SH2 domain binding,GO:0042609~CD4 receptor binding,GO:0042610~CD8 receptor binding,GO:0042802~identical protein binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0051117~ATPase binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa05166:HTLV-I infection,hsa05340:Primary immunodeficiency,	615758~Immunodeficiency 22,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Host-virus interaction,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase LCK,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PTPRH,region of interest:Interactions with CD4 and CD8,sequence conflict,sequence variant,splice variant,strand,turn,
200784_s_at, 200785_s_at	LDL receptor related protein 1(LRP1)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0001523~retinoid metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007568~aging,GO:0008283~cell proliferation,GO:0010715~regulation of extracellular matrix disassembly,GO:0010875~positive regulation of cholesterol efflux,GO:0010977~negative regulation of neuron projection development,GO:0014912~negative regulation of smooth muscle cell migration,GO:0021987~cerebral cortex development,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032370~positive regulation of lipid transport,GO:0032374~regulation of cholesterol transport,GO:0032429~regulation of phospholipase A2 activity,GO:0032956~regulation of actin cytoskeleton organization,GO:0035909~aorta morphogenesis,GO:0042157~lipoprotein metabolic process,GO:0042953~lipoprotein transport,GO:0043277~apoptotic cell clearance,GO:0043524~negative regulation of neuron apoptotic process,GO:0051222~positive regulation of protein transport,GO:0097242~beta-amyloid clearance,GO:2000587~negative regulation of platelet-derived growth factor receptor-beta signaling pathway,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005905~clathrin-coated pit,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0030425~dendrite,GO:0030666~endocytic vesicle membrane,GO:0043025~neuronal cell body,GO:0043235~receptor complex,	GO:0002020~protease binding,GO:0004872~receptor activity,GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0034185~apolipoprotein binding,GO:0042954~lipoprotein transporter activity,GO:0044822~poly(A) RNA binding,GO:0070325~lipoprotein particle receptor binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,	hsa05010:Alzheimer's disease,hsa05144:Malaria,			SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Acetylation,Alternative splicing,Calcium,Cell membrane,Coated pit,Complete proteome,Cytoplasm,Developmental protein,Direct protein sequencing,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 1 515 kDa subunit,chain:Low-density lipoprotein receptor-related protein 1 85 kDa subunit,chain:Low-density lipoprotein receptor-related protein 1 intracellular domain,chain:Prolow-density lipoprotein receptor- related protein 1,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12; calcium-binding,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19,domain:EGF-like 20,domain:EGF-like 21,domain:EGF-like 22,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,modified residue,mutagenesis site,region of interest:Interaction with MAFB,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,short sequence motif:Recognition site for proteolytical processing,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
201412_at	LDL receptor related protein 10(LRP10)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0048839~inner ear development,	GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005041~low-density lipoprotein receptor activity,	IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00042:CUB,SM00192:LDLa,	Alternative splicing,Coated pit,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 10,compositionally biased region:Arg-rich,compositionally biased region:Pro-rich,disulfide bond,domain:CUB 1,domain:CUB 2,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220253_s_at, 219631_at, 220254_at	LDL receptor related protein 12(LRP12)	Homo sapiens				GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0040008~regulation of growth,	GO:0005887~integral component of plasma membrane,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,	GO:0005041~low-density lipoprotein receptor activity,GO:0005515~protein binding,	IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00042:CUB,SM00192:LDLa,	Alternative splicing,Coated pit,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 12,disulfide bond,domain:CUB 1,domain:CUB 2,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219643_at	LDL receptor related protein 1B(LRP1B)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0015031~protein transport,	GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0005509~calcium ion binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 1B,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 32,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 35,repeat:LDL-receptor class B 36,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
205710_at	LDL receptor related protein 2(LRP2)	Homo sapiens			Function unknown,	GO:0001523~retinoid metabolic process,GO:0003281~ventricular septum development,GO:0006486~protein glycosylation,GO:0006629~lipid metabolic process,GO:0006766~vitamin metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0008283~cell proliferation,GO:0030900~forebrain development,GO:0035904~aorta development,GO:0042359~vitamin D metabolic process,GO:0042953~lipoprotein transport,GO:0060976~coronary vasculature development,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030139~endocytic vesicle,GO:0031526~brush border membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0042954~lipoprotein transporter activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR019825:Legume lectin, beta chain, Mn/Ca-binding site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,	hsa04340:Hedgehog signaling pathway,hsa04918:Thyroid hormone synthesis,	222448~Donnai-Barrow syndrome,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Calcium,Coated pit,Complete proteome,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,SH3-binding,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 2,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12; calcium-binding,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15; calcium-binding,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6; calcium-binding,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 32,domain:LDL-receptor class A 33,domain:LDL-receptor class A 34,domain:LDL-receptor class A 35,domain:LDL-receptor class A 36,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 35,repeat:LDL-receptor class B 36,repeat:LDL-receptor class B 37,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,short sequence motif:SH2-binding,short sequence motif:SH3-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
204381_at	LDL receptor related protein 3(LRP3)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,	GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,		IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00042:CUB,SM00192:LDLa,	Coated pit,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 3,compositionally biased region:Poly-Pro,disulfide bond,domain:CUB 1,domain:CUB 2,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212850_s_at	LDL receptor related protein 4(LRP4)	Homo sapiens				GO:0001822~kidney development,GO:0001942~hair follicle development,GO:0006897~endocytosis,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0016055~Wnt signaling pathway,GO:0030279~negative regulation of ossification,GO:0030509~BMP signaling pathway,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042733~embryonic digit morphogenesis,GO:0048513~animal organ development,GO:0048813~dendrite morphogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050771~negative regulation of axonogenesis,GO:0050808~synapse organization,GO:0051124~synaptic growth at neuromuscular junction,GO:0051290~protein heterotetramerization,GO:0060173~limb development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,GO:1901631~positive regulation of presynaptic membrane organization,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,	GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0016600~flotillin complex,GO:0030425~dendrite,GO:0031594~neuromuscular junction,GO:0043025~neuronal cell body,GO:0097060~synaptic membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0034185~apolipoprotein binding,GO:0042803~protein homodimerization activity,GO:0097110~scaffold protein binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,		212780~Cenani-Lenz syndactyly syndrome,614305~Sclerosteosis 2,616304~Myasthenic syndrome, congenital, 17,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	Calcium,Complete proteome,Congenital myasthenic syndrome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Low-density lipoprotein receptor-related protein 4,disulfide bond,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
214873_at	LDL receptor related protein 5 like(LRP5L)	Homo sapiens				GO:0044332~Wnt signaling pathway involved in dorsal/ventral axis specification,GO:0060070~canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0043235~receptor complex,	GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR000033:LDLR class B repeat,IPR011042:Six-bladed beta-propeller, TolB-like,				SM00135:LY,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Low-density lipoprotein receptor-related protein 5-like protein,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,sequence variant,splice variant,
209468_at	LDL receptor related protein 5(LRP5)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002076~osteoblast development,GO:0006007~glucose catabolic process,GO:0006897~endocytosis,GO:0008203~cholesterol metabolic process,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0016055~Wnt signaling pathway,GO:0033690~positive regulation of osteoblast proliferation,GO:0035019~somatic stem cell population maintenance,GO:0035426~extracellular matrix-cell signaling,GO:0042074~cell migration involved in gastrulation,GO:0042632~cholesterol homeostasis,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0043434~response to peptide hormone,GO:0044332~Wnt signaling pathway involved in dorsal/ventral axis specification,GO:0045600~positive regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045840~positive regulation of mitotic nuclear division,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046849~bone remodeling,GO:0046850~regulation of bone remodeling,GO:0048539~bone marrow development,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060033~anatomical structure regression,GO:0060042~retina morphogenesis in camera-type eye,GO:0060070~canonical Wnt signaling pathway,GO:0060349~bone morphogenesis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060612~adipose tissue development,GO:0060764~cell-cell signaling involved in mammary gland development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061304~retinal blood vessel morphogenesis,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:1902262~apoptotic process involved in patterning of blood vessels,GO:1904886~beta-catenin destruction complex disassembly,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:1990851~Wnt-Frizzled-LRP5/6 complex,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0019534~toxin transporter activity,GO:0042813~Wnt-activated receptor activity,GO:0071936~coreceptor activity involved in Wnt signaling pathway,GO:1904928~coreceptor activity involved in canonical Wnt signaling pathway,	IPR000033:LDLR class B repeat,IPR000742:Epidermal growth factor-like domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR011042:Six-bladed beta-propeller, TolB-like,IPR017049:Low density lipoprotein receptor-related protein, 5/6,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04310:Wnt signaling pathway,	144750~Hyperostosis, endosteal,144750~Osteosclerosis,166710~Osteoporosis,259770~Osteoporosis-pseudoglioma syndrome,601813~Exudative vitreoretinopathy 4,601884~Bone mineral density variability 1,607634~Osteopetrosis, autosomal dominant 1,607636~van Buchem disease, type 2,	PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types,	SM00135:LY,SM00181:EGF,SM00192:LDLa,	Complete proteome,Developmental protein,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Endoplasmic reticulum,Glycoprotein,Membrane,Osteogenesis imperfecta,Osteopetrosis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Low-density lipoprotein receptor-related protein 5,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,repeat:YWTD 1,repeat:YWTD 10,repeat:YWTD 11,repeat:YWTD 2,repeat:YWTD 3,repeat:YWTD 4,repeat:YWTD 5,repeat:YWTD 6,repeat:YWTD 7,repeat:YWTD 8,repeat:YWTD 9,sequence conflict,sequence variant,short sequence motif:PPPSP motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
34697_at, 205606_at	LDL receptor related protein 6(LRP6)	Homo sapiens		h_wnt-Lrp6Pathway:Wnt/LRP6 Signalling,		GO:0001843~neural tube closure,GO:0001933~negative regulation of protein phosphorylation,GO:0003344~pericardium morphogenesis,GO:0006469~negative regulation of protein kinase activity,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007268~chemical synaptic transmission,GO:0009880~embryonic pattern specification,GO:0014029~neural crest formation,GO:0014033~neural crest cell differentiation,GO:0016055~Wnt signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0021587~cerebellum morphogenesis,GO:0021794~thalamus development,GO:0021987~cerebral cortex development,GO:0030917~midbrain-hindbrain boundary development,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0035261~external genitalia morphogenesis,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043434~response to peptide hormone,GO:0044332~Wnt signaling pathway involved in dorsal/ventral axis specification,GO:0044335~canonical Wnt signaling pathway involved in neural crest cell differentiation,GO:0044340~canonical Wnt signaling pathway involved in regulation of cell proliferation,GO:0045787~positive regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060021~palate development,GO:0060026~convergent extension,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060070~canonical Wnt signaling pathway,GO:0060325~face morphogenesis,GO:0060535~trachea cartilage morphogenesis,GO:0071397~cellular response to cholesterol,GO:0071542~dopaminergic neuron differentiation,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0072659~protein localization to plasma membrane,GO:0090009~primitive streak formation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090118~receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport,GO:0090244~Wnt signaling pathway involved in somitogenesis,GO:0090245~axis elongation involved in somitogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1901998~toxin transport,GO:1904886~beta-catenin destruction complex disassembly,GO:1904948~midbrain dopaminergic neuron differentiation,GO:1904953~Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,GO:2000055~positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,	GO:0005576~extracellular region,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:0031901~early endosome membrane,GO:0043025~neuronal cell body,GO:0043235~receptor complex,GO:0045202~synapse,GO:1990851~Wnt-Frizzled-LRP5/6 complex,GO:1990909~Wnt signalosome,	GO:0005041~low-density lipoprotein receptor activity,GO:0005102~receptor binding,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0019210~kinase inhibitor activity,GO:0019534~toxin transporter activity,GO:0034185~apolipoprotein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0042813~Wnt-activated receptor activity,GO:0071936~coreceptor activity involved in Wnt signaling pathway,GO:1904928~coreceptor activity involved in canonical Wnt signaling pathway,	IPR000033:LDLR class B repeat,IPR000742:Epidermal growth factor-like domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR011042:Six-bladed beta-propeller, TolB-like,IPR017049:Low density lipoprotein receptor-related protein, 5/6,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04310:Wnt signaling pathway,	610947~Coronary artery disease, autosomal dominant, 2,616724~Tooth agenesis, selective, 7,	PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types,	SM00135:LY,SM00181:EGF,SM00192:LDLa,	3D-structure,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Endoplasmic reticulum,Glycoprotein,Isopeptide bond,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,Wnt signaling pathway,	chain:Low-density lipoprotein receptor-related protein 6,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence variant,short sequence motif:PPPSP motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
208433_s_at, 205282_at	LDL receptor related protein 8(LRP8)	Homo sapiens		h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development,h_reelinPathway:Reelin Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001523~retinoid metabolic process,GO:0006508~proteolysis,GO:0006629~lipid metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0021541~ammon gyrus development,GO:0021987~cerebral cortex development,GO:0032793~positive regulation of CREB transcription factor activity,GO:0038026~reelin-mediated signaling pathway,GO:0042493~response to drug,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050804~modulation of synaptic transmission,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0071363~cellular response to growth factor stimulus,GO:0071397~cellular response to cholesterol,GO:1900006~positive regulation of dendrite development,	GO:0005576~extracellular region,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005041~low-density lipoprotein receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008035~high-density lipoprotein particle binding,GO:0019894~kinesin binding,GO:0030229~very-low-density lipoprotein particle receptor activity,GO:0034185~apolipoprotein binding,GO:0038025~reelin receptor activity,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,		608446~Myocardial infarction, susceptibility to,		SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Low-density lipoprotein receptor-related protein 8,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,glycosylation site:N-linked (GlcNAc...),region of interest:Clustered O-linked oligosaccharides,repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201186_at	LDL receptor related protein associated protein 1(LRPAP1)	Homo sapiens				GO:0006457~protein folding,GO:0010916~negative regulation of very-low-density lipoprotein particle clearance,GO:0016192~vesicle-mediated transport,GO:0032091~negative regulation of protein binding,GO:0048259~regulation of receptor-mediated endocytosis,GO:1900116~extracellular negative regulation of signal transduction,GO:1900222~negative regulation of beta-amyloid clearance,	GO:0005576~extracellular region,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0048237~rough endoplasmic reticulum lumen,	GO:0004873~asialoglycoprotein receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0035473~lipase binding,GO:0048019~receptor antagonist activity,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051082~unfolded protein binding,GO:0070326~very-low-density lipoprotein particle receptor binding,	IPR009066:Alpha-2-macroglobulin receptor-associated protein, domain 1,IPR010483:Alpha-2-macroglobulin RAP, C-terminal,		615431~Myopia 23, autosomal recessive,			3D-structure,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Glycoprotein,Heparin-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Alpha-2-macroglobulin receptor-associated protein,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,region of interest:LDL receptor binding,sequence conflict,sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,strand,turn,
218604_at	LEM domain containing 3(LEMD3)	Homo sapiens				GO:0006998~nuclear envelope organization,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0070197~meiotic attachment of telomere to nuclear envelope,	GO:0005637~nuclear inner membrane,GO:0005639~integral component of nuclear inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,	IPR003887:LEM domain,IPR011015:LEM/LEM-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018996:Inner nuclear membrane protein MAN1,		155950~Melorheostosis with osteopoikilosis,166700~Buschke-Ollendorff syndrome,166700~Osteopoikilosis,		SM00540:LEM,	3D-structure,Acetylation,Complete proteome,DNA-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Inner nuclear membrane protein Man1,compositionally biased region:Ala-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Leu,domain:LEM,helix,modified residue,mutagenesis site,region of interest:Interaction with SMAD1, SMAD2, SMAD3 and SMAD5,sequence conflict,sequence variant,strand,transmembrane region,turn,
207170_s_at	LETM1 domain containing 1(LETMD1)	Homo sapiens					GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0043022~ribosome binding,	IPR011685:LETM1-like,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion outer membrane,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Transmembrane,Transmembrane helix,	chain:LETM1 domain-containing protein 1,domain:LETM1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
215270_at	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase(LFNG)	Homo sapiens		h_hesPathway:Segmentation Clock,		GO:0001541~ovarian follicle development,GO:0001756~somitogenesis,GO:0002315~marginal zone B cell differentiation,GO:0007143~female meiotic division,GO:0007386~compartment pattern specification,GO:0008593~regulation of Notch signaling pathway,GO:0009887~organ morphogenesis,GO:0014807~regulation of somitogenesis,GO:0030217~T cell differentiation,GO:0032092~positive regulation of protein binding,GO:0045747~positive regulation of Notch signaling pathway,GO:1902367~negative regulation of Notch signaling pathway involved in somitogenesis,	GO:0005576~extracellular region,GO:0016020~membrane,GO:0030173~integral component of Golgi membrane,GO:1903561~extracellular vesicle,	GO:0016757~transferase activity, transferring glycosyl groups,GO:0033829~O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,GO:0046872~metal ion binding,	IPR003378:Fringe-like,IPR017374:Fringe,	hsa00514:Other types of O-glycan biosynthesis,hsa04330:Notch signaling pathway,	609813~Spondylocostal dysostosis 3, autosomal recessive,	PIRSF038073:beta-1,3-N-acetylglucosaminyltransferase, radical fringe type,		Alternative splicing,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Dwarfism,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,site:Cleavage; by furin-like protease,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
200618_at	LIM and SH3 protein 1(LASP1)	Homo sapiens				GO:0006811~ion transport,GO:0009967~positive regulation of signal transduction,GO:0034220~ion transmembrane transport,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0030864~cortical actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015075~ion transmembrane transporter activity,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000900:Nebulin 35 residue motif,IPR001452:Src homology-3 domain,IPR001781:Zinc finger, LIM-type,				SM00132:LIM,SM00227:NEBU,SM00326:SH3,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Ion transport,LIM domain,Metal-binding,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH3 domain,Transport,Zinc,	chain:LIM and SH3 domain protein 1,compositionally biased region:Poly-Gly,domain:LIM zinc-binding,domain:SH3,helix,modified residue,repeat:Nebulin 1,repeat:Nebulin 2,sequence conflict,splice variant,strand,
212325_at, 212328_at, 212327_at	LIM and calponin homology domains 1(LIMCH1)	Homo sapiens				GO:0031032~actomyosin structure organization,		GO:0003779~actin binding,GO:0008270~zinc ion binding,	IPR001715:Calponin homology domain,IPR001781:Zinc finger, LIM-type,IPR001997:Calponin,IPR003096:Smooth muscle protein/calponin,				SM00033:CH,SM00132:LIM,	Alternative splicing,Coiled coil,Complete proteome,LIM domain,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:LIM and calponin homology domains- containing protein 1,compositionally biased region:Glu-rich,domain:CH,domain:LIM zinc-binding,modified residue,sequence conflict,sequence variant,splice variant,
218574_s_at	LIM and cysteine rich domains 1(LMCD1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0010611~regulation of cardiac muscle hypertrophy,GO:0044267~cellular protein metabolic process,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031012~extracellular matrix,	GO:0003714~transcription corepressor activity,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR010442:PET domain,				SM00132:LIM,	Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,	chain:LIM and cysteine-rich domains protein 1,compositionally biased region:Cys-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:PET,
202674_s_at	LIM domain 7(LMO7)	Homo sapiens				GO:0016337~single organismal cell-cell adhesion,GO:0016567~protein ubiquitination,GO:0023051~regulation of signaling,GO:0030155~regulation of cell adhesion,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,	IPR001478:PDZ domain,IPR001715:Calponin homology domain,IPR001781:Zinc finger, LIM-type,IPR003096:Smooth muscle protein/calponin,	hsa04520:Adherens junction,			SM00033:CH,SM00132:LIM,SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,LIM domain,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	chain:LIM domain only protein 7,domain:CH,domain:LIM zinc-binding,domain:PDZ,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
217892_s_at	LIM domain and actin binding 1(LIMA1)	Homo sapiens		h_s1pPathway:SREBP control of lipid synthesis,		GO:0030835~negative regulation of actin filament depolymerization,GO:0031529~ruffle organization,GO:0051017~actin filament bundle assembly,GO:0098609~cell-cell adhesion,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0032154~cleavage furrow,	GO:0003785~actin monomer binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Acetylation,Actin-binding,Alternative promoter usage,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,LIM domain,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,	chain:LIM domain and actin-binding protein 1,domain:LIM zinc-binding,helix,modified residue,sequence conflict,splice variant,strand,turn,
203451_at, 35160_at	LIM domain binding 1(LDB1)	Homo sapiens		h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,		GO:0000972~transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0001702~gastrulation with mouth forming second,GO:0001942~hair follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009948~anterior/posterior axis specification,GO:0010669~epithelial structure maintenance,GO:0016055~Wnt signaling pathway,GO:0021702~cerebellar Purkinje cell differentiation,GO:0022607~cellular component assembly,GO:0030182~neuron differentiation,GO:0030334~regulation of cell migration,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0035019~somatic stem cell population maintenance,GO:0043549~regulation of kinase activity,GO:0043973~histone H3-K4 acetylation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045785~positive regulation of cell adhesion,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:0051893~regulation of focal adhesion assembly,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0031252~cell leading edge,GO:0043234~protein complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0030274~LIM domain binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,		hsa05202:Transcriptional misregulation in cancer,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:LIM domain-binding protein 1,modified residue,mutagenesis site,region of interest:LIM-binding domain (LID),sequence variant,splice variant,
206481_s_at	LIM domain binding 2(LDB2)	Homo sapiens				GO:0001942~hair follicle development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010669~epithelial structure maintenance,GO:0030334~regulation of cell migration,GO:0035019~somatic stem cell population maintenance,GO:0043549~regulation of kinase activity,GO:0044089~positive regulation of cellular component biogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0031252~cell leading edge,	GO:0000989~transcription factor activity, transcription factor binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0030274~LIM domain binding,						Alternative splicing,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Ubl conjugation,	chain:LIM domain-binding protein 2,region of interest:LIM-binding domain (LID),splice variant,
213717_at, 216887_s_at, 216888_at, 213371_at	LIM domain binding 3(LDB3)	Homo sapiens				GO:0045214~sarcomere organization,	GO:0005856~cytoskeleton,GO:0030018~Z disc,GO:0031143~pseudopodium,GO:0048471~perinuclear region of cytoplasm,	GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0051371~muscle alpha-actinin binding,	IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,IPR006643:ZASP,		601493~Cardiomyopathy, dilated, 1C, with or without LVNC,601493~Cardiomyopathy, hypertrophic, 24,601493~Left ventricular noncompaction 3,609452~Myopathy, myofibrillar, 4,		SM00132:LIM,SM00228:PDZ,SM00735:ZM,	3D-structure,Alternative splicing,Cardiomyopathy,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,LIM domain,Metal-binding,Methylation,Myofibrillar myopathy,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:LIM domain-binding protein 3,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:PDZ,helix,sequence conflict,sequence variant,splice variant,strand,
218600_at	LIM domain containing 2(LIMD2)	Homo sapiens						GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Acetylation,Complete proteome,LIM domain,Metal-binding,Proteomics identification,Reference proteome,Zinc,	chain:LIM domain-containing protein 2,domain:LIM zinc-binding,modified residue,sequence conflict,
202821_s_at, 214902_x_at, 202822_at	LIM domain containing preferred translocation partner in lipoma(LPP)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005925~focal adhesion,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,		601626~Leukemia, acute myeloid,Lipoma~Lipoma,		SM00132:LIM,	Acetylation,Activator,Cell adhesion,Cell junction,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Isopeptide bond,LIM domain,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Zinc,	chain:Lipoma-preferred partner,compositionally biased region:Pro-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,modified residue,mutagenesis site,sequence variant,site:Breakpoint for translocation to form HMGA2-LPP,site:Breakpoint for translocation to form HMGA2-LPP and MLL-LPP,
204357_s_at, 204356_at, 208372_s_at	LIM domain kinase 1(LIMK1)	Homo sapiens		h_ccr3Pathway:CCR3 signaling in Eosinophils,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_rhoPathway:Rho cell motility signaling pathway,		GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007266~Rho protein signal transduction,GO:0007399~nervous system development,GO:0030036~actin cytoskeleton organization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0045773~positive regulation of axon extension,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051496~positive regulation of stress fiber assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0043005~neuron projection,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0031072~heat shock protein binding,GO:0046982~protein heterodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04360:Axon guidance,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,			SM00132:LIM,SM00228:PDZ,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,LIM domain,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Ubl conjugation,Williams-Beuren syndrome,Zinc,	binding site:ATP,chain:LIM domain kinase 1,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:PDZ,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
217475_s_at, 210582_s_at, 202193_at	LIM domain kinase 2(LIMK2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007283~spermatogenesis,GO:0016310~phosphorylation,GO:0042325~regulation of phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0046982~protein heterodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,IPR008025:PKC-activated phosphatase-1 inhibitor,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04360:Axon guidance,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,			SM00132:LIM,SM00228:PDZ,	3D-structure,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Kinase,LIM domain,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Zinc,	binding site:ATP,chain:LIM domain kinase 2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:PDZ,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
206718_at	LIM domain only 1(LMO1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046013~regulation of T cell homeostatic proliferation,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,		Leukemia, T-cell acute lymphoblastic~Leukemia, T-cell acute lymphoblastic,		SM00132:LIM,	Alternative splicing,Chromosomal rearrangement,Complete proteome,LIM domain,Metal-binding,Nucleus,Proto-oncogene,Reference proteome,Repeat,Zinc,	chain:Rhombotin-1,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,
204249_s_at	LIM domain only 2(LMO2)	Homo sapiens				GO:0007275~multicellular organism development,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043425~bHLH transcription factor binding,GO:0048037~cofactor binding,GO:0070888~E-box binding,	IPR001781:Zinc finger, LIM-type,	hsa05202:Transcriptional misregulation in cancer,	Leukemia, acute T-cell~Leukemia, acute T-cell,		SM00132:LIM,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,LIM domain,Metal-binding,Nucleus,Proto-oncogene,Reference proteome,Repeat,Zinc,	chain:Rhombotin-2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,splice variant,
204424_s_at	LIM domain only 3(LMO3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:2000324~positive regulation of glucocorticoid receptor signaling pathway,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	Alternative splicing,Complete proteome,LIM domain,Metal-binding,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM domain only protein 3,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,
209205_s_at, 209204_at	LIM domain only 4(LMO4)	Homo sapiens				GO:0001843~neural tube closure,GO:0003281~ventricular septum development,GO:0006366~transcription from RNA polymerase II promoter,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021522~spinal cord motor neuron differentiation,GO:0021527~spinal cord association neuron differentiation,GO:0030334~regulation of cell migration,GO:0031333~negative regulation of protein complex assembly,GO:0033674~positive regulation of kinase activity,GO:0042659~regulation of cell fate specification,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048538~thymus development,GO:0050865~regulation of cell activation,	GO:0005667~transcription factor complex,GO:0031252~cell leading edge,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Complete proteome,LIM domain,Metal-binding,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM domain transcription factor LMO4,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,
218850_s_at, 222353_at	LIM domains containing 1(LIMD1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0002076~osteoblast development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0035195~gene silencing by miRNA,GO:0035331~negative regulation of hippo signaling,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0016442~RISC complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,	hsa04390:Hippo signaling pathway,			SM00132:LIM,	Cell junction,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Tumor suppressor,Zinc,	chain:LIM domain-containing protein 1,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,modified residue,region of interest:Interaction with RB1,region of interest:Mediates nuclear export,region of interest:Necessary for nuclear localization,sequence variant,
206230_at	LIM homeobox 1(LHX1)	Homo sapiens				GO:0001655~urogenital system development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001702~gastrulation with mouth forming second,GO:0001705~ectoderm formation,GO:0001706~endoderm formation,GO:0001822~kidney development,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0007389~pattern specification process,GO:0007399~nervous system development,GO:0008045~motor neuron axon guidance,GO:0009653~anatomical structure morphogenesis,GO:0009791~post-embryonic development,GO:0009880~embryonic pattern specification,GO:0009887~organ morphogenesis,GO:0009948~anterior/posterior axis specification,GO:0009952~anterior/posterior pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0010468~regulation of gene expression,GO:0010842~retina layer formation,GO:0021517~ventral spinal cord development,GO:0021527~spinal cord association neuron differentiation,GO:0021537~telencephalon development,GO:0021549~cerebellum development,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021871~forebrain regionalization,GO:0021937~cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,GO:0032525~somite rostral/caudal axis specification,GO:0035502~metanephric part of ureteric bud development,GO:0035846~oviduct epithelium development,GO:0035847~uterine epithelium development,GO:0035849~nephric duct elongation,GO:0035852~horizontal cell localization,GO:0040019~positive regulation of embryonic development,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0048793~pronephros development,GO:0060059~embryonic retina morphogenesis in camera-type eye,GO:0060065~uterus development,GO:0060066~oviduct development,GO:0060067~cervix development,GO:0060068~vagina development,GO:0060322~head development,GO:0060429~epithelium development,GO:0061205~paramesonephric duct development,GO:0072049~comma-shaped body morphogenesis,GO:0072050~S-shaped body morphogenesis,GO:0072077~renal vesicle morphogenesis,GO:0072177~mesonephric duct development,GO:0072178~nephric duct morphogenesis,GO:0072224~metanephric glomerulus development,GO:0072278~metanephric comma-shaped body morphogenesis,GO:0072283~metanephric renal vesicle morphogenesis,GO:0072284~metanephric S-shaped body morphogenesis,GO:0090009~primitive streak formation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0097477~lateral motor column neuron migration,GO:2000543~positive regulation of gastrulation,GO:2000744~positive regulation of anterior head development,GO:2000768~positive regulation of nephron tubule epithelial cell differentiation,	GO:0005634~nucleus,GO:0043234~protein complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	Complete proteome,Developmental protein,Differentiation,DNA-binding,Homeobox,LIM domain,Metal-binding,Neurogenesis,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx1,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,
206140_at, 211219_s_at	LIM homeobox 2(LHX2)	Homo sapiens				GO:0001843~neural tube closure,GO:0001942~hair follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007411~axon guidance,GO:0007498~mesoderm development,GO:0009953~dorsal/ventral pattern formation,GO:0021772~olfactory bulb development,GO:0021978~telencephalon regionalization,GO:0021987~cerebral cortex development,GO:0045199~maintenance of epithelial cell apical/basal polarity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048675~axon extension,GO:0060041~retina development in camera-type eye,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0005634~nucleus,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	Activator,Complete proteome,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx2,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,short sequence motif:Nuclear localization signal,
221670_s_at	LIM homeobox 3(LHX3)	Homo sapiens				GO:0001890~placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008045~motor neuron axon guidance,GO:0009887~organ morphogenesis,GO:0021520~spinal cord motor neuron cell fate specification,GO:0021521~ventral spinal cord interneuron specification,GO:0021526~medial motor column neuron differentiation,GO:0021527~spinal cord association neuron differentiation,GO:0021983~pituitary gland development,GO:0030324~lung development,GO:0043066~negative regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		221750~Pituitary hormone deficiency, combined, 3,		SM00132:LIM,SM00389:HOX,	Activator,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Dwarfism,Homeobox,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx3,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence conflict,sequence variant,splice variant,
208333_at	LIM homeobox 5(LHX5)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0021527~spinal cord association neuron differentiation,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021766~hippocampus development,GO:0021846~cell proliferation in forebrain,GO:0021879~forebrain neuron differentiation,GO:0021937~cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00132:LIM,SM00389:HOX,	Complete proteome,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx5,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,modified residue,
219884_at	LIM homeobox 6(LHX6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021800~cerebral cortex tangential migration,GO:0021853~cerebral cortex GABAergic interneuron migration,GO:0048469~cell maturation,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00132:LIM,SM00389:HOX,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,DNA-binding,Homeobox,LIM domain,Metal-binding,Neurogenesis,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM/homeobox protein Lhx6,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,region of interest:Required for interaction with LBD1,sequence conflict,splice variant,
208487_at	LIM homeobox transcription factor 1 beta(LMX1B)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0009953~dorsal/ventral pattern formation,GO:0030182~neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071542~dopaminergic neuron differentiation,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001781:Zinc finger, LIM-type,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		161200~Nail-patella syndrome,		SM00132:LIM,SM00389:HOX,	Activator,Alternative splicing,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,LIM domain,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,	chain:LIM homeobox transcription factor 1-beta,compositionally biased region:Poly-Gln,DNA-binding region:Homeobox,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,sequence variant,splice variant,
220765_s_at	LIM zinc finger domain containing 2(LIMS2)	Homo sapiens				GO:0016337~single organismal cell-cell adhesion,GO:0034329~cell junction assembly,GO:0043066~negative regulation of apoptotic process,GO:0045216~cell-cell junction organization,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000346~negative regulation of hepatocyte proliferation,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,LIM domain,Limb-girdle muscular dystrophy,Membrane,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:LIM and senescent cell antigen-like- containing domain protein 2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,domain:LIM zinc-binding 5,modified residue,sequence conflict,splice variant,
207198_s_at, 212687_at	LIM zinc finger domain containing 4(LIMS4)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Proteomics identification,Reference proteome,Zinc,
219955_at	LINE1 type transposase domain containing 1(L1TD1)	Homo sapiens				GO:0032197~transposition, RNA-mediated,	GO:0030529~intracellular ribonucleoprotein complex,	GO:0003727~single-stranded RNA binding,	IPR004244:Transposase, L1,					3D-structure,Acetylation,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:LINE-1 type transposase domain-containing protein 1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,
206124_s_at, 206123_at	LLGL1, scribble cell polarity complex component(LLGL1)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006887~exocytosis,GO:0006893~Golgi to plasma membrane transport,GO:0007409~axonogenesis,GO:0008593~regulation of Notch signaling pathway,GO:0017157~regulation of exocytosis,GO:0022008~neurogenesis,GO:0030866~cortical actin cytoskeleton organization,GO:0032878~regulation of establishment or maintenance of cell polarity,GO:0043547~positive regulation of GTPase activity,GO:0050708~regulation of protein secretion,GO:0051294~establishment of spindle orientation,	GO:0000137~Golgi cis cisterna,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030424~axon,GO:0030864~cortical actin cytoskeleton,GO:0031901~early endosome membrane,GO:0032588~trans-Golgi network membrane,	GO:0005096~GTPase activator activity,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0019901~protein kinase binding,GO:0019905~syntaxin binding,	IPR000664:Lethal(2) giant larvae protein,IPR001680:WD40 repeat,IPR013577:Lethal giant larvae homologue 2,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	hsa04390:Hippo signaling pathway,hsa04530:Tight junction,			SM00320:WD40,	Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,Exocytosis,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Lethal(2) giant larvae protein homolog 1,modified residue,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,
203713_s_at	LLGL2, scribble cell polarity complex component(LLGL2)	Homo sapiens				GO:0006887~exocytosis,GO:0008593~regulation of Notch signaling pathway,GO:0017157~regulation of exocytosis,GO:0022008~neurogenesis,GO:0030866~cortical actin cytoskeleton organization,GO:0032878~regulation of establishment or maintenance of cell polarity,GO:0043547~positive regulation of GTPase activity,GO:0050708~regulation of protein secretion,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030864~cortical actin cytoskeleton,GO:0043231~intracellular membrane-bounded organelle,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0019905~syntaxin binding,GO:0030165~PDZ domain binding,	IPR000664:Lethal(2) giant larvae protein,IPR001680:WD40 repeat,IPR013577:Lethal giant larvae homologue 2,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	hsa04390:Hippo signaling pathway,hsa04530:Tight junction,			SM00320:WD40,	3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Exocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Lethal(2) giant larvae protein homolog 2,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 14,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence variant,splice variant,
209779_at	LLP homolog, long-term synaptic facilitation(LLPH)	Homo sapiens				GO:0060999~positive regulation of dendritic spine development,GO:0097484~dendrite extension,	GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0044822~poly(A) RNA binding,	IPR018784:Learning associated protein 18-like,					Chromosome,Complete proteome,Isopeptide bond,Nucleus,Reference proteome,Ubl conjugation,	chain:Protein LLP homolog,compositionally biased region:Lys-rich,sequence conflict,
218191_s_at	LMBR1 domain containing 1(LMBRD1)	Homo sapiens				GO:0009235~cobalamin metabolic process,GO:0015889~cobalamin transport,GO:0016032~viral process,GO:0038016~insulin receptor internalization,GO:0046325~negative regulation of glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045334~clathrin-coated endocytic vesicle,	GO:0005158~insulin receptor binding,GO:0015235~cobalamin transporter activity,GO:0031419~cobalamin binding,	IPR006876:LMBR1-like membrane protein,	hsa04977:Vitamin digestion and absorption,	277380~Methylmalonic aciduria and homocystinuria, cblF type,			Alternative splicing,Cobalamin,Cobalt,Complete proteome,Glycoprotein,Host-virus interaction,Lysosome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Probable lysosomal cobalamin transporter,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
202332_at	LOC400927-CSNK1E readthrough(LOC400927-CSNK1E)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006281~DNA repair,GO:0006364~rRNA processing,GO:0006468~protein phosphorylation,GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0016055~Wnt signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032922~circadian regulation of gene expression,GO:0034613~cellular protein localization,GO:0042752~regulation of circadian rhythm,GO:0048512~circadian behavior,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902004~positive regulation of beta-amyloid formation,GO:1903827~regulation of cellular protein localization,GO:1904340~positive regulation of dopaminergic neuron differentiation,GO:1990090~cellular response to nerve growth factor stimulus,GO:2000052~positive regulation of non-canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0043025~neuronal cell body,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04068:FoxO signaling pathway,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04390:Hippo signaling pathway,hsa04710:Circadian rhythm,			SM00220:S_TKc,	3D-structure,ATP-binding,Biological rhythms,Complete proteome,Cytoplasm,Kinase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,
215322_at	LON peptidase N-terminal domain and ring finger 1(LONRF1)	Homo sapiens			General function prediction only,	GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,	GO:0005829~cytosol,	GO:0004176~ATP-dependent peptidase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR003111:Peptidase S16, lon N-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015947:PUA-like domain,IPR017907:Zinc finger, RING-type, conserved site,IPR019734:Tetratricopeptide repeat,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00028:TPR,SM00184:RING,SM00464:LON,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Zinc,Zinc-finger,	chain:LON peptidase N-terminal domain and RING finger protein 1,domain:Lon,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type 1,zinc finger region:RING-type 2,
220009_at	LON peptidase N-terminal domain and ring finger 3(LONRF3)	Homo sapiens				GO:0006508~proteolysis,		GO:0004176~ATP-dependent peptidase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR003111:Peptidase S16, lon N-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015947:PUA-like domain,IPR017907:Zinc finger, RING-type, conserved site,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,SM00184:RING,SM00464:LON,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Zinc,Zinc-finger,	chain:LON peptidase N-terminal domain and RING finger protein 3,domain:Lon,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence variant,splice variant,zinc finger region:RING-type 1,zinc finger region:RING-type 2,
212692_s_at, 214109_at	LPS responsive beige-like anchor protein(LRBA)	Homo sapiens					GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR010508:Domain of unknown function DUF1088,IPR011993:Pleckstrin homology-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR023362:PH-BEACH domain,		614700~Immunodeficiency, common variable, 8, with autoimmunity,		SM00320:WD40,SM01026:SM01026,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Endoplasmic reticulum,Golgi apparatus,Lysosome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,WD repeat,	chain:Lipopolysaccharide-responsive and beige- like anchor protein,compositionally biased region:Poly-Arg,domain:BEACH,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,sequence variant,splice variant,strand,transmembrane region,turn,
207797_s_at	LRP2 binding protein(LRP2BP)	Homo sapiens			General function prediction only,		GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR006597:Sel1-like,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00671:SEL1,	Alternative splicing,Complete proteome,Cytoplasm,Reference proteome,Repeat,TPR repeat,	chain:LRP2-binding protein,modified residue,repeat:Sel1-like 1,repeat:Sel1-like 2,repeat:Sel1-like 3,repeat:Sel1-like 4,repeat:Sel1-like 5,repeat:Sel1-like 6,repeat:TPR,splice variant,
215375_x_at, 211452_x_at, 201861_s_at, 201862_s_at	LRR binding FLII interacting protein 1(LRRFIP1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032481~positive regulation of type I interferon production,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,	GO:0003677~DNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR019139:Leucine-rich repeat flightless-interacting protein,					3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Leucine-rich repeat flightless- interacting protein 1,compositionally biased region:Lys-rich,modified residue,region of interest:DNA-binding,sequence conflict,sequence variant,splice variant,
218364_at, 220610_s_at	LRR binding FLII interacting protein 2(LRRFIP2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006355~regulation of transcription, DNA-templated,GO:0016055~Wnt signaling pathway,		GO:0005515~protein binding,GO:0030275~LRR domain binding,	IPR019139:Leucine-rich repeat flightless-interacting protein,					Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Wnt signaling pathway,	chain:Leucine-rich repeat flightless- interacting protein 2,compositionally biased region:Ser-rich,modified residue,region of interest:DVL3-binding,sequence variant,splice variant,
219653_at	LSM family member 14B(LSM14B)	Homo sapiens				GO:0006417~regulation of translation,GO:0007275~multicellular organism development,	GO:0030529~intracellular ribonucleoprotein complex,	GO:0044822~poly(A) RNA binding,	IPR010920:Like-Sm (LSM) domain,IPR019050:FDF domain,IPR025609:Lsm14 N-terminal,IPR025761:FFD box,IPR025762:DFDF domain,IPR025768:TFG box,				SM01199:SM01199,SM01271:SM01271,	Acetylation,Alternative splicing,Complete proteome,Developmental protein,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Translation regulation,	chain:Protein LSM14 homolog B,domain:FFD-TFG box,modified residue,sequence conflict,short sequence motif:FDF,splice variant,
203534_at	LSM1 homolog, mRNA degradation associated(LSM1)	Homo sapiens				GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0000375~RNA splicing, via transesterification reactions,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0019827~stem cell population maintenance,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045665~negative regulation of neuron differentiation,GO:0071044~histone mRNA catabolic process,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:1990124~messenger ribonucleoprotein complex,	GO:0000339~RNA cap binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	hsa03018:RNA degradation,			SM00651:Sm,	Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,	chain:U6 snRNA-associated Sm-like protein LSm1,
212529_at, 212532_s_at	LSM12 homolog(LSM12)	Homo sapiens							IPR019181:Anticodon-binding domain,				SM00995:SM00995,	Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein LSM12 homolog,modified residue,sequence variant,splice variant,
212132_at, 222099_s_at, 212131_at	LSM14A, mRNA processing body assembly factor(LSM14A)	Homo sapiens				GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0039529~RIG-I signaling pathway,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0043231~intracellular membrane-bounded organelle,	GO:0003690~double-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0044822~poly(A) RNA binding,	IPR010920:Like-Sm (LSM) domain,IPR019050:FDF domain,IPR025609:Lsm14 N-terminal,IPR025761:FFD box,IPR025762:DFDF domain,IPR025768:TFG box,				SM01199:SM01199,SM01271:SM01271,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Ribonucleoprotein,Translation regulation,	chain:Protein LSM14 homolog A,domain:FFD-TFG box,modified residue,sequence conflict,sequence variant,short sequence motif:FDF,splice variant,
209449_at	LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM2)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005654~nucleoplasm,GO:0005688~U6 snRNP,GO:0005829~cytosol,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017070~U6 snRNA binding,GO:0017160~Ral GTPase binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR016654:U6 snRNA-associated Sm-like protein LSm2,	hsa03018:RNA degradation,hsa03040:Spliceosome,		PIRSF016394:U6 snRNA-associated Sm-like protein LSm2,	SM00651:Sm,	3D-structure,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm2,modified residue,
202209_at	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM3)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005688~U6 snRNP,GO:0005829~cytosol,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	hsa03018:RNA degradation,hsa03040:Spliceosome,			SM00651:Sm,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm3,modified residue,
202737_s_at, 212924_s_at, 202736_s_at	LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM4)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005829~cytosol,GO:0043005~neuron projection,GO:0097526~spliceosomal tri-snRNP complex,	GO:0005515~protein binding,GO:0017070~U6 snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	hsa03018:RNA degradation,hsa03040:Spliceosome,			SM00651:Sm,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm4,modified residue,
211747_s_at, 202904_s_at, 202903_at	LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM5)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005829~cytosol,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	hsa03018:RNA degradation,hsa03040:Spliceosome,			SM00651:Sm,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm5,modified residue,
205036_at	LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM6)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0008033~tRNA processing,GO:0008380~RNA splicing,GO:0030490~maturation of SSU-rRNA,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005829~cytosol,GO:0030532~small nuclear ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR016487:Small nuclear ribonucleoprotein SmF,	hsa03018:RNA degradation,hsa03040:Spliceosome,		PIRSF006609:small nuclear ribonucleoprotein SmF,	SM00651:Sm,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Reference proteome,Ribonucleoprotein,RNA-binding,rRNA processing,Spliceosome,tRNA processing,	chain:U6 snRNA-associated Sm-like protein LSm6,modified residue,
204559_s_at	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated(LSM7)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0005654~nucleoplasm,GO:0005688~U6 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005829~cytosol,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017070~U6 snRNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR017132:U6 snRNA-associated Sm-like protein LSm7,	hsa03018:RNA degradation,hsa03040:Spliceosome,		PIRSF037188:U6 snRNA-associated Sm-like protein LSm7,	SM00651:Sm,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm7,
219119_at	LSM8 homolog, U6 small nuclear RNA associated(LSM8)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017070~U6 snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,	hsa03018:RNA degradation,hsa03040:Spliceosome,			SM00651:Sm,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Proteomics identification,Reference proteome,Ribonucleoprotein,RNA-binding,Spliceosome,	chain:U6 snRNA-associated Sm-like protein LSm8,modified residue,
208835_s_at, 220044_x_at, 203804_s_at	LUC7 like 3 pre-mRNA splicing factor(LUC7L3)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005685~U1 snRNP,GO:0016607~nuclear speck,GO:0071004~U2-type prespliceosome,	GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004882:LUC7-related,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Luc7-like protein 3,compositionally biased region:Arg/Ser-rich,compositionally biased region:Glu-rich,modified residue,sequence conflict,splice variant,
220143_x_at	LUC7 like(LUC7L)	Homo sapiens				GO:0006376~mRNA splice site selection,GO:0045843~negative regulation of striated muscle tissue development,	GO:0005685~U1 snRNP,GO:0071004~U2-type prespliceosome,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0050733~RS domain binding,	IPR004882:LUC7-related,					Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Putative RNA-binding protein Luc7-like 1,compositionally biased region:Arg/Ser-rich,modified residue,sequence conflict,splice variant,zinc finger region:C2H2-type; atypical,
212909_at	LY6/PLAUR domain containing 1(LYPD1)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001775~cell activation,GO:0007271~synaptic transmission, cholinergic,GO:0035094~response to nicotine,GO:0095500~acetylcholine receptor signaling pathway,GO:1903077~negative regulation of protein localization to plasma membrane,GO:2000272~negative regulation of receptor activity,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0030550~acetylcholine receptor inhibitor activity,GO:0033130~acetylcholine receptor binding,						Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Signal,	chain:Ly6/PLAUR domain-containing protein 1,domain:UPAR/Ly6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,
204952_at	LY6/PLAUR domain containing 3(LYPD3)	Homo sapiens				GO:0007160~cell-matrix adhesion,	GO:0005615~extracellular space,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0043236~laminin binding,	IPR016054:Ly-6 antigen / uPA receptor -like,				SM00134:LU,	Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Repeat,Signal,	chain:Ly6/PLAUR domain-containing protein 3,domain:UPAR/Ly6 1,domain:UPAR/Ly6 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,signal peptide,
203799_at	LY75-CD302 readthrough(LY75-CD302)	Homo sapiens				GO:0006897~endocytosis,GO:0006954~inflammatory response,GO:0006955~immune response,	GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,
210044_s_at	LYL1, basic helix-loop-helix family member(LYL1)	Homo sapiens				GO:0001955~blood vessel maturation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030183~B cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa05202:Transcriptional misregulation in cancer,	Leukemia, T-cell acute lymphoblastoid~Leukemia, T-cell acute lymphoblastoid,		SM00353:HLH,	Chromosomal rearrangement,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Protein lyl-1,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,
210754_s_at, 202626_s_at, 202625_at	LYN proto-oncogene, Src family tyrosine kinase(LYN)	Homo sapiens	74.CD47-IAP_with_avB3,	h_bcrPathway:BCR Signaling Pathway,h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0001782~B cell homeostasis,GO:0001817~regulation of cytokine production,GO:0001932~regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002513~tolerance induction to self antigen,GO:0002553~histamine secretion by mast cell,GO:0002576~platelet degranulation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002774~Fc receptor mediated inhibitory signaling pathway,GO:0002902~regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0006991~response to sterol depletion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007417~central nervous system development,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009725~response to hormone,GO:0009743~response to carbohydrate,GO:0010976~positive regulation of neuron projection development,GO:0014003~oligodendrocyte development,GO:0014070~response to organic cyclic compound,GO:0016032~viral process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030168~platelet activation,GO:0030218~erythrocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0030889~negative regulation of B cell proliferation,GO:0031175~neuron projection development,GO:0031295~T cell costimulation,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031668~cellular response to extracellular stimulus,GO:0032868~response to insulin,GO:0033003~regulation of mast cell activation,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0034136~negative regulation of toll-like receptor 2 signaling pathway,GO:0034144~negative regulation of toll-like receptor 4 signaling pathway,GO:0034605~cellular response to heat,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042493~response to drug,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043200~response to amino acid,GO:0043304~regulation of mast cell degranulation,GO:0043407~negative regulation of MAP kinase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045087~innate immune response,GO:0045646~regulation of erythrocyte differentiation,GO:0046777~protein autophosphorylation,GO:0048013~ephrin receptor signaling pathway,GO:0048678~response to axon injury,GO:0050663~cytokine secretion,GO:0050707~regulation of cytokine secretion,GO:0050727~regulation of inflammatory response,GO:0050777~negative regulation of immune response,GO:0050853~B cell receptor signaling pathway,GO:0050855~regulation of B cell receptor signaling pathway,GO:0050861~positive regulation of B cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051272~positive regulation of cellular component movement,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0060252~positive regulation of glial cell proliferation,GO:0060369~positive regulation of Fc receptor mediated stimulatory signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070447~positive regulation of oligodendrocyte progenitor proliferation,GO:0070667~negative regulation of mast cell proliferation,GO:0070668~positive regulation of mast cell proliferation,GO:0071300~cellular response to retinoic acid,GO:0090025~regulation of monocyte chemotaxis,GO:0090330~regulation of platelet aggregation,GO:0097028~dendritic cell differentiation,GO:1902532~negative regulation of intracellular signal transduction,GO:2000670~positive regulation of dendritic cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005758~mitochondrial intermembrane space,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0030061~mitochondrial crista,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0034666~integrin alpha2-beta1 complex,GO:0042629~mast cell granule,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005161~platelet-derived growth factor receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0043015~gamma-tubulin binding,GO:0043208~glycosphingolipid binding,GO:0044325~ion channel binding,GO:0051219~phosphoprotein binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04611:Platelet activation,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04730:Long-term depression,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Adaptive immunity,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,Host-virus interaction,Immunity,Inflammatory response,Innate immunity,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase Lyn,domain:Protein kinase,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
203897_at	LYR motif containing 1(LYRM1)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0045171~intercellular bridge,		IPR008011:Complex 1 LYR protein,					Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:LYR motif-containing protein 1,
221311_x_at	LYR motif containing 2(LYRM2)	Homo sapiens					GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR008011:Complex 1 LYR protein,IPR026868:LYR motif-containing protein 2,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:LYR motif-containing protein 2,sequence variant,
218561_s_at	LYR motif containing 4(LYRM4)	Homo sapiens				GO:0044281~small molecule metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,		IPR008011:Complex 1 LYR protein,		615595~Combined oxidative phosphorylation deficiency 19,			Complete proteome,Direct protein sequencing,Disease mutation,Mitochondrion,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:LYR motif-containing protein 4,sequence variant,
213195_at	LYR motif containing 9(LYRM9)	Homo sapiens							IPR008011:Complex 1 LYR protein,					Complete proteome,Reference proteome,	chain:UPF0631 protein HSD24,
210966_x_at, 212137_at, 212193_s_at	La ribonucleoprotein domain family member 1(LARP1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones / Translation, ribosomal structure and biogenesis,	GO:0006413~translational initiation,GO:0008283~cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0031929~TOR signaling,GO:0045070~positive regulation of viral genome replication,GO:0045727~positive regulation of translation,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031931~TORC1 complex,	GO:0000339~RNA cap binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008494~translation activator activity,GO:0031369~translation initiation factor binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006607:Protein of unknown function DM15,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00684:DM15,SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:La-related protein 1,compositionally biased region:Poly-Gly,domain:HTH La-type RNA-binding,modified residue,sequence conflict,splice variant,
214155_s_at, 212714_at	La ribonucleoprotein domain family member 4(LARP4)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0022604~regulation of cell morphogenesis,	GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:La-related protein 4,domain:HTH La-type RNA-binding,domain:RRM,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
214216_s_at, 208954_s_at, 208953_at, 208952_s_at, 214215_s_at	La ribonucleoprotein domain family member 4B(LARP4B)	Homo sapiens				GO:0045727~positive regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00715:LA,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:La-related protein 4B,domain:HTH La-type RNA-binding,domain:RRM,modified residue,
218651_s_at	La ribonucleoprotein domain family member 6(LARP6)	Homo sapiens				GO:0006396~RNA processing,GO:0006417~regulation of translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,	IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024642:SUZ-C domain,				SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:La-related protein 6,domain:HTH La-type RNA-binding,modified residue,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,
212785_s_at, 215246_at	La ribonucleoprotein domain family member 7(LARP7)	Homo sapiens				GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014886:RNA-binding motif,		615071~Alazami syndrome,		SM00360:RRM,SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Dwarfism,Mental retardation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:La-related protein 7,compositionally biased region:Lys-rich,domain:HTH La-type RNA-binding,domain:RRM,modified residue,mutagenesis site,sequence conflict,splice variant,
202020_s_at, 202019_s_at	LanC like 1(LANCL1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017124~SH3 domain binding,GO:0043295~glutathione binding,GO:0050750~low-density lipoprotein particle receptor binding,	IPR007822:Lanthionine synthetase C-like,IPR012341:Six-hairpin glycosidase,IPR020464:LanC-like protein, eukaryotic,				SM01260:SM01260,	3D-structure,Acetylation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Metal-binding,Proteomics identification,Reference proteome,Zinc,	binding site:Glutathione,chain:LanC-like protein 1,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Glutathione binding,strand,turn,
218219_s_at	LanC like 2(LANCL2)	Homo sapiens				GO:0009789~positive regulation of abscisic acid-activated signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030864~cortical actin cytoskeleton,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,	IPR007822:Lanthionine synthetase C-like,IPR012341:Six-hairpin glycosidase,IPR020464:LanC-like protein, eukaryotic,				SM01260:SM01260,	Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:LanC-like protein 2,lipid moiety-binding region:N-myristoyl glycine,modified residue,mutagenesis site,region of interest:Interaction with inositol phospholipids,sequence variant,
219541_at, 57539_at	Lck interacting transmembrane adaptor 1(LIME1)	Homo sapiens				GO:0002250~adaptive immune response,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR026072:Lck-interacting transmembrane adapter 1,					Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Immunity,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Lck-interacting transmembrane adapter 1,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Interaction with CSK,region of interest:Interaction with GRB2,region of interest:Interaction with LCK and PIK3R1,region of interest:Interaction with LCK, PLCG2 and PIK3R1,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212885_at	M-phase phosphoprotein 10(MPHOSPH10)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0000375~RNA splicing, via transesterification reactions,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0010923~negative regulation of phosphatase activity,GO:0030490~maturation of SSU-rRNA,	GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR012173:U3 small nucleolar ribonucleoprotein complex, subunit Mpp10p,	hsa03008:Ribosome biogenesis in eukaryotes,		PIRSF017300:U3 small nucleolar ribonucleoprotein (snoRNP) complex, Mpp10p subunit,		Acetylation,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,rRNA processing,Ubl conjugation,	chain:U3 small nucleolar ribonucleoprotein protein mpp10,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,modified residue,sequence variant,
203740_at	M-phase phosphoprotein 6(MPHOSPH6)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR019324:M-phase phosphoprotein 6,	hsa03018:RNA degradation,				Complete proteome,Cytoplasm,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,rRNA processing,Ubl conjugation,	chain:M-phase phosphoprotein 6,compositionally biased region:Poly-Glu,modified residue,sequence variant,short sequence motif:Nuclear localization signal,
221771_s_at	M-phase phosphoprotein 8(MPHOSPH8)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0016567~protein ubiquitination,GO:0044030~regulation of DNA methylation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000151~ubiquitin ligase complex,GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0035064~methylated histone binding,	IPR000953:Chromo domain/shadow,IPR002110:Ankyrin repeat,IPR016197:Chromo domain-like,IPR020683:Ankyrin repeat-containing domain,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,				SM00248:ANK,SM00298:CHROMO,	3D-structure,Acetylation,Alternative splicing,ANK repeat,Chromosome,Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:M-phase phosphoprotein 8,compositionally biased region:Lys-rich,domain:Chromo,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,splice variant,
215731_s_at, 206205_at	M-phase phosphoprotein 9(MPHOSPH9)	Homo sapiens					GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005886~plasma membrane,GO:0016020~membrane,		IPR026636:M-phase phosphoprotein 9,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:M-phase phosphoprotein 9,modified residue,sequence conflict,sequence variant,splice variant,
219188_s_at	MACRO domain containing 1(MACROD1)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0042278~purine nucleoside metabolic process,GO:0051725~protein de-ADP-ribosylation,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0005515~protein binding,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0019213~deacetylase activity,	IPR002589:Appr-1-p processing,				SM00506:A1pp,	3D-structure,Acetylation,Chromosomal rearrangement,Complete proteome,DNA damage,Hydrolase,Nucleus,Reference proteome,	chain:MACRO domain-containing protein 1,domain:Macro,modified residue,site:Breakpoint for translocation to form RUNX1-MACROD1,
204857_at	MAD1 mitotic arrest deficient like 1(MAD1L1)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0042130~negative regulation of T cell proliferation,GO:0048538~thymus development,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0090235~regulation of metaphase plate congression,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0072686~mitotic spindle,	GO:0005515~protein binding,	IPR008672:Spindle assembly checkpoint component Mad1,	hsa04110:Cell cycle,hsa04914:Progesterone-mediated oocyte maturation,hsa05203:Viral carcinogenesis,	176807~Prostate cancer, somatic,Lymphoma, somatic~Lymphoma, somatic,			3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Mitotic spindle assembly checkpoint protein MAD1,helix,modified residue,region of interest:Necessary for interaction with NEK2,sequence conflict,sequence variant,strand,turn,
203362_s_at	MAD2 mitotic arrest deficient-like 1 (yeast)(MAD2L1)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0007062~sister chromatid cohesion,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:1904667~negative regulation of ubiquitin protein ligase activity,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003511:DNA-binding HORMA,IPR027097:Mitotic spindle checkpoint protein Mad2,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,hsa05166:HTLV-I infection,				3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Mitotic spindle assembly checkpoint protein MAD2A,domain:HORMA,helix,modified residue,mutagenesis site,region of interest:Required for assuming the closed conformation and for interaction with CDC20,sequence conflict,strand,turn,
203094_at	MAD2L1 binding protein(MAD2L1BP)	Homo sapiens				GO:0007093~mitotic cell cycle checkpoint,GO:0007096~regulation of exit from mitosis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,	GO:0005515~protein binding,	IPR009511:Mad1/Cdc20-bound-Mad2 binding protein,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Reference proteome,	chain:MAD2L1-binding protein,helix,modified residue,mutagenesis site,region of interest:Interaction with MAD2L1,sequence conflict,strand,turn,
218559_s_at	MAF bZIP transcription factor B(MAFB)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007379~segment specification,GO:0007399~nervous system development,GO:0007423~sensory organ development,GO:0007585~respiratory gaseous exchange,GO:0021571~rhombomere 5 development,GO:0021572~rhombomere 6 development,GO:0033077~T cell differentiation in thymus,GO:0035284~brain segmentation,GO:0042472~inner ear morphogenesis,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048538~thymus development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR013592:Maf transcription factor, N-terminal,IPR024874:Transcription factor Maf,		166300~Multicentric carpotarsal osteolysis syndrome,		SM00338:BRLZ,	Activator,Complete proteome,Disease mutation,DNA-binding,Isopeptide bond,Nucleus,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Transcription factor MafB,compositionally biased region:Poly-His,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,
205193_at, 36711_at	MAF bZIP transcription factor F(MAFF)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001701~in utero embryonic development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007567~parturition,GO:0007596~blood coagulation,GO:0035914~skeletal muscle cell differentiation,GO:0045604~regulation of epidermal cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR024874:Transcription factor Maf,				SM00338:BRLZ,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Repressor,Stress response,Transcription,Transcription regulation,	chain:Transcription factor MafF,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,
204970_s_at	MAF bZIP transcription factor G(MAFG)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007596~blood coagulation,GO:0010628~positive regulation of gene expression,GO:0030534~adult behavior,GO:0030641~regulation of cellular pH,GO:0042127~regulation of cell proliferation,GO:0045604~regulation of epidermal cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR024874:Transcription factor Maf,				SM00338:BRLZ,	Acetylation,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor MafG,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,mutagenesis site,
206750_at	MAF bZIP transcription factor K(MAFK)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007596~blood coagulation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0043565~sequence-specific DNA binding,GO:0071535~RING-like zinc finger domain binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR016491:Septin,IPR024874:Transcription factor Maf,				SM00338:BRLZ,	Coiled coil,Complete proteome,DNA-binding,GTP-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor MafK,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
206363_at, 209347_s_at, 209348_s_at	MAF bZIP transcription factor(MAF)	Homo sapiens		h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001816~cytokine production,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0032330~regulation of chondrocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048468~cell development,GO:0048839~inner ear development,GO:0070306~lens fiber cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR013592:Maf transcription factor, N-terminal,IPR024874:Transcription factor Maf,	hsa05202:Transcriptional misregulation in cancer,hsa05321:Inflammatory bowel disease (IBD),	601088~Ayme-Gripp syndrome,610202~Cataract 21, multiple types,		SM00338:BRLZ,	Activator,Alternative splicing,Cataract,Chromosomal rearrangement,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Dwarfism,Isopeptide bond,Mental retardation,Nucleus,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Transcription factor Maf,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:His-rich,DNA-binding region:Basic motif,domain:Leucine-zipper,region of interest:Represses ARE-mediated transcription,sequence variant,splice variant,
207325_x_at	MAGE family member A1(MAGEA1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0045746~negative regulation of Notch signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0042826~histone deacetylase binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	3D-structure,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Tumor antigen,	chain:Melanoma-associated antigen 1,compositionally biased region:Poly-Ser,domain:MAGE,mutagenesis site,sequence variant,
210295_at	MAGE family member A10(MAGEA10)	Homo sapiens					GO:0005634~nucleus,		IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 10,compositionally biased region:Poly-Ser,domain:MAGE,sequence variant,
210503_at	MAGE family member A11(MAGEA11)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 11,domain:MAGE,modified residue,sequence variant,splice variant,
210467_x_at	MAGE family member A12(MAGEA12)	Homo sapiens							IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 12,compositionally biased region:Poly-Ser,domain:MAGE,sequence conflict,sequence variant,
214603_at	MAGE family member A2B(MAGEA2B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0033234~negative regulation of protein sumoylation,GO:0044257~cellular protein catabolic process,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0072331~signal transduction by p53 class mediator,GO:0090398~cellular senescence,GO:1901984~negative regulation of protein acetylation,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042826~histone deacetylase binding,GO:0070491~repressing transcription factor binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen 2,compositionally biased region:Poly-Ser,domain:MAGE,mutagenesis site,
209942_x_at	MAGE family member A3(MAGEA3)	Homo sapiens				GO:0010955~negative regulation of protein processing,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,	GO:0005783~endoplasmic reticulum,	GO:0005515~protein binding,GO:0089720~caspase binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	3D-structure,Complete proteome,Proteomics identification,Reference proteome,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen 3,compositionally biased region:Poly-Ser,domain:MAGE,mutagenesis site,
214254_at	MAGE family member A4(MAGEA4)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	3D-structure,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 4,compositionally biased region:Poly-Ser,domain:MAGE,helix,sequence conflict,sequence variant,strand,turn,
214612_x_at	MAGE family member A6(MAGEA6)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen 6,compositionally biased region:Poly-Ser,domain:MAGE,sequence variant,
210274_at	MAGE family member A8(MAGEA8)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Tumor antigen,	chain:Melanoma-associated antigen 8,compositionally biased region:Poly-Ser,domain:MAGE,sequence variant,
210437_at	MAGE family member A9(MAGEA9)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 9,compositionally biased region:Poly-Glu,domain:MAGE,sequence conflict,
207534_at	MAGE family member B1(MAGEB1)	Homo sapiens							IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen B1,domain:MAGE,sequence conflict,sequence variant,
206218_at	MAGE family member B2(MAGEB2)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen B2,domain:MAGE,modified residue,sequence variant,
207579_at	MAGE family member B3(MAGEB3)	Homo sapiens							IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen B3,domain:MAGE,sequence variant,
207580_at, 207581_s_at	MAGE family member B4(MAGEB4)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Cytoplasm,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen B4,domain:MAGE,sequence conflict,
206609_at	MAGE family member C1(MAGEC1)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,				SM01373:SM01373,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Tumor antigen,	chain:Melanoma-associated antigen C1,domain:MAGE,sequence conflict,sequence variant,
220062_s_at, 215932_at	MAGE family member C2(MAGEC2)	Homo sapiens				GO:0044257~cellular protein catabolic process,GO:0051443~positive regulation of ubiquitin-protein transferase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR002190:MAGE protein,				SM01373:SM01373,	Complete proteome,Cytoplasm,Nucleus,Polymorphism,Reference proteome,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen C2,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,domain:MAGE,modified residue,sequence conflict,sequence variant,
216592_at	MAGE family member C3(MAGEC3)	Homo sapiens							IPR002190:MAGE protein,				SM01373:SM01373,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Tumor antigen,	chain:Melanoma-associated antigen C3,compositionally biased region:Pro-rich,domain:MAGE 1,domain:MAGE 2,modified residue,sequence conflict,sequence variant,
209014_at	MAGE family member D1(MAGED1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0042981~regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050680~negative regulation of epithelial cell proliferation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043234~protein complex,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002190:MAGE protein,	hsa04722:Neurotrophin signaling pathway,			SM01373:SM01373,	Alternative splicing,Biological rhythms,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen D1,compositionally biased region:Pro-rich,domain:MAGE,modified residue,region of interest:22 X 6 AA tandem repeats of W-[PQ]-X-P-X- X,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20; approximate,repeat:21,repeat:22,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,
208682_s_at, 213627_at	MAGE family member D2(MAGED2)	Homo sapiens				GO:0007565~female pregnancy,GO:0070294~renal sodium ion absorption,	GO:0016020~membrane,	GO:0005515~protein binding,	IPR002190:MAGE protein,				SM01373:SM01373,	Acetylation,Alternative splicing,Bartter syndrome,Complete proteome,Direct protein sequencing,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen D2,compositionally biased region:Arg-rich,domain:MAGE,modified residue,sequence conflict,sequence variant,splice variant,
218176_at	MAGE family member F1(MAGEF1)	Homo sapiens					GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR002190:MAGE protein,				SM01373:SM01373,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen F1,domain:MAGE,sequence variant,
218573_at	MAGE family member H1(MAGEH1)	Homo sapiens				GO:0006915~apoptotic process,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002190:MAGE protein,				SM01373:SM01373,	Complete proteome,Phosphoprotein,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen H1,domain:MAGE,
219894_at	MAGE family member L2(MAGEL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051127~positive regulation of actin nucleation,GO:0070534~protein K63-linked ubiquitination,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0030904~retromer complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR002190:MAGE protein,		615547~Schaaf-Yang syndrome,		SM01373:SM01373,	Autism spectrum disorder,Biological rhythms,Complete proteome,Cytoplasm,Endosome,Mental retardation,Nucleus,Obesity,Reference proteome,Repressor,Transcription,Transcription regulation,Transport,Ubl conjugation pathway,	chain:MAGE-like protein 2,domain:MAGE,
214642_x_at	MAGEA10-MAGEA5 readthrough(MAGEA10-MAGEA5)	Homo sapiens							IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,
219965_s_at	MAGI family member, X-linked(MAGIX)	Homo sapiens							IPR001478:PDZ domain,				SM00228:PDZ,	3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:PDZ domain-containing protein MAGIX,domain:PDZ,helix,modified residue,sequence variant,splice variant,strand,
211686_s_at	MAK16 homolog(MAK16)	Homo sapiens				GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,	GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0043231~intracellular membrane-bounded organelle,	GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR006958:Mak16 protein,			PIRSF003352:ribosomal biogenesis protein MAK16,		Acetylation,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein MAK16 homolog,compositionally biased region:Asp-rich,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
210017_at, 210018_x_at, 208309_s_at	MALT1 paracaspase(MALT1)	Homo sapiens				GO:0001923~B-1 B cell differentiation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002726~positive regulation of T cell cytokine production,GO:0006508~proteolysis,GO:0006952~defense response,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0009620~response to fungus,GO:0016567~protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032743~positive regulation of interleukin-2 production,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042098~T cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0050852~T cell receptor signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051168~nuclear export,GO:0051259~protein oligomerization,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0032449~CBM complex,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0002020~protease binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0019209~kinase activator activity,GO:0043621~protein self-association,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR011029:Death-like domain,IPR013783:Immunoglobulin-like fold,	hsa04064:NF-kappa B signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa05152:Tuberculosis,	615468~Immunodeficiency 12,		SM00408:IGc2,SM00409:IG,	3D-structure,Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,Hydrolase,Immunoglobulin domain,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Mucosa-associated lymphoid tissue lymphoma translocation protein 1,disulfide bond,domain:Death,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,helix,modified residue,mutagenesis site,region of interest:Caspase-like,sequence variant,short sequence motif:Nuclear export signal,site:Breakpoint for translocation to form BIRC2-MALT1,splice variant,
220945_x_at	MANSC domain containing 1(MANSC1)	Homo sapiens					GO:0016021~integral component of membrane,		IPR011106:Seven cysteines, N-terminal,IPR013980:Seven cysteines,				SM00765:MANEC,	Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:MANSC domain-containing protein 1,compositionally biased region:Thr-rich,domain:MANSC,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
210252_s_at, 38398_at	MAP kinase activating death domain(MADD)	Homo sapiens		h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0000187~activation of MAPK activity,GO:0007166~cell surface receptor signaling pathway,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0032483~regulation of Rab protein signal transduction,GO:0042981~regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051726~regulation of cell cycle,GO:0097194~execution phase of apoptosis,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001236~regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0030295~protein kinase activator activity,	IPR001194:DENN domain,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Reference proteomeFT   VAR_SEQ    1575   1582       VFIELNHI -> FLKLKKW (in isoform 6 and,	chain:MAP kinase-activating death domain protein,compositionally biased region:Ser-rich,domain:dDENN,domain:Death,domain:DENN,domain:uDENN,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
209467_s_at	MAP kinase interacting serine/threonine kinase 1(MKNK1)	Homo sapiens	107.mRNA_translation-protein_synthesis,	h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_mapkPathway:MAPKinase Signaling Pathway,h_mtorPathway:mTOR Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,		GO:0006417~regulation of translation,GO:0006468~protein phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Translation regulation,	active site:Proton acceptor,binding site:ATP,chain:MAP kinase-interacting serine/threonine- protein kinase 1,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
218205_s_at	MAP kinase interacting serine/threonine kinase 2(MKNK2)	Homo sapiens		h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0006417~regulation of translation,GO:0006468~protein phosphorylation,GO:0007166~cell surface receptor signaling pathway,GO:0018105~peptidyl-serine phosphorylation,GO:0030097~hemopoiesis,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,GO:0071243~cellular response to arsenic-containing substance,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016605~PML body,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0009931~calcium-dependent protein serine/threonine kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04910:Insulin signaling pathway,			SM00220:S_TKc,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Translation regulation,Zinc,	active site:Proton acceptor,binding site:ATP,chain:MAP kinase-interacting serine/threonine- protein kinase 2,domain:Protein kinase,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
218411_s_at	MAP3K12 binding inhibitory protein 1(MBIP)	Homo sapiens				GO:0000173~inactivation of MAPK activity involved in osmosensory signaling pathway,GO:0043966~histone H3 acetylation,	GO:0005634~nucleus,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR026062:MAP3K12-binding inhibitory protein 1,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:MAP3K12-binding inhibitory protein 1,domain:Leucine-zipper,modified residue,region of interest:Interaction with MAP3K12,sequence conflict,sequence variant,splice variant,
221211_s_at	MAP3K7 C-terminal like(MAP3K7CL)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004709~MAP kinase kinase kinase activity,GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:TAK1-like protein,sequence variant,splice variant,
221713_s_at	MAP6 domain containing 1(MAP6D1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007026~negative regulation of microtubule depolymerization,GO:0018009~N-terminal peptidyl-L-cysteine N-palmitoylation,	GO:0005798~Golgi-associated vesicle,GO:0005801~cis-Golgi network,GO:0005874~microtubule,	GO:0005516~calmodulin binding,GO:0008017~microtubule binding,	IPR007882:STOP/MAP6,					Calmodulin-binding,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Lipoprotein,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,	chain:MAP6 domain-containing protein 1,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,
217943_s_at	MAP7 domain containing 1(MAP7D1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0015630~microtubule cytoskeleton,	GO:0005198~structural molecule activity,	IPR008604:E-MAP-115,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:MAP7 domain-containing protein 1,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,
219626_at, 219576_at	MAP7 domain containing 3(MAP7D3)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0046785~microtubule polymerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,	GO:0005198~structural molecule activity,GO:0008017~microtubule binding,GO:0015631~tubulin binding,	IPR008604:E-MAP-115,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:MAP7 domain-containing protein 3,modified residue,sequence conflict,sequence variant,splice variant,
219817_at, 212868_x_at, 64432_at	MAPKAPK5 antisense RNA 1(MAPKAPK5-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C12orf47,compositionally biased region:Poly-Ala,modified residue,
200644_at	MARCKS like 1(MARCKSL1)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR002101:Myristoylated alanine-rich C-kinase substrate MARCKS,	hsa04666:Fc gamma R-mediated phagocytosis,hsa05140:Leishmaniasis,				Actin-binding,Calmodulin-binding,Cell membrane,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Phosphoprotein,Reference proteome,	chain:MARCKS-related protein,compositionally biased region:Poly-Lys,lipid moiety-binding region:N-myristoyl glycine,modified residue,region of interest:Calmodulin-binding (PSD),sequence conflict,
208210_at	MAS1 proto-oncogene, G protein-coupled receptor(MAS1)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0009653~anatomical structure morphogenesis,GO:0014823~response to activity,GO:0021766~hippocampus development,GO:0034698~response to gonadotropin,GO:0038166~angiotensin-activated signaling pathway,GO:0042493~response to drug,GO:0045740~positive regulation of DNA replication,GO:0050727~regulation of inflammatory response,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0070528~protein kinase C signaling,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0001595~angiotensin receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004945~angiotensin type II receptor activity,GO:0005515~protein binding,GO:0017046~peptide hormone binding,GO:0042277~peptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000820:Proto-oncogene Mas,IPR017452:GPCR, rhodopsin-like, 7TM,IPR026234:Mas-related G protein-coupled receptor family,	hsa04080:Neuroactive ligand-receptor interaction,hsa04614:Renin-angiotensin system,				Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Proto-oncogene,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:MAS proto-oncogene,glycosylation site:N-linked (GlcNAc...),mutagenesis site,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
212505_s_at, 216927_at, 217652_at, 216926_s_at	MAU2 sister chromatid cohesion factor(MAU2)	Homo sapiens				GO:0007064~mitotic sister chromatid cohesion,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032116~SMC loading complex,	GO:0005515~protein binding,GO:0047485~protein N-terminus binding,	IPR011990:Tetratricopeptide-like helical,IPR019440:Cohesin loading factor,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Cell cycle,Cell division,Chromosome partition,Complete proteome,Mitosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Cohesin loading complex subunit SCC4 homolog,compositionally biased region:Ala-rich,region of interest:Sufficient for interaction with NIPBL,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,splice variant,
206877_at	MAX dimerization protein 1(MXD1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Max dimerization protein 1,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,helix,short sequence motif:Nuclear localization signal,strand,
221250_s_at	MAX dimerization protein 3(MXD3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Max dimerization protein 3,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,region of interest:Interaction with SIN3A and SIN3B,sequence conflict,sequence variant,splice variant,
202364_at	MAX interactor 1, dimerization protein(MXI1)	Homo sapiens	61.Myc_network,			GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008285~negative regulation of cell proliferation,GO:0042994~cytoplasmic sequestering of transcription factor,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,		176807~Prostate cancer, susceptibility to,Neurofibrosarcoma~Neurofibrosarcoma,		SM00353:HLH,	Alternative splicing,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Nucleus,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Max-interacting protein 1,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,sequence variant,splice variant,
204206_at	MAX network transcriptional repressor(MNT)	Homo sapiens	61.Myc_network,		Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0007569~cell aging,GO:0008285~negative regulation of cell proliferation,GO:0051726~regulation of cell cycle,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Acetylation,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Max-binding protein MNT,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence variant,
212935_at, 35147_at, 220464_at	MCF.2 cell line derived transforming sequence like(MCF2L)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0035091~phosphatidylinositol binding,	IPR000219:Dbl homology (DH) domain,IPR001251:CRAL-TRIO domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR002017:Spectrin repeat,IPR011511:Variant SH3,IPR011993:Pleckstrin homology-like domain,IPR018159:Spectrin/alpha-actinin,				SM00150:SPEC,SM00233:PH,SM00325:RhoGEF,SM00326:SH3,SM00516:SEC14,	Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Signal,	chain:Guanine nucleotide exchange factor DBS,compositionally biased region:Poly-Glu,domain:CRAL-TRIO,domain:DH,domain:PH,domain:SH3,modified residue,repeat:Spectrin,splice variant,
214884_at, 208017_s_at, 217004_s_at	MCF.2 cell line derived transforming sequence(MCF2)	Homo sapiens				GO:0016358~dendrite development,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:Dbl homology (DH) domain,IPR001251:CRAL-TRIO domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018159:Spectrin/alpha-actinin,				SM00150:SPEC,SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,	chain:DBL-transforming protein,chain:MCF2-transforming protein,chain:Proto-oncogene DBL,domain:CRAL-TRIO,domain:DH,domain:PH,mutagenesis site,repeat:Spectrin,sequence conflict,splice variant,
215112_x_at	MCF.2 cell line derived transforming sequence-like 2(MCF2L2)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001251:CRAL-TRIO domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018159:Spectrin/alpha-actinin,				SM00150:SPEC,SM00233:PH,SM00325:RhoGEF,SM00516:SEC14,	Alternative splicing,Complete proteome,Diabetes mellitus,Guanine-nucleotide releasing factor,Polymorphism,Reference proteome,	chain:Probable guanine nucleotide exchange factor MCF2L2,domain:CRAL-TRIO,domain:DH,domain:PH,repeat:Spectrin,sequence conflict,sequence variant,splice variant,
218163_at	MCTS1, re-initiation and release factor(MCTS1)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0001731~formation of translation preinitiation complex,GO:0002188~translation reinitiation,GO:0002192~IRES-dependent translational initiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0032790~ribosome disassembly,GO:0040008~regulation of growth,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0022627~cytosolic small ribosomal subunit,	GO:0003743~translation initiation factor activity,GO:0005515~protein binding,	IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR004521:Uncharacterised domain CHP00451,IPR015947:PUA-like domain,IPR016437:Translation-associated RNA-binding, predicted,			PIRSF005067:translation machinery-associated RNA binding protein,	SM00359:PUA,	3D-structure,Alternative splicing,Cell cycle,Complete proteome,Cytoplasm,DNA damage,Growth regulation,Initiation factor,Phosphoprotein,Polymorphism,Protein biosynthesis,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	chain:Malignant T cell amplified sequence 1,domain:PUA,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
217542_at, 217373_x_at, 205385_at, 205386_s_at, 211832_s_at	MDM2 proto-oncogene(MDM2)	Homo sapiens		h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001974~blood vessel remodeling,GO:0002027~regulation of heart rate,GO:0003181~atrioventricular valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003281~ventricular septum development,GO:0003283~atrial septum development,GO:0006461~protein complex assembly,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007089~traversing start control point of mitotic cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009743~response to carbohydrate,GO:0010039~response to iron ion,GO:0010628~positive regulation of gene expression,GO:0010955~negative regulation of protein processing,GO:0010977~negative regulation of neuron projection development,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0018205~peptidyl-lysine modification,GO:0031648~protein destabilization,GO:0032026~response to magnesium ion,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034504~protein localization to nucleus,GO:0036369~transcription factor catabolic process,GO:0042176~regulation of protein catabolic process,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043278~response to morphine,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045184~establishment of protein localization,GO:0045472~response to ether,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0046677~response to antibiotic,GO:0046827~positive regulation of protein export from nucleus,GO:0048545~response to steroid hormone,GO:0051865~protein autoubiquitination,GO:0060411~cardiac septum morphogenesis,GO:0070301~cellular response to hydrogen peroxide,GO:0071157~negative regulation of cell cycle arrest,GO:0071236~cellular response to antibiotic,GO:0071301~cellular response to vitamin B1,GO:0071312~cellular response to alkaloid,GO:0071363~cellular response to growth factor stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071391~cellular response to estrogen stimulus,GO:0071456~cellular response to hypoxia,GO:0071494~cellular response to UV-C,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901797~negative regulation of signal transduction by p53 class mediator,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1990785~response to water-immersion restraint stress,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0030666~endocytic vesicle membrane,GO:0043234~protein complex,GO:0045202~synapse,	GO:0002039~p53 binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0061630~ubiquitin protein ligase activity,GO:0097110~scaffold protein binding,	IPR001841:Zinc finger, RING-type,IPR001876:Zinc finger, RanBP2-type,IPR003121:SWIB/MDM2 domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015459:Ubiquitin-protein ligase E3 MDM2,IPR016495:p53 negative regulator Mdm2/Mdm4,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,	614401~Accelerated tumor formation, susceptibility to,	PIRSF006748:p53 negative regulator Mdm2/Mdm4,PIRSF500700:p53 negative regulator Mdm2 [Parent=PIRSF006748],		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase Mdm2,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ser,domain:SWIB,helix,modified residue,mutagenesis site,region of interest:ARF-binding,region of interest:Interaction with MTBP,region of interest:Interaction with PYHIN1,region of interest:Interaction with USP7,region of interest:Region II,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,short sequence motif:Nucleolar localization signal,splice variant,strand,turn,zinc finger region:RanBP2-type,zinc finger region:RING-type,
205655_at	MDM4, p53 regulator(MDM4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045023~G0 to G1 transition,GO:0050821~protein stabilization,GO:0071157~negative regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR001876:Zinc finger, RanBP2-type,IPR003121:SWIB/MDM2 domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015458:MDM4,IPR016495:p53 negative regulator Mdm2/Mdm4,	hsa04115:p53 signaling pathway,hsa05206:MicroRNAs in cancer,		PIRSF006748:p53 negative regulator Mdm2/Mdm4,PIRSF500699:p53 negative regulator Mdm4 [Parent=PIRSF006748],		3D-structure,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Protein Mdm4,compositionally biased region:Asp/Glu-rich (acidic),domain:SWIB,helix,mutagenesis site,region of interest:Region II,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:RanBP2-type,zinc finger region:RING-type,
208434_at, 221884_at, 215851_at	MDS1 and EVI1 complex locus(MECOM)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0030154~cell differentiation,GO:0034968~histone lysine methylation,GO:0043069~negative regulation of programmed cell death,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046329~negative regulation of JNK cascade,GO:0051726~regulation of cell cycle,GO:0071425~hematopoietic stem cell proliferation,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016235~aggresome,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR026710:MDS1-EVI1 complex locus protein MDS1,	hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,	616738~Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,		SM00317:SET,SM00355:ZnF_C2H2,	Acetylation,Alternative promoter usage,Alternative splicing,Apoptosis,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:MDS1 and EVI1 complex locus protein EVI1,chain:MDS1 and EVI1 complex locus protein MDS1,compositionally biased region:Asp/Glu-rich (acidic),modified residue,mutagenesis site,region of interest:Interaction with MAPK9, SMAD3 and probably SUV39H1,sequence conflict,sequence variant,short sequence motif:CTBP-binding motif 1,short sequence motif:CTBP-binding motif 2,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
211912_at, 206028_s_at, 211913_s_at	MER proto-oncogene, tyrosine kinase(MERTK)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0006468~protein phosphorylation,GO:0006909~phagocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007283~spermatogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030168~platelet activation,GO:0032940~secretion by cell,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0050766~positive regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0051250~negative regulation of lymphocyte activation,GO:0060041~retina development in camera-type eye,GO:0060068~vagina development,GO:2000107~negative regulation of leukocyte apoptotic process,	GO:0001750~photoreceptor outer segment,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016028~rhabdomere,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613862~Retinitis pigmentosa 38,		SM00060:FN3,SM00219:TyrKc,SM00409:IG,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Mer,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
213816_s_at, 211599_x_at, 213807_x_at, 203510_at	MET proto-oncogene, receptor tyrosine kinase(MET)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0001886~endothelial cell morphogenesis,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008283~cell proliferation,GO:0010507~negative regulation of autophagy,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0048754~branching morphogenesis of an epithelial tube,GO:0050918~positive chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:2001028~positive regulation of endothelial cell chemotaxis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005008~hepatocyte growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017154~semaphorin receptor activity,GO:0019903~protein phosphatase binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR002909:Cell surface receptor IPT/TIG,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR016244:Tyrosine-protein kinase, HGF/MSP receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05144:Malaria,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,hsa05230:Central carbon metabolism in cancer,	114550~Hepatocellular carcinoma, childhood type, somatic,605074~Renal cell carcinoma, papillary, 1, familial and somatic,616705~Deafness, autosomal recessive 97,	PIRSF000617:tyrosine-protein kinase, HGF/MSP receptor type,	SM00219:TyrKc,SM00423:PSI,SM00429:IPT,SM00630:Sema,	3D-structure,Alternative splicing,ATP-binding,Chromosomal rearrangement,Complete proteome,Deafness,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Non-syndromic deafness,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Hepatocyte growth factor receptor,domain:IPT/TIG 1,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:Protein kinase,domain:Sema,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with MUC20,region of interest:Interaction with RANBP9,sequence conflict,sequence variant,signal peptide,site:Breakpoint for translocation to form TPR- MET oncogene,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
204153_s_at, 213783_at, 204152_s_at	MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase(MFNG)	Homo sapiens				GO:0002315~marginal zone B cell differentiation,GO:0007389~pattern specification process,GO:0032092~positive regulation of protein binding,GO:0045747~positive regulation of Notch signaling pathway,	GO:0005615~extracellular space,GO:0016020~membrane,GO:0030173~integral component of Golgi membrane,	GO:0016757~transferase activity, transferring glycosyl groups,GO:0033829~O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,GO:0046872~metal ion binding,	IPR003378:Fringe-like,IPR017374:Fringe,	hsa00514:Other types of O-glycan biosynthesis,hsa04330:Notch signaling pathway,		PIRSF038073:beta-1,3-N-acetylglucosaminyltransferase, radical fringe type,		Alternative splicing,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-N-acetylglucosaminyltransferase manic fringe,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
212945_s_at	MGA, MAX dimerization protein(MGA)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR018186:Transcription factor, T-box, conserved site,				SM00353:HLH,SM00425:TBOX,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:MAX gene-associated protein,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ser,compositionally biased region:Thr-rich,DNA-binding region:Basic motif,DNA-binding region:T-box,domain:Helix-loop-helix motif,modified residue,sequence conflict,sequence variant,splice variant,
207447_s_at	MGAT4 family member C(MGAT4C)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006491~N-glycan processing,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008454~alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0046872~metal ion binding,	IPR006759:Glycosyl transferase, family 54,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Metal-binding,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase C,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
205904_at, 205905_s_at	MHC class I polypeptide-related sequence A(MICA)	Homo sapiens				GO:0001913~T cell mediated cytotoxicity,GO:0002418~immune response to tumor cell,GO:0006974~cellular response to DNA damage stimulus,GO:0009408~response to heat,GO:0019835~cytolysis,GO:0019882~antigen processing and presentation,GO:0032815~negative regulation of natural killer cell activation,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042742~defense response to bacterium,GO:0045953~negative regulation of natural killer cell mediated cytotoxicity,GO:0046629~gamma-delta T cell activation,GO:0050776~regulation of immune response,GO:0051607~defense response to virus,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0003823~antigen binding,GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0046703~natural killer cell lectin-like receptor binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Cytolysis,Cytoplasm,Disulfide bond,Glycoprotein,Host-virus interaction,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,
206247_at	MHC class I polypeptide-related sequence B(MICB)	Homo sapiens				GO:0001913~T cell mediated cytotoxicity,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0016032~viral process,GO:0019835~cytolysis,GO:0019882~antigen processing and presentation,GO:0032526~response to retinoic acid,GO:0042267~natural killer cell mediated cytotoxicity,GO:0046629~gamma-delta T cell activation,GO:0050689~negative regulation of defense response to virus by host,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0003823~antigen binding,GO:0046703~natural killer cell lectin-like receptor binding,	IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Cytolysis,Disulfide bond,Glycoprotein,Host-virus interaction,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:MHC class I polypeptide-related sequence B,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
212310_at, 212305_s_at	MIA family member 3, ER export factor(MIA3)	Homo sapiens				GO:0002687~positive regulation of leukocyte migration,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007162~negative regulation of cell adhesion,GO:0015031~protein transport,GO:0030336~negative regulation of cell migration,GO:0042060~wound healing,GO:0042953~lipoprotein transport,GO:0090110~cargo loading into COPII-coated vesicle,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070971~endoplasmic reticulum exit site,	GO:0005515~protein binding,GO:0042954~lipoprotein transporter activity,	IPR001452:Src homology-3 domain,IPR011511:Variant SH3,					Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Exocytosis,Glycoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,SH3 domain,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Melanoma inhibitory activity protein 3,compositionally biased region:Pro-rich,domain:SH3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:In membrane,transmembrane region,
219807_x_at	MIA-RAB4B readthrough (NMD candidate)(MIA-RAB4B)	Homo sapiens							IPR001452:Src homology-3 domain,IPR011511:Variant SH3,				SM00326:SH3,	Complete proteome,Reference proteome,Signal,
221779_at, 55081_at	MICAL like 1(MICALL1)	Homo sapiens				GO:0006612~protein targeting to membrane,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0031175~neuron projection development,GO:0032456~endocytic recycling,GO:0032458~slow endocytic recycling,GO:0036010~protein localization to endosome,GO:0097320~membrane tubulation,GO:0098609~cell-cell adhesion,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990126~retrograde transport, endosome to plasma membrane,	GO:0005769~early endosome,GO:0005770~late endosome,GO:0005802~trans-Golgi network,GO:0005913~cell-cell adherens junction,GO:0019898~extrinsic component of membrane,GO:0031902~late endosome membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017137~Rab GTPase binding,GO:0042802~identical protein binding,GO:0070300~phosphatidic acid binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001715:Calponin homology domain,IPR001781:Zinc finger, LIM-type,IPR022735:Domain of unknown function DUF3585,				SM00033:CH,SM00132:LIM,	3D-structure,Coiled coil,Complete proteome,Endocytosis,Endosome,LIM domain,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,Zinc,	chain:MICAL-like protein 1,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:CH,domain:LIM zinc-binding,modified residue,sequence conflict,sequence variant,
219332_at	MICAL like 2(MICALL2)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0031175~neuron projection development,GO:0031532~actin cytoskeleton reorganization,GO:0032456~endocytic recycling,GO:0034446~substrate adhesion-dependent cell spreading,GO:0070830~bicellular tight junction assembly,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0032432~actin filament bundle,GO:0043005~neuron projection,GO:0055037~recycling endosome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017137~Rab GTPase binding,GO:0031005~filamin binding,GO:0042805~actinin binding,GO:0051015~actin filament binding,	IPR001715:Calponin homology domain,IPR001781:Zinc finger, LIM-type,IPR022735:Domain of unknown function DUF3585,				SM00033:CH,SM00132:LIM,	Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,LIM domain,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Signal,Tight junction,Zinc,	chain:MICAL-like protein 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Ser,domain:CH,domain:LIM zinc-binding,modified residue,sequence conflict,sequence variant,splice variant,
218251_at	MID1 interacting protein 1(MID1IP1)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0007026~negative regulation of microtubule depolymerization,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0046890~regulation of lipid biosynthetic process,GO:0051258~protein polymerization,GO:0051351~positive regulation of ligase activity,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,	IPR009786:Spot 14 family,					Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,Lipid biosynthesis,Lipid metabolism,Microtubule,Nucleus,Phosphoprotein,Reference proteome,	chain:Mid1-interacting protein 1,modified residue,
44822_s_at, 221863_at, 221862_at	MIER family member 2(MIER2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,				SM00717:SANT,SM01189:SM01189,	Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Mesoderm induction early response protein 2,domain:ELM2,domain:SANT,sequence variant,
37005_at	MINOS1-NBL1 readthrough(MINOS1-NBL1)	Homo sapiens				GO:0007399~nervous system development,GO:0030514~negative regulation of BMP signaling pathway,GO:0035582~sequestering of BMP in extracellular matrix,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0045666~positive regulation of neuron differentiation,GO:0048263~determination of dorsal identity,GO:0048812~neuron projection morphogenesis,GO:0090027~negative regulation of monocyte chemotaxis,	GO:0005615~extracellular space,GO:0061617~MICOS complex,	GO:0016015~morphogen activity,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,	IPR004133:DAN,IPR006207:Cystine knot, C-terminal,IPR007512:Protein of unknown function DUF543,IPR016728:Neuroblastoma suppressor of tumorigenicity 1,	hsa04350:TGF-beta signaling pathway,		PIRSF018557:DAN protein,	SM00041:CT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Tumor suppressor,
221559_s_at	MIS12, kinetochore complex component(MIS12)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0034501~protein localization to kinetochore,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051382~kinetochore assembly,	GO:0000444~MIS12/MIND type complex,GO:0000775~chromosome, centromeric region,GO:0000818~nuclear MIS12/MIND complex,GO:0005634~nucleus,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR008685:Centromere protein Mis12,					Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Kinetochore,Mitosis,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein MIS12 homolog,sequence variant,
206500_s_at	MIS18 binding protein 1(MIS18BP1)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0034080~CENP-A containing nucleosome assembly,GO:0051301~cell division,	GO:0000778~condensed nuclear chromosome kinetochore,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR015216:SANT associated,IPR017884:SANT domain,				SM00717:SANT,	3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Kinetochore-associated protein KNL-2 homolog,compositionally biased region:Poly-Asp,domain:SANT,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
219004_s_at	MIS18 kinetochore protein A(MIS18A)	Homo sapiens				GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0034080~CENP-A containing nucleosome assembly,GO:0044030~regulation of DNA methylation,GO:0051301~cell division,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004910:Yippee-like protein,					Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Metal-binding,Mitosis,Nucleus,Phosphoprotein,Reference proteome,Zinc,	chain:Protein Mis18-alpha,modified residue,mutagenesis site,
218259_at	MKL1/myocardin like 2(MKL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007517~muscle organ development,GO:0045844~positive regulation of striated muscle tissue development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051145~smooth muscle cell differentiation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005913~cell-cell adherens junction,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003713~transcription coactivator activity,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003034:SAP domain,IPR004018:RPEL repeat,				SM00513:SAP,SM00707:RPEL,	Actin-binding,Activator,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Developmental protein,Differentiation,Glycoprotein,Isopeptide bond,Myogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:MKL/myocardin-like protein 2,compositionally biased region:Gln-rich,domain:SAP,modified residue,region of interest:Required for interaction with itself and with MKL1,repeat:RPEL 1,repeat:RPEL 2,repeat:RPEL 3,sequence conflict,splice variant,
214477_at	MLLT1, super elongation complex subunit(MLLT1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR005033:YEATS,	hsa05202:Transcriptional misregulation in cancer,				Acetylation,Activator,Chromosomal rearrangement,Complete proteome,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Protein ENL,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:YEATS,modified residue,sequence conflict,
204917_s_at, 204918_s_at	MLLT3, super elongation complex subunit(MLLT3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007379~segment specification,GO:0009952~anterior/posterior pattern specification,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005634~nucleus,GO:0008023~transcription elongation factor complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR005033:YEATS,	hsa05202:Transcriptional misregulation in cancer,				3D-structure,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Protein AF-9,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:YEATS,modified residue,sequence conflict,short sequence motif:Nuclear localization signal,site:MLL fusion point (in acute myeloid leukemia patient CO),site:MLL fusion point (in acute myeloid leukemia patient F1),
221163_s_at	MLX interacting protein like(MLXIPL)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0009653~anatomical structure morphogenesis,GO:0010255~glucose mediated signaling pathway,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0042593~glucose homeostasis,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0045821~positive regulation of glycolytic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046889~positive regulation of lipid biosynthetic process,GO:0055089~fatty acid homeostasis,GO:0070328~triglyceride homeostasis,GO:0071157~negative regulation of cell cycle arrest,GO:0071322~cellular response to carbohydrate stimulus,GO:0090324~negative regulation of oxidative phosphorylation,GO:2000505~regulation of energy homeostasis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0035538~carbohydrate response element binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),			SM00353:HLH,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Williams-Beuren syndrome,	chain:Williams-Beuren syndrome chromosomal region 14 protein,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,splice variant,
211789_s_at, 202519_at	MLX interacting protein(MLXIP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:1900402~regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005741~mitochondrial outer membrane,	GO:0000989~transcription factor activity, transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),			SM00353:HLH,	Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transcription,Transcription regulation,	chain:MLX-interacting protein,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,region of interest:Mediates heterotypic interactions between MLXIP and MLX and is required for cytoplasmic localization,region of interest:Required for cytoplasmic localization,region of interest:Transactivation domain,sequence variant,splice variant,
213708_s_at, 217909_s_at, 210752_s_at, 217910_x_at	MLX, MAX dimerization protein(MLX)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),			SM00353:HLH,	Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Max-like protein X,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,splice variant,
78047_s_at, 221953_s_at, 49679_s_at	MMP24 antisense RNA 1(MMP24-AS1)	Homo sapiens												Complete proteome,Proteomics identification,Reference proteome,
202167_s_at	MMS19 homolog, cytosolic iron-sulfur assembly component(MMS19)	Homo sapiens				GO:0000160~phosphorelay signal transduction system,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007059~chromosome segregation,GO:0009725~response to hormone,GO:0016226~iron-sulfur cluster assembly,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005675~holo TFIIH complex,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016020~membrane,GO:0071817~MMXD complex,GO:0097361~CIA complex,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0030159~receptor signaling complex scaffold activity,GO:0030331~estrogen receptor binding,GO:0030674~protein binding, bridging,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024687:Transcription protein MMS19, N-terminal domain,					Acetylation,Activator,Alternative splicing,Chromosome partition,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA repair,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:MMS19 nucleotide excision repair protein homolog,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,sequence conflict,sequence variant,splice variant,
205330_at	MN1 proto-oncogene, transcriptional regulator(MN1)	Homo sapiens				GO:0001957~intramembranous ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,					607174~Meningioma,			Acetylation,Activator,Chromosomal rearrangement,Coiled coil,Complete proteome,Developmental protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	chain:Probable tumor suppressor protein MN1,compositionally biased region:Poly-Gln,modified residue,sequence conflict,sequence variant,
203565_s_at	MNAT1, CDK activating kinase assembly factor(MNAT1)	Homo sapiens		h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006461~protein complex assembly,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007094~mitotic spindle assembly checkpoint,GO:0007512~adult heart development,GO:0008283~cell proliferation,GO:0021591~ventricular system development,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051592~response to calcium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005675~holo TFIIH complex,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0008270~zinc ion binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0047485~protein N-terminus binding,	IPR001841:Zinc finger, RING-type,IPR003511:DNA-binding HORMA,IPR003903:Ubiquitin interacting motif,IPR004575:Cdk-activating kinase assembly factor MAT1/Tfb3,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015877:Cdk-activating kinase assembly factor MAT1, centre,IPR017907:Zinc finger, RING-type, conserved site,IPR027097:Mitotic spindle checkpoint protein Mad2,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,		PIRSF003338:CDK-activating kinase assembly factor MAT1,	SM00184:RING,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Coiled coil,Complete proteome,Direct protein sequencing,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:CDK-activating kinase assembly factor MAT1,helix,modified residue,repeat:UIM,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
202919_at	MOB family member 4, phocein(MOB4)	Homo sapiens				GO:0006810~transport,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0032580~Golgi cisterna membrane,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,				SM01388:SM01388,	Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Golgi apparatus,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transport,Zinc,	chain:Mps one binder kinase activator-like 3,metal ion-binding site:Zinc,modified residue,sequence conflict,splice variant,
201298_s_at, 214812_s_at, 201299_s_at, 201297_s_at	MOB kinase activator 1A(MOB1A)	Homo sapiens				GO:0035329~hippo signaling,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,	hsa04390:Hippo signaling pathway,			SM01388:SM01388,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Metal-binding,Phosphoprotein,Reference proteome,Zinc,	chain:Mps one binder kinase activator-like 1B,helix,metal ion-binding site:Zinc,modified residue,sequence conflict,splice variant,strand,turn,
219265_at	MOB kinase activator 3B(MOB3B)	Homo sapiens						GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005301:Mob1/phocein,				SM01388:SM01388,	Complete proteome,Metal-binding,Reference proteome,Zinc,	chain:Mps one binder kinase activator-like 2B,metal ion-binding site:Zinc,sequence conflict,
205130_at	MOK protein kinase(MOK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005929~cilium,GO:0097546~ciliary base,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:MAPK/MAK/MRK overlapping kinase,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
203644_s_at	MON1 homolog B, secretory trafficking associated(MON1B)	Homo sapiens				GO:0016192~vesicle-mediated transport,GO:0019085~early viral transcription,GO:0019086~late viral transcription,	GO:0005737~cytoplasm,GO:0012505~endomembrane system,	GO:0005515~protein binding,	IPR004353:Vacuolar fusion protein MON1,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Vacuolar fusion protein MON1 homolog B,modified residue,
212755_at, 212754_s_at	MON2 homolog, regulator of endosome-to-Golgi trafficking(MON2)	Homo sapiens				GO:0006895~Golgi to endosome transport,GO:0015031~protein transport,GO:0015986~ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,	IPR001421:ATPase, F0 complex, subunit 8, mitochondrial, Metazoan,IPR011989:Armadillo-like helical,IPR015403:Domain of unknown function DUF1981, SEC7 associated,IPR016024:Armadillo-type fold,					Acetylation,Alternative splicing,ATP synthesis,CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Protein MON2 homolog,modified residue,sequence conflict,sequence variant,splice variant,
220850_at	MORC family CW-type zinc finger 1(MORC1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,					Alternative splicing,Coiled coil,Complete proteome,Developmental protein,Differentiation,Metal-binding,Nucleus,Polymorphism,Reference proteome,Spermatogenesis,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 1,sequence variant,zinc finger region:CW-type,
203956_at, 216863_s_at	MORC family CW-type zinc finger 2(MORC2)	Homo sapiens				GO:0006631~fatty acid metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,		616688~Charcot-Marie-Tooth disease, axonal, type 2Z,			Acetylation,Alternative splicing,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Fatty acid metabolism,Isopeptide bond,Lipid metabolism,Metal-binding,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 2,modified residue,zinc finger region:CW-type,
213000_at	MORC family CW-type zinc finger 3(MORC3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007569~cell aging,GO:0009791~post-embryonic development,GO:0016032~viral process,GO:0018105~peptidyl-serine phosphorylation,GO:0048147~negative regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0051457~maintenance of protein location in nucleus,	GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,	GO:0003723~RNA binding,GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,					3D-structure,Coiled coil,Complete proteome,Host-virus interaction,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 3,zinc finger region:CW-type,
219038_at	MORC family CW-type zinc finger 4(MORC4)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,					Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Nucleus,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 4,modified residue,sequence conflict,sequence variant,zinc finger region:CW-type,
219852_s_at	MORN repeat containing 1(MORN1)	Homo sapiens			Function unknown,				IPR003409:MORN motif,				SM00698:MORN,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:MORN repeat-containing protein 1,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,sequence variant,splice variant,
207550_at, 216825_s_at, 211903_s_at	MPL proto-oncogene, thrombopoietin receptor(MPL)	Homo sapiens		h_tpoPathway:TPO Signaling Pathway,		GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0038163~thrombopoietin-mediated signaling pathway,GO:0050671~positive regulation of lymphocyte proliferation,GO:0070527~platelet aggregation,GO:0071456~cellular response to hypoxia,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0004888~transmembrane signaling receptor activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0038164~thrombopoietin receptor activity,	IPR003528:Long hematopoietin receptor, single chain, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015152:Growth hormone/erythropoietin receptor, ligand binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,	254450~Myelofibrosis with myeloid metaplasia, somatic,601977~Thrombocythemia 2,604498~Thrombocytopenia, congenital amegakaryocytic,		SM00060:FN3,	Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Isopeptide bond,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Thrombopoietin receptor,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
203466_at	MPV17, mitochondrial inner membrane protein(MPV17)	Homo sapiens				GO:0000002~mitochondrial genome maintenance,GO:0032836~glomerular basement membrane development,GO:0034614~cellular response to reactive oxygen species,GO:0042592~homeostatic process,GO:0048839~inner ear development,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0016021~integral component of membrane,		IPR007248:Mpv17/PMP22,	hsa04146:Peroxisome,	256810~Mitochondrial DNA depletion syndrome 6 (hepatocerebral type),			Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Neuropathy,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein Mpv17,sequence variant,transmembrane region,
211334_at, 205395_s_at	MRE11 homolog, double strand break repair nuclease(MRE11)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000019~regulation of mitotic recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007004~telomere maintenance via telomerase,GO:0007062~sister chromatid cohesion,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007129~synapsis,GO:0007131~reciprocal meiotic recombination,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0031573~intra-S DNA damage checkpoint,GO:0031860~telomeric 3' overhang formation,GO:0031954~positive regulation of protein autophosphorylation,GO:0032206~positive regulation of telomere maintenance,GO:0032481~positive regulation of type I interferon production,GO:0032508~DNA duplex unwinding,GO:0032876~negative regulation of DNA endoreduplication,GO:0033674~positive regulation of kinase activity,GO:0043066~negative regulation of apoptotic process,GO:0051321~meiotic cell cycle,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0098609~cell-cell adhesion,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0016605~PML body,GO:0030870~Mre11 complex,GO:0035861~site of double-strand break,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008408~3'-5' exonuclease activity,GO:0030145~manganese ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003701:DNA repair protein Mre11,IPR004843:Metallophosphoesterase domain,IPR007281:Mre11, DNA-binding,	hsa03440:Homologous recombination,hsa03450:Non-homologous end-joining,	604391~Ataxia-telangiectasia-like disorder,	PIRSF000882:double-strand break repair protein MRE11,	SM01347:SM01347,	3D-structure,Acetylation,Alternative splicing,Chromosome,Ciliopathy,Complete proteome,Disease mutation,DNA damage,DNA repair,Endonuclease,Exonuclease,Host-virus interaction,Hydrolase,Manganese,Meiosis,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,	active site:Proton donor,chain:Double-strand break repair protein MRE11A,modified residue,sequence conflict,sequence variant,splice variant,
218586_at	MRG domain binding protein(MRGBP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016573~histone acetylation,GO:0040008~regulation of growth,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0005515~protein binding,	IPR012423:Chromatin modification-related protein EAF7,					3D-structure,Acetylation,Activator,Chromatin regulator,Complete proteome,Direct protein sequencing,Growth regulation,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:MRG-binding protein,compositionally biased region:Poly-Gly,modified residue,
220341_s_at	MRN complex interacting protein(MRNIP)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteomeFT   VAR_SEQ     222    229       VTATSSKW -> DGYKEILF (in isoform 2),	chain:UPF0544 protein C5orf45,sequence variant,splice variant,
46167_at	MROH7-TTC4 readthrough (NMD candidate)(MROH7-TTC4)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Complete proteome,Reference proteome,
218538_s_at, 218536_at	MRS2, magnesium transporter(MRS2)	Homo sapiens				GO:0045016~mitochondrial magnesium ion transport,GO:0055085~transmembrane transport,GO:1990614~mitochondrial magnesium ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0015095~magnesium ion transmembrane transporter activity,						Alternative splicing,Complete proteome,Ion transport,Magnesium,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:Magnesium transporter MRS2 homolog, mitochondrial,sequence variant,splice variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transit peptide:Mitochondrion,transmembrane region,
220688_s_at	MRT4 homolog, ribosome maturation factor(MRTO4)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0022625~cytosolic large ribosomal subunit,GO:0030687~preribosome, large subunit precursor,GO:0031965~nuclear membrane,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR001790:Ribosomal protein L10/acidic P0,					Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,Ribosome biogenesis,	chain:mRNA turnover protein 4 homolog,modified residue,sequence conflict,
205122_at, 205123_s_at	MSANTD3-TMEFF1 readthrough(MSANTD3-TMEFF1)	Homo sapiens				GO:0007275~multicellular organism development,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR002350:Kazal domain,IPR013032:EGF-like, conserved site,				SM00280:KAZAL,	Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,EGF-like domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,
210410_s_at, 212913_at, 221406_s_at	MSH5-SAPCD1 readthrough (NMD candidate)(MSH5-SAPCD1)	Homo sapiens				GO:0006298~mismatch repair,		GO:0005524~ATP binding,GO:0030983~mismatched DNA binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00534:MUTSac,	Complete proteome,Reference proteome,
220587_s_at	MTOR associated protein, LST8 homolog(MLST8)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0016236~macroautophagy,GO:0030838~positive regulation of actin filament polymerization,GO:0031295~T cell costimulation,GO:0032008~positive regulation of TOR signaling,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:1900034~regulation of cellular response to heat,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031931~TORC1 complex,GO:0031932~TORC2 complex,	GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,			SM00320:WD40,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Target of rapamycin complex subunit LST8,modified residue,mutagenesis site,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,splice variant,
203036_s_at, 210360_s_at, 203037_s_at, 210359_at	MTSS1, I-BAR domain containing(MTSS1)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007009~plasma membrane organization,GO:0007155~cell adhesion,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0030035~microspike assembly,GO:0030036~actin cytoskeleton organization,GO:0050680~negative regulation of epithelial cell proliferation,GO:0061333~renal tubule morphogenesis,GO:0071498~cellular response to fluid shear stress,GO:0072102~glomerulus morphogenesis,GO:0072160~nephron tubule epithelial cell differentiation,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0030139~endocytic vesicle,	GO:0003785~actin monomer binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR003124:WH2 domain,IPR013606:IRSp53/MIM homology domain (IMD),					3D-structure,Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Metastasis suppressor protein 1,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:IMD,domain:WH2,helix,modified residue,sequence conflict,sequence variant,splice variant,
213978_at	MTSS1L, I-BAR domain containing(MTSS1L)	Homo sapiens				GO:0007009~plasma membrane organization,GO:0097581~lamellipodium organization,	GO:0001726~ruffle,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0030864~cortical actin cytoskeleton,	GO:0003785~actin monomer binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0048365~Rac GTPase binding,	IPR013606:IRSp53/MIM homology domain (IMD),					Actin-binding,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,	chain:MTSS1-like protein,compositionally biased region:Ser-rich,domain:IMD,domain:WH2,modified residue,splice variant,
218463_s_at	MUS81 structure-specific endonuclease subunit(MUS81)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000712~resolution of meiotic recombination intermediates,GO:0000727~double-strand break repair via break-induced replication,GO:0000737~DNA catabolic process, endonucleolytic,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0031297~replication fork processing,GO:0031573~intra-S DNA damage checkpoint,GO:0036297~interstrand cross-link repair,GO:0072429~response to intra-S DNA damage checkpoint signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0048476~Holliday junction resolvase complex,	GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008821~crossover junction endodeoxyribonuclease activity,GO:0046872~metal ion binding,GO:0048257~3'-flap endonuclease activity,	IPR006166:ERCC4 domain,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR011335:Restriction endonuclease  type II-like,IPR020819:DNA repair nuclease, XPF-type/Helicase,IPR027420:DNA polymerase beta, N-terminal domain,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,			SM00891:SM00891,	3D-structure,Complete proteome,DNA damage,DNA recombination,DNA repair,Endonuclease,Hydrolase,Magnesium,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Crossover junction endonuclease MUS81,domain:ERCC4,helix,modified residue,mutagenesis site,region of interest:Interaction with BLM,sequence variant,strand,turn,
202086_at	MX dynamin like GTPase 1(MX1)	Homo sapiens				GO:0006915~apoptotic process,GO:0006952~defense response,GO:0007165~signal transduction,GO:0009615~response to virus,GO:0034340~response to type I interferon,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0048285~organelle fission,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008017~microtubule binding,	IPR000375:Dynamin central domain,IPR001401:Dynamin, GTPase domain,IPR003130:Dynamin GTPase effector,IPR019762:Dynamin, GTPase region, conserved site,IPR020850:GTPase effector domain, GED,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05162:Measles,hsa05164:Influenza A,			SM00053:DYNc,SM00302:GED,	3D-structure,Acetylation,Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,GTP-binding,Immunity,Innate immunity,Membrane,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Interferon-induced GTP-binding protein Mx1,chain:Interferon-induced GTP-binding protein Mx1, N-terminally processed,domain:GED,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
204994_at	MX dynamin like GTPase 2(MX2)	Homo sapiens			General function prediction only,	GO:0006952~defense response,GO:0009615~response to virus,GO:0015031~protein transport,GO:0035455~response to interferon-alpha,GO:0045087~innate immune response,GO:0046822~regulation of nucleocytoplasmic transport,GO:0048285~organelle fission,GO:0051028~mRNA transport,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:0060337~type I interferon signaling pathway,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008017~microtubule binding,	IPR000375:Dynamin central domain,IPR001401:Dynamin, GTPase domain,IPR003130:Dynamin GTPase effector,IPR019762:Dynamin, GTPase region, conserved site,IPR020850:GTPase effector domain, GED,IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00053:DYNc,SM00302:GED,	3D-structure,Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,GTP-binding,Immunity,Innate immunity,mRNA transport,Nuclear pore complex,Nucleotide-binding,Nucleus,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Interferon-induced GTP-binding protein Mx2,domain:GED,modified residue,nucleotide phosphate-binding region:GTP,
219098_at	MYB binding protein 1a(MYBBP1A)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006913~nucleocytoplasmic transport,GO:0022904~respiratory electron transport chain,GO:0032922~circadian regulation of gene expression,GO:0042149~cellular response to glucose starvation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0071158~positive regulation of cell cycle arrest,GO:0071897~DNA biosynthetic process,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2000210~positive regulation of anoikis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042564~NLS-dependent protein nuclear import complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR007015:DNA polymerase V,IPR016024:Armadillo-type fold,					Acetylation,Activator,Alternative splicing,Biological rhythms,Citrullination,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Signal,Transcription,Transcription regulation,	chain:Myb-binding protein 1A,compositionally biased region:Glu-rich,modified residue,region of interest:Interaction with MYB,region of interest:Required for nuclear and nucleolar localization,sequence conflict,sequence variant,short sequence motif:Nuclear export signal 1,short sequence motif:Nuclear export signal 2,splice variant,
213906_at	MYB proto-oncogene like 1(MYBL1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0003677~DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR012642:Transcription regulator Wos2-domain,IPR015395:C-myb, C-terminal,IPR017877:Myb-like domain,IPR017930:Myb domain,				SM00717:SANT,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Myb-related protein A,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,domain:HTH myb-type 3,modified residue,region of interest:Negative regulatory domain,region of interest:Transcriptional activation domain,
201710_at	MYB proto-oncogene like 2(MYBL2)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051726~regulation of cell cycle,GO:0090307~mitotic spindle assembly,	GO:0005654~nucleoplasm,GO:0031523~Myb complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR015395:C-myb, C-terminal,IPR017930:Myb domain,				SM00717:SANT,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Myb-related protein B,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,domain:HTH myb-type 3,modified residue,sequence variant,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear localization signal,
215152_at, 204798_at	MYB proto-oncogene, transcription factor(MYB)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0045624~positive regulation of T-helper cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,	GO:0005634~nucleus,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR012642:Transcription regulator Wos2-domain,IPR015395:C-myb, C-terminal,IPR017877:Myb-like domain,IPR017930:Myb domain,	hsa04151:PI3K-Akt signaling pathway,hsa05166:HTLV-I infection,	T-cell acute lymphoblastic leukemia~T-cell acute lymphoblastic leukemia,		SM00717:SANT,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Myb proto-oncogene protein,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,domain:HTH myb-type 3,domain:Leucine-zipper,modified residue,region of interest:Interaction with HIPK2 and NLK,region of interest:Negative regulatory domain,region of interest:Transcriptional activation domain,sequence conflict,sequence variant,splice variant,
208403_x_at, 214108_at, 210734_x_at, 209332_s_at, 209331_s_at	MYC associated factor X(MAX)	Homo sapiens	61.Myc_network,	h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,		GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0009267~cellular response to starvation,GO:0010629~negative regulation of gene expression,GO:0032868~response to insulin,GO:0048678~response to axon injury,GO:0051402~neuron apoptotic process,GO:0060041~retina development in camera-type eye,GO:0071375~cellular response to peptide hormone stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0030425~dendrite,GO:0071339~MLL1 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05222:Small cell lung cancer,	171300~Pheochromocytoma, susceptibility to,		SM00353:HLH,	3D-structure,Acetylation,Activator,Alternative splicing,Cell projection,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Protein max,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,helix,modified residue,mutagenesis site,short sequence motif:Nuclear localization signal,splice variant,
207824_s_at, 212064_x_at	MYC associated zinc finger protein(MAZ)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006369~termination of RNA polymerase II transcription,	GO:0005634~nucleus,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Signal,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Myc-associated zinc finger protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,sequence conflict,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6; atypical,
201960_s_at, 201959_s_at	MYC binding protein 2, E3 ubiquitin protein ligase(MYCBP2)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000408:Regulator of chromosome condensation, RCC1,IPR001841:Zinc finger, RING-type,IPR003646:SH3-like domain, bacterial,IPR004939:Anaphase-promoting complex, subunit 10/DOC domain,IPR008979:Galactose-binding domain-like,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR012983:PHR,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,				SM00184:RING,SM01337:SM01337,	Alternative splicing,Complete proteome,Disulfide bond,Ligase,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Probable E3 ubiquitin-protein ligase MYCBP2,compositionally biased region:Cys-rich,compositionally biased region:Gly-rich,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,domain:DOC,modified residue,repeat:Filamin,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,sequence conflict,sequence variant,splice variant,zinc finger region:B box-type,zinc finger region:RING-type; atypical,
213189_at, 213188_s_at	MYC induced nuclear antigen(MINA)	Homo sapiens			Function unknown,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0018193~peptidyl-amino acid modification,GO:0042254~ribosome biogenesis,GO:0043687~post-translational protein modification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0005506~iron ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0042802~identical protein binding,	IPR003347:JmjC domain,					3D-structure,Alternative splicing,Complete proteome,Dioxygenase,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,Transcription,Transcription regulation,	chain:MYC-induced nuclear antigen,domain:JmjC,sequence conflict,sequence variant,splice variant,
207028_at, 216188_at	MYCN opposite strand(MYCNOS)	Homo sapiens				GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0031647~regulation of protein stability,GO:0033673~negative regulation of kinase activity,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,						Complete proteome,Cytoplasm,Nucleus,Reference proteome,	chain:N-cym protein,compositionally biased region:Arg/Lys-rich (basic),sequence conflict,
218165_at	MYST/Esa1 associated factor 6(MEAF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016573~histone acetylation,GO:0043968~histone H2A acetylation,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043983~histone H4-K12 acetylation,GO:0043984~histone H4-K16 acetylation,GO:0044154~histone H3-K14 acetylation,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000123~histone acetyltransferase complex,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0035267~NuA4 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0005515~protein binding,	IPR015418:Histone H4 acetyltransferase, NuA4 complex, Eaf6,					Acetylation,Activator,Alternative splicing,Centromere,Chromatin regulator,Chromosomal rearrangement,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Kinetochore,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Chromatin modification-related protein MEAF6,modified residue,sequence conflict,splice variant,
218138_at	McKusick-Kaufman syndrome(MKKS)	Homo sapiens				GO:0001947~heart looping,GO:0006457~protein folding,GO:0007286~spermatid development,GO:0007368~determination of left/right symmetry,GO:0007507~heart development,GO:0007601~visual perception,GO:0007608~sensory perception of smell,GO:0008406~gonad development,GO:0010629~negative regulation of gene expression,GO:0014824~artery smooth muscle contraction,GO:0021756~striatum development,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0030837~negative regulation of actin filament polymerization,GO:0032402~melanosome transport,GO:0034260~negative regulation of GTPase activity,GO:0035058~nonmotile primary cilium assembly,GO:0035176~social behavior,GO:0038108~negative regulation of appetite by leptin-mediated signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042311~vasodilation,GO:0042384~cilium assembly,GO:0045444~fat cell differentiation,GO:0045494~photoreceptor cell maintenance,GO:0045776~negative regulation of blood pressure,GO:0046907~intracellular transport,GO:0048854~brain morphogenesis,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051131~chaperone-mediated protein complex assembly,GO:0051216~cartilage development,GO:0051492~regulation of stress fiber assembly,GO:0051877~pigment granule aggregation in cell center,GO:0060027~convergent extension involved in gastrulation,GO:0060271~cilium morphogenesis,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,GO:0060324~face development,	GO:0005622~intracellular,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031514~motile cilium,GO:1902636~kinociliary basal body,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0051082~unfolded protein binding,	IPR002423:Chaperonin Cpn60/TCP-1,IPR027409:GroEL-like apical domain,IPR027413:GroEL-like equatorial domain,		236700~McKusick-Kaufman syndrome,605231~Bardet-Biedl syndrome 6,			ATP-binding,Bardet-Biedl syndrome,Chaperone,Ciliopathy,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Nucleotide-binding,Obesity,Polymorphism,Proteomics identification,Reference proteome,Sensory transduction,Transmembrane,Transmembrane helix,Vision,	chain:McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin,nucleotide phosphate-binding region:ATP,sequence variant,
213761_at, 220397_at	Mdm1 nuclear protein(MDM1)	Homo sapiens				GO:0046600~negative regulation of centriole replication,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005874~microtubule,GO:0016021~integral component of membrane,	GO:0008017~microtubule binding,						Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Microtubule,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nuclear protein MDM1,modified residue,sequence variant,splice variant,
218630_at	Meckel syndrome, type 1(MKS1)	Homo sapiens				GO:0001843~neural tube closure,GO:0007368~determination of left/right symmetry,GO:0010669~epithelial structure maintenance,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0042733~embryonic digit morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048754~branching morphogenesis of an epithelial tube,GO:0060122~inner ear receptor stereocilium organization,GO:0060271~cilium morphogenesis,GO:0060322~head development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061009~common bile duct development,GO:1901620~regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:1903887~motile primary cilium assembly,GO:1990403~embryonic brain development,GO:2000095~regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0016020~membrane,GO:0036038~MKS complex,GO:0036064~ciliary basal body,	GO:0005515~protein binding,	IPR010796:B9 domain,		249000~Meckel syndrome 1,615990~Bardet-Biedl syndrome 13,			Alternative splicing,Bardet-Biedl syndrome,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Meckel syndrome,Mental retardation,Obesity,Polymorphism,Proteomics identification,Reference proteome,	chain:Meckel syndrome type 1 protein,domain:B9,sequence variant,splice variant,
208262_x_at	Mediterranean fever(MEFV)	Homo sapiens				GO:0006954~inflammatory response,GO:0010508~positive regulation of autophagy,GO:0032691~negative regulation of interleukin-1 beta production,GO:0032695~negative regulation of interleukin-12 production,GO:0034341~response to interferon-gamma,GO:0050728~negative regulation of inflammatory response,GO:0071641~negative regulation of macrophage inflammatory protein 1 alpha production,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900226~negative regulation of NLRP3 inflammasome complex assembly,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0001726~ruffle,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0030027~lamellipodium,GO:0031410~cytoplasmic vesicle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR004020:DAPIN domain,IPR006574:SPRY-associated,IPR011029:Death-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04621:NOD-like receptor signaling pathway,	134610~Familial Mediterranean fever, AD,249100~Familial Mediterranean fever, AR,		SM00336:BBOX,SM00449:SPRY,SM00589:PRY,SM01289:SM01289,	3D-structure,Actin-binding,Alternative splicing,Amyloidosis,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Disease mutation,Immunity,Inflammatory response,Innate immunity,Metal-binding,Microtubule,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Pyrin,domain:B30.2/SPRY,domain:DAPIN,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:B box-type,
204069_at	Meis homeobox 1(MEIS1)	Homo sapiens				GO:0001525~angiogenesis,GO:0002089~lens morphogenesis in camera-type eye,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007626~locomotory behavior,GO:0035855~megakaryocyte development,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,	hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05202:Transcriptional misregulation in cancer,			SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,	chain:Homeobox protein Meis1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Asp,compositionally biased region:Ser/Thr-rich,DNA-binding region:Homeobox; TALE-type,region of interest:Required for transcriptional activation,splice variant,
207480_s_at	Meis homeobox 2(MEIS2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001654~eye development,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0008542~visual learning,GO:0009612~response to mechanical stimulus,GO:0031016~pancreas development,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070848~response to growth factor,	GO:0005634~nucleus,GO:0048471~perinuclear region of cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,				SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,DNA-binding,Homeobox,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Meis2,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Asp,compositionally biased region:Ser/Thr-rich,DNA-binding region:Homeobox; TALE-type,modified residue,splice variant,
214077_x_at	Meis homeobox 3 pseudogene 1(MEIS3P1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR001356:Homeodomain,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,				SM00389:HOX,	Complete proteome,DNA-binding,Homeobox,Nucleus,Reference proteome,
212199_at	Morf4 family associated protein 1 like 1(MRFAP1L1)	Homo sapiens						GO:0005515~protein binding,GO:0042802~identical protein binding,						Coiled coil,Complete proteome,Reference proteome,	chain:MORF4 family-associated protein 1-like 1,sequence conflict,
221208_s_at	Myb/SANT DNA binding domain containing 2(MSANTD2)	Homo sapiens												Alternative splicing,Complete proteome,Isopeptide bond,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Uncharacterized protein C11orf61,compositionally biased region:Gly-rich,modified residue,sequence conflict,splice variant,
211675_s_at, 217599_s_at	MyoD family inhibitor domain containing(MDFIC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007257~activation of JUN kinase activity,GO:0016032~viral process,GO:0030111~regulation of Wnt signaling pathway,GO:0042308~negative regulation of protein import into nucleus,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050434~positive regulation of viral transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0030332~cyclin binding,GO:0030957~Tat protein binding,	IPR026134:MyoD family inhibitor/MyoD family inhibitor domain-containing protein,					Activator,Alternative initiation,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:MyoD family inhibitor domain-containing protein,compositionally biased region:Cys-rich,modified residue,splice variant,
205375_at	MyoD family inhibitor(MDFI)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0007257~activation of JUN kinase activity,GO:0009790~embryo development,GO:0009950~dorsal/ventral axis specification,GO:0030178~negative regulation of Wnt signaling pathway,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0043392~negative regulation of DNA binding,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048704~embryonic skeletal system morphogenesis,GO:0060707~trophoblast giant cell differentiation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR026134:MyoD family inhibitor/MyoD family inhibitor domain-containing protein,					Complete proteome,Cytoplasm,Developmental protein,Differentiation,Nucleus,Proteomics identification,Reference proteome,	chain:MyoD family inhibitor,compositionally biased region:Cys-rich,
203025_at	N(alpha)-acetyltransferase 10, NatA catalytic subunit(NAA10)	Homo sapiens			General function prediction only,	GO:0006323~DNA packaging,GO:0006474~N-terminal protein amino acid acetylation,GO:0006475~internal protein amino acid acetylation,GO:0017198~N-terminal peptidyl-serine acetylation,GO:0018002~N-terminal peptidyl-glutamic acid acetylation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0022626~cytosolic ribosome,GO:0031415~NatA complex,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0043022~ribosome binding,GO:1990189~peptide-serine-N-acetyltransferase activity,GO:1990190~peptide-glutamate-N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,		300855~Ogden syndrome,309800~Microphthalmia, syndromic 1,			Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Microphthalmia,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:N-terminal acetyltransferase complex ARD1 subunit homolog A,domain:N-acetyltransferase,modified residue,region of interest:Interaction with NARG1,
210603_at	N(alpha)-acetyltransferase 11, NatA catalytic subunit(NAA11)	Homo sapiens			General function prediction only,	GO:0006474~N-terminal protein amino acid acetylation,GO:0006475~internal protein amino acid acetylation,GO:0017198~N-terminal peptidyl-serine acetylation,GO:0018002~N-terminal peptidyl-glutamic acid acetylation,	GO:0005634~nucleus,GO:0022626~cytosolic ribosome,GO:0031415~NatA complex,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:1990189~peptide-serine-N-acetyltransferase activity,GO:1990190~peptide-glutamate-N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:N-terminal acetyltransferase complex ARD1 subunit homolog B,domain:N-acetyltransferase,modified residue,region of interest:Interaction with NARG1,sequence variant,
219158_s_at	N(alpha)-acetyltransferase 15, NatA auxiliary subunit(NAA15)	Homo sapiens				GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006474~N-terminal protein amino acid acetylation,GO:0017196~N-terminal peptidyl-methionine acetylation,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031415~NatA complex,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0016407~acetyltransferase activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR021183:N-terminal acetyltransferase A, auxiliary subunit,			PIRSF000422:N-terminal acetyltransferase A, auxiliary subunit,	SM00028:TPR,	Acetylation,Alternative splicing,Angiogenesis,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transcription,Transcription regulation,	chain:NMDA receptor-regulated protein 1,compositionally biased region:Poly-Asp,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,short sequence motif:Bipartite nuclear localization signal,splice variant,
219378_at	N(alpha)-acetyltransferase 16, NatA auxiliary subunit(NAA16)	Homo sapiens			General function prediction only,	GO:0006474~N-terminal protein amino acid acetylation,GO:0017196~N-terminal peptidyl-methionine acetylation,GO:0043066~negative regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0031415~NatA complex,GO:0070062~extracellular exosome,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0016407~acetyltransferase activity,GO:0043022~ribosome binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,IPR021183:N-terminal acetyltransferase A, auxiliary subunit,			PIRSF000422:N-terminal acetyltransferase A, auxiliary subunit,	SM00028:TPR,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Receptor,Reference proteome,Repeat,TPR repeat,	chain:NMDA receptor-regulated 1-like protein,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,sequence variant,splice variant,
220925_at, 219362_at	N(alpha)-acetyltransferase 35, NatC auxiliary subunit(NAA35)	Homo sapiens				GO:0006474~N-terminal protein amino acid acetylation,GO:0043066~negative regulation of apoptotic process,GO:0048659~smooth muscle cell proliferation,	GO:0005737~cytoplasm,GO:0005844~polysome,GO:0031417~NatC complex,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,	IPR007244:NatC N(alpha)-terminal acetyltransferase, Mak10 subunit,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Transferase,	chain:Protein MAK10 homolog,sequence conflict,
222369_at, 218734_at	N(alpha)-acetyltransferase 40, NatD catalytic subunit(NAA40)	Homo sapiens				GO:0006629~lipid metabolic process,		GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					3D-structure,Acyltransferase,Alternative splicing,Complete proteome,Lipoprotein,Myristate,Proteomics identification,Reference proteome,Transferase,	chain:N-acetyltransferase 11,domain:N-acetyltransferase,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,splice variant,
217745_s_at	N(alpha)-acetyltransferase 50, NatE catalytic subunit(NAA50)	Homo sapiens				GO:0006474~N-terminal protein amino acid acetylation,GO:0043967~histone H4 acetylation,GO:0071962~mitotic sister chromatid cohesion, centromeric,	GO:0005737~cytoplasm,GO:0031415~NatA complex,GO:0070062~extracellular exosome,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0052858~peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					3D-structure,Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:N-acetyltransferase 13,domain:N-acetyltransferase,helix,modified residue,region of interest:Coenzyme A binding,splice variant,strand,turn,
218661_at, 45526_g_at	N(alpha)-acetyltransferase 60, NatF catalytic subunit(NAA60)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0007059~chromosome segregation,GO:0008283~cell proliferation,GO:0017196~N-terminal peptidyl-methionine acetylation,GO:0043967~histone H4 acetylation,	GO:0000139~Golgi membrane,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					3D-structure,Acetylation,Acyltransferase,Alternative promoter usage,Alternative splicing,Chromatin regulator,Chromosome partition,Complete proteome,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:N-acetyltransferase 15,domain:N-acetyltransferase,sequence conflict,sequence variant,
220311_at	N-6 adenine-specific DNA methyltransferase 1 (putative)(N6AMT1)	Homo sapiens				GO:0006415~translational termination,GO:0006479~protein methylation,GO:0030307~positive regulation of cell growth,GO:0032259~methylation,	GO:0005829~cytosol,GO:0043234~protein complex,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008276~protein methyltransferase activity,	IPR002052:DNA methylase, N-6 adenine-specific, conserved site,IPR004557:Eukaryotic/archaeal PrmC-related,IPR007848:Methyltransferase small domain,					Alternative splicing,Complete proteome,Methyltransferase,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:N(6)-adenine-specific DNA methyltransferase 1,sequence variant,
215880_at, 204360_s_at	N-acetyl-alpha-glucosaminidase(NAGLU)	Homo sapiens				GO:0006027~glycosaminoglycan catabolic process,GO:0007040~lysosome organization,GO:0007399~nervous system development,GO:0021680~cerebellar Purkinje cell layer development,GO:0042474~middle ear morphogenesis,GO:0045475~locomotor rhythm,GO:0046548~retinal rod cell development,GO:0060119~inner ear receptor cell development,	GO:0005764~lysosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0004561~alpha-N-acetylglucosaminidase activity,	IPR007781:Alpha-N-acetylglucosaminidase,IPR017853:Glycoside hydrolase, superfamily,IPR024240:Alpha-N-acetylglucosaminidase, N-terminal,IPR024732:Alpha-N-acetylglucosaminidase, C-terminal,IPR024733:Alpha-N-acetylglucosaminidase, tim-barrel domain,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa04142:Lysosome,	252920~Mucopolysaccharidosis type IIIB (Sanfilippo B),616491~Charcot-Marie-Tooth disease, axonal, type 2V,			3D-structure,Charcot-Marie-Tooth disease,Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Mucopolysaccharidosis,Neurodegeneration,Neuropathy,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Alpha-N-acetylglucosaminidase 77 kDa form,chain:Alpha-N-acetylglucosaminidase 82 kDa form,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
222161_at	N-acetylated alpha-linked acidic dipeptidase 2(NAALAD2)	Homo sapiens				GO:0006508~proteolysis,GO:0008652~cellular amino acid biosynthetic process,GO:0042135~neurotransmitter catabolic process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004180~carboxypeptidase activity,GO:0008236~serine-type peptidase activity,GO:0008237~metallopeptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0016805~dipeptidase activity,GO:0046872~metal ion binding,GO:0050129~N-formylglutamate deformylase activity,	IPR003137:Protease-associated domain, PA,IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,					3D-structure,Alternative splicing,Calcium,Carboxypeptidase,Cell membrane,Complete proteome,Dipeptidase,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Multifunctional enzyme,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Charge relay system,active site:Nucleophile; for NAALADase activity,chain:N-acetylated-alpha-linked acidic dipeptidase 2,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,region of interest:NAALADase,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
207895_at	N-acetylated alpha-linked acidic dipeptidase like 1(NAALADL1)	Homo sapiens				GO:0006508~proteolysis,	GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0004180~carboxypeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0016805~dipeptidase activity,GO:0046872~metal ion binding,	IPR003137:Protease-associated domain, PA,IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,					3D-structure,Alternative splicing,Carboxypeptidase,Cell membrane,Complete proteome,Dipeptidase,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Multifunctional enzyme,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Charge relay system,active site:Nucleophile; for NAALADase activity,chain:N-acetylated-alpha-linked acidic dipeptidase-like protein,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,region of interest:NAALADase,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
218231_at	N-acetylglucosamine kinase(NAGK)	Homo sapiens				GO:0006044~N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006051~N-acetylmannosamine metabolic process,GO:0019262~N-acetylneuraminate catabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009384~N-acylmannosamine kinase activity,GO:0045127~N-acetylglucosamine kinase activity,	IPR002731:ATPase, BadF/BadG/BcrA/BcrD type,	hsa00520:Amino sugar and nucleotide sugar metabolism,				3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:N-acetyl-D-glucosamine kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Substrate binding,sequence conflict,sequence variant,strand,turn,
212959_s_at, 220398_at	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits(GNPTAB)	Homo sapiens				GO:0007040~lysosome organization,GO:0016256~N-glycan processing to lysosome,GO:0033299~secretion of lysosomal enzymes,GO:0046835~carbohydrate phosphorylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0003976~UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000800:Notch domain,IPR002048:EF-hand domain,IPR010506:DMAP1-binding,IPR018247:EF-Hand 1, calcium-binding site,IPR021520:Protein of unknown function DUF3184,	hsa04142:Lysosome,	252500~Mucolipidosis II alpha/beta,252600~Mucolipidosis III alpha/beta,		SM00004:NL,SM01137:SM01137,	3D-structure,Alternative splicing,Calcium,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Membrane,Metal-binding,Mucolipidosis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:N-acetylglucosamine-1-phosphotransferase subunit alpha,chain:N-acetylglucosamine-1-phosphotransferase subunit beta,compositionally biased region:Gly-rich,disulfide bond,domain:EF-hand,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,repeat:LNR 1,repeat:LNR 2,sequence conflict,sequence variant,splice variant,transmembrane region,
205090_s_at	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase(NAGPA)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006464~cellular protein modification process,GO:0006486~protein glycosylation,GO:0006622~protein targeting to lysosome,GO:0007040~lysosome organization,GO:0033299~secretion of lysosomal enzymes,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0003944~N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,IPR018711:Domain of unknown function DUF2233,	hsa04142:Lysosome,				Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zymogen,	chain:N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:NPF internalization motif,short sequence motif:Tyrosine-based internalization motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
221210_s_at	N-acetylneuraminate pyruvate lyase(NPL)	Homo sapiens			Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane,	GO:0005975~carbohydrate metabolic process,GO:0008152~metabolic process,GO:0019262~N-acetylneuraminate catabolic process,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008747~N-acetylneuraminate lyase activity,GO:0016829~lyase activity,GO:0042802~identical protein binding,	IPR002220:Dihydrodipicolinate synthetase-like,IPR005264:N-acetylneuraminate lyase,IPR013785:Aldolase-type TIM barrel,	hsa00520:Amino sugar and nucleotide sugar metabolism,		PIRSF001365:dihydrodipicolinate synthase,	SM01130:SM01130,	Alternative splicing,Carbohydrate metabolism,Complete proteome,Cytoplasm,Lyase,Proteomics identification,Reference proteome,Schiff base,	active site:Schiff-base intermediate with substrate,chain:N-acetylneuraminate lyase,region of interest:Substrate binding,sequence conflict,site:Involved in proton transfer during cleavage,splice variant,
218189_s_at	N-acetylneuraminate synthase(NANS)	Homo sapiens				GO:0009103~lipopolysaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0008781~N-acylneuraminate cytidylyltransferase activity,GO:0047444~N-acylneuraminate-9-phosphate synthase activity,GO:0050462~N-acetylneuraminate synthase activity,	IPR006013:Antifreeze, type III,IPR006190:Antifreeze-like/N-acetylneuraminic acid synthase C-terminal,IPR013132:N-acetylneuraminic acid synthase, N-terminal,IPR013785:Aldolase-type TIM barrel,IPR013974:SAF domain,	hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,			SM00858:SM00858,	3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Disease mutation,Dwarfism,Mental retardation,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Sialic acid synthase,domain:AFP-like,helix,modified residue,sequence conflict,sequence variant,site:Not acetylated,strand,
214440_at	N-acetyltransferase 1(NAT1)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,	GO:0005829~cytosol,	GO:0004060~arylamine N-acetyltransferase activity,GO:0016407~acetyltransferase activity,	IPR001447:Arylamine N-acetyltransferase,	hsa00232:Caffeine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				3D-structure,Acetylation,Acyltransferase,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Transferase,	active site:Acyl-thioester intermediate,binding site:Coenzyme A,binding site:Coenzyme A; via amide nitrogen,chain:Arylamine N-acetyltransferase 1,helix,mutagenesis site,region of interest:Substrate binding,sequence variant,strand,turn,
217884_at	N-acetyltransferase 10(NAT10)	Homo sapiens			General function prediction only,	GO:0000154~rRNA modification,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0042274~ribosomal small subunit biogenesis,GO:0051391~tRNA acetylation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008080~N-acetyltransferase activity,GO:0044822~poly(A) RNA binding,	IPR000182:GNAT domain,IPR007807:Helicase domain,IPR013562:Domain of unknown function DUF1726,IPR016181:Acyl-CoA N-acyltransferase,	hsa03008:Ribosome biogenesis in eukaryotes,				Acetylation,Acyltransferase,Alternative splicing,ATP-binding,Complete proteome,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,rRNA processing,Transferase,tRNA processing,	chain:N-acetyltransferase 10,compositionally biased region:Lys-rich,domain:N-acetyltransferase,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Required for localization to the nucleolus and midbody,sequence conflict,sequence variant,
206797_at	N-acetyltransferase 2(NAT2)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:0015807~L-amino acid transport,GO:1902475~L-alpha-amino acid transmembrane transport,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004060~arylamine N-acetyltransferase activity,GO:0005515~protein binding,GO:0015179~L-amino acid transmembrane transporter activity,GO:0016407~acetyltransferase activity,	IPR001447:Arylamine N-acetyltransferase,	hsa00232:Caffeine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	243400~Acetylation, slow,			3D-structure,Acyltransferase,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	active site:Acyl-thioester intermediate,binding site:Coenzyme A,binding site:Coenzyme A; via amide nitrogen,chain:Arylamine N-acetyltransferase 2,helix,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,strand,
210874_s_at	N-acetyltransferase 6(NAT6)	Homo sapiens					GO:0005737~cytoplasm,	GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Transferase,Tumor suppressor,	chain:N-acetyltransferase 6,domain:N-acetyltransferase,sequence variant,splice variant,
206963_s_at, 210289_at, 206964_at	N-acetyltransferase 8B (putative, gene/pseudogene)(NAT8B)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0010628~positive regulation of gene expression,GO:0018003~peptidyl-lysine N6-acetylation,GO:0043066~negative regulation of apoptotic process,GO:0044267~cellular protein metabolic process,GO:0050435~beta-amyloid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Probable N-acetyltransferase 8,chain:Probable N-acetyltransferase 8B,domain:N-acetyltransferase,sequence conflict,sequence variant,transmembrane region,
204382_at	N-acetyltransferase 9 (putative)(NAT9)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0006474~N-terminal protein amino acid acetylation,	GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:N-acetyltransferase 9,domain:N-acetyltransferase,sequence conflict,sequence variant,splice variant,
215178_x_at, 214765_s_at	N-acylethanolamine acid amidase(NAAA)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0007269~neurotransmitter secretion,	GO:0005737~cytoplasm,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,GO:0098793~presynapse,	GO:0008134~transcription factor binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,	IPR016699:Acid ceramidase-like,			PIRSF017632:acid ceramidase,		Alternative splicing,Autocatalytic cleavage,Complete proteome,Direct protein sequencing,Glycoprotein,Hydrolase,Lysosome,Polymorphism,Proteomics identification,Reference proteome,Signal,Zymogen,	chain:N-acylethanolamine-hydrolyzing acid amidase,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
210979_at, 213902_at, 213702_x_at, 210980_s_at	N-acylsphingosine amidohydrolase 1(ASAH1)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,		GO:0006629~lipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006687~glycosphingolipid metabolic process,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0016787~hydrolase activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0017040~ceramidase activity,	IPR003199:Choloylglycine hydrolase,IPR016699:Acid ceramidase-like,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,hsa04142:Lysosome,	159950~Spinal muscular atrophy with progressive myoclonic epilepsy,228000~Farber lipogranulomatosis,	PIRSF017632:acid ceramidase,		Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Epilepsy,Glycoprotein,Hydrolase,Lysosome,Membrane,Neurodegeneration,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Acid ceramidase subunit alpha,chain:Acid ceramidase subunit beta,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
202607_at, 202608_s_at	N-deacetylase and N-sulfotransferase 1(NDST1)	Homo sapiens				GO:0000165~MAPK cascade,GO:0000271~polysaccharide biosynthetic process,GO:0003279~cardiac septum development,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006477~protein sulfation,GO:0006954~inflammatory response,GO:0007224~smoothened signaling pathway,GO:0007585~respiratory gaseous exchange,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030210~heparin biosynthetic process,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0035904~aorta development,GO:0048702~embryonic neurocranium morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0060976~coronary vasculature development,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0015016~[heparan sulfate]-glucosamine N-sulfotransferase activity,GO:0016787~hydrolase activity,GO:0050119~N-acetylglucosamine deacetylase activity,	IPR000863:Sulfotransferase domain,IPR021930:Heparan sulphate-N-deacetylase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	616116~Mental retardation, autosomal recessive 46,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Hydrolase,Inflammatory response,Membrane,Mental retardation,Multifunctional enzyme,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	active site:For sulfotransferase activity,binding site:PAPS,chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,nucleotide phosphate-binding region:PAPS,region of interest:Heparan sulfate N-deacetylase 1,region of interest:Heparan sulfate N-sulfotransferase 1,sequence conflict,splice variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
203916_at	N-deacetylase and N-sulfotransferase 2(NDST2)	Homo sapiens				GO:0002002~regulation of angiotensin levels in blood,GO:0006024~glycosaminoglycan biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030210~heparin biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0015016~[heparan sulfate]-glucosamine N-sulfotransferase activity,GO:0016787~hydrolase activity,GO:0050119~N-acetylglucosamine deacetylase activity,	IPR000863:Sulfotransferase domain,IPR021930:Heparan sulphate-N-deacetylase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Multifunctional enzyme,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	active site:For sulfotransferase activity,binding site:PAPS,chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:PAPS,region of interest:Heparan sulfate N-deacetylase 2,region of interest:Heparan sulfate N-sulfotransferase 2,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
220429_at	N-deacetylase and N-sulfotransferase 3(NDST3)	Homo sapiens				GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030210~heparin biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0015016~[heparan sulfate]-glucosamine N-sulfotransferase activity,GO:0016787~hydrolase activity,	IPR000863:Sulfotransferase domain,IPR021930:Heparan sulphate-N-deacetylase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Multifunctional enzyme,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	active site:For sulfotransferase activity,binding site:PAPS,chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:PAPS,region of interest:Heparan sulfate N-deacetylase 3,region of interest:Heparan sulfate N-sulfotransferase 3,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
208334_at	N-deacetylase and N-sulfotransferase 4(NDST4)	Homo sapiens				GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030210~heparin biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0015016~[heparan sulfate]-glucosamine N-sulfotransferase activity,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,	IPR000863:Sulfotransferase domain,IPR021930:Heparan sulphate-N-deacetylase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Multifunctional enzyme,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	active site:For sulfotransferase activity,binding site:PAPS,chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:PAPS,region of interest:Heparan sulfate N-deacetylase 4,region of interest:Heparan sulfate N-sulfotransferase 4,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
202395_at	N-ethylmaleimide sensitive factor, vesicle fusing ATPase(NSF)	Homo sapiens		h_gabaPathway:Gamma-aminobutyric Acid Receptor Life Cycle,		GO:0001921~positive regulation of receptor recycling,GO:0006813~potassium ion transport,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0016192~vesicle-mediated transport,GO:0017157~regulation of exocytosis,GO:0035494~SNARE complex disassembly,GO:0043001~Golgi to plasma membrane protein transport,GO:0045026~plasma membrane fusion,GO:0045732~positive regulation of protein catabolic process,GO:0048208~COPII vesicle coating,GO:0048211~Golgi vesicle docking,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043198~dendritic shaft,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0000149~SNARE binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017075~syntaxin-1 binding,GO:0017137~Rab GTPase binding,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,GO:0032403~protein complex binding,GO:0035255~ionotropic glutamate receptor binding,GO:0042623~ATPase activity, coupled,GO:0046872~metal ion binding,	IPR003338:CDC48, N-terminal subdomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR004201:CDC48, domain 2,IPR009010:Aspartate decarboxylase-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04721:Synaptic vesicle cycle,hsa04727:GABAergic synapse,hsa04962:Vasopressin-regulated water reabsorption,			SM00382:AAA,SM01072:SM01072,SM01073:SM01073,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Hydrolase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Vesicle-fusing ATPase,metal ion-binding site:Magnesium,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
220742_s_at, 207492_at	N-glycanase 1(NGLY1)	Homo sapiens				GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0006516~glycoprotein catabolic process,GO:0006517~protein deglycosylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000224~peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002931:Transglutaminase-like,IPR006588:Peptide N glycanase, PAW domain,IPR008979:Galactose-binding domain-like,IPR018997:PUB domain,	hsa04141:Protein processing in endoplasmic reticulum,	615273~Congenital disorder of deglycosylation,		SM00460:TGc,SM00580:PUG,SM00613:PAW,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	active site:Nucleophile,chain:Peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase,domain:PAW,domain:PUB,helix,metal ion-binding site:Zinc,modified residue,sequence variant,splice variant,strand,turn,
203686_at	N-methylpurine DNA glycosylase(MPG)	Homo sapiens				GO:0006284~base-excision repair,GO:0006307~DNA dealkylation involved in DNA repair,GO:0045007~depurination,	GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0042645~mitochondrial nucleoid,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003905~alkylbase DNA N-glycosylase activity,GO:0005515~protein binding,GO:0008725~DNA-3-methyladenine glycosylase activity,GO:0019104~DNA N-glycosylase activity,GO:0043916~DNA-7-methylguanine glycosylase activity,GO:0052821~DNA-7-methyladenine glycosylase activity,GO:0052822~DNA-3-methylguanine glycosylase activity,	IPR003180:Methylpurine-DNA glycosylase (MPG),IPR011034:Formyl transferase, C-terminal-like,	hsa03410:Base excision repair,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA damage,DNA repair,Hydrolase,Membrane,Mitochondrion,Mitochondrion nucleoid,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,	chain:DNA-3-methyladenine glycosylase,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
203964_at	N-myc and STAT interactor(NMI)	Homo sapiens		h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,		GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007259~JAK-STAT cascade,GO:0045355~negative regulation of interferon-alpha biosynthetic process,GO:0045358~negative regulation of interferon-beta biosynthetic process,GO:0045824~negative regulation of innate immune response,GO:0060333~interferon-gamma-mediated signaling pathway,GO:1902524~positive regulation of protein K48-linked ubiquitination,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR009909:Nmi/IFP 35,IPR009938:Interferon induced 35kDa, N-terminal,					Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:N-myc-interactor,sequence conflict,sequence variant,
200632_s_at	N-myc downstream regulated 1(NDRG1)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,GO:0010038~response to metal ion,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0032287~peripheral nervous system myelin maintenance,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0045576~mast cell activation,GO:0071456~cellular response to hypoxia,GO:0090232~positive regulation of spindle checkpoint,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0015630~microtubule cytoskeleton,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0017137~Rab GTPase binding,GO:0043015~gamma-tubulin binding,GO:0045296~cadherin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004142:Ndr,		601455~Charcot-Marie-Tooth disease, type 4D,			Acetylation,Alternative splicing,Cell membrane,Charcot-Marie-Tooth disease,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Membrane,Microtubule,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Protein NDRG1,modified residue,region of interest:3 X 10 AA tandem repeats of G-T-R-S-R-S- H-T-S-E,repeat:1,repeat:2,repeat:3,sequence conflict,sequence variant,
201157_s_at, 201158_at, 201159_s_at	N-myristoyltransferase 1(NMT1)	Homo sapiens			Lipid metabolism,	GO:0001701~in utero embryonic development,GO:0006499~N-terminal protein myristoylation,GO:0018008~N-terminal peptidyl-glycine N-myristoylation,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,	GO:0004379~glycylpeptide N-tetradecanoyltransferase activity,GO:0019107~myristoyltransferase activity,	IPR000903:Myristoyl-CoA:protein N-myristoyltransferase,IPR016181:Acyl-CoA N-acyltransferase,IPR022676:Myristoyl-CoA:protein N-myristoyltransferase, N-terminal,IPR022677:Myristoyl-CoA:protein N-myristoyltransferase, C-terminal,IPR022678:Myristoyl-CoA:protein N-myristoyltransferase, conserved site,			PIRSF015892:N-myristoyl transferase,		3D-structure,Acyltransferase,Alternative splicing,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glycylpeptide N-tetradecanoyltransferase 1,compositionally biased region:Poly-Lys,helix,modified residue,mutagenesis site,sequence variant,splice variant,strand,turn,
205006_s_at, 215743_at, 205005_s_at, 215069_at	N-myristoyltransferase 2(NMT2)	Homo sapiens				GO:0006499~N-terminal protein myristoylation,GO:0018008~N-terminal peptidyl-glycine N-myristoylation,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0075733~intracellular transport of virus,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,	GO:0004379~glycylpeptide N-tetradecanoyltransferase activity,	IPR000903:Myristoyl-CoA:protein N-myristoyltransferase,IPR016181:Acyl-CoA N-acyltransferase,IPR022676:Myristoyl-CoA:protein N-myristoyltransferase, N-terminal,IPR022677:Myristoyl-CoA:protein N-myristoyltransferase, C-terminal,IPR022678:Myristoyl-CoA:protein N-myristoyltransferase, conserved site,			PIRSF015892:N-myristoyl transferase,		3D-structure,Acyltransferase,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,	chain:Glycylpeptide N-tetradecanoyltransferase 2,compositionally biased region:Poly-Lys,modified residue,sequence conflict,
35626_at, 204293_at	N-sulfoglucosamine sulfohydrolase(SGSH)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006027~glycosaminoglycan catabolic process,GO:0008152~metabolic process,GO:0030200~heparan sulfate proteoglycan catabolic process,	GO:0005764~lysosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0008484~sulfuric ester hydrolase activity,GO:0016250~N-sulfoglucosamine sulfohydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024607:Sulfatase, conserved site,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa04142:Lysosome,	252900~Mucopolysaccharidisis type IIIA (Sanfilippo A),			3D-structure,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Metal-binding,Mucopolysaccharidosis,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:N-sulphoglucosamine sulphohydrolase,compositionally biased region:Poly-Leu,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via 3-oxoalanine,modified residue,sequence variant,signal peptide,
215005_at	N-terminal EF-hand calcium binding protein 2(NECAB2)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002048:EF-hand domain,IPR007138:Antibiotic biosynthesis monooxygenase,IPR011008:Dimeric alpha-beta barrel,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Methylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:N-terminal EF-hand calcium-binding protein 2,domain:ABM,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
210720_s_at	N-terminal EF-hand calcium binding protein 3(NECAB3)	Homo sapiens				GO:0009306~protein secretion,GO:0019538~protein metabolic process,GO:0042984~regulation of amyloid precursor protein biosynthetic process,	GO:0000137~Golgi cis cisterna,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR007138:Antibiotic biosynthesis monooxygenase,IPR011008:Dimeric alpha-beta barrel,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Golgi apparatus,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:N-terminal EF-hand calcium-binding protein 3,domain:ABM,domain:EF-hand,sequence conflict,sequence variant,splice variant,
213061_s_at, 213062_at	N-terminal asparagine amidase(NTAN1)	Homo sapiens				GO:0007613~memory,GO:0008344~adult locomotory behavior,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008418~protein-N-terminal asparagine amidohydrolase activity,	IPR026750:Protein N-terminal asparagine amidohydrolase,					Complete proteome,Cytoplasm,Hydrolase,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein N-terminal asparagine amidohydrolase,sequence variant,
213630_at	NAC alpha domain containing(NACAD)	Homo sapiens				GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR002715:Nascent polypeptide-associated complex NAC domain,IPR016641:Nascent polypeptide-associated complex subunit alpha,				SM01407:SM01407,	Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Transport,	chain:NAC-alpha domain-containing protein 1,compositionally biased region:Poly-Glu,domain:NAC-A/B,modified residue,sequence conflict,sequence variant,
212993_at	NACC family member 2(NACC2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010608~posttranscriptional regulation of gene expression,GO:0016575~histone deacetylation,GO:0034629~cellular protein complex localization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051260~protein homooligomerization,GO:1900477~negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0016581~NuRD complex,GO:0016604~nuclear body,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR018379:BEN domain,				SM00225:BTB,SM01025:SM01025,	Complete proteome,Isopeptide bond,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nucleus accumbens-associated protein 2,domain:BEN,domain:BTB,
208918_s_at, 213607_x_at, 215159_s_at, 213613_s_at, 208919_s_at, 208917_x_at	NAD kinase(NADK)	Homo sapiens				GO:0006741~NADP biosynthetic process,GO:0016310~phosphorylation,GO:0019674~NAD metabolic process,GO:0046034~ATP metabolic process,	GO:0005829~cytosol,	GO:0003951~NAD+ kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR002504:Inorganic polyphosphate/ATP-NAD kinase, predicted,IPR016064:ATP-NAD kinase-like domain,IPR017437:ATP-NAD kinase, PpnK-type, all-beta,IPR017438:Inorganic polyphosphate/ATP-NAD kinase, domain 1,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,ATP-binding,Complete proteome,Kinase,Metal-binding,NAD,NADP,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:NAD kinase,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,modified residue,sequence conflict,sequence variant,
218840_s_at	NAD synthetase 1(NADSYN1)	Homo sapiens			General function prediction only,	GO:0006807~nitrogen compound metabolic process,GO:0009435~NAD biosynthetic process,GO:0019674~NAD metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003952~NAD+ synthase (glutamine-hydrolyzing) activity,GO:0004359~glutaminase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,	IPR003010:Carbon-nitrogen hydrolase,IPR003694:NAD synthase,IPR014445:Glutamine-dependent NAD(+) synthetase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR022310:NAD/GMP synthase,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,		PIRSF006630:glutamine-dependent NAD(+) synthetase with GAT domain,		Alternative splicing,ATP-binding,Complete proteome,Ligase,NAD,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Glutamine-dependent NAD(+) synthetase,domain:CN hydrolase,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Ligase,sequence conflict,sequence variant,
209279_s_at, 215093_at	NAD(P) dependent steroid dehydrogenase-like(NSDHL)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0001942~hair follicle development,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0007224~smoothened signaling pathway,GO:0055114~oxidation-reduction process,GO:0060716~labyrinthine layer blood vessel development,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000252~C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,GO:0003854~3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0047012~sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,	IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase,IPR016040:NAD(P)-binding domain,	hsa00100:Steroid biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	300831~CK syndrome,308050~CHILD syndrome,			Acetylation,Cholesterol biosynthesis,Cholesterol metabolism,Complete proteome,Disease mutation,Endoplasmic reticulum,Ichthyosis,Lipid biosynthesis,Lipid droplet,Lipid metabolism,Membrane,Mental retardation,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:NAD,chain:Sterol-4-alpha-carboxylate 3- dehydrogenase, decarboxylating,sequence variant,transmembrane region,
201467_s_at, 210519_s_at, 201468_s_at	NAD(P)H quinone dehydrogenase 1(NQO1)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,		GO:0006521~regulation of cellular amino acid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0007271~synaptic transmission, cholinergic,GO:0007568~aging,GO:0007584~response to nutrient,GO:0009636~response to toxic substance,GO:0019430~removal of superoxide radicals,GO:0032355~response to estradiol,GO:0043066~negative regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043525~positive regulation of neuron apoptotic process,GO:0045471~response to ethanol,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0003955~NAD(P)H dehydrogenase (quinone) activity,GO:0004128~cytochrome-b5 reductase activity, acting on NAD(P)H,GO:0004784~superoxide dismutase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR003680:Flavodoxin-like fold,	hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis,	Benzene toxicity, susceptibility to~Benzene toxicity, susceptibility to,Breast cancer, poor survival after chemotherapy for~Breast cancer, poor survival after chemotherapy for,Leukemia, post-chemotherapy, susceptibility to~Leukemia, post-chemotherapy, susceptibility to,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,FAD,Flavoprotein,Membrane,NAD,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:FAD,chain:NAD(P)H dehydrogenase [quinone] 1,helix,modified residue,nucleotide phosphate-binding region:FAD,region of interest:Substrate binding,sequence variant,strand,turn,
203814_s_at	NAD(P)H quinone dehydrogenase 2(NQO2)	Homo sapiens				GO:0007613~memory,GO:0043525~positive regulation of neuron apoptotic process,GO:0055114~oxidation-reduction process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008753~NADPH dehydrogenase (quinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR003680:Flavodoxin-like fold,		114480~Breast cancer susceptibility,			3D-structure,Complete proteome,Cytoplasm,FAD,Flavoprotein,Metal-binding,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	binding site:FAD,chain:Ribosyldihydronicotinamide dehydrogenase [quinone],helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,region of interest:Substrate binding,sequence conflict,sequence variant,strand,turn,
217940_s_at	NAD(P)HX dehydratase(NAXD)	Homo sapiens				GO:0006769~nicotinamide metabolic process,GO:0046496~nicotinamide nucleotide metabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0047453~ATP-dependent NAD(P)H-hydrate dehydratase activity,GO:0052855~ADP-dependent NAD(P)H-hydrate dehydratase activity,	IPR000631:YjeF C-terminal domain, carbohydrate kinase-related,					Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Lyase,Mitochondrion,NAD,NADP,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Transit peptide,	chain:Carbohydrate kinase domain-containing protein,domain:YjeF C-terminal,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
204125_at	NADH:ubiquinone oxidoreductase complex assembly factor 1(NDUFAF1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006461~protein complex assembly,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR008979:Galactose-binding domain-like,IPR013857:NADH:ubiquinone oxidoreductase intermediate-associated protein 30,		252010~Mitochondrial complex I deficiency,			Chaperone,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Ubiquinone,	chain:Complex I intermediate-associated protein 30, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
209177_at	NADH:ubiquinone oxidoreductase complex assembly factor 3(NDUFAF3)	Homo sapiens				GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005634~nucleus,GO:0005743~mitochondrial inner membrane,	GO:0005515~protein binding,	IPR007523:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,		252010~Mitochondrial complex I deficiency,			Alternative splicing,Complete proteome,Disease mutation,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleus,Reference proteome,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,sequence variant,
219006_at	NADH:ubiquinone oxidoreductase complex assembly factor 4(NDUFAF4)	Homo sapiens				GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0031966~mitochondrial membrane,	GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR009622:Uncharacterised protein family UPF0240,		252010~Mitochondrial complex I deficiency,			Calmodulin-binding,Complete proteome,Disease mutation,Lipoprotein,Membrane,Mitochondrion,Myristate,Phosphoprotein,Reference proteome,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4,mutagenesis site,sequence variant,
219524_s_at	NADH:ubiquinone oxidoreductase complex assembly factor 5(NDUFAF5)	Homo sapiens				GO:0030961~peptidyl-arginine hydroxylation,GO:0032259~methylation,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0031314~extrinsic component of mitochondrial inner membrane,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0016491~oxidoreductase activity,	IPR013216:Methyltransferase type 11,		252010~Mitochondrial complex 1 deficiency,			Alternative splicing,Complete proteome,Disease mutation,Leigh syndrome,Membrane,Methyltransferase,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:Probable methyltransferase C20orf7, mitochondrial,sequence variant,splice variant,transit peptide:Mitochondrion,
220943_s_at	NADH:ubiquinone oxidoreductase complex assembly factor 7(NDUFAF7)	Homo sapiens			Function unknown,	GO:0019918~peptidyl-arginine methylation, to symmetrical-dimethyl arginine,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0046034~ATP metabolic process,	GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0019899~enzyme binding,GO:0035243~protein-arginine omega-N symmetric methyltransferase activity,	IPR003788:Putative S-adenosyl-L-methionine-dependent methyltransferase MidA,					Alternative splicing,Complete proteome,Methyltransferase,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transit peptide,	chain:Protein midA homolog, mitochondrial,sequence variant,splice variant,transit peptide:Mitochondrion,
203039_s_at	NADH:ubiquinone oxidoreductase core subunit S1(NDUFS1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0008637~apoptotic mitochondrial changes,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042773~ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0046034~ATP metabolic process,GO:0051881~regulation of mitochondrial membrane potential,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0043209~myelin sheath,	GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000283:NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site,IPR001041:2Fe-2S ferredoxin-type domain,IPR006656:Molybdopterin oxidoreductase,IPR006963:Molybdopterin oxidoreductase, 4Fe-4S domain,IPR010228:NADH:ubiquinone oxidoreductase, subunit G,IPR012675:Beta-grasp domain,IPR015405:NADH-quinone oxidoreductase, chain G, C-terminal,IPR019574:NADH:ubiquinone oxidoreductase, subunit G, iron-sulphur binding,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,		SM00929:SM00929,	2Fe-2S,4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S); via pros nitrogen,metal ion-binding site:Iron-sulfur 3 (4Fe-4S),modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
201966_at	NADH:ubiquinone oxidoreductase core subunit S2(NDUFS2)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006979~response to oxidative stress,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0048038~quinone binding,GO:0051287~NAD binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001135:NADH-quinone oxidoreductase, subunit D,IPR014029:NADH:ubiquinone oxidoreductase, 49kDa subunit, conserved site,IPR022885:NAD(P)H-quinone oxidoreductase subunit D/H,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,			4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Methylation,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 2, mitochondrial,metal ion-binding site:Iron-sulfur (4Fe-4S),sequence conflict,sequence variant,transit peptide:Mitochondrion,
201740_at	NADH:ubiquinone oxidoreductase core subunit S3(NDUFS3)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0021762~substantia nigra development,GO:0030308~negative regulation of cell growth,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0072593~reactive oxygen species metabolic process,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,GO:0043209~myelin sheath,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,	IPR001268:NADH:ubiquinone oxidoreductase, 30kDa subunit,IPR010218:NADH dehydrogenase, subunit C,IPR020396:NADH:ubiquinone oxidoreductase, 30kDa subunit, conserved site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,256000~Leigh syndrome due to mitochondrial complex I deficiency,			Alternative splicing,Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Signal,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 3, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
211752_s_at	NADH:ubiquinone oxidoreductase core subunit S7(NDUFS7)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0097060~synaptic membrane,	GO:0002020~protease binding,GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016655~oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,GO:0046872~metal ion binding,GO:0048038~quinone binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006137:NADH:ubiquinone oxidoreductase-like, 20kDa subunit,IPR006138:NADH-ubiquinone oxidoreductase, 20 Kd subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome,			4Fe-4S,Alternative splicing,Complete proteome,Disease mutation,Electron transport,Hydroxylation,Iron,Iron-sulfur,Leigh syndrome,Metal-binding,Mitochondrion,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 7, mitochondrial,metal ion-binding site:Iron-sulfur (4Fe-4S),sequence variant,transit peptide:Mitochondrion,
208714_at	NADH:ubiquinone oxidoreductase core subunit V1(NDUFV1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0009060~aerobic respiration,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,	GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0010181~FMN binding,GO:0046872~metal ion binding,GO:0051287~NAD binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001949:NADH:ubiquinone oxidoreductase, 51kDa subunit, conserved site,IPR011537:NADH ubiquinone oxidoreductase, F subunit,IPR011538:NADH:ubiquinone oxidoreductase, 51kDa subunit,IPR019554:Soluble ligand binding domain,IPR019575:NADH ubiquinone oxidoreductase, F subunit, iron sulphur binding,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,		SM00928:SM00928,	4Fe-4S,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Electron transport,Flavoprotein,FMN,Iron,Iron-sulfur,Leigh syndrome,Membrane,Metal-binding,Methylation,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,metal ion-binding site:Iron-sulfur (4Fe-4S),modified residue,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NAD(H),sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
202941_at	NADH:ubiquinone oxidoreductase core subunit V2(NDUFV2)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0007399~nervous system development,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0048738~cardiac muscle tissue development,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0043209~myelin sheath,GO:0045272~plasma membrane respiratory chain complex I,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR002023:Thioredoxin-like 2Fe-2S ferredoxin,IPR012336:Thioredoxin-like fold,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,	PIRSF000216:NADH dehydrogenase [ubiquinone] (complex I), flavoprotein 2/NADH:quinone oxidoreductase (complex I), NuoE subunit,		2Fe-2S,Acetylation,Complete proteome,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,metal ion-binding site:Iron-sulfur (2Fe-2S),sequence variant,transit peptide:Mitochondrion,
202298_at	NADH:ubiquinone oxidoreductase subunit A1(NDUFA1)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR017384:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex subunit 1,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,	PIRSF038095:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex subunit 1,		Complete proteome,Disease mutation,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,sequence variant,transmembrane region,
217860_at	NADH:ubiquinone oxidoreductase subunit A10(NDUFA10)	Homo sapiens			Nucleotide transport and metabolism,	GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042493~response to drug,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0043209~myelin sheath,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR015828:NADH:ubiquinone oxidoreductase, 42kDa subunit,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome,	PIRSF000543:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 10,		Alternative splicing,Complete proteome,Electron transport,FAD,Flavoprotein,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
220864_s_at	NADH:ubiquinone oxidoreductase subunit A13(NDUFA13)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0010952~positive regulation of peptidase activity,GO:0030308~negative regulation of cell growth,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0035458~cellular response to interferon-beta,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045039~protein import into mitochondrial inner membrane,GO:0045732~positive regulation of protein catabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0071300~cellular response to retinoic acid,GO:0072593~reactive oxygen species metabolic process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0070062~extracellular exosome,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR009346:GRIM-19,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	607464~Thyroid carcinoma, Hurthle cell,			Acetylation,Alternative splicing,Apoptosis,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Nucleus,Polymorphism,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,modified residue,region of interest:Important for inducing cell death,sequence conflict,sequence variant,transmembrane region,
209223_at, 209224_s_at	NADH:ubiquinone oxidoreductase subunit A2(NDUFA2)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0031966~mitochondrial membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR007741:Ribosomal protein/NADH dehydrogenase domain,IPR012336:Thioredoxin-like fold,IPR016464:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 2,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome due to mitochondrial complex I deficiency,	PIRSF005822:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 2,	SM00916:SM00916,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,disulfide bond,helix,modified residue,sequence variant,strand,
218563_at	NADH:ubiquinone oxidoreductase subunit A3(NDUFA3)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR026626:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,sequence variant,transmembrane region,
201304_at, 215850_s_at	NADH:ubiquinone oxidoreductase subunit A5(NDUFA5)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0022904~respiratory electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,	IPR006806:ETC complex I subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,modified residue,sequence conflict,
202000_at, 202001_s_at	NADH:ubiquinone oxidoreductase subunit A6(NDUFA6)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006979~response to oxidative stress,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0031966~mitochondrial membrane,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR008011:Complex 1 LYR protein,IPR016488:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF006643:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6,		Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,modified residue,sequence conflict,sequence variant,
202785_at	NADH:ubiquinone oxidoreductase subunit A7(NDUFA7)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032543~mitochondrial translation,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0042773~ATP synthesis coupled electron transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005761~mitochondrial ribosome,	GO:0003735~structural constituent of ribosome,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR009947:NADH:ubiquinone oxidoreductase subunit B14.5a,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,modified residue,sequence variant,
218160_at	NADH:ubiquinone oxidoreductase subunit A8(NDUFA8)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0032403~protein complex binding,	IPR010625:CHCH,IPR016680:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 8,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF017016:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 8,		Complete proteome,Direct protein sequencing,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Repeat,Respiratory chain,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,domain:CHCH 1,domain:CHCH 2,sequence variant,
208969_at	NADH:ubiquinone oxidoreductase subunit A9(NDUFA9)	Homo sapiens			Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism,	GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006814~sodium ion transport,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:1901006~ubiquinone-6 biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,	GO:0003954~NADH dehydrogenase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0032403~protein complex binding,GO:0050662~coenzyme binding,	IPR001509:NAD-dependent epimerase/dehydratase,IPR016040:NAD(P)-binding domain,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	256000~Leigh syndrome due to mitochondrial complex I deficiency,			Acetylation,Complete proteome,Electron transport,FAD,Flavoprotein,Mitochondrion,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial,modified residue,transit peptide:Mitochondrion,
202077_at	NADH:ubiquinone oxidoreductase subunit AB1(NDUFAB1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006633~fatty acid biosynthetic process,GO:0009249~protein lipoylation,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0046487~glyoxylate metabolic process,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0031966~mitochondrial membrane,	GO:0000036~ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,GO:0005504~fatty acid binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR003231:Acyl carrier protein (ACP),IPR006162:Phosphopantetheine attachment site,IPR009081:Acyl carrier protein-like,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Electron transport,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Mitochondrion,Phosphopantetheine,Phosphoprotein,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,	chain:Acyl carrier protein, mitochondrial,helix,modified residue,sequence conflict,transit peptide:Mitochondrion,turn,
206790_s_at	NADH:ubiquinone oxidoreductase subunit B1(NDUFB1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR012575:NADH:ubiquinone oxidoreductase, MNLL subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,splice variant,transmembrane region,
218320_s_at	NADH:ubiquinone oxidoreductase subunit B11(NDUFB11)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR019329:NADH:ubiquinone oxidoreductase, ESSS subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	300952~Linear skin defects with multiple congenital anomalies 3,			Alternative splicing,Cardiomyopathy,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial,sequence conflict,splice variant,transit peptide:Mitochondrion,transmembrane region,
218201_at, 218200_s_at	NADH:ubiquinone oxidoreductase subunit B2(NDUFB2)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR026627:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Direct protein sequencing,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial,transit peptide:Mitochondrion,
203371_s_at	NADH:ubiquinone oxidoreductase subunit B3(NDUFB3)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0022900~electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR012576:NADH:ubiquinone oxidoreductase, B12 subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,			Acetylation,Complete proteome,Electron transport,Membrane,Methylation,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,modified residue,transmembrane region,
218226_s_at	NADH:ubiquinone oxidoreductase subunit B4(NDUFB4)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006979~response to oxidative stress,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR009866:NADH:ubiquinone oxidoreductase, subunit NDUFB4,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Proteomics identification,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,modified residue,transmembrane region,
203621_at	NADH:ubiquinone oxidoreductase subunit B5(NDUFB5)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR019173:NADH:ubiquinone oxidoreductase, NDUFB5/SGDH subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Alternative splicing,Coiled coil,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Signal,Transit peptide,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial,sequence variant,transit peptide:Mitochondrion,transmembrane region,
203613_s_at	NADH:ubiquinone oxidoreductase subunit B6(NDUFB6)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR019174:NADH dehydrogenase 1, beta subcomplex, subunit 6,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,modified residue,transmembrane region,
202839_s_at, 211407_at	NADH:ubiquinone oxidoreductase subunit B7(NDUFB7)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR008698:NADH:ubiquinone oxidoreductase, B18 subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Disulfide bond,Electron transport,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,lipid moiety-binding region:N-myristoyl glycine,sequence variant,
201227_s_at, 201226_at, 214241_at	NADH:ubiquinone oxidoreductase subunit B8(NDUFB8)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR008699:NADH:ubiquinone oxidoreductase, ASHI subunit,IPR016551:NADH:ubiquinone oxidoreductase, beta subcomplex, subunit 8,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF009288:NADH dehydrogenase [ubiquinone] (complex I), beta subcomplex, subunit 8,		Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial,sequence conflict,transit peptide:Mitochondrion,transmembrane region,
203478_at	NADH:ubiquinone oxidoreductase subunit C1(NDUFC1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR026192:NADH-ubiquinone oxidoreductase 1 subunit C1,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transit peptide,Transmembrane,Transmembrane helix,Transport,	chain:NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial,transit peptide:Mitochondrion,transmembrane region,
209303_at	NADH:ubiquinone oxidoreductase subunit S4(NDUFS4)	Homo sapiens				GO:0001932~regulation of protein phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0007420~brain development,GO:0019933~cAMP-mediated signaling,GO:0022900~electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0045333~cellular respiration,GO:0048146~positive regulation of fibroblast proliferation,GO:0051591~response to cAMP,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0045271~respiratory chain complex I,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NAD(P)H,	IPR006885:NADH dehydrogenase ubiquinone Fe-S protein 4, mitochondrial,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,256000~Leigh syndrome,			Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 4, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
201757_at	NADH:ubiquinone oxidoreductase subunit S5(NDUFS5)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR019342:NADH:ubiquinone oxidoreductase, iron-sulphur subunit 5,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Disulfide bond,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Respiratory chain,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 5,
203606_at	NADH:ubiquinone oxidoreductase subunit S6(NDUFS6)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006631~fatty acid metabolic process,GO:0006936~muscle contraction,GO:0010259~multicellular organism aging,GO:0022904~respiratory electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0035264~multicellular organism growth,GO:0061458~reproductive system development,GO:0070584~mitochondrion morphogenesis,GO:0072358~cardiovascular system development,	GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,	IPR016668:NADH dehydrogenase [ubiquinone] (complex I), iron-sulphur protein 6, mitochondria,IPR019401:Zinc finger, CHCC-type,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252010~Mitochondrial complex I deficiency,	PIRSF016564:NADH dehydrogenase [ubiquinone] (complex I), iron-sulfur protein 6, mitochondrial type,		Acetylation,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Respiratory chain,Transit peptide,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 6, mitochondrial,transit peptide:Mitochondrion,
219899_x_at	NADPH dependent diflavin oxidoreductase 1(NDOR1)	Homo sapiens				GO:0008219~cell death,GO:0016226~iron-sulfur cluster assembly,GO:0036245~cellular response to menadione,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,GO:0048471~perinuclear region of cytoplasm,	GO:0003958~NADPH-hemoprotein reductase activity,GO:0005515~protein binding,GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR001094:Flavodoxin,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR003097:FAD-binding, type 1,IPR008254:Flavodoxin/nitric oxide synthase,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR023173:NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain-3,					3D-structure,Alternative splicing,Complete proteome,Cytoplasm,FAD,Flavoprotein,FMN,NADP,Oxidoreductase,Polymorphism,Reference proteome,	chain:NADPH-dependent diflavin oxidoreductase 1,compositionally biased region:Poly-Pro,domain:FAD-binding FR-type,domain:Flavodoxin-like,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NADP,sequence variant,splice variant,
207217_s_at, 206418_at, 207380_x_at, 210808_s_at	NADPH oxidase 1(NOX1)	Homo sapiens		h_ccr3Pathway:CCR3 signaling in Eosinophils,h_freePathway:Free Radical Induced Apoptosis,		GO:0001525~angiogenesis,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0006739~NADP metabolic process,GO:0006801~superoxide metabolic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0015992~proton transport,GO:0016477~cell migration,GO:0030198~extracellular matrix organization,GO:0034765~regulation of ion transmembrane transport,GO:0042554~superoxide anion generation,GO:0042743~hydrogen peroxide metabolic process,GO:0045726~positive regulation of integrin biosynthetic process,GO:0045730~respiratory burst,GO:0046330~positive regulation of JNK cascade,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051454~intracellular pH elevation,GO:0055114~oxidation-reduction process,GO:0071455~cellular response to hyperoxia,GO:0072592~oxygen metabolic process,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1990451~cellular stress response to acidic pH,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0043020~NADPH oxidase complex,GO:0071438~invadopodium membrane,	GO:0005515~protein binding,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0030171~voltage-gated proton channel activity,GO:0046872~metal ion binding,GO:0048365~Rac GTPase binding,GO:0050661~NADP binding,	IPR000778:Cytochrome b245, heavy chain,IPR013112:FAD-binding 8,IPR013121:Ferric reductase, NAD binding,IPR013130:Ferric reductase transmembrane component-like domain,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,	hsa04380:Osteoclast differentiation,				Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Electron transport,FAD,Flavoprotein,Glycoprotein,Heme,Ion channel,Ion transport,Iron,Membrane,Metal-binding,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:NADPH oxidase 1,domain:FAD-binding FR-type,domain:Ferric oxidoreductase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Iron (heme axial ligand),nucleotide phosphate-binding region:FAD,region of interest:Interaction with NOXO1,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
221089_at	NADPH oxidase 3(NOX3)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0009590~detection of gravity,GO:0042554~superoxide anion generation,GO:0048840~otolith development,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043020~NADPH oxidase complex,GO:0070062~extracellular exosome,	GO:0016175~superoxide-generating NADPH oxidase activity,	IPR000778:Cytochrome b245, heavy chain,IPR013112:FAD-binding 8,IPR013121:Ferric reductase, NAD binding,IPR013130:Ferric reductase transmembrane component-like domain,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,	hsa04380:Osteoclast differentiation,				Complete proteome,Glycoprotein,Membrane,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:NADPH oxidase 3,domain:FAD-binding FR-type,domain:Ferric oxidoreductase,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
219773_at	NADPH oxidase 4(NOX4)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0000902~cell morphogenesis,GO:0001666~response to hypoxia,GO:0006801~superoxide metabolic process,GO:0006954~inflammatory response,GO:0007569~cell aging,GO:0008285~negative regulation of cell proliferation,GO:0010467~gene expression,GO:0014911~positive regulation of smooth muscle cell migration,GO:0042554~superoxide anion generation,GO:0043065~positive regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0045453~bone resorption,GO:0050667~homocysteine metabolic process,GO:0051496~positive regulation of stress fiber assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0055007~cardiac muscle cell differentiation,GO:0055114~oxidation-reduction process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0071333~cellular response to glucose stimulus,GO:0071480~cellular response to gamma radiation,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072593~reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0001725~stress fiber,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043020~NADPH oxidase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016174~NAD(P)H oxidase activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0016491~oxidoreductase activity,GO:0019826~oxygen sensor activity,GO:0020037~heme binding,GO:0050660~flavin adenine dinucleotide binding,GO:0072341~modified amino acid binding,	IPR000778:Cytochrome b245, heavy chain,IPR013112:FAD-binding 8,IPR013121:Ferric reductase, NAD binding,IPR013130:Ferric reductase transmembrane component-like domain,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,					Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Membrane,NADP,Nucleus,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:NADPH oxidase 4,domain:FAD-binding FR-type,domain:Ferric oxidoreductase,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Mediates interaction with TLR4,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
220641_at	NADPH oxidase 5(NOX5)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0000302~response to reactive oxygen species,GO:0000910~cytokinesis,GO:0001525~angiogenesis,GO:0001935~endothelial cell proliferation,GO:0006915~apoptotic process,GO:0008283~cell proliferation,GO:0010155~regulation of proton transport,GO:0015992~proton transport,GO:0042554~superoxide anion generation,GO:0043012~regulation of fusion of sperm to egg plasma membrane,GO:0050663~cytokine secretion,GO:0055114~oxidation-reduction process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0015252~hydrogen ion channel activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0020037~heme binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013112:FAD-binding 8,IPR013121:Ferric reductase, NAD binding,IPR013130:Ferric reductase transmembrane component-like domain,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Angiogenesis,Calcium,Complete proteome,Electron transport,Endoplasmic reticulum,FAD,Flavoprotein,Ion channel,Ion transport,Membrane,Metal-binding,NADP,Oxidoreductase,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3; first part,calcium-binding region:3; second part,calcium-binding region:4,chain:NADPH oxidase 5,compositionally biased region:Poly-Leu,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3; atypical; contains an insert of 28 residues,domain:EF-hand 4,domain:FAD-binding FR-type,domain:Ferric oxidoreductase,mutagenesis site,region of interest:C-terminal catalytic region,region of interest:N-terminal regulatory region; interacts with the C-terminal catalytic region in a calcium-dependent manner,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
201383_s_at, 201384_s_at	NBR1, autophagy cargo receptor(NBR1)	Homo sapiens				GO:0016236~macroautophagy,GO:0030500~regulation of bone mineralization,GO:0032872~regulation of stress-activated MAPK cascade,GO:0045668~negative regulation of osteoblast differentiation,GO:0051259~protein oligomerization,	GO:0000407~pre-autophagosomal structure,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0031430~M band,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043130~ubiquitin binding,GO:0051019~mitogen-activated protein kinase binding,	IPR000270:Phox/Bem1p,IPR000433:Zinc finger, ZZ-type,IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,				SM00291:ZnF_ZZ,SM00666:PB1,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Lysosome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Next to BRCA1 gene 1 protein,compositionally biased region:Poly-Glu,domain:OPR,domain:UBA,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:ZZ-type,
204725_s_at, 211063_s_at	NCK adaptor protein 1(NCK1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0006469~negative regulation of protein kinase activity,GO:0006930~substrate-dependent cell migration, cell extension,GO:0007015~actin filament organization,GO:0007172~signal complex assembly,GO:0010976~positive regulation of neuron projection development,GO:0016192~vesicle-mediated transport,GO:0030032~lamellipodium assembly,GO:0030334~regulation of cell migration,GO:0030838~positive regulation of actin filament polymerization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0036493~positive regulation of translation in response to endoplasmic reticulum stress,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0051707~response to other organism,GO:0060548~negative regulation of cell death,GO:0070262~peptidyl-serine dephosphorylation,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903676~positive regulation of cap-dependent translational initiation,GO:1903679~positive regulation of cap-independent translational initiation,GO:1903898~negative regulation of PERK-mediated unfolded protein response,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0000164~protein phosphatase type 1 complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0012506~vesicle membrane,	GO:0004860~protein kinase inhibitor activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0019904~protein domain specific binding,GO:0030159~receptor signaling complex scaffold activity,GO:0030674~protein binding, bridging,GO:0030971~receptor tyrosine kinase binding,GO:0046875~ephrin receptor binding,GO:0071074~eukaryotic initiation factor eIF2 binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR017304:Cytoplasmic, NCK,	hsa04012:ErbB signaling pathway,hsa04360:Axon guidance,hsa04660:T cell receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,		PIRSF037874:adapter protein NCK,	SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Endoplasmic reticulum,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Translation regulation,	chain:Cytoplasmic protein NCK1,domain:SH2,domain:SH3 1,domain:SH3 2,domain:SH3 3,helix,modified residue,sequence variant,strand,turn,
203315_at	NCK adaptor protein 2(NCK2)	Homo sapiens				GO:0001771~immunological synapse formation,GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0008285~negative regulation of cell proliferation,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0030032~lamellipodium assembly,GO:0030838~positive regulation of actin filament polymerization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0036493~positive regulation of translation in response to endoplasmic reticulum stress,GO:0042102~positive regulation of T cell proliferation,GO:0042110~T cell activation,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0060996~dendritic spine development,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903898~negative regulation of PERK-mediated unfolded protein response,GO:1903912~negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0012506~vesicle membrane,GO:0045202~synapse,	GO:0005070~SH3/SH2 adaptor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0030159~receptor signaling complex scaffold activity,GO:0032403~protein complex binding,GO:0097110~scaffold protein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR017304:Cytoplasmic, NCK,	hsa04012:ErbB signaling pathway,hsa04360:Axon guidance,hsa04660:T cell receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,		PIRSF037874:adapter protein NCK,	SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Endoplasmic reticulum,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Translation regulation,	chain:Cytoplasmic protein NCK2,domain:SH2,domain:SH3 1,domain:SH3 2,domain:SH3 3,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
217549_at, 209734_at	NCK associated protein 1 like(NCKAP1L)	Homo sapiens				GO:0001782~B cell homeostasis,GO:0002262~myeloid cell homeostasis,GO:0006461~protein complex assembly,GO:0006935~chemotaxis,GO:0030011~maintenance of cell polarity,GO:0030593~neutrophil chemotaxis,GO:0030838~positive regulation of actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0030890~positive regulation of B cell proliferation,GO:0032147~activation of protein kinase activity,GO:0032700~negative regulation of interleukin-17 production,GO:0032715~negative regulation of interleukin-6 production,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035509~negative regulation of myosin-light-chain-phosphatase activity,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042102~positive regulation of T cell proliferation,GO:0042327~positive regulation of phosphorylation,GO:0042493~response to drug,GO:0043029~T cell homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043378~positive regulation of CD8-positive, alpha-beta T cell differentiation,GO:0043547~positive regulation of GTPase activity,GO:0045579~positive regulation of B cell differentiation,GO:0045588~positive regulation of gamma-delta T cell differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048821~erythrocyte development,GO:0050853~B cell receptor signaling pathway,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0070358~actin polymerization-dependent cell motility,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0031209~SCAR complex,GO:0070062~extracellular exosome,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0030295~protein kinase activator activity,GO:0032403~protein complex binding,	IPR019137:Nck-associated protein 1,	hsa04810:Regulation of actin cytoskeleton,				Alternative splicing,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nck-associated protein 1-like,sequence conflict,sequence variant,transmembrane region,
207738_s_at, 217465_at	NCK associated protein 1(NCKAP1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,		GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0010592~positive regulation of lamellipodium assembly,GO:0016032~viral process,GO:0016601~Rac protein signal transduction,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0031209~SCAR complex,GO:0031258~lamellipodium membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,	IPR019137:Nck-associated protein 1,	hsa04810:Regulation of actin cytoskeleton,				3D-structure,Acetylation,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Host-virus interaction,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Nck-associated protein 1,splice variant,transmembrane region,
218697_at, 216114_at	NCK interacting protein with SH3 domain(NCKIPSD)	Homo sapiens				GO:0006607~NLS-bearing protein import into nucleus,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0008180~COP9 signalosome,	GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0017124~SH3 domain binding,	IPR001452:Src homology-3 domain,IPR018556:Domain of unknown function DUF2013,				SM00326:SH3,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH3 domain,SH3-binding,	chain:NCK-interacting protein with SH3 domain,compositionally biased region:Leu-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser/Thr-rich,domain:SH3,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MLL- AF3P21 oncogene,splice variant,
218073_s_at	NDC1 transmembrane nucleoporin(NDC1)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0007077~mitotic nuclear envelope disassembly,GO:0007129~synapsis,GO:0007283~spermatogenesis,GO:0010827~regulation of glucose transport,GO:0015031~protein transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0019083~viral transcription,GO:0030474~spindle pole body duplication,GO:0031047~gene silencing by RNA,GO:0031081~nuclear pore distribution,GO:0051292~nuclear pore complex assembly,GO:0071790~establishment of spindle pole body localization to nuclear envelope,GO:0075733~intracellular transport of virus,GO:1900034~regulation of cellular response to heat,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005816~spindle pole body,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0070762~nuclear pore transmembrane ring,	GO:0017056~structural constituent of nuclear pore,	IPR019049:Nucleoporin protein Ndc1-Nup,	hsa03013:RNA transport,				Alternative splicing,Complete proteome,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transmembrane,Transmembrane helix,Transport,	chain:Nucleoporin NDC1,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Perinuclear space,transmembrane region,
204162_at	NDC80, kinetochore complex component(NDC80)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000942~condensed nuclear chromosome outer kinetochore,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0031262~Ndc80 complex,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR005550:Kinetochore protein Ndc80,					3D-structure,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Kinetochore protein NDC80 homolog,helix,modified residue,mutagenesis site,region of interest:Interaction with NEK2 and ZWINT,region of interest:Interaction with PSMC2 and SMC1A,region of interest:Interaction with RB1,region of interest:Interaction with SMC1A,region of interest:Interaction with the C-terminus of CDCA1 and the SPBC24-SPBC25 subcomplex,region of interest:Interaction with the N-terminus of CDCA1,region of interest:Nuclear localization,sequence variant,turn,
206022_at	NDP, norrin cystine knot growth factor(NDP)	Homo sapiens				GO:0001890~placenta development,GO:0007033~vacuole organization,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0008283~cell proliferation,GO:0016055~Wnt signaling pathway,GO:0035426~extracellular matrix-cell signaling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060070~canonical Wnt signaling pathway,GO:0061299~retina vasculature morphogenesis in camera-type eye,	GO:0005615~extracellular space,GO:0009986~cell surface,GO:0031012~extracellular matrix,	GO:0005109~frizzled binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042803~protein homodimerization activity,	IPR003064:Norrie disease protein,IPR006207:Cystine knot, C-terminal,IPR006208:Cystine knot,		305390~Exudative vitreoretinopathy 2, X-linked,310600~Norrie disease,		SM00041:CT,	3D-structure,Complete proteome,Deafness,Disease mutation,Disulfide bond,Polymorphism,Reference proteome,Secreted,Sensory transduction,Signal,Vision,Wnt signaling pathway,	chain:Norrin,disulfide bond,domain:CTCK,mutagenesis site,sequence variant,signal peptide,
214278_s_at, 206453_s_at, 214279_s_at	NDRG family member 2(NDRG2)	Homo sapiens				GO:0001818~negative regulation of cytokine production,GO:0007165~signal transduction,GO:0010574~regulation of vascular endothelial growth factor production,GO:0016055~Wnt signaling pathway,GO:0021762~substantia nigra development,GO:0030154~cell differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0090361~regulation of platelet-derived growth factor production,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0030426~growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR004142:Ndr,					3D-structure,Acetylation,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,Wnt signaling pathway,	chain:Protein NDRG2,modified residue,sequence conflict,sequence variant,splice variant,
221082_s_at, 217286_s_at	NDRG family member 3(NDRG3)	Homo sapiens				GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,		IPR004142:Ndr,					Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Protein NDRG3,modified residue,sequence conflict,splice variant,
209159_s_at	NDRG family member 4(NDRG4)	Homo sapiens				GO:0001947~heart looping,GO:0006950~response to stress,GO:0007420~brain development,GO:0008542~visual learning,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0010976~positive regulation of neuron projection development,GO:0014912~negative regulation of smooth muscle cell migration,GO:0016049~cell growth,GO:0030154~cell differentiation,GO:0035050~embryonic heart tube development,GO:0048278~vesicle docking,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0060038~cardiac muscle cell proliferation,GO:0060973~cell migration involved in heart development,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2001135~regulation of endocytic recycling,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0031253~cell projection membrane,	GO:0005515~protein binding,	IPR004142:Ndr,					Alternative splicing,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein NDRG4,compositionally biased region:Poly-Thr,modified residue,splice variant,
218484_at	NDUFA4, mitochondrial complex associated like 2(NDUFA4L2)	Homo sapiens				GO:0055114~oxidation-reduction process,GO:1902600~hydrogen ion transmembrane transport,	GO:0005751~mitochondrial respiratory chain complex IV,GO:0016021~integral component of membrane,	GO:0004129~cytochrome-c oxidase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR010530:NADH-ubiquinone reductase complex 1 MLRQ subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,
217773_s_at	NDUFA4, mitochondrial complex associated(NDUFA4)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,GO:1902600~hydrogen ion transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0005751~mitochondrial respiratory chain complex IV,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004129~cytochrome-c oxidase activity,GO:0005515~protein binding,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0032403~protein complex binding,	IPR010530:NADH-ubiquinone reductase complex 1 MLRQ subunit,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				Acetylation,Complete proteome,Electron transport,Leigh syndrome,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4,modified residue,
58916_at, 219545_at, 218101_s_at	NDUFC2-KCTD14 readthrough(NDUFC2-KCTD14)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,		PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2,		Alternative splicing,Complete proteome,Electron transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,
209300_s_at	NECAP endocytosis associated 1(NECAP1)	Homo sapiens				GO:0006897~endocytosis,GO:0015031~protein transport,	GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0030125~clathrin vesicle coat,		IPR011993:Pleckstrin homology-like domain,IPR012466:Adaptin ear-binding coat-associated protein 1 NECAP-1,		615833~Epileptic encephalopathy, early infantile, 21,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endocytosis,Epilepsy,Membrane,Methylation,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Adaptin ear-binding coat-associated protein 1,modified residue,sequence conflict,sequence variant,short sequence motif:WXXF motif 1,short sequence motif:WXXF motif 2,splice variant,
220731_s_at	NECAP endocytosis associated 2(NECAP2)	Homo sapiens				GO:0006897~endocytosis,GO:0015031~protein transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0030125~clathrin vesicle coat,		IPR011993:Pleckstrin homology-like domain,IPR012466:Adaptin ear-binding coat-associated protein 1 NECAP-1,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endocytosis,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Adaptin ear-binding coat-associated protein 2,sequence variant,short sequence motif:WXXF motif 1,short sequence motif:WXXF motif 2,splice variant,
48612_at, 32069_at, 221867_at, 204601_at	NEDD4 binding protein 1(N4BP1)	Homo sapiens				GO:0031397~negative regulation of protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034644~cellular response to UV,	GO:0005730~nucleolus,GO:0016605~PML body,	GO:0005515~protein binding,	IPR021869:Ribonuclease Zc3h12a-like,					Complete proteome,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:NEDD4-binding protein 1,modified residue,sequence conflict,
214906_x_at, 217197_x_at, 214886_s_at, 213375_s_at, 214887_at, 211390_at	NEDD4 binding protein 2 like 1(N4BP2L1)	Homo sapiens							IPR026567:NEDD4-binding protein 2-like 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:NEDD4-binding protein 2-like 1,splice variant,
214753_at, 221899_at, 214748_at, 202259_s_at, 202258_s_at	NEDD4 binding protein 2 like 2(N4BP2L2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:1902035~positive regulation of hematopoietic stem cell proliferation,GO:1902037~negative regulation of hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0017053~transcriptional repressor complex,GO:0070062~extracellular exosome,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,	IPR026568:NEDD4-binding protein 2-like 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:NEDD4-binding protein 2-like 2,compositionally biased region:Poly-Pro,modified residue,sequence variant,splice variant,
214775_at	NEDD4 binding protein 3(N4BP3)	Homo sapiens					GO:0030659~cytoplasmic vesicle membrane,							Coiled coil,Complete proteome,Cytoplasmic vesicle,Membrane,Phosphoprotein,Reference proteome,	chain:NEDD4-binding protein 3,modified residue,sequence conflict,
202268_s_at	NEDD8 activating enzyme E1 subunit 1(NAE1)	Homo sapiens				GO:0007165~signal transduction,GO:0033314~mitotic DNA replication checkpoint,GO:0042981~regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0045116~protein neddylation,GO:0051402~neuron apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0008641~small protein activating enzyme activity,GO:0019781~NEDD8 activating enzyme activity,GO:0031625~ubiquitin protein ligase binding,GO:0046982~protein heterodimerization activity,	IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR016040:NAD(P)-binding domain,	hsa05010:Alzheimer's disease,				3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell cycle,Cell membrane,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:NEDD8-activating enzyme E1 regulatory subunit,helix,modified residue,mutagenesis site,region of interest:Interaction with UBA3,sequence variant,site:Interaction with UBA3,strand,turn,
201502_s_at	NFKB inhibitor alpha(NFKBIA)	Homo sapiens	17.Activators-CAM,77.IkBa_Kinase_JNK_MEKK1,90.IB_and-cat-Arm_processing_of_Ci,	h_41BBPathway:The 4-1BB-dependent immune response,h_aktPathway:AKT Signaling Pathway,h_atmPathway:ATM Signaling Pathway,h_cd40Pathway:CD40L Signaling Pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il1rPathway:Signal transduction through IL1R,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_pkcPathway:Activation of PKC through G protein coupled receptor,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0000060~protein import into nucleus, translocation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006915~apoptotic process,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010875~positive regulation of cholesterol efflux,GO:0010888~negative regulation of lipid storage,GO:0016032~viral process,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032495~response to muramyl dipeptide,GO:0034142~toll-like receptor 4 signaling pathway,GO:0035994~response to muscle stretch,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0043066~negative regulation of apoptotic process,GO:0043330~response to exogenous dsRNA,GO:0043392~negative regulation of DNA binding,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070417~cellular response to cold,GO:0070427~nucleotide-binding oligomerization domain containing 1 signaling pathway,GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0071345~cellular response to cytokine stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0033256~I-kappaB/NF-kappaB complex,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008139~nuclear localization sequence binding,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0051059~NF-kappaB binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04210:Apoptosis,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,	612132~Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency,		SM00248:ANK,	3D-structure,ANK repeat,Complete proteome,Cytoplasm,Disease mutation,Ectodermal dysplasia,Host-virus interaction,Hydroxylation,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:NF-kappa-B inhibitor alpha,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence variant,short sequence motif:Nuclear export signal,short sequence motif:Nuclear import signal,strand,turn,
214448_x_at, 214062_x_at	NFKB inhibitor beta(NFKBIB)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,		GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0071222~cellular response to lipopolysaccharide,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003713~transcription coactivator activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05131:Shigellosis,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,			SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NF-kappa-B inhibitor beta,compositionally biased region:Asp/Glu-rich (acidic),modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,splice variant,
203927_at	NFKB inhibitor epsilon(NFKBIE)	Homo sapiens				GO:0042942~D-serine transport,GO:0042994~cytoplasmic sequestering of transcription factor,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05169:Epstein-Barr virus infection,			SM00248:ANK,	ANK repeat,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NF-kappa-B inhibitor epsilon,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,
218240_at, 222105_s_at	NFKB inhibitor interacting Ras like 2(NKIRAS2)	Homo sapiens				GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:NF-kappa-B inhibitor-interacting Ras-like protein 2,nucleotide phosphate-binding region:GTP,region of interest:Small GTPase-like,short sequence motif:Effector region,splice variant,
209973_at	NFKB inhibitor like 1(NFKBIL1)	Homo sapiens				GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032720~negative regulation of tumor necrosis factor production,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0071222~cellular response to lipopolysaccharide,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,	GO:0005515~protein binding,	IPR020683:Ankyrin repeat-containing domain,		180300~Rheumatoid arthritis, susceptibility to,			Alternative splicing,ANK repeat,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NF-kappa-B inhibitor-like protein 1,modified residue,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,
205004_at	NFKB repressing factor(NKRF)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR001374:Single-stranded nucleic acid binding R3H,IPR014720:Double-stranded RNA-binding-like domain,				SM00358:DSRM,SM00393:R3H,SM00443:G_patch,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:NF-kappa-B-repressing factor,domain:G-patch,domain:R3H,region of interest:Active repression domain,sequence conflict,short sequence motif:Nuclear localization signal,
218455_at	NFS1, cysteine desulfurase(NFS1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0000096~sulfur amino acid metabolic process,GO:0006461~protein complex assembly,GO:0006777~Mo-molybdopterin cofactor biosynthetic process,GO:0018283~iron incorporation into metallo-sulfur cluster,GO:0032324~molybdopterin cofactor biosynthetic process,GO:0044281~small molecule metabolic process,GO:0044571~[2Fe-2S] cluster assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0030170~pyridoxal phosphate binding,GO:0031071~cysteine desulfurase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR010240:Cysteine desulfurase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR016454:Cysteine desulfurase, NifS,IPR020578:Aminotransferase class-V pyridoxal-phosphate binding site,	hsa00730:Thiamine metabolism,hsa01100:Metabolic pathways,hsa04122:Sulfur relay system,		PIRSF005572:cysteine desulfurase, NifS type,		3D-structure,Alternative initiation,Alternative splicing,Complete proteome,Cytoplasm,Iron,Iron-sulfur,Metal-binding,Mitochondrion,Molybdenum cofactor biosynthesis,Nucleus,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	chain:Cysteine desulfurase, mitochondrial,modified residue,sequence conflict,splice variant,transit peptide:Mitochondrion,
218946_at	NFU1 iron-sulfur cluster scaffold(NFU1)	Homo sapiens				GO:0016226~iron-sulfur cluster assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001075:NIF system FeS cluster assembly, NifU, C-terminal,IPR014824:NIF system FeS cluster assembly, NifU-like scaffold, N-terminal,IPR017065:HIRA-interacting protein 5,		605711~Multiple mitochondrial dysfunctions syndrome 1,		SM00932:SM00932,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:NFU1 iron-sulfur cluster scaffold homolog, mitochondrial,region of interest:NifU,sequence conflict,sequence variant,transit peptide:Mitochondrion,
209272_at, 208047_s_at, 211139_s_at	NGFI-A binding protein 1(NAB1)	Homo sapiens				GO:0001958~endochondral ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0014037~Schwann cell differentiation,GO:0042552~myelination,GO:0045682~regulation of epidermis development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000989~transcription factor activity, transcription factor binding,GO:0008134~transcription factor binding,	IPR006986:Nab1, C-terminal,IPR006988:Nab, N-terminal,IPR006989:NAB co-repressor, domain,					3D-structure,Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:NGFI-A-binding protein 1,helix,modified residue,region of interest:NCD1,region of interest:NCD2,region of interest:Necessary for nuclear localization,sequence conflict,splice variant,turn,
216017_s_at, 212803_at	NGFI-A binding protein 2(NAB2)	Homo sapiens				GO:0001958~endochondral ossification,GO:0006351~transcription, DNA-templated,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0014037~Schwann cell differentiation,GO:0016480~negative regulation of transcription from RNA polymerase III promoter,GO:0042552~myelination,GO:0045682~regulation of epidermis development,	GO:0005634~nucleus,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR006988:Nab, N-terminal,IPR006989:NAB co-repressor, domain,					Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:NGFI-A-binding protein 2,modified residue,region of interest:NCD1,region of interest:NCD2,region of interest:Necessary for nuclear localization,sequence conflict,splice variant,
218133_s_at	NGG1 interacting factor 3 like 1(NIF3L1)	Homo sapiens				GO:0030182~neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR002678:Ngg1p interacting factor 3, NIF3,IPR017222:Uncharacterised conserved protein UCP037490, NIF3, eukaryota,			PIRSF037490:uncharacterized protein with NIF3 domain, eukaryotic type,		Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:NIF3-like protein 1,modified residue,sequence conflict,sequence variant,splice variant,
219353_at	NHL repeat containing 2(NHLRC2)	Homo sapiens				GO:0045454~cell redox homeostasis,	GO:0005623~cell,	GO:0005515~protein binding,	IPR001258:NHL repeat,IPR011042:Six-bladed beta-propeller, TolB-like,IPR012336:Thioredoxin-like fold,IPR013017:NHL repeat, subgroup,IPR013766:Thioredoxin domain,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:NHL repeat-containing protein 2,domain:Thioredoxin,modified residue,repeat:NHL 1,repeat:NHL 2,repeat:NHL 3,repeat:NHL 4,repeat:NHL 5,repeat:NHL 6,sequence conflict,sequence variant,splice variant,
209104_s_at	NHP2 ribonucleoprotein(NHP2)	Homo sapiens				GO:0000469~cleavage involved in rRNA processing,GO:0000470~maturation of LSU-rRNA,GO:0006412~translation,GO:0007004~telomere maintenance via telomerase,GO:0031118~rRNA pseudouridine synthesis,GO:0031120~snRNA pseudouridine synthesis,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0022625~cytosolic large ribosomal subunit,GO:0031429~box H/ACA snoRNP complex,GO:0072589~box H/ACA scaRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR002415:H/ACA ribonucleoprotein complex, subunit Nhp2, eukaryote,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR018492:Ribosomal protein L7Ae/L8/Nhp2 family,	hsa03008:Ribosome biogenesis in eukaryotes,	613987~Dyskeratosis congenita, autosomal recessive 2,			Complete proteome,Disease mutation,Dyskeratosis congenita,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosome biogenesis,RNA-binding,rRNA processing,Ubl conjugation,	chain:H/ACA ribonucleoprotein complex subunit 2,
211086_x_at, 213328_at, 216213_at, 213331_s_at	NIMA related kinase 1(NEK1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007067~mitotic nuclear division,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0042384~cilium assembly,GO:0051301~cell division,GO:0060271~cilium morphogenesis,	GO:0000242~pericentriolar material,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,		263520~Short-rib thoracic dysplasia 6 with or without polydactyly,		SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Cell division,Ciliopathy,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Metal-binding,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek1,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
219542_at	NIMA related kinase 11(NEK11)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0016572~histone phosphorylation,GO:0031572~G2 DNA damage checkpoint,GO:0031573~intra-S DNA damage checkpoint,GO:0035556~intracellular signal transduction,GO:0044772~mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell cycle,Coiled coil,Complete proteome,Kinase,Magnesium,Manganese,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek11,domain:Protein kinase,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
211080_s_at, 204641_at	NIMA related kinase 2(NEK2)	Homo sapiens				GO:0000070~mitotic sister chromatid segregation,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001824~blastocyst development,GO:0006468~protein phosphorylation,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007088~regulation of mitotic nuclear division,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0043392~negative regulation of DNA binding,GO:0046602~regulation of mitotic centrosome separation,GO:0046777~protein autophosphorylation,GO:0051225~spindle assembly,GO:0051299~centrosome separation,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051973~positive regulation of telomerase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0090307~mitotic spindle assembly,GO:1903126~negative regulation of centriole-centriole cohesion,GO:1904355~positive regulation of telomere capping,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000794~condensed nuclear chromosome,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0030496~midbody,GO:0043234~protein complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,		615565~Retinitis pigmentosa 67,		SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Kinetochore,Magnesium,Meiosis,Metal-binding,Microtubule,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek2,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with MAD1L1,sequence conflict,sequence variant,splice variant,strand,turn,
211089_s_at, 213116_at	NIMA related kinase 3(NEK3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007017~microtubule-based process,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0030010~establishment of cell polarity,GO:0048812~neuron projection morphogenesis,GO:0051301~cell division,GO:0090043~regulation of tubulin deacetylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030424~axon,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Acetylation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Cell projection,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Mitosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek3,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
204634_at	NIMA related kinase 4(NEK4)	Homo sapiens				GO:0000278~mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007067~mitotic nuclear division,GO:0023014~signal transduction by protein phosphorylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:1900062~regulation of replicative cell aging,GO:2000772~regulation of cellular senescence,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005737~cytoplasm,GO:0005929~cilium,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0030145~manganese ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell cycle,Cell division,Cell projection,Complete proteome,Cytoplasm,Kinase,Magnesium,Metal-binding,Methylation,Mitosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek4,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
212530_at	NIMA related kinase 7(NEK7)	Homo sapiens				GO:0000910~cytokinesis,GO:0006468~protein phosphorylation,GO:0007346~regulation of mitotic cell cycle,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051225~spindle assembly,GO:0051973~positive regulation of telomerase activity,GO:1904355~positive regulation of telomere capping,	GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005874~microtubule,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Metal-binding,Microtubule,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek7,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
214738_s_at, 212299_at	NIMA related kinase 9(NEK9)	Homo sapiens			Cell division and chromosome partitioning / Cytoskeleton,	GO:0006468~protein phosphorylation,GO:0007017~microtubule-based process,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007077~mitotic nuclear envelope disassembly,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR011009:Protein kinase-like domain,				SM00220:S_TKc,	3D-structure,Acetylation,ATP-binding,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Kinase,Magnesium,Metal-binding,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Nek9,compositionally biased region:Poly-Gly,compositionally biased region:Pro/Ser/Thr-rich,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with NEK6,repeat:RCC1 1,repeat:RCC1 2,repeat:RCC1 3,repeat:RCC1 4,repeat:RCC1 5,repeat:RCC1 6,sequence conflict,sequence variant,
219031_s_at	NIP7, nucleolar pre-rRNA processing protein(NIP7)	Homo sapiens				GO:0042255~ribosome assembly,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030687~preribosome, large subunit precursor,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR005155:Ribosome biogenesis factor NIP7-like,IPR015947:PUA-like domain,IPR016686:Ribosome biogenesis factor, NIP7,			PIRSF017190:60S ribosome subunit biogenesis protein NIP7,	SM00359:PUA,	3D-structure,Alternative splicing,Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,	chain:60S ribosome subunit biogenesis protein NIP7 homolog,domain:PUA,helix,sequence variant,splice variant,strand,turn,
220128_s_at	NIPA like domain containing 2(NIPAL2)	Homo sapiens				GO:0015693~magnesium ion transport,GO:1903830~magnesium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0015095~magnesium ion transmembrane transporter activity,	IPR008521:Magnesium transporter NIPA,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:NIPA-like protein 2,glycosylation site:N-linked (GlcNAc...),transmembrane region,
210267_at, 214579_at	NIPA like domain containing 3(NIPAL3)	Homo sapiens				GO:0002377~immunoglobulin production,GO:0015693~magnesium ion transport,GO:1903830~magnesium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0015095~magnesium ion transmembrane transporter activity,	IPR008521:Magnesium transporter NIPA,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:NIPA-like protein 3,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,transmembrane region,
207108_s_at, 213918_s_at, 212483_at, 212469_at	NIPBL, cohesin loading factor(NIPBL)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0003007~heart morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0006974~cellular response to DNA damage stimulus,GO:0007064~mitotic sister chromatid cohesion,GO:0007420~brain development,GO:0007605~sensory perception of sound,GO:0010468~regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0031065~positive regulation of histone deacetylation,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034613~cellular protein localization,GO:0035115~embryonic forelimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035261~external genitalia morphogenesis,GO:0040018~positive regulation of multicellular organism growth,GO:0042471~ear morphogenesis,GO:0042634~regulation of hair cycle,GO:0045444~fat cell differentiation,GO:0045778~positive regulation of ossification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048638~regulation of developmental growth,GO:0048703~embryonic viscerocranium morphogenesis,GO:0050890~cognition,GO:0060325~face morphogenesis,GO:0061010~gall bladder development,GO:0061038~uterus morphogenesis,GO:0071481~cellular response to X-ray,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032116~SMC loading complex,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0036033~mediator complex binding,GO:0042826~histone deacetylase binding,GO:0047485~protein N-terminus binding,GO:0070087~chromo shadow domain binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024986:Sister chromatid cohesion C-terminal domain,IPR026003:HEAT repeat associated with sister chromatid cohesion protein,		122470~Cornelia de Lange syndrome 1,			Acetylation,Alternative splicing,Cell cycle,Complete proteome,Disease mutation,Mental retardation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Nipped-B-like protein,compositionally biased region:Gln-rich,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,sequence variant,short sequence motif:PxVxL motif,splice variant,
210673_x_at, 211024_s_at	NK2 homeobox 1(NKX2-1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001764~neuron migration,GO:0006351~transcription, DNA-templated,GO:0006644~phospholipid metabolic process,GO:0007411~axon guidance,GO:0007420~brain development,GO:0007492~endoderm development,GO:0007626~locomotory behavior,GO:0009725~response to hormone,GO:0010628~positive regulation of gene expression,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0021759~globus pallidus development,GO:0021766~hippocampus development,GO:0021795~cerebral cortex cell migration,GO:0021798~forebrain dorsal/ventral pattern formation,GO:0021877~forebrain neuron fate commitment,GO:0021892~cerebral cortex GABAergic interneuron differentiation,GO:0021983~pituitary gland development,GO:0030324~lung development,GO:0030336~negative regulation of cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030878~thyroid gland development,GO:0030900~forebrain development,GO:0031128~developmental induction,GO:0033327~Leydig cell differentiation,GO:0042753~positive regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048709~oligodendrocyte differentiation,GO:0060430~lung saccule development,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060486~Clara cell differentiation,GO:0060510~Type II pneumocyte differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001047~core promoter binding,GO:0001161~intronic transcription regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0044212~transcription regulatory region DNA binding,GO:0044213~intronic transcription regulatory region DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,		118700~Chorea, hereditary benign,188550~Thyroid cancer, monmedullary, 1,610978~Choreoathetosis, hypothyroidism, and neonatal respiratory distress,		SM00389:HOX,	Activator,Alternative splicing,Biological rhythms,Complete proteome,Congenital hypothyroidism,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeobox protein Nkx-2.1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,DNA-binding region:Homeobox,sequence conflict,sequence variant,splice variant,
206915_at	NK2 homeobox 2(NKX2-2)	Homo sapiens				GO:0003323~type B pancreatic cell development,GO:0003326~pancreatic A cell fate commitment,GO:0003327~type B pancreatic cell fate commitment,GO:0003329~pancreatic PP cell fate commitment,GO:0006351~transcription, DNA-templated,GO:0007224~smoothened signaling pathway,GO:0007420~brain development,GO:0009749~response to glucose,GO:0014003~oligodendrocyte development,GO:0021522~spinal cord motor neuron differentiation,GO:0021530~spinal cord oligodendrocyte cell fate specification,GO:0021554~optic nerve development,GO:0031018~endocrine pancreas development,GO:0032570~response to progesterone,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048665~neuron fate specification,GO:0048708~astrocyte differentiation,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060580~ventral spinal cord interneuron fate determination,	GO:0005654~nucleoplasm,	GO:0001159~core promoter proximal region DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,	hsa04950:Maturity onset diabetes of the young,			SM00389:HOX,	Activator,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Nkx-2.2,DNA-binding region:Homeobox,
206578_at	NK2 homeobox 5(NKX2-5)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_hopPathway:Hop Pathway in Cardiac Development,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001947~heart looping,GO:0003007~heart morphogenesis,GO:0003148~outflow tract septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003161~cardiac conduction system development,GO:0003166~bundle of His development,GO:0003168~Purkinje myocyte differentiation,GO:0003211~cardiac ventricle formation,GO:0003221~right ventricular cardiac muscle tissue mor